Neural Stem Cells by unknown
Neural Stem Cells 
New Perspectives
Edited by Luca Bonfanti
Edited by Luca Bonfanti
Twenty years after the discovery of neural stem cells, the question whether the central 
nervous system can be considered among regenerative tissues is still open. On one 
side, deep characterization of neural stem and progenitor cells, their niches, and their 
progeny in brain neurogenic sites overtly showed that new neurons can be generated 
in the brain of adult mammals, including humans. On the other side, many problems 
arise when stem cells encounter the mature brain parenchyma, still hampering the 
development of efficacious therapeutic approaches with endogenous or exogenously-
delivered neural stem cells. This book tries to make the point on these extremely 
promising, yet unresolved, issues.








NEURAL STEM CELLS -
NEW PERSPECTIVES
Edited by Luca Bonfanti
NEURAL STEM CELLS -
NEW PERSPECTIVES
Edited by Luca Bonfanti
Neural Stem Cells - New Perspectives
http://dx.doi.org/10.5772/56573
Edited by Luca Bonfanti 
Contributors
Kaneyasu Nishimura, Luca Colucci-D\’Amato, Maria Teresa Gentile, Luca Bonfanti, Emilia Madarász, Caetana Carvalho, 
Bruno P Carreira, Ines Araujo, Ana Isabel Santos, Angelique Bordey, Manavendra Pathania, Shan Bian, Emmanuel 
Moyse, Young Gyu Chai, Nando Dulal Das, Verdon Taylor, Stefano Pluchino, Matteo Donega, Elena Giusto, Chiara 
Cossetti, Teri Belecky-Adams, Luciano Conti, Simona Casarosa, Jacopo Zasso, Joshua Goldberg
© The Editor(s) and the Author(s) 2013
The moral rights of the and the author(s) have been asserted.
All rights to the book as a whole are reserved by INTECH. The book as a whole (compilation) cannot be reproduced, 
distributed or used for commercial or non-commercial purposes without INTECH’s written permission.  
Enquiries concerning the use of the book should be directed to INTECH rights and permissions department 
(permissions@intechopen.com).
Violations are liable to prosecution under the governing Copyright Law.
Individual chapters of this publication are distributed under the terms of the Creative Commons Attribution 3.0 
Unported License which permits commercial use, distribution and reproduction of the individual chapters, provided 
the original author(s) and source publication are appropriately acknowledged. If so indicated, certain images may not 
be included under the Creative Commons license. In such cases users will need to obtain permission from the license 
holder to reproduce the material. More details and guidelines concerning content reuse and adaptation can be 
foundat http://www.intechopen.com/copyright-policy.html.
Notice
Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those 
of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published 
chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the 
use of any materials, instructions, methods or ideas contained in the book.
First published in Croatia, 2013 by INTECH d.o.o.
eBook (PDF) Published by  IN TECH d.o.o.
Place and year of publication of eBook (PDF): Rijeka, 2019.
IntechOpen is the global imprint of IN TECH d.o.o.
Printed in Croatia
Legal deposit, Croatia: National and University Library in Zagreb
Additional hard and PDF copies can be obtained from orders@intechopen.com
Neural Stem Cells - New Perspectives
Edited by Luca Bonfanti 
p. cm.
ISBN 978-953-51-1069-9
eBook (PDF) ISBN 978-953-51-7133-1
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
4,200+ 




Contributors from top 500 universities








the world’s leading publisher of 
Open Access books




Luca Bonfanti, DVM, PhD, graduated (with honors) in 
1987 at the School of Veterinary Medicine of the Uni-
versity of Turin, Italy. After a PhD in Functional Neuro-
anatomy and a postdoc at the Bordeaux University, he 
was appointed Assistant Professor in 1994 and Associate 
Professor in 2000 at the Turin University. He is now 
Professor of Veterinary Anatomy at the Department 
of Veterinary Sciences, and group leader at the Neuroscience Institute 
Cavalieri-Ottolenghi (NICO), a research center on brain repair. Since 1992 
his research activity is devoted to study brain structural plasticity with 
particular reference to adult neurogenesis. In 2011 he was Visiting Profes-
sor at Northeastern University (Boston); he is receiving editor in the peer 
reviewed journal Frontiers in Neurogenesis. 
Contents
Preface VII
Section 1 Neural Stem Cells as Progenitor Cells    1
Chapter 1 Systems for ex-vivo Isolation and  Culturing of Neural
Stem Cells   3
Simona Casarosa, Jacopo Zasso and Luciano Conti
Chapter 2 Neural Stem Cell Heterogeneity   29
Verdon Taylor
Chapter 3 Diversity of Neural Stem/Progenitor Populations: Varieties by
Age, Regional Origin and Environment   45
Emília Madarász
Chapter 4 Reactive Muller Glia as Potential Retinal Progenitors   73
Teri L. Belecky-Adams, Ellen C. Chernoff, Jonathan M. Wilson and
Subramanian Dharmarajan
Chapter 5 Neural Stem Cell: Tools to Unravel Pathogenetic Mechanisms
and to Test Novel Drugs for CNS Diseases   119
Luca Colucci-D'Amato and MariaTeresa Gentile
Section 2 Neural Stem Cells and Neurogenesis    135
Chapter 6 Postnatal Neurogenesis in the Subventricular Zone:  A
Manipulable Source for CNS Plasticity and Repair   137
Manavendra Pathania and Angelique Bordey
Chapter 7 Modulation of Adult Neurogenesis by  the Nitric
Oxide System   163




Section 1 Neural Stem Cells as Progenitor Cells    1
Chapter 1 Systems for ex-vivo Isolation and  Culturing of Neural
Stem Cells   3
Simona Casarosa, Jacopo Zasso and Luciano Conti
Chapter 2 Neural Stem Cell Heterogeneity   29
Verdon Taylor
Chapter 3 Diversity of Neural Stem/Progenitor Populations: Varieties by
Age, Regional Origin and Environment   45
Emília Madarász
Chapter 4 Reactive Muller Glia as Potential Retinal Progenitors   73
Teri L. Belecky-Adams, Ellen C. Chernoff, Jonathan M. Wilson and
Subramanian Dharmarajan
Chapter 5 Neural Stem Cell: Tools to Unravel Pathogenetic Mechanisms
and to Test Novel Drugs for CNS Diseases   119
Luca Colucci-D'Amato and MariaTeresa Gentile
Section 2 Neural Stem Cells and Neurogenesis    135
Chapter 6 Postnatal Neurogenesis in the Subventricular Zone:  A
Manipulable Source for CNS Plasticity and Repair   137
Manavendra Pathania and Angelique Bordey
Chapter 7 Modulation of Adult Neurogenesis by  the Nitric
Oxide System   163
Bruno P. Carreira, Ana I. Santos, Caetana M. Carvalho and Inês M.
Araújo
Chapter 8 A Vascular Perspective on Neurogenesis   199
Joshua S. Goldberg and Karen K. Hirschi
Chapter 9 Parenchymal Neuro-Glio-Genesis Versus Germinal Layer-
Derived Neurogenesis: Two Faces of Central Nervous System
Structural Plasticity   241
Luca Bonfanti, Giovanna Ponti, Federico Luzzati, Paola Crociara,
Roberta Parolisi and Maria Armentano
Section 3 Neural Stem Cells and Regenerative Medicine    269
Chapter 10 A Survey of the Molecular Basis for the Generation of
Functional Dopaminergic Neurons from Pluripotent Stem Cells:
Insights from Regenerative Biology and Regenerative
Medicine   271
Kaneyasu Nishimura, Yoshihisa Kitamura, Kiyokazu Agata and Jun
Takahashi
Chapter 11 Systemic Neural Stem Cell-Based Therapeutic Interventions for
Inflammatory CNS Disorders   287
Matteo Donegà, Elena Giusto, Chiara Cossetti and Stefano Pluchino
Chapter 12 Cell Adhesion Molecules in Neural Stem Cell and Stem Cell-
Based Therapy for Neural Disorders   349
Shan Bian
Chapter 13 Neuroinflammation on the Epigenetics  of Neural
Stem Cells   381
Nando Dulal Das and Young Gyu Chai
Chapter 14 Primary Neural Stem Cell Cultures from  Adult Pig Brain and
Their Nerve-Regenerating Properties: Novel Strategies for
Cell Therapy   397
Olivier Liard and Emmanuel Moyse
X Contents
Preface
During the last two decades stem cell biology has changed the field of basic research in life
science as well as our perspective of its possible outcomes in medicine. At the beginning of the
nineties, the discovery of neural stem cells in the mammalian central nervous system (CNS)
made the generation of new neurons a real biological process occurring in the adult brain. Since
then, a vast community of neuroscientists started to think in terms of regenerative medicine as
a possible solution for incurable CNS diseases, such as traumatic injuries, stroke and neurode‐
generative disorders. Nevertheless, in spite of the remarkable expansion of the field, the devel‐
opment of techniques to image neurogenesis in vivo, sophisticated in vitro stem cell cultures,
and experimental transplantation techniques, no efficacious therapies capable of restoring CNS
structure and functions through cell replacement have been convincingly developed so far.
Deep anatomical, developmental, molecular and functional investigations have shown that
new neurons can be generated only within restricted brain regions under the control of specific
environmental signals. In the rest of the CNS, many problems arise when stem cells encounter
the mature parenchyma, which still behaves as 'dogmatically' static tissue. More recent studies
have added an additional level of complexity, specifically in the context of CNS structural plas‐
ticity, where stem cells lie within germinal layer-derived neurogenic sites whereas progenitor
cells are widespread through the CNS.
Hence, two decades after the seminal discovery of neural stem cells, the real astonishing fact is
the occurrence of such cells in a largely nonrenewable tissue. Still, the most intriguing question
is which possible functional or evolutionary reasons might justify such oddity.
In other self-renewing tissues, such as skin, cornea, and blood, the role of stem cells in the tis‐
sue homeostasis is largely known and efficacious stem cell therapies are already available. The
most urgent question is whether and how the potential of neural stem cells could be exploited
within the harsh territory of the mammalian CNS. In this case, unlike other tissues, more in‐
tense and time-consuming basic research is required before achieving a regenerative outcome.
The road of such research should travel through a better knowledge of several aspects which
are still poorly understood, including the developmental programs leading to postnatal brain
maturation, the heterogeneity of progenitor cells involved, the bystander effect that stem cell
grafts exert even in the absence of cell replacement, and the cohort of stem cell-to-tissue interac‐
tions occurring both in homeostatic and pathological conditions.
In this book, the experience and expertise of many leaders in neural stem cell research are gathered
with the aim of making the point on a number of extremely promising, yet unresolved, issues.
Luca Bonfanti DVM, PhD
Dept. of Veterinary Sciences, University of Turin
Neuroscience Institute Cavalieri-Ottolenghi (NICO)
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1. Introduction
During neural development, a relatively small and formerly considered homogeneous
population of Neural Stem cells (NSCs) gives rise to the extraordinary complexity proper of
the Central Nervous System (CNS). These represent populations of self-renewing multipotent
cells able to differentiate into a variety of neuronal and glial cell types in a time- and region-
specific manner throughout developmental stages and that account for a weak regenerative
potential in the adult brain [1].
In the adult mammalian CNS, the presence of NSCs has been extensively investigated in two
regions, the SVZ and the SGZ of the hippocampus, two specialized niches that control NSCs
divisions in order to physiologically regulate their proliferative (symmetrical divisions) vs
differentiative fate (asymmetrical divisions) [2].
In the early ‘90s it was shown that NSCs could be extracted from the developing and adult
mammalian brain and expanded/manipulated/differentiated in vitro (Fig. 1).
This  has  represented a  key  step  in  the  field,  since  the  obtainment  of  in  vitro  NSC sys‐
tems has been very useful in the last years in order to progress toward disclosure of the
complex  interplay  of  different  extrinsic  (signaling  pathways)  and intrinsic  (transcription
factors  and  epigenetics)  signals  that  govern  identity  and  functional  properties  of  brain
tissue-specific stem/progenitors [3].  Furthermore, it  will  also be a key step towards their
exploitation for a better dissection of the molecular processes occurring in neurodegenera‐
tion [4]. Finally, NSC systems might represent major tools for the potential development
of new cell-based and pharmacological treatments of neurodegenerative disorders and for
assaying their toxicological effects [5].
© 2013 Casarosa et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
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Here we will review the functional properties of different in vitro NSC systems, providing also
a direct comparison with NSCs present in vivo. Furthermore, we will discuss some of recent
advancements in the development of in vitro systems that try to re-create in vitro some of the
aspects of the physiological NSCs niches.
2. In vivo and in vitro developmental heterogeneity of NSCs populations
Vertebrate neural development starts with the process of neural induction, during and after
gastrulation, which allows the formation of NEUROECTODERM from the dorsal-most part of
the ectoderm. The molecular nature of the inductive signals that drive this process has been
unveiled by studies in Xenopus laevis. These have shown that neural differentiation is promot‐
Figure 1. Process of NSC self-renewal and differentiation. NSCs are tri-potent cells. These cells during the differen‐
tiation process give rise to transiently dividing progenitors (transit amplifying progenitors) that subsequently undergo
lineage restrictions toward neuronal, astrocytic and oligodendroglial mature cells.
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ed by secretion of an array of BMP inhibitors, chordin, noggin and follistatin produced by an
embryonic structure called “organizer” [6, 7]. The organizer also produces inhibitors of the Wnt
signaling pathway, such as Dickkopf, frzb and cerberus [8]. Neural induction has shown a
remarkable evolutionary conservation and a "default" model has been proposed, which states
that ectodermal cells have an intrinsic predisposition to differentiate into neuroectoderm, unless
inhibited by BMP signaling [9]. While in certain conditions this seems to be the case, in other
assays positive inducers are needed, such as FGFs [10]. Finally, more recent studies show that
inhibition of Activin/Nodal pathways also seems to be important for neural induction [8].
Progresses in cell culture technologies combined with a better understanding of these devel‐
opmental progressions have allowed now to recapitulate these processes in vitro through
neuralization of mouse and human pluripotent cells, i.e. Embryonic Stem cells derived from
blastocyst stage (ESC; [11]) and reprogrammed cells (iPSC; [12, 13]), leading to the generation
of populations of EARLY NEUROEPITHELIAL CELLS (Fig. 2). These cells give rise to all of
the neural cells in the mature CNS thus denoting their extensive multipotential aptitude in
terms of different cellular subtypes they can produce. Sox1 is the earliest identified marker of
neural precursors in the mouse embryo and is present in dividing neural precursors from the
NEURAL PLATE and NEURAL TUBE stages [3]. Studies on pluripotent cells support the
"default" model for mammalian neural induction. In vitro studies have in fact shown that
during neuronal differentiation, ESCs and iPSCs undertake gradual lineage restrictions
analogous to those observed through in vivo fetal development, and a variety of distinctive
progenitors can be generated. Accordingly, mouse and human pluripotent cells differentiate
into sox 1 positive neuroepithelial cells (note that in human the earliest neuroepithelial marker
is represented by pax6 that precedes sox1 expression) when grown in serum-free conditions
in the absence of patterning signals [14-16]. ESCs and iPSCs neural induction can be enhanced
by the addition of BMP-, Nodal- and Wnt-inhibitors, to minimize endogenous signals pro‐
duced by ESCs/iPSCs themselves and recent studies have shown that paracrine signals (i.e.
FGF4) are also needed for neurulation [17, 18].
Figure 2. The different NSC populations that can be obtained in vitro correspond to stage-specific neural progenitors
present at defined in vivo developmental stages.
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Soon after neural induction process, pluripotent cell-derived neuroepithelial cells give rise to
NEURAL ROSETTE structures, in which cells elongate and align radially, in a manner that
mimics neural tube formation [19]. In vivo, the neural tube is formed after neurulation from
the newly-induced neural plate and, as it closes, it is regionalized along the antero-posterior
(A/P) axis (Fig. 3A), giving rise to four main areas: forebrain, midbrain, hindbrain and spinal
cord. In amniotes, dorso-ventral (D/V) patterning takes place only after A/P patterning has
occurred, after neural tube closure. The variety of neuronal cells that will be generated will
have specific functions according to their position along these two axes.
Several evidences suggest that primary neural induction obtained by BMP inhibition generates
anterior neural tissue, while to obtain tissue with posterior characteristics other molecules,
known as "transformers", are needed. Three molecules with posteriorizing activities are
known: retinoic acid (RA), Fgfs and Wnts [20, 21]. These signals are produced by the sur‐
rounding axial and paraxial mesoderm and endoderm, in addition two secondary signaling
centers exist within the neural tube [22]. These are the Anterior Neural Ridge (ANR), located
at the border between the forebrain and the non-neural ectoderm, and the isthmic organizer,
located at the mid-hindbrain boundary. The ANR secretes the organizer molecules noggin and
chordin, the resulting BMP signaling inhibition activates Fgf8, which in turn induces the
expression of the transcription factor FoxG1 (Bf1), necessary for forebrain development [23].
The isthmic organizer is located at the boundary between the expression domains of the
transcription factors Otx2 and Gbx2, and it is formed and maintained by an intricate regulatory
network among these and other (En1/2, Pax2/5/8) transcription factors. The isthmic organizer
secretes Fgf8, and the feedback loop that is set up assures the maintenance of the tissue identity
[22]. RA and Wnts are produced by paraxial mesoderm with a high-posterior/low-anterior
gradient and they are responsible for the patterning of midbrain, hindbrain and anterior spinal
cord. Among the genes differentially regulated by varying concentrations of RA are the Hox
genes, necessary for hindbrain and spinal cord A/P patterning [24, 25]. D/V patterning is
mediated by signaling molecules secreted by the surrounding tissues (Fig. 3B). The overlying
ectoderm produces TGFβ-family molecules that promote the formation of the roof plate in the
dorsal neural tube, while the underlying notochord secretes SHH, that induces the ventral
neural tube to become the floor plate. The roof plate and the floor plate in turn become a source
of TGFβ and SHH, respectively. This creates two opposing gradients that provide positional
information along the D/V axis, regulating the expression of key transcription factors. These
will then act in a combinatorial manner to regulate the differentiation of specific neuronal and
glial cell types in the correct position [26].
These in vivo studies have ultimately revealed that different neural progenitor populations can
exist in a time and space-dependent manner and that their fate is greatly influenced by the
interplay between specific extrinsic and intrinsic signaling molecules. ESCs- and iPSCs-
derived neuroepithelial cells are able to perceive the positional information of patterning
signals. These progenitors, when obtained in conditions that minimize endogenous signals,
intrinsically acquire anterior identity, while they can be caudalized by the addition of FGFs,
Wnts, RA [1, 19, 27, 28].
Neural Stem Cells - New Perspectives6
Some studies have shown that NEUROEPITHELIAL CELLS cannot be maintained in vitro by
the exposure to commonly used mitogens, i.e. basic fibroblast growth factor (FGF-2) and
epidermal growth factor (EGF). These indeed convert these cells into radial glia populations
characterized by a limited potentiality in neuronal sub-types they can give rise to. Nonetheless,
it has been shown that a neuroepithelial population that grows in rosette-like structures
(termed “R-NSCs”) can be generated in vitro from human and mouse pluripotent cells when
exposed to SHH/FGF8 signalling coupled to a N-Cadherin/Forse-1 cell sorting-based protocols
[19]. These cells can be maintained in vitro for some passages by exposure to SHH and Notch
(a) 
(b) 
Figure 3. Regional patterning of the neural tube. Schematic diagrams showing antero-posterior (A) and dorso-ventral
(B) patterning of the neural tube. The patterning process is driven by opposing gradients of signaling molecules that
induce the expression of region-specific transcription factors in discrete areas. ANR: anterior neural ridge. IsO: Isthmic
organizer. RP: roof plate. FP: floor plate.
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occurred, after neural tube closure. The variety of neuronal cells that will be generated will
have specific functions according to their position along these two axes.
Several evidences suggest that primary neural induction obtained by BMP inhibition generates
anterior neural tissue, while to obtain tissue with posterior characteristics other molecules,
known as "transformers", are needed. Three molecules with posteriorizing activities are
known: retinoic acid (RA), Fgfs and Wnts [20, 21]. These signals are produced by the sur‐
rounding axial and paraxial mesoderm and endoderm, in addition two secondary signaling
centers exist within the neural tube [22]. These are the Anterior Neural Ridge (ANR), located
at the border between the forebrain and the non-neural ectoderm, and the isthmic organizer,
located at the mid-hindbrain boundary. The ANR secretes the organizer molecules noggin and
chordin, the resulting BMP signaling inhibition activates Fgf8, which in turn induces the
expression of the transcription factor FoxG1 (Bf1), necessary for forebrain development [23].
The isthmic organizer is located at the boundary between the expression domains of the
transcription factors Otx2 and Gbx2, and it is formed and maintained by an intricate regulatory
network among these and other (En1/2, Pax2/5/8) transcription factors. The isthmic organizer
secretes Fgf8, and the feedback loop that is set up assures the maintenance of the tissue identity
[22]. RA and Wnts are produced by paraxial mesoderm with a high-posterior/low-anterior
gradient and they are responsible for the patterning of midbrain, hindbrain and anterior spinal
cord. Among the genes differentially regulated by varying concentrations of RA are the Hox
genes, necessary for hindbrain and spinal cord A/P patterning [24, 25]. D/V patterning is
mediated by signaling molecules secreted by the surrounding tissues (Fig. 3B). The overlying
ectoderm produces TGFβ-family molecules that promote the formation of the roof plate in the
dorsal neural tube, while the underlying notochord secretes SHH, that induces the ventral
neural tube to become the floor plate. The roof plate and the floor plate in turn become a source
of TGFβ and SHH, respectively. This creates two opposing gradients that provide positional
information along the D/V axis, regulating the expression of key transcription factors. These
will then act in a combinatorial manner to regulate the differentiation of specific neuronal and
glial cell types in the correct position [26].
These in vivo studies have ultimately revealed that different neural progenitor populations can
exist in a time and space-dependent manner and that their fate is greatly influenced by the
interplay between specific extrinsic and intrinsic signaling molecules. ESCs- and iPSCs-
derived neuroepithelial cells are able to perceive the positional information of patterning
signals. These progenitors, when obtained in conditions that minimize endogenous signals,
intrinsically acquire anterior identity, while they can be caudalized by the addition of FGFs,
Wnts, RA [1, 19, 27, 28].
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Some studies have shown that NEUROEPITHELIAL CELLS cannot be maintained in vitro by
the exposure to commonly used mitogens, i.e. basic fibroblast growth factor (FGF-2) and
epidermal growth factor (EGF). These indeed convert these cells into radial glia populations
characterized by a limited potentiality in neuronal sub-types they can give rise to. Nonetheless,
it has been shown that a neuroepithelial population that grows in rosette-like structures
(termed “R-NSCs”) can be generated in vitro from human and mouse pluripotent cells when
exposed to SHH/FGF8 signalling coupled to a N-Cadherin/Forse-1 cell sorting-based protocols
[19]. These cells can be maintained in vitro for some passages by exposure to SHH and Notch
(a) 
(b) 
Figure 3. Regional patterning of the neural tube. Schematic diagrams showing antero-posterior (A) and dorso-ventral
(B) patterning of the neural tube. The patterning process is driven by opposing gradients of signaling molecules that
induce the expression of region-specific transcription factors in discrete areas. ANR: anterior neural ridge. IsO: Isthmic
organizer. RP: roof plate. FP: floor plate.
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agonists while showing a rostral BF1+ neuroepithelial identity evocative of the signalling that
in vivo are required for the induction of the anterior neuroepithelium. R-NSCs are characterized
by a comprehensive differentiation potential toward CNS and PNS fates, supporting the idea
that the R-NSCs represent neural precursors of the neural plate stage.
Another population of hESC-derived Sox1 positive self-renewing neuroepithelial cells named
“lt-hESNSCs”, has been described [29]. These cells can be grown as a nearly homogeneous
population exhibiting clonogenicity and stable neurogenic potential. Remarkably, they can be
maintained for many in vitro passages in the presence of FGF-2 and EGF and they preserve
some properties of the R-NSCs, such as rosette-like growth, the expression of Bf1 and sensi‐
tivity to instructive signals that stimulate their conversion into distinct neuronal subpopula‐
tions. Molecular analyses have shown that lt-hESNSCs partly maintain rosette properties,
possibly embodying an intermediate developmental stage between rosette-organized neuro‐
epithelial cells and radial glia (see below).
As development proceeds, neuroepithelial cells lose sox1 expression and convert themselves
into another transitory stem cell type, the so-called “RADIAL GLIA” (RG). This rapidly
constitutes the main progenitor cell population in late development and early postnatal life
while disappearing at later postnatal and adult stages [30, 31]. Large numbers of RG cells are
found in primary cell cultures from dissociated E10.5-18.5 CNS tissue. Different populations
of RG, characterized by lineage heterogeneity, with both regional and temporal varieties, give
rise to sequential waves of neurogenesis, gliogenesis and oligodendrogenesis that build up the
CNS. The in vivo developmental heterogeneity of RG has been also revealed by in vitro primary
cultures studies that have shown a temporal constraint from neurogenesis to gliogenesis from
RG isolated at initial or later developmental periods, respectively [32, 33].
The transition of neuroepithelial cells to RG cells is well recapitulated in vitro during neural
differentiation of pluripotent cells. RG populations can be efficiently generated from ESCs/
iPSCs using differentiation protocols that differ in major aspects between them. Bibel and
collaborators generated transient (not expandable) populations of homogeneous RG cells that
mature into glutamatergic neurons, as occurring during cortical development [34]. A different
population of ESCs/iPSCs-derived RG cells can be obtained by exposing neuroepithelial cells
to EGF and FGF-2. These rapidly lose Sox1 expression and acquire RG markers as BLBP and
RC2 giving rise to RG-like cells which can be long term expanded in monolayer and at
homogeneousness [35]. This conversion is dependent on Notch activity and on the exposure
to EGF and FGF-2 [19, 35]. These self-renewing RG cells (called “NS cells”) retain the marker
signature of RG and the full capacity for tri-lineage neural differentiation, although their
neuronal differentiation is limited to the GABAergic lineage [36-38]. These results indicate that
pluripotent cells can be differentiated into distinct subtypes of RG – a non self-renewing type
with aptitude to generate glutamatergic neurons, and a subtype that self-renews and exhibits
a GABAergic differentiation. Such radial glial subtypes can also be found in the developing
CNS in vivo although RG expansion in vivo is restricted to a defined time window.
Along with RG, a further immature population of cells with neuronal-restricted potential is
represented by the BASAL PROGENITORs (BPs) that are located in the subventricular zone
(SVZ) and can be generated both by neuroepithelial cells and RG [39, 40]. In vitro studies on
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BPs are less comprehensive. Transitory induction of neurogenic Tbr2-positive BPs has been
reported during the differentiation of ESCs to glutamatergic cortical neurons [27]. It has also
been shown that BPs can be isolated from a subgroup of RG populations characterized by a
high immunoreactivity for prominin that can make neurons only indirectly through the
generation of BPs [41].
At the end of neurogenesis (in mice approximately at birth), neurogenic RG cells are exhausted
and the remaining RG convert into astrocytes. The presence of stem cells has been reported in
two regions of the adult mammalian brain, the SVZ and the SGZ of the hippocampus. Fate-
mapping studies have shown that these adult NSC populations are represented by the type B
astrocytes that directly derive from subpopulations of fetal RG cells. Therefore, RG and type
B astrocytes appear to form a continuous lineage with stem cell potential [2]. These in vivo
studies find a parallel indirect proof from the fact that in vitro adult-derived NSCs reacquire
fetal characteristics, such as radial glia markers.
3. In vitro systems for NSCs isolation and expansion
The study of different types of stem cells has greatly beneficed from in vitro  approaches
that  allow  the  reduction  the  intrinsic  complexity  of  tissues.  In  order  to  allow  stable
maintenance in vitro,  cells have to be immortalized, a procedure that blocks the progres‐
sion of developmental programmes by pushing the cells to remain in enduring prolifera‐
tion. Immortalization can be achieved by means of various methods, most usually by viral
transduction of immortalizing oncogenes such as c-myc or SV40 Large T Antigen. Several
immortalized murine and human NSC lines have been reported and, interestingly, it has
been shown that they maintain many equivalences to non-immortalized lines,  exhibiting
neglectable  signs  of  transformation  both  in  vivo  or  in  vitro  [42-45].  Nevertheless,  the
physiological relevance of these lines might be weakened by the expression of potential‐
ly transforming oncogenes.
In  the  developing  CNS,  exponential  cell  division  occurs  only  for  brief  developmental
windows and NSCs represent transient populations. In the brain, NSC division is rigorous‐
ly regulated by many factors of the “NICHE”. The niche represents the particular cellu‐
lar microenvironment that provides the appropriate milieu to support self-renewal and that
controls  the  balance  between  symmetrical  proliferative  (producing  two  stem  cells)  and
asymmetric  cell  divisions  (generating  one  stem  cell  and  one  committed  progenitor).
Accordingly, for a stem cell to give rise to a clonal cell line, the physiological hindrances
to continuous cell division have to be bypassed. However, until few years ago, it has been
extremely difficult to stably propagate homogenous cultures of NSCs without oncogene-
mediated immortalization procedures.
In the last two decades, oncogene-free procedures based on the use of soluble factors for
selection  and  expansion  of  NSCs  have  been  developed,  permitting  long-term  mainte‐
nance of NSCs. The first report was from Reynolds and Weiss that in 1992 showed that
the fetal and adult rodent brains contain cells competent for continuing ex vivo prolifera‐
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agonists while showing a rostral BF1+ neuroepithelial identity evocative of the signalling that
in vivo are required for the induction of the anterior neuroepithelium. R-NSCs are characterized
by a comprehensive differentiation potential toward CNS and PNS fates, supporting the idea
that the R-NSCs represent neural precursors of the neural plate stage.
Another population of hESC-derived Sox1 positive self-renewing neuroepithelial cells named
“lt-hESNSCs”, has been described [29]. These cells can be grown as a nearly homogeneous
population exhibiting clonogenicity and stable neurogenic potential. Remarkably, they can be
maintained for many in vitro passages in the presence of FGF-2 and EGF and they preserve
some properties of the R-NSCs, such as rosette-like growth, the expression of Bf1 and sensi‐
tivity to instructive signals that stimulate their conversion into distinct neuronal subpopula‐
tions. Molecular analyses have shown that lt-hESNSCs partly maintain rosette properties,
possibly embodying an intermediate developmental stage between rosette-organized neuro‐
epithelial cells and radial glia (see below).
As development proceeds, neuroepithelial cells lose sox1 expression and convert themselves
into another transitory stem cell type, the so-called “RADIAL GLIA” (RG). This rapidly
constitutes the main progenitor cell population in late development and early postnatal life
while disappearing at later postnatal and adult stages [30, 31]. Large numbers of RG cells are
found in primary cell cultures from dissociated E10.5-18.5 CNS tissue. Different populations
of RG, characterized by lineage heterogeneity, with both regional and temporal varieties, give
rise to sequential waves of neurogenesis, gliogenesis and oligodendrogenesis that build up the
CNS. The in vivo developmental heterogeneity of RG has been also revealed by in vitro primary
cultures studies that have shown a temporal constraint from neurogenesis to gliogenesis from
RG isolated at initial or later developmental periods, respectively [32, 33].
The transition of neuroepithelial cells to RG cells is well recapitulated in vitro during neural
differentiation of pluripotent cells. RG populations can be efficiently generated from ESCs/
iPSCs using differentiation protocols that differ in major aspects between them. Bibel and
collaborators generated transient (not expandable) populations of homogeneous RG cells that
mature into glutamatergic neurons, as occurring during cortical development [34]. A different
population of ESCs/iPSCs-derived RG cells can be obtained by exposing neuroepithelial cells
to EGF and FGF-2. These rapidly lose Sox1 expression and acquire RG markers as BLBP and
RC2 giving rise to RG-like cells which can be long term expanded in monolayer and at
homogeneousness [35]. This conversion is dependent on Notch activity and on the exposure
to EGF and FGF-2 [19, 35]. These self-renewing RG cells (called “NS cells”) retain the marker
signature of RG and the full capacity for tri-lineage neural differentiation, although their
neuronal differentiation is limited to the GABAergic lineage [36-38]. These results indicate that
pluripotent cells can be differentiated into distinct subtypes of RG – a non self-renewing type
with aptitude to generate glutamatergic neurons, and a subtype that self-renews and exhibits
a GABAergic differentiation. Such radial glial subtypes can also be found in the developing
CNS in vivo although RG expansion in vivo is restricted to a defined time window.
Along with RG, a further immature population of cells with neuronal-restricted potential is
represented by the BASAL PROGENITORs (BPs) that are located in the subventricular zone
(SVZ) and can be generated both by neuroepithelial cells and RG [39, 40]. In vitro studies on
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BPs are less comprehensive. Transitory induction of neurogenic Tbr2-positive BPs has been
reported during the differentiation of ESCs to glutamatergic cortical neurons [27]. It has also
been shown that BPs can be isolated from a subgroup of RG populations characterized by a
high immunoreactivity for prominin that can make neurons only indirectly through the
generation of BPs [41].
At the end of neurogenesis (in mice approximately at birth), neurogenic RG cells are exhausted
and the remaining RG convert into astrocytes. The presence of stem cells has been reported in
two regions of the adult mammalian brain, the SVZ and the SGZ of the hippocampus. Fate-
mapping studies have shown that these adult NSC populations are represented by the type B
astrocytes that directly derive from subpopulations of fetal RG cells. Therefore, RG and type
B astrocytes appear to form a continuous lineage with stem cell potential [2]. These in vivo
studies find a parallel indirect proof from the fact that in vitro adult-derived NSCs reacquire
fetal characteristics, such as radial glia markers.
3. In vitro systems for NSCs isolation and expansion
The study of different types of stem cells has greatly beneficed from in vitro  approaches
that  allow  the  reduction  the  intrinsic  complexity  of  tissues.  In  order  to  allow  stable
maintenance in vitro,  cells have to be immortalized, a procedure that blocks the progres‐
sion of developmental programmes by pushing the cells to remain in enduring prolifera‐
tion. Immortalization can be achieved by means of various methods, most usually by viral
transduction of immortalizing oncogenes such as c-myc or SV40 Large T Antigen. Several
immortalized murine and human NSC lines have been reported and, interestingly, it has
been shown that they maintain many equivalences to non-immortalized lines,  exhibiting
neglectable  signs  of  transformation  both  in  vivo  or  in  vitro  [42-45].  Nevertheless,  the
physiological relevance of these lines might be weakened by the expression of potential‐
ly transforming oncogenes.
In  the  developing  CNS,  exponential  cell  division  occurs  only  for  brief  developmental
windows and NSCs represent transient populations. In the brain, NSC division is rigorous‐
ly regulated by many factors of the “NICHE”. The niche represents the particular cellu‐
lar microenvironment that provides the appropriate milieu to support self-renewal and that
controls  the  balance  between  symmetrical  proliferative  (producing  two  stem  cells)  and
asymmetric  cell  divisions  (generating  one  stem  cell  and  one  committed  progenitor).
Accordingly, for a stem cell to give rise to a clonal cell line, the physiological hindrances
to continuous cell division have to be bypassed. However, until few years ago, it has been
extremely difficult to stably propagate homogenous cultures of NSCs without oncogene-
mediated immortalization procedures.
In the last two decades, oncogene-free procedures based on the use of soluble factors for
selection  and  expansion  of  NSCs  have  been  developed,  permitting  long-term  mainte‐
nance of NSCs. The first report was from Reynolds and Weiss that in 1992 showed that
the fetal and adult rodent brains contain cells competent for continuing ex vivo prolifera‐
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tion  upon  exposure  to  EGF  and  FGF-2  and  that  upon  mitogen  withdrawal  exhibit  tri-
neural lineage differentiation [46, 47]. According to this procedure, freshly dissociated SVZ
cells  plated  at  low  density  (roughly  103-104  cells/cm2)  in  the  absence  of  cell  adhesion
substrates and in presence of EGF and/or FGF-2 have the tendency to loosely adhere to
the plastic plate. Within few days, most of the cells die except a minor fraction of them
that  become smooth-edged and begin to  proliferate  while  staying attached to  the  plate.
Later,  the progeny of these proliferating cells  stick to each other forming sphere-shaped
clones that detach from the plate thus floating in suspension giving rise to the so-called
NEUROSPHERES. This assay, named “Neurosphere Assay” has thus been widely consid‐
ered as a valuable method for isolating, enriching and maintaining embryonic and adult
NSC populations in vitro  [48].  Indeed, whereas NSCs in culture are characterized by the
ability to considerably divide and self-renew thus giving rise to long-term expanding NSC
lines, transit amplifying progenitors exhibit partial proliferative competence without self-
renewal  potential,  and  are  eliminated  during  extensive  sub-culturing.  Notably,  only  a
fraction  of  cells  composing  the  neurosphere  (commonly  1-10%  for  optimal  cultures,
although this  value greatly  differs  depending on the age and on the brain area consid‐
ered) are true stem cells, the remainder being differentiating progenitors at different stages,
and  even  terminally  differentiated  neurons  and  glia  [49].  Neurospheres  can  be  sub-
cultured by mechanical or enzymatic dissociation and by re-plating under the identical in
vitro  settings.  As  for  the  primary  neurosphere  culture,  at  every  sub-culturing  passage,
differentiating/differentiated cells are supposed to die while the NSCs divide, generating
secondary spheres that can then be further sub-cultured [50]. This procedure can be serially
reiterated  and,  since  each  NSC gives  rise  to  many  NSCs  by  the  time  a  neurosphere  is
generated, it ends in the expansion of the NSC population in culture.
Once established, neurosphere cultures can be expanded to obtain large amounts of cells that
can then be cryopreserved. This permits the creation a pool of cells that can be later thawed
and expanded for future experimentations. Nonetheless, several studies have shown that after
few passages, the neurospheres greatly decrease their efficiency in neurogenic differentiation
[51] and in the neuronal subtypes they can give rise to, mostly restricting their potential to the
GABAergic lineage [52] (Fig. 4).
The accurate identification of the identity of the sphere-forming cell represents a key question.
As committed progenitors are capable of only restricted proliferative capability and can
generate only up to tertiary neurospheres, actually the designation of a cell as bona fide NSC
should be retrospectively refereed only to a founder cell that self-renews extensively and can
be propagated in long-term cultures. To this regard, it has been suggested that at least five
sub-culturing passages are required to exclude the contribution of committed progenitors to
the maintenance of the cell population. More rigorously, the assay should be performed with
single dissociated cells (i.e. to plate a single cell per well) in order to avoid cell clustering and
also fusion between neurospheres [53, 54].
Some researchers consider that three-dimensional organisation and the cellular milieu of the
neurosphere as the in vitro equivalent of the in vivo neurogenic compartment [55, 56]. Although
this view is a pure speculation, it is broadly accepted that the issue of the complexity of the
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neurosphere system represents a barrier for fine biochemical and molecular studies. The
prospect of refining the neurosphere culture and of developing alternative in vitro systems,
not only to enrich but also to select and clonally expand the bona fide stem cell population
Figure 4. Neurospheres and monolayer NSCs can be obtained by different sources and have different neuronal
differentiation efficiency. NSCs grown in monolayer and neurospheres can be derived from ESCs or iPS cells and
from the germinative areas of the fetal and adult brain. The homogenous cellular composition of the NSCs grown in
monolayer results in a higher neurogenic potential than neurospheres
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substrates and in presence of EGF and/or FGF-2 have the tendency to loosely adhere to
the plastic plate. Within few days, most of the cells die except a minor fraction of them
that  become smooth-edged and begin to  proliferate  while  staying attached to  the  plate.
Later,  the progeny of these proliferating cells  stick to each other forming sphere-shaped
clones that detach from the plate thus floating in suspension giving rise to the so-called
NEUROSPHERES. This assay, named “Neurosphere Assay” has thus been widely consid‐
ered as a valuable method for isolating, enriching and maintaining embryonic and adult
NSC populations in vitro  [48].  Indeed, whereas NSCs in culture are characterized by the
ability to considerably divide and self-renew thus giving rise to long-term expanding NSC
lines, transit amplifying progenitors exhibit partial proliferative competence without self-
renewal  potential,  and  are  eliminated  during  extensive  sub-culturing.  Notably,  only  a
fraction  of  cells  composing  the  neurosphere  (commonly  1-10%  for  optimal  cultures,
although this  value greatly  differs  depending on the age and on the brain area consid‐
ered) are true stem cells, the remainder being differentiating progenitors at different stages,
and  even  terminally  differentiated  neurons  and  glia  [49].  Neurospheres  can  be  sub-
cultured by mechanical or enzymatic dissociation and by re-plating under the identical in
vitro  settings.  As  for  the  primary  neurosphere  culture,  at  every  sub-culturing  passage,
differentiating/differentiated cells are supposed to die while the NSCs divide, generating
secondary spheres that can then be further sub-cultured [50]. This procedure can be serially
reiterated  and,  since  each  NSC gives  rise  to  many  NSCs  by  the  time  a  neurosphere  is
generated, it ends in the expansion of the NSC population in culture.
Once established, neurosphere cultures can be expanded to obtain large amounts of cells that
can then be cryopreserved. This permits the creation a pool of cells that can be later thawed
and expanded for future experimentations. Nonetheless, several studies have shown that after
few passages, the neurospheres greatly decrease their efficiency in neurogenic differentiation
[51] and in the neuronal subtypes they can give rise to, mostly restricting their potential to the
GABAergic lineage [52] (Fig. 4).
The accurate identification of the identity of the sphere-forming cell represents a key question.
As committed progenitors are capable of only restricted proliferative capability and can
generate only up to tertiary neurospheres, actually the designation of a cell as bona fide NSC
should be retrospectively refereed only to a founder cell that self-renews extensively and can
be propagated in long-term cultures. To this regard, it has been suggested that at least five
sub-culturing passages are required to exclude the contribution of committed progenitors to
the maintenance of the cell population. More rigorously, the assay should be performed with
single dissociated cells (i.e. to plate a single cell per well) in order to avoid cell clustering and
also fusion between neurospheres [53, 54].
Some researchers consider that three-dimensional organisation and the cellular milieu of the
neurosphere as the in vitro equivalent of the in vivo neurogenic compartment [55, 56]. Although
this view is a pure speculation, it is broadly accepted that the issue of the complexity of the
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Figure 4. Neurospheres and monolayer NSCs can be obtained by different sources and have different neuronal
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without losing the original prevalent neuronal fate, has been a recurrent issue in the stem cell
field.
As an alternative to the neurosphere system, other researchers have developed monolayer-
based methods [57]. In 1997, Gage and colleagues reported that progenitor cells with properties
similar to NSCs from adult SVZ could be obtained from the adult hippocampus [58]. These
hippocampal precursor cells propagate in monolayer and using in vitro procedures similar to
the ones used for SVZ NSCs. Hippocampal precursors divide in response to FGF-2 and show
tri-neural potential being able to differentiate into astroglia, oligodendroglia, and neurons in
vitro. More recently, the optimization of novel and efficient strategies for the derivation and
stable long-term propagation of NSCs from developing and adult neural tissue and from
pluripotent cellular sources has been reported. It has been shown that transiently generated
ESC-derived neural precursors, normally destined to differentiate to neuronal and glial cells,
can be efficiently expanded as adherent clonal NSC lines in EGF and FGF-2 supplemented
medium [19, 35]. In these growth conditions, cells undergo symmetrical division with
neglectable accompanying differentiation, while shifting of the cultures to differentiative
conditions prompts the cells to efficiently generate mature neurons, astrocytes and oligoden‐
drocytes, thus indicating their NSC essence. The cells obtained by this procedure have been
named Neural Stem (NS) cells. Notably, these results suggest that expansion of NS cells can
occur in the absence of a complex cellular niche. Accordingly, NS cell expansion in monolayer
conditions restrains spontaneous differentiation and permits proliferation of homogeneous
bona fide NSCs.
Phenotypic characterization of NS cell cultures indicates a close similarity to forebrain RG
[35].  Indeed,  NS  cells  are  homogenously  immunopositive  for  nestin,  SSEA1/Lex1,  Pax6,
prominin, RC2, vimentin, 3CB2, Glast, and BLBP, a set of markers diagnostic for neurogen‐
ic  RG.  NS  cells  keep  their  neurogenic  potential  after  extensive  expansion  (over  100
passages),  yet  retaining the capability  to  produce a  large proportion of  mature  neurons
(Fig.  4).  These results  further  indicate  that  the  acquisition of  RG properties  endows the
cells with a “niche” that traps them in a state of symmetric cell division. Significantly, NS
cells do not represent a peculiarity of ESCs and iPSCs cell differentiation [35, 59]. In fact,
similar  lines  can also be  obtained from foetal  or  adult  CNS and established from long-
term  expanded  neurosphere  cultures  [35,  60,  61].  It  is  therefore  possible  that  NS  cells
embody  the  resident  NSC  population  within  neurospheres.  Further  characterization  of
different mouse NS cell  lines has demonstrated a close similarity in self-renewal,  neuro‐
nal differentiation potential and molecular markers,  independently from their origin. NS
cells  are  not  exclusive  for  mouse  sources  but  it  has  indeed described the  possibility  to
generate  NS  cells  both  from  human  fetal  neural  tissue  and  from  human  ESCs  [62].
Interestingly,  similar cells  can be developed also from brain tumors and might serve as
systems  for  find  new  targets  in  order  to  develop  new  therapeutic  approaches  [63,  64].
Similarly to NS cells, also lt-hESNSCs grow in monolayer and can be long-term expand‐
ed but differently from NS cells, they maintain sox 1 expression and a wide developmen‐
tal  competence  [29,  65].  These  aspects  might  be  suggestive  for  some  species-specific
differences.
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4. Influences of the in vitro systems on the molecular and biological
properties of NSC lines
For brain tissue, founder NSCs existing during embryogenesis do not endure in adulthood but
switch to a quiescent state following completion of development. Therefore, it might be expected
that in order to achieve persistent propagation of NSCs in vitro it might not be merely suffi‐
cient to follow intrinsic programmed mechanisms but also modifications of the “Neural Stem
Cells cellular “character” are required to adapt to the synthetic in vitro milieu might also be
required. Indeed, the interaction of typical transient progenitor populations with the artificial
in vitro environment (i.e. high levels of growth factor stimulation and/or different matrix or cell-
cell interactions) may modify their transcriptional and epigenetic status, allowing them to be
“turned” into NSC lines.
In this view, when coming to the nature of the NSCs, the crucial issue is if they do exactly represent
a definite sub-population of NSC/progenitor existing in vivo. Currently, it is still not entirely
understood if the accomplishment of the NSC status might be the effect of phenotypic altera‐
tions due to culture set and how physiologically relevant the consequent in vitro phenotype
might be [3]. Thus, it is preferable to refer to in vitro expanded NSCs as NSC-like cells.
To this regard, the possibility that the mixture of mitogens may produce an artificial cell condition
with a proper balance of key transcription factors able to suppress lineage commitment and
allow self-maintaining divisions has to be considered. It has been shown that FGF-2 and EGF,
two growth factors typically used for the in vitro maintenance of NSCs can alter the transcription‐
al and epigenetic phenotype. For example, expression of several genes can be directly stimulat‐
ed in vitro in neural progenitors by exposure to FGF-2, suggesting that these genes might exert
fundamental functions in the establishment of NSCs lines [66]. Similarly, foetal neural progen‐
itors in vitro exposed to FGF-2, rapidly activate expression of Egfr (ErbB1) and Olig2, the latter
being a bHLH transcription factor linked with the oligodendrocyte lineage and ventral CNS
identity [66, 67]. Under expansion conditions with high levels of EGF and FGF-2, induction of
Olig2 is required for the proliferation and self-renewal of neurosphere cells and NS cells, as
demonstrated by analyses in which experimental interference with Olig2 expression severely
decreases the amount and the quality of neurospheres [68]. Besides Olig2, it has been shown that
acute exposure to FGF-2 induces neural progenitors to upregulate expression of a broad set of
genes (for example CD44, GLAST, Olig1, Cdh20, Adam12 and Vav3) likely playing significant
roles in the phenotype of the cells [69]. Likewise, EGF has been shown to deregulate expres‐
sion of Dlx-2 in NS cells, NSC cultures and in transit-amplifying cells of the SVZ, inducing their
switch into RG-like neurosphere-forming cells [51, 61, 69, 70]. Remarkably, stimulation of several
of these genes (for instance Vav3 and CD44) occurs within few hours of FGF-2 exposure, possibly
indicating that mitogen-mediated action is not suggestive for a physiological developmental
progress but rather an acute transcriptional rearrangement [69].
NSCs in vivo have been shown to be tremendously heterogeneous in terms of transcriptional
factors expression pattern, a feature predictable to confer a complex elaboration of positional
signals [33]. To this regard, several reports have shown the occurrence in vitro of profound
variations in the expression pattern of positional genes compared with primary precursors
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without losing the original prevalent neuronal fate, has been a recurrent issue in the stem cell
field.
As an alternative to the neurosphere system, other researchers have developed monolayer-
based methods [57]. In 1997, Gage and colleagues reported that progenitor cells with properties
similar to NSCs from adult SVZ could be obtained from the adult hippocampus [58]. These
hippocampal precursor cells propagate in monolayer and using in vitro procedures similar to
the ones used for SVZ NSCs. Hippocampal precursors divide in response to FGF-2 and show
tri-neural potential being able to differentiate into astroglia, oligodendroglia, and neurons in
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stable long-term propagation of NSCs from developing and adult neural tissue and from
pluripotent cellular sources has been reported. It has been shown that transiently generated
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can be efficiently expanded as adherent clonal NSC lines in EGF and FGF-2 supplemented
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conditions prompts the cells to efficiently generate mature neurons, astrocytes and oligoden‐
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occur in the absence of a complex cellular niche. Accordingly, NS cell expansion in monolayer
conditions restrains spontaneous differentiation and permits proliferation of homogeneous
bona fide NSCs.
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cells  are  not  exclusive  for  mouse  sources  but  it  has  indeed described the  possibility  to
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differences.
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4. Influences of the in vitro systems on the molecular and biological
properties of NSC lines
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and progenitors in vivo thus leading to a mixed regional identity and limited neuronal
differentiation. For example, neurospheres from the spinal cord have been shown to undergo
upregulation of Olig2 and downregulation of the dorsal spinal cord transcription factors Pax3
and Pax7 [71]. Olig2 and Mash1 are also induced in E14 cortex or ganglionic eminence
precursors, short- or long-term grown as neurospheres [72]. With some exceptions, a similar
deregulation of the regional patterning is evident in the adherent NS cells and lt-hESNSCs
cultures [29].
Importantly, this relaxation in the positional code might be related to a recurrent restriction in
the competence to generate diverse neuronal subtypes. Indeed, NSCs have been reported to
rapidly lose their original competence to generate site-specific neuronal subtypes when
cultured in vitro, both in monolayer and in aggregation, in the presence of EGF and/or FGF-2,
becoming mainly constrained to adopt a GABAergic fate [35, 52, 73, 74]. A notable exception
is represented by the lt-hESNSCs [29], possibly indicating that for some reasons neuroepithelial
cells derived from human pluripotent sources are more “predisposed” to long-term better
preserve a broad neuronal sub-types developmental competence.
On the whole, these results might thus emphasize an artificial nature of cell culture, under‐
lining the requirement for prudence in extrapolation of in vitro results to normal development
or physiology without corresponding in vivo data [3]. Alternatively, this might be due to
inadequate culture conditions that are not actually competent to preserve the molecular and
biological properties of genuine NSCs.
5. Reconstruction of NSC niche in vitro
NSC niches present distinctive features leading to diverse ways to ensure neurogenesis. In the
adult SVZ, three main immature neural populations lie adjacent to a layer of ependymal cells
lining the lateral ventricle wall [2]. The Type B cells, representing the NSCs, reside interposed
into the ependymal layer, displaying connections with both the ventricular wall and the blood
vessels-network characterizing this niche. They are relatively quiescent but capable of giving
rise to transit amplifying cells (Type C cells), a more rapidly dividing population that in turn
generate the third population composed by neuroblasts (Type A cells) that migrate into glial
tubes to reach the olfactory bulb. Besides these populations, a vital role for the maintenance
of the niche is played by ependymal cells (Type E cells), astrocytes and endothelial cells. A
comparable organization has been reported also for hippocampal SGZ niche although this
exhibits a more planar structure [75, 76]. For a more detailed description of the neurogenic
niches refer to of this book.
It emerges that both of these neurogenic niches are arranged to allow NSCs integration and to
permit a strict responsiveness to signals from the “external world” (blood vessels and ventricles)
and the “neighboring world” (newly generated neuroblasts, resident astrocytes and microglia,
ECM components-forming scaffolds, etc.). All of these components harmoniously interact with
each other providing both positive and negative signals and feedback that regulate NSCs
activity.
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Even though it is still a long way to fully understand the complex physiological context of a
niche, researchers are now trying to reproduce in vitro at least some aspects of the dynamic in
vivo environment. A better comprehension of the mechanisms underlying the NSC niche and
the development of systems aimed at the reconstruction of this milieu will fill the gap between
bi-dimensional (2D) simplified in vitro studies and the complex but physiological conditions
of in vivo methods.
To this purpose, a synthetic NSC niche should recreate the complex interactions between NSCs
and others cells, extracellular matrix, gradients of regulatory molecules and physical factors
(Figure 5). In particular an ideal in vitro mimicked SVZ niche should contemplate the following
minimal requirements:
1. presence of NSCs
2. production of the characteristic NSC niche-signaling molecules
3. presence of a basal lamina and extracellular matrix
4. autonomous production of cellular and molecular factors necessary for self-renewal and
differentiation of resident stem cells
5. incorporation of extra-neural (i.e. endothelial cells) cells
6. spatial assembly reproducing the SVZ in vivo architecture.
In vitro generation of structures grossly simulating the SVZ NSC niche have been reported
from mouse ESC-derived NSCs without the administration of mitogenic factors and complex
physical scaffolds. In these studies, following a neuralization process with retinoic acid and
plating the NSCs at high density on an entactin-collagen-laminin coated surface, heterogene‐
ous multicellular aggregates appeared spontaneously, showing some of the characteristics
postulated above, although a well-defined structural architecture was lacking [77]. In the last
years, the development of new 3D culture systems that can allow to better reproduce in vitro
structures in between standard monolayer culture and living organisms have been/are under
investigation.
In this direction, standard culture methods involving petri dishes are being replaced with more
accurate micro-scale devices, allowing procedures at the time and length scales of biological
phenomena, enabling the control of multiple parameters, such as molecular and physical
factors [78]. More attention is now focused on both the generation of morphogen-gradients,
taking advantage of microfluidic systems, and three-dimensional extracellular matrix mimic-
scaffolds in which multiple cells can be entangled allowing spatiotemporal control of the
system and satisfying all of the features of a niche [79].
Microfluidic systems can reproduce a niche-like microenvironment permitting also the
generation of concentration gradients of signaling molecules, often without the application of
an external power source. Indeed, two different solutions can be introduced into the main
channel of a microfluidic-chip by an osmotic pump. Since at this scale fluids mix only by
diffusion, at the interface of the two solutions, diffusion generates a stable concentration
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gradient. To this regard, it has been shown that solutions of SHh, FGF8 or BMP4 are able to
induce human ESC-derived NSCs neuronal differentiation, leading to the formation of a
complex cellular network [80].
Figure 5. Schematic illustration of the different colture methods to reproduce in vitro the NSC niche.
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A fundamental impulse has come from the advance in the field of BIOMATERIALS. These
have been greatly improved in the last few years, allowing now to finely control cell-matrix
interactions, to direct cell migration and to permit the precise topographical administration of
defined physical (both soluble or not) signals.
While it is quite difficult to modify only one variable with a naïve ECM component, the use of
biomaterials has improved and simplified many experimental approaches. For example, when
using natural matrices, decreasing the concentration of collagen leads to a decrease stiffness
of the gel, nonetheless this also determines a decreasing in the concentration of adhesive
ligands and an increase in diffusion, resulting in accumulation of variables to the system. This
can be avoided with engineered biomaterials that enable isolation of individual variables,
without varying others. Nowadays, synthetic biomaterials are greatly exploited to mimic the
physical and mechanical features of the ECM. They allow to control a number of important
parameters, including polymerization, degradation, and biocompatibility and to combine
them with fully defined chemical components [81-87].
Another point of control allowed by new biomaterials is the possibility to incorporate cells
releasing molecules or molecules per se as soluble factors, such as cytokines, NFs and GFs.
Indeed, these molecules are constantly synthesized, secreted, transported, and depleted in
NSC niches. To this regard, Zhang and colleagues have described a 16-residues peptide capable
of self-assembly into membrane upon addition of a physiological concentration of salt [88].
Now commercially available as PuraMatrix™, it has been shown to support neurite outgrowth
and synapse formation [89] and more recently to regulate murine and human NSCs growth
and differentiation following adjunction of NSCs-active molecules [90-93].
Synthetic peptides can also be used in combination with a variety of polymers to provide
materials with cell-adhesive, enzymatically degradable, and GFs-binding properties. Amino‐
acid sequences commonly include collagen-, laminin-, and fibronectin-cell-adhesive domains,
these can be mixed together and with other bioactive motifs, such as proteolytically degradable
sequences, to create a multifunctional peptide material with different physical properties. For
instance, NSCs survival has been shown to be improved in a collagen hydrogel that incorpo‐
rates laminin-derived adhesion motifs [94]. Peptides can also be used as structural compo‐
nents.
The reconstructions of a NSC niche can be translated to multiwell-based high-throughput
methods for screening compounds that can positively regulate neurogenesis and thus be
developed as potential therapeutic drugs. Protein-based microarrays have been developed
and applied to diverse stem-cell populations [95-97]. These devices consist of robotically
spotted GFs or ECM molecules in combinations, on cell repellent substrates in order to avoid
cell migration, and cell fate changes are often analyzed via immunocytochemistry assays.
Platforms like these have been used to analyze human NSCs differentiation and proliferation
in response to combinations of ECM components, morphogens and other signaling proteins.
A joint effect of Wnt and Notch pathways to maintain human NSCs in an undifferentiated
state, a dose dependent activity of Notch ligands in shifting neuronal differentiation towards
glial fate and a neurogenic effect of Wnt3A have thus been reported. Consequently, it is
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possible to highlight specific responses of single versus combination of stimuli in a high-
throughput way [97].
These platforms are limited to adherent cells only and do not allow cell fates determination
on single cells. The hydrogel microwell array, developed on micrometer-sized cavities, permits
to analyze both adherent and nonadherent cells, trapped by gravitational sedimentation. The
device has been used to analyze single cell-forming neurospheres, avoiding the usual merging
events of neurosphere assay [98] and more recently it has been combined with robotic protein
spotting to address the role of biochemical and biophysical factors on single nonadherent
neural stem cell self-renewal [99].
6. Conclusions
Our knowledge of the neural progenitor identity and properties during development has been
radically revolutionized by the possibility to isolate and expand NSCs in vitro. We have
reviewed here the current and most commonly used in vitro methodologies to isolate, expand
and functionally characterize NSC populations. The real identity and the potential lineage
relationships between different types of stem/precursor cells isolated and cultured in vitro by
these different methodologies represents a field of open and intense investigation.
In light of the complexity of the biological concerns governing stem cell maintenance and
differentiation, significant progress will require a close coordination between in vivo and in
vitro approaches. In this scenario, in vitro systems of NSCs shall allow a deep analysis at cellular
level providing useful information to be further validate in the embryo and adult in order to
identify relevance to normal physiology.
Establishment of in vitro settings necessarily results in disruption of the three-dimensional
tissue structure, loss of specific cell-to cell contacts and modification of the extracellular
environment and signaling. This might also lead to alteration of biological and molecular
properties and acquisition of stem cell features by committed progenitors. Thus, although the
versatility shown by NSC cultures in vitro can be envisaged as an advantage, extreme caution
is necessary when considering the potential in vivo translation to developmental biology.
NSC biology holds tremendous potential for neurological therapy. It should be emphasized
that the study of the intrinsic properties of NSCs and understanding the mechanisms of
interaction between resident CNS cells and grafted NSCs will be mandatory for the develop‐
ment of new therapies able to slow the progression of neurodegenerative diseases.
Beside the therapeutical applications, NSCs systems present unique opportunities that are
starting to be successfully explored for genetic or chemical screens in order to identify and
optimize molecules/drugs that may allow a tight control on self-renewal and lineage specifi‐
cation of NSCs as well as their functional maturation, thus moving forward NSCs-based
therapies.
We can anticipate that a rigorous characterization of the functional features of the NSC
populations isolated and propagated by means of different cell culture systems shall allow us
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to exploit the advantages offered by one method or the other, depending on the goal of our
research.
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Establishment of in vitro settings necessarily results in disruption of the three-dimensional
tissue structure, loss of specific cell-to cell contacts and modification of the extracellular
environment and signaling. This might also lead to alteration of biological and molecular
properties and acquisition of stem cell features by committed progenitors. Thus, although the
versatility shown by NSC cultures in vitro can be envisaged as an advantage, extreme caution
is necessary when considering the potential in vivo translation to developmental biology.
NSC biology holds tremendous potential for neurological therapy. It should be emphasized
that the study of the intrinsic properties of NSCs and understanding the mechanisms of
interaction between resident CNS cells and grafted NSCs will be mandatory for the develop‐
ment of new therapies able to slow the progression of neurodegenerative diseases.
Beside the therapeutical applications, NSCs systems present unique opportunities that are
starting to be successfully explored for genetic or chemical screens in order to identify and
optimize molecules/drugs that may allow a tight control on self-renewal and lineage specifi‐
cation of NSCs as well as their functional maturation, thus moving forward NSCs-based
therapies.
We can anticipate that a rigorous characterization of the functional features of the NSC
populations isolated and propagated by means of different cell culture systems shall allow us
Neural Stem Cells - New Perspectives18
to exploit the advantages offered by one method or the other, depending on the goal of our
research.
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1. Introduction
The concept of neurogenic neural stem cells in the brains of adult mammals including humans
is now widely accepted. In rodents these cells have been studied extensively both in vitro and
in vivo. Of the two primary neurogenic regions in the rodent brain, the subventricular zone of
the lateral ventricle wall generates the most neurons of multiple phenotypes. The newly
generated neurons in the subventricular zone migrate to the olfactory bulb replenishing
neurons and reconstituting the local circuitry responsible for olfaction. The dentate gyrus of
the hippocampus generates a single neuron type, glutamatergic granule cells. These newborn
granule cells contribute to specific forms of memory by integrating into existent circuits (Shors
et al., 2001; Clelland et al., 2009; Garthe et al., 2009). Over the last few years, what was once
considered to be a homogeneous population of astrocytic stem cells in both neurogenic brain
regions is now turning out to be a more complex mixture of cells. Heterogeneous populations
of cells with stem cell properties are being discovered in both the subventricular zone and
dentate gyrus. This heterogeneity combined with potential diversity in signals forming the
local niches could provide a situation where these multiple neural stem cell subpopulations
contribute of tissue homeostasis and regeneration.
2. Neurogenesis in the subventricular zone
The lateral walls of the forebrain ventricles contain stem cells that generate neuronal subpo‐
pulations of the olfactory bulb throughout life (Reynolds and Weiss, 1992; Morshead et al.,
1994; Doetsch et al., 1999b; Gage, 2000; Mirzadeh et al., 2008). Although much remains to be
learnt about the neurogenic process and the fate determinants controlling maintenance,
proliferation and differentiation of stem and progenitors cells in the subventricular zone,
morphological, immunological and lineage tracing has recently uncovered a striking hetero‐
© 2013 Taylor; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
Chapter 2
Neural Stem Cell Heterogeneity
Verdon Taylor
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/55676
1. Introduction
The concept of neurogenic neural stem cells in the brains of adult mammals including humans
is now widely accepted. In rodents these cells have been studied extensively both in vitro and
in vivo. Of the two primary neurogenic regions in the rodent brain, the subventricular zone of
the lateral ventricle wall generates the most neurons of multiple phenotypes. The newly
generated neurons in the subventricular zone migrate to the olfactory bulb replenishing
neurons and reconstituting the local circuitry responsible for olfaction. The dentate gyrus of
the hippocampus generates a single neuron type, glutamatergic granule cells. These newborn
granule cells contribute to specific forms of memory by integrating into existent circuits (Shors
et al., 2001; Clelland et al., 2009; Garthe et al., 2009). Over the last few years, what was once
considered to be a homogeneous population of astrocytic stem cells in both neurogenic brain
regions is now turning out to be a more complex mixture of cells. Heterogeneous populations
of cells with stem cell properties are being discovered in both the subventricular zone and
dentate gyrus. This heterogeneity combined with potential diversity in signals forming the
local niches could provide a situation where these multiple neural stem cell subpopulations
contribute of tissue homeostasis and regeneration.
2. Neurogenesis in the subventricular zone
The lateral walls of the forebrain ventricles contain stem cells that generate neuronal subpo‐
pulations of the olfactory bulb throughout life (Reynolds and Weiss, 1992; Morshead et al.,
1994; Doetsch et al., 1999b; Gage, 2000; Mirzadeh et al., 2008). Although much remains to be
learnt about the neurogenic process and the fate determinants controlling maintenance,
proliferation and differentiation of stem and progenitors cells in the subventricular zone,
morphological, immunological and lineage tracing has recently uncovered a striking hetero‐
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geneity in the putative stem cell pool. In the first sections of this chapter I will look at some of
the key findings and experiments identifying the stem cells and following their fate. I will also
ask the question of whether single neural stem cells are multipotent in vivo and look at some
for the experimental data addressing this and also cover emerging experimental data showing
heterogeneity within the stem cell pool.
3. The subventricular zone and its progenitors
Continued neurogenesis from cells within the subependymal layer of the lateral ventricle wall
implies stem cells as a driving force and a regulatory niche. Ultrastructural electronmicroscopic
analysis has been instrumental in defining the morphological differences among cells within
the subependymal layer of the ventricle wall (Doetsch et al., 1997; Doetsch et al., 1999a;
Mirzadeh et al., 2008). Combining electromicroscopy with functional regeneration of the
neurogenic niche, astrocytes have been shown to be primary progenitors of the subventricular
zone (Doetsch et al., 1999b; Doetsch et al., 1999a; Doetsch et al., 2002). The subventricular zone
astrocytes are defined as B-cells. B-cells have a polarized morphology extending an apical
process and sensory cilium that projects between the ependymal call (E-cells) lining the lateral
ventricle. These B-cell projections organize the E-cells into characteristic pinwheel structure
(Mirzadeh et al., 2008). This is likely to be an important structural and signaling center in the
stem cell niche. Based on their ultrastructural characteristics and location the B-cell population
can be divided into two. B1-cells have their cell body between the chains of neuroblasts (A-
cells) and the ependymal lining. B1-cells are quiescent and, based on thymidine incorporation
assays and electronmicroscopic analysis, they rarely divide. B2-cells are more displaced
towards the parenchyma of the underlying striatum and unsheathe the migrating chains of
neuroblasts on route to the olfactory bulb (Doetsch et al., 1997). Unlike the structurally related
B1-cells, B2-cells divide more prevalently. C-cells are the committed progeny of the B-cells,
likely generated by asymmetric cell division, and they are mitotically highly active but undergo
a limited number of divisions before differentiating. The progeny of the transient amplifying
C-cells, the A-cells, migrate in chains through tubes formed by B-cells to the olfactory bulb. In
adulthood, interneurons of the granule cell layer are the major newborn neuron type in the
olfactory bulb, and together with periglomerular neurons, reform local circuits. In addition to
neurons of the olfactory bulb, oligodendrocytes are also continuously generated in the
subventricular zone and migrate to the corpus callosum. These oligodendrocytes are the
product of Olig2-positive transient amplifying cells (a second type of C-cell). The relationship
between the neurogenic C-cells and those that generate oligodendrocytes is hotly debated, as
is whether they are the products of the same multipotent neural stem cells in the subventricular
zone.
4. Heterogeneity within the subventricular zone neural stem cell pool
The mechanisms controlling the fate of progenitors in the subventricular zone remain unclear.
The niche and its local interactions, morphogens and growth factors are one potential mode by
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which the differentiation potential of the neural stem cells is controlled (Basak and Taylor, 2009).
Assuming that all  stem cells with the subventricular zone have the same potential,  local
differences within the niche or signals interpreted by committed progenitors en route to their
final destination would be responsible for determining the multiple neuronal fates. The ectopic
grafting of stem cells into the subventricular zone indicates some degree of plasticity within the
neural stem cell population and suggest niche specific signals as fate determinants (Suhonen et
al., 1996). However, even with the same niche, some neural stem cells seem to have autono‐
mous fates and be heterogeneous in their potential (Kohwi et al., 2007; Merkle et al., 2007). By
using homochronic/heterochronic transplantation experiments it has been shown that progen‐
itor cells at different ontogenetic stages are intrinsically directed toward specific lineages (De
Marchis et al., 2007). In addition, neuroblasts in the rostral migratory stream are also heteroge‐
neous and may be committed to specific neuronal fates even before reaching the olfactory bulb
(Hack et al., 2005; Kohwi et al., 2005). Thus, rather than being universally plastic, the neural stem
cell pool may be made up of many stem cells with restricted potentials. This is also supported
by region specific, viral-mediated genetic labeling of the subventricular neural stem cells in
juvenile mice which show diversity in neuronal progeny generated rather than generating all
neuron types (Merkle et al., 2007). Granule cells, the major neuron subtypes to be generated
during adulthood, are produced from all anteroposterior and dorsoventral locations in the
subventricular zone. However, most granule cells are generated from the dorsal and ventral
most aspects of the subventricular zone (Merkle et al., 2007). Within this regionalization, the
granule neurons generated from the dorsal subventricular zone migrate to a more superficial
location in the granule cell layer of the olfactory bulb while those generated ventrally settle
deeper in the granule cell layer (Merkle et al., 2007). This regional specification can also be mapped
to the location of the stem cells during early postnatal development indicating not only a regional
but also a developmentally-regulated fate specification (Merkle et al., 2007). Similarly, periglo‐
merular neurons that migrate to the outer layer of the olfactory bulb also show a region-
specific origin. Dorsal regions of the subventricular zone generate the majority of the thymidine
hydroxylase-positive  neurons  whereas  Calbindin-positive  periglomerular  neurons  are
generated preferentially from the ventral subventricular zone (Merkle et al., 2007). Calretinin-
positive periglomerular and granule cells are generated from the medial wall of the lateral
ventricle. As this region produces proportionally fewer granule cells in total this suggests that
the niche of the medial wall directs the fate of neural stem cells towards Calretinin neuron
generation. Although these findings do not rule out niche specific programming of multipo‐
tent cell fate, heterotopic transplantation strongly suggests that stem cells retain their differen‐
tial potential when grafted into a different axial location (Merkle et al., 2007).
5. Mitotically active or quiescent neural stem cells
For many years mitotic inactivity or quiescence has been viewed as a primary stem cell trait.
However, recent data in many systems including the intestine and blood suggest that stem cell
may not need to be quiescent and some can divide frequently to drive the generation of new
cells (Wilson et al., 2008; Essers et al., 2009; Fuchs, 2009; Li and Clevers, 2010). These active
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geneity in the putative stem cell pool. In the first sections of this chapter I will look at some of
the key findings and experiments identifying the stem cells and following their fate. I will also
ask the question of whether single neural stem cells are multipotent in vivo and look at some
for the experimental data addressing this and also cover emerging experimental data showing
heterogeneity within the stem cell pool.
3. The subventricular zone and its progenitors
Continued neurogenesis from cells within the subependymal layer of the lateral ventricle wall
implies stem cells as a driving force and a regulatory niche. Ultrastructural electronmicroscopic
analysis has been instrumental in defining the morphological differences among cells within
the subependymal layer of the ventricle wall (Doetsch et al., 1997; Doetsch et al., 1999a;
Mirzadeh et al., 2008). Combining electromicroscopy with functional regeneration of the
neurogenic niche, astrocytes have been shown to be primary progenitors of the subventricular
zone (Doetsch et al., 1999b; Doetsch et al., 1999a; Doetsch et al., 2002). The subventricular zone
astrocytes are defined as B-cells. B-cells have a polarized morphology extending an apical
process and sensory cilium that projects between the ependymal call (E-cells) lining the lateral
ventricle. These B-cell projections organize the E-cells into characteristic pinwheel structure
(Mirzadeh et al., 2008). This is likely to be an important structural and signaling center in the
stem cell niche. Based on their ultrastructural characteristics and location the B-cell population
can be divided into two. B1-cells have their cell body between the chains of neuroblasts (A-
cells) and the ependymal lining. B1-cells are quiescent and, based on thymidine incorporation
assays and electronmicroscopic analysis, they rarely divide. B2-cells are more displaced
towards the parenchyma of the underlying striatum and unsheathe the migrating chains of
neuroblasts on route to the olfactory bulb (Doetsch et al., 1997). Unlike the structurally related
B1-cells, B2-cells divide more prevalently. C-cells are the committed progeny of the B-cells,
likely generated by asymmetric cell division, and they are mitotically highly active but undergo
a limited number of divisions before differentiating. The progeny of the transient amplifying
C-cells, the A-cells, migrate in chains through tubes formed by B-cells to the olfactory bulb. In
adulthood, interneurons of the granule cell layer are the major newborn neuron type in the
olfactory bulb, and together with periglomerular neurons, reform local circuits. In addition to
neurons of the olfactory bulb, oligodendrocytes are also continuously generated in the
subventricular zone and migrate to the corpus callosum. These oligodendrocytes are the
product of Olig2-positive transient amplifying cells (a second type of C-cell). The relationship
between the neurogenic C-cells and those that generate oligodendrocytes is hotly debated, as
is whether they are the products of the same multipotent neural stem cells in the subventricular
zone.
4. Heterogeneity within the subventricular zone neural stem cell pool
The mechanisms controlling the fate of progenitors in the subventricular zone remain unclear.
The niche and its local interactions, morphogens and growth factors are one potential mode by
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which the differentiation potential of the neural stem cells is controlled (Basak and Taylor, 2009).
Assuming that all  stem cells with the subventricular zone have the same potential,  local
differences within the niche or signals interpreted by committed progenitors en route to their
final destination would be responsible for determining the multiple neuronal fates. The ectopic
grafting of stem cells into the subventricular zone indicates some degree of plasticity within the
neural stem cell population and suggest niche specific signals as fate determinants (Suhonen et
al., 1996). However, even with the same niche, some neural stem cells seem to have autono‐
mous fates and be heterogeneous in their potential (Kohwi et al., 2007; Merkle et al., 2007). By
using homochronic/heterochronic transplantation experiments it has been shown that progen‐
itor cells at different ontogenetic stages are intrinsically directed toward specific lineages (De
Marchis et al., 2007). In addition, neuroblasts in the rostral migratory stream are also heteroge‐
neous and may be committed to specific neuronal fates even before reaching the olfactory bulb
(Hack et al., 2005; Kohwi et al., 2005). Thus, rather than being universally plastic, the neural stem
cell pool may be made up of many stem cells with restricted potentials. This is also supported
by region specific, viral-mediated genetic labeling of the subventricular neural stem cells in
juvenile mice which show diversity in neuronal progeny generated rather than generating all
neuron types (Merkle et al., 2007). Granule cells, the major neuron subtypes to be generated
during adulthood, are produced from all anteroposterior and dorsoventral locations in the
subventricular zone. However, most granule cells are generated from the dorsal and ventral
most aspects of the subventricular zone (Merkle et al., 2007). Within this regionalization, the
granule neurons generated from the dorsal subventricular zone migrate to a more superficial
location in the granule cell layer of the olfactory bulb while those generated ventrally settle
deeper in the granule cell layer (Merkle et al., 2007). This regional specification can also be mapped
to the location of the stem cells during early postnatal development indicating not only a regional
but also a developmentally-regulated fate specification (Merkle et al., 2007). Similarly, periglo‐
merular neurons that migrate to the outer layer of the olfactory bulb also show a region-
specific origin. Dorsal regions of the subventricular zone generate the majority of the thymidine
hydroxylase-positive  neurons  whereas  Calbindin-positive  periglomerular  neurons  are
generated preferentially from the ventral subventricular zone (Merkle et al., 2007). Calretinin-
positive periglomerular and granule cells are generated from the medial wall of the lateral
ventricle. As this region produces proportionally fewer granule cells in total this suggests that
the niche of the medial wall directs the fate of neural stem cells towards Calretinin neuron
generation. Although these findings do not rule out niche specific programming of multipo‐
tent cell fate, heterotopic transplantation strongly suggests that stem cells retain their differen‐
tial potential when grafted into a different axial location (Merkle et al., 2007).
5. Mitotically active or quiescent neural stem cells
For many years mitotic inactivity or quiescence has been viewed as a primary stem cell trait.
However, recent data in many systems including the intestine and blood suggest that stem cell
may not need to be quiescent and some can divide frequently to drive the generation of new
cells (Wilson et al., 2008; Essers et al., 2009; Fuchs, 2009; Li and Clevers, 2010). These active
Neural Stem Cell Heterogeneity
http://dx.doi.org/10.5772/55676
31
stem cells are the force behind tissue homeostasis and may reside side-by-side with quiescent
stem cells that rarely if ever divide but that could be responsible for tissue regeneration.
Ultrastructural cellular analysis of the subventricular zone implied that even within the B-cell
compartment, B1 cells rarely if ever divide whereas B2 cells are detected in cell cycle (Doetsch
et al., 1997). This raised the possibility that in the adult brain stem cells may also either be able
to adopt different fates or, different neural stem cells exist which show strikingly different
mitotic potential. More recently, mitotically active cells in the subventricular zone were show
to be in close proximity to blood vessels suggesting a mitotic influence of the endothelium or
blood-born factors (Shen et al., 2008; Tavazoie et al., 2008). This is particularly intriguing as
endothelial cells express the Notch ligand Jagged1 and can active neural stem cells regulating
maintenance and proliferation both in vitro and in vivo thus implying that activated neural
stem cells my have a vascular contribution to their niche (Shen et al., 2004; Nyfeler et al., 2005).
In summary of current and past data, the heterogeneous mitotic activity among neural stem
cells suggests at least two potential scenarios. Either individual cells are able to transit between
a quiescent and an activated state, or, that there are different stem cells, some which are
quiescent and rarely divide, and others that are more mitotically active, dividing frequently
and driving the production of new neurons destined for the olfactory bulb. A similar situation
of active and dormant stem cells is present in the crypts of the large intestine where previously
identified slow or rarely dividing stem cells in the +4 position seem to be the cells responsible
for regenerating the epithelial lining of the gut. Conversely, mitotically active cells that are
interdigitated with paneth cells at the base of the crypt replenish the epithelial cells lining the
villi (Li and Clevers, 2010).
6. Active and quiescent stem cells show differences in Notch signaling
Notch signaling regulates cell fate in many cell systems and across species (Artavanis-
Tsakonas et al., 1999; Louvi and Artavanis-Tsakonas, 2006). Lateral signaling between
neighboring cells presenting Notch ligands and expressing receptors classically results in
binary fate decisions, often in cells undergoing cell division. Notch signaling is active in the
subventricular zone and multiple ligands are present on B, C and E cells providing the potential
for lateral signaling (Stump et al., 2002; Nyfeler et al., 2005; Imayoshi et al., 2010). Genetic
ablation of Notch signaling in stem cells of the subventricular zone results in precocious
differentiation and neurogenesis (Imayoshi et al., 2010; Basak et al., 2012). This in turn results
in a loss of neural stem cells and a subsequent long-term suppression of neurogenesis. This is
a “classical” role for Notch in the regulation of cell fate, whereby loss of Notch signaling during
what should be an asymmetric neural stem cell division results in both daughter cells adopting
a differentiated cell fate and a concomitant loss of stem cell self-renewal. However, the ablation
of Notch from B-cells also results in quiescent B1-cells entering the cell cycle and the active
neurogenic pool. This activation of cells that are normally in a mitotically inactive state
contributes to a pulse of increased neuroblast production before extinction of the stem cells
pool following inactivation of canonical Notch signaling (Imayoshi et al., 2010; Basak et al.,
2012). Hence, Notch signaling through its canonical pathway not only regulates stem cell
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maintenance in the subventricular zone by repressing neuronal commitment of the stem cell
but also suppresses mitotic activity of B1 cells. In addition, canonical Notch signaling is
implicated in repressing the mitotic activity in ependymal cells lining the lateral ventricle
during ischemic lesions (Carlen et al., 2009). Although the role of ependymal cells as stem cells
is highly controversial, it remains possible that, under some degenerative/regenerative
conditions, even these differentiated cells may be able to dedifferentiate or transdifferentiate
to generate neuroblasts. How this regulation of proliferation function is controlled by Notch
is unclear. However, analysis of Notch1 function in the subventricular zone suggests differ‐
ential receptor usage by neural stem cell in different mitotic states. The Notch gene family
contains four genes encoding highly related receptors. These receptors are able to bind all five
canonical ligands. At least three Notchs, Notch1, Notch2 and Notch3 are expressed in the
subventriuclar zone (Stump et al., 2002; Basak et al., 2012). Notch1, Notch2 and Notch3 are
expressed by B-cells whereas Notch1 is also expressed by C-cells, A-cells and E-cells (Nyfeler
et al., 2005; Carlen et al., 2009; Imayoshi et al., 2010; Basak et al., 2012). Genetic conditional
inactivation of Notch1 from B-cells induces a loss of self-renewal during homeostatic neuro‐
genesis. Notch1-deficient active stem cells fail to self-renew and spontaneously differentiate –
similar to ablation of the canonical DNA-binding component of the pathway RBP-J in these
cells. However, unlike when RBP-J is deleted, Notch1-deficiency in B1-cells does not result in
spontaneous mitotic activity (Basak et al., 2012). The regulation of cell proliferation by Notch
signaling has also been implicated in vitro where cultured neural stem cells lacking Notch1
fail to self-renew and differentiate and in the adult zebrafish quiescent progenitors proliferate
when treated with the gamma-secretase inhibitor DAPT, which blocks Notch (Nyfeler et al.,
2005; Chapouton et al., 2010). Conversely, B1-cells, although they express Notch1, do not seem
to depend upon it for a quiescence signal. Thus, it is likely that molecular compensation or
signal diversity between the Notch receptors is responsible for the quiescence of B1-cells. This
remains to be examined in detail.
It has been difficult to identify and study active neural stem cell in the adult mouse subven‐
tricular zone due to an absence of selective markers. Most transgenes used to label neurogenic
stem cells utilize the Nestin, GLAST or Hes5 promoters (Mori et al., 2006; Balordi and Fishell,
2007; Lagace et al., 2007; Giachino and Taylor, 2009; Imayoshi et al., 2010; Bonaguidi et al.,
2011; Basak et al., 2012). These promoters are all expressed by both quiescent and mitotic stem
cells. However, combinations of transgenic reporter and surface expression of the Prominin1-
associated glycoepitope CD133 and binding of the mitogen epidermal growth factor is able to
select active from quiescent stem cells, C-cells and neuroblasts (Pastrana et al., 2009). Con‐
versely, Inhibitor of DNA binding protein 1 (Id1) a target of transforming growth factor-β
signaling, is expressed predominantly by quiescent B1-cells. Transgenic mice expressing green
fluorescent protein under the control of the Id1 promoter label quiescent B1-cells in the
subventricular zone (Nam and Benezra, 2009). These Id1-positive GFAP-positive B1 cells are
relatively rare and divide infrequently to generate neuroblasts likely by asymmetric cell
division. Interestingly, mitotic activity of subventricular zone neural stem cells requires Id
proteins with loss of function resulting in a loss of self-renewal and neurogenesis (Nam and
Benezra, 2009). It remains to be shown whether and how the quiescent and active stem cells
in the subventricular zone are related to each other or whether they fulfill distinct functions
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stem cells are the force behind tissue homeostasis and may reside side-by-side with quiescent
stem cells that rarely if ever divide but that could be responsible for tissue regeneration.
Ultrastructural cellular analysis of the subventricular zone implied that even within the B-cell
compartment, B1 cells rarely if ever divide whereas B2 cells are detected in cell cycle (Doetsch
et al., 1997). This raised the possibility that in the adult brain stem cells may also either be able
to adopt different fates or, different neural stem cells exist which show strikingly different
mitotic potential. More recently, mitotically active cells in the subventricular zone were show
to be in close proximity to blood vessels suggesting a mitotic influence of the endothelium or
blood-born factors (Shen et al., 2008; Tavazoie et al., 2008). This is particularly intriguing as
endothelial cells express the Notch ligand Jagged1 and can active neural stem cells regulating
maintenance and proliferation both in vitro and in vivo thus implying that activated neural
stem cells my have a vascular contribution to their niche (Shen et al., 2004; Nyfeler et al., 2005).
In summary of current and past data, the heterogeneous mitotic activity among neural stem
cells suggests at least two potential scenarios. Either individual cells are able to transit between
a quiescent and an activated state, or, that there are different stem cells, some which are
quiescent and rarely divide, and others that are more mitotically active, dividing frequently
and driving the production of new neurons destined for the olfactory bulb. A similar situation
of active and dormant stem cells is present in the crypts of the large intestine where previously
identified slow or rarely dividing stem cells in the +4 position seem to be the cells responsible
for regenerating the epithelial lining of the gut. Conversely, mitotically active cells that are
interdigitated with paneth cells at the base of the crypt replenish the epithelial cells lining the
villi (Li and Clevers, 2010).
6. Active and quiescent stem cells show differences in Notch signaling
Notch signaling regulates cell fate in many cell systems and across species (Artavanis-
Tsakonas et al., 1999; Louvi and Artavanis-Tsakonas, 2006). Lateral signaling between
neighboring cells presenting Notch ligands and expressing receptors classically results in
binary fate decisions, often in cells undergoing cell division. Notch signaling is active in the
subventricular zone and multiple ligands are present on B, C and E cells providing the potential
for lateral signaling (Stump et al., 2002; Nyfeler et al., 2005; Imayoshi et al., 2010). Genetic
ablation of Notch signaling in stem cells of the subventricular zone results in precocious
differentiation and neurogenesis (Imayoshi et al., 2010; Basak et al., 2012). This in turn results
in a loss of neural stem cells and a subsequent long-term suppression of neurogenesis. This is
a “classical” role for Notch in the regulation of cell fate, whereby loss of Notch signaling during
what should be an asymmetric neural stem cell division results in both daughter cells adopting
a differentiated cell fate and a concomitant loss of stem cell self-renewal. However, the ablation
of Notch from B-cells also results in quiescent B1-cells entering the cell cycle and the active
neurogenic pool. This activation of cells that are normally in a mitotically inactive state
contributes to a pulse of increased neuroblast production before extinction of the stem cells
pool following inactivation of canonical Notch signaling (Imayoshi et al., 2010; Basak et al.,
2012). Hence, Notch signaling through its canonical pathway not only regulates stem cell
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maintenance in the subventricular zone by repressing neuronal commitment of the stem cell
but also suppresses mitotic activity of B1 cells. In addition, canonical Notch signaling is
implicated in repressing the mitotic activity in ependymal cells lining the lateral ventricle
during ischemic lesions (Carlen et al., 2009). Although the role of ependymal cells as stem cells
is highly controversial, it remains possible that, under some degenerative/regenerative
conditions, even these differentiated cells may be able to dedifferentiate or transdifferentiate
to generate neuroblasts. How this regulation of proliferation function is controlled by Notch
is unclear. However, analysis of Notch1 function in the subventricular zone suggests differ‐
ential receptor usage by neural stem cell in different mitotic states. The Notch gene family
contains four genes encoding highly related receptors. These receptors are able to bind all five
canonical ligands. At least three Notchs, Notch1, Notch2 and Notch3 are expressed in the
subventriuclar zone (Stump et al., 2002; Basak et al., 2012). Notch1, Notch2 and Notch3 are
expressed by B-cells whereas Notch1 is also expressed by C-cells, A-cells and E-cells (Nyfeler
et al., 2005; Carlen et al., 2009; Imayoshi et al., 2010; Basak et al., 2012). Genetic conditional
inactivation of Notch1 from B-cells induces a loss of self-renewal during homeostatic neuro‐
genesis. Notch1-deficient active stem cells fail to self-renew and spontaneously differentiate –
similar to ablation of the canonical DNA-binding component of the pathway RBP-J in these
cells. However, unlike when RBP-J is deleted, Notch1-deficiency in B1-cells does not result in
spontaneous mitotic activity (Basak et al., 2012). The regulation of cell proliferation by Notch
signaling has also been implicated in vitro where cultured neural stem cells lacking Notch1
fail to self-renew and differentiate and in the adult zebrafish quiescent progenitors proliferate
when treated with the gamma-secretase inhibitor DAPT, which blocks Notch (Nyfeler et al.,
2005; Chapouton et al., 2010). Conversely, B1-cells, although they express Notch1, do not seem
to depend upon it for a quiescence signal. Thus, it is likely that molecular compensation or
signal diversity between the Notch receptors is responsible for the quiescence of B1-cells. This
remains to be examined in detail.
It has been difficult to identify and study active neural stem cell in the adult mouse subven‐
tricular zone due to an absence of selective markers. Most transgenes used to label neurogenic
stem cells utilize the Nestin, GLAST or Hes5 promoters (Mori et al., 2006; Balordi and Fishell,
2007; Lagace et al., 2007; Giachino and Taylor, 2009; Imayoshi et al., 2010; Bonaguidi et al.,
2011; Basak et al., 2012). These promoters are all expressed by both quiescent and mitotic stem
cells. However, combinations of transgenic reporter and surface expression of the Prominin1-
associated glycoepitope CD133 and binding of the mitogen epidermal growth factor is able to
select active from quiescent stem cells, C-cells and neuroblasts (Pastrana et al., 2009). Con‐
versely, Inhibitor of DNA binding protein 1 (Id1) a target of transforming growth factor-β
signaling, is expressed predominantly by quiescent B1-cells. Transgenic mice expressing green
fluorescent protein under the control of the Id1 promoter label quiescent B1-cells in the
subventricular zone (Nam and Benezra, 2009). These Id1-positive GFAP-positive B1 cells are
relatively rare and divide infrequently to generate neuroblasts likely by asymmetric cell
division. Interestingly, mitotic activity of subventricular zone neural stem cells requires Id
proteins with loss of function resulting in a loss of self-renewal and neurogenesis (Nam and
Benezra, 2009). It remains to be shown whether and how the quiescent and active stem cells
in the subventricular zone are related to each other or whether they fulfill distinct functions
Neural Stem Cell Heterogeneity
http://dx.doi.org/10.5772/55676
33
for example homeostatic neurogenesis and regeneration. It is likely that the elucidation of the
diverse neural stem cells in the subventricular zone is going to require the combination of
different markers and genetic tools (Beckervordersandforth et al., 2010).
7. The hippocampus continually generates neurons which participate in
memory formation
In contrast to the subventricular zone where proliferation and neurogenesis are eradicat‐
ed  soon  after  birth  in  humans,  the  dentate  gyrus  of  the  human  hippocampus,  like  in
rodents, continues to generate neurons from mitotically active progenitors cells all the way
into adulthood. The cellular composition of the neurogenic niche in the dentate gyrus has
been studied extensively (Seri  et  al.,  2001;  Kempermann et  al.,  2004;  Steiner et  al.,  2006;
Steiner et al., 2008). However, the identity and regulation of neural stem cells in the dentate
gyrus remains unclear.
8. The progenitor pool in the dentate gyrus is morphologically and
functionally heterogeneous
Self-renewing neural  stem cells  in  the  subgranular  zone of  the  adult  hippocampal  den‐
tate  gyrus  (also  referred  to  as  Type-1  cells)  produce  intermediate  progenitor  cells  (IPs,
Type-2a cells), NeuroD1 and Doublecortin-positive neuroblasts (Type-2b) and subsequent‐
ly granule neurons (Seri et al., 2001; Kempermann et al., 2004; Steiner et al., 2006). Type-1
neural stem cells have their cell bodies in the subgranular zone and extend a long process
through the granule cell  layer to the overlaying molecular layer.  Type-2 cells  are transi‐
ent intermediate progenitors. They also have their cell body in the subgranular zone but
lack  a  long  radial  process  and  have  a  more  rounded  morphology  with  short  stubby
processes (Seri et al.,  2001; Steiner et al.,  2006). Neuroblasts by contrast extend a leading
process  and  migrate  into  the  granule  cell  layer.  Whereas  radial  Type-1  cells  are  quies‐
cent, Type-2 cells divide readily expanding the progenitor pool. Previous Bromodeoxyuri‐
dine  labeling  experiments  suggested  that  Type-2a  cells,  which  express  proneural
transcription  factors,  are  the  major  proliferative  progenitor  in  the  adult  dentate  gyrus
(Steiner et al.,  2006). In addition, retroviral-labeling experiments showed that neuroblasts
that have extended a radial process, exit cell cycle, and only go through one or two cell
divisions (Seri et al.,  2001). However, recent genetic labeling and lineage tracing of stem
cells  in  the  dentate  gyrus  revealed  that  Ascl1-positive  Type-2a  cells  do  not  undergo
symmetric  cell  divisions  but  generate  an  addition  intermediate  cell  type,  Tbr2-positive
Type-2 cells (recently referred to as Type-2ab cells) (Bonaguidi et al.,  2012; Lugert et al.,
2012). The Tbr2-positive cells divide frequently to amplify the progenitor pool and increase
the number of neurons generated from each stem cell division (Lugert et al., 2012).
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9. Multiple stem cell populations in the dentate gyrus
The classical view of stem cells in the adult dentate gyrus implicates the quiescent radial
glial like Type-1 cells as the primary progenitor. However, retroviral labeling is common‐
ly used to examine neurogenesis in the dentate and to label cells that continue to gener‐
ate multiple neurons over time (Seri et al., 2001; Suh et al., 2007). As retroviral integration
and thus viral  gene expression are dependent upon cells  passing through the cell  cycle,
some long-term neurogenic  stem cells  in  the  dentate  must  be  mitotically  active.  Radial
Type-1 cells are rarely labeled in these retroviral experiments suggesting that other cells
that lack a radial process must also display self-renewing and long-term neurogenic stem
cell  potential  (Suh et al.,  2007).  This is  also supported by lentiviral  labeling experiments
driving reporter expression from the Sox2  promoter (Suh et  al.,  2007).  Expression of the
transcription factor Sox2 is associated with progenitor cells of the brain and required for
their  maintenance  by  regulating  Notch,  Sonic  Hedgehog  expression  and  Wnt  activity
(Steiner et al., 2008; Favaro et al., 2009; Kuwabara et al., 2009). A population of none radial
stem cells with horizontally orientated processes has been identified by Cre-recombinase
mediated  lineage  tracing  (Suh  et  al.,  2007).  These  horizontal  cells  display  stem  cell
characteristics  but  are  clearly  distinct  from the previously described Type-1  and Type-2
cells. Horizontal Type-1 neural stem cells like radial Type-1 stem cells in the dentate gyrus
have active Notch signaling and are labeled with a Notch signal reporter allele Hes5::GFP
(Ables et al., 2010; Ehm et al., 2010; Lugert et al., 2010). However, although they express
Nestin they do not express the astrocytic protein GFAP. Hence, there remains some debate
and despite their similarity in morphology to Type-2 cells, horizontal Type-1 stem cells do
not express classic Type-2 cell markers including the proneural transcription factor Ascl1
– a Notch repressed target gene – Tbr2 or Doublecortin (Steiner et al., 2006; Lugert et al.,
2010).  In  addition,  horizontal  Type-1  cells  are  more  mitotically  active  than  their  radial
counterparts  (Lugert  et  al.,  2010).  Therefore,  the  horizontal  Hes5-positive  cells  likely
represent the Sox2-positive population of stem cells and those stem cells commonly traced
and  analyzed  by  retroviral  labeling.  Although  the  relationship  between  the  radial  and
horizontal stem cells is not clear, horizontal cells rarely generate radial Type-1 cells in viral
lineage tracing experiments.  Interestingly,  activated neurogenic stem cells  in the dentate
gyrus express Sox1, which, like Sox2 and Sox3, is a member of the SoxB1 family. Sox1, like
Hes5, is expressed by radial and horizontal Type-1 cells (Venere et al., 2012). Lineage tracing
shows that Sox1-positive Type-1 cells include the active neural stem cells and support that
neurogenic stem cells in the dentate gyrus may switch between active and inactive states
(Lugert et al., 2010; Venere et al., 2012).
10. Radial and horizontal hippocampal stem cells respond selectively to
external cues
The classical view is that radial Type-1 stem cells divide infrequently to generate transient
amplifying progenitors through asymmetric cell divisions. However, as described above there
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for example homeostatic neurogenesis and regeneration. It is likely that the elucidation of the
diverse neural stem cells in the subventricular zone is going to require the combination of
different markers and genetic tools (Beckervordersandforth et al., 2010).
7. The hippocampus continually generates neurons which participate in
memory formation
In contrast to the subventricular zone where proliferation and neurogenesis are eradicat‐
ed  soon  after  birth  in  humans,  the  dentate  gyrus  of  the  human  hippocampus,  like  in
rodents, continues to generate neurons from mitotically active progenitors cells all the way
into adulthood. The cellular composition of the neurogenic niche in the dentate gyrus has
been studied extensively (Seri  et  al.,  2001;  Kempermann et  al.,  2004;  Steiner et  al.,  2006;
Steiner et al., 2008). However, the identity and regulation of neural stem cells in the dentate
gyrus remains unclear.
8. The progenitor pool in the dentate gyrus is morphologically and
functionally heterogeneous
Self-renewing neural  stem cells  in  the  subgranular  zone of  the  adult  hippocampal  den‐
tate  gyrus  (also  referred  to  as  Type-1  cells)  produce  intermediate  progenitor  cells  (IPs,
Type-2a cells), NeuroD1 and Doublecortin-positive neuroblasts (Type-2b) and subsequent‐
ly granule neurons (Seri et al., 2001; Kempermann et al., 2004; Steiner et al., 2006). Type-1
neural stem cells have their cell bodies in the subgranular zone and extend a long process
through the granule cell  layer to the overlaying molecular layer.  Type-2 cells  are transi‐
ent intermediate progenitors. They also have their cell body in the subgranular zone but
lack  a  long  radial  process  and  have  a  more  rounded  morphology  with  short  stubby
processes (Seri et al.,  2001; Steiner et al.,  2006). Neuroblasts by contrast extend a leading
process  and  migrate  into  the  granule  cell  layer.  Whereas  radial  Type-1  cells  are  quies‐
cent, Type-2 cells divide readily expanding the progenitor pool. Previous Bromodeoxyuri‐
dine  labeling  experiments  suggested  that  Type-2a  cells,  which  express  proneural
transcription  factors,  are  the  major  proliferative  progenitor  in  the  adult  dentate  gyrus
(Steiner et al.,  2006). In addition, retroviral-labeling experiments showed that neuroblasts
that have extended a radial process, exit cell cycle, and only go through one or two cell
divisions (Seri et al.,  2001). However, recent genetic labeling and lineage tracing of stem
cells  in  the  dentate  gyrus  revealed  that  Ascl1-positive  Type-2a  cells  do  not  undergo
symmetric  cell  divisions  but  generate  an  addition  intermediate  cell  type,  Tbr2-positive
Type-2 cells (recently referred to as Type-2ab cells) (Bonaguidi et al.,  2012; Lugert et al.,
2012). The Tbr2-positive cells divide frequently to amplify the progenitor pool and increase
the number of neurons generated from each stem cell division (Lugert et al., 2012).
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9. Multiple stem cell populations in the dentate gyrus
The classical view of stem cells in the adult dentate gyrus implicates the quiescent radial
glial like Type-1 cells as the primary progenitor. However, retroviral labeling is common‐
ly used to examine neurogenesis in the dentate and to label cells that continue to gener‐
ate multiple neurons over time (Seri et al., 2001; Suh et al., 2007). As retroviral integration
and thus viral  gene expression are dependent upon cells  passing through the cell  cycle,
some long-term neurogenic  stem cells  in  the  dentate  must  be  mitotically  active.  Radial
Type-1 cells are rarely labeled in these retroviral experiments suggesting that other cells
that lack a radial process must also display self-renewing and long-term neurogenic stem
cell  potential  (Suh et al.,  2007).  This is  also supported by lentiviral  labeling experiments
driving reporter expression from the Sox2  promoter (Suh et  al.,  2007).  Expression of the
transcription factor Sox2 is associated with progenitor cells of the brain and required for
their  maintenance  by  regulating  Notch,  Sonic  Hedgehog  expression  and  Wnt  activity
(Steiner et al., 2008; Favaro et al., 2009; Kuwabara et al., 2009). A population of none radial
stem cells with horizontally orientated processes has been identified by Cre-recombinase
mediated  lineage  tracing  (Suh  et  al.,  2007).  These  horizontal  cells  display  stem  cell
characteristics  but  are  clearly  distinct  from the previously described Type-1  and Type-2
cells. Horizontal Type-1 neural stem cells like radial Type-1 stem cells in the dentate gyrus
have active Notch signaling and are labeled with a Notch signal reporter allele Hes5::GFP
(Ables et al., 2010; Ehm et al., 2010; Lugert et al., 2010). However, although they express
Nestin they do not express the astrocytic protein GFAP. Hence, there remains some debate
and despite their similarity in morphology to Type-2 cells, horizontal Type-1 stem cells do
not express classic Type-2 cell markers including the proneural transcription factor Ascl1
– a Notch repressed target gene – Tbr2 or Doublecortin (Steiner et al., 2006; Lugert et al.,
2010).  In  addition,  horizontal  Type-1  cells  are  more  mitotically  active  than  their  radial
counterparts  (Lugert  et  al.,  2010).  Therefore,  the  horizontal  Hes5-positive  cells  likely
represent the Sox2-positive population of stem cells and those stem cells commonly traced
and  analyzed  by  retroviral  labeling.  Although  the  relationship  between  the  radial  and
horizontal stem cells is not clear, horizontal cells rarely generate radial Type-1 cells in viral
lineage tracing experiments.  Interestingly,  activated neurogenic stem cells  in the dentate
gyrus express Sox1, which, like Sox2 and Sox3, is a member of the SoxB1 family. Sox1, like
Hes5, is expressed by radial and horizontal Type-1 cells (Venere et al., 2012). Lineage tracing
shows that Sox1-positive Type-1 cells include the active neural stem cells and support that
neurogenic stem cells in the dentate gyrus may switch between active and inactive states
(Lugert et al., 2010; Venere et al., 2012).
10. Radial and horizontal hippocampal stem cells respond selectively to
external cues
The classical view is that radial Type-1 stem cells divide infrequently to generate transient
amplifying progenitors through asymmetric cell divisions. However, as described above there
Neural Stem Cell Heterogeneity
http://dx.doi.org/10.5772/55676
35
are additional progenitors in the hippocampal dentate gyrus that can function as stem cells.
Hence, the question arises what are the functions of these multiple putative neural stem cells?
Do they both contribute to neurogenesis in the adult hippocampus and are they in a lineage
relationship with each other? Genetic labeling experiments suggest that both radial and
horizontal stem cells may be functionally distinct or at least they respond differently to
different pathophysiological cues (Lugert et al., 2010).
Analysis of hippocampal neurogenesis has shown it to be a dynamic process that diminishes
with age but can be stimulated and modulated by physiology and pathology (Kuhn et al.,
1996; Kempermann et al., 1998; Ben Abdallah et al., 2008; Fabel and Kempermann, 2008; Parent
and Murphy, 2008; Steiner et al., 2008; Zhao et al., 2008). Voluntary physical exercise induces
increased proliferation and generation of immature neurons. These neurons do not readily
integrate into the dentate gyrus but the increased proliferation of the stem cells is significant
(Fabel and Kempermann, 2008). Notch signaling also controls neural stem cell maintenance
and differentiation within the dentate gyrus (Breunig et al., 2007; Ables et al., 2010; Ehm et al.,
2010; Lugert et al., 2010; Lugert et al., 2012). Loss of Notch activity results in the loss of neural
stem cells and their precocious differentiation culminating in a loss of neuron production
(Ables et al., 2010; Ehm et al., 2010; Lugert et al., 2010). Genetic labeling of neural stem cells in
the dentate that display Notch signaling has uncovered diversity in stem cell responses to
pathophysiology (Lugert et al., 2010). Physical exercise stimulates proliferation of the radial
type1 cells but not the horizontal stem cells (Lugert et al., 2010). Running induces the radial
cells to enter the active stem cell pool without expanding the total stem cell population. This
suggests that radial cells in physically active animals undergo asymmetric cell divisions to
generate committed progenitors that increase the number of newborn neurons whilst main‐
taining the Type-1 stem cell pool through self-renewal. This also implies that radial stem cells
respond to stimuli generated by increased physical activity that are not seen or are not
interpreted in the same way by the horizontal stem cells. These findings seem, at first glance,
to contradict previous experiments where Nestin expressing progenitors were labeled and
suggested that radial Type-1 cells do not proliferate significantly in running mice (Steiner et
al., 2008). It is likely that the differences in result reflect the different experimental paradigms
used to identify the stem cells of the dentate gyrus. Where as Hes5 expression identifies a
smaller population of cells more restricted to the stem cell pools in the subgranular cell layer,
the Nestin promoter is expressed by stem cells and more committed progenitors (Bonaguidi et
al., 2012). Hence, it remains possible that the different labeling techniques and the extent of
cell labeling could effect the quantification and interpretation.
11. Selective loss of active stem cells in the hippocampus of aged mice
Neurogenesis  in  the  mammalian  brain  diminishes  dramatically  after  birth,  even  in  the
dentate  gyrus  where  neurons  are  continuously  generated  throughout  life.  This  reduced
neurogenesis is associated with a loss of mitotic cells (Kuhn et al., 1996; Kempermann et
al.,  1998;  Ben  Abdallah  et  al.,  2008;  Steiner  et  al.,  2008).  Whereas  some  reports  have
suggested an irreversible loss of neural stem cells in the dentate gyrus due to exit  from
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the  stem cell  pool  and  differentiation  into  astrocytes  (Encinas  et  al.,  2011;  Encinas  and
Sierra, 2012), others suggest that the stem cells are not lost but become dormant with age
(Lugert et al., 2010; Bonaguidi et al., 2011; Venere et al., 2012). Hence, the reason for the
substantial  reduction  in  neuron  production  remains  unclear  but  may  be  caused  by  a
culmination of physiological changes.
Genetic  lineage  tracing  of  Nestin  expressing  cells  revealed  that,  parallel  to  the  reduced
number of neurons generated from the labeled stem cells, radial Type-1 cells in the aged
mouse brain enter cell cycle and, following a few cell divisions, differentiate into polymor‐
phic astrocytes that lose radial morphology and presumably stem cell  potential (Encinas
et al., 2011). This “deforestation” or expenditure of the stem cells likely contributes to the
reduction in mitotic progenitors and neurons (Encinas and Sierra, 2012). Surprisingly, in a
parallel study using the same genetic tools, clonal analysis indicated that Nestin  express‐
ing  stem  cells  within  the  subgranular  layer  can  undergo  prolonged  neurogenesis.  In
addition, these clonal experiments revealed an additional degree of heterogeneity within
the stem cell population of the dentate gyrus. Some labeled Type-1 cells remained quiescent
over many months and failed to generate any viable offspring. Other Type-1 cells divided
and generated clones  of  cells  that  included progenitors,  neurons and astrocytes  indicat‐
ing  multipotency  (Bonaguidi  et  al.,  2011).  Partially  supporting  the  proposal  that  some
Nestin-expressing Type-1 cells may exit the stem cell pool, clones were found that contained
only differentiated cells. Taken together these data indicate heterogeneity within the stem
cells  pools  and it  seems that  a  combination of  entry  of  stem cells  into  a  dormant  state
coupled with a partial loss of some progenitors may contribute to the age related decline
in neurogenesis (Bonaguidi et al., 2011; Encinas et al., 2011).
In contrast, neural stem cells in the dentate gyrus labeled by Notch activity and Sox2 expression
remain in the aged dentate gyrus (Lugert et al., 2010; Bonaguidi et al., 2011; Lugert et al.,
2012). Interestingly however, the proportion of the cells that are mitotically active, which is
predominantly the horizontal population, are lost. Hence, even in aged mice the number of
stem cells remains relatively constant but their mitotic activity reduces and actively prolifer‐
ating cells are lost, become quiescent, or dormant (Lugert et al., 2010; Bonaguidi et al., 2011;
Lugert et al., 2012). This is similar to findings that Sox1–positive stem cells remain long-term
neurogenic and can enter and exit the active stem cells pools (Venere et al., 2012).
A loss of stem cells in the dentate gyrus would suggest that the neurogenic process cannot be
rescued or reversed in aged animals. However, physical exercise and pathological stimulation
both stimulate proliferation, neural stem cell activation and under some conditions increased
numbers of newly generated neurons (Rao et al., 2005; van Praag et al., 2005; Hattiangady et
al., 2008; Jessberger and Gage, 2008; Rao et al., 2008; Zhao et al., 2008). Hence, although loss of
stem cells could contribute to the age-related decline in neuron production, some cells with
stem cell potential remain even in the dentate gyrus of old mice and these can be activated to
proliferate and generate new cells (Lugert et al., 2010; Venere et al., 2012). It still remains
unclear whether radial Type-1 cells in old mice enter the cell cycle during physical exercise or
whether the few remaining horizontal cells could reactivate in the aged brain or whether a
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are additional progenitors in the hippocampal dentate gyrus that can function as stem cells.
Hence, the question arises what are the functions of these multiple putative neural stem cells?
Do they both contribute to neurogenesis in the adult hippocampus and are they in a lineage
relationship with each other? Genetic labeling experiments suggest that both radial and
horizontal stem cells may be functionally distinct or at least they respond differently to
different pathophysiological cues (Lugert et al., 2010).
Analysis of hippocampal neurogenesis has shown it to be a dynamic process that diminishes
with age but can be stimulated and modulated by physiology and pathology (Kuhn et al.,
1996; Kempermann et al., 1998; Ben Abdallah et al., 2008; Fabel and Kempermann, 2008; Parent
and Murphy, 2008; Steiner et al., 2008; Zhao et al., 2008). Voluntary physical exercise induces
increased proliferation and generation of immature neurons. These neurons do not readily
integrate into the dentate gyrus but the increased proliferation of the stem cells is significant
(Fabel and Kempermann, 2008). Notch signaling also controls neural stem cell maintenance
and differentiation within the dentate gyrus (Breunig et al., 2007; Ables et al., 2010; Ehm et al.,
2010; Lugert et al., 2010; Lugert et al., 2012). Loss of Notch activity results in the loss of neural
stem cells and their precocious differentiation culminating in a loss of neuron production
(Ables et al., 2010; Ehm et al., 2010; Lugert et al., 2010). Genetic labeling of neural stem cells in
the dentate that display Notch signaling has uncovered diversity in stem cell responses to
pathophysiology (Lugert et al., 2010). Physical exercise stimulates proliferation of the radial
type1 cells but not the horizontal stem cells (Lugert et al., 2010). Running induces the radial
cells to enter the active stem cell pool without expanding the total stem cell population. This
suggests that radial cells in physically active animals undergo asymmetric cell divisions to
generate committed progenitors that increase the number of newborn neurons whilst main‐
taining the Type-1 stem cell pool through self-renewal. This also implies that radial stem cells
respond to stimuli generated by increased physical activity that are not seen or are not
interpreted in the same way by the horizontal stem cells. These findings seem, at first glance,
to contradict previous experiments where Nestin expressing progenitors were labeled and
suggested that radial Type-1 cells do not proliferate significantly in running mice (Steiner et
al., 2008). It is likely that the differences in result reflect the different experimental paradigms
used to identify the stem cells of the dentate gyrus. Where as Hes5 expression identifies a
smaller population of cells more restricted to the stem cell pools in the subgranular cell layer,
the Nestin promoter is expressed by stem cells and more committed progenitors (Bonaguidi et
al., 2012). Hence, it remains possible that the different labeling techniques and the extent of
cell labeling could effect the quantification and interpretation.
11. Selective loss of active stem cells in the hippocampus of aged mice
Neurogenesis  in  the  mammalian  brain  diminishes  dramatically  after  birth,  even  in  the
dentate  gyrus  where  neurons  are  continuously  generated  throughout  life.  This  reduced
neurogenesis is associated with a loss of mitotic cells (Kuhn et al., 1996; Kempermann et
al.,  1998;  Ben  Abdallah  et  al.,  2008;  Steiner  et  al.,  2008).  Whereas  some  reports  have
suggested an irreversible loss of neural stem cells in the dentate gyrus due to exit  from
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the  stem cell  pool  and  differentiation  into  astrocytes  (Encinas  et  al.,  2011;  Encinas  and
Sierra, 2012), others suggest that the stem cells are not lost but become dormant with age
(Lugert et al., 2010; Bonaguidi et al., 2011; Venere et al., 2012). Hence, the reason for the
substantial  reduction  in  neuron  production  remains  unclear  but  may  be  caused  by  a
culmination of physiological changes.
Genetic  lineage  tracing  of  Nestin  expressing  cells  revealed  that,  parallel  to  the  reduced
number of neurons generated from the labeled stem cells, radial Type-1 cells in the aged
mouse brain enter cell cycle and, following a few cell divisions, differentiate into polymor‐
phic astrocytes that lose radial morphology and presumably stem cell  potential (Encinas
et al., 2011). This “deforestation” or expenditure of the stem cells likely contributes to the
reduction in mitotic progenitors and neurons (Encinas and Sierra, 2012). Surprisingly, in a
parallel study using the same genetic tools, clonal analysis indicated that Nestin  express‐
ing  stem  cells  within  the  subgranular  layer  can  undergo  prolonged  neurogenesis.  In
addition, these clonal experiments revealed an additional degree of heterogeneity within
the stem cell population of the dentate gyrus. Some labeled Type-1 cells remained quiescent
over many months and failed to generate any viable offspring. Other Type-1 cells divided
and generated clones  of  cells  that  included progenitors,  neurons and astrocytes  indicat‐
ing  multipotency  (Bonaguidi  et  al.,  2011).  Partially  supporting  the  proposal  that  some
Nestin-expressing Type-1 cells may exit the stem cell pool, clones were found that contained
only differentiated cells. Taken together these data indicate heterogeneity within the stem
cells  pools  and it  seems that  a  combination of  entry  of  stem cells  into  a  dormant  state
coupled with a partial loss of some progenitors may contribute to the age related decline
in neurogenesis (Bonaguidi et al., 2011; Encinas et al., 2011).
In contrast, neural stem cells in the dentate gyrus labeled by Notch activity and Sox2 expression
remain in the aged dentate gyrus (Lugert et al., 2010; Bonaguidi et al., 2011; Lugert et al.,
2012). Interestingly however, the proportion of the cells that are mitotically active, which is
predominantly the horizontal population, are lost. Hence, even in aged mice the number of
stem cells remains relatively constant but their mitotic activity reduces and actively prolifer‐
ating cells are lost, become quiescent, or dormant (Lugert et al., 2010; Bonaguidi et al., 2011;
Lugert et al., 2012). This is similar to findings that Sox1–positive stem cells remain long-term
neurogenic and can enter and exit the active stem cells pools (Venere et al., 2012).
A loss of stem cells in the dentate gyrus would suggest that the neurogenic process cannot be
rescued or reversed in aged animals. However, physical exercise and pathological stimulation
both stimulate proliferation, neural stem cell activation and under some conditions increased
numbers of newly generated neurons (Rao et al., 2005; van Praag et al., 2005; Hattiangady et
al., 2008; Jessberger and Gage, 2008; Rao et al., 2008; Zhao et al., 2008). Hence, although loss of
stem cells could contribute to the age-related decline in neuron production, some cells with
stem cell potential remain even in the dentate gyrus of old mice and these can be activated to
proliferate and generate new cells (Lugert et al., 2010; Venere et al., 2012). It still remains
unclear whether radial Type-1 cells in old mice enter the cell cycle during physical exercise or
whether the few remaining horizontal cells could reactivate in the aged brain or whether a
Neural Stem Cell Heterogeneity
http://dx.doi.org/10.5772/55676
37
distinct cell population, previously not studied or labeled with the tools and techniques current
available, replenishes the neural stem cell pools.
12. Seizures induce neural stem cell proliferation in the hippocampus
Chronic temporal lobe epilepsy is associated with an increase production of neurons in the
dentate gyrus (Parent, 2007; Scharfman and Gray, 2007). Conversely, acute seizures dramati‐
cally induce abnormal production of neurons in the dentate gyrus, which may contribute to
chronic epilepsy. Whether generation of new neurons in the hippocampus of patients with
epilepsy is a result of the disease or contributes to the cause is not clear. In mice, experimentally
induced seizures effect neuron production at multiple levels and not least by disproportion‐
ately increasing the number of neuroblasts (Type-3 cells) (Jessberger et al., 2005). Both the radial
Type-1 and the horizontal stem cells are activated in response to experimentally induced
seizures (Huttmann et al., 2003; Lugert et al., 2012; Venere et al., 2012). However, the proportion
of radial cells that enter cell cycle is rather modest and the population is not expanded
suggesting that their divisions generate more committed progenitors. The horizontal stem cells
respond more homogeneously to seizures. The majority of them enter the cell cycle and the
total number increases significantly (Lugert et al., 2010). The increase in horizontal cells could
be the result of symmetric cell division but also generation of horizontal cells from the radial
stem cell pool. Although current tools and techniques have not been able to address the
mechanism, the increase in mitotically active stem cells following chronic seize and the
differential response of the different stem cell pools has important implications for the cause
and progression of temporal lobe epilepsy in humans.
13. Future perspectives
In the future it will be a major challenge to elucidate the heterogeneity within the stem cells
pools and to address there cellular function. This will include understanding how these
different populations and cell states are regulated and whether their functions are controlled
by distinct niche signals or genetic and epigenetic mechanisms. Only the detailed analysis of
neural stem cells in the adult brain could uncover their functions in homeostasis, aging and
disease. This would raise the exciting possibility that specific neural stem cell subtypes could
be directly targeted for therapy.
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distinct cell population, previously not studied or labeled with the tools and techniques current
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Chronic temporal lobe epilepsy is associated with an increase production of neurons in the
dentate gyrus (Parent, 2007; Scharfman and Gray, 2007). Conversely, acute seizures dramati‐
cally induce abnormal production of neurons in the dentate gyrus, which may contribute to
chronic epilepsy. Whether generation of new neurons in the hippocampus of patients with
epilepsy is a result of the disease or contributes to the cause is not clear. In mice, experimentally
induced seizures effect neuron production at multiple levels and not least by disproportion‐
ately increasing the number of neuroblasts (Type-3 cells) (Jessberger et al., 2005). Both the radial
Type-1 and the horizontal stem cells are activated in response to experimentally induced
seizures (Huttmann et al., 2003; Lugert et al., 2012; Venere et al., 2012). However, the proportion
of radial cells that enter cell cycle is rather modest and the population is not expanded
suggesting that their divisions generate more committed progenitors. The horizontal stem cells
respond more homogeneously to seizures. The majority of them enter the cell cycle and the
total number increases significantly (Lugert et al., 2010). The increase in horizontal cells could
be the result of symmetric cell division but also generation of horizontal cells from the radial
stem cell pool. Although current tools and techniques have not been able to address the
mechanism, the increase in mitotically active stem cells following chronic seize and the
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and progression of temporal lobe epilepsy in humans.
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Diversity of Neural Stem/Progenitor Populations:
Varieties by Age, Regional Origin and Environment
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1. Introduction
Criteria of „neural stemness” characterize a large number of terminally non-differentiated
neural tissue cells. Neural stem/progenitor cells capable for asymmetric mitoses (resulting in
a similar and a differently committed daughter cell which may adopt neuronal or glial
phenotypes in further development) are present during the entire life-span of vertebrates and
have been found in almost all regions of the brain. With the advancement of neural tissue
genesis and maturation, more and more stem/progenitor-like cells adopt “quiescent” states,
but can be activated by appropriate (yet not properly understood) stimuli. Besides asymmetric
(stem cell specific) division, these cells can multiply by symmetric mitoses resulting in identical
progenies. Self-renewal and symmetric multiplication are responsible for maintaining or
expanding stem/progenitor populations at the actual stage of neural commitment. Expanded
pools of cells with similar, but yet flexible developmental potential can provide the desired
number and type of cells for genesis, maintenance and repair of the nervous tissue. Except the
ontogenetically and phylogenetically “oldest” pioneer and/or large projection-type neurons
[1], the majority of neural tissue cells are produced through successive stem/progenitor stages
[2]. The extreme cellular diversity of the mature CNS implies huge diversity in the precursor
populations. Accordingly, a large number of neural stem/progenitor populations exist in
different stages of neural cell fate commitment and display different cellular characteristics,
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transient amplifying progenitor populations and migrating or resident progenitor/precursor
cells reside at various “niches” including the “professional” neurogenic zones, migratory
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1. Introduction
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changes of the local environment including neighbouring cells, extracellular matrix, metabo‐
lite-, oxygen- and growth factor-supply and activity-driven ionic composition.
With improvement of methodologies, different populations of NS cells have been isolated,
propagated and investigated in vitro. Despite of rapidly accumulating data, however, the
similarities and differences among various NS populations are not properly understood either
in vivo or in vitro. This chapter intends to give an insight in the intrinsic varieties of NSC
populations. As examples, fairly distinct features of in vitro propagated early embryonic and
adult-derived mouse neural stem/progenitor populations will be presented.
2. Diversity of neural stem cells from early embryonic tissue genesis to
adult-hood cell production
2.1. Neural stem cells in the neural plate and in primary geminative zones
The earliest neural stem populations, the cylindrical neuroepithelial cells of the early embry‐
onic neural plate (Fig.1) appear in the embryonic disc soon after embedding. As it was learned
from studies on chick embryos, the anterior epiblast cells acquire „pre-neural” fate [3] as it is
indicated by Sox2 expression [4] under the influence of morphogen gradients established by
two early organizers, the anterior visceral endoderm (AVE) [5] and the primitive streak and
later by the node. The different morphogen concentrations result in different activation of
positional (region-specific) genes, predestinating regions for different future fate in both chick
and mammalian embryos [6,7] (Fig.1). Accordingly, despite of the apparent morphological
homogeneity [8], neuroepithelial cells are not identical from the very beginning of neural tissue
genesis.
Figure 1. Scheme of formation and regionalization of the neural plate. The neural plate forms from the anterior epi‐
blast in response to morphogens produced by the anterior visceral entoderm (AVE), the primitive streak and nodus
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and the non-neural ectodermal ridge of the epiblast. The positions along the anterior (A) and posterior (P) body axes -
imply regional differences among neuroectodermal cells.
During neural folding, a single layer of proliferating pre-neural stem cells called radial
neuroepithel cells compose the neural plate and rapidly enlarge the neural primordium. These
cells will give rise to primary neural stem cells, the embryonic radial glia (Fig.2), during the
formation and closing of the neural tube (7-10 pcd in mouse). While the anterior cells of the
epiblast of vertebrates were shown to generate neurons, if separated from their natural
environment, (“default neural fate” [9]), or by blocking mesoderm-inducing morphogen
actions, the mechanisms behind the transition of radial neuroepithel cells to radial glia cells
are not properly understood.
Embryonic radial glial cells line the lumen of the neural tube in a single cell layer and compose
the primary neural germinative zone (ventricular zone; VZ). The first neurons are generated
in this layer by asymmetric mitoses of radial glial cells (Fig.2). Such division produces a
daughter cell, which preserves radial glia characteristics and another one, a neuronal precur‐
sor, which looses proliferation capability and migrates outward from the lumen along a radial
glia neighbour [10]. These early neuronal precursors will develop mainly to large, projecting
type neurons [1]. Immediate cell-to cell interactions including Notch/Delta signalling [11] and
growth factor – receptor signals (as neuregulin – ErbB; [12]) play inevitable roles in the
determination and maintenance of asymmetric commitment of the two daughter cells.
Figure 2. Formation of the primary neurogenic zone from radial neuroepithelial cells and generation of the first post‐
mitotic neuronal precursors by asymmetric division of radial glial cells in the ventricular zone.
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The earliest neural stem populations, the cylindrical neuroepithelial cells of the early embry‐
onic neural plate (Fig.1) appear in the embryonic disc soon after embedding. As it was learned
from studies on chick embryos, the anterior epiblast cells acquire „pre-neural” fate [3] as it is
indicated by Sox2 expression [4] under the influence of morphogen gradients established by
two early organizers, the anterior visceral endoderm (AVE) [5] and the primitive streak and
later by the node. The different morphogen concentrations result in different activation of
positional (region-specific) genes, predestinating regions for different future fate in both chick
and mammalian embryos [6,7] (Fig.1). Accordingly, despite of the apparent morphological
homogeneity [8], neuroepithelial cells are not identical from the very beginning of neural tissue
genesis.
Figure 1. Scheme of formation and regionalization of the neural plate. The neural plate forms from the anterior epi‐
blast in response to morphogens produced by the anterior visceral entoderm (AVE), the primitive streak and nodus
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and the non-neural ectodermal ridge of the epiblast. The positions along the anterior (A) and posterior (P) body axes -
imply regional differences among neuroectodermal cells.
During neural folding, a single layer of proliferating pre-neural stem cells called radial
neuroepithel cells compose the neural plate and rapidly enlarge the neural primordium. These
cells will give rise to primary neural stem cells, the embryonic radial glia (Fig.2), during the
formation and closing of the neural tube (7-10 pcd in mouse). While the anterior cells of the
epiblast of vertebrates were shown to generate neurons, if separated from their natural
environment, (“default neural fate” [9]), or by blocking mesoderm-inducing morphogen
actions, the mechanisms behind the transition of radial neuroepithel cells to radial glia cells
are not properly understood.
Embryonic radial glial cells line the lumen of the neural tube in a single cell layer and compose
the primary neural germinative zone (ventricular zone; VZ). The first neurons are generated
in this layer by asymmetric mitoses of radial glial cells (Fig.2). Such division produces a
daughter cell, which preserves radial glia characteristics and another one, a neuronal precur‐
sor, which looses proliferation capability and migrates outward from the lumen along a radial
glia neighbour [10]. These early neuronal precursors will develop mainly to large, projecting
type neurons [1]. Immediate cell-to cell interactions including Notch/Delta signalling [11] and
growth factor – receptor signals (as neuregulin – ErbB; [12]) play inevitable roles in the
determination and maintenance of asymmetric commitment of the two daughter cells.
Figure 2. Formation of the primary neurogenic zone from radial neuroepithelial cells and generation of the first post‐
mitotic neuronal precursors by asymmetric division of radial glial cells in the ventricular zone.
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The early radial glial cells express several “marker” features (Table 1), which together with
cell shape and localization may identify them. In contrast to later neural stem/progenitor
populations, radial neuroepithelial and early radial glial cells express Oct4 and nanog
embryonic stem cell genes and the anterior epiblast-characterizing Otx2 and En1,2 “positional”
genes (see ref. in Table 1). These cells span the whole thickness of the early neural tube, and
can divide without changing their spanned shape [8].
These early neural stem cells proliferate rapidly (with cycle time of about 14-16 hours), but not
continuously, and with both symmetric and asymmetric divisions. The symmetric mitoses
assure the expansion and maintenance of neural stem populations at the given stage of
commitment. Intermittent non-mitotic periods help the attachment and out-migration of
neuronal precursors. During the formation and closure of the tube, the neural primordium is
composed by a single neurogenic zone, but with heterogeneous cellular constituents [13]
comprising asymmetrically and symmetrically dividing stem/progenitor cells, and migrating,
differentiating neuronal precursors.
The cellular diversity of the early neural tube is further enhanced by the time-delay in
development along the anterior – posterior and dorso-ventral body axes. The tube formation
and closure proceed with a delay from the zone of brachial arches (the region for future hind
brain) to both, rostral and caudal directions, and the production and maturation of neural cells
on the ventral face always precede those on the dorsal part in each neural domain [14]. It means
that even small samples of the tissue will contain diverse populations of (stem/amplifying/
differentiating) neural cells.
The cellular heterogeneity is further increased by the ongoing regional specification, which
results in well-distinguishable domains with characteristic gene expression patterns along
both the anterio-posterior and dorso-ventral axes of the growing CNS [28, 29]. Differential
expression of positional master genes results in diverging expression patterns of “down-hill”
genes including those coding for adhesion receptors and extracellular matrix proteins, and
leads to the formation of morphological boundaries between the expression domains: the
developing CNS is composed by segments called neuromeres [7, 30]. Along the A-P body axis,
transversal segments will delineate primary brain vesicles (prosencephalon, mesencephalon,
rhombencephalon) first, and smaller neuromeres later on. Inside the larger segment bounda‐
ries, smaller developmental / morphological entities will develop as the prosomeres in the
telencephalon or rhombomeres in the hindbrain. In parallel with the anterior-posterior
segmentation, dorso–ventral specification will identify longitudinal domains in the develop‐
ing CNS. Dorso–ventral specification is initiated by the early lateral–medial determination of
the neural plate, namely, the midline expression of sonic hedgehog and the lateral expression
of bone morphogenic (BMP) proteins (Fig.3). With tube formation, progenies of midline plate
cells become the ventral-most tube cells composing the notoplate. Derivatives of lateral-most
neural plate cells will compose the neural crest and the closing dorsal lip of the tube, the later
roof plate. Notoplate cells produce Shh, while roof plate cells produce BMPs and Wnt
morphogenic factors, establishing dorso-ventral morphogen gradients throughout the
developing CNS (for a recent review: [31]).
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„Marker” features References
cell shape
Elongated, bipolar shape; Adherent junctions at the lumen-face; laminin
receptors at the apical and basal ends;
[10, 8]
cellular motion





vimentin (characterizes many non-differentiated cells)
[refs in 1]
GFAP (characterizes astrocytes; expression by radial glia cells is species-
dependent )
nestin (expressed by many progenitor-type cells including muscle progenitors)
RC (1,2) nestin-associated protein-epitope; radial glia marker in the CNS
master-gene
expression
Oct3/4, nanog (embryonic stem cell/pluripotency genes; expressed in the
epiblast and sporadically in the forming neural plate)
[16]
Otx2 (anterior positional gene; expressed in the anterior epiblast and in the
neural plate; later restricted to the forebrain regions)
[17, 18]
En1,2 (engrailed positional gene; expressed in the anterior epiblast, in the
neural plate; later restricted to isthmus and mesencephalic, cerebellar areas)
[19, 20]
Sox2 (codes for a HMG box transcription factor; expressed generally by CNS
neural stem cells)
[4,21,22]
Pax6 (codes for a paired-box transcription factor; plays important roles in CNS
patterning and eye development; expressed by multiple neural stem/
progenitor cells)
[23, 24 ]






Notch1,3 (protein product: cell surface receptor with cleavable intracellular
transcription fragment (NICD)
[11]
ErbB (Neuregulin Trk receptor); [12]
GLAST (Glutamate-aspartate transporter; astrocytes also express) [26]
Intracellular
transporter
BLBP (brain lipid binding protein; Intracellar transporter of hydrophobic
molecules including small nuclear ligand molecules)
[27]
Table 1. Radial glia “marker” features for characterization of radial glial cells
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on the ventral face always precede those on the dorsal part in each neural domain [14]. It means
that even small samples of the tissue will contain diverse populations of (stem/amplifying/
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expression of positional master genes results in diverging expression patterns of “down-hill”
genes including those coding for adhesion receptors and extracellular matrix proteins, and
leads to the formation of morphological boundaries between the expression domains: the
developing CNS is composed by segments called neuromeres [7, 30]. Along the A-P body axis,
transversal segments will delineate primary brain vesicles (prosencephalon, mesencephalon,
rhombencephalon) first, and smaller neuromeres later on. Inside the larger segment bounda‐
ries, smaller developmental / morphological entities will develop as the prosomeres in the
telencephalon or rhombomeres in the hindbrain. In parallel with the anterior-posterior
segmentation, dorso–ventral specification will identify longitudinal domains in the develop‐
ing CNS. Dorso–ventral specification is initiated by the early lateral–medial determination of
the neural plate, namely, the midline expression of sonic hedgehog and the lateral expression
of bone morphogenic (BMP) proteins (Fig.3). With tube formation, progenies of midline plate
cells become the ventral-most tube cells composing the notoplate. Derivatives of lateral-most
neural plate cells will compose the neural crest and the closing dorsal lip of the tube, the later
roof plate. Notoplate cells produce Shh, while roof plate cells produce BMPs and Wnt
morphogenic factors, establishing dorso-ventral morphogen gradients throughout the
developing CNS (for a recent review: [31]).
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Figure 3. Schematic presentation of the establishment of dorso–ventral specification (longitudinal segmentation) in
the neural tube. The lateral-medial (L-M) regionalization turns into dorso-ventral (D-V) regionalization when the neu‐
ral plate folds and forms the neural tube. BMP: bone morphogenic proteins; SHH: sonic hedgehog protein; Zic, Gli-3,
Pax6, Emx2, Dlx, Nkx are examples of genes expressed in different dorso-ventral domains.
The position along the antero-posterior and dorso–ventral axes determines the identity of
future brain regions and seems to predict the phenotype of neurons through the orchestrated
expression of defined region-specific, pro-neural and neuron-specific genes [28]. Boundaries
between embryonic segments provide routes for the elongation of pioneer axons and delineate
the paths for future fiber tracks.
For the time being, it is not clear whether the early embryonic position can (or how far can)
determine the intrinsic developmental potential of individual cells. There are contradictory
results on the “positional memory” of stem/progenitor cells if removed from their original
position [32]. Our own data [33] indicate that neural stem-like cells isolated from early
embryonic (E9) mouse forebrain do not display regional “memory” after in vitro propagation.
In the course of in vitro neuron formation they express divergent region-specific genes, those
not expressed in overlapping regions of the developing CNS. The data suggest that permanent
presence of region-specifying factors is required for maintaining regional commitment, at least
in case of early embryonic neural stem cells. This finding, however, does not compromise the
fact that in vivo, neural stem/progenitor cells of the primary germinative (VZ) zone display
important molecular and cell biological differences.
2.2. Diversity of stem/progenitor cells in the secondary germinative zones of the developing
brain
With the thickening of the neural wall, increasing number of proliferation-capable cells loose
contact either with the lumen-face (outer progenitors; OSVZ progenitors) or the pial surface
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(short progenitors; SNPs) or both (inner progenitors; ISVZ progenitors), and accordingly,
change morphology and developmental characteristics [34, 8]. The number of primary radial
glial cells decreases gradually, while their derivatives dividing at a distance from the luminar
surface generate a novel germinative zone, the subventricular zone (SVZ). While a few SNP
cells remain in contact with the luminar surface and thought to preserve “ancient” (primary)
stem cell properties, the layer lining the ventricle wall transforms to the future ependyma and
neural cell production is transposed to the secondary germinative layer, the SVZ. The SVZs
along the entire neuraxis generate large number of progenitors and precursors including
smaller projecting-type neurons, interneurons, astrocytes, oligodendrocytes and produces also
enough stem cells to maintain an appropriate neurogenic capacity (for review see [1]). Novel
precursors migrate from the SVZs to final destinations along defined routes in the developing
neural parenchyma. While the lineage relations among different SVZ progenitors are not fully
explored [8, 35], it is clear that evolutionary new SVZ progenitors provide the cell generating
capacity for the enlarged interneuron and glia populations of the avian and mammalian CNS
and provide cell-pools for the enormous expansion of the cerebellar cortex and the mammalian
forebrain. With the appearance of SVZs, the developing CNS comprises a large variety of
coexisting neural stem/progenitor cells both, in multiple neurogenic zones and inside / around
the cell migratory routes.
While secondary (SVZ) germinative zones form all along the wall of brain ventricles and the
spinal canal, the time of formation and the cell productivity of these zones are not uniform
along the neuraxis. At most parts of the developing CNS, SVZs generate neuronal and glial
precursors for local tissues, and the cell-generating activity decreases with the maturation of
the local neural parenchyma. Such zones, still containing “resting” stem/progenitor cells, can
restore cell-generating activity in response to tissue loss or specific (not yet properly under‐
stood) physiological/pathophysiological stimuli. The most productive secondary germinative
zones, including the ventral forebrain SVZ [36], the external germinative layer (EGL) of the
cerebellum [37] and the subgranular zone (SGZ) of the hippocampus [38], however, generate
huge amounts of novel neural cells and function for a relatively long time, in case of the ventral
forebrain SVZ and the SGZ, for the entire life-time.
The SVZ at the latero-ventral wall of the forebrain vesicles forms in a relatively early period
(second embryonic week in mouse) of forebrain development [36]. It derives from the primary
germinative (VZ) zone of the highly regionalized subpallial ganglionic eminences (LGE, MGE
and CGE,) [39]. The enhanced cell production with preserved regional characteristics results
in the formation of a variety of neuronal progenitors/precursors for developing subcortical
and cortical tissue formations [39]. This zone generates neurons for the striatum and globus
pallidus, provides the vast majority of interneurons of the cortex [40, 41], produces small
connecting neurons for the ventral amygdala complex [42, 43] and, exclusively in humans, also
for the dorsal thalamus [44]. Large number of forebrain oligodendrocytes also derives from
the ventral SVZ complex [45, 46].
In contrast to the early appearance of the ventral forebrain SVZ, the external germinative layer
(EGL) of the cerebellum appears around birth [47]. Secondary stem/progenitor cells from the
dorsal lip of the IVth ventricle migrate on the top of developing Purkinje cells, and produce
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Figure 3. Schematic presentation of the establishment of dorso–ventral specification (longitudinal segmentation) in
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ral plate folds and forms the neural tube. BMP: bone morphogenic proteins; SHH: sonic hedgehog protein; Zic, Gli-3,
Pax6, Emx2, Dlx, Nkx are examples of genes expressed in different dorso-ventral domains.
The position along the antero-posterior and dorso–ventral axes determines the identity of
future brain regions and seems to predict the phenotype of neurons through the orchestrated
expression of defined region-specific, pro-neural and neuron-specific genes [28]. Boundaries
between embryonic segments provide routes for the elongation of pioneer axons and delineate
the paths for future fiber tracks.
For the time being, it is not clear whether the early embryonic position can (or how far can)
determine the intrinsic developmental potential of individual cells. There are contradictory
results on the “positional memory” of stem/progenitor cells if removed from their original
position [32]. Our own data [33] indicate that neural stem-like cells isolated from early
embryonic (E9) mouse forebrain do not display regional “memory” after in vitro propagation.
In the course of in vitro neuron formation they express divergent region-specific genes, those
not expressed in overlapping regions of the developing CNS. The data suggest that permanent
presence of region-specifying factors is required for maintaining regional commitment, at least
in case of early embryonic neural stem cells. This finding, however, does not compromise the
fact that in vivo, neural stem/progenitor cells of the primary germinative (VZ) zone display
important molecular and cell biological differences.
2.2. Diversity of stem/progenitor cells in the secondary germinative zones of the developing
brain
With the thickening of the neural wall, increasing number of proliferation-capable cells loose
contact either with the lumen-face (outer progenitors; OSVZ progenitors) or the pial surface
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(short progenitors; SNPs) or both (inner progenitors; ISVZ progenitors), and accordingly,
change morphology and developmental characteristics [34, 8]. The number of primary radial
glial cells decreases gradually, while their derivatives dividing at a distance from the luminar
surface generate a novel germinative zone, the subventricular zone (SVZ). While a few SNP
cells remain in contact with the luminar surface and thought to preserve “ancient” (primary)
stem cell properties, the layer lining the ventricle wall transforms to the future ependyma and
neural cell production is transposed to the secondary germinative layer, the SVZ. The SVZs
along the entire neuraxis generate large number of progenitors and precursors including
smaller projecting-type neurons, interneurons, astrocytes, oligodendrocytes and produces also
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cerebellum [37] and the subgranular zone (SGZ) of the hippocampus [38], however, generate
huge amounts of novel neural cells and function for a relatively long time, in case of the ventral
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The SVZ at the latero-ventral wall of the forebrain vesicles forms in a relatively early period
(second embryonic week in mouse) of forebrain development [36]. It derives from the primary
germinative (VZ) zone of the highly regionalized subpallial ganglionic eminences (LGE, MGE
and CGE,) [39]. The enhanced cell production with preserved regional characteristics results
in the formation of a variety of neuronal progenitors/precursors for developing subcortical
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pallidus, provides the vast majority of interneurons of the cortex [40, 41], produces small
connecting neurons for the ventral amygdala complex [42, 43] and, exclusively in humans, also
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In contrast to the early appearance of the ventral forebrain SVZ, the external germinative layer
(EGL) of the cerebellum appears around birth [47]. Secondary stem/progenitor cells from the
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basket and stellar neurons and billiards of cerebellar granule cells [37] for the cerebellar cortex.
The third “professional” secondary neurogenic zone of the mammalian brain is the subgra‐
nular zone (SGZ) of the hippocampus [38], which derives from the ventricular (primary
germinative) zone of the most dorsal forebrain structure, the hem [48, 49]. In addition to
astrocytes and oligodendrocytes, SGZ produces a single type of projecting neurons, the
granule cells of the dentate gyrus.
2.3. Neural stem/progenitor cells in the adult mammalian brain
At most sites, the subventricular zones cease producing neurons and reduce their glia-
production after a short postnatal period of normal development, except the external germi‐
native layer (EGL) of the cerebellum, where cerebellar granule cells are generated for at least
10 days after birth in mouse and 1-2 years in human [47], the SVZ of the ventral forebrain [50]
and SGZ of the hippocampus [51], where neuro- and gliogenic capacity is maintained for the
entire life-time. The adult SVZ generates neuronal precursors mainly for regularly remodelling
forebrain circuits, as the higher voice centre of singing birds [52] or the olfactory bulb in rodents
[53]. Incorporation of adult SVZ-derived novel neurons, however, had been reported also in
the neocortex, piriform cortex, olfactory tubercle and amygdala in rodents and in primates, as
well [42, 43,54, 55]. In contrast to the SVZ, available data indicate that SGZ produces precursors
solely to the dentate gyrus. Both, the SVZ [46] and the SGZ [51, 56], however, contain consec‐
utive descendent populations of progenitor cells, which seem to mutually regulate each other’s
generation [57].
The routes of migration and integration of newly generated “adult” neuronal precursors into
olfactory and hippocampal networks have been explored in many details [51, 53, 58, 59, 60],
and the exploration has been highly facilitated by the use of multiple transgenic reporter mouse
straits (reviewed in [35]). Novel neurons are integrated by functioning neuronal networks and
tune the physiological parameters of functional circuits in both, the olfactory bulb [61] and the
hippocampus [59, 60]. As it is widely accepted, continuous neurogenesis in the adult SVZ and
SGZ plays organic roles in the physiological performance of the olfactory bulb and the
hippocampus of mammals. In case of SVZ-derived precursors, however, further studies
should explore the mechanisms behind the detachment of novel progenitors from the common
migratory paths and the acquirement of different mature phenotypes.
Outside of adult neurogenic zones and migratory routes, developing novel neurons have been
described in many regions of the adult brain, both in rodents (for ref. see [62]) and primates
[54]. Local neuron formation was found at the striatum [63], hypothalamus [64], associate
cortex [54, 65], ventral forebrain [43] and the substantia nigra of the midbrain (for review see
[66]. Beside sporadic neuron formation, ongoing astroglia production and low-rate but
permanent oligodendroglia replacement [67] also indicate that differentiation-capable neural
stem/progenitor cells are scattered throughout the adult nervous tissue. Many of these
progenitors might derive from continuously active (“professional”) adult neurogenic zones [1,
45]. Quiescent cells with stem/progenitor capabilities however are present in the wall of brain
ventricles and spinal canal [68] along the entire neuraxis, in large fibre bundles [69, 70] and in
the functioning CNS parenchyma [71], as well. In response to stimuli, many quiescent tissue-
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resident neural cells can re-enter the cell cycle [72], can renew themselves and generate
different – more than one - types of mature neural cells in vivo [69, 71, 73].
While such cells are regarded as neural stem cells according to „neural stemness” criteria, the
time of birth, the route of migration, the conditions for settlement and quiescence are far from
clear. The multiplicity of CNS derived stem/progenitor cells has been indicated also by the
diversity of neural stem/progenitor cells investigated in vitro [74]; the data argue for a massive
presence of tissue-resident neural cells with “stemness” properties throughout the CNS. To
find single scattered quiescent cells in the healthy brain tissue or to determine their lineage
relations are hard tasks, even with the use of transgenic reporter mice [35]. These neural stem /
progenitor cells may have different origin, may represent different stages of neural cell
differentiation and may adopt different cell physiological characteristics depending on the
host environment. As they serve as resident progenitor pools for tissue repair and limited
remodelling, it is of primary importance to explore their physiological characteristics and
environmental requirements in order to understand local neural tissue reactions to physio‐
logical stimuli and various pathophysiological effects.
3. Neural stem cells in vitro: Experimental data on diverse clones
In vivo lineage analyses can hardly determine whether divergent fate decision could be made
by a single cell or diversity was resulted by selective interactions inside a group of mixed cells
[75]. Sophisticated cell isolation/propagation methods helped to prove the existence of
multipotent neural stem cells. In vitro studies can describe neural stem cell features appearing
under artificial conditions and can predict the potential phenotypes which can be acquired by
the investigated cells. The in vivo fate and the phenotype manifested under in vivo conditions,
however, can not be forecasted from in vitro data. For the time being, our knowledge on local
microenvironmental factors governing the fate of differentiating neural cells or our under‐
standing on characteristics and cell physiological requirements of differentiating cells do not
allow extrapolating in vitro data to in vivo cell fates.
Neural stem/progenitor cells had been isolated and investigated in many laboratories using
different methods and divergent source materials including developing or adult brain tissues
and embryonic stem (ES) cells. Excellent recent reviews summarize the collected data includ‐
ing the expression of various gene clusters, the inducibility of different neuronal phenotypes
and the growth factor requirements of various neural stem/progenitor preparations (for a
recent review see [76]). Recent knowledge on differentiation-dependent changes in require‐
ments for O2 and adhesive environment has been also summarized [77]. The diverse experi‐
mental approaches, however, hinder comparative characterization of neural stem/progenitor
populations derived from different CNS regions and developmental ages.
Based on more than 10 different neural stem cell clones isolated and characterized in our
laboratory, this chapter presents a comparative summary on important differences displayed
by one-cell derived neural stem cell populations isolated from different ages and/or from
different regions of the mouse brain.
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hippocampus [59, 60]. As it is widely accepted, continuous neurogenesis in the adult SVZ and
SGZ plays organic roles in the physiological performance of the olfactory bulb and the
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should explore the mechanisms behind the detachment of novel progenitors from the common
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permanent oligodendroglia replacement [67] also indicate that differentiation-capable neural
stem/progenitor cells are scattered throughout the adult nervous tissue. Many of these
progenitors might derive from continuously active (“professional”) adult neurogenic zones [1,
45]. Quiescent cells with stem/progenitor capabilities however are present in the wall of brain
ventricles and spinal canal [68] along the entire neuraxis, in large fibre bundles [69, 70] and in
the functioning CNS parenchyma [71], as well. In response to stimuli, many quiescent tissue-
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While such cells are regarded as neural stem cells according to „neural stemness” criteria, the
time of birth, the route of migration, the conditions for settlement and quiescence are far from
clear. The multiplicity of CNS derived stem/progenitor cells has been indicated also by the
diversity of neural stem/progenitor cells investigated in vitro [74]; the data argue for a massive
presence of tissue-resident neural cells with “stemness” properties throughout the CNS. To
find single scattered quiescent cells in the healthy brain tissue or to determine their lineage
relations are hard tasks, even with the use of transgenic reporter mice [35]. These neural stem /
progenitor cells may have different origin, may represent different stages of neural cell
differentiation and may adopt different cell physiological characteristics depending on the
host environment. As they serve as resident progenitor pools for tissue repair and limited
remodelling, it is of primary importance to explore their physiological characteristics and
environmental requirements in order to understand local neural tissue reactions to physio‐
logical stimuli and various pathophysiological effects.
3. Neural stem cells in vitro: Experimental data on diverse clones
In vivo lineage analyses can hardly determine whether divergent fate decision could be made
by a single cell or diversity was resulted by selective interactions inside a group of mixed cells
[75]. Sophisticated cell isolation/propagation methods helped to prove the existence of
multipotent neural stem cells. In vitro studies can describe neural stem cell features appearing
under artificial conditions and can predict the potential phenotypes which can be acquired by
the investigated cells. The in vivo fate and the phenotype manifested under in vivo conditions,
however, can not be forecasted from in vitro data. For the time being, our knowledge on local
microenvironmental factors governing the fate of differentiating neural cells or our under‐
standing on characteristics and cell physiological requirements of differentiating cells do not
allow extrapolating in vitro data to in vivo cell fates.
Neural stem/progenitor cells had been isolated and investigated in many laboratories using
different methods and divergent source materials including developing or adult brain tissues
and embryonic stem (ES) cells. Excellent recent reviews summarize the collected data includ‐
ing the expression of various gene clusters, the inducibility of different neuronal phenotypes
and the growth factor requirements of various neural stem/progenitor preparations (for a
recent review see [76]). Recent knowledge on differentiation-dependent changes in require‐
ments for O2 and adhesive environment has been also summarized [77]. The diverse experi‐
mental approaches, however, hinder comparative characterization of neural stem/progenitor
populations derived from different CNS regions and developmental ages.
Based on more than 10 different neural stem cell clones isolated and characterized in our
laboratory, this chapter presents a comparative summary on important differences displayed
by one-cell derived neural stem cell populations isolated from different ages and/or from
different regions of the mouse brain.
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3.1. Lessons from primary brain cell cultures
From the middle of the last century, “primary” neural cell cultures gave a statistical insight
into the cellular composition of many studied brain area and gained high importance in
understanding the cellular characteristics of neural tissue constituents. It became clear that
neuron-enriched cultures can be easily initiated from early stages of development (embryonic
brain material), while tissue samples from later stages of brain maturation provide mainly glial
cultures.
As terminally differentiated neurons and oligodendrocytes do not divide and display poor
regeneration potential, primary neural cell cultures gave a hint on the presence and distribu‐
tion of non-differentiated cells in the brain tissue, which served as precursors for the majority
of cultured neurons and oligodendroglia cells. The in vitro preservation of many neuronal
characteristics of the source region including the size, shape, neurotransmitter phenotypes and
specific vulnerability of neurons [78] indicates either a relatively stable fate commitment of in
vitro surviving progenitors/precursors or continued production of factors, which help to
maintain some region-specific features.
In case of astrocytes, usually identified solely by GFAP expression, it was clear that in vitro
propagation results in a “juvenile”, “de-differentiated” phenotype, fairly distinct from in vivo
astroglial cells [79]. In purified (90-95% GFAP-positive) mouse astroglial cultures many cells
express nestin, and a few of them express also SSEA-1 stem cell antigen (Fig.4). After longer
(2 -3 weeks) propagation, “epithel dome”-like structures of rapidly dividing cells and GFAP-
negative process-bearing O2A bipotential glial progenitor cells [69] often appear in purified
astroglial cultures (Fig.4) [80,81].
Figure 4. Non-differentiated cells in purified cultures of newborn (P1) mouse forebrain astroglial cells. Left: a SSEA-1
and GFAP double-immureactive cell on the 7th day in vitro. Middle: an “epithel dome”-like cellular expansion on the
21st day in vitro. Right: O2A-type progenitor cells in a 15-day old hypothalamic astrocyte culture.
As long-term propagation selects for rapidly proliferating cells, the size of such populations can
be enlarged and one-cell derived clones may also emerge from such cells. Proliferation-based
cloning from long-term propagated cultures, however, favours the selection for tumorigen,
transformed cells and also, hinders the identification of in vivo origin of selected cells.
If primary neural cultures are prepared form early embryonic (E9-12 mouse) forebrain vesicles,
clusters of rapidly proliferating non-differentiated cells occur with high frequency. From early
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embryonic source tissue, the larger frequency and rapid proliferation of non-differentiated cells
allow isolating “almost primary” neural stem/progenitor cells after short-term in vitro propaga‐
tion. Using the “serial splitting” method [82], we established and cloned various neural stem cell
lines from E9 - E11.5 mouse forebrain vesicles from, both, p53-/- [83] and wild-type embryos.
While non-differentiated cells from the early embryonic (E9-12) brain attach readily to poly-
L-lysine or collagen coated surfaces in the presence of serum, cells isolated from more
developed (E14-15) mouse forebrain form aggregates under such conditions indicating that
the surface of neighbouring cells provide better adherence than the provided artificial surface.
The majority of cells exist inside the aggregates (e.g. in completely unknown microenviron‐
ments), for a 2-3 day period before large-scale migration starts from the aggregates.
Rapid attachment of freshly seeded cells from “older” forebrain suspensions was achieved, if
pre-patterned integrin-ligands were provided as adherent surfaces. Brush-like peptide-
conjugates built on a poly-L-lysine backbone and carrying rigid integrin-ligands (cyclic RGDfC
pentapeptides) at the N-termini of regularly spaced poly-D/L lanine “spacer” side-chains (AK-
c[RGDfC]) [84] proved to support the attachment and serum-free propagation of a number of
non-differentiated cells including mouse and human ES cells (manuscript in preparation). As
neurons do not attach to the peptide-coated surface and differentiated glial cells do not
proliferate in serum–free conditions, non-differentiated cells of brain cell suspensions could
be selectively propagated under serum-free conditions on the peptide-coated surface (Fig.5).
From forebrain suspension of transgenic mouse embryos (E14.5) carrying the human GFAP-
promoter-driven GFP construct [85], GFP-labelled but GFAP-negative cells grew rapidly on
AK-c(RGDfC)-coated surfaces indicating that the surface-attached populations comprised
neural progenitor-type cells (Fig.5) [74].
Figure 5. Embryonic (E 14.5) mousehGFAP-GFP forebrain cells on the 3rd day on poly-L-lysine coated surface with serum (A)
and on AK-c(RGDfC) coated surface without serum (B). After two passages on AK-c(RGDfC) sureum and in serum-free
conditions, the cultures were composed by GFP-expressing morphologically homogeneous, surface-attached cells (C).
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The “selective adhesion and serum free propagation” method allowed isolating and cloning cell
lines from various parts of the embryonic (E 14-15) and adult (P50-75) mouse brains (Table 2).
3.2. Comparative characterization of neural stem/progenitor clones
Our first neural stem cell clones (NE-4C [ATTC CRL 2925] and NE-7C2) were established 15
years ago, from early embryonic (E9) anterior brain vesicles of p53-deficient mouse embryos
[82,86]. The lack of p53 tumour suppressor protein did not prevent the in vitro formation of
postmitotic neuronal precursors and later neurons [82], as did not hinder normal neural
development of transgenic animals despite of increased tumour frequency in aging animals
[83]. For control, however, similar cell lines had been established from wild-type mouse
embryos (WNE cell lines) and were proved to display similar characteristics including
morphology, chromosome-stability, cell cycle-time, regional gene expression and the schedule
of in vitro neuron and glia formation. NE-4C, NE-7C2 and WNE cells showed similarities to
P19 EC and embryoid body-derived ES cells in many aspects [33,87], and showed marked
differences if compared to AK-c(RGDfC) adherent stem/progenitor cells isolated either from
late embryonic or adult brain regions (Table 2). All clones shown on Table 2 can be propagated
in vitro without differentiation or changing phenotype, and can generate neurons, astrocytes
and oligodendrocytes in response to appropriate inducing stimuli.
Cell clone tissue origin age of source tissue method of isolation
NE-4C
(ATTC;CRL-2925) anterior brain vesicles;
p53-/- mouse embryo








serum-free growth on AK-















Table 2. Neural stem/progenitor clones investigated in the presented studies
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Multiple differences were found among the characterized cell  lines indicating important
diversity of neural cells, those fulfilling the criteria of “stemness”.
3.2.1. Morphological and cell biological characteristics of cloned stem/progenitor cell populations
Early embryonic neuroectoderm-derived (NE-4C, NE-7C2 and WNE) cells display epithel
morphology (Fig.6), and produce uniform monolayers. These cells divide continuously (16-
hour cycle-time in average) on poly-L-lysine in 10% FCS containing medium, but can not be
propagated in serum-free conditions on AK-c(RGDfC) coated surfaces. NE cells express nestin
intermedier filamentum protein [82,86] and two-third of the cells carries the mouse stem cell
antigen, SSEA-1 [88]. In non-induced stage, the cells express Oct4, carry blbp and glast mRNAs
(proteins could not be demonstrated), but do not express pax6, mash1 or neurogenins and do
not produce GFAP and RC2 proteins [87].
In contrast to NE cells, embryo-derived AK-c(RGDfC)-adherent cells (RGl-1, A2, C4) prolifer‐
ate on AK-c(RGDfC)-coated surfaces in serum-free, EGF (20 ng/ml) containing medium (cycle-
time: 18-20 hrs) (Fig.6). The cells show elongated morphology, display nestin, RC2 and Sox2
immunreactivity, but are immune-negative for GFAP. They transcribe large amount of blbp,
glast, pax6, olig2 and also gfap mRNAs [74]. All clones express mash1, while neurogenin (ngn2)
is not transcribed in the ventral forebrain-derived A2 clone. Oct4 or nanog expression was never
detected. According to the above characteristics, these cells were identified as embryonic radial
glia-like (eRGl) cells.
Adult-derived AK-c(RGDfC) adherent cells were prepared from the ventral forebrain SVZ
(clones: SVZ_I,  SVZ_K, SVZ_M, SVZ_T) from the hippocampus (HC_A), from the parie‐
tal cortex far from corpus callosum (CTX_H) and also from the dorsal midbrain parenchy‐
ma (colliculus superior), far from the wall of the ventricle (MES_D). As it was expected,
AK-c(RGDfC)  adherent  cells  were  much  less  frequent  in  the  adult  brain-derived  cell
suspensions,  than  in  the  embryonic  preparations.  The  selective  adhesivity  and  EGF-
supported proliferation, however, resulted in several clones from the adult mouse brain.
Isolation of CTX_H and MES_D clones indicates that cells with stem/progenitor features
are present in the non-neurogenic adult brain parenchyma at a frequency high enough to
sort them out easily.
Regardless of origin, adult-derived clones display GFAP-, nestin- and RC2 immunpositivity,
and carry immunocytochemically detectable Sox2 and Pax6 proteins [74]. None of the cloned
cells express Oct4 or nanog pluripotency genes. According to these features, the cells are
regarded as adult-derived RGl cells (aRGl). Adult RGl cells grow in two dimensional clusters,
where elongated cells line up along each other (Fig.6 right panel) and divide with a cycle-time
of 20-22 hours in average. By today, eRGl and aRGl clones are over 50-80 passages without
pheno- or genotypic changes; they preserved 2n (40 chromosome) euploidity, morphological
features and neural inducibility.
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in vitro without differentiation or changing phenotype, and can generate neurons, astrocytes
and oligodendrocytes in response to appropriate inducing stimuli.
Cell clone tissue origin age of source tissue method of isolation
NE-4C
(ATTC;CRL-2925) anterior brain vesicles;
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Table 2. Neural stem/progenitor clones investigated in the presented studies
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Multiple differences were found among the characterized cell  lines indicating important
diversity of neural cells, those fulfilling the criteria of “stemness”.
3.2.1. Morphological and cell biological characteristics of cloned stem/progenitor cell populations
Early embryonic neuroectoderm-derived (NE-4C, NE-7C2 and WNE) cells display epithel
morphology (Fig.6), and produce uniform monolayers. These cells divide continuously (16-
hour cycle-time in average) on poly-L-lysine in 10% FCS containing medium, but can not be
propagated in serum-free conditions on AK-c(RGDfC) coated surfaces. NE cells express nestin
intermedier filamentum protein [82,86] and two-third of the cells carries the mouse stem cell
antigen, SSEA-1 [88]. In non-induced stage, the cells express Oct4, carry blbp and glast mRNAs
(proteins could not be demonstrated), but do not express pax6, mash1 or neurogenins and do
not produce GFAP and RC2 proteins [87].
In contrast to NE cells, embryo-derived AK-c(RGDfC)-adherent cells (RGl-1, A2, C4) prolifer‐
ate on AK-c(RGDfC)-coated surfaces in serum-free, EGF (20 ng/ml) containing medium (cycle-
time: 18-20 hrs) (Fig.6). The cells show elongated morphology, display nestin, RC2 and Sox2
immunreactivity, but are immune-negative for GFAP. They transcribe large amount of blbp,
glast, pax6, olig2 and also gfap mRNAs [74]. All clones express mash1, while neurogenin (ngn2)
is not transcribed in the ventral forebrain-derived A2 clone. Oct4 or nanog expression was never
detected. According to the above characteristics, these cells were identified as embryonic radial
glia-like (eRGl) cells.
Adult-derived AK-c(RGDfC) adherent cells were prepared from the ventral forebrain SVZ
(clones: SVZ_I,  SVZ_K, SVZ_M, SVZ_T) from the hippocampus (HC_A), from the parie‐
tal cortex far from corpus callosum (CTX_H) and also from the dorsal midbrain parenchy‐
ma (colliculus superior), far from the wall of the ventricle (MES_D). As it was expected,
AK-c(RGDfC)  adherent  cells  were  much  less  frequent  in  the  adult  brain-derived  cell
suspensions,  than  in  the  embryonic  preparations.  The  selective  adhesivity  and  EGF-
supported proliferation, however, resulted in several clones from the adult mouse brain.
Isolation of CTX_H and MES_D clones indicates that cells with stem/progenitor features
are present in the non-neurogenic adult brain parenchyma at a frequency high enough to
sort them out easily.
Regardless of origin, adult-derived clones display GFAP-, nestin- and RC2 immunpositivity,
and carry immunocytochemically detectable Sox2 and Pax6 proteins [74]. None of the cloned
cells express Oct4 or nanog pluripotency genes. According to these features, the cells are
regarded as adult-derived RGl cells (aRGl). Adult RGl cells grow in two dimensional clusters,
where elongated cells line up along each other (Fig.6 right panel) and divide with a cycle-time
of 20-22 hours in average. By today, eRGl and aRGl clones are over 50-80 passages without
pheno- or genotypic changes; they preserved 2n (40 chromosome) euploidity, morphological
features and neural inducibility.
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Figure 6. Phase-contrast view of NE-4C early embryonic neuroectodermal stem cells, the embryo-derived radial glia
like RGl-1 cells and the adult cortex-derived CTX_H cells.
NE-4C RGl-1; A2 HC_A; SVZ_M
Cytochemical markers
nestin + + +
RC2 - + +
GFAP - - +
βIII-tub - - -
Gene expression
Oct 4 + - -
Nanog + - -
Sox2 + + +
Pax6 - + +
Blbp + + +
GLAST + + +
Ngn2 - + +
Mash1 - + +
Math2 - - -




Table 3. Similarities and differences between NE and RGl cells
Beside marked differences in shape, proliferation activity, pluripotency gene expression and
GFAP and RC2 immunreactivity, RGl cells display different electrophysiological properties in
comparison to early embryonic neuroectodermal (NE) cells. While both NE and RGl cells exist
in multiple gap junction coupling, and consequently, display symmetric passive conductance
in response to current injections [88], voltage-dependent K-currents (KDR) can be registered in
RGl cells [74], but not in NE cells.
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3.2.2. Generation of neural tissue-type cells by NE and RGl type neural stem/progenitor cells
Studies on neuron and glia formation revealed further important differences between early
embryonic neuroectoderm (NE) derived and embryonic or adult radial glia like stem/progen‐
itor cells (Table 3).
Neural differentiation of NE cells is induced by retinoic acid (all-trans retinoic acid; RA;
10-8-10-6 M) [82, 86, 89]. A short (6-hour) RA treatment initiate aggregation of cells and the rate
of aggregation increases at higher RA-concentrations and/or longer treatment. Forced aggre‐
gation of cells without RA, however, does not induce neural development, and, if initial
aggregation is prevented, RA-treatment alone results in severe cell decay without differentia‐
tion [89]. It seems, that RA primes the cells for intercellular inductive signalling, what takes
places inside RA-primed aggregates. After RA-priming, neural differentiation proceeds along
an apparently stable program (Fig.7), in the absence of RA, in both serum-containing and
serum-free culture conditions. RA-priming is required also for the formation of astrocytes from
NE cells, even if glia genesis starts only 7-10 days after RA-priming [87].
Figure 7. The scheme of RA-primed neural differentiation of NE cells.
20 hours after RA-priming, RC2 radial glia marker protein appears in the aggregated NE cells,
and the first IIIβ-tubulin- and MAP2-positive neuronal precursors appear on the 3rd– 4rd day
of induction, inside the aggregates. Expression of the proneural bHLH transcription factor
ngn2 is detected soon after induction (24-48 hours), increases during the first 5 days and
decreases thereafter, when the “neuron-specific” math2 transcription starts and increases
gradually. The proportion of neurons reaches 50-55% of total cells during the second week of
induction, and the first GFAP-positive cells appear around the 9th day of induction. Non-
differentiated stem/progenitor cells persist during the entire period of neural differentiation
as groups of SSEA-1 immunreactive epithelioid cells (Fig.8.) [33, 82, 87].
In contrast to NE cells, tissue-type differentiation of RGl cells is not induced by RA-treatment,
regardless of the age and region of the source tissue [74, 90]. In RGl cells, neuronal differen‐
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induction, and the first GFAP-positive cells appear around the 9th day of induction. Non-
differentiated stem/progenitor cells persist during the entire period of neural differentiation
as groups of SSEA-1 immunreactive epithelioid cells (Fig.8.) [33, 82, 87].
In contrast to NE cells, tissue-type differentiation of RGl cells is not induced by RA-treatment,
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tiation is induced by withdrawal of EGF from the medium of dense cultures. Large-scale
astroglia formation is initiated by adding serum (10% FCS), and oligodendroglia production
is achieved by treating the cells with FGF, PDGF and forskolin followed by treatment with
thyroid hormone (T3) and ascorbic acid, according to the protocol of Glaser [91] (Fig.9.).
Figure 9. The scheme of in vitro neural tissue-type differentiation of RGl cells.
Figure 8. Immunocytochemical characterization of differentiating NE cells cells and the expression of some develop‐
mental neuronal “master” genes in the course of in vitro induced neural development. Developmental stages are indi‐
cated by days after RA-priming.
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Regardless of origin, RGl cells give rise to neurons in a 5-day period after withdrawal of EGF,
to astrocytes in 3 days after treatment with serum, and to oligodendrocytes 8 days after the
onset of oligodendroglia induction (Fig.9 and 10).
Figure 10. Neurons and oligodendrocytes generated by adult hippocampus- and mesencaphalon-derived (HC_A and
MES_D) RGl cells are hown after neuron-specific IIIβ-tubulin and oligodendroglia-indicating O4 immunostaining, re‐
spectively.
RGl cells generate neurons in smaller proportion than NE cells; the ratio of neurons among
total cells does not exceed 20-30%, and the yield varies among the different clones. Significant
differences among the RGl clones were found also in the rate of oligodenroglia production [74].
The time-course of formation of “mature” phenotypes, however, is shorter in RGl cells than
in NE cells.
3.2.3. RA-production and RA-responsiveness of NE and RGl cells
The retinoid-dependent and independent neuron formation is a striking difference between
NE and RGl clones, respectively [90]. During development, RA regulates the formation of the
neural tube and interferes with the patterning of the future hindbrain and spinal cord [92].
Important morphogenic roles of retinoids were demonstrated also in the developing forebrain
[93], and the presence and production of RA were described in the developing lateral gan‐
glionic eminence (LGE) [94,95]. RA-responsive cells persist in the main neural stem cell niches
of the postnatal rodent brain including the SVZ and the dentate gyrus [96]. Depletion of RA
in adult mice results in impaired neuronal differentiation in the dentate gyrus [97,98] and RA
synthesis seems to regulate proliferation and gene transcription of at least a subset of neural
stem cells in the SVZ [99,100]. As retinoid signalling seems to influence the fate of neural stem
cells throughout life, the fundamental differences in RA-responsiveness between NE and RGl
type neural stem/progenitor cells have been investigated in details.
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of the postnatal rodent brain including the SVZ and the dentate gyrus [96]. Depletion of RA
in adult mice results in impaired neuronal differentiation in the dentate gyrus [97,98] and RA
synthesis seems to regulate proliferation and gene transcription of at least a subset of neural
stem cells in the SVZ [99,100]. As retinoid signalling seems to influence the fate of neural stem
cells throughout life, the fundamental differences in RA-responsiveness between NE and RGl
type neural stem/progenitor cells have been investigated in details.
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Non-differentiated NE cells do not produce detectable retinoids [101], but differentiating
daughter cells produce considerable amounts of RA [87, 90]. In contrast, RGl cells produce
well-detectable amount of RA and retinoid production increases further with the advancement
of neuronal differentiation. Endogenous RA production, on the other hand, does not influence
the neuron formation by RGl cells: treatment with retinoic acid receptor (RAR) antagonist
(AGN193109) does not result in significant changes in the number or morphology of RGl-
derived neurons [90]. Expression of genes coding components of the retinoid metabolism and
signalling revealed significant differences between NE and RGl cells. NE and RGl cells express
non-identical sets of retinaldehyde-dehydrogenases (RALDHs) and nuclear retinoid receptor
subunits. Moreover, some defined retinoid transporters (as STRA6), and catabolising enzymes
(as CYP26s) are not expressed by RGl cells [90]. In accordance with Haskell and LaMantia [99],
we concluded that retinoid metabolism and responsiveness are distinctive characteristics of
defined subtypes of neural stem/progenitor populations.
3.2.4. “Regional memory”
NE-4C cells, in non-induced „stem cell stage”, express only otx2 and en from the investigated
“region-specific”, positional genes. In differentiated NE-4C cultures, however, many positional
genes including hoxb2 are actively transcribed (Table 4) [33] indicating that these early embryon‐
ic stem cells are “open” for a variety of “position-determined” development. Accordingly,
glutamatergic, GABAergic and also serotonin producing neurons develop from NE-4C cells.
Non-induced RGl cells, on the other hand, express gbx2, dlx2, emx2, but not hoxb2 or nkx2.1 (Table
4), regardless of origin. The pattern of investigated genes indicates an “anterior to hindbrain”
(lack of active hoxb2), and a “not caudo-ventral” (lack of nkx2.1 expression) origin, but does not





Embryonic (E14.5) Adult (P 50-75)
A2 C4 RGl-1 HC_A CTX_H MES_D SVZ_I SVZ_K SVZ_T SVZ_M
Gene expression
Emx2 - + + + + + + + + + +
Nkx2.1 - - - - - - - - - - -
Gbx2 - ni ni + + + + + + + +
Dlx2 - + + + + + + + + ni ni
Hoxb2 - ni ni - - - - - - ni ni
Ngn2 - - + + + + + + - + +
Mash1 - + + + + + + + + + +
(ni: non investigated)
Table 4. Positional gene expression by non-induced stem/progenitor cells.
The neurotransmitter phenotype of neuronal progenies, on the other hand, still indicates
preservation of some fine region-restricted commitment. All RGl cells give rise to GABA-
producing, VGAT-positive neurons. In adult-derived clones, vesicular glutamate transporter
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(vglut) expression and VGLUT-immunpositivity [102] however was found only in the hippo‐
campus-derived HC_A clone. As HC_A neurons express only vglut1 [74], it seems that these
cells preserve some regional, neurotransmitter-related identity, even after long-term in vitro
propagation. Similarly, all adult SVZ-derived clones give rise to tyrosin-hydroxylase(TH)-
expressing neurons [74]. This observation might be in accord with the known production of
TH-positive olfactory neuron-precursors [103] in the adult SVZ.
The embryo-derived RGl-1 cells, on the other hand, express both, vglut1, vglut2 and also TH.
The finding may indicate a less advanced stage of commitment of these cells, but needs further
studies.
Available sporadic results do not allow deciding on the preservation or loss of regional identity
of in vitro propagated stem/progenitor cells. As clones comprise progenies of single cells, for
far-range conclusions we need further studies on statistically sufficient number of clones from
each brain region.
4. Distinct neural stem/progenitor stages require distinct environmental
conditions
One cell derived, cloned populations are useful subjects to show the types of cells which can
or can not derive from a given stem cell population, but neither of such studies can predict
what sort of phenotypes can be manifested in vivo. In the course of in vivo tissue genesis,
differentiating cells and their environment change in an orchestrated way: the conditions either
help tissue integration or kill the differentiating cells assuring the survival of the right types
and number of cells at the right places.
In our experience, NE-4C cells give rise to neurons with large frequency if implanted into early
embryonic brain vesicles, but produce non-differentiating, tumour-like expansions in the
subcortical regions of newborn mice. Moreover, the same cells diminish from the adult mouse
forebrain, except the forebrain SVZ, where some cells reside for longer than 3 weeks [104]. The
data demonstrate that the fate of NE stem/progenitor cells is strictly governed by environ‐
mental factors provided by the host tissue, and which are far from being explored.
In addition to initial requirements for stem/progenitor survival, the successive progenies need
different environment and change basic physiological demands including O2 -supply [105; 77].
Under hypoxic conditions, NE-4C stem cells survive and proliferate, but do not generate
neurons. Soon after the onset of in vitro neuronal differentiation (48 hrs after RA-priming),
however, hypoxia severely impairs cell survival [105] indicating that the basic metabolic
characteristics of cells change soon after neural fate decision. The in vitro results were
supported by data obtained on the sporadic neuron formation by NE-4C cells implanted into
the adult mouse forebrain in response to hyperbaric oxygenation [105].
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The presented results on some selected NS populations demonstrate that neural stem/
progenitor cells derived from different brain regions and different ages may display significant
diversity in many aspects including cell physiological and developmental features. The
selected clones represent derivatives of a single stem cell and had been propagated under fairly
artificial in vitro conditions; accordingly, none of them can represent “the” stem cells in
general of the region of origin. From the data obtained on 3 different NE and 10 RGl cell clones,
however, we could conclude that early embryonic neuroectoderm-derived stem cells display
distinct in vitro features from those isolated by selective adhesion from later CNS tissues. In
case of RGl cells, the adhesive preference-based selection and EGF-supported growth, imply
a strong selection. Cells corresponding to such selection could be isolated from fairly distinct
brain regions including areas not listed among “professional” neurogenic zones. Correspond‐
ingly, RGl cells may not represent a defined lineage of stem/progenitor population, rather a common
stage of neural progenitor-succession, which may appear in many lineages. The integrin-based
adhesion, EGF-supported proliferation, voltage-dependent K+-flux, RA-production and RA-
insensitivity may be characteristics of stem/progenitor cells in a defined stage of tissue
integration.
While many NS populations have been characterized in vitro [76], were implanted into
different brain regions of healthy and disease-model animals and have been considered also
as potential tools for clinical cell therapy (for critical review: [106, 107]), the basic physiology
of such cells, their needs for survival in successive developmental stages as well as the
harmonization of such needs with conditions provided by the host tissue are rarely taken into
account. As a further task, physiological demands of various NS populations and descending
progenies should be explored and the roles of basic physiological factors in tuning differen‐
tiation should be understood.
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The presented results on some selected NS populations demonstrate that neural stem/
progenitor cells derived from different brain regions and different ages may display significant
diversity in many aspects including cell physiological and developmental features. The
selected clones represent derivatives of a single stem cell and had been propagated under fairly
artificial in vitro conditions; accordingly, none of them can represent “the” stem cells in
general of the region of origin. From the data obtained on 3 different NE and 10 RGl cell clones,
however, we could conclude that early embryonic neuroectoderm-derived stem cells display
distinct in vitro features from those isolated by selective adhesion from later CNS tissues. In
case of RGl cells, the adhesive preference-based selection and EGF-supported growth, imply
a strong selection. Cells corresponding to such selection could be isolated from fairly distinct
brain regions including areas not listed among “professional” neurogenic zones. Correspond‐
ingly, RGl cells may not represent a defined lineage of stem/progenitor population, rather a common
stage of neural progenitor-succession, which may appear in many lineages. The integrin-based
adhesion, EGF-supported proliferation, voltage-dependent K+-flux, RA-production and RA-
insensitivity may be characteristics of stem/progenitor cells in a defined stage of tissue
integration.
While many NS populations have been characterized in vitro [76], were implanted into
different brain regions of healthy and disease-model animals and have been considered also
as potential tools for clinical cell therapy (for critical review: [106, 107]), the basic physiology
of such cells, their needs for survival in successive developmental stages as well as the
harmonization of such needs with conditions provided by the host tissue are rarely taken into
account. As a further task, physiological demands of various NS populations and descending
progenies should be explored and the roles of basic physiological factors in tuning differen‐
tiation should be understood.
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1. Introduction
Regenerative medicine has become a driving force in the treatment of disease and injury over
the last decade [1]. This is due to the accumulation of knowledge in several key areas; 1) the
mechanisms of disease processes, 2) creation of stem cells/induced pluripotent stem cells that
might be used for therapeutic purposes, and 3) factors that are necessary for the proper
differentiation of specific cell types. In any tissue, it might be possible to regenerate lost cells
from exogenous stem cells, endogenous stem or progenitor cells, or endogenous cells that can
dedifferentiate, proliferate and re-differentiate. Several endogenous populations of cells
localized to the eye have been shown to be capable of replacing some or all retinal cell types
in various species; 1) an endogenous population of progenitor cells in the periphery of the eye
referred to as the ciliary marginal zone (CMZ), 2) the retinal pigmented epithelium, 3) non-
pigmented cells adjacent to peripheral retina, 4) NG2+ glial progenitors of the optic nerve, and
finally 5) Müller glia of the retina [2]. This chapter will focus specifically on the responsiveness
of Müller glia to disease or injury to the retina with a special emphasis on signals that have
been shown to lead to the injury response and changes to the extracellular matrix that play a
role in dedifferentiation and proliferation.
2. Müller Glial cell basics
Müller Glia, named after their discoverer Heinrich Müller, were first described in 1851 [3].
Müller Glia are a unique blend of radial glia, astrocytes, and oligodendrocytes that span the
width of the mature retina from the outer limiting memberane in the outer nuclear layer to the
inner limiting membrane at the edge of the retina and vitreous humor [4]. Müller cells are one
of three possible macroglial cells that can be found in the retina. Astrocytes also migrate into
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1. Introduction
Regenerative medicine has become a driving force in the treatment of disease and injury over
the last decade [1]. This is due to the accumulation of knowledge in several key areas; 1) the
mechanisms of disease processes, 2) creation of stem cells/induced pluripotent stem cells that
might be used for therapeutic purposes, and 3) factors that are necessary for the proper
differentiation of specific cell types. In any tissue, it might be possible to regenerate lost cells
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pigmented cells adjacent to peripheral retina, 4) NG2+ glial progenitors of the optic nerve, and
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of Müller glia to disease or injury to the retina with a special emphasis on signals that have
been shown to lead to the injury response and changes to the extracellular matrix that play a
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2. Müller Glial cell basics
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the retina from the optic nerve and some species also contain oligodendrocytes in the nerve
fiber layer [5]. However, Müller glia are the only glial cells that are derived from retinal
progenitors. Müller cells play a wide variety of roles in both the developing and mature retina.
In order to consider the full effect of gliosis in the diseased or injured retina, we must first
understand their function in the normal retina.
2.1. Retinal histogenesis
Lineage analysis of retinal progenitors using various techniques have shown that many retinal
progenitors have the capacity to produce all retinal cell types [6-10]. Retinal cells undergo a
stereotypical pattern of differentiation in which some cells leave the cell cycle (are born) very
early in retinal histogenesis, such as cone photoreceptors, ganglion cells, and horizontal cells,
while other cells are generated at later timepoints [6, 7, 9-12]. Müller glia are born in the group
of cells that are generated late in the ontogenic period.
Vertebrate retinal cells are arranged in a specific fashion in both layers and in columns [6-8,
13-17]. Figure 1 shows the arrangement of mature retinal cells in the outer, inner and ganglion
cell layers. However, some of the cells are also arranged in a columnar fashion. The later-born
cells, which include the rods, bipolar, and subpopulation of the amacrine cells, all migrate
along the radially arranged Müller glial cells. These cells remain in close contact with the
Müller glia even as differentiation continues and are thought to comprise a metabolic and/or
processing circuit within the retina [17]. The early-born cells are not a part of this columnar
unit. Rather than relying on the Müller glia to migrate to the correct layer of the retina, these
cells undergo nuclear translocation in the relatively thinner early retina [18, 19].
Müller glia also share properties that allow them to organize the laminar structure of the retina.
Cultured Müller glia or Müller glial conditioned-medium are capable of organizing the retinal
neurospheres into a layered pattern which closely resembles that seen in the mature retina [20,
21]. While these experiments suggest that there may be a secreted factor which may mediate
the organizational properties of Müller glia, recent experiments done in zebrafish suggest that
the apico-basal polarity that is inherent in the development of Müller glia is also a critical part
of its organizational capacity [22]. A disrupted apical Müller glial cell process in zebrafish
mutated in the P50 subunit of dynactin leads to a disruption in the normal laminar develop‐
ment of the retina [22]. In mice, disruption of the outer limiting membrane that is comprised
of the apical Müller glial endfeet disrupts the placement of photoreceptors such that misplaced
photoreceptor nuclei are found adjacent to the retinal pigmented epithelium, in a region where
photoreceptor outer segments would normally be located [23].
2.2. Synapse formation
The role of astrocytes in synaptogenesis in the CNS has been established by many investigators
[24-26]. Müller glial cells have been considered by many to be astrocyte-related cells (See Table
1), hence Müller glia may play some role in synapse formation and/or maintenance in the
retina. This idea has been tested in zebrafish retina with somewhat contradictory results [27,
28]. While it appears that the Müller glial cell processes do not invade the outer plexiform later
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until after synapses have already formed and deletion of Müller glia during early retinal
development does not affect cone synaptogenesis, a separate study examining the role of
harmonin (USH1C) in zebrafish which is found in the retinal Müller glia, have disrupted ribbon
synapses [27, 28]. Until this conflict can be resolved and the role of these cells have been
investigated in other species, the role of Müller glia remains open.
Figure 1. Organization of the mature retina: The retinal cells, which consist of neurons and glia, are organized into the
outer nuclear layer (ONL), inner nuclear layer (INL) and the ganglion cell layer (GCL). The ONL consists of the rod and
cone photoreceptor cells. The INL is made up of the horizontal cells, amacrine cells as well as the bipolar cells. The
Müller glial cell bodies are also present in this layer. However, the processes of the Müller glial cells extend outward
into the adjacent layers, extending throughout the thickness of the retina. The GCL is primarily consists of the gan‐
glion cells which send out their axons out of the eye through the optic disc.
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until after synapses have already formed and deletion of Müller glia during early retinal
development does not affect cone synaptogenesis, a separate study examining the role of
harmonin (USH1C) in zebrafish which is found in the retinal Müller glia, have disrupted ribbon
synapses [27, 28]. Until this conflict can be resolved and the role of these cells have been
investigated in other species, the role of Müller glia remains open.
Figure 1. Organization of the mature retina: The retinal cells, which consist of neurons and glia, are organized into the
outer nuclear layer (ONL), inner nuclear layer (INL) and the ganglion cell layer (GCL). The ONL consists of the rod and
cone photoreceptor cells. The INL is made up of the horizontal cells, amacrine cells as well as the bipolar cells. The
Müller glial cell bodies are also present in this layer. However, the processes of the Müller glial cells extend outward
into the adjacent layers, extending throughout the thickness of the retina. The GCL is primarily consists of the gan‐
glion cells which send out their axons out of the eye through the optic disc.




Location • Throughout the nervous system, including the
retina and optic nerve [226]
• Found exclusively in the inner nuclear
layer of the retina with the process
spanning the entire width of the retina
[227, 228]
Origin • Originate from the glial restricted neural stem
cells or the bipotent O2A progenitor cell type
[229]
• Originate from the neural retinal
progenitor cells [227, 228]
Morphology • Have a stellate or star like morphology [226] • Have a radial morphology [227]
Functions • Scaffolding for migration of developing
neurons [230]
• Aid in the formation of synapses [231-233]
• Aid in the formation of the blood brain barrier
[234]
• Serve as a source of nourishment and energy
reserve for the neurons by providing glucose and
storing excess glucose in the form of glycogen
[235, 236]
• Possess various channels and transporter (Na
+/K+ channels, aquaporins etc.) which aid in the
maintenance of homeostasis, pH levels and
removal of toxic metabolites [237, 238]
• Possess transporters for neurotransmitters
(such as GABA, glycine, glutamate)which aid in
clearance and release of these molecules into
the synaptic space which can affect synaptic
transmission[232, 239]
• Serve as a scaffolding for retinal
organizations [227]
• Help direct light through the retinal layers
to the photoreceptor cells [240]
• Help in recycling photopigments [241]
• Aid in the formation of the blood retinal
barrier [242]
• Similar to astrocytes serve as a source of
nourishment and energy reserve in the
form of glucose and lactate respectively
[227]
• Help in maintenance of homeostasis and
removal of toxic metabolites in a manner
similar to astrocytes [115]
• Neurotransmitter receptors (AMPA,
GluR4, NMDA, GABA-A etc.), transporters
and modulators (GLAST, GS, GAT etc.) help




• Changes in gliosis based on extent of injury
which ranges from mild to moderate to severe
[243]
• Cells hypertrophy (particularly by increasing
the expression of GFAP), change in morphology
and upregulate various markers [244]
• Increase proliferation and in severe cases form
the “glial scar” [245]
• Similar to astrocytes following retinal
damage, cells hypertrophy, change
morphology and upregulate various
markers [246]
• Based on the ability or the lack of cells to
proliferate, Müller cell gliosis is referred to
as non conservative or conservative gliosis,
respectively [115]
• Glial scar is not a prominent feature of
gliosis of the Müller glia [114, 115]
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Astrocytes Müller glia
Stem cell potential Following injury –
• Cells dedifferentiate and have the potential to
re-enter cell cycle [111]
• Begin to express proteins associated to neural
stem cells or radial glia (NG2, BLBP, nestin, DSD1,
CD15) [99]
Following retinal injury –
• Müller glial cells re-enter cell cycle and can
proliferate [111, 114]
• Following targeted ablation of
photoreceptor and ganglion cells,
regeneration of the respective cell types
was observed from the Müller glia [111,
247]
Table 1. Comparison of Astrocyte and Müller glial Characteristics
2.3. Blood retinal barrier development and maintenance
The blood-brain barrier refers to the separation between the circulating blood and extracellular
fluid found within the central nervous system. In the brain, this barrier is formed through the
interactions between astrocytes and endothelial cells that form the vasculature [29]. In the eye,
the blood-retinal barrier is maintained at two junctures; 1) an „outer barrier“ in the form of the
retinal pigmented epithelium (RPE), and 2) the „inner barrier“ that is comprised of the
endothelial cells of the retinal vasculature [30]. The endothelial cells of the retinal vasculature
form tight junctions that are selectively permeable to hydrophobic molecules such as O2, CO2,
and hormones, while restricting the entrance of bacteria and large or hydrophilic molecules
(See Fig 2). Endothelial cells and pericytes that adhere to the outside of the endothelial cells
are both encompassed by a basal lamina as well as the astrocytic endfeet. There is evidence
that inner barrier is induced and maintained by both Müller glial and retinal astrocytic endfeet
that ensheath retinal blood vessels [31]. The processes of retinal astrocytes, however, are
limited to the never fiber and ganglion cell layer and can only interact with superficial
vasculature near the inner surface of the retina [32]
Müller glia (as well as retinal astrocytes and retinal pigment epithelium) express factors that
are critical to the formation of the deep plexus vasculature in the retina [33]. Angiogenesis is
the result of a balance between the pro-angiogenic factor vascular endothelial growth factor
(VEGF) and anti-angiogenic factor pigment-epithelium derived factor (PEDF) [33, 34]. The
ratio of these factors carefully controls the growth of the deep plexus retinal vasculature. Not
surprisingly, misregulation of these factors can lead to pathological neovascularization, a topic
which will be covered later in this chaper. Many other interactions between Müller glia/
astrocytes and the vasculature have been proposed and/or documented. For instance, Paulson
and Newman simulated a process whereby the activity of neurons indirectly regulated blood
vessel dilation [35]. In a process referred to as siphoning, the Müller glia are proposed to take
up K+ released by active neurons and then release the K+ at the endfeet that are in close
proximity to the vasculature [35]. Thus the astrocyte can effectively redistribute the K+ from
the neuron, which may be some distance away from the nearest blood vessel, to a region
immediately adjacent to the arteriole in a manner that is faster than would otherwise take place
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are critical to the formation of the deep plexus vasculature in the retina [33]. Angiogenesis is
the result of a balance between the pro-angiogenic factor vascular endothelial growth factor
(VEGF) and anti-angiogenic factor pigment-epithelium derived factor (PEDF) [33, 34]. The
ratio of these factors carefully controls the growth of the deep plexus retinal vasculature. Not
surprisingly, misregulation of these factors can lead to pathological neovascularization, a topic
which will be covered later in this chaper. Many other interactions between Müller glia/
astrocytes and the vasculature have been proposed and/or documented. For instance, Paulson
and Newman simulated a process whereby the activity of neurons indirectly regulated blood
vessel dilation [35]. In a process referred to as siphoning, the Müller glia are proposed to take
up K+ released by active neurons and then release the K+ at the endfeet that are in close
proximity to the vasculature [35]. Thus the astrocyte can effectively redistribute the K+ from
the neuron, which may be some distance away from the nearest blood vessel, to a region
immediately adjacent to the arteriole in a manner that is faster than would otherwise take place
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if the K+ was undergoing simple diffusion. Further, this could also concentrate K+ released over
a wider area to the smaller area of the endfeet.
Figure 2. Aquaporin-4 (AQ-4), bipolar cell/ horizontal cell (BC/HC), excitatory amino acid transporter (EAAT), excitato‐
ry amino acid carrier (EAAC), glial cell derived neurotrophic factor (GDNF), glutamate transporter (GLT), glycine trans‐
porter(GlyT), glutamine synthetase (GS), interleukins (IL), L-type amino acid transporter (LAT), matrix
metalloproteinases (MMP), photoreceptor cell (PC), pigment epithelium derived factor (PEDF), Na+ coupled neutral
amino acid transporter (SNAT), glutamate aspartate transporter (GLAST), vascular endothelial growth factor (VEGF).
Müller glia are also known for releasing many growth factors, and many of these factors effect
the endothelial cells. Transforming growth factor β1 (TGFβ1) is released by Müller glia and
can increase the expression of tissue plasminogen activator inhibitor-1, which could potentially
have the protective effect of reducing hemorhaging in the brain [36-38]. TGF-β1 also has been
shown to have a morphological effect on cultured endothelial cells, inducing them to form
capillary-like structures [39]. Mice with a loss of the integrin αVβ8 that is necesary for TGF-β
activation within the retina also have abnormal superficial as well as deep plexus formation
Neural Stem Cells - New Perspectives78
[40]. Glial-derived neurotrophic factor (GDNF) and neurturin are also released by Müller glia
and appear to enhance barrier function as measured by transendothelial resistance [41].
Communication between Müller glia and endothelial cells is not a one-way street. There also
appear to be inductive signals released from the endothelial cells that effect Müller glial differen‐
tiation/function. It is well established that leukemia inhibitory factor (LIF) is secreted from
endothelial cells and that it helps to induce astrocyte differentiation in optic nerve astrocytes [42,
43]. LIF and ciliary neurotrophic factor (CNTF) share a part of their receptor complex and
intracellular signaling pathway; therefore it is not surprising to find that CNTF has also been
shown to have effects on astrocyte development [44, 45]. Both CNTF and LIF are present in the
developing retina and CNTF does increase the production of Müller glia [46]. However, an
increase in the expression of LIF from the lens during retinogenesis inhibited the development of
retinal vasculature and increased the expression of VEGF in retinal astrocytes and Müller glia [47].
Hence it is unclear whether LIF plays a role in Müller glial cell differentiation.
2.4. Metabolic coupling with neurons
The brain is a high energy consuming organ, using approximately 25% of the glucose present in
the human body [48]. There is very tight coupling between the demand and supply in the central
nervous system (CNS), and most of this expenditure is due to neuronal activity [48, 49]. Howev‐
er, neurons do not store much glycogen and therefore are reliant upon external sources to fuel
their oxidative metabolism. In the retina, this need is met by both the Müller glia and retinal
astrocytes. Glucose enters Müller glia via glucose transporter-1 (GLUT-1) and is phosporylated
by hexokinase to produce glucose-6-phosphate (Fig 2). From here, part of the glucose-6-phos‐
phate is stored with the Müller glial cell body as glycogen and the rest is metabolized to various
carbohydrate intermediates [50-52]. Neurons can use a variety of substrates to fuel their oxida‐
tive metabolism, including lactate, pyruvate, alanine, glutamine, and glutamate [53, 54]. Müller
glia metabolize glucose and glycogen deposits predominantly to pyruvate and lactate which is
released to the extracellular milieu by the monocarboxylate transporter MCT2 [55, 56]. Neurons
can then take up pyruvate and use it directly in the Krebs cycle to compensate during times of low
glucose [50, 57]. Lactate generated by Müller glia is converted by lactate dehydorgenase and
pyruvate kinase to pyruvate to power the Krebs cycle [55].
Active neurons, in turn, release glutamate, NH4+, K+, and CO2, all of which are taken up by the
Müller glial cells and are either disposed of or recycled [4]. Glutamate is an excitatory neuro‐
toxin, even at low extracellular concentrations, and is tightly regulated by Müller glia in the
retina [58]. Müller cells take up glutamate via the glutamate/aspartate transporter, GLAST,
and NH4+ via an ammonia transporter (AMT) [59, 60]. In addition to transporting glutamate
into Müller glial cells, the GLAST protein co-transports 3Na+ ions and one H+ and counter-
transports one K+ [61]. The influx of Na+ into the Müller cell activates the Na+/K+ ATPase which
further stimulates glycolysis [4, 62]. Both the NH4+ and glutamate are use to create L-glutamine
by glutamine synthetase [60, 63-65]. The glutamine produced by Müller glia is then transported
back to neuronal cells to aid in the synthesis of neurotransmitters glutamate and GABA [54].
The presence of glutamate and NH4+ have a combined action of increasing glycolysis by the
Müller glia, in part by increasing the expression levels of glutamine synthetase [54, 66, 67].
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Müller glia also act as a sink for excess extracellular K+ in the retina, which is taken up by the
inwardly rectifying K+ (Kir) channels and the Na+/K+ ATPase of the Müller cells [62]. This
elevation of K+ concentration increases the glycogenolysis in cultured Müller glia, tightly
coupling the breakdown of glycogen to neuronal activity [17]. The K+ is then disposed of by
passing K+ into the subretinal space, the vitreous body, or the blood. [68, 69]. Finally, carbonic
anhydrase converts CO2 to bicarbonate which is then released by way of the H+/HCO3-
exchanger into the vitreous or blood (Fig 2) [70-73].
2.5. Regulation of neurotransmission
In the retina, glutamate is the primary excitatory neurotransmitter [74]. Müller glia have
transporters for a wide variety of transmitters, including glutamate, GABA, Glycine, D-serine,
dopamine, and ATP [75, 76]. The Müller glia take up neurotransmitters and other neuroactive
substances and convert them to substances that can be supplied to retinal neurons as neuro‐
transmitters or neurotransmitter precursors (Fig 2). The modulation of neuronal excitability
through regulation of neurotransmitter availability is thought to serve three functions; 1)
termination of neuronal signaling, 2) prevention of neurotransmitter spread to adjacent
synapses, and 3) prevention of neurotoxicity resulting from prolonged presence of a trans‐
mitter at a synapse [4, 75]. In this section, we will briefly cover transport of the major retinal
neurotransmitters into Müller glia, processing of the transmitter by the Müller glia and
transport of products back to retinal neurons.
Müller glia express several glutamate transporters, depending upon the species, including the
previously mentioned GLAST protein (also known as excitatory amino acid transporter 1 or
EAAT1). In humans for instance, the dominant transporter is EAAT1, but EAAT2 and 3 can
also be found [77]. Glutamate is the most widely used neurotransmitter used by retinal
neurons, including photoreceptors, bipolar and ganglion cells. Both the photoreceptors and
the bipolar cells have graded potentials, hence the amount of neurotransmitter released is
directly correlated to the amount of stimulus. In addition, photoreceptors are wired a little
differently than other neurons that transduce sensory information; they release glutamate in
the dark and less glutamate upon transduction of light signals. Hence, removal of glutamate
from the synaptic region is critical for normal tranmission of light signals to take place.
Knockdown and knockout studies in the retina have indicated that a loss of GLAST leads to a
loss of the electroretinogram b-wave, primarily because it aids in signal processing between
photoreceptors and bipolar cells, rather than any neurotoxicity associated with high levels of
glutamate [78, 79]. Consistent with the idea that Müller glia are critical for clearing away
glutamate released at synapses are studies in which clearance of D-aspartate was tracked first
to Müller glia followed by a redistribution into other neuronal cell types of the retina [80].
Glutamate can be converted to glutamine by glutamine synthetase, and is then transported
back to neurons as a precursor to glutamate [63, 81]. Loss of glutamine synthetase activity leads
to a loss of glutamate content in retinal neurons which leads to functional blindness within 2
minutes [82, 83].
There are several other neurotransmitters used in the retina, such as GABA, glycine, and
dopamine. Since the interactions of these neurotransmitters are not as heavily studied as
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glutamate, only their uptake mechanism and potential processing within Müller glia will be
discussed here. GABA is used by horizontal and amacrine cells within the retina and termina‐
tion of GABA activity is brought about through the uptake of GABA by Na+/Cl- - dependent GABA
transporters (GATs) found in presynaptic neurons, Müller glia, and retinal astrocytes [76, 84, 85].
After uptake into Müller glia, GABA can be converted to glutamine via glutamine synthetase and,
as specified above, is returned to neurons to act as substrates for neurotransmitters [86]. Müller
glia also express glutamate decarboxylase which catalyzes the decarboxylation of glutamate to
GABA. It is unclear, however, whether GABA can be released by Müller glia [76].
Dopamine performs a large number of functions in the developing and mature retina that are
well out of the scope of this chapter. A full discussion of this topic can be found elsewhere [87].
Both the transporter and enzymes necessary for converting tyrosine to dopamine are expressed
in Müller glia [88]. Likewise, ATP also performs a large number of functions in the developing
and mature retina [89-91]. Müller glia express a subset of the P2X and P2Y ATP receptors and
they also have the ability to convert ATP to adenosine and release both ATP and adenosine
into the intracellular space [91, 92].
Müller glia also carry glutamate, GABA, purinergic, glycine, dopaminergic, noradrenergic and
cholinergic receptors [76]. In some instances these receptors have been shown to coordinate
release of neurotransmitters by neurons with enzymatic activity and or gene regulation in the
Müller glial cells. An excellent example of this coordination is the regulation of glutamate
receptors on GLAST activity and expression of GLAST. When glutamate receptors are
activated on Müller glial membranes it leads to an increase in intracellular Ca2+ and protein
kinase C (PKC). The activation of metabotropic glutamate receptors in Müller cells leads to an
increase in Ca2+ and protein kinase C, and phosphorylation of GLAST by PKC leads to an
increase in transport of glutamate [82, 93]. The increased transport of glutamate through
GLAST appears to regulate activation of mammalian target of rapamycin (mTOR), which
activates DNA binding of the transcription factor activator protein-1 (AP-1) and an increase
in GLAST mRNA [94].
2.6. Other
Müller glia perform a variety of other functions beyond those already mentioned. For instance,
in addition to siphoning K+ released by retinal neurons, the Müller glia are also responsible
for the transport of water that accumulates in the tissue as the end product of ATP synthesis
[95]. The movement of water is specifically coupled to the movement of Na+ and K+ and, like
K+, is released into the bloodstream. Müller cells are also involved in phagocytosis of debris in
the retina and in the release of antioxidant glutathione [96, 97]
3. Properties that are similar to stem cells/astrocytes
Studies using reactive astrocytes have shown the potential to dedifferentiate into cells having
neural progenitor or stem cell like properties (Table 1) [98, 99]. Following stimulation, these
cells show activation of signaling pathways such as EGF, FGF, SHH and Wnts, previously
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transporters (GATs) found in presynaptic neurons, Müller glia, and retinal astrocytes [76, 84, 85].
After uptake into Müller glia, GABA can be converted to glutamine via glutamine synthetase and,
as specified above, is returned to neurons to act as substrates for neurotransmitters [86]. Müller
glia also express glutamate decarboxylase which catalyzes the decarboxylation of glutamate to
GABA. It is unclear, however, whether GABA can be released by Müller glia [76].
Dopamine performs a large number of functions in the developing and mature retina that are
well out of the scope of this chapter. A full discussion of this topic can be found elsewhere [87].
Both the transporter and enzymes necessary for converting tyrosine to dopamine are expressed
in Müller glia [88]. Likewise, ATP also performs a large number of functions in the developing
and mature retina [89-91]. Müller glia express a subset of the P2X and P2Y ATP receptors and
they also have the ability to convert ATP to adenosine and release both ATP and adenosine
into the intracellular space [91, 92].
Müller glia also carry glutamate, GABA, purinergic, glycine, dopaminergic, noradrenergic and
cholinergic receptors [76]. In some instances these receptors have been shown to coordinate
release of neurotransmitters by neurons with enzymatic activity and or gene regulation in the
Müller glial cells. An excellent example of this coordination is the regulation of glutamate
receptors on GLAST activity and expression of GLAST. When glutamate receptors are
activated on Müller glial membranes it leads to an increase in intracellular Ca2+ and protein
kinase C (PKC). The activation of metabotropic glutamate receptors in Müller cells leads to an
increase in Ca2+ and protein kinase C, and phosphorylation of GLAST by PKC leads to an
increase in transport of glutamate [82, 93]. The increased transport of glutamate through
GLAST appears to regulate activation of mammalian target of rapamycin (mTOR), which
activates DNA binding of the transcription factor activator protein-1 (AP-1) and an increase
in GLAST mRNA [94].
2.6. Other
Müller glia perform a variety of other functions beyond those already mentioned. For instance,
in addition to siphoning K+ released by retinal neurons, the Müller glia are also responsible
for the transport of water that accumulates in the tissue as the end product of ATP synthesis
[95]. The movement of water is specifically coupled to the movement of Na+ and K+ and, like
K+, is released into the bloodstream. Müller cells are also involved in phagocytosis of debris in
the retina and in the release of antioxidant glutathione [96, 97]
3. Properties that are similar to stem cells/astrocytes
Studies using reactive astrocytes have shown the potential to dedifferentiate into cells having
neural progenitor or stem cell like properties (Table 1) [98, 99]. Following stimulation, these
cells show activation of signaling pathways such as EGF, FGF, SHH and Wnts, previously
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shown to be associated with the neural stem cells [98, 100-102]. Similarly, activated Müller glial
cells following retinal injury have also shown the capacity to dedifferentiate into retinal
progenitor cells [103]. Studies in lower vertebrates such as fish, amphibians and birds have
shown the presence of a stem cell niche in the ciliary marginal zone (CMZ) of the retina
[104-107]. Mammals, however, do not have a CMZ [108]. In mammals, a small group of cells
in the non-pigmented portion adjacent to the retina can proliferate up to postnatal day 21, but
these cells are low in abundance and are not thought to generate many cells [103, 109]. It may
be more feasible to generate many retinal progenitor cells from activated Müller glia. Expres‐
sion profiling of proliferating Müller cells suggests a stem cell like role for these cells [110,
111]. Culture of the Müller cells in an enriched medium generated “multipotent neuro‐
spheres”, elucidating the stem cell role of Müller cells in vitro. Further transplantation of
enriched Müller glial cells into injured retina generated cells with neuron like characteristics
[112]. Müller cells have been shown to dedifferentiate, proliferate and give rise to amacrine
cells, bipolar cells, retinal ganglion neurons as well as the photoreceptor cells. [110, 111, 113].
One important factor aiding the transformation of the Müller glial cells is the membrane
depolarization due to a reduction of potassium ion conductance, primarily due to downregu‐
lation of the Kir channels in the Müller cell [114]. The dowregulation of the Kir channels leads
to a decrease in the p27kip1 cyclin kinase inhibitor, which is then succeeded by re-entry into
cell cycle. The downregulation of the Kir channels pushes these cells towards the proliferative
stage [115].
4. Response of Müller Glia to injury or disease states
When there is injury or disease within the CNS, astrocytes respond by entering a state referred
to as reactive gliosis. Reactive gliosis is an ill-defined set of molecular changes that alters the
homeostatic role of the cells and their interactions with neurons, vasculature, and the immune
system. Reactive gliosis is thought to be the result of signals received from the injured or
diseased tissue that begins a molecular cascade within the glial cells resulting in a change of
state [103]. There are a mulitude of questions that have arisen as a result of our limited
understanding of gliois, and investigators are currently working to answer these questions.
Among them:
• Is reactive gliosis one condition, or a host of related conditions?
• What are the molecular triggers of gliosis?
• Do all the triggers that appear to be involved in gliosis converge on one or two pathways
that mediate the changes in Müller glial state, or, are their multiple pathways that can
mediate multiple changes?
• Do different signals mitigate mild, moderate or severe reactive gliosis? How are these forms
of gliosis related?
• Can severe reactive gliosis be attenuated, even when triggers are chronically present?
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• Can the reactive gliosis be used to „supply“ multipotent stem cells to the retina to replace
dead or dying neurons?
• Can the multipotent stem cells that arise from Müller glial cells be directed in their differ‐
entiation in vivo and can the number of progenitor cells differentiating into cell types other
than Müller glia be increased substantially?
There appears to be a continuum in the states of reactive gliosis, from mild to severe. In the
mild to moderate forms of gliosis, the cells may hypertrophy and show some changes to their
functionality, but, if the trigger is removed, the cells may revert back to their former condition
without altering the tissue [116]. In the more severe forms of reactive gliosis, cells hypertrophy,
lose functionality, form glial scars that are inhibitory to axonal regeneration and neuronal
surivival, and may also proliferate [116, 117]. The severe state is marked by the persistance of
these characteristics. Within the mammalian retina, both the Müller glia and retinal astrocytes
display reactivity to injury and disease. In this section we will talk about triggers of Müller
glia, evidence that BMP7 may also be a trigger, and the changes in retinal homeostasis that
result from reactive gliosis in the retina.
5. Triggers of reactive gliosis
5.1. Known triggers
Müller glial reactivity can be found in every identified disease and injury that plagues the eye,
including diabetic retinopathy, glaucoma, age-related macular degeneration, retinitis pig‐
mentosa, and many many others [118-122]. In considering reactive gliosis, there appears to
multiple levels of complexity. For instance, there are a wide range of factors which have been
shown to trigger reactive gliosis in Müller glia (Figure 3 and Table 2). Some of these triggers
can have concentration-dependent effects upon astrocytes [116]. Further, different triggers can
lead to specific molecular and functional changes in the Müller glia that may correspond to
the various aspects of reactive gliosis [123]. Not only are there multiple triggers, but there is
heterogeneity in the response of Müller glia to the same factor [118].
5.2. Bone morphogenetic proteins in Müller cell gliosis
Studies in the injured spinal cord have indicated a role for another family of growth factors;
the bone morphogenetic proteins (BMPs). The BMPs are members of the TGF-β superfam‐
ily of growth factors. The receptors include two basic types, Type I and Type II, both of
which are serine-threonine kinases. Receptors from each type must form heterodimers in
order for signaling to occur, although the Type I receptors are downstream of the Type II.
There are two non-canonical signaling pathways, BMP-MAPK and FRAP-STAT, that have
more  recently  been  identified  in  addition  to  the  canonical  SMAD-related  pathway  [45,
124-129]. Three type I receptors have been associated with the BMPs, activin-like kinase 2
(ALK2), ALK 3 and ALK6. Accumulated evidence has shown that in regards to the Type
I receptor, BMP 6 and 7 activate the ALK2 receptor preferentially, whereas BMPs 2 and 4
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shown to be associated with the neural stem cells [98, 100-102]. Similarly, activated Müller glial
cells following retinal injury have also shown the capacity to dedifferentiate into retinal
progenitor cells [103]. Studies in lower vertebrates such as fish, amphibians and birds have
shown the presence of a stem cell niche in the ciliary marginal zone (CMZ) of the retina
[104-107]. Mammals, however, do not have a CMZ [108]. In mammals, a small group of cells
in the non-pigmented portion adjacent to the retina can proliferate up to postnatal day 21, but
these cells are low in abundance and are not thought to generate many cells [103, 109]. It may
be more feasible to generate many retinal progenitor cells from activated Müller glia. Expres‐
sion profiling of proliferating Müller cells suggests a stem cell like role for these cells [110,
111]. Culture of the Müller cells in an enriched medium generated “multipotent neuro‐
spheres”, elucidating the stem cell role of Müller cells in vitro. Further transplantation of
enriched Müller glial cells into injured retina generated cells with neuron like characteristics
[112]. Müller cells have been shown to dedifferentiate, proliferate and give rise to amacrine
cells, bipolar cells, retinal ganglion neurons as well as the photoreceptor cells. [110, 111, 113].
One important factor aiding the transformation of the Müller glial cells is the membrane
depolarization due to a reduction of potassium ion conductance, primarily due to downregu‐
lation of the Kir channels in the Müller cell [114]. The dowregulation of the Kir channels leads
to a decrease in the p27kip1 cyclin kinase inhibitor, which is then succeeded by re-entry into
cell cycle. The downregulation of the Kir channels pushes these cells towards the proliferative
stage [115].
4. Response of Müller Glia to injury or disease states
When there is injury or disease within the CNS, astrocytes respond by entering a state referred
to as reactive gliosis. Reactive gliosis is an ill-defined set of molecular changes that alters the
homeostatic role of the cells and their interactions with neurons, vasculature, and the immune
system. Reactive gliosis is thought to be the result of signals received from the injured or
diseased tissue that begins a molecular cascade within the glial cells resulting in a change of
state [103]. There are a mulitude of questions that have arisen as a result of our limited
understanding of gliois, and investigators are currently working to answer these questions.
Among them:
• Is reactive gliosis one condition, or a host of related conditions?
• What are the molecular triggers of gliosis?
• Do all the triggers that appear to be involved in gliosis converge on one or two pathways
that mediate the changes in Müller glial state, or, are their multiple pathways that can
mediate multiple changes?
• Do different signals mitigate mild, moderate or severe reactive gliosis? How are these forms
of gliosis related?
• Can severe reactive gliosis be attenuated, even when triggers are chronically present?
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• Can the reactive gliosis be used to „supply“ multipotent stem cells to the retina to replace
dead or dying neurons?
• Can the multipotent stem cells that arise from Müller glial cells be directed in their differ‐
entiation in vivo and can the number of progenitor cells differentiating into cell types other
than Müller glia be increased substantially?
There appears to be a continuum in the states of reactive gliosis, from mild to severe. In the
mild to moderate forms of gliosis, the cells may hypertrophy and show some changes to their
functionality, but, if the trigger is removed, the cells may revert back to their former condition
without altering the tissue [116]. In the more severe forms of reactive gliosis, cells hypertrophy,
lose functionality, form glial scars that are inhibitory to axonal regeneration and neuronal
surivival, and may also proliferate [116, 117]. The severe state is marked by the persistance of
these characteristics. Within the mammalian retina, both the Müller glia and retinal astrocytes
display reactivity to injury and disease. In this section we will talk about triggers of Müller
glia, evidence that BMP7 may also be a trigger, and the changes in retinal homeostasis that
result from reactive gliosis in the retina.
5. Triggers of reactive gliosis
5.1. Known triggers
Müller glial reactivity can be found in every identified disease and injury that plagues the eye,
including diabetic retinopathy, glaucoma, age-related macular degeneration, retinitis pig‐
mentosa, and many many others [118-122]. In considering reactive gliosis, there appears to
multiple levels of complexity. For instance, there are a wide range of factors which have been
shown to trigger reactive gliosis in Müller glia (Figure 3 and Table 2). Some of these triggers
can have concentration-dependent effects upon astrocytes [116]. Further, different triggers can
lead to specific molecular and functional changes in the Müller glia that may correspond to
the various aspects of reactive gliosis [123]. Not only are there multiple triggers, but there is
heterogeneity in the response of Müller glia to the same factor [118].
5.2. Bone morphogenetic proteins in Müller cell gliosis
Studies in the injured spinal cord have indicated a role for another family of growth factors;
the bone morphogenetic proteins (BMPs). The BMPs are members of the TGF-β superfam‐
ily of growth factors. The receptors include two basic types, Type I and Type II, both of
which are serine-threonine kinases. Receptors from each type must form heterodimers in
order for signaling to occur, although the Type I receptors are downstream of the Type II.
There are two non-canonical signaling pathways, BMP-MAPK and FRAP-STAT, that have
more  recently  been  identified  in  addition  to  the  canonical  SMAD-related  pathway  [45,
124-129]. Three type I receptors have been associated with the BMPs, activin-like kinase 2
(ALK2), ALK 3 and ALK6. Accumulated evidence has shown that in regards to the Type
I receptor, BMP 6 and 7 activate the ALK2 receptor preferentially, whereas BMPs 2 and 4
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activate either ALK3 or ALK6 [130]. In addition to the canonical SMAD pathway, ALK3
and 6 also activate the BMP-MAPK and FRAP-STAT pathways [45, 124, 129]. The BMPs
have  been  shown  to  act  as  a  gliosis  trigger  in  penetrating  spinal  cord  injuries,  and  a
differential role for ALK3 and 6 receptors has been ascribed to various aspects of gliosis,
including hypertrophy,  inflammation,  and tissue loss  [131,  132].  While  BMPs have been
studied in retinal injury, primarily as a survival factor for retinal neurons, it has not been
studied as a potential trigger for reactive gliosis in Müller glia [133].
My lab has investigated the role of BMP7 as a potential trigger for reactive gliosis in Müller glia
and retinal astrocytes. We and others have documented changes in BMP expression and signal‐
ing following injury or disease in the retina and optic nerve [134]. We have determined expres‐
sion levels of BMPs and BMP intracellular signaling pathway members in a diabetic mouse model,
the Akita mouse model (InsAKITA). These mice contain a naturally occurring missense mutation in
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Figure 3. Schematic representation of various signaling mechanisms which trigger and regulate reactive gliosis in
Müller glia. Growth factors such as TGF-β, BMP, EGF and CNTF; interleukins; as well as reactive oxygen species and free
radicals are known factors to trigger gliosis in Müller glial cells. Activator protein-1 (AP1), adenosine triphosphate
(ATP), bone morphogenetic protein (BMP), ciliary neurotrophic factor (CNTF), calcineurin (CN), cAMP response ele‐
ment binding protein (CREB), epidermal growth factor (EGF), endothelin 1 (ET1), extracellular-signal-regulated kinase
(ERK), fibroblast growth factor (FGF), interleukin (IL), inhibitor of differentiation (ID), janus kinase (JAK), mitogen acti‐
vated protein kinase (MAPK), mammalian target of rapamycin (mTOR), nuclear factor of activated T-cells (NFAT), nu‐
clear factor kappa-light-chain-enhancer of activated B cells (NF-κB), nitric oxide (NO), reactive oxygen species (ROS),
tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β), uridine triphosphate (UTP), uridine diphos‐
phate (UDP).
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activate either ALK3 or ALK6 [130]. In addition to the canonical SMAD pathway, ALK3
and 6 also activate the BMP-MAPK and FRAP-STAT pathways [45, 124, 129]. The BMPs
have  been  shown  to  act  as  a  gliosis  trigger  in  penetrating  spinal  cord  injuries,  and  a
differential role for ALK3 and 6 receptors has been ascribed to various aspects of gliosis,
including hypertrophy,  inflammation,  and tissue loss  [131,  132].  While  BMPs have been
studied in retinal injury, primarily as a survival factor for retinal neurons, it has not been
studied as a potential trigger for reactive gliosis in Müller glia [133].
My lab has investigated the role of BMP7 as a potential trigger for reactive gliosis in Müller glia
and retinal astrocytes. We and others have documented changes in BMP expression and signal‐
ing following injury or disease in the retina and optic nerve [134]. We have determined expres‐
sion levels of BMPs and BMP intracellular signaling pathway members in a diabetic mouse model,
the Akita mouse model (InsAKITA). These mice contain a naturally occurring missense mutation in
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Figure 3. Schematic representation of various signaling mechanisms which trigger and regulate reactive gliosis in
Müller glia. Growth factors such as TGF-β, BMP, EGF and CNTF; interleukins; as well as reactive oxygen species and free
radicals are known factors to trigger gliosis in Müller glial cells. Activator protein-1 (AP1), adenosine triphosphate
(ATP), bone morphogenetic protein (BMP), ciliary neurotrophic factor (CNTF), calcineurin (CN), cAMP response ele‐
ment binding protein (CREB), epidermal growth factor (EGF), endothelin 1 (ET1), extracellular-signal-regulated kinase
(ERK), fibroblast growth factor (FGF), interleukin (IL), inhibitor of differentiation (ID), janus kinase (JAK), mitogen acti‐
vated protein kinase (MAPK), mammalian target of rapamycin (mTOR), nuclear factor of activated T-cells (NFAT), nu‐
clear factor kappa-light-chain-enhancer of activated B cells (NF-κB), nitric oxide (NO), reactive oxygen species (ROS),
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phate (UDP).
Reactive Muller Glia as Potential Retinal Progenitors
http://dx.doi.org/10.5772/55150
85
the insulin 2 gene that causes a switch from a cysteine to a tyrosine residue at amino acid 96,
removing one of the cysteines necessary for an intramolecular disulfide bond [135]. Heterozy‐
gous mice are severely insulin deficient and become diabetic at about 6 weeks of age [135]. For
these studies we used two stages; mice that are 3 weeks of age have mild to no reactive gliosis,
while 6 weeks of age has moderate gliosis. Levels of BMP expression were determined by reverse
transcription – quantitative polymerase chain reaction (RT-qPCR) of RNA samples from 3 and 6
week old wild type and heterozygous mice. The graphs show changes in mRNA levels in the 3
and 6 week InsAKITA mice relative to levels of mRNA in wild type samples (Fig 4A, B). Further,
genes that are known downstream targets of the BMP pathway, such as inhibitor of differentia‐
tion (ID) 1, 3, and MSX2 are also increased, consistent with an increase in BMP signaling (Fig 4A,
B). To verify there was an increase in canonical BMP signaling, an increase in nuclear localiza‐
tion of phospho-SMAD1 (p-SMAD1,5,8) sections through wild-type and 6 week InsAKITA retina
were immunolabeled for p-SMAD1,5,8 and glutamine synthetase (Fig 4C-N). The InsAKITA retina
showed a clear increase in p-SMAD1,5,8 expression in the inner nuclear layer at 6 weeks of age,
some of which was coincident with cells glutamine synthetase-expressing Müller glia (Fig 4L-
N). There was also clear increase in p-SMAD1, 5, 8 in other cells of the inner nuclear layer and cells
of the ganglion cell layer.
To test the role of BMPs in reactive gliosis in vivo, adult murine eyes were injected intravitreally
with vehicle or BMP7 and analyzed 3 or 7 days post injection. At both 3 and 7 days post vehicle
injection, there were the normal low levels of GFAP expression and moderate levels of gluta‐
mine synthetase in Müller glia (Fig 5A, B, G, H). A low level of the chondroitin sulfate proteogly‐
can, neurocan, is present throughout the retina (Fig 5C, I). Three days post BMP7 injection, no
increase in GFAP was detected, but an increase in both glutamine synthetase and neurocan levels
were detected (Fig 5D-F). Immunolabel of BMP7-injected eyes showed an increase of GFAP,
glutamine synthetase and neurocan in comparson to vehicle-injected eyes (Fig 5J-L).
6. Characteristics of reactive gliosis in Müller Glial cells
Müller glia display many changes during reactive gliosis (Fig 6). We have grouped these
changes into 6 broad categories; 1) hypertrophy, 2) loss of functionality, 3) neuroprotection, 4)
inflammation, 5) proliferation, 6) remodeling.
6.1. Hypertrophy
Hypertrophy refers to the swelling of the Müller glial cell body and processes. The swelling
is, in part, brought about by an increase in the expression of two type III intermediate filament
genes, GFAP and vimentin. As with many changes that occur with reactive gliosis, upregula‐
tion of intermediate filaments and the ensuing hypertrophy has both good and bad charac‐
teristics associated with it. Hypertrophic glia help to form and maintain a barrier around
injured tissue which helps to protect surrounding tissues from inflammatory signals [136,
137]. On one hand, there is evidence that the increased production of GFAP does not lead to
diminished neuronal metabolism, eletrophysiology or visual function [138]. However,
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evidence from injured spinal cord indicates axonal regeneration and functional recovery was
increased in GFAP/vimentin double-knockouts in comparison to wild type controls [139].
Further, the retinas of GFAP/vimentin double knockouts were also protected from retinal
degeneration following retinal detachment, and integration and neurite extension from
transplanted cells is also enhanced [140].
In addition to increased intermediate filament expression, hypertrophy is also the product of
a loss of K+ conductance into the blood stream as already covered in section 1.3, Müller glia
take up K+ released by retinal neurons and release it into the bloodstream. Water in the tissue,
created through the process of oxidative synthesis of ATP, is removed through the pigmented
epithelium and Müller glia. The movement of water is coupled to the movement of osmolytes,
including Na+ and K+ ions, and are subsequently removed from the Müller cell bodies via
release into the bloodstream [4]. Müller glia undergoing gliosis downregulate the K+ channel,
Kir4.1, that delivers K+ to the vasculature, which uncouples the movement of K+ and water into
the blood. The end result is swelling of the Müller cell body.
6.2. Loss of functionality
Loss of functionality is a part of the general response of the cells to undergo dedifferentiation.
However, the response of the Müller cells can vary depending upon the disease or injury
present. A good example of this is the regulation of the glutamate transporter in disease and
following mechanical injury. Downregulation of glutamate transporters is observed in
glaucoma, ischemia and diabetic retinopathy, due to a decrease in the activity of the glutamate
transporter GLAST. This in turn downregulates the activity of glutamine synthetase, an
enzyme involved in glutamate recycling [141]. However, following mechanical nerve injury,
as seen with the optic nerve crush model, glutamine synthetase was found to localize to the
ganglion cell layer, aiding in the recycling of the excess glutamate released due to neuronal
injury. [142].
The Kir channels (potassium channels) in the Müller glial cell membrane play an important
role in the gliosis response as well. Decrease in conductance of the potassium ions due to down
regulation of Kir 4.1 leads to an increase in potassium ions outside the membrane. This, in turn,
decreases the transport of glutamate, glucose and water across the Müller glial cell surface.
Consequently, an increase in the glutamate toxicity, decrease in glutathione synthase activity
and osmotic swelling were observed in the retina, which contribute to the loss of glia/neuron
interactions [97, 114, 120, 143-146].
There is also a reduction in the blood-retinal barrier function under hypoxic conditions. This
appears to be driven by changes Müller cell expression of growth factors that regulate
endothelial cell tight junctions. The balance between factors that increase endothelial cell tight
junctions (PEDF, glial derived neurotrophic factor (GDNF), transforming growth factor Beta
(TGFβ), thrombospondin, etc) and factors that decrease barrier function (VEGF, TNFα, FGF2,
etc) is disrupted by reactive gliosis [34, 41, 147-153]. VEGF appears to be the dominant factor
released from Müller glial cells in decrease of barrier function and angiogenesis that occurs in
many forms of retinal injury and disease [153].
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the insulin 2 gene that causes a switch from a cysteine to a tyrosine residue at amino acid 96,
removing one of the cysteines necessary for an intramolecular disulfide bond [135]. Heterozy‐
gous mice are severely insulin deficient and become diabetic at about 6 weeks of age [135]. For
these studies we used two stages; mice that are 3 weeks of age have mild to no reactive gliosis,
while 6 weeks of age has moderate gliosis. Levels of BMP expression were determined by reverse
transcription – quantitative polymerase chain reaction (RT-qPCR) of RNA samples from 3 and 6
week old wild type and heterozygous mice. The graphs show changes in mRNA levels in the 3
and 6 week InsAKITA mice relative to levels of mRNA in wild type samples (Fig 4A, B). Further,
genes that are known downstream targets of the BMP pathway, such as inhibitor of differentia‐
tion (ID) 1, 3, and MSX2 are also increased, consistent with an increase in BMP signaling (Fig 4A,
B). To verify there was an increase in canonical BMP signaling, an increase in nuclear localiza‐
tion of phospho-SMAD1 (p-SMAD1,5,8) sections through wild-type and 6 week InsAKITA retina
were immunolabeled for p-SMAD1,5,8 and glutamine synthetase (Fig 4C-N). The InsAKITA retina
showed a clear increase in p-SMAD1,5,8 expression in the inner nuclear layer at 6 weeks of age,
some of which was coincident with cells glutamine synthetase-expressing Müller glia (Fig 4L-
N). There was also clear increase in p-SMAD1, 5, 8 in other cells of the inner nuclear layer and cells
of the ganglion cell layer.
To test the role of BMPs in reactive gliosis in vivo, adult murine eyes were injected intravitreally
with vehicle or BMP7 and analyzed 3 or 7 days post injection. At both 3 and 7 days post vehicle
injection, there were the normal low levels of GFAP expression and moderate levels of gluta‐
mine synthetase in Müller glia (Fig 5A, B, G, H). A low level of the chondroitin sulfate proteogly‐
can, neurocan, is present throughout the retina (Fig 5C, I). Three days post BMP7 injection, no
increase in GFAP was detected, but an increase in both glutamine synthetase and neurocan levels
were detected (Fig 5D-F). Immunolabel of BMP7-injected eyes showed an increase of GFAP,
glutamine synthetase and neurocan in comparson to vehicle-injected eyes (Fig 5J-L).
6. Characteristics of reactive gliosis in Müller Glial cells
Müller glia display many changes during reactive gliosis (Fig 6). We have grouped these
changes into 6 broad categories; 1) hypertrophy, 2) loss of functionality, 3) neuroprotection, 4)
inflammation, 5) proliferation, 6) remodeling.
6.1. Hypertrophy
Hypertrophy refers to the swelling of the Müller glial cell body and processes. The swelling
is, in part, brought about by an increase in the expression of two type III intermediate filament
genes, GFAP and vimentin. As with many changes that occur with reactive gliosis, upregula‐
tion of intermediate filaments and the ensuing hypertrophy has both good and bad charac‐
teristics associated with it. Hypertrophic glia help to form and maintain a barrier around
injured tissue which helps to protect surrounding tissues from inflammatory signals [136,
137]. On one hand, there is evidence that the increased production of GFAP does not lead to
diminished neuronal metabolism, eletrophysiology or visual function [138]. However,
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evidence from injured spinal cord indicates axonal regeneration and functional recovery was
increased in GFAP/vimentin double-knockouts in comparison to wild type controls [139].
Further, the retinas of GFAP/vimentin double knockouts were also protected from retinal
degeneration following retinal detachment, and integration and neurite extension from
transplanted cells is also enhanced [140].
In addition to increased intermediate filament expression, hypertrophy is also the product of
a loss of K+ conductance into the blood stream as already covered in section 1.3, Müller glia
take up K+ released by retinal neurons and release it into the bloodstream. Water in the tissue,
created through the process of oxidative synthesis of ATP, is removed through the pigmented
epithelium and Müller glia. The movement of water is coupled to the movement of osmolytes,
including Na+ and K+ ions, and are subsequently removed from the Müller cell bodies via
release into the bloodstream [4]. Müller glia undergoing gliosis downregulate the K+ channel,
Kir4.1, that delivers K+ to the vasculature, which uncouples the movement of K+ and water into
the blood. The end result is swelling of the Müller cell body.
6.2. Loss of functionality
Loss of functionality is a part of the general response of the cells to undergo dedifferentiation.
However, the response of the Müller cells can vary depending upon the disease or injury
present. A good example of this is the regulation of the glutamate transporter in disease and
following mechanical injury. Downregulation of glutamate transporters is observed in
glaucoma, ischemia and diabetic retinopathy, due to a decrease in the activity of the glutamate
transporter GLAST. This in turn downregulates the activity of glutamine synthetase, an
enzyme involved in glutamate recycling [141]. However, following mechanical nerve injury,
as seen with the optic nerve crush model, glutamine synthetase was found to localize to the
ganglion cell layer, aiding in the recycling of the excess glutamate released due to neuronal
injury. [142].
The Kir channels (potassium channels) in the Müller glial cell membrane play an important
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Figure 4. Analysis of retinas of the Ins2Akita diabetic mouse shows increase in BMP signaling in the diseased eye when
compared to the wild type eye. A and B: qPCR results analyzing the levels of various BMP molecules shown to be regu‐
lated during reactive gliosis and some of the targets of the canonical BMP signaling pathway, using RNA obtained
from whole retinas in 3 week and 6 week diseased eye, respectively, normalized to their respective wild types. At the 3
week stage (A), when little or no gliosis is observed (data not shown) levels of BMP 2, 4 and 6 appear to be high. At
the 6 week stage (B) when we do seen an increase in expression of GFAP, GS and neurocan (data not shown), there is
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an increase in levels of BMP7 with a subsequent decrease in the levels of other BMP molecules, indicating a role for
BMP7 in reactive gliosis in the diseased state. Immunohistochemistry was performed to determine the localization of
phospho SMAD with glutamine synthetase in the retinas (C – N). The 3 week retinas show similar nuclear phospho
SMAD levels in both the wild type and the Ins2Akita (C, E, F and H). In the 6 week Ins2Akita, there is a clear increase in the
phospho SMAD levels in the inner nuclear layer nuclei (L and N) when compared to the wild type (I and K), possibly
due to the increase in BMP7 shown previously (B).
Figure 5. Effect of intra vitreal injections of BMP7 into normal mouse eyes – Retinal sections of eyes injected with ei‐
ther vehicle or BMP7 were analyzed 3 days (A – F) and 7 days (G – L) post injection via immunohistochemistry for the
localization of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS) and neurocan. Retinas isolated 3 days
post injections do not show an increase in GFAP (A and D) or neurocan (C and F), although GS does seem to show an
increase when compared to the vehicle injected eyes (B and E). Retinas isolated 7 days post injection did show a clear
increase in GFAP (G and J), GS (H and K) and neurocan (I and L) in the BMP7 injected eyes compared to the control
eyes, suggesting the BMP7 was able to trigger gliosis in these retinas.
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Figure 6. Schematic representation of reactive gliosis response in Müller glia depending on the extent of the injury.
Mild changes in reactive gliosis comprises of hypertrophy of the cells due to an increase in glial fibrillary acidic protein
and changes to the function and morphology of the cell, with little or no proliferation which has the potential to re‐
solve once the stimulus subdues. Severe reactive gliosis occurs following tissue damage and induces Müller glial cell
proliferation, overlapping of cell processes, hypertrophy, functional and morphological changes. Under severe gliosis
conditions reactive Müller cells have shown the ability to dedifferentiate and give rise to some of the retinal cells
types.
6.3. Neuroprotection
Reactive gliosis in Müller cells is a complex response dependent on the injury or disease.
Diseases which lead to retinal degeneration such as retinal detachment, retinitis pigmentosa
or physical damage to the retina elucidate such a response from the Müller cells to aid in
neuoprotection and prevent apoptosis [114, 141]. A wide range of growth factors secreted by
the reactive Müller cells, including bFGF, GDNF, CNTF, and VEGF [114, 141, 150, 154, 155].
Upregulation of CNTF and bFGF have been observed following mechanical injury, ischemia
and NMDA mediated neuronal death [156-158]. These growth factors help to increase neuron
survival and inhibit apoptosis, either directly as is the case for bFGF, or indirectly in the case
of CNTF and GDNF [159, 160]. GDNF also upregulates GLAST, thereby, protecting neurons
from excessive glutamate excitotoxicity [160]. VEGF is another factor which is upregulated
following gliosis. Hypoxia as well as diabetes has shown to increase the VEGF secretion by
Müller glial cells [161, 162]. VEGF may act directly by increasing the permeability of the
endothelial cells [163]. VEGF may also be regulated by TGF-β released during hypoxia, which,
along with other cytokines such as TNF-α, increase the expression of matrix metalloproteinases
which can clear the basement membranes of these cells generating leaky vessels [38, 164].
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Müller cells also protect retinal neurons from oxidative stress, excitotoxicity and from dam‐
aging reactive oxygen species via conversion of glutamate to glutamine as well as synthesis
and release of antioxidants such as glutathione [165, 166]. However, concomitant with an
increase in the antioxidant glutathione, during hypoxia, diabetic retinopathy, hyperglycemia
and ischemia there is also an increase in the expression of inducible nitric oxide synthase and
cyclooxygenase-2 [167, 168]. These enzymes can lead to production of nitric oxide, prosta‐
glandins and superoxides which are detrimental to retinal neurons and may induce apoptosis
in neural cells [169]. Nitric oxide also has a beneficial role as it increases blood flow by dilating
blood vessels and prevents glutamate toxicity by closing N-methyl –D-aspartate (NMDA)
receptors [170].
6.4. Inflammation
Müller cells also play a role in the inflammatory response observed in the retina, primarily
seen in the diabetic retina. Under these conditions, the activated Müller cells begin expressing
pro inflammatory cytokine interleukin-6 (IL-6) and IL-1B [171, 172]. They also increase
expression of TNF-α which increases the expression of the chemokine IL-8 and MCP-8, and
promotes infiltration of inflammatory cells [173]. The inflammatory response is further
supported by the decrease in glutamate uptake in diabetic retinas. This increases the expression
of glutaredoxin, which translocates NF-κB to the nucleus and increases the expression of pro-
inflammatory proteins [141].
6.5. Proliferation
Dedifferentiation  and  proliferation  of  Müller  glia  is  known  to  occur  in  many  different
species, including chick, fish, and even mammalians [108, 110, 174-177]. Several aspects of
Müller cell proliferation are of interest here; 1) the molecular pathways that result in the
release of the cells from their normally quiescent state, 2) extrinsic signals that are necessa‐
ry  for  the  proliferative  reponse,  and  3)  directing  progenitor  cells  to  differentiation  and
integration into retinal tissue.
Several intracellular signaling pathways have been investigated to determine those that may
be important for the proliferative response in dedifferentiating Müller glia. The FGF-MAPK
pathway appears to be indespensible for the proliferative activity seen during reactive gliosis
[178, 179]. The heparin binding epidermal growth factor (HBEGF)-MAPK pathway is be also
induced in the Müller glia found in injured areas and appears to be associated with regener‐
ation-associated genes [180]. Further, the HB-EGF pathway appears to be upstream of the
WNT-β-catenin pathway, which has been very clearly associated wth re-entrance of Müller
glia into the cell cycle [181]. More specifically, Müller glia that are poised to re-enter the cell
cycle accumulate β-catenin in injured zebrafish retina, whereas those Müller cells that remain
quiescent do not accumulate β-catenin [181]. Further, activation of the WNT/β-catenin
pathway stimulates a loss of Müller glia and a concomitant increase in newly generated
photoreceptors [181].
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In order for Müller glia to re-enter and progress in the cell cycle, the cells would also have to
suppress some of the cell cycle check-points that are responsible for the quiescent state of the
cells. Inhibition of the cyclin kinase inhibitor p27 has been shown to play a pivitol role in the
ability of Müller glia to re-enter the cell cycle. P27 regulates the cell cycle by blocking cell cycle
progression into the S-phase, and hence is necessary for maintainance of the quiescent state
[182]. Knock-out mice for p27 show many of the characteristics of reactive gliosis, including
an increase in GFAP expression and proliferation and migration of cells into the subretinal
space [138, 182-184].
6.6. Remodeling
There appears to be three elements of the retina which can undergo remodeling as a result of
gliosis; 1) vasculature, 2) the Müller glia themselves, and 3) the extracellular matrix. The
neovascularization is, for the most part, due to an imbalance between the antiangiogenic factor
PEDF and and the angiogenic factor VEGF [162, 185-190]. Under hypoxic conditions, tran‐
scriptional activation of VEGF occurs by translocation of the newly stabilized hypoxia
inducible factor-1α (HIF-1α) and it’s partner HIF-1β to the nucleus where they bind to the
hypoxia responsive element (HRE) in the 5‘ flanking regions of the VEGF gene [191, 192]. VEGF
is released into the extracellular mileu, where it penetrates the basal laminae and interacts with
retinal endothelial cells. This interaction results in an increase in the release of a family of zinc-
dependent endopeptidases called the matrix metalleoproteinases (MMPs), plasminogen
activators, and other proteinases which degrade proteins, such as occludens, which necessary
for the tight junction formation between endothelial cells [192-196]. The VEGF activates the
MAPK pathway via phospholipase C-γ, which mediates proliferation of the endolthelial cells
[197]. The MMPs also degrade the basal laminae, removing contact inhibition of the endothelial
cells and permitting proliferation [38].
The Müller glia participate in remodeling themselves by extending hypertrophied processes
into areas they are not typically found. For instance, processes can protrude into the subretinal
space, plexiform layers, the vitreous, into occluded blood vessels, and even into the choroid
[122, 198-203]. In some respects, the Müller glia are expanding into areas where degenerating
neurons and/or axonal processes are found, such as the subretinal space or plexiform layers
[204]. If these new processes persist, the end result is the formation of scar tissue, which can
permanently block the reattachment of the retina, regeneration of outer segments or regener‐
ation of synaptic contacts in the plexiform layers [118, 122, 205-209]. The extension of processes
onto the vitreal surface of the retina results in the formation of periretinal membranes that may
under epithelial to mesenchymal transformation into myofibrocytes that spread and become
contractile [210]. The contractility leads to folds and/or deformations in the retina, causing
visual distortions at the very least, and, at worst, can cause retinal detachments [211, 212]. Glial
membranes/scars are a significant issue in the treatment of visual disorders in humans,
occuring in appoximately 15% of retinal detachments [213].
The last element of the retina that undergoes remodeling during reactive gliosis is the extrac‐
ellular matrix (ECM). During reactive gliosis, Müller glia upregulate expression of MMPs and
the gene products are secreted and activated [196, 214-218]. Each MMP specifically targets and
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proteolytically cleaves one or more ECM molecules. The activity of MMPs is regulated by
activators as well as inhibitors; the precursor molecules must be processed, either by already
activated MMPs or by one of a variety of serine proteases and the MMPs can be inhibited by
the tissue inhibitors of metalloproteinases (TIMPs) [219]. When activated, the MMPs degrade
the existing ECM in preparation for replacement with an ECM that partially inhibits neurite
outgrowth or supports abnormal neurite outgrowth [141]. In the normal adult retina heparin
sulfate proeoglycans (HSPGs) are typically found on Müller glial endfeet and in retinal basal
lamina, serving as a substrate for axonal outgrowth. The HSPG, via the HS chains, is also a
ligand for the protein tyrosine phosphatase-sigma (PTP-σ), used in signaling in axons and
growth cones in response to matrix cues. The HSPGs involved are agrin and collagen XVIII
[220]. The HSPGs are lost in favor of the axonal outgrowth inhibitory molecules known as the
chondroitan sulfate proteoglycans (CSPGs). The CSPGs include phosphacan, aggrecan, NG2,
brevican, versican, and neurocan [221]. In addition to turning over the ECM, the degradation
of the ECM also releases growth factors that are bound to the ECM, such as EGF, FGFs, BMPs,
insulin, and VEGFs [219].
Müller glia can form new neurons in a process said to involve dedifferentiation of the Müller
glia. Tenascin C (TNC), a matricellular protein, influences the dedifferentiation behavior of
Müller glia in response to FGF2 in vitro, affecting the composition of the ECM. Sulfated
chondroitin glycosaminoglycan chains in CSPG are the main target. Chondroitin sulfate
increases in TNC-deficient mouse ECM [222]. The proteoglycan most affected by TNC is the
CSPG Phosphacan/RPTPβ/ζ which bind to TNC [223]. TNC shows overlapping expression
with phosphacan [224]. In a TNC knock out mouse TNC level rise. Studies using immunocy‐
tochemistry for phosphacan, Western Blots and PCR for mRNA levels show that it is the
chondroitin sulfate chains that increase, not the amount of mRNA for CSPG core protein.
Proliferation rates also increase in the TNC-deficient mice, but it is not clear if this affects exit
from the cell cycle and differentiation [222].
SPARC (secreted protein, acidic and rich in cysteine)/osteonectin is also a matricellular. It interacts
with growth factors and ECM forming a link that modulates the cell cycle and other cell behav‐
ior. SPARC remains expressed at significant levels in the adult CNS, moreso than in most normal
adult tissues. SPARC is widely expressed in remodeling injured tissue and in morphogenesis in
development [225]. In normal newborn and adult bovine retinas SPARC is found in ganglion cell
soma and in ganglion cell axons, with higher expression in the adult tissue. SPARC is thought to
have a function in maintaining healthy retinas and is localized to the ganglion cell layer (GCL),
nerve fiber layer (NFL) and some retinal capillaries. Müller glia showed no immunoreactivity,
but the GFAP-positive retinal astrocytes were SPARC-positive [225].
7. Conclusion
The evidence to date has shown that Müller glia undergo dedifferentiation and generate retinal
progenitors that may be capable of differentiating into retinal neurons. Several potential
problems have arisen that impact on the ability of those progentiors to effectively be used to
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regenerate large numbers of neurons following injury or during disease. Of the proliferating
population that arise from dedifferentiated Müller glia, a very small percentage go on to
become retinal neurons [4, 141]. The inability of the cells to differentiate into retinal neurons
implies that either the signals and/or competence necessary for differentiation have been lost
or there are signals present that direct progenitor cells away from differentiation into retinal
neurons. Further, if the progenitor cells can be induced to differentiate, they will have to
functionally integrate into the diseased or injured retina. This, in and of itself, will be a
challenge if glial scars are present in the tissue as the glial scars will prevent ntegration by
inhibiting migration, placement, and/or synapse formation. Clearly, investigators have been
untangling which signaling pathways are critical for various aspects of reactive gliosis to occur.
If signals that are necessary for proliferation can be separated from those necessary for glial
scars to form, there is the possibility that therapeutic approaches could be engineered that will
block scar formation while allowing proliferation to occur. There are many challenges ahead
before the potential of Müller glia as a source for retinal regeneration can be realized.
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regenerate large numbers of neurons following injury or during disease. Of the proliferating
population that arise from dedifferentiated Müller glia, a very small percentage go on to
become retinal neurons [4, 141]. The inability of the cells to differentiate into retinal neurons
implies that either the signals and/or competence necessary for differentiation have been lost
or there are signals present that direct progenitor cells away from differentiation into retinal
neurons. Further, if the progenitor cells can be induced to differentiate, they will have to
functionally integrate into the diseased or injured retina. This, in and of itself, will be a
challenge if glial scars are present in the tissue as the glial scars will prevent ntegration by
inhibiting migration, placement, and/or synapse formation. Clearly, investigators have been
untangling which signaling pathways are critical for various aspects of reactive gliosis to occur.
If signals that are necessary for proliferation can be separated from those necessary for glial
scars to form, there is the possibility that therapeutic approaches could be engineered that will
block scar formation while allowing proliferation to occur. There are many challenges ahead
before the potential of Müller glia as a source for retinal regeneration can be realized.
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1. Introduction
1.1. Neurogenesis, stem cells and cellular models of diseases
In a study published in 1992, Weiss and Reynolds at University of Calgary, demonstrated for
the first time that cells isolated from the brain of adult mice have the ability to proliferate in
vitro and differentiate into neurons, astrocytes and oligodendrocytes using a specific cocktails
of growth factors [1]. In 1999, similar stem/progenitor cells were isolated from the human adult
periventricular subependymal zone and expanded in vitro [2].
Neural stem cells (NSC) are self-renewing, multipotent cells residing in the nervous system.
NSC during development produce the enormous diversity of neurons, astrocytes and oligo‐
dendrocytes within the developing nervous system. However, accumulating evidence has
clearly shown that a number of newborn neurons can be generated also from adult NSC,
integrates into pre-existing neural circuits and is functional [3]. In the adult brain, neurogenesis
is not a diffuse event and occurs in restricted regions, where classical developmental signals
and morphogens such as, Bone Morphogenic Proteins (BMPs), ephrins, Noggin, Sonic
hedgehog homolog (Shh), and Notch expression are maintained even after differentiation [4].
In particular, the Notch pathway is a highly conserved arbiter of cell fate decisions and is
intimately involved in developmental processes [5]. Thus, besides its pivotal role in neural
development, it is also involved in the control of neurogenesis, neuritic growth [6], neural stem
cell maintenance [7], synaptic plasticity [8] and long term memory [9] both in the developing
and adult brain.
In the adult brain the well-established restricted regions of neurogenesis, named niches, are
the sub ventricular zone (SVZ) of the lateral ventricle wall and the dentate gyrus subgranular
zone (SGZ) of the hippocampus [9]. Several reports describe that neurogenesis may also occur
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in other brain areas, including substantia nigra [10], and neocortex [11] even if these studies
have not been confirmed by others.
In the currently prevalent view, primary adult SVZ NSCs in vivo are slowly dividing, long-
term 5-bromo-2’-deoxyuridine (BrdU)-retaining progenitors that exhibit several common
features of subventricular radial glia-like astrocytes and ventricular ependymal cells, including
morphological characteristics and expression of the glial fibrillary acidic protein (GFAP) and
the glycoprotein CD133, also known as Prominin-1.
Adult neurogenesis in either the SVZ or the SGZ is highly sensitive to environmental cues,
physiological stimuli and neuronal activity, suggesting that the tailored addition of new
neurons might serve specific neuronal functions. In fact, the complex dynamic equilibrium
present in healthy adult CNS involves also the participation of functional NSC niches [12, 13].
The occurrence of major events breaking niches homeostasis may overcome their adaptive
capacities and contribute or lead to disease. In CNS, various pathogenic events acting by
different mechanisms may cause neural cell loss and chronic inflammation. Several agents and
mediators sustaining these mechanisms also act on niche homeostasis and it is therefore
expected that these two conditions may have a deep impact on NSC biology and niche
properties. The neurogenesis within SVZ niche is differentially activated in various neurode‐
generative pathologies. An increase in endogenous neurogenesis in the lateral ventricular
walls occurs in several diseases including traumatic brain injury, vascular dementia, Hun‐
tington’s disease, multiple sclerosis or epilepsy and physiological events such as ageing.
[14-19]. In these pathophysiological conditions, a common feature leading to neurogenesis is
represented by the upregulation of inflammatory cytokines production. In several cases it has
been shown that the niche reaction to inflammation leads to generation of new neurons that
integrate within the pre-existing circuitry [20].
In pathological conditions, such as stroke, NSC niches can appear also at unexpected ectopic
sites as in brain parenchyma. In particular, part of the stroke-induced ectopic cells positive for
doublecortin, a widely accepted marker of neurogenesis, originates from the SVZ resident
NSCs that have migrated to the injured site where they differentiated into mature neurons [21]
However, it is also possible that part of this ectopic pool may originate locally, leading to an
injury-induced ectopic NSC niche formation [22]. Niche reaction to injury may thus proceed
by amplification of pre-existing NSC niche and migration toward the damaged site or by
activation of local and pre-existing quiescent NSC niches or by conversion of a normal tissue
into a newly established NSC niche. The mechanisms and signals driving these reactions are
many, some of them peculiar to the pathological condition and most of them endogenous to
the NSC niche and already acting in physiological condition.
Altogether the findings described above lead to speculate that NSC may be therapeutically
useful for CNS self-repair if properly mobilized and can supply cells for neuronal substitution
in CNS injury or degeneration, providing potential therapeutic tools in CNS diseases. NSC,
on the other hand, can be also useful for studying the mechanisms and molecules involved in
neuronal differentiation, regulation of neurotransmitter biosynthesis and also physiopathol‐
ogy of brain diseases. Indeed, to date, deciphering the molecular and cellular basis of CNS
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disorders has been met with success in animal models for neurological disease. However,
while the continued importance of animals in translational research is unquestionable, genetic
and anatomical variation between rodents and humans have led to imperfect phenotypic
correlations between genetic models and the human disease. Moreover, most neurodegener‐
ative diseases are sporadic and depend on the complex interaction of genetic and environ‐
mental risk factors. Thus, it may be difficult to fully clarify these conditions in animals. For
these reasons, it would be advisable if neurological disease cellular models should be devel‐
oped and studied in concert with existing animal models. Recent advances in the areas of stem
cell and reprogramming biology seem to provide a novel route to the generation of a wide
variety of neural cell types for studying neurological diseases.
A critical point of neurological disease modelling using NSCs is the availability of reliable
protocols that efficiently direct stem cells differentiation into the specific neural cell types
affected in disorders of interest. Knowledge of the pathways that drives neural differentiation
has led to rational approaches now routinely used to direct the differentiation of NSCs in vitro.
It appears that a variety of neural phenotypes can be achieved, depending on the combination
and timing of the inductive signals to which progenitors are exposed. Recently, several disease-
related cell types have been generated in vitro by directed differentiation of NSCs such as
spinal motor neurons, midbrain dopaminergic neurons, basal forebrain cholinergic neurons,
cortical progenitors and oligodendrocytes [23-38]. Moreover, Lee and co-workers also
generated sensory neurons and Schwann cells [39]. One of the first differentiation method has
been developed for the production of spinal motor neurons. In particular, NSCs can be directed
to differentiate into functional spinal motor neurons when challenged with retinoic acid and
Sonic Hedgehog. Retinoic acid induces neuralization and caudalization of stem cells, while
the induction of Sonic Hedgehog signalling converts spinal progenitors cells into motor
neurons [40]. The NSCs derived spinal motor neurons, when transplanted in developing chick
embryos, were able to form long axonal projections into skeletal muscle [27]. The ability to
direct the differentiation of NSCs into specific motor neurons could have important implica‐
tions for modelling of diseases such as amyotrophic lateral sclerosis (ASL) and understanding
molecular mechanisms of selective vulnerability. Another clinically relevant neural subtype
that has been generated in vitro from NSCs is dopaminergic neurons which could be used as
cellular model of Parkinson Disease (PD). One of the strategies used to obtain dopaminergic
neurons from NSCs rely on the combined activity of Sonic Hedgehog and FGF8, as first shown
by Lee et al. [27]. Methodological improvements to enhance dopaminergic differentiation in
vitro include co-culture with immortalized fetal astrocytes and dual inhibition of BMP/TGF
beta signalling during neural induction. The in vivo functionality of dopaminergic neurons
derived from NSCs has been demonstrated by transplantation assays into the striatum of 6-
hydroxydopamine-lesioned parkinsonian rats showing partial recovery of motor function
[41-46]. A recent study reported the controlled differentiation of NSCs to basal forebrain
cholinergic neurons, the neuronal population affected in Azheimer’s disease (AD) and
associated with cognitive decline [33]. In particular, two methods have been applied to obtain
basal forebrain cholinergic neurons from NSCs: the use of the diffusible ligand BMP9 and the
transfection of two developmentally relevant transcription factors, Lhx8 and Gbx1, which were
further shown to act downstream of BMP9 signalling. Basal forebrain cholinergic neurons
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expected that these two conditions may have a deep impact on NSC biology and niche
properties. The neurogenesis within SVZ niche is differentially activated in various neurode‐
generative pathologies. An increase in endogenous neurogenesis in the lateral ventricular
walls occurs in several diseases including traumatic brain injury, vascular dementia, Hun‐
tington’s disease, multiple sclerosis or epilepsy and physiological events such as ageing.
[14-19]. In these pathophysiological conditions, a common feature leading to neurogenesis is
represented by the upregulation of inflammatory cytokines production. In several cases it has
been shown that the niche reaction to inflammation leads to generation of new neurons that
integrate within the pre-existing circuitry [20].
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doublecortin, a widely accepted marker of neurogenesis, originates from the SVZ resident
NSCs that have migrated to the injured site where they differentiated into mature neurons [21]
However, it is also possible that part of this ectopic pool may originate locally, leading to an
injury-induced ectopic NSC niche formation [22]. Niche reaction to injury may thus proceed
by amplification of pre-existing NSC niche and migration toward the damaged site or by
activation of local and pre-existing quiescent NSC niches or by conversion of a normal tissue
into a newly established NSC niche. The mechanisms and signals driving these reactions are
many, some of them peculiar to the pathological condition and most of them endogenous to
the NSC niche and already acting in physiological condition.
Altogether the findings described above lead to speculate that NSC may be therapeutically
useful for CNS self-repair if properly mobilized and can supply cells for neuronal substitution
in CNS injury or degeneration, providing potential therapeutic tools in CNS diseases. NSC,
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neuronal differentiation, regulation of neurotransmitter biosynthesis and also physiopathol‐
ogy of brain diseases. Indeed, to date, deciphering the molecular and cellular basis of CNS
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mental risk factors. Thus, it may be difficult to fully clarify these conditions in animals. For
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affected in disorders of interest. Knowledge of the pathways that drives neural differentiation
has led to rational approaches now routinely used to direct the differentiation of NSCs in vitro.
It appears that a variety of neural phenotypes can be achieved, depending on the combination
and timing of the inductive signals to which progenitors are exposed. Recently, several disease-
related cell types have been generated in vitro by directed differentiation of NSCs such as
spinal motor neurons, midbrain dopaminergic neurons, basal forebrain cholinergic neurons,
cortical progenitors and oligodendrocytes [23-38]. Moreover, Lee and co-workers also
generated sensory neurons and Schwann cells [39]. One of the first differentiation method has
been developed for the production of spinal motor neurons. In particular, NSCs can be directed
to differentiate into functional spinal motor neurons when challenged with retinoic acid and
Sonic Hedgehog. Retinoic acid induces neuralization and caudalization of stem cells, while
the induction of Sonic Hedgehog signalling converts spinal progenitors cells into motor
neurons [40]. The NSCs derived spinal motor neurons, when transplanted in developing chick
embryos, were able to form long axonal projections into skeletal muscle [27]. The ability to
direct the differentiation of NSCs into specific motor neurons could have important implica‐
tions for modelling of diseases such as amyotrophic lateral sclerosis (ASL) and understanding
molecular mechanisms of selective vulnerability. Another clinically relevant neural subtype
that has been generated in vitro from NSCs is dopaminergic neurons which could be used as
cellular model of Parkinson Disease (PD). One of the strategies used to obtain dopaminergic
neurons from NSCs rely on the combined activity of Sonic Hedgehog and FGF8, as first shown
by Lee et al. [27]. Methodological improvements to enhance dopaminergic differentiation in
vitro include co-culture with immortalized fetal astrocytes and dual inhibition of BMP/TGF
beta signalling during neural induction. The in vivo functionality of dopaminergic neurons
derived from NSCs has been demonstrated by transplantation assays into the striatum of 6-
hydroxydopamine-lesioned parkinsonian rats showing partial recovery of motor function
[41-46]. A recent study reported the controlled differentiation of NSCs to basal forebrain
cholinergic neurons, the neuronal population affected in Azheimer’s disease (AD) and
associated with cognitive decline [33]. In particular, two methods have been applied to obtain
basal forebrain cholinergic neurons from NSCs: the use of the diffusible ligand BMP9 and the
transfection of two developmentally relevant transcription factors, Lhx8 and Gbx1, which were
further shown to act downstream of BMP9 signalling. Basal forebrain cholinergic neurons
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obtained in these ways were also shown to stably engraft into murin hippocampal slice cultures
and to generate electrophysiologically functional cholinergic synapses [33]. In addition, NSCs
are also able to differentiate into glial cell types of the CNS. However, directed differentiation
protocols and functional characterization of astrocytes derived from NSCs have yet to be
reported. In contrast, there are already many approaches to obtain oligodendrocytes from
NSCs [47-50]. The ability of these differentiated cells to myelinate axons has been demonstrated
both in vitro by co-culture with rat hippoampal neurons [51] and in vivo by transplantation
into the mouse model of dysmielination [52]. Moreover, studies evaluating NSCs-derived
oligodendrocytes transplants into adult rats have reported improvement of locomotor
recovery in both thoracic and spinal cord injury models [53].
Neural progenitors generated in vitro can also be directed towards cell types of the peripheral
nervous system (PNS).
Disease modeling using pluripotent stem cells might greatly benefit if the genome of these cells
could be readily modified. For instance, the generation of transgenic ‘‘reporter’’ cell lines using
fluorescent reporter genes under the control of cell type-specific promoters could enable the
purification, tracking, and functional characterization of disease cells models after directed
differentiation. Indeed, most in vitro differentiation strategies result in a heterogenous popula‐
tion of differentiated cells, which can include progenitors and a variety of cellular intermedi‐
ates. Thus, having the ability to prospectively identify, purify, and easily track the desired cell
type by means of reporter-gene expression can facilitate downstream disease-specific assays,
which could be hindered by the presence of other cell types. However, in spite of their self-
renewal properties, NSCs cells can still be difficult to genetically manipulate. Various techni‐
ques for stem cell genetic modification have been reported, and these can result in random (i.e.,
transgenic) or targeted integration of the DNA construct [54]. Transgenic approaches include the
use of plasmid transfection, lentiviral transduction, transposases, and bacterial artificial chromo‐
somes (BAC) as DNA delivery systems [55-59]. In particular, Placantonakis and colleagues used
BAC transgenesis of different reporter constructs to generate motor neuron lineages [59]. Some
of the limitations associated with transgenic approaches include the possibility of insertional
mutagenesis, transgene silencing or ectopic expression of the transgene due to position effects,
and lack of faithful expression of a reporter transgene due to absence of regulatory elements in the
promoter fragment driving its expression [56].
Development of methods to accurately correlate how a stem cell-derived neuron in culture
correlates ontologically with the in vivo equivalent could be useful. In fact, neuronal dysfunc‐
tion and degeneration as a result of the neurodegenerative process probably occurs much
earlier than the initial neurological manifestations that characterize the disease. For example,
prior to the onset of the motor component of the Parkinson disease (PD), a significant number
of dopaminergic neurons have already been lost. Moreover, non-motor manifestations can
predate motor manifestations by years. In PD, one of the earliest symptoms of disease may be
olfactory and autonomic dysfunction and initial alpha-synuclein positive Lewy body pathol‐
ogy may occur in the dorsal motor nucleus of the glosso-pharyngeal and vagal nerves and
anterior olfactory nucleus [60]. It would seem reasonable, in addition to studying midbrain
dopaminergic neurons, to dissect the molecular causes that lead to degeneration of the motor
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component of PD, to obtain the cell types affected earliest in the disease. Methods to accelerate
the time of the pathology in vitro will probably be important in adult-onset disease. Cellular
stressors such as oxidative stress, growth factor withdrawal, starvation, selective neurotoxins,
and heat shock may reveal differences in NSCs models. Dopaminergic neurons obtained from
a neural stem cell line with a known mutation in LRRK2, typical of an early-onset PD,
demonstrated increased proportions of caspase-3 activation suggesting a selective vulnera‐
bility when exposed to a variety of cellular stressors including hydrogen peroxide, proteosome
inhibition, and 6-OHDA exposure [60].
In addition, with better methods to direct differentiation of pluripotent stem cells to non‐
neuronal cells, it may be possible to recapitulate the relevant microenvironments that are
important in several neurodegenerative diseases [61]. In this regard, NSC cell-based co-culture
models have provided informative models of the effects of glia in SOD-1-related Amyotrophic
lateral sclerosis (ALS). For example, NSC-derived spinal motor neurons cultured in the
presence of glial cells, either derived from SOD-1 transgenic mice or primary astrocytes
genetically modified to express mutant SOD-1, are selectively vulnerable to the toxic effects
[62, 63]. Furthermore, these culture models allowed subsequent searches for candidate
mechanisms by which mutant glia exerted its effects and testing of drugs to rescue motor
neuron death. Thus, future NSC-based models composed of titrated populations of neurons,
glia, and skeletal muscle to create a functional motor unit in vitro would be informative for
studies on several neurologic diseases.
2. Isolation and establishment of pluripotent neural cell line endowed with
stemness properties
Here we describe briefly, the establishment of a novel neural cell line obtained from mesen‐
cephalic primary cultures generated from 11-day-old mouse embryos and showing staminal
properties when appropriately cultured.
In particular, these cells were infected with a replication-defective retrovirus bearing c-myc
and neomycin resistance genes. Neomycin-resistant clones were isolated and a stable cell line
was further characterized and named mes-c-myc A1 (A1). The proto-oncogene c-myc was
chosen because of its efficiency in immortalizing cells including neuroepithelial cells without
neoplastic transformation. A1 cells deprived of serum and treated with cAMP show arrest of
cell division, which is considered a prerequisite for neural cells to enter a differentiation
program. Under both conditions, A1 cells express nestin and vimentin, markers of neural
precursors, and the glial fibrillary acidic protein (GFAP), a marker of glial cells. A1 cells present
numerous neuronal features, such as peripherin, neuron specific enolase (NSE), microtubule-
associated protein 1 (MAP1), N-CAM. In addition, morphologically differentiated A1 cells
show functional voltage-gated channels, a neuronal hallmark. Finally, these cells synthesize
and accumulate GABA, the principal inhibitory neurotransmitter in CNS. A1 cells present
features of neural progenitors and have a broad potential because they may represent a new
tool in CNS developmental studies and could be useful in therapeutic applications.
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earlier than the initial neurological manifestations that characterize the disease. For example,
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anterior olfactory nucleus [60]. It would seem reasonable, in addition to studying midbrain
dopaminergic neurons, to dissect the molecular causes that lead to degeneration of the motor
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component of PD, to obtain the cell types affected earliest in the disease. Methods to accelerate
the time of the pathology in vitro will probably be important in adult-onset disease. Cellular
stressors such as oxidative stress, growth factor withdrawal, starvation, selective neurotoxins,
and heat shock may reveal differences in NSCs models. Dopaminergic neurons obtained from
a neural stem cell line with a known mutation in LRRK2, typical of an early-onset PD,
demonstrated increased proportions of caspase-3 activation suggesting a selective vulnera‐
bility when exposed to a variety of cellular stressors including hydrogen peroxide, proteosome
inhibition, and 6-OHDA exposure [60].
In addition, with better methods to direct differentiation of pluripotent stem cells to non‐
neuronal cells, it may be possible to recapitulate the relevant microenvironments that are
important in several neurodegenerative diseases [61]. In this regard, NSC cell-based co-culture
models have provided informative models of the effects of glia in SOD-1-related Amyotrophic
lateral sclerosis (ALS). For example, NSC-derived spinal motor neurons cultured in the
presence of glial cells, either derived from SOD-1 transgenic mice or primary astrocytes
genetically modified to express mutant SOD-1, are selectively vulnerable to the toxic effects
[62, 63]. Furthermore, these culture models allowed subsequent searches for candidate
mechanisms by which mutant glia exerted its effects and testing of drugs to rescue motor
neuron death. Thus, future NSC-based models composed of titrated populations of neurons,
glia, and skeletal muscle to create a functional motor unit in vitro would be informative for
studies on several neurologic diseases.
2. Isolation and establishment of pluripotent neural cell line endowed with
stemness properties
Here we describe briefly, the establishment of a novel neural cell line obtained from mesen‐
cephalic primary cultures generated from 11-day-old mouse embryos and showing staminal
properties when appropriately cultured.
In particular, these cells were infected with a replication-defective retrovirus bearing c-myc
and neomycin resistance genes. Neomycin-resistant clones were isolated and a stable cell line
was further characterized and named mes-c-myc A1 (A1). The proto-oncogene c-myc was
chosen because of its efficiency in immortalizing cells including neuroepithelial cells without
neoplastic transformation. A1 cells deprived of serum and treated with cAMP show arrest of
cell division, which is considered a prerequisite for neural cells to enter a differentiation
program. Under both conditions, A1 cells express nestin and vimentin, markers of neural
precursors, and the glial fibrillary acidic protein (GFAP), a marker of glial cells. A1 cells present
numerous neuronal features, such as peripherin, neuron specific enolase (NSE), microtubule-
associated protein 1 (MAP1), N-CAM. In addition, morphologically differentiated A1 cells
show functional voltage-gated channels, a neuronal hallmark. Finally, these cells synthesize
and accumulate GABA, the principal inhibitory neurotransmitter in CNS. A1 cells present
features of neural progenitors and have a broad potential because they may represent a new
tool in CNS developmental studies and could be useful in therapeutic applications.
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Figure 1. a) Proliferating/undifferentiated A1-mes-c-myc cells and (b) unproliferating/differentiated A1 mes-cmyc
cells with their phenotypic profiles. [64].
When cultivated in suspension in a serum free medium with the addition of epidermal growth
factor (EGF) with or without basic fibroblast growth factor (bFGF), these cells are able to form
neurosphere.
NSCs express EGF and bFGF receptors. The stimulation of these EGF and FGF cell-surface
receptors promotes the activation of specific signal transduction pathways, such as the mitogen
activated protein kinase (MAPK) and the phospholipase C (PLC) signal pathways [65]. Thus, A1
cells similarly to NSC derived from brain respond to such growth factors by generating neuro‐
spheres. Moreover, neurosphere are cellular clones derived from a single neural stem cell which
divides to produce other NSC and/or other progenitors cells. Neurospheres can form not only
from the clonal progeny of a single NSC, but also by the aggregation of cells into neurospheres
[66]. For these reasons, the neurosphere assay (NSA) is one of the most frequently used methods
to isolate, expand and also calculate the frequency of neural stem cells (NSCs). Furthermore, this
serum-free culture system has also been employed to expand stem cells and determine their
frequency from a variety of tumors and normal tissues. In our system, cells were counted and
cultured in suspension (2,5×105/ml) with neurosphere medium [MEM/F12, N2, bFGF and EGF] in
25 cm2 flasks with no substrate pre-treatment. Primary neurospheres formed after 4–5 days in
vitro once every 7 days they were gently spun down [75 g), mechanically dissociated, and the
medium was changed. To evaluate neural differentiation potential, neurospheres were dissociat‐
ed and plated on poly-D-lysine precoated plates in neurosphere medium. After 6 days in culture,
cells were kept for additional 3 days without b-FGF and EGF, and neuronal, astroglial and
oligodendroglial differentiation was assessed by immunocytochemical analysis. Immunostain‐
ing for markers of neural (β-III-tubulin), astrocyte (GFAP) and oligodendrocyte (O4) cells clearly
showed the presence of all three CNS cell types among the neurosphere derived cells. Further
characterization of neuronal, astroglial, oligodendroglial and stem cells markers has been
performed by real-time PCR. In particular, our analysis identified several stem cell genes and
pluripotency-associated gene in neurosphere cells, including nestin, Nanog, and Sox2. By means
of real-time PCR we also confirmed the presence of genes of neural cells such as β-III-tubulin and
astrocyte such as GFAP. Finally, to definitely confirm the NSCs features of A1 mes-c-myc cells,
we determined the self-renewal ability of secondary neurospheres. In particular, primary
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neurospheres were mechanically dissociated into single cells, counted and cultured in neuro‐
sphere medium in suspension in 25 cm2 flasks again. As expected from NSCs, cells dissociated
from primary neurosphere were able to generate secondary neurosphere.
Figure 2. Neurospheres originated from A1mes-c-myc cells 2 days (a) and 10 days (b) after cultured in neurosphere
medium.
It cannot be excluded that the contemporary maintainance of precursors and differentiated
markers could be attributed to the persistent expression of the exogenous c-myc. However, in our
model system the exogenous expression of c-myc does not impair block of proliferation elicited
by serum deprivation and/or cAMP treatment. Moreover, it is generally accepted that c-myc is
not oncogenic by itself likely because of its dual action as a promoter of cell division and as an
apoptotic mediator in absence of growth factors. In addition, it has been reported that in genetical‐
ly manipulated NSC clones there is a spontaneous and significant down-regulation of c-myc in
concomitance with mitogen removal and the onset of differentiation [67, 68]. Moreover, it is worth
noting that c-myc is one of the genes used to generate iPS cells. Indeed, viral vectors have been
used to transfer transcription factors, such as Oct4, Sox2, c-myc, Klf4, and nanog, to induce
reprogramming of mouse fibroblasts, neural stem cells, neural progenitor cells, keratinocytes, B
lymphocytes and meningeal membrane cells towards pluripotency [69-71]. Immortalization
using the myc transcription factor has proven highly effective at extending the normal life span
of human NSCs in vitro and maintaining a stable genotype and phenotype. Long term cell
expansion with associated karyotype stability is a feature of myc immortalization. Traditional‐
ly thought of as a proto-oncogene, it has been recently reported that myc may be a 'stemness' gene
driving rapid proliferation yet maintain multipotentiality in stem cells. Indeed, two NSC lines
were recently immortalized from human progenitors by means of v-myc and c-myc [72], although
useful to test drugs on molecular targets, the human origin of these cells may hamper the efficacy
of transplants into mice due to species barrier.
3. NSC lines as model to test new therapeutic compounds
Given the potential of neural stem cells and their differentiated cell types to model keys aspects
of neurological diseases, an obvious extension of this platform is represented by its use for
drug discovery and predictive toxicology. Nearly 90% of new drugs tested in humans fail to
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we determined the self-renewal ability of secondary neurospheres. In particular, primary
Neural Stem Cells - New Perspectives124
neurospheres were mechanically dissociated into single cells, counted and cultured in neuro‐
sphere medium in suspension in 25 cm2 flasks again. As expected from NSCs, cells dissociated
from primary neurosphere were able to generate secondary neurosphere.
Figure 2. Neurospheres originated from A1mes-c-myc cells 2 days (a) and 10 days (b) after cultured in neurosphere
medium.
It cannot be excluded that the contemporary maintainance of precursors and differentiated
markers could be attributed to the persistent expression of the exogenous c-myc. However, in our
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not oncogenic by itself likely because of its dual action as a promoter of cell division and as an
apoptotic mediator in absence of growth factors. In addition, it has been reported that in genetical‐
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noting that c-myc is one of the genes used to generate iPS cells. Indeed, viral vectors have been
used to transfer transcription factors, such as Oct4, Sox2, c-myc, Klf4, and nanog, to induce
reprogramming of mouse fibroblasts, neural stem cells, neural progenitor cells, keratinocytes, B
lymphocytes and meningeal membrane cells towards pluripotency [69-71]. Immortalization
using the myc transcription factor has proven highly effective at extending the normal life span
of human NSCs in vitro and maintaining a stable genotype and phenotype. Long term cell
expansion with associated karyotype stability is a feature of myc immortalization. Traditional‐
ly thought of as a proto-oncogene, it has been recently reported that myc may be a 'stemness' gene
driving rapid proliferation yet maintain multipotentiality in stem cells. Indeed, two NSC lines
were recently immortalized from human progenitors by means of v-myc and c-myc [72], although
useful to test drugs on molecular targets, the human origin of these cells may hamper the efficacy
of transplants into mice due to species barrier.
3. NSC lines as model to test new therapeutic compounds
Given the potential of neural stem cells and their differentiated cell types to model keys aspects
of neurological diseases, an obvious extension of this platform is represented by its use for
drug discovery and predictive toxicology. Nearly 90% of new drugs tested in humans fail to
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ultimately come to clinical approval, with central nervous system disorders as a therapeutic
area, among those with the highest rate of attrition. Arguably, these failures have resulted from
a reliance on imperfect models used during preclinical development.
Neural stem cells (NSCs) are a good model to screen effective drugs that increase neurogenesis.
Several classes of drugs have been reported to interfere with NSC homeostasis. Most of the
interest has been focused on psychiatric drugs since the early discovery of links between
neurogenesis and stress-related disorders. Several extensive reviews have already been
published on this topic in the recent years. In particular, association between neurogenesis and
depression has been the object of debate since the report of Malberg et al. showing, in 2000 by
BrdU assay, that chronic antidepressant treatment significantly increased neurogenesis in the
dentate gyrus of the hippocampus, and that the new cells became neurons [73-75]. These effects
were in agreement with previous data showing that serotoninergic depletion decreased
neurogenesis in the dentate gyrus and the SVZ [76]. The effects on neurogenesis were consis‐
tent with the time course for the therapeutic action of antidepressants. Chronic treatment with
the classical antidepressant fluoxetine accelerated the maturation of immature neurons and
enhanced a specific form of long term potentiation in the dentate gyrus; neurogenesis was also
linked to the behavioral effect of fluoxetine measured by the novelty-suppressed feeding test
[77, 78]. We have recently demonstrated, by means of western blotting and real time PCR, that
A1 immortalized cell line is able to express serotonergic markers before and after differentia‐
tion. In particular, we demonstrated that A1 cells express the transcripts of the two rate-
limiting enzymes necessary for the serotonin synthesis TPH1 and TPH2 and that the two
enzymes were differently expressed in proliferating and differentiated cells. We also found
that TPHs were modulated by fluoxetine and citalopram, two SSRI drugs widely used in
therapy [79, 80].
In addition to synthetic chemicals, recent results show that some natural products also affect
cell fate of NSCs [81]. Until recently, neuroprotective effects of natural products have been
intensely studied. In particular, methanol extracts of Jeju native plants protected apoptosis
induced by hydrogen peroxides. Visnagin, an active component extracted from the fruits of
Ammi visnaga, which has been used as treatment for low blood-pressure, showed protective
effects on kainic acid-induced mouse hippocampal cell death by reducing inflammation. BF-7
extracted from a sericultural product has significant protective effects on amyloid β peptide
induced apoptosis through reduction of ROS generation and diminished caspase activity
[82-85]. On this issue, also in our lab, we are in progress to test the biological effects of a natural
compound on NSCs. In fact, in CNS, aberrant proliferation causes cancer whereas impaired
survival of differentiated neurons induces neurodegenerative disorders. In order to find novel
therapeutic targets able to inhibit aberrant cell proliferation and/or enhance differentiated cells
survival, we analyzed properties of the aqueous extract of Ruta graveolens (Ruta g. a.e) on
differentiated, non-proliferating and undifferentiated, proliferating neural cells. Ruta g. is
currently used for its diuretic, sedative, and analgesic effects and recent studies described
antiproliferative effects on different cancer cells.
In A1 cell system, Ruta g. a.e. induces increase of ERK 1/2 (ERKs) phosphorylation and death
of A1 proliferating cells. In presence of the ERKs pathway inhibitor, Ruta g. a.e.-induced cell
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death decreases, indicating that ERKs is involved in the Ruta g. effect on A1 proliferating cells.
Moreover, when Ruta g. a.e. is added, the number of differentiated A1 cells appears signifi‐
cantly higher as compared to control conditions and the analysis of the cell cycle showed an
increased number of cells in G2/M phase in differentiated cells treated with Ruta g. a.e.
Thus, our data suggest that A1 cells could represent a model system of neural stem cell line
able to allow a deep insight into the mechanisms of regulation neural gene expression and to
identify novel therapeutic targets in the development of more useful drugs for the manage‐
ment of disorders of the CNS
4. Conclusion and future perspectives
Research in the area of stem cell biology and regenerative medicine, along with developmental
and molecular neuroscience, will further our understanding of drug-induced effects ( i.e.
death, survival, neurotransmission) on neurons during their development. Moreover, in vitro
models of stem cell-derived neural cell lines allow investigators, under control conditions and
during intense neuronal growth, to delve deep into molecular mechanisms underlying the
actions of various drugs and pathophysiological conditions at various developmental stages.
In addition, since NSCs lines are capable to differentiate into non proliferating neuronal
phenotypes, they represent a powerful tool to screen drugs exerting different effects according
to the cell cycle.
In conclusion, the use of this models will likely lead to fewer pharmacological risks and/or
identification of new compounds exerting biological effects on healthy and diseased neurons.
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1. Introduction
Neurogenesis is the production of new nerve cells or neurons, a specialized class of cells that
make up the functional components of the central nervous system (CNS). Throughout most
of the CNS this process of neurogenesis is limited to the developmental period before birth,
after which time no new cells are added to the pre-established circuitry. In mammals including
humans however, neurogenesis persists into the early postnatal period in two discrete brain
regions: the subgranular zone in the hippocampus and the subventricular zone (SVZ) lining
the lateral ventricles [1-5]. It is unknown why neurogenesis continues in such discrete locations
yet is excluded from most other brain regions. A finite number of neurons is thought to afford
us a stable set of circuitry that is able to accumulate and assimilate experiential information
throughout our lifetimes. However, this predetermined number of neurons is also our Achilles’
heel as any accidental or pathological damage to the CNS often results in irreparable damage
to neurons. Consequently, there is a great unmet need for endogenous sources of brain repair,
for conditions such as neurodegenerative disorders, cognitive neurological impairments,
epilepsy, and cancer. This reason is one of the primary driving forces behind the study of
postnatal neurogenesis and it is hoped that once the mechanisms are understood, this process
can be harnessed to provide therapeutic avenues for intractable neuropathologies. Consider‐
able progress has been made in the last twenty years to unravel the mechanisms that both
define and limit postnatal neurogenesis.
In this chapter we will limit our discussion to therapeutically relevant regulators of SVZ
neurogenesis. We will first start with potentially manipulable intracellular and extracellular
factors that have been found to control SVZ neurogenesis. Then, we will evaluate the signaling
cascades downstream of neurotransmitter receptor activity that have also been shown to play
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regulatory roles within the SVZ. Finally, we will discuss the neuropathologies in which SVZ
neurogenesis has been implicated.
In the two neurogenic regions, resident pools of slow-dividing, astrocyte-like stem cells
generate highly proliferative transit amplifying progenitors that then give rise to fate-com‐
mitted neuronal or glial precursors [1-4]. These precursors (called neuroblasts or glioblasts)
then migrate to their final destinations and differentiate into postmitotic neurons, astrocytes
and oligodendrocytes. In the case of neurogenesis, newborn neurons undergo additional
maturation steps to develop an appropriate dendritic morphology, receive and form synapses,
and survive an activity-dependent competitive process to integrate into the local circuitry [5].
Thus, neurogenesis may be broadly divided into two phases: an early phase that includes (a)
stem cell proliferation, neuronal vs. glial fate commitment and migration; and a later phase
that involves the (b) morphological and synaptic development and survival of newborn
neurons. Throughout this chapter, astrocytic stem cells are defined as the self-renewing,
multipotent cells present in the SVZ that express glial markers, including the glutamate
aspartate transporter (GLAST), the intermediate filament proteins glial fibrillary acidic protein
(GFAP) and nestin, and the carbohydrate Lewis X (Lex) [1;6]. Intermediate progenitors, also
called transit amplifying progenitors, express epidermal growth factor receptor (EGFR) and
mammalian achaete-scute homolog 1 (Ascl1/Mash1), while neuroblasts, or neuronal precur‐
sors, are defined by the presence of immature neuronal markers, including doublecortin (DCX)
and βIII-tubulin (Tuj1) [7-10].
In the SVZ, astrocytic stem cells reside in-between the striatal parenchyma and the ependymal
cell layer that lines the lateral ventricles [11]. These stem cells generate rapidly dividing transit
amplifying progenitors, which give rise to neuroblasts that migrate by moving tangentially
through the rostral migratory stream (RMS) and into the olfactory bulb (OB) [12-14]. During
migration these proliferative cells travel in chains, and are ensheathed by specialized astrocytes
[15]. In the OB the neuroblasts exit the RMS, change direction and migrate radially outward
to differentiate into dopaminergic and GABAergic periglomerular and granule interneurons
[16-20]. Granule cells form dendrodendritic reciprocal synapses with mitral and tufted neurons
in the bulb and inhibit their activity to fine-tune their output, ultimately playing a role in
olfactory discrimination and learning [21]. Periglomerular cells make one-way as well as
reciprocal synapses with the apical dendrites of the mitral/tufted cells and the terminals of the
olfactory nerves that converge into the glomeruli [20;22;23]. The progression from astrocytic
stem cell to neuronal progenitor to synaptic integration requires tightly coordinated, complex
regulation by a multitude of factors.
2. Progenitor proliferation, fate commitment and migration in the SVZ
2.1. Intracellular factors
SVZ neurogenesis is subject to tight regulation, confined to isolated microenvironments and
sensitive to neuronal activity, stress, and aging. This control may be required to prevent
network instability, maintain experience-driven memory and behavioral patterns, and prevent
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tumorigenesis. To this end, cell-intrinsic factors comprise a major component of this regulation
and help coordinate neurogenesis by forming the bulwark of how cells make choices and adapt
to changes in their environments. Importantly, these intracellular factors may represent
clinically tractable opportunities for the treatment of neuropathologies.
In the postnatal SVZ, progenitor fate commitment is sequentially driven by a family of
proneural proteins called the basic helix-loop-helix (bHLH) transcription factors, such as
Mash1/Ascl1, neurogenin2 (Ngn2), Neuro-D1, Neuro-D2, Tbr1 and Tbr2, in a pattern similar
to cortical and hippocampal neurogenesis [24;25]. This bHLH-driven fate commitment is
thought to develop in a temporally successive fashion, from more broadly proneural proteins
(Mash1/Ascl1) to more neuronal and subtype-specifying (Neuro-D1) [26]. Although more
work needs to be done to fully flesh out the role of bHLH proteins in the postnatal SVZ, in
vitro transient expression of bHLH proteins is sufficient to induce neuronal fate commitment.
Recently, a synthetic small molecule isoxazole 9 (Isx-9) has shown promise in enhancing
hippocampal neurogenesis in vivo, by targeting a family of regulatory interactors of Mash1/
Ascl1, the myocyte-enhancer family (Mef2) [27]. This study heralds future therapies that can
target and harness specific intracellular pathways within the neurogenic niche to direct
neurogenesis.
The bHLH proteins are thought to induce differentiation in part by activating cyclin-depend‐
ent kinase inhibitors that then induce cell cycle exit. This finding has been shown in culture
and awaits confirmation in vivo [28]. Cdk inhibitors p27KIP1 and p19INK4d have also been
shown to modulate proliferation in the SVZ. Mice lacking p27KIP1 show increased progenitor
proliferation and a reduction in neuroblast number [29;30]. Furthermore, mice deficient for
both p27KIP1 and p19INK4d display renewed proliferation of post-mitotic neurons and
increased cell death- causing seizures, movement disorders, and death by postnatal day 18
[31]. This indicates that cdk inhibitors positively regulate cell cycle exit in SVZ progenitors and
their absence prolongs or renews cell cycling. Cdk inhibitors mediate cell cycle exit by
inhibiting phosphorylation of the retinoblastoma protein (Rb) [32]. Dephosphorylated Rb
binds to and sequesters the E2F transcription factor that normally functions in the nucleus to
positively regulate cell cycle progression, thereby promoting cell cycle exit. In the SVZ, E2F-
deficient mice show reduced progenitor proliferation and neuroblast numbers, suggesting that
E2F transcriptional activity is required for cell cycle progression and the maintenance of
neurogenic ability [33]. Additionally, mice lacking the gene encoding the tumor suppressor
p53, another cell cycle regulator, displayed enhanced proliferative capacity and increased
differentiation into neurons and oligodendrocytes [34]. Taken together, these results outline a
stereotyped program of cell-intrinsic mechanisms at work within the SVZ to regulate the
proliferation and fate commitment of SVZ progenitors in the early steps of postnatal neuro‐
genesis. The development of therapies that can target these pathways within neurogenic niches
is the next step for endogenous sources of brain repair.
MicroRNAs (miRs) are short, non-coding, single-stranded RNA molecules approximately
19-23 nucleotides in length that regulate gene expression by binding to complementary
elements in the untranslated regions of target mRNAs and inhibiting protein synthesis. They
exert epigenetic control either to maintain the status quo in a cell, (i.e. to maintain tissue
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p53, another cell cycle regulator, displayed enhanced proliferative capacity and increased
differentiation into neurons and oligodendrocytes [34]. Taken together, these results outline a
stereotyped program of cell-intrinsic mechanisms at work within the SVZ to regulate the
proliferation and fate commitment of SVZ progenitors in the early steps of postnatal neuro‐
genesis. The development of therapies that can target these pathways within neurogenic niches
is the next step for endogenous sources of brain repair.
MicroRNAs (miRs) are short, non-coding, single-stranded RNA molecules approximately
19-23 nucleotides in length that regulate gene expression by binding to complementary
elements in the untranslated regions of target mRNAs and inhibiting protein synthesis. They
exert epigenetic control either to maintain the status quo in a cell, (i.e. to maintain tissue
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identity), or they act in dynamic processes occurring within cells to refine and sharpen
transitional states, (i.e. facilitating the switch in expression profile occurring at active synapses
that were previously silent) [35-37]. Their role in shaping the temporal dynamics and pheno‐
typic outcome of gene regulatory networks means that the functions of particular miRs become
especially resolvable in plastic processes like postnatal neurogenesis, and miRs have recently
been implicated in regulating the fate commitment of SVZ progenitors [38]. Although as yet
untested, one idea for how bHLH proteins are sequentially activated and repressed and the
transitions from multipotent progenitor to post-mitotic neuron more sharply defined is the
successive miR-mediated downregulation of targeted bHLH proteins. In the SVZ, micro‐
RNA-124 was shown to be upregulated upon neuronal differentiation in the SVZ, and
overexpression increased the number of mature neurons at the cost of proliferative progenitors
and neuroblasts, while knockdown decreased mature neuron production and increased the
number of glia [38]. MiR-124 was shown to mediate these effects by antagonizing Sox9, a
transcription factor that directs glial differentiation. MiR-124 has also been shown to target
SCP1, a component of the REST/NRSF complex that represses neuronal genes in non-neuronal
cells and PTBP1, a repressor of neuron-specific alternative splicing [39-42].
Together these results indicate that miR-124 is a critical regulator of neuronal development
and tissue identity, acting early on in the shift from neuronal precursor to mature neuron.
Synthetic miR anologues composed of locked nucleic acid technology (LNA) demonstrate a
robust half-life and good tolerance in animal models and may prove a good strategy to induce
neurogenesis in a therapeutic setting. Furthermore, transplantable cells stably expressing a
complement of miRs may prove beneficial in cellular replacement strategies. Cell-intrinsic
factors and their roles in the early phases of postnatal neurogenesis have only begun to become
amenable to experimental dissection, and exciting developments are forthcoming.
2.2. Extracellular factors
Neurotrophic factors have long been implicated in the dynamic regulation of postnatal
neurogenesis. In the SVZ, fibroblast growth factor 2 (FGF-2) has been shown to affect the early
steps in neurogenesis, positively regulating progenitor proliferation and leading to an increase
in the number of neurons migrating from the SVZ into the OB [43;44]. Furthermore, FGF-2 is
known to interact with epidermal growth factor (EGF) receptor signaling in neuronal progen‐
itors, wherein prior FGF exposure is necessary for progenitors to respond to EGF or trans‐
forming growth factor β (TGFβ), the endogenous ligand for EGF receptors [45-49]. EGF has
been shown to also increase proliferation specifically in the SVZ transit amplifying progenitor
population at the cost of neuronal differentiation. Exposure to EGF induces transit amplifying
progenitors to increase their cycling and downregulate neurogenic markers [50]. Vascular
endothelial growth factor (VEGF), an angiogenic protein that can produce neurotrophic effects,
has been shown to stimulate proliferation and neuroblast production in the SVZ, while insulin-
like growth factor-I (IGF-I), a growth factor implicated in mediating the positive effects of
exercise on adult neurogenesis, has been also implicated in enhancing proliferation and
migration in the postnatal SVZ [51;52].
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Apart from modulating proliferation, diffusible factors have also been shown to affect the
initial establishment of the neurogenic niche itself, by influencing stem cell self-renewal and
cell fate decisions. The factors that regulate such homeostatic effects within the niche may
comprise a separate class of growth factors and unlike FGF-2, VEGF and IGF-I, are not
circulating systemically in the bloodstream at appreciable levels nor produced in an acute,
dynamically regulated manner. Based on this hypothesis, sonic hedgehog (Shh), Wnts, bone
morphogenic proteins (BMPs) and Notch/Delta are extracellular factors possibly acting in a
more local fashion. Sonic hedgehog signaling is required for establishing and maintaining the
quiescent pool of stem cells in the postnatal SVZ. Ablating Smoothened, the transmembrane
protein required for hedgehog signaling, specifically in the SVZ results in the depletion of stem
cells and proliferative transit amplifying progenitors by postnatal day 8 and the depletion of
neuroblasts by postnatal day 30 [53]. The Notch-DSL (Delta/Serrate/LAG-2) pathway is a very
highly conserved cell-cell signaling system that acts through single-pass transmembrane
proteins. Binding of Notch to its ligand causes cleavage of an intracellular domain that
translocates to the nucleus where it interacts with transcriptional regulators to initiate
expression of target genes like Hes1 and Hes5. In mammals, Notch ligands like Delta-like and
Jagged bind Notch on stem and proliferative cells to maintain self-renewal and prevent
terminal differentiation. In the neonatal SVZ, retrovirally delivered activated Notch enhances
the numbers of quiescent SVZ progenitors at the cost of migratory neuroblasts [54]. Another
study shows that conditional ablation of Notch signaling in the ependymal cells reprograms
these cells and enables them to leave their position in the epithelium, take on SVZ stem cell
characteristics and differentiate into granule and periglomerular neurons in the OB [55]. BMPs,
a family of growth factors within the transforming growth factor β superfamily, have been
shown to instruct a glial lineage in SVZ stem cells, and noggin, a BMP antagonist secreted by
the adjacent ependymal cells, blocks glial differentiation of stem cells in favor of neurogenesis
[56]. However, deletion of Smad4, a downstream target of BMP signaling, instead of increasing
neurogenesis has been shown to result in oligodendrocyte production and a neurogenic deficit
[57]. Therefore, it seems that BMP signaling can have divergent effects in the SVZ.
Exciting justification for these disparate lines of research is now beginning to emerge. Small
molecule inhibitors of glycogen-synthase kinase 3 (GSK-3) inhibitors have shown promise in
enhancing neurogenesis in human neural progenitor cells [58]. GSK-3 is involved in the notch,
Shh, Wnt/β-catenin and FGF signaling pathways and represents a movement of the field
toward a more clinically oriented direction.
In the SVZ, neuroblasts have to migrate a greater distance than do their analogues in the
dentate gyrus, to arrive at their ultimate destinations in the OB. Furthermore, the migration
behavior exhibited by SVZ neuroblasts has two phases; it is tangential from the SVZ to the
RMS-OB, and then becomes radial-like as the neuroblasts exit the RMS and begin synaptic
integration into the granule cell layer. For our purposes in this review both phases of this
migration are being considered within the “early” phase of neurogenesis, prior to dendritic
arborization, reception of synaptic inputs, and survival. This feature of SVZ neurogenesis
distinguishes it from hippocampal neurogenesis where the neuroblasts migrate very short
distances, and has allowed for the isolation of a few important guidance molecules that enable
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been implicated in regulating the fate commitment of SVZ progenitors [38]. Although as yet
untested, one idea for how bHLH proteins are sequentially activated and repressed and the
transitions from multipotent progenitor to post-mitotic neuron more sharply defined is the
successive miR-mediated downregulation of targeted bHLH proteins. In the SVZ, micro‐
RNA-124 was shown to be upregulated upon neuronal differentiation in the SVZ, and
overexpression increased the number of mature neurons at the cost of proliferative progenitors
and neuroblasts, while knockdown decreased mature neuron production and increased the
number of glia [38]. MiR-124 was shown to mediate these effects by antagonizing Sox9, a
transcription factor that directs glial differentiation. MiR-124 has also been shown to target
SCP1, a component of the REST/NRSF complex that represses neuronal genes in non-neuronal
cells and PTBP1, a repressor of neuron-specific alternative splicing [39-42].
Together these results indicate that miR-124 is a critical regulator of neuronal development
and tissue identity, acting early on in the shift from neuronal precursor to mature neuron.
Synthetic miR anologues composed of locked nucleic acid technology (LNA) demonstrate a
robust half-life and good tolerance in animal models and may prove a good strategy to induce
neurogenesis in a therapeutic setting. Furthermore, transplantable cells stably expressing a
complement of miRs may prove beneficial in cellular replacement strategies. Cell-intrinsic
factors and their roles in the early phases of postnatal neurogenesis have only begun to become
amenable to experimental dissection, and exciting developments are forthcoming.
2.2. Extracellular factors
Neurotrophic factors have long been implicated in the dynamic regulation of postnatal
neurogenesis. In the SVZ, fibroblast growth factor 2 (FGF-2) has been shown to affect the early
steps in neurogenesis, positively regulating progenitor proliferation and leading to an increase
in the number of neurons migrating from the SVZ into the OB [43;44]. Furthermore, FGF-2 is
known to interact with epidermal growth factor (EGF) receptor signaling in neuronal progen‐
itors, wherein prior FGF exposure is necessary for progenitors to respond to EGF or trans‐
forming growth factor β (TGFβ), the endogenous ligand for EGF receptors [45-49]. EGF has
been shown to also increase proliferation specifically in the SVZ transit amplifying progenitor
population at the cost of neuronal differentiation. Exposure to EGF induces transit amplifying
progenitors to increase their cycling and downregulate neurogenic markers [50]. Vascular
endothelial growth factor (VEGF), an angiogenic protein that can produce neurotrophic effects,
has been shown to stimulate proliferation and neuroblast production in the SVZ, while insulin-
like growth factor-I (IGF-I), a growth factor implicated in mediating the positive effects of
exercise on adult neurogenesis, has been also implicated in enhancing proliferation and
migration in the postnatal SVZ [51;52].
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more local fashion. Sonic hedgehog signaling is required for establishing and maintaining the
quiescent pool of stem cells in the postnatal SVZ. Ablating Smoothened, the transmembrane
protein required for hedgehog signaling, specifically in the SVZ results in the depletion of stem
cells and proliferative transit amplifying progenitors by postnatal day 8 and the depletion of
neuroblasts by postnatal day 30 [53]. The Notch-DSL (Delta/Serrate/LAG-2) pathway is a very
highly conserved cell-cell signaling system that acts through single-pass transmembrane
proteins. Binding of Notch to its ligand causes cleavage of an intracellular domain that
translocates to the nucleus where it interacts with transcriptional regulators to initiate
expression of target genes like Hes1 and Hes5. In mammals, Notch ligands like Delta-like and
Jagged bind Notch on stem and proliferative cells to maintain self-renewal and prevent
terminal differentiation. In the neonatal SVZ, retrovirally delivered activated Notch enhances
the numbers of quiescent SVZ progenitors at the cost of migratory neuroblasts [54]. Another
study shows that conditional ablation of Notch signaling in the ependymal cells reprograms
these cells and enables them to leave their position in the epithelium, take on SVZ stem cell
characteristics and differentiate into granule and periglomerular neurons in the OB [55]. BMPs,
a family of growth factors within the transforming growth factor β superfamily, have been
shown to instruct a glial lineage in SVZ stem cells, and noggin, a BMP antagonist secreted by
the adjacent ependymal cells, blocks glial differentiation of stem cells in favor of neurogenesis
[56]. However, deletion of Smad4, a downstream target of BMP signaling, instead of increasing
neurogenesis has been shown to result in oligodendrocyte production and a neurogenic deficit
[57]. Therefore, it seems that BMP signaling can have divergent effects in the SVZ.
Exciting justification for these disparate lines of research is now beginning to emerge. Small
molecule inhibitors of glycogen-synthase kinase 3 (GSK-3) inhibitors have shown promise in
enhancing neurogenesis in human neural progenitor cells [58]. GSK-3 is involved in the notch,
Shh, Wnt/β-catenin and FGF signaling pathways and represents a movement of the field
toward a more clinically oriented direction.
In the SVZ, neuroblasts have to migrate a greater distance than do their analogues in the
dentate gyrus, to arrive at their ultimate destinations in the OB. Furthermore, the migration
behavior exhibited by SVZ neuroblasts has two phases; it is tangential from the SVZ to the
RMS-OB, and then becomes radial-like as the neuroblasts exit the RMS and begin synaptic
integration into the granule cell layer. For our purposes in this review both phases of this
migration are being considered within the “early” phase of neurogenesis, prior to dendritic
arborization, reception of synaptic inputs, and survival. This feature of SVZ neurogenesis
distinguishes it from hippocampal neurogenesis where the neuroblasts migrate very short
distances, and has allowed for the isolation of a few important guidance molecules that enable
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this directed migration. Slit-1 and Slit-2 expression in the SVZ and septum is thought to repel
neuroblasts away from the SVZ and towards the OB, while netrin expression in the mitral cells
of the OB, and the coincident expression of netrin receptors neogenin and deleted in colorectal
cancer (DCC) in neuroblasts may form a chemoattractive cue drawing neuroblasts towards
the OB [59-61]. The secreted protein prokineticin2 (PK2) has also been shown to act as potent
chemoattractant for SVZ neuronal progenitors. PK2 is expressed in the OB, and attracts SVZ
cells to the OB through the two G-protein coupled prokineticin receptors (PRK1 and PRK2]
[62]. Both ephrins and their Eph tyrosine kinase receptors are expressed in the SVZ and have
been shown to play a role in both regulation of progenitor proliferation and neuroblast
migration. EphA7, EphB2 and ephrin-B2 are associated with astrocytic progenitors in the SVZ,
while ephrin-A2 is expressed in the neuroblasts. Ephrin-B2 and EphB2 signaling seem to
positively regulate progenitor proliferation while also disrupting neuroblast migration in the
postnatal SVZ, while ephrin-A2 seemed to positively regulate progenitor proliferation [63;64].
Tangential migration in the RMS has also been shown to involve the α6β1 integrin [65]. Once
in the OB, neuroblasts have to reorient from tangential to radial migration into the GCL. This
process has been shown to involve the expression of tenascin-R, in both the GCL and internal
plexiform layers of the OB, and reelin, expressed by the mitral cells [66-68].
There is now a large amount of information regarding the effects of neurotrophic factors on
early stages of SVZ neurogenesis, all of which is not discussed here. Many exciting avenues
are emerging for therapeutic intervention into neurodegenerative diseases and psychiatric
illnesses and knowledge of how neurogenic niches are formed, maintained, and neuronal and
glial programs directed is fundamental for devising a clinical paradigm of directed neurogen‐
esis. However, these data on extracellular factor-based modulation of postnatal neurogenesis
needs more critical validation within the context of in vivo experiments and behavioral
analyses.
2.3. Dopamine
The SVZ is innervated by dopaminergic fibers originating in the substantia nigra, while the SGZ
is innervated by dopaminergic fibers coming from the ventral tegmental area (VTA). Dopami‐
nergic signaling has been shown to regulate progenitor proliferation through D2 receptors in
both the SVZ and SGZ and D3 receptors in the SVZ [69-71]. In patients with Parkinson’s Disease,
SVZ proliferation is markedly reduced. This effect on proliferation has been shown to be mediated
through the induction of EGF and CNTF secretion from SVZ stem cells in response to dopami‐
nergic activity [72;73]. Dopaminergic deafferentiation reduces proliferation in the SVZ, and one
study reports that this decrease in overall SVZ cell proliferation is nonetheless accompanied by
an increase in numbers of cells expressing Pax6 in the dorsal SVZ. Pax6 is a transcription factor
responsible for enabling a dopaminergic differentiation program in postnatally generated
periglomerular neurons. Therefore, dopaminergic activity may not only affect proliferation but
may also impact cell fate choice in the SVZ [74]. Drugs that potentiate dopamingergic signal‐
ing may represent one strategy to maintain neurongenesis postnatally. Dopaminergic regula‐
tion of postnatal neurogenesis is only beginning to be uncovered, and its role in neurogenesis
has not been conclusively established as yet.
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2.4. GABA
GABA, a major inhibitory neurotransmitter in the mature CNS, has a well-established role in
the development of neuronal circuits in both the embryo and adult [8;75-77]. Its ambient release
in the form of spillover from synaptic and extra-synaptic sources has led researchers to its role
in regulating the functional integration of new neurons into both immature and mature
networks. Owing to the initial abundance of the Cl- importer NKCC1 and the low expression
of the Cl- exporter KCC2, internal Cl- concentrations are higher in immature neurons than
mature neurons [76]. The resultant high equilibrium potential for Cl- in neuroblasts causes
GABA, acting through GABAA receptors, to depolarize immature cells in the first few weeks
after fate determination. The depolarizing effect of GABA on young neurons and progenitors
has been shown to regulate key stages of neurogenesis such as proliferation, migration and
morphogenesis, in both the embryonic and adult neurogenic zones [78-80].
Adult neurogenesis in the SVZ recapitulates the embryonic role for GABA [8;81;82]. In the
SVZ, both astrocytic stem cells and their neuroblast progeny express GABAA receptors [5;83].
Electrophysiological evidence indicates that neuroblasts release GABA in a non-synaptic and
non-vesicular fashion, and that this tonically activates GABAA receptors on SVZ astrocytic
stem cells [84;85]. The SVZ astrocytes also express GABA transporters that may further
regulate levels of ambient GABA within the niche. Pharmacological inhibition of GABAA
receptors in SVZ slice-culture preparations increases mitotic activity within the SVZ [85;86].
Blocking GABA transporters or enhancing GABA release from neuroblasts on the other hand,
slows the speed of their own migration, in a paracrine/autocrine fashion in the SVZ and RMS
[87]. Furthermore, knocking down Na-K-2Cl cotransporter NKCC1 and thereby reducing
GABA(A)-induced depolarization in the SVZ reduced proliferation, migration as well dendrite
development [79;80]. These data together suggest that GABA has a role as a negative regulator
of early stages of neurogenesis in the SVZ, where it reduces neuroblasts and SVZ astrocyte
proliferation and decreases the speed of neuroblast migration. This is analogous to the role of
GABAA activation in the developing cortex, where it also serves to limit proliferation of
ventricular zone progenitors and migration of postmitotic neuroblasts [88-90].
GABA’s role in regulating early phases of neurogenesis such as proliferation and migration
has been examined more extensively in the SVZ where it has been shown to act as a negative
regulator of early neurogenesis. Whether these effects are corroborated in the SGZ is as yet
unknown. An attractive hypothesis explaining GABA’s disparate roles in development,
postnatal neurogenesis, and at the synapse is that neurotransmitter-based signaling may serve
as a bridge that brings an activity-dependence to cell-autonomous and locally present
instructive signals that drive neurogenesis and network plasticity. In this way, neuronal and
metabolic activity may loop back onto the SVZ and SGZ.
2.5. Glutamate
During embryonic neurogenesis, glutamate signaling has been shown to influence prolifera‐
tion, fate commitment, and migration of newborn neurons [88;89;91-93]. During postnatal
neurogenesis, in the SVZ neuroblasts have been shown to express functional NMDA receptors
as well as functional mGluR5 and GLUk5-containing kainate receptors, using both electro‐
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study reports that this decrease in overall SVZ cell proliferation is nonetheless accompanied by
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responsible for enabling a dopaminergic differentiation program in postnatally generated
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proliferation and decreases the speed of neuroblast migration. This is analogous to the role of
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has been examined more extensively in the SVZ where it has been shown to act as a negative
regulator of early neurogenesis. Whether these effects are corroborated in the SGZ is as yet
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instructive signals that drive neurogenesis and network plasticity. In this way, neuronal and
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physiology and calcium imaging [94;95]. Evidence from our lab suggests glutamate released
spontaneously from SVZ-RMS astrocytes generates phasic NMDA receptor activity in
neuroblasts migrating towards the OB [96]. Both mGluR5 and GLUk5 activation have also been
shown to mediate increases in intracellular Ca2+ transients in SVZ neuroblasts [95;97]. A mosaic
of GABAA, NMDA, mGluR5, and GLUk5 (now known as GluK2) receptor-expressing cells
reside in the SVZ, where most cells express GABAA receptors in caudal SVZ and moving
rostrally, a greater proportion of cells begin to express a combination of receptors. Ultimately,
nearly half of all cells in the rostral RMS express all four types of receptors, indicating the
continuing maturation of newborn cells along the SVZ-OB neurogenic axis. Mice lacking
mGluR5, or in which mGluR5 was pharmacologically blocked, displayed a marked decrease
in the number of proliferating cells in the SVZ [98]. This indicates a role for glutamate -acting
tonically through metabotropic receptors- in positively regulating SVZ progenitor prolifera‐
tion and antagonizing tonic GABAA-ergic receptor-induced anti-mitotic activity; perhaps
acting as a positive regulator of early neurogenic processes. Blocking GLUk5 in the RMS on the
other hand, increased the speed of neuroblast migration, suggesting that tonic GLUk5-mediated
glutamatergic transmission decreases neuroblast clearance from the SVZ and acts in concert
with GABA’s effect on migration in the SVZ [97]. mGluR5 activity however, does not influence
migration speed. It could be that GLUk5-mediated signaling activated different Ca2+-dependent
intracellular cascades than mGluR5 signaling. It remains to be seen whether AMPA/kainate
or NMDA receptor activity can have a positive effect on migration in the SVZ/RMS. These data
together suggest that although glutamate receptor heterogeneity and the multiple intracellular
pathways they may activate introduce ambiguity into what role glutamate may play in early
neurogenesis in the SVZ, metabotropic glutamate receptor signaling enhances proliferation,
while AMPA/kainate receptor signaling acts together with GABA to decrease migration of
neuroblasts. More work is needed to fully flesh out the roles that the three different glutamate
receptor families (NMDA, mGluR and AMPA/kainate) have in the SVZ. Work also is needed
to elucidate how glutamate receptor heterogeneity parses among the different SVZ sublineages
(Emx-1, Gsh2, Nkx2.1).
The diversity of glutamate receptors, the myriad intracellular pathways that they may activate
and the many mechanisms by which levels of ambient glutamate are regulated suggests that
glutamate, despite being nearly ubiquitously present, can have very specific and differential
effects on SVZ cells. The data so far suggests glutamate may regulate the early phases of
neurogenesis in manner that reflects this complexity. However, further work will involve
clarifying some of the associated ambiguity surrounding glutamate availability, the receptor
complement, the different intracellular pathways, and their effects on neurogenesis.
3. Morphogenesis, synaptogenesis and circuit integration in the OB
3.1. Intracellular factors
Later stages of neurogenesis include the survival, synaptic integration and dendritic elabora‐
tion of neuronal precursors within their target sites. CREB (cAMP response element binding)
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is a long-studied transcription factor known for underlying the later stages of synaptic
plasticity and memory formation, as well as for linking neuronal activity to survival. In the
postnatal SVZ-OB, CREB has been shown to be important in the survival and dendritic
arborization of SVZ neuroblasts [99]. CREB phosphorylation is transient and parallels
maturation, increasing during migration towards the OB and decreasing once radial migration
and synaptic integration are completed. CREB-deficient mice show deficits in neuroblast
survival in the OB, and CREB inhibition in vitro severely attenuates neurite outgrowth,
suggesting that CREB positively modulates survival and dendritic elaboration in the OB and
plays an important role in the later phases of SVZ neurogenesis. Data from our lab and others
suggests that a CREB-regulated microRNA, miR-132, is involved in mediating some of the
effects seen by impairing CREB activity in the SVZ. miR-132 expression is upregulated along
the migratory route of the SVZ neuroblasts, peaking in the OB, and miR-132 overexpression
enhances morphological complexity, spine density and survival of newborn neurons in vivo
[100]. These data suggest that CREB and a CREB-regulated miRNA may form the basis of a
structural plasticity program seen in SVZ postnatal neurogenesis. Intrinsic mechanisms
regulating later stages of neurogenesis are some of the least elaborated aspects of postnatal
neurogenesis. Additionally, with the emergence of inducible and conditional manipulation
techniques, it has become possible to discretely assay the roles of many factors within the
context of postnatal neurogenesis. Work is also emerging that utilizes the stop-flox-mediated
overexpression of factors in a conditional and inducible manner. MiR-132 and other recently
identified miRs that promote synapse maintenance because of their ease of delivery represent
therapeutic strategies for the stable maintenance of newly generated neurons in disease states.
3.2. Extracellular factors
Later stages of postnatal neurogenesis have also been shown to be responsive to neurotrophic
factor signaling. A single nucleotide polymorphism in the human brain derived neurotrophic
factor (BDNF)-encoding gene (Val66Met) has been shown to correlate with mood disorders
and memory deficits, and knock-in mice possessing the human SNP showed reduced activity-
dependent BDNF secretion ultimately resulting in reduced survival of SVZ neuroblasts and
impaired spontaneous olfactory discrimination [101]. In this study, activity-dependent BDNF
signaling in the SVZ was shown to exert its effects on survival and olfactory function through
TrkB receptors on neuroblasts. BDNF signaling and Trk receptor activity have been widely
shown to have neurotrophic and synapse-potentiating effects in neurons and may represent
a general strategy to promote the survival and maintenance of newly generated neurons.
Later stages of neurogenesis are poorly studied in the SVZ. Knowledge of molecules regulat‐
ing the survival, synaptic integration and morphogenesis of newborn cells is more limited in
comparison to the literature covering the DG. However, BDNF-signaling is an example of
emerging data within the field that unites hypotheses between the two neurogenic niches. It is
also interesting to note the sustained differences between the two niche microenvironments.
NT-3-signaling is exclusive to the DG and may promote excitatory versus inhibitory neurogen‐
ic potential. It has also been suggested that the convergence of dopaminergic and serotonergic
fibers defines the SVZ, while convergence of noradrenergic and serotonergic projections may
define the SGZ [68].
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physiology and calcium imaging [94;95]. Evidence from our lab suggests glutamate released
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is a long-studied transcription factor known for underlying the later stages of synaptic
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GABA-mediated depolarization of immature neurons has been shown to be critical for synapse
formation in the developing cortex [102]. Postnatally, following migration into the OB SVZ
neuroblasts begin the process of integrating into the local circuitry by radially migrating out
of the RMS core, elaborating a complex dendritic structure and establishing appropriate
synapses [5;103]. A role for GABAA signaling in the initiation, elongation and stabilization of
dendritic structures in immature neurons has been established in the OB. Specifically, it was
discovered that ambient GABA-induced depolarization and Ca2+-influx was necessary for the
stabilization of emerging dendritic protrusions and enhanced the number and length of
preexisting dendrites, in SVZ culture as well as OB slice preparations [104]. This effect was
specific to the immature neuron population because six days following plating, KCC2 levels
had increased sufficiently to block the depolarizing effects of GABA and the modulatory effects
of GABA-depolarization on dendrite development. Furthermore, GABA activity promoted
initiation and elongation of immature neuroblast dendrites in culture by stabilizing tubulin in
its polymerized form. Knockdown of NKCC1 and prevention of GABA-mediated depolari‐
zation in immature neurons also resulted in dendritic morphological deficits. However, this
effect was transient and dendritiric morphology recovered in adults [80].
This regulation by GABA in both the OB and DG helps shape neurogenesis as an activity-
dependent process where GABA is involved in regulating later stages of postnatal neurogen‐
esis orchestrating synapse formation and dendritic outgrowth. However, although GABA’s
role in the synaptic integration of postnatally generated neurons is becoming clearer, more
work is needed to fully flesh out the internal mechanisms by which GABA activity leads to
modulation of actions as disparate as proliferation, migration, synaptic integration, and
dendritogenesis.
3.4. Glutamate
Glutamate has been shown to be important for neuroblast survival, dendritic development, and
synaptogenesis in the developing CNS [105]. In the postnatal SVZ, spontaneous glutamate
release from astrocytes onto neuroblasts results in phasic NMDAR activation that increases in
frequency and amplitude upon migration towards the bulb. Genetic ablation of the NR1 subunit
in migrating neuroblasts results in 60% of these NR1-deficient newborn neurons entering
apoptosis, suggesting that NMDAR-dependent glutamatergic signaling is an important factor
in regulating neuroblast survival and numbers of new neurons in the OB [106]. Once in the bulb,
newly generated neurons begin to integrate synaptically into the local circuitry, generate action
potentials and first establish GABAergic inputs followed by glutamatergic inputs ~4 weeks after
birth [103]. Recently, newborn granule cells in the OB were shown to express a transient form of
LTP in response to focal glutamatergic stimulation in the granule cell layer. This type of LTP was
not present in mature granule cells and was observed in cells between 2 and 8 weeks old, implying
that new neurons have a capacity for synaptic plasticity that is different from their mature
counterparts [107]. Perhaps this sort of synaptic enhancement can help explain the positive effects
olfactory learning has on SVZ neuroblast survival, as well as the negative effects anti-mitotic
activity in the SVZ has on olfactory discrimination.
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4. Responsiveness and involvement of postnatal neurogenesis in distinct
neuropathologies
4.1. Alzheimer’s disease
Alzheimer's disease (AD) is a late-onset neurological disease with a heritable component
characterized by deposition of β-amyloid peptides (Aβ), formation of neurofibrillary tangles,
reactive astrocytosis, activation of microglial cells and cholinergic deficits [108]. The effect of
AD is a progressive neurodegeneration throughout the neocortex and hippocampus, and
severe dementia [109]. SVZ neurogenesis is reduced in mouse models of AD and has also been
shown to be diminished in postmortem tissue from human AD patients. Mice harboring
familial mutations in amyloid precursor protein (APP) and presinilin 1 (PS1) show decreased
proliferation in the SVZ [110;111]. Infusion of Aβ peptide into the lateral ventricles also
decreases proliferation in the postnatal SVZ [112]. SVZ-derived neural progenitor cells from
PS1 mutants and the APPSwe/PS1ΔE9 double-mutants showed decreased cycling in vitro [112;
113]. In postmortem tissue, AD patients showed decreased numbers of proliferative (Ki67+)
cells in the SVZ [114]. Anosmia or hyposmia, the inability or reduced ability to perceive smell,
are predictive indicators of Alzheimer’s progression in the clinic. However, it remains to be
conclusively established whether altered SVZ neurogenesis is the cause of this disrupted
olfaction in AD patients.
4.2. Parkinson’s disease
Parkinson’s disease (PD) develops due to the specific loss of dopaminergic neurons in the
substantia nigra (SN) and results in impaired regulation of movement, mood, and motivation
[69]. In mouse models of PD SVZ proliferation is reduced. This is thought to be due to the loss
of dopaminergic inputs to the SVZ from the SN via the nigrostriatal pathway, as chemical
ablation of these fibers results in decreased proliferation in the SVZ and decreased numbers
of mature granule neurons in the OB [69;74]. This effect on proliferation was partially rescued
with the application of the dopamine precursor levodopa. Furthermore, in postmortem tissue
from human AD patients SVZ proliferation was reduced, as were numbers of immature
neurons in the granule cell layer of the OB [69]. However, increases in numbers of periglo‐
merular dopaminergic neurons have also been reported in mouse models of PD using chemical
ablation, and in PD postmortem human tissue [74;115]. Because dopaminergic activity of
periglomerular cells generally inhibits the transmission of olfactory information, it is thought
that the decreased numbers of granule cells and the increased numbers of periglomerular cells
together contribute to the hyposmia and disturbed olfaction seen in PD patients.
4.3. Huntington’s disease
Huntington’s disease (HD) is caused by expansions in CAG repeat elements in the gene
encoding huntingin. This leads to aggregation of mutant huntingtin and neurodegeneration
in the striatum [116]. In mouse models of HD there is little striatal neurodegeneration and
consequently SVZ neurogenesis remains unchanged. However, in rat models of striatal
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degeneration SVZ proliferation is increased [117;118]. Some cells from the SVZ are seen to
ectopically migrate into the damaged striatum and begin expressing markers of newborn
neurons, although any functional recovery was not reported [118]. In HD patients an increase
in proliferation in the SVZ is observed that corresponds with the number of CAG repeats, and
SVZ cells are seen to migrate into the damaged striatum where they express both proliferative
as well as mature neuronal markers. It remains to be seen whether the expression of both
proliferative and mature markers in SVZ-derived cells within the HD-damaged striatum is
symptomatic of HD or in fact, can contribute to functional recovery [119-121]. However, the
potential for endogenous repair for HD can still be seen as promising, as newborn neurons
would take a long time to develop huntingtin inclusions and in the meantime participate in
the maintenance of striatal circuitry.
4.4. Ischemic stroke
A stroke results from either a hemorrhage or blocked cerebral arteries, leading to diminished
local blood flow (ischemia) in a brain region and loss of neurons. In stroked tissue, the core
infarcted area is distinguishable from the surrounding penumbral area by the exaggerated
necrosis and little potential for regeneration. In the penumbral region on the other hand,
neuronal regeneration has been demonstrated as it is perfused by collateral arteries and not
wholly dependent on the occluded artery for oxygen. As ischemic stroke is one of the most
frequent causes of mortality in industrialized countries, a lot of research has been undertaken
to probe the capacity for regeneration in this condition. In rodent and primate models of stroke
where the medial cerebral artery is occluded (MCAO), SVZ proliferation and the numbers of
neurons in the OB are increased [122-124]. In addition, ectopic neurogenesis is also observed
in the penumbral areas, such as the striatum [125]. Some groups have also reported ectopic
neurogenesis in cortical regions following stroke (Gu 2000, sun 2003) but this has been denied
by others [125]. In the stroked striatum, SVZ-derived cells differentiate into medium spiny
GABAergic neurons which represent 90% of striatal neurons and are lost there, although once
in the striatum many of the newborn neurons undergo cell death [125]. However, this finding
is greatly encouraging for the continued study of an effective neuronal replacement strategy
as a means to treat stroke damage in the CNS. As proof of this idea, ablating neurogenesis in
mouse models of stroke greatly exacerbated cell death and postischemic sensorimotor deficits,
suggesting that neurogenesis can account for some amelioration of stroke-induced damage
[126]. In human stroke patients, increased proliferation has been observed in the ipsilateral
SVZ and traces of ectopic neurogenesis were seen in the cortex [127-129]. The functional
recovery that this observed increase in neurogenesis following stroke is able to accomplish
remains to be validated, but it does suggest that some measure of recovery is endogenously
possible and may be drawn out with continued research and more-tailored therapeutic
intervention.
4.5. Epilepsy
Epilepsy has also been shown to alter SVZ neurogenesis. In rats, pilocarpine-induced seizures
increased SVZ proliferation as well as expanded the extent of the RMS. Ectopic migration and
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increased immature neurons were also observed [130]. In humans, increases proliferation and
ectopic migration have also been observed in organotypic slice preparations [131]. These effects
on neurogenesis seem to be symptomatic of epilepsy, whether they can be harnessed as a way
to treat the damage caused by repeated seizure activity remains to be seen.
4.6. Precancerous lesions and cortical heterotopias
It has long been suggested that the SVZ is the source of origin for malignant gliomas. The
prognosis for these cancers is very poor and for glioblastoma, the most common variant in
adults, the median survival rate is only 9-12 months [132-134]. A few years ago, in a mouse
model of malignant astrocytoma that included a p53 deletion and a conditional disruption of
the neurofibromatosis type 1 (NF1) gene, researchers conclusively established that the
originating tumorigenic mutation arises within the SVZ atrocyte-like stem cell [135]. Recently
it was further shown that although the mutation arises in the neural stem cell, the cancer begins
at a subsequent stage, when these stem cells have committed to the oligodendrocytic lineage
[136]. Studies of the molecular characteristics of low-grade human astrocytomas suggested
that most often in these conditions p53 is deleted and Ras signaling is elevated. Since NF1 is a
negative regulator of Ras, its deletion would result in increased Ras activity and in conjunction
with the p53 deletion more accurately model human astrocytomas. In mice, this genetic
strategy produced astrocytomas with complete penetrance, suggesting that NF1 and p53
deletion are sufficient to induce cancer. When tumor development was closely followed in
these mice, it was discovered to arise from the SVZ in nearly every instance before dispersing
to other brain regions. These results demonstrate that therapeutic intervention utilizing SVZ
neurogenesis must guarantee against the elevated risk of tumorigenesis, and that continued
research is necessary to manipulate the proliferation, fate choice, migration and differentiation
of SVZ progenitors. Perhaps one day a therapy can be conceived to induce cell death in
progenitors that have become transformed into precancerous cell types.
It has also been recently demonstrated that SVZ dysfunction can contribute to the pathophysiol‐
ogy of neuropsychiatric conditions like tuberous sclerosis complex (TSC). TSC is caused by loss
of either one of two tumor suppressor genes, TSC1 and TSC2, which encode hamartin and tuberin,
respectively.  Mutations in these genes lead to hyperactivity of  the mammalian target  of
rapamycin (mTOR) signaling pathway. Neurological symptoms of TSC include seizures, autism,
psychiatric  problems  and  the  presence  or  subendymal  nodules,  heterotopias  and  giant,
ectopically localized cells with both neuronal and glial characteristics. A recent study mod‐
eled TSC in mice by conditionally ablating Tsc1 specifically in the postnatal SVZ. This pro‐
duced ectopic migration and differentiation of neuronal precursors, resulting in hetertopias and
micronodules containing neurons with a hypertrophic dendritic tree in aberrant locations.
Furthermore, Tsc1-mutant cells were shown to be rerouted to forebrain structures where they
differentiated into neurons and glia. This remarkable rerouting of SVZ cells to the cortex is
thought to be occurring at a very low rate under normal circumstances, but becomes elevated
when mTOR activity is pathogenically increased [137]. It is hypothesized that these ectopic cells
in the cortex contribute to network malfunction in higher-order cognitive function. This research
also opens up the exciting idea of actively rerouting cells to the cortex, or other desired brain
regions, for directed endogenous circuit repair.
Postnatal Neurogenesis in the Subventricular Zone: A Manipulable Source for CNS Plasticity and Repair
http://dx.doi.org/10.5772/55679
149
degeneration SVZ proliferation is increased [117;118]. Some cells from the SVZ are seen to
ectopically migrate into the damaged striatum and begin expressing markers of newborn
neurons, although any functional recovery was not reported [118]. In HD patients an increase
in proliferation in the SVZ is observed that corresponds with the number of CAG repeats, and
SVZ cells are seen to migrate into the damaged striatum where they express both proliferative
as well as mature neuronal markers. It remains to be seen whether the expression of both
proliferative and mature markers in SVZ-derived cells within the HD-damaged striatum is
symptomatic of HD or in fact, can contribute to functional recovery [119-121]. However, the
potential for endogenous repair for HD can still be seen as promising, as newborn neurons
would take a long time to develop huntingtin inclusions and in the meantime participate in
the maintenance of striatal circuitry.
4.4. Ischemic stroke
A stroke results from either a hemorrhage or blocked cerebral arteries, leading to diminished
local blood flow (ischemia) in a brain region and loss of neurons. In stroked tissue, the core
infarcted area is distinguishable from the surrounding penumbral area by the exaggerated
necrosis and little potential for regeneration. In the penumbral region on the other hand,
neuronal regeneration has been demonstrated as it is perfused by collateral arteries and not
wholly dependent on the occluded artery for oxygen. As ischemic stroke is one of the most
frequent causes of mortality in industrialized countries, a lot of research has been undertaken
to probe the capacity for regeneration in this condition. In rodent and primate models of stroke
where the medial cerebral artery is occluded (MCAO), SVZ proliferation and the numbers of
neurons in the OB are increased [122-124]. In addition, ectopic neurogenesis is also observed
in the penumbral areas, such as the striatum [125]. Some groups have also reported ectopic
neurogenesis in cortical regions following stroke (Gu 2000, sun 2003) but this has been denied
by others [125]. In the stroked striatum, SVZ-derived cells differentiate into medium spiny
GABAergic neurons which represent 90% of striatal neurons and are lost there, although once
in the striatum many of the newborn neurons undergo cell death [125]. However, this finding
is greatly encouraging for the continued study of an effective neuronal replacement strategy
as a means to treat stroke damage in the CNS. As proof of this idea, ablating neurogenesis in
mouse models of stroke greatly exacerbated cell death and postischemic sensorimotor deficits,
suggesting that neurogenesis can account for some amelioration of stroke-induced damage
[126]. In human stroke patients, increased proliferation has been observed in the ipsilateral
SVZ and traces of ectopic neurogenesis were seen in the cortex [127-129]. The functional
recovery that this observed increase in neurogenesis following stroke is able to accomplish
remains to be validated, but it does suggest that some measure of recovery is endogenously
possible and may be drawn out with continued research and more-tailored therapeutic
intervention.
4.5. Epilepsy
Epilepsy has also been shown to alter SVZ neurogenesis. In rats, pilocarpine-induced seizures
increased SVZ proliferation as well as expanded the extent of the RMS. Ectopic migration and
Neural Stem Cells - New Perspectives148
increased immature neurons were also observed [130]. In humans, increases proliferation and
ectopic migration have also been observed in organotypic slice preparations [131]. These effects
on neurogenesis seem to be symptomatic of epilepsy, whether they can be harnessed as a way
to treat the damage caused by repeated seizure activity remains to be seen.
4.6. Precancerous lesions and cortical heterotopias
It has long been suggested that the SVZ is the source of origin for malignant gliomas. The
prognosis for these cancers is very poor and for glioblastoma, the most common variant in
adults, the median survival rate is only 9-12 months [132-134]. A few years ago, in a mouse
model of malignant astrocytoma that included a p53 deletion and a conditional disruption of
the neurofibromatosis type 1 (NF1) gene, researchers conclusively established that the
originating tumorigenic mutation arises within the SVZ atrocyte-like stem cell [135]. Recently
it was further shown that although the mutation arises in the neural stem cell, the cancer begins
at a subsequent stage, when these stem cells have committed to the oligodendrocytic lineage
[136]. Studies of the molecular characteristics of low-grade human astrocytomas suggested
that most often in these conditions p53 is deleted and Ras signaling is elevated. Since NF1 is a
negative regulator of Ras, its deletion would result in increased Ras activity and in conjunction
with the p53 deletion more accurately model human astrocytomas. In mice, this genetic
strategy produced astrocytomas with complete penetrance, suggesting that NF1 and p53
deletion are sufficient to induce cancer. When tumor development was closely followed in
these mice, it was discovered to arise from the SVZ in nearly every instance before dispersing
to other brain regions. These results demonstrate that therapeutic intervention utilizing SVZ
neurogenesis must guarantee against the elevated risk of tumorigenesis, and that continued
research is necessary to manipulate the proliferation, fate choice, migration and differentiation
of SVZ progenitors. Perhaps one day a therapy can be conceived to induce cell death in
progenitors that have become transformed into precancerous cell types.
It has also been recently demonstrated that SVZ dysfunction can contribute to the pathophysiol‐
ogy of neuropsychiatric conditions like tuberous sclerosis complex (TSC). TSC is caused by loss
of either one of two tumor suppressor genes, TSC1 and TSC2, which encode hamartin and tuberin,
respectively.  Mutations in these genes lead to hyperactivity of  the mammalian target  of
rapamycin (mTOR) signaling pathway. Neurological symptoms of TSC include seizures, autism,
psychiatric  problems  and  the  presence  or  subendymal  nodules,  heterotopias  and  giant,
ectopically localized cells with both neuronal and glial characteristics. A recent study mod‐
eled TSC in mice by conditionally ablating Tsc1 specifically in the postnatal SVZ. This pro‐
duced ectopic migration and differentiation of neuronal precursors, resulting in hetertopias and
micronodules containing neurons with a hypertrophic dendritic tree in aberrant locations.
Furthermore, Tsc1-mutant cells were shown to be rerouted to forebrain structures where they
differentiated into neurons and glia. This remarkable rerouting of SVZ cells to the cortex is
thought to be occurring at a very low rate under normal circumstances, but becomes elevated
when mTOR activity is pathogenically increased [137]. It is hypothesized that these ectopic cells
in the cortex contribute to network malfunction in higher-order cognitive function. This research
also opens up the exciting idea of actively rerouting cells to the cortex, or other desired brain
regions, for directed endogenous circuit repair.
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1. Introduction
Nitric oxide (NO) is a gaseous free radical that acts as a second messenger having an important
biological role in intercellular communication and in intracellular signaling in many tissues,
including the brain (reviewed by [1]). NO is synthesized by the nitric oxide synthase (NOS)
family of enzymes, which convert L-arginine to L-citrulline and NO. There are three different
isoforms of NOS: a) neuronal NOS (nNOS or NOS I), b) endothelial NOS (eNOS or NOS III),
and c) inducible NOS (iNOS or NOS II) (reviewed by [2]). Different members of the NOS family
control different functions of NO (reviewed by [1]).
In  the central  nervous system (CNS),  NO has been linked to  the regulation of  synaptic
plasticity and cognitive functions,  and it  is  also associated with the control of biological
functions including sleep-wake cycle, appetite, body temperature, and modulation of hor‐
mone release as reviewed by [3]. In the last decade, there has been a growing interest in
the  study  of  the  role  of  NO  in  neurogenesis,  the  process  by  which  new  neurons  are
formed in  the  brain.  NO regulates  neurogenesis  in  diverse  ways,  and the  different  NO
synthases  are  important  players  in  the  different  effects  on  neurogenesis.  Under  physio‐
logical conditions NO synthesized from nNOS acts as a negative regulator of neurogene‐
sis [4-9], while in inflammatory conditions, such as neurodegenerative disorders or acute
brain  insults,  a  decrease  in  nNOS  and  an  increase  in  iNOS  expression  may  act  as  a
mechanism to enhance neurogenesis [8,10-13].  In fact,  depending on the source, NO has
a pro-neurogenic  effect  either  by promoting neural  stem cell  (NSC)  proliferation,  as  re‐
cently  described by our group [13,14],  but  also by favoring other  steps of  neurogenesis
such as migration [15], differentiation and survival [10,16]. Although the exact molecular
mechanisms underlying this dual effect of NO on neurogenesis are not fully clarified, the
© 2013 Carreira et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
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modulation of the NO system seems be a good target for the development of strategies
to improve endogenous neurogenesis following brain damage.
In  this  chapter,  we  describe  the  use  of  two different  strategies  for  the  enhancement  of
endogenous  neurogenesis  using  drugs  that  are  linked  to  the  nitrergic  system:  1)  Nitric
oxide-releasing non-steroidal anti-inflammatory drugs (NO-NSAID); 2) Phosphodiesterase
type  5  (PDE5)  inhibitors.  PDE5  inhibitors  are  suitable  to  be  used  in  the  clinic  for  the
treatment of several pathologies, such as erectile dysfunction [17] and pulmonary arterial
hypertension [18], while NO-NSAID are being studied as an alternative to NSAID in the
treatment  of  systemic  inflammatory  conditions  [19].  Although little  is  known about  the
use of  these drugs for the treatment of  CNS disorders,  the evidence so far is  encourag‐
ing.  Several  reports  describe these drugs as  a  good strategy to promote regeneration of
lesioned areas or to be used as an adjuvant approach in cell replacement therapies since
they  favor  neurogenesis  [20-22].  Thus,  the  design  of  therapeutic  strategies  using  these
drugs to efficiently enhance the different steps of  neurogenesis,  such as a)  proliferation,
b)  migration,  c)  differentiation,  d)  integration  and,  e)  survival  of  NSC  in  the  injured
CNS, seems to be a valuable therapeutic approach to improve brain repair.
2. Neurogenesis in the adult mammalian brain
The discovery of NSC in the adult mammalian brain had a strong contribution for the
understanding of adult CNS plasticity. Two regions have been classically described as having
the characteristics necessary for the maintenance of NSC: a) the subgranular zone (SGZ) of the
dentate gyrus (DG) of the hippocampus [23,24], and b) the subventricular zone (SVZ) of the
lateral ventricles [25]. NSC can be isolated from the SGZ or SVZ and cultured in vitro, since
some of the characteristics of these regions can be kept in culture in the presence of growth
factors such as the epidermal growth factor (EGF) [26] and/or basic fibroblast growth factor
(bFGF) [27].
In vivo, from the SVZ and SGZ, NSC undergo a complex process leading ultimately to the
formation of new neurons, a phenomenon referred to as neurogenesis, which enables the
continuous production of neuronal cells throughout the adult life of mammals, including
humans. Neurogenesis can be summarized into six main stages: 1) proliferation of precursor
cells; 2) fate determination; 3) migration; 4) differentiation; 5) integration in the neuronal
circuitry, and 6) long-term survival of functional newborn neurons. Each of these stages is
tightly regulated locally, and numerous agents have been described to be responsible for the
physiological regulation of neurogenesis, such as EGF, bFGF, Numb, Notch, Sox, Sonic
hedgehog, Noggin, among others (for review see [28,29]).
When trauma occurs  in the CNS,  new needs arise  for  the brain,  mainly for  repair,  and
various signals are released from injured areas influencing neurogenic niches and the be‐
havior  of  NSC,  which can migrate  to  the affected sites.  Brain damage may be a)  acute,
such as traumatic brain injury, ischemic stroke or prolonged brain seizures, or b) chron‐
ic,  such  as  slow-progressing  neurodegenerative  diseases.  All  these  conditions  are  fol‐
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lowed by an inflammatory response [30].  Indeed, several studies have shown that adult
neurogenesis  is  influenced  by  various  pathological  conditions,  as  discussed  previously
[31].  Models  of  brain  damage  were  used  to  demonstrate  that  neurogenesis  may  be  fa‐
vored  following  injury,  particularly  acute  injury,  which  is  generally  accepted  as  an  at‐
tempt  of  the  brain  to  repair  [31].  On  the  other  hand,  the  neurogenic  capacity  is
decreased in neurodegenerative diseases,  such as  Alzheimer's  disease,  Huntington's  dis‐
ease or Parkinson’s disease [32-34].
However,  several  questions remain unclear  about  this  issue,  in  particular:  a)  which fac‐
tors  regulate  neurogenesis  during  inflammation;  b)  which  signaling  pathways  are  in‐
volved  in  the  recruitment  of  NSC  for  the  injured  sites;  c)  how  new  neurons  are
integrated and are able to survive long term; d) how can neurogenesis be modulated to
improve its efficiency in an inflammatory context. The search for the answers to some of
these questions is the challenge of regenerative medicine and a major target by the scien‐
tific community nowadays.
3. Neuroinflammation
Neuroinflammation is a biological response to noxious stimuli affecting the CNS, such as
stress, injury or infection by external pathogens [35,36]. The main role of the inflammato‐
ry response is  that  of  providing an harmful  environment  for  external  agents  that  cause
injury and to regain homeostasis, being mediated by the activation of two major groups
of cells from the immune system: a) CNS resident cells - microglia and astrocytes, and b)
hematopoietic system migrating cells - lymphocytes, monocytes and macrophages [37,38].
The activation  of  these  cells  is  characterized  by  the  release  of  different  regulatory  sub‐
stances,  including chemokines such as stromal derived factor  (SDF)-1alpha,  complement
molecules,  monocytes  chemoattractant  protein-1  (MCP-1),  cytokines  such  as  interferon
(IFN)-gamma, tumor necrosis  factor  (TNF)-alpha,  interleukine (IL)-1beta,  IL-18 and IL-6,
glutamate,  reactive  oxygen  species  (ROS)  and  reactive  nitrogen  species  (RNS)  like  NO
(for review see [31]).  Although the main function of neuroinflammation is to protect the
brain by promoting the removal  of  noxious stimuli  and committed/dead cells,  and thus
reestablishing brain tissue homeostasis, neuroinflammation may also become deregulated
and  contribute  to  perpetuate  secondary  tissue  damage,  as  reported  previously  [39].  In
fact,  the  creation  of  a  positive  feedback loop through inflammation itself  may result  in
neuronal loss and/or neuronal damage.
In short, neuroinflammation may have a dual effect on the cellular environment, being
beneficial or detrimental, depending on the time and state of activation of inflammatory cells
[40]. Accordingly, the inflammatory response has been linked to the mechanisms that lead to
various CNS diseases, also affecting SVZ and SGZ niches, therefore compromising neurogen‐
esis [41]. Whether this means that inflammation is always detrimental to neurogenesis, or
whether it is harmful only when the homeostasis of SVZ and/or SGZ is compromised, will be
discussed in the next section.
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4. Neuroinflammation and neurogenesis
As  mentioned  in  the  previous  section,  it  is  now  widely  accepted  that  neuroinflamma‐
tion  modulates  neurogenesis  in  different  ways,  either  by  increasing  or,  alternatively,
decreasing  it  [42].  Depending  on  the  severity  and  complexity  of  the  inflammatory  re‐
sponse,  which  can  range  from  a  mild  acute  to  a  chronic  uncontrolled  process,  neuro‐
genesis  may  be  dually  regulated.  Factors  such  as  a)  the  type  of  inflammatory  stimuli,
b)  the  type of  inflammatory cells,  c)  the  type of  inflammatory mediator,  d)  the  area  of
injured  tissue  and  e)  for  how  long  the  inflammatory  cells,  particularly  microglia,  re‐
main  activated,  are  decisive  for  the  shift  from  a  pro-neurogenic  to  an  anti-neurogenic
inflammatory status [43].
In  this  context,  the  involvement  of  a  particular  type  of  inflammatory  cells  such  as  mi‐
croglia,  considered  by  most  authors  as  the  "hallmark  of  neuroinflammation",  seems  to
be  of  major  importance  in  the  modulation  of  neurogenesis.  The  main  features  of  mi‐
croglial  cells  are a)  the expression of  scavenger receptors,  b)  antigen presentation mole‐
cules  (Major  Histocompatibility  Complex  (MHC)  class  II),  c)  pattern-recognition
receptors,  and d)  production of  various  cytokines  and other  inflammatory factors  (ROS
and  RNS)  [44].  For  a  long  time,  microglial  cells  were  considered  as  the  damaging
agents  of  the  inflammatory  response,  with  a  default  response  always  leading  to  detri‐
mental  effects  on  neuronal  surrounding  environment.  However,  recent  studies  describe
microglial  activity  to  be  plastic  (for  review see  [42]).  In  fact,  the  plasticity  of  microglia
seems  to  be  a  determining  factor  in  this  dual  regulation  of  neurogenesis,  since  it  can
assume  different  morphologies  and  different  phenotypes  and  subsequently  release  me‐
diators  along  an  inflammatory  response  that  may influence  the  physiology  of  the  NSC
[45].  Apparently,  microglial  cells  and  factors  released  during  inflammatory  responses
appear to  have a  dual  role  in neurogenesis  [13,42].
Therefore,  numerous  studies  have  reported  the  involvement  of  different  microglial-de‐
rived  inflammatory  mediators  in  the  regulation  of  neurogenesis  and/or  neuroprotection
[31,46,47].  Moreover,  it  has  been  reported  that  chronic  microglial  activation  can  stimu‐
late  one  or  more  stages  of  neurogenesis,  such  as  NSC proliferation,  migration  and dif‐
ferentiation,  while  the  long-term  survival  of  newborn  neurons  seems  to  be  reduced  in
this  context  [31].
4.1. Anti-neurogenic role of inflammation
Neuroinflammation,  in  particular  microglial  activation,  was  initially  described  to  be
detrimental  to neurogenesis  [48,49].  Several  studies have demonstrated microglia  activa‐
tion by lipopolysaccharide (LPS)  to  hinder  neurogenesis  in  adult  rats  [48],  by a  mecha‐
nism  mediated  through  TNF-alpha  increased  production  [50,51].  Other  studies  have
linked  this  anti-neurogenic  effect  of  inflammation  to  the  increased  production  of  other
proinflammatory  mediators  such  as  interleukins  IL-1  beta  and  IL-6,  or  cytokines  IFN-
gamma and TNF-alpha [52-55].  In  addition,  ROS and RNS,  in  particular  NO, have also
been described as  being involved in  the  detrimental  effect  of  neuroinflammation in  the
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formation of  new neurons  in  the  adult  brain  of  rodents  [49,56,57].  In  Table  1  we sum‐
marize  the  main  findings  concerning  the  effect  of  the  most  important  proinflammatory
mediators  in neurogenesis.
In  addition,  the  deleterious  role  of  inflammation  in  neurogenesis  was  corroborated  by
numerous  studies  which  demonstrated  that  neurogenesis  can  be  restored  when  the  in‐
flammatory response is controlled by the administration of:  a) antibiotics,  such as mino‐
cycline  [48,58,59],  or  b)  non-steroidal  anti-inflammatory  drugs,  such  as  indomethacin
[48,49,60,61].
4.2. Pro-neurogenic role of inflammation
Contrary to initial observations, recent studies indicate that neuroinflammation may also
support different stages of neurogenesis, thus favoring the formation of new neurons follow‐
ing injury to the CNS [44]. Thus, the inflammatory microenvironment is responsible for
sending “activating signals” to NSC resident in neurogenic niches, such as SVZ or SGZ, that
thereafter migrate to the injured areas where they differentiate and integrate the neuronal
network [62,63]. In this context, microglial cells are described as central in the regulation of
this process, suggesting an ambiguous role of microglia in the regulation of neurogenesis in
inflammatory conditions [64].
Apparently, although microglia may be detrimental to neurogenesis in early stages of the
inflammatory response after acute insults, prolonged inflammatory response, also referred as
chronic inflammation, appears to have a protective effect by directing the replacement of
damaged or lost cells [45,65-68]. Thus, it was shown in several studies that inhibition of
microglial activation results in continuous production of new neurons from adult NSC [69,70].
Moreover, chronic activation of microglia is concomitant with long-term survival of newly
formed neurons [71,72].
Several proinflammatory mediators have been related to the pro-neurogenic effect of inflam‐
mation, including: a) cytokines such as IFN-gamma or TNF-alpha, b) chemokines such as
SDF-1alpha and its receptor CXCR4 [69,73], or c) trophic factors such as brain-derived
neurotrophic factor (BDNF) and glial-derived neurotrophic factor (GDNF) involved in the
removal of damaged synapses [72] (see Table 1). In addition to the pro-neurogenic effect, these
studies also suggest a neuroprotective role of microglial cells for newborns cells.
4.3. Future studies
Overall, it seems clear that more knowledge about the crosstalk between inflammation and
neurogenesis is lacking. For instance, it is necessary to better characterize the genetic and
proteomics of the microglial response, as well as more targeted studies are needed to clarify
how neuroinflammation modulates each of the neurogenic stages. Identifying which genes are
expressed, and subsequently, what kind of proteins are present during an inflammatory
response will allow the development of different strategies to control or mitigate the delete‐
rious effects of neuroinflammation on neurogenesis.
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4.1. Anti-neurogenic role of inflammation
Neuroinflammation,  in  particular  microglial  activation,  was  initially  described  to  be
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nism  mediated  through  TNF-alpha  increased  production  [50,51].  Other  studies  have
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gamma and TNF-alpha [52-55].  In  addition,  ROS and RNS,  in  particular  NO, have also
been described as  being involved in  the  detrimental  effect  of  neuroinflammation in  the
Neural Stem Cells - New Perspectives166
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sending “activating signals” to NSC resident in neurogenic niches, such as SVZ or SGZ, that
thereafter migrate to the injured areas where they differentiate and integrate the neuronal
network [62,63]. In this context, microglial cells are described as central in the regulation of
this process, suggesting an ambiguous role of microglia in the regulation of neurogenesis in
inflammatory conditions [64].
Apparently, although microglia may be detrimental to neurogenesis in early stages of the
inflammatory response after acute insults, prolonged inflammatory response, also referred as
chronic inflammation, appears to have a protective effect by directing the replacement of
damaged or lost cells [45,65-68]. Thus, it was shown in several studies that inhibition of
microglial activation results in continuous production of new neurons from adult NSC [69,70].
Moreover, chronic activation of microglia is concomitant with long-term survival of newly
formed neurons [71,72].
Several proinflammatory mediators have been related to the pro-neurogenic effect of inflam‐
mation, including: a) cytokines such as IFN-gamma or TNF-alpha, b) chemokines such as
SDF-1alpha and its receptor CXCR4 [69,73], or c) trophic factors such as brain-derived
neurotrophic factor (BDNF) and glial-derived neurotrophic factor (GDNF) involved in the
removal of damaged synapses [72] (see Table 1). In addition to the pro-neurogenic effect, these
studies also suggest a neuroprotective role of microglial cells for newborns cells.
4.3. Future studies
Overall, it seems clear that more knowledge about the crosstalk between inflammation and
neurogenesis is lacking. For instance, it is necessary to better characterize the genetic and
proteomics of the microglial response, as well as more targeted studies are needed to clarify
how neuroinflammation modulates each of the neurogenic stages. Identifying which genes are
expressed, and subsequently, what kind of proteins are present during an inflammatory
response will allow the development of different strategies to control or mitigate the delete‐
rious effects of neuroinflammation on neurogenesis.












SVZ DG SVZ DG SVZ DG
IL-1 beta - - 0 0 + + SAPK/JNK [74,75]
IL-6 - - - - - - JAK/STAT and MAPK [48,56,67]
IFN-gamma
- 0 + + - 0 ERK 1/2 pathway [52,64,76-78]
+ 0 0 0 = 0 NF-kappaB [79,80]
TNF-alpha
+ 0 0 - 0 - 0 [50]
0 0 0 0 - - TNF-R1 and TNF-R2 [53,76]
+ 0 - 0 = 0 TNF-R1 [81]
+ + + + + + TNF-R2 [82]
+ 0 + 0 + 0 TNF-R1 [83]
0 - 0 - + 0 TNR-R1 [54]
+ + + + + + TNF-R2 [43,54]
SDF-1alpha + + + 0 + 0 CXC-R4 [69,73,84]
The effects listed in Table 1 may not be direct. +, Increase; -, decrease; =, not changed; 0, not reported.
Table 1. Modulation of adult neurogenesis by inflammatory mediators.
5. Nitric oxide
NO is a short-lived gaseous free radical synthesized by different members of the nitric oxide
synthase family of enzymes. NOS are present in most tissues of the body and convert L-
arginine to L-citrulline and NO [2,85]. The NOS family of enzymes is characterized by the
existence of three different isoforms in mammalian cells: a) neuronal NOS (nNOS, type I), is
constitutively expressed in neurons, where it localizes to synaptic spines, and is activated by
calcium/calmodulin following the activation of glutamate receptors; b) endothelial NOS
(eNOS, type III), is constitutively expressed in endothelial cells and astrocytes, is regulated by
phosphorylation/dephosphorylation and/or by calcium/calmodulin; and c) inducible NOS
(iNOS, type II), which regulation is dependent on de novo synthesis of the enzyme, particularly
in inflammatory conditions [2,86,87].
Involved in a variety of physiological processes, NO has been described as an important
regulator of the activity of systems such as the cardiovascular, immune and nervous systems
[88]. There are several biological functions that depend on NO formation, including the
regulation of body temperature, appetite and sleep-wake cycle (for review see [3]). The main
mechanism regulating NO activity is at the level of its synthesis. In the CNS, NO has a distinct
action when compared to classical neurotransmitters, as it is synthesized on demand, diffusing
from synaptic terminals, acting not only in NO-releasing cells, but also in neighboring cells
[89]. Initially described as an intracellular messenger, NO has also been associated with
synaptic plasticity, which is linked to cognitive function, neuronal development and modu‐
lation of hormone release [90]. In this context, the role of NO as an intracellular messenger is
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mediated by increasing cyclic guanosine 3', 5'-monophosphate (cGMP) levels, following the
activation of N-Methyl-D-aspartate (NMDA)-type glutamate receptors [91]. Unlike classical
neurotransmitters, which are stored in vesicles or released by exocytosis and further inacti‐
vated by re-uptake or enzymatic degradation, NO ends its action after reacting with intracel‐
lular substrates [1]. According to the literature, the action of NO in the brain has been associated
with two different outcomes: a) regulation of physiological events, by its action as an intra‐
cellular messenger [90], or b) regulation of cell death mechanisms, due to its action as a
cytotoxic agent [92,93]. This will be explored next in section 5.1.
5.1. Nitric oxide and neuroinflammation
As mentioned in the previous section, the action of NO in the CNS is characterized by the
interaction with multiple intracellular targets, activating or inhibiting various signaling
pathways. Thus, NO has been described to be involved in the regulation of several physio‐
logical functions, but also of various pathophysiological processes [2,85]. This dual action
depends on the NOS isoform that catalyzes the formation of NO: a) nNOS and eNOS-derived
NO is more involved in the regulation of physiological functions, and b) iNOS-derived NO is
more involved in pathophysiological processes. In fact, iNOS is not normally expressed in the
healthy brain, but in the presence of pro-inflammatory stimuli such as cytokines, external
pathogens, such as bacteria or virus, or stress, such as hypoxia, iNOS may be expressed
primarily on macrophages, astrocytes, microglia and endothelial cells [3,86,94,95], but also in
neurons [96,97]. However, it should be mentioned that NO overproduction has also been
linked to nNOS activation following persistent glutamate excitatory input during an inflam‐
matory response, which has also been linked to iNOS expression [3]. Once expressed, iNOS
continuously produces NO, and high levels are reached, in a process that can last for several
days, having a cytotoxic effect by inhibiting mitochondrial respiratory chain enzymes,
ultimately inducing apoptosis in target cells [95,98-101]. A key factor for the local effect of NO
is the concentration achieved. Thus, in physiological conditions, NO concentrations could
range from 0.1 to 100 nM, which is lower than those observed in inflammatory conditions,
being less reactive. Accordingly, the action of NO is accomplished primarily by binding to the
heme group of soluble guanylate cyclase (sGC), whose activation leads to the subsequent
production of cGMP [102].
Increased levels of NO have been linked to oxidative and nitrosative stress phenomena, which
have been described as involved in the development of several neurodegenerative disorders
[2,85]. Thus, a massive release of NO can lead to the production of nitrogen dioxide (NO2),
after the direct reaction between NO and oxygen. NO2 is a highly reactive nitrosative specie
that can react with NO, producing dinitrogen trioxide (N2O3). Moreover, NO2 can also oxidize
or nitrate a wide variety of molecules, being the nitration of tyrosine to 3-nitrotyrosine a
classical example [103]. N2O3, in turn, is involved in other phenomena such as nitrosation/
nitrosylation, by reacting with amine or thiol groups, being a good example cysteine, which
may be nitrosated to S-nitrosocysteine [103]. Furthermore, NO can also react with superoxide
to produce peroxynitrite (ONOO-), another extremely reactive molecule which can oxidize or
nitrate other molecules, which has been described to be involved in the pathogenesis of several
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existence of three different isoforms in mammalian cells: a) neuronal NOS (nNOS, type I), is
constitutively expressed in neurons, where it localizes to synaptic spines, and is activated by
calcium/calmodulin following the activation of glutamate receptors; b) endothelial NOS
(eNOS, type III), is constitutively expressed in endothelial cells and astrocytes, is regulated by
phosphorylation/dephosphorylation and/or by calcium/calmodulin; and c) inducible NOS
(iNOS, type II), which regulation is dependent on de novo synthesis of the enzyme, particularly
in inflammatory conditions [2,86,87].
Involved in a variety of physiological processes, NO has been described as an important
regulator of the activity of systems such as the cardiovascular, immune and nervous systems
[88]. There are several biological functions that depend on NO formation, including the
regulation of body temperature, appetite and sleep-wake cycle (for review see [3]). The main
mechanism regulating NO activity is at the level of its synthesis. In the CNS, NO has a distinct
action when compared to classical neurotransmitters, as it is synthesized on demand, diffusing
from synaptic terminals, acting not only in NO-releasing cells, but also in neighboring cells
[89]. Initially described as an intracellular messenger, NO has also been associated with
synaptic plasticity, which is linked to cognitive function, neuronal development and modu‐
lation of hormone release [90]. In this context, the role of NO as an intracellular messenger is
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mediated by increasing cyclic guanosine 3', 5'-monophosphate (cGMP) levels, following the
activation of N-Methyl-D-aspartate (NMDA)-type glutamate receptors [91]. Unlike classical
neurotransmitters, which are stored in vesicles or released by exocytosis and further inacti‐
vated by re-uptake or enzymatic degradation, NO ends its action after reacting with intracel‐
lular substrates [1]. According to the literature, the action of NO in the brain has been associated
with two different outcomes: a) regulation of physiological events, by its action as an intra‐
cellular messenger [90], or b) regulation of cell death mechanisms, due to its action as a
cytotoxic agent [92,93]. This will be explored next in section 5.1.
5.1. Nitric oxide and neuroinflammation
As mentioned in the previous section, the action of NO in the CNS is characterized by the
interaction with multiple intracellular targets, activating or inhibiting various signaling
pathways. Thus, NO has been described to be involved in the regulation of several physio‐
logical functions, but also of various pathophysiological processes [2,85]. This dual action
depends on the NOS isoform that catalyzes the formation of NO: a) nNOS and eNOS-derived
NO is more involved in the regulation of physiological functions, and b) iNOS-derived NO is
more involved in pathophysiological processes. In fact, iNOS is not normally expressed in the
healthy brain, but in the presence of pro-inflammatory stimuli such as cytokines, external
pathogens, such as bacteria or virus, or stress, such as hypoxia, iNOS may be expressed
primarily on macrophages, astrocytes, microglia and endothelial cells [3,86,94,95], but also in
neurons [96,97]. However, it should be mentioned that NO overproduction has also been
linked to nNOS activation following persistent glutamate excitatory input during an inflam‐
matory response, which has also been linked to iNOS expression [3]. Once expressed, iNOS
continuously produces NO, and high levels are reached, in a process that can last for several
days, having a cytotoxic effect by inhibiting mitochondrial respiratory chain enzymes,
ultimately inducing apoptosis in target cells [95,98-101]. A key factor for the local effect of NO
is the concentration achieved. Thus, in physiological conditions, NO concentrations could
range from 0.1 to 100 nM, which is lower than those observed in inflammatory conditions,
being less reactive. Accordingly, the action of NO is accomplished primarily by binding to the
heme group of soluble guanylate cyclase (sGC), whose activation leads to the subsequent
production of cGMP [102].
Increased levels of NO have been linked to oxidative and nitrosative stress phenomena, which
have been described as involved in the development of several neurodegenerative disorders
[2,85]. Thus, a massive release of NO can lead to the production of nitrogen dioxide (NO2),
after the direct reaction between NO and oxygen. NO2 is a highly reactive nitrosative specie
that can react with NO, producing dinitrogen trioxide (N2O3). Moreover, NO2 can also oxidize
or nitrate a wide variety of molecules, being the nitration of tyrosine to 3-nitrotyrosine a
classical example [103]. N2O3, in turn, is involved in other phenomena such as nitrosation/
nitrosylation, by reacting with amine or thiol groups, being a good example cysteine, which
may be nitrosated to S-nitrosocysteine [103]. Furthermore, NO can also react with superoxide
to produce peroxynitrite (ONOO-), another extremely reactive molecule which can oxidize or
nitrate other molecules, which has been described to be involved in the pathogenesis of several
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neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, Huntington's
disease, multiple sclerosis and amyotrophic lateral sclerosis [2,104-106]. Likewise, both S-
nitrosylation and nitration lead to alterations in the function of proteins, which may be
regarded as regulatory phenomena of its activity [103].Thus, understanding the involvement
of these phenomena in the pathoetiology of disorders affecting the brain may highlight a
potential therapeutic role in modulating these events.
5.2. Nitric oxide and neurogenesis
The involvement of NO in the regulation of neurogenesis is a matter of debate given the range
of different observations reported in the literature. In fact, the role of NO in neurogenesis only
recently has been identified [4,5,107]. Depending on the source and concentration attained
locally in the brain, NO has a dual influence in the neurogenic process both by inhibiting or
stimulating neurogenesis.
Based on the distribution of NO-producing cells in stem cell niches, several works have
proposed to study the involvement of NO produced at the perivascular niche - which includes
pericytes and smooth muscle fibroblasts, endothelial cells, microglia, glial progenitors and
astrocytic endfeet – in the regulation of neurogenesis, thus reinforcing the involvement of NO
signaling in angiogenesis and neurogenesis [4,108,109]. Indeed, the discovery of blood vessels
expressing eNOS and neurons expressing nNOS, close to SVZ and SGZ neurogenic niches,
was essential for the establishment of a causal relationship between NO and the formation of
new neurons. Moreover, it was also shown that nNOS-derived NO is involved in the regulation
of neurogenesis, particularly by regulating NSC function, so that a cytostatic function can be
assigned to NO in the CNS [4,5,107]. Thus, NO production occurs in close proximity to the
NSC. Other authors have shown that nitrergic neurons expressing nNOS are arranged in close
relationship throughout the rostral migratory stream (RMS), also describing a regulatory
action of NO in the migration of SVZ-derived progenitor cells along the RMS [110].
Although most studies initially performed reported NO as an anti-neurogenic agent in the
normal adult brain, in hypoxic ischemic stress conditions its effect can be radically different
favoring stem cell proliferation, as demonstrated in recent studies [4,12,13,108,111,112]. In fact,
the oxygen tension environment appears to modulate the effect of perivascular NO in
neurogenesis [112,113], which may vary from: a) pro-neurogenic action, dependent on the
expression of eNOS and nNOS, in physiological condition [108]; b) to anti-neurogenic action,
dependent on the expression of iNOS, in extreme environments such as hypoxic and ischemic
tissue and/or tumors [12,13,114,115]. However, more studies should be conducted to clearly
understand how NO produced by different cell types from the perivascular niche regulate
neurogenesis. In fact, it still remains to clarify the limit of oxidative stress and other redox
states that lead to the differential production of NO by each NOS isoforms - nNOS, eNOS and
iNOS - so that one can describe its perivascular action for neurogenesis.
During development, NO is differentially and transiently produced in the brain [116-118].
Moreover, the differential cellular and subcellular localization of nNOS in the CNS may explain
different functions of NO produced by nNOS [119]. In fact, in the cortex, there are two types
of NOS neurons whose distribution is of particular interest due to the relationship between
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the sites of NO production and the sites of development of particular pathologies [119].
Furthermore, its pre- or postsynaptical expression influences nNOS functions [120,121]. In the
adult olfactory bulb (OB), nNOS is highly expressed in developing neurons of the olfactory
epithelium during embryogenesis [120,122] and in the periglomerular cells and granule cells
in the OB in the adult [120,123], being necessary for the early postnatal development and for
the glomerular OB organization, respectively [123,124]. Furthermore, following a lesion in the
OB, nNOS expression is upregulated causing repopulation of this region [117,122,123].
Moreover, developing ependymal cells, which are in close association with SVZ-derived
progenitor cells, also transiently express nNOS after birth, but its activity decreases with the
maturation of the central canal [125], thus suggesting a role of NO synthesized by nNOS in the
development of ependymal cells [125]. Ependymal cells, together with astrocytes, create an
appropriate environment for neurogenesis [126].
NO production may be induced by neurotrophic factors, which results in an antiproliferative
effect on target cells by inducing cell cycle arrest/exit favoring cell differentiation [127-129].
Most of the studies on the involvement of NO in adult neurogenesis characterized its effect on
cell proliferation. However, the evaluation of survival and integration of newly-generated
neurons in the neuronal circuitry is also important, since NO is known to be an important
regulator of apoptosis [130]. In this context, different studies have shown that NO increases
short-term survival of progenitor cell progeny in the DG of adult rats by inhibiting apoptosis
after SE [131], and further preventing increases in the activity of caspase-3 [132].
5.2.1. Anti-neurogenic role of nitric oxide
The  anti-neurogenic  effect  of  NO  has  been  attributed  to  its  production  via  nNOS,  as
demonstrated in several  studies using in vitro  and in vivo  experimental  models.  Thus,  it
was reported that nNOS-derived NO has an antiproliferative effect,  and may be also in‐
volved in neuronal differentiation, survival and synaptic plasticity [4-6,133,134]. The anti‐
proliferative  effect  of  NO  was  confirmed  by  several  authors,  which  showed  that  the
inhibition  of  NO production  by  intra-ventricular  infusion  of  a  NOS inhibitor  or  by  the
knockout of nNOS increase cell proliferation in the DG or in the olfactory subependymal
zone of rodents [4,6,7,108]. Indeed, other studies were performed where the selective in‐
hibition of nNOS with 7-nitroindazole (7-NI) was shown to greatly increase cell prolifera‐
tion  in  the  SVZ,  RMS  and  OB  of  adult  rats,  but  not  in  the  DG  [5].  Moreover,  the
inhibition of  nNOS was also shown to increase neurogenesis  and to reduce infarct  size,
following a stroke [135]. The presence of differentiated nitrergic neurons in the periphery
of  the  neurogenic  areas,  mainly  surrounding  the  SVZ,  and  its  anatomical  organization,
contributes  to  this  physiological  downregulation  of  neurogenesis  [5,110].  However,  the
inhibitory role of  nNOS-derived NO in neurogenesis  was also demonstrated in the DG,
after  cerebral  ischemia  [135].  In  the  DG,  the  neural  precursors  of  the  SGZ are  in  close
proximity  with  the  nitrergic  neurons  of  the  hilus,  also  suggesting a  role  for  NO in  the
control of adult neurogenesis in this region [136].  These studies showed that chronic in‐
hibition  of  nNOS increases  neurogenesis,  supporting  the  idea  that,  physiologically,  NO
produced by nNOS has an anti-neurogenic effect. Recently, several studies have suggest‐
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neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, Huntington's
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nitrosylation and nitration lead to alterations in the function of proteins, which may be
regarded as regulatory phenomena of its activity [103].Thus, understanding the involvement
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potential therapeutic role in modulating these events.
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the oxygen tension environment appears to modulate the effect of perivascular NO in
neurogenesis [112,113], which may vary from: a) pro-neurogenic action, dependent on the
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Moreover, the differential cellular and subcellular localization of nNOS in the CNS may explain
different functions of NO produced by nNOS [119]. In fact, in the cortex, there are two types
of NOS neurons whose distribution is of particular interest due to the relationship between
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the sites of NO production and the sites of development of particular pathologies [119].
Furthermore, its pre- or postsynaptical expression influences nNOS functions [120,121]. In the
adult olfactory bulb (OB), nNOS is highly expressed in developing neurons of the olfactory
epithelium during embryogenesis [120,122] and in the periglomerular cells and granule cells
in the OB in the adult [120,123], being necessary for the early postnatal development and for
the glomerular OB organization, respectively [123,124]. Furthermore, following a lesion in the
OB, nNOS expression is upregulated causing repopulation of this region [117,122,123].
Moreover, developing ependymal cells, which are in close association with SVZ-derived
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development of ependymal cells [125]. Ependymal cells, together with astrocytes, create an
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short-term survival of progenitor cell progeny in the DG of adult rats by inhibiting apoptosis
after SE [131], and further preventing increases in the activity of caspase-3 [132].
5.2.1. Anti-neurogenic role of nitric oxide
The  anti-neurogenic  effect  of  NO  has  been  attributed  to  its  production  via  nNOS,  as
demonstrated in several  studies using in vitro  and in vivo  experimental  models.  Thus,  it
was reported that nNOS-derived NO has an antiproliferative effect,  and may be also in‐
volved in neuronal differentiation, survival and synaptic plasticity [4-6,133,134]. The anti‐
proliferative  effect  of  NO  was  confirmed  by  several  authors,  which  showed  that  the
inhibition  of  NO production  by  intra-ventricular  infusion  of  a  NOS inhibitor  or  by  the
knockout of nNOS increase cell proliferation in the DG or in the olfactory subependymal
zone of rodents [4,6,7,108]. Indeed, other studies were performed where the selective in‐
hibition of nNOS with 7-nitroindazole (7-NI) was shown to greatly increase cell prolifera‐
tion  in  the  SVZ,  RMS  and  OB  of  adult  rats,  but  not  in  the  DG  [5].  Moreover,  the
inhibition of  nNOS was also shown to increase neurogenesis  and to reduce infarct  size,
following a stroke [135]. The presence of differentiated nitrergic neurons in the periphery
of  the  neurogenic  areas,  mainly  surrounding  the  SVZ,  and  its  anatomical  organization,
contributes  to  this  physiological  downregulation  of  neurogenesis  [5,110].  However,  the
inhibitory role of  nNOS-derived NO in neurogenesis  was also demonstrated in the DG,
after  cerebral  ischemia  [135].  In  the  DG,  the  neural  precursors  of  the  SGZ are  in  close
proximity  with  the  nitrergic  neurons  of  the  hilus,  also  suggesting a  role  for  NO in  the
control of adult neurogenesis in this region [136].  These studies showed that chronic in‐
hibition  of  nNOS increases  neurogenesis,  supporting  the  idea  that,  physiologically,  NO
produced by nNOS has an anti-neurogenic effect. Recently, several studies have suggest‐
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ed  a  mechanism  for  the  negative  effect  of  NO  on  neurogenesis  in  the  SVZ.  These  au‐
thors suggested the inhibition of  the EGF receptor [134]  by a mechanism dependent on
the nitrosylation of  specific  cysteine residues and the activation of  the phosphoinositide
3-kinase (PI3-K)/Akt signaling pathway [9] as the main mechanisms by which NO nega‐
tively regulates neurogenesis in the SVZ (Table II). Furthermore, these authors described
the  antimitotic  effect  of  NO  as  being  related  to  the  nuclear  presence  of  the  cyclin-de‐
pendent kinase inhibitor p27Kip1 [9].
5.2.2. Neurogenic role of nitric oxide
The pro-neurogenic effect of NO has been reported in several studies using genetic or phar‐
macological approaches, showing that increased levels of iNOS after an insult to the brain are
related to increased neurogenesis in the hippocampus, an event correlated with concurrent
decreases in nNOS levels [8,137-139] (Table 2). However, in a study regarding the effect of NO
on cell proliferation it was described the involvement of NO derived from both iNOS and
nNOS in the enhancement of neurogenesis in the DG of adult rats, following seizures [140].
Other studies also showed that NO synthesized by iNOS following ischemia or by eNOS
stimulates neurogenesis in the SVZ or DG, respectively [12,111]. Furthermore, we recently
showed that the iNOS-derived NO promotes the proliferation of NSC in the hippocampus of
adult rats following SE [13]. Following an injury, the concomitant neuroinflammation results
in the activation of microglial cells, which continuously express iNOS [141]. This event leads
to the production of large amounts of NO that was shown to be favorable to increasing
neurogenesis following acute brain injuries.
Although some questions remain to be assessed,  several  studies have sought to explore
the signaling pathways by which NO from inflammatory origin exerts its pro-neurogenic
effect, namely in the regulation of proliferation. Recently, we have shown that supraphy‐
siological concentrations of NO induce the proliferation of SVZ-derived NSC through the
activation of at  least two signaling pathways, in a biphasic manner:  a)  the mitogen-acti‐
vated protein (MAP) kinase ERK 1/2 pathway, and/or b) the cGMP/cGMP-dependent kin‐
ase  (protein  kinase  G;  PKG)  pathway.  Thus,  the  proliferative  effect  of  NO seems to  be
initially  mediated  by  the  direct  activation  of  ERK1/2  signaling  pathway  [13].  The  in‐
creased activation of the ERK 1/2 signaling pathway after exposure to NO, leads to the ac‐
tivation of several downstream targets, namely the kinase p90RSK, subsequently leading
to decreased nuclear levels of its target p27Kip1, allowing cell cycle progression and cell di‐
vision  [13].  Moreover,  the  activation  of  cGMP/cGMP-dependent  kinase  (PKG)  pathway
appears to be involved following longer periods of exposure to supraphysiological levels
of  NO [14].  NO involvement  in  the  regulation of  other  stages  of  neurogenesis  has  also
been investigated. NO released in inflammatory conditions is also involved in NSC differ‐
entiation into  astrocytes,  a  process  also  referred to  as  astrogliogenesis,  by a  mechanism
dependent on the activation of JAK/STAT-1 signal transduction pathway [142].
Taken together, these findings show that NO is an important regulator of neurogenesis. The
effect of NO on neurogenesis seems to be dependent on the developmental period and of the
source of NO. Furthermore, depending on the local concentration and surrounding molecular
Neural Stem Cells - New Perspectives172
environment NO may regulate neurogenesis in various ways, either favoring it, or impairing
it [136,143,144]. As discussed above, NO has concentration-dependent effects. Thus, under
physiological conditions NO acts as a negative regulator of neurogenesis [4,5,107], whereas in
inflammatory conditions a decrease in nNOS and an increase in iNOS can act as a mechanism
to enhance neurogenesis [12,13,134,145,146]. However, the exact molecular mechanisms
underlying this dual effect are not fully understood and more studies are needed to determine
the downstream targets of NO, particularly to identify potential therapeutic targets and to
assess whether modulation of these players is possible to improve the outcome of neurogen‐
esis. Most of the drugs used in studies for the characterization of NO involvement in neuro‐
genesis are therapeutically used with other purposes unrelated to brain injury recovery. So,
its implementation as a therapeutic strategy to modulate neurogenesis should be explored.
Next, some of the most promising pharmacological approaches intended to modulate signal‐
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- 0 = 0 0 0 (PI3-K)/Akt pathway [9,134]
0 - 0 - 0 0 PSA-NCAM and CREB [147]
0 - 0 - 0 - cAMP phosphorylation [6]
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+ 0 + 0 0 0 BDNF and VEGF [148]
0 + 0 + 0 = VEGF [111]
iNOS
+ 0 0 0 = 0
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cGMP/PKG pathway [14]
+ + + + 0 = NMDA receptor [62,149,150]
+ + + + 0 0 L-VGCC [151]
+ 0 +* 0 = 0 JAK/STAT-1 pathway [142]
The effects listed in Table II may not be direct. +, increase; -, decrease; =, not changed; 0, not reported; Polysialylated-
neuronal cell adhesion molecule, PSA-NCAM; cAMP response element-binding, CREB; Brain-derived neurotrophic factor,
BDNF; Vascular endothelial growth factor, VEGF; L-type voltage-gated Ca2+ channel, L-VGCC. * - astrogliogenesis.
Table 2. NO-dependent modulation of adult neurogenesis.
6. The nitric oxide system as a target to enhance endogenous neurogenesis
In physiological conditions, damaged cells and tissues are continuously being repaired in order
to maintain homeostasis and normal function of the organism. A deregulation or malfunction
of self-repair mechanisms could lead to the emergence of several pathologies as referred in
sections 3 and 4. In the adult CNS, the major limitation that researchers face is the restricted
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ability for regeneration. Moreover, this process is even more limited during an inflammatory
process as the surrounding environment is detrimental to the survival of newborn cells [43].
Acute brain lesions, such as stroke, spinal cord injury, trauma and seizures, which are
accompanied by an inflammatory response, have a strong participation on neuronal loss [43].
Neuroinflammation is also a hallmark of chronic pathologies, such as Alzheimer’s disease,
Huntington’s disease and Parkinson’s disease [31]. Thus, to overcome the limited ability for
brain repair and as an attempt to revert the loss of neurons following inflammation, some
strategies have been studied. The most promising strategies include a) stimulation of endog‐
enous neurogenesis, or b) transplantation of exogenous neural precursors/stem cells. Trans‐
plantation of exogenous stem cells is a complex approach with several disadvantages including
ethical concerns. Furthermore, the risk of rejection and uncontrolled proliferation of grafted
cells, which may lead to tumor formation, raises some concerns about its therapeutic applic‐
ability. However, although the potentiation of endogenous neurogenesis appears to be a better
approach, with higher possibility for therapeutic application, some disadvantages/limitations
should be taken into account, such as: a) low yield in the formation of new neurons, b) low
rate of long-term survival of new neurons, and c) poor specificity for increasing neurogenesis
in the target/lesioned tissue. Here we focus on the stimulation of endogenous neurogenesis by
targeting the pre-existing pools of NSC, particularly in SVZ and SGZ niches, mainly by
modulating the nitrergic pathways.
As discussed in section 5.2, NO has been widely described as a dual regulator of adult
neurogenesis, being involved in the regulation of proliferation, migration, neuronal differen‐
tiation and survival of NSC (see Table II). The great majority of studies in the literature
characterized the involvement of NO in the regulation of NSC proliferation. In fact, as reported
by our group, NO from inflammatory origin has a proliferative effect in the SVZ and SGZ [13].
However, more studies about the involvement of NO in the regulation of migration, differen‐
tiation in functional neurons that must correctly integrate neuronal circuits and survival of the
newly formed neurons must be performed in order to understand how these neurogenic steps
are regulated in an inflammatory context. Although little is known about the in vivo applica‐
bility of this strategy, recent encouraging evidences are already in the literature where the
pharmacological modulation of different players in the nitrergic system has been proved to
promote neurogenesis. However, we believe that this approach in a regenerative context
should not be considered as an isolated approach, but instead, it could be adjuvant to other
strategies in order to ensure an efficacious therapy. Therefore, two different strategies should
be considered to enhance neurogenesis: a) controlled increase in NO levels by using NO
donors, particularly NO-NSAID and, b) prevention of cGMP degradation by the use of PDE5
inhibitors. Next, these therapeutic approaches for brain repair will be discussed.
6.1. Nitric oxide-releasing non-steroidal anti-inflammatory drugs
NO-releasing drugs have been widely used in several studies for the characterization of the
involvement of NO in the regulation of different steps of endogenous neurogenesis. These
pharmacological tools were essential to understand that NO-mediated effects on neurogenesis
are time and concentration-dependent [14,142]. A wide variety of NO-releasing compounds
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are available, being the most common the diazeniumdiolates, also referred as NONOates (such
as DEA/NO, SPER/NO or DETA/NO), that spontaneously release NO under physiological
conditions [152]. NONOates were also used in numerous studies to investigate the effect of
supraphysiological concentrations of NO on neurogenesis, thus mimicking high NO concen‐
tration achieved in the brain in inflammatory conditions [13,142]. However, NO-releasing
drugs are chemically distinct, having different half-life times, releasing different amounts of
NO in vitro. The major disadvantages of the use of these drugs lie in the inability to control the
amount of NO released in vivo, and the incapacity to specifically release NO in the target tissue/
cells. Moreover, factors such as pH, temperature, some co-factors and light, are able to alter
the release of NO by these compounds [152,153]. As described above, given that different
amounts of NO have different effects on neurogenesis, it is essential to control the release of
NO in order to keep it in levels that are beneficial to neurogenesis. Thus, it arises the need to
develop new NO-releasing drugs in order to overcome these disadvantages.
More recently, a new class of NO-releasing compounds has been developed, NO-NSAID.
These drugs are synthesized by adding a nitric oxide donating group to classical NSAID.
Conventional NSAID are broad-spectrum compounds used worldwide due to their properties
as analgesics, antipyretics and, at higher doses, anti-inflammatory. However, chronic use of
NSAID is limited, mainly due to increased side effects in the gastrointestinal (GI) tract,
cardiovascular system and kidneys (extensively reviewed by [154-156]). Traditional NSAID
exert their effect by inhibiting both isoforms of cyclooxygenase enzyme (COX-1 and COX-2),
thus blocking the synthesis of prostaglandins. The great majority of side effects associated to
the use of these drugs are associated with the inhibition of COX-1 pathway, and subsequent
decrease in gastroprotective prostaglandins.
To overcome these side effects and improve safety of NSAID, new drugs were designed
a) coxibs, selective COX-2 inhibitors, and b) hybrid prodrugs, which include NO-NSAID.
The latter drugs take advantage of some characteristics of NO such as its potent vasodila‐
tor effect, inhibition of leukocyte adherence to the gastric vascular endothelium and inhib‐
ition of caspase activity, thus mimicking the biological effects of prostaglandins in the GI
tract [19,157,158]. Several in vivo studies have shown that NO released by NO-NSAID has
a reduced GI toxicity profile compared to NSAID alone, without affecting the anti-inflam‐
matory effectiveness [159-161]. In fact, low levels of conventional NO donors were shown
to inhibit cell apoptosis in vivo by inhibiting caspase activity and, thus, sparing the gastric
mucosa from the pro-apoptotic  effect  induced by TNF-alpha,  an effect  that  seems to be
dependent on cGMP formation [161-164]. In addition, NO released by NO-NSAID inacti‐
vates caspases,  contributing to the gastric-sparing effect  of  these drugs.  Moreover,  these
NO-donating drugs release NO in amounts that mimics in vivo NO production by constit‐
utive NOS, which seems to be linked to a reduced toxicity when compared to the parent
NSAID [19,165]. In addition, the relatively slow rate of NO release by NO-NSAID when
compared to classic NO donors, such as sodium nitroprusside (SNP) [166], allows a more
controlled release of NO and a long-lasting protective effect, which should be considered
a major advantage in the use of these drugs. Since there is no massive burst in NO levels,
excitotoxic events are prevented when compared to classical drugs.
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vates caspases,  contributing to the gastric-sparing effect  of  these drugs.  Moreover,  these
NO-donating drugs release NO in amounts that mimics in vivo NO production by constit‐
utive NOS, which seems to be linked to a reduced toxicity when compared to the parent
NSAID [19,165]. In addition, the relatively slow rate of NO release by NO-NSAID when
compared to classic NO donors, such as sodium nitroprusside (SNP) [166], allows a more
controlled release of NO and a long-lasting protective effect, which should be considered
a major advantage in the use of these drugs. Since there is no massive burst in NO levels,
excitotoxic events are prevented when compared to classical drugs.
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Chronic inflammatory events were linked to Alzheimer’s disease, where several pro-inflam‐
matory mediators are released, such as the cytokines IL-1beta and TNF-alpha [167], and
caspase enzymes are activated [168]. Chronic administration of NSAID appears to reduce the
risk for developing Alzheimer’s disease [169-172], also ameliorating impairment of cognitive
functions in patients (reviewed in [173]). Other studies have been performed to study the effect
of anti-inflammatory drugs in the treatment of acute brain lesions, such as status epilepticus and
ischemia. In this context, anti-inflammatory drugs, such as indomethacin, have been described
to reduce microglial activation and to promote NSC proliferation and improve migration and
survival of newborn cells, thus restoring neurogenesis following cranial irradiation or focal
ischemia [49,174]. Therefore, although the neuroprotective effects of NSAID in models of
chronic brain inflammation have been recently described in the literature, the side effects of
NSAID in other biological systems should not be ignored. Given the advantages of NO-NSAID,
and given their ability to rapidly cross the blood-brain barrier (BBB) [175], NO-NSAID have
been considered for the treatment of CNS disorders, particularly for the control of neuroin‐
flammation that, as already discussed, may affect neurogenesis [165]. However, to date, little
is known about the effect of NO-NSAID on neurogenesis following acute or chronic brain
injury. Nevertheless, studies in models of chronic brain inflammation showed that chronic
administration of NO-flurbiprofen significantly attenuated brain inflammation by decreasing
the density and reactive state of microglial cells [176,177]. In this study, treatment with NO-
flurbiprofen reduced brain inflammation and attenuated the effects of LPS-activated microglia
in young and adult rats, but not in aged rats, which suggested this drug to be a possible
therapeutic tool to be used in the onset of Alzheimer’s disease, before the development of
chronic inflammatory events associated with age [178]. Besides the reports that NSAID
decrease the expression of iNOS in inflammatory cells, NO-flurbiprofen appears to upregulate
the expression of this enzyme in LPS-activated microglial cells [179]. This effect leads to an
even higher increase in NO production, which has been attributed to NO released from NO-
flurbiprofen, since traditional NO donors lead to similar results. Interestingly, the activation
of microglial iNOS following a brain insult enhances NSC proliferation in the SGZ following
epileptic seizures, thus promoting neurogenesis [13].
Overall, the beneficial effects of NO-NSAID observed in experimental models of neurodege‐
nerative diseases are encouraging for the development of strategies to control neuroinflam‐
mation and target endogenous neurogenesis by using these drugs [165]. However, further
studies need to be conducted in order to understand the mechanisms and within which
concentrations NO-derived from NO-NSAID may promote neurogenesis.
6.2. Phosphodiesterase 5 inhibitors
The main intracellular target of NO is the heme-containing enzyme sGC. Activation of sGC
leads to an increased production of cGMP [102,180], which subsequently activates cGMP-de‐
pendent PKG [181,182]. PKG regulates various physiological events, such as synaptic plastici‐
ty  or  synthesis  and  release  of  neurotransmitters  (reviewed  by  [183]).  In  physiological
conditions, intracellular cGMP levels are controlled through cyclic nucleotide phosphodiester‐
ases (PDE), enzymes that hydrolyze the 3’-phosphodiester bound of cyclic AMP (cAMP) or
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cGMP, originating their respective inactive monophosphates, 5’-AMP or 5’-GMP. PDE are
ubiquitous enzymes classified in 11 families by their different substrate specificity, kinetic
properties and cellular and subcellular distribution (extensively reviewed in [184]). As differ‐
ent PDE families present such a wide distribution among the tissues, including the brain, inhib‐
ition of one or more PDE has been studied as an approach for the treatment of several diseases,
mainly by controlling the levels of the respective second messengers cAMP and/or cGMP.
cGMP-dependent physiological functions, may be regulated by controlling PDE type 5
isoenzyme activity, which specifically hydrolyzes cGMP. Thus, a good strategy to increase
intracellular levels of cGMP may be through inhibition of this enzyme [185]. PDE5 is a widely
expressed cytosolic enzyme, whose protein activity was found in the lung, vascular and
tracheal smooth muscle, spleen, platelets, corpus cavernosum [186-188], being also highly
present in several brain regions, including Purkinje cells and SVZ [189-191]. PDE5 and PDE5
inhibition have been extensively studied in the last decades and several PDE5 inhibitors have
been developed. The most characterized PDE5 inhibitor is sildenafil, commercially available
as Viagra, a drug used for the treatment of erectile dysfunction and pulmonary arterial
hypertension. However, besides PDE5, sildenafil also inhibits PDE 1 and 6 with lower potency
[192]. In order to overcome this issue, more selective PDE5 inhibitors were developed for the
treatment of erectile dysfunction: vardenafil (Levitra), tadalafil (Cialis) and, more recently,
avanafil (Stendra). In addition, a new compound with even higher selectivity for PDE5 was
also developed, T0156 [193].
The decrease in cGMP levels appears to be one of the causes for the decreased neurogenesis in
aging, which normally correlates with the development of neurodegenerative diseases [194].
Although neurogenesis is increased in early stages of neurodegenerative diseases, as a compen‐
satory mechanism, the more advanced or severe stages are characterized by impairment of neu‐
rogenesis [195]. In the aged brain, there is a decrease in NO levels with a concomitant decline in
cGMP levels, ultimately resulting in the abolishment of cell proliferation and impairments in
learning and memory [194]. Targeting an enzyme specific for the hydrolysis of cGMP, such as
PDE5, has been proven to be a good strategy to reverse this process and, thus, enhance neuro‐
genesis following acute or chronic brain insults. In fact, PDE5 inhibitors are known to modu‐
late several functions in the adult brain. Several reports showed that PDE5 inhibitors, such as
sildenafil, have a neuroprotective role, by improving memory and learning [20,196-201]. Be‐
yond the important role in memory and cognition, PDE5 inhibitors could also be used to target
endogenous neurogenesis in the adult brain. In neurodegenerative diseases such as Alzheim‐
er’s disease, the progressive neurodegeneration results in cognitive dysfunction, with memory
loss and motoneural impairment. The administration of PDE5 inhibitors has been studied as a
possible therapy for this disease, due to their ability to reverse long-term memory deficits
[202,203]. Sildenafil has also been described to improve symptoms of multiple sclerosis [22],
while chronic administration of sildenafil or tadalafil appears to have an anxiolytic effect [204].
Moreover, following an acute injury, PDE5 inhibitors are described to enhance endogenous
neurogenesis and neuronal function recovery in models of ischemic injury or stroke [205-208].
In addition, sildenafil was shown to stimulate SVZ-derived NSC proliferation, an effect that ap‐
pears to be dependent on the activation of the PI3-K/Akt pathway [191].
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sildenafil, have a neuroprotective role, by improving memory and learning [20,196-201]. Be‐
yond the important role in memory and cognition, PDE5 inhibitors could also be used to target
endogenous neurogenesis in the adult brain. In neurodegenerative diseases such as Alzheim‐
er’s disease, the progressive neurodegeneration results in cognitive dysfunction, with memory
loss and motoneural impairment. The administration of PDE5 inhibitors has been studied as a
possible therapy for this disease, due to their ability to reverse long-term memory deficits
[202,203]. Sildenafil has also been described to improve symptoms of multiple sclerosis [22],
while chronic administration of sildenafil or tadalafil appears to have an anxiolytic effect [204].
Moreover, following an acute injury, PDE5 inhibitors are described to enhance endogenous
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pears to be dependent on the activation of the PI3-K/Akt pathway [191].
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Overall, apart from small differences in the selectivity for PDE5, the majority of PDE5 inhibitors
present similar effects in increasing cGMP levels and subsequent activation of nitrergic
pathways. In spite of the fact that inhibition of PDE5 does not have an anti-inflammatory effect
as NO-NSAID, the neuroprotective effect of PDE5 inhibitors appears to be consensual.
However, in the CNS, the effect of PDE5 inhibitors is highly dependent on their permeability
to the BBB, and more studies need to be conducted in order to correctly characterize the kinetics
on PDE5 inhibitors permeabilization into the CNS. Within this background, the modulation
of PDE5 activity could be a good approach to control the levels of cGMP, which could be used
in the treatment of several pathologies in which the levels of cGMP are altered. Although there
are some studies focused on the stimulation of neurogenesis, the use of inhibitors for PDE5
deserves further investigation in order to clarify their role in controlling different stages of
neurogenesis, including migration, differentiation, functionality and survival of newborn
neurons, and further understand the mechanisms underlying these effects.
6.3. Other strategies
The involvement of NO in a wide-range of physiological processes and cell function makes it
a desirable molecule to use in the clinics, being a major target of pharmaceutical industry.
Besides the strategies mentioned above, many synthetic compounds with various chemical
and biological modifications have been developed in order to overcome some limiting factors
of NO such as its short half-life, the instability during storage and its potential toxicity. Thus,
recent innovations in the field of nanotechnology of the profile of NO-donating drugs are being
tested to increase the utility and the safety of these compounds in order to be used in biomedical
applications, as described below.
There is a wide variety of NO donors that are capable of releasing NO spontaneously or in a
controlled way to certain target tissues. The great challenge is how to release NO and to achieve
an optimal concentration locally in the brain, thus promoting a therapeutic effect with
minimum toxicity [209]. Recent investigations aim at incorporating NO donors into biopoly‐
mers mimicking endogenous production of NO at target sites [202]. Nanomaterials are
delivery systems with many advantages and a promising therapeutic applicability. These new
systems are advantageous due to their: a) small size; b) ability to target specific tissues or cells,
having the capacity to cross several biological barriers, such as BBB, reaching tissues that are
inaccessible to classic drugs; c) ability to accumulate high drug concentrations; d) enhancement
of bioavailability and drug solubility; e) facilitation of drug administration; f) increase of drug
circulation in the blood; g) reduction of the dose required to exert an efficient therapeutic effect;
and e) decreased local toxicity and reduction of side effects (reviewed by [203]).
The application of nanomaterials to classic NO donors may be an alternative to improve their
stability and to therapeutically deliver NO. Among the most studied nanosystems are
liposomes and polymeric nanocarriers, such as micelles and hydrogels. Overall, this emergent
field of study is of great interest since it allows the development of compounds that release
NO in a controlled and sustained way. However, there is a lack of studies concerning the
application of these strategies to the CNS. To date, none of these nanosystems is commercially
available to target/improve endogenous neurogenesis and further studies are needed in order
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to develop effective NO-releasing drugs. By these strategies, NO levels in certain targets can
be regulated overcoming the traditional limitations of classical NO donors, thus allowing the
control of NO levels in specific regions of adult brain in an attempt to repair the lesioned brain.
7. Future directions
Most brain disorders have common features such as neurodegeneration and neuroinflamma‐
tion. Understanding the mechanisms underlying the evolution of these pathologies, the factors
that lead to their onset and the biology of neuronal injury is of extreme importance for the
development of efficient therapies, thus allowing to act on risk groups in order to prevent their
occurrence. Neurogenesis is an important mechanism of repair in the adult brain, being
considered as a critical target to counteract the loss of neurons. As discussed above, two
promising strategies could be considered to improve neurogenesis, which include a) trans‐
plantation of exogenous neural precursors/stem cells, or b) stimulation of endogenous
neurogenesis. However, both strategies for increasing neurogenesis have been linked to an
inflammatory response.
Transplantation of exogenous stem cells is a complex and invasive approach with several
disadvantages, raising questions about its therapeutic applicability, such as: a) uncontrolled
proliferation of grafted cells that may lead to tumor formation, b) the risk of rejection, and c)
ethical concerns. However, potentiation of endogenous neurogenesis appears to be a better
approach, although with some disadvantages/limitations, such as: a) low yield in the formation
of new brain cells, b) low rate of long-term survival of newly generated neurons, and c) poor
specificity for increasing local neurogenesis in the target/lesioned tissue. Overall, stimulation
of endogenous neurogenesis appears to have higher possibilities for a therapeutic application
although it is a less efficient strategy, it has been considered a safer approach when compared
to the invasive transplantation of exogenous precursor/stem cells.
Knowing how the inflammatory response affects neurogenesis and the factors that are altered
following brain lesion will allow the modulation of certain signaling pathways involved in the
regulation of neurogenesis. In fact, the modulation of the nitrergic system could be beneficial
for controlling neurogenesis following brain inflammation.
Nitric oxide, by its importance as a regulator of neurogenesis, appears as potential target for
the enhancement of endogenous neurogenesis, thus, the development of selective drugs for
modulation of the nitrergic signaling pathways is an increasing challenge to pharmaceutical
companies. Currently, many strategies are under study for the treatment of CNS disorders,
some of them targeting the nitrergic system. The development of NO-NSAID is of great interest
as it combines the anti-inflammatory effect to the release of NO, thus reducing the deleterious
effects of neuroinflammation and, simultaneously, taking advantage of the pro-neurogenic
effect of NO [165]. Moreover, PDE5 inhibitors also seem to be a good strategy to improve
neurogenesis, although they lack an anti-inflammatory effect when compared to NO-NSAID
[210]. Although little is known about the applicability of this strategy in a regenerative context,
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The application of nanomaterials to classic NO donors may be an alternative to improve their
stability and to therapeutically deliver NO. Among the most studied nanosystems are
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development of efficient therapies, thus allowing to act on risk groups in order to prevent their
occurrence. Neurogenesis is an important mechanism of repair in the adult brain, being
considered as a critical target to counteract the loss of neurons. As discussed above, two
promising strategies could be considered to improve neurogenesis, which include a) trans‐
plantation of exogenous neural precursors/stem cells, or b) stimulation of endogenous
neurogenesis. However, both strategies for increasing neurogenesis have been linked to an
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Transplantation of exogenous stem cells is a complex and invasive approach with several
disadvantages, raising questions about its therapeutic applicability, such as: a) uncontrolled
proliferation of grafted cells that may lead to tumor formation, b) the risk of rejection, and c)
ethical concerns. However, potentiation of endogenous neurogenesis appears to be a better
approach, although with some disadvantages/limitations, such as: a) low yield in the formation
of new brain cells, b) low rate of long-term survival of newly generated neurons, and c) poor
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of endogenous neurogenesis appears to have higher possibilities for a therapeutic application
although it is a less efficient strategy, it has been considered a safer approach when compared
to the invasive transplantation of exogenous precursor/stem cells.
Knowing how the inflammatory response affects neurogenesis and the factors that are altered
following brain lesion will allow the modulation of certain signaling pathways involved in the
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for controlling neurogenesis following brain inflammation.
Nitric oxide, by its importance as a regulator of neurogenesis, appears as potential target for
the enhancement of endogenous neurogenesis, thus, the development of selective drugs for
modulation of the nitrergic signaling pathways is an increasing challenge to pharmaceutical
companies. Currently, many strategies are under study for the treatment of CNS disorders,
some of them targeting the nitrergic system. The development of NO-NSAID is of great interest
as it combines the anti-inflammatory effect to the release of NO, thus reducing the deleterious
effects of neuroinflammation and, simultaneously, taking advantage of the pro-neurogenic
effect of NO [165]. Moreover, PDE5 inhibitors also seem to be a good strategy to improve
neurogenesis, although they lack an anti-inflammatory effect when compared to NO-NSAID
[210]. Although little is known about the applicability of this strategy in a regenerative context,
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recent encouraging evidences support that NO-NSAID and PDE5 inhibitors should be
considered as therapeutic strategies to enhance neurogenesis as discussed in this chapter.
In spite of all the evidences showing the important role of the nitrergic system in the modula‐
tion of neurogenesis, further studies are needed. In fact, more studies regarding the regulation
of migration, differentiation in functional neurons and survival of the newly generated cells
must be performed in order to fully understand how these neurogenic events are regulated in
an inflammatory context, given the large number of molecular players involved besides NO.
Modulation of the nitrergic pathways in a regenerative context should be considered, not as an
isolated approach, but instead, as an adjuvant strategy in order to ensure an efficacious therapy.
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recent encouraging evidences support that NO-NSAID and PDE5 inhibitors should be
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tion of neurogenesis, further studies are needed. In fact, more studies regarding the regulation
of migration, differentiation in functional neurons and survival of the newly generated cells
must be performed in order to fully understand how these neurogenic events are regulated in
an inflammatory context, given the large number of molecular players involved besides NO.
Modulation of the nitrergic pathways in a regenerative context should be considered, not as an
isolated approach, but instead, as an adjuvant strategy in order to ensure an efficacious therapy.
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1. Introduction
The vasculature has been identified as a prominent feature across several stem cell niches,
suggesting a crucial role in their regulation and maintenance. While a critical component of
every organ and tissue, it has adopted specific features for specialized microenvironments.
Most notably, the subventricular (SVZ) and subgranular (SGZ) zones of the adult brain harbor
unique vascular plexi that are finely tuned to support neural stem cell (NSC) function and
behavior. Whether it is through direct contact with, and paracrine signaling from, endothelial
and mural cells that comprise blood vessels, or systemically via distribution of soluble factors
from the circulation, the vasculature serves as a multifaceted stem cell niche regulator. As
emerging evidence continues to emphasize the importance of vascular and nervous system
interdependency, it is clear that the vascular compartment in the neural stem cell niche is
uniquely poised to coordinate responses of both systems to ensure proper maintenance and
regeneration, as needed.
2. Vascular composition and function in the brain
2.1. Brain vascular endothelium
The vasculature is a critical component of every organ and tissue, and has the remarka‐
ble ability to integrate systemic signals and directly regulate the local microenvironment.
In  general,  the  vasculature  provides  nutrients  and  protection;  however,  it  has  adopted
specialized  features  for  specialized  microenvironments.  Accordingly,  not  only  does  the
composition of  blood vessels  vary (e.g.  smooth muscle  cell  and pericyte  coverage,  peri‐
vascular  cell  recruitment,  extracellular  matrix  (ECM)  deposition),  but  heterogeneity
among the endothelium itself is recognized. Indeed, this endothelial cell (EC) heterogene‐
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ity  may  be  at  the  heart  of  their  vast  regulatory  potential,  allowing  control  of  multiple
processes.  These include,  but are not limited to,  angiogenesis,  microvascular permeabili‐
ty,  vessel  wall  tone,  coagulation and anticoagulation,  blood cell  generation and traffick‐
ing, inflammation, and microenvironment regulation [1-3].  From a functional standpoint,
the endothelium displays an incredible division of labor, where a spectrum of responses,
both to internal and external stimuli,  is  carried out.  Thus, heterogeneity among the vas‐
cular endothelium is a core property bestowing vast regulatory potential [4].
Within the brain, capillaries are tightly integrated within the neural parenchyma. As arterioles
traverse deeper into the brain, they become progressively smaller and lose portions of their
smooth muscle layer, and are thus termed cerebral capillaries [5]. These capillaries are tubes
of EC that are variably surrounded by pericytes or pericyte processes, astrocytes, neurons, and
ECM. This minimal composition of capillaries allows for a unique interface that facilitates
communication with the underlying tissue environment. Distribution of cerebral capillaries
within the brain is relatively heterogeneous, due to regional differences in blood flow and
metabolic demand. Owing to their thin walls and slow rate of blood flow, capillaries are
engineered to minimize diffusion path length and optimize diffusion time [2]. Surprisingly,
the average luminal diameter is ~4.8 µm [6], a length that is somewhat smaller than the
diameter of an erythrocyte, requiring red blood cells to deform slightly as they progress
through these vessels.
The brain endothelium is characterized by unique features that allow it to selectively control
permeability between blood and the central nervous system, which manifests as the blood-
brain-barrier (BBB). Specifically, this endothelium is discontinuous and nonfenestrated, with
few caveolae at the luminal surface and large numbers of mitochondria [7]. The barrier function
is mediated by both a physical barrier, owing to high expression of tight interendothelial
junctions, and a highly selective transport system. Interestingly, the basal lamina in capillary
beds is common with that of perivascular astrocytic endfeet and pericytes, allowing direct
contact of neural cells with the underlying endothelium [8]. These capillary EC are ~0.1 µm
thick, giving them a cell volume of only ~20µL/cm3, cumulatively amounting to just 0.2% of
the volume of the entire brain [9]. As the demand for energy must be matched by nutrient
supply, the remarkable thinness and surface area of these EC allows for quick, selective, and
efficient transport across endothelial membranes.
3. Development and vascularization of the brain
3.1. Embryonic brain development
The initial steps of central nervous system (CNS) development occur prior to gastrulation,
beginning with neural plate induction from ectoderm [10]. The neural plate is then patterned
along its anterioposterior (AP) and dorsoventral (DV) axes in a dose-dependent fashion, where
gradients of secreted morphogens specify distinct neural fates by inducing expression of
region-specific transcription factors. It has been reported that fibroblast growth factor (FGF),
retinioic acid, and secreted Wnt family members determine AP polarity, while bone morpho‐
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genetic proteins (BMPs) and members of the Hedgehog family control mediolateral polarity
[11-18]. As the neural tube fuses from the neural plate, the neuroepithelium begins to undergo
a complex series of morphological transformations, and begins expressing proteins such as
vimentin and nestin, thus marking the first appearance of radial glia in the cerebral cortex [19].
The appearance of projection neurons, originating from the neuroepithelium between E8.5 and
E10, is followed closely by the onset of neurogenesis at E11 [20].
In the early stages of embryonic neurogenesis (E11-E13), the first mitotic cortical neurons leave
the VZ to form the preplate via interkinetic nuclear migration, independent of radial fibers,
creating an intermediate zone (IZ) where postmitotic neurons accumulate to commence
differentiation [21]. Subsequently generated neurons continue to leave the VZ and enter the
preplate to form the CP (E13-18), further subdividing this region into the subplate and marginal
zone (MZ), where the latter becomes lamina I, the most superficial layer of the brain [22]. At
this same time, SVZ progenitors generated in the VZ divide and expand the progenitor pool.
Excluding layer I, subsequent development is said to occur in an “inside-out” manner, where
earlier-born neurons reside in the deeper layers (V, VI), and later-born neurons occupy the
more superficial layers (II,III) [23].
Between E11 and E18, neurons proceed radially from the ventricular zone (VZ) to the CP, while
interneurons originating from the ganglionic eminence migrate tangentially, traveling
perpendicular to radial fibers and parallel to the pial surface [24]. As these neurons reach their
final destination, migration ceases, detachment from radial glia occurs, and differentiation
begins. Cell lineage studies have revealed that proliferative progenitors of the neural epithe‐
lium are for the most part multipotent up until their final mitosis [25-30]. However, committed
progenitors appear to be an exception, as their existence in secondary proliferative zones, such
as the SVZ and other regions in the adult, have been documented to give rise to various
neuronal subtypes, astrocytes, and glia [31, 32].
3.2. Vascularization of the brain
The brain, in general, has a specialized vasculature relative to other organs, and there are
specialized microenvironments within the brain that exhibit distinct characteristics and
functions. For example, it has been proposed that a unique vascular plexus exists in neurogenic
regions of the brain, both during embryonic and adult neurogenesis [33-35], where EC-NSC
interactions aid in stem cell maintenance while promoting cell division and NSC expansion
[36, 37]. How then, does the vasculature become specialized to fulfill such distinct roles, even
within the same tissue?
During early stages of embryonic brain development, the perivascular neural plexus (PVNP)
forms around the neural tube at E8.5-E10, from anterior to posterior, yet does not invade the
neural tissue until later in development [38]. During E10-E11, the periventricular vascular
network advances into the dorsal telencephalon, and by E11 forms a lattice shaped plexus.
However, a distinct vascular plexus of periventricular vessels appears in the ventral telence‐
phalon at E9, and by E13 EC invasion into the ventricular zone (VZ) and subventricular zone
(SVZ) has generated radially oriented capillaries that extend towards the cortical plate (CP),
eventually joining the pial vasculature [39, 40].
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Recently, the identification of distinct vascular origins within the developing brain [41]
suggests that specialized features of vascular beds of adult germinal regions may begin during
embryonic development and persist into adolescence. Previously, the long-standing model of
CNS angiogenesis suggested that pial vessels, originating from the perineural plexus sur‐
rounding the neural tube, passively sprout into the brain parenchyma and extend radial
branches toward the ventricles, where the neurogenic VZ and SVZ are established. Upon
arrival to the periventricular area, these pial vessels were thought to form new branches,
reverse direction to grow towards the pial surface, and ultimately branch into plexuses [42-44].
However, recent studies suggest that pial and periventricular vessels not only have distinct
origins, but develop along independent schedules. In fact, periventricular vessels in the ventral
telencephalon are thought to originate from a basal vessel, most likely arising from pharangeal
arch arteries [42, 45], situated on the floor of the telencephalic vesicle within the basal ganglia
primoridum. As early as E9, pial vessels are observed to encircle the telencephalon, while a
spatially distinct population of periventricular vessels is restricted to the ventral telencephalon.
From E9-E10, the basal vessel matures to produce periventricular branches in a ventral-to-
dorsal and lateral-medial direction, eventually giving rise to a vascular lattice in the dorsal
telencephalon. As narrow branches from the periventricular and pial networks fuse, the first
arterial-venous communication is thought to occur, as early reports suggest venous sinuses
and arterial networks develop from pial and periventricular vessels, respectively [41, 45]. At
E15, the first tangential vessels to the pial surface emerge in the intermediate zone, and by E16,
these vessels appear in the presumptive rostral migratory stream (RMS). By E18, extensive
vascular remodeling has taken place, and the ventricular plexus loses much of its definition.
However, upon reaching postnatal ages and adulthood, blood vessels begin to align them‐
selves longitudinally and parallel to each other in the direction of the RMS, presenting a more
homogeneous structure [35, 40].
Interestingly, the periventricular vascular network is present in the telencephalon prior to the
formation of neuronal networks and before the appearance of radial units and striosome-
matrix compartments in the dorsal and ventral telencephalon, respectively. Thus, the peri‐
ventricular network is temporally and spatially poised to influence neural maturation, as well
as guide tangential migration in the developing brain [41]. A similar vascular niche for NSC
has been reported to exist in the adult SVZ and SGZ, and may have been established early
during embryonic brain development. This suggests that the vasculature may be critical in
promoting and regulating neural development.
3.3. Establishment of neurogenic regions of the brain
During brain development, three different NSPC types make their appearance in a tightly
coordinated spatiotemporal manner, seeding the brain with committed progenitors that
differentiate into the various cell types of the mature brain. The first of these to appear are
pseudostratified epithelial cells termed radial glia, regarded as the bona fide NSC in the
embryonic VZ [46, 47]. Morphological studies have identified two processes emanating from
their cell bodies, suggesting an inherent bipolar nature. A short and thick apical process
directed towards the ventricle is thought to anchor radial glia, while a longer basal radial fiber
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projects towards the basement membrane of the pia mater, acting as a scaffold for prospective
neuronal migration [21, 48]. These radial fibers are often observed to contact blood vessels and
exhibit multiple branched endfeet at the pial surface [49]. Interestingly, their apical regions are
typically folded and contain a single cilium [50, 51], reminiscent of the proposed location,
structural morphology, and vascular contacts of adult NSC in the SVZ.
During the early stages of cortical development, the cerebral cortex is composed almost
exclusively of proliferative radial glia dividing at the ventricular surface in the VZ [52]. As
proliferating radial glia progress through the cell cycle, they undergo interkinetic nuclear
migration, where the nucleus migrates away from the ventricle during G1 phase, and enters
S phase at the top of the VZ. Upon return through the VZ to the ventricular surface, they
proceed through G2 phase and M-phase, respectively [19, 52-54]. A switch from symmetric
self-renewing to asymmetric neurogenic divisions occurs as development proceeds, leading
to pairs of daughter cells with distinct progenitor or early neuronal fates; symmetric divisions
have also occasionally been observed to produce early neurons or intermediate progenitor
cells (IPC) [19, 23, 49]. However, during peak neurogenesis, radial glia give rise to one radial
glial cell, and either one post-mitotic neuron or a neuronally committed IPC [49, 55]. Similarly
in adult neurogenesis, adult NSC asymmetrically divide to generate transit-amplifying cells
that produce committed progenitors. In both cases, regulation of the symmetry of cell division
is critical, and ultimately controls cerebral cortical size during brain development [52].
At the onset of neurogenesis, radial glia progeny migrate away from the ventricle and begin
to establish the first layers of the developing brain, separate from the VZ. IPC establish the
SVZ as a distinct proliferative region, while young cortical neurons migrate to a superficial
position to establish the cortical plate [48]. These migrating cortical neurons are intimately
associated with the long pial fiber of radial glia, utilizing it to traverse relatively long distances
to the overlying cortex in a process termed radial migration. Once telophase is complete and
radial glia have entered M-phase, the apical plasma membrane becomes unequally segregated
into the two daughter cells. Interestingly, the apical daughter inherits a larger portion of the
membrane while the basal daughter receives a smaller proportion in addition to the radial
fiber, indicating the latter assumes the stem cell radial glia fate [46, 47, 49, 56]. However, this
is not absolute, as instances of basal daughters becoming post-mitotic and apical daughters
remaining proliferative have been reported. Instead, it has been suggested that fate decisions
involving asymmetric division may also depend on developmental stage [47, 48]. Thus, the
function of radial glia is two-fold, wherein they generate and guide migration of their own
daughter cells [52, 57].
After the VZ reaches its maximal size during midstage cortical neurogenesis, the VZ begins to
shrink while the SVZ begins to expand [57]. Derived from radial glia, IPC are the first cell types
to initially seed the SVZ [48]. While some observations describe the distribution of IPC
throughout the upper VZ and lower intermediate zones [49, 58], they are predominantly
concentrated in the SVZ, where they almost exclusively divide symmetrically to generate
postmitotic daughter neurons [59-62]. In contrast to radial glia, IPC are multipolar, extending
and retracting multiple processes [19, 49]. Additionally, they do not appear to sustain contact
with either the ventricular or pial surfaces, and are in fact defined by their lack of prominent
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Recently, the identification of distinct vascular origins within the developing brain [41]
suggests that specialized features of vascular beds of adult germinal regions may begin during
embryonic development and persist into adolescence. Previously, the long-standing model of
CNS angiogenesis suggested that pial vessels, originating from the perineural plexus sur‐
rounding the neural tube, passively sprout into the brain parenchyma and extend radial
branches toward the ventricles, where the neurogenic VZ and SVZ are established. Upon
arrival to the periventricular area, these pial vessels were thought to form new branches,
reverse direction to grow towards the pial surface, and ultimately branch into plexuses [42-44].
However, recent studies suggest that pial and periventricular vessels not only have distinct
origins, but develop along independent schedules. In fact, periventricular vessels in the ventral
telencephalon are thought to originate from a basal vessel, most likely arising from pharangeal
arch arteries [42, 45], situated on the floor of the telencephalic vesicle within the basal ganglia
primoridum. As early as E9, pial vessels are observed to encircle the telencephalon, while a
spatially distinct population of periventricular vessels is restricted to the ventral telencephalon.
From E9-E10, the basal vessel matures to produce periventricular branches in a ventral-to-
dorsal and lateral-medial direction, eventually giving rise to a vascular lattice in the dorsal
telencephalon. As narrow branches from the periventricular and pial networks fuse, the first
arterial-venous communication is thought to occur, as early reports suggest venous sinuses
and arterial networks develop from pial and periventricular vessels, respectively [41, 45]. At
E15, the first tangential vessels to the pial surface emerge in the intermediate zone, and by E16,
these vessels appear in the presumptive rostral migratory stream (RMS). By E18, extensive
vascular remodeling has taken place, and the ventricular plexus loses much of its definition.
However, upon reaching postnatal ages and adulthood, blood vessels begin to align them‐
selves longitudinally and parallel to each other in the direction of the RMS, presenting a more
homogeneous structure [35, 40].
Interestingly, the periventricular vascular network is present in the telencephalon prior to the
formation of neuronal networks and before the appearance of radial units and striosome-
matrix compartments in the dorsal and ventral telencephalon, respectively. Thus, the peri‐
ventricular network is temporally and spatially poised to influence neural maturation, as well
as guide tangential migration in the developing brain [41]. A similar vascular niche for NSC
has been reported to exist in the adult SVZ and SGZ, and may have been established early
during embryonic brain development. This suggests that the vasculature may be critical in
promoting and regulating neural development.
3.3. Establishment of neurogenic regions of the brain
During brain development, three different NSPC types make their appearance in a tightly
coordinated spatiotemporal manner, seeding the brain with committed progenitors that
differentiate into the various cell types of the mature brain. The first of these to appear are
pseudostratified epithelial cells termed radial glia, regarded as the bona fide NSC in the
embryonic VZ [46, 47]. Morphological studies have identified two processes emanating from
their cell bodies, suggesting an inherent bipolar nature. A short and thick apical process
directed towards the ventricle is thought to anchor radial glia, while a longer basal radial fiber
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projects towards the basement membrane of the pia mater, acting as a scaffold for prospective
neuronal migration [21, 48]. These radial fibers are often observed to contact blood vessels and
exhibit multiple branched endfeet at the pial surface [49]. Interestingly, their apical regions are
typically folded and contain a single cilium [50, 51], reminiscent of the proposed location,
structural morphology, and vascular contacts of adult NSC in the SVZ.
During the early stages of cortical development, the cerebral cortex is composed almost
exclusively of proliferative radial glia dividing at the ventricular surface in the VZ [52]. As
proliferating radial glia progress through the cell cycle, they undergo interkinetic nuclear
migration, where the nucleus migrates away from the ventricle during G1 phase, and enters
S phase at the top of the VZ. Upon return through the VZ to the ventricular surface, they
proceed through G2 phase and M-phase, respectively [19, 52-54]. A switch from symmetric
self-renewing to asymmetric neurogenic divisions occurs as development proceeds, leading
to pairs of daughter cells with distinct progenitor or early neuronal fates; symmetric divisions
have also occasionally been observed to produce early neurons or intermediate progenitor
cells (IPC) [19, 23, 49]. However, during peak neurogenesis, radial glia give rise to one radial
glial cell, and either one post-mitotic neuron or a neuronally committed IPC [49, 55]. Similarly
in adult neurogenesis, adult NSC asymmetrically divide to generate transit-amplifying cells
that produce committed progenitors. In both cases, regulation of the symmetry of cell division
is critical, and ultimately controls cerebral cortical size during brain development [52].
At the onset of neurogenesis, radial glia progeny migrate away from the ventricle and begin
to establish the first layers of the developing brain, separate from the VZ. IPC establish the
SVZ as a distinct proliferative region, while young cortical neurons migrate to a superficial
position to establish the cortical plate [48]. These migrating cortical neurons are intimately
associated with the long pial fiber of radial glia, utilizing it to traverse relatively long distances
to the overlying cortex in a process termed radial migration. Once telophase is complete and
radial glia have entered M-phase, the apical plasma membrane becomes unequally segregated
into the two daughter cells. Interestingly, the apical daughter inherits a larger portion of the
membrane while the basal daughter receives a smaller proportion in addition to the radial
fiber, indicating the latter assumes the stem cell radial glia fate [46, 47, 49, 56]. However, this
is not absolute, as instances of basal daughters becoming post-mitotic and apical daughters
remaining proliferative have been reported. Instead, it has been suggested that fate decisions
involving asymmetric division may also depend on developmental stage [47, 48]. Thus, the
function of radial glia is two-fold, wherein they generate and guide migration of their own
daughter cells [52, 57].
After the VZ reaches its maximal size during midstage cortical neurogenesis, the VZ begins to
shrink while the SVZ begins to expand [57]. Derived from radial glia, IPC are the first cell types
to initially seed the SVZ [48]. While some observations describe the distribution of IPC
throughout the upper VZ and lower intermediate zones [49, 58], they are predominantly
concentrated in the SVZ, where they almost exclusively divide symmetrically to generate
postmitotic daughter neurons [59-62]. In contrast to radial glia, IPC are multipolar, extending
and retracting multiple processes [19, 49]. Additionally, they do not appear to sustain contact
with either the ventricular or pial surfaces, and are in fact defined by their lack of prominent
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apical or basal processes and a basal location relative to the apical surface [52]. While their
contact with neighboring blood vessels has not been confirmed, their appearance in the cortex
seems to follow that of blood vessel invasion in the cortical wall [19]. Furthermore, behavioral
differences between radial glia and IPC have been noted. IP cells progress through the cell
cycle away from the ventricle, and do not undergo interkinetic nuclear migration, thus,
allowing differentiation from radial glia based on spatial location during mitosis [19, 63].
At later stages of cortical development, the SVZ progenitor pool continues to expand via IPC
symmetric divisions. Further aiding in expansion, progenitors from the ventral telencephalon
may even migrate dorsally to contribute to the SVZ progenitor pool [19]. Upon completion of
cortical neurogenesis, radial glia transition into astrocytes and exit the VZ, leaving a single
layer of ependymal cells lining the ventricle [57]. Consequently, proliferative IPC become the
predominant component of the cortical progenitor pool, and eventually comprise the majority
of mitotic progenitors as embryonic neurogenesis nears completion. Interestingly, while only
a single layer of VZ-derived ependymal cells remains postnatally, IPC are present in large
numbers in the postnatal SVZ, and persist into adulthood [19]. Aside from generating cortical
neurons, postnatal and adult progenitors have been demonstrated to generate neurons
destined for the olfactory bulb [49, 58, 64], and possibly all excitatory neurons of the upper
cortical layers [58]. Thus, IPC in the SVZ play a vital role in cortical neurogenesis during
embryonic development as well as in the adult.
Interestingly, a novel progenitor type termed the outer SVZ (OSVZ) progenitor has recently
been identified and appears to exist in all mammals, albeit to varying extents [52]. These
progenitors have a modified radial morphology, but are exclusively localized to the SVZ.
OSVZ cells are enriched in mammals with larger cerebral cortices, and their appearance during
mid-gestation seems to coincide with the onset of neurogenesis [52, 65-69]. OSVZ progenitors
are peculiar in that they possess characteristics reminiscent of both radial glia and IPC. They
display radial morphology and express radial glial markers paired box protein-6 (Pax6),
phospho-vimentin, glial fibrillary acidic protein (GFAP), and brain lipid-binding protein
(BLBP), and also display random cleavage planes, where both proliferative self-renewing
symmetrical divisions and asymmetric divisions producing OSVZ daughter and progenitor
have been reported. However, an apical process is absent in these cells while their basal process
is retained throughout mitosis [65-67].
3.4. Vascular cues during embryonic neurogenesis
It has been suggested that the developing cortical vasculature within the SVZ promotes IPC
expansion during neurogenesis by providing a suitable microenvironment for IPC accumu‐
lation and division [39]. It is noteworthy that brain EC share similar molecular profiles with
their neighboring NSC. For example, ventral and dorsal EC, as well as NSC, express Dlx1/5
and Nkx2.1, and Pax6, respectively, while pial EC are negative for all three [41]. This strongly
suggests that mechanisms of patterning during early angiogenesis and neurogenesis in the
brain are shared.
A strong association between NSC and blood vessels exists during embryonic and adult neuro‐
genesis, especially in regard to cell cycle regulation [33-35]. The filopodia of endothelial tip cells
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extend towards the ventricular surface where radial glia divide, and even interact with pial fi‐
bers of radial glia in the hindbrain [39]. Additionally, dividing cells in the embryonic SVZ reside
statistically closer to blood vessels than predicted by chance, and recent studies report a syn‐
chronization of SVZ cell division with the formation of ventricular vascular plexuses [40]. This
vascular relationship is apparent in the emerging RMS as well, where dividing cells have been
reported to associate with blood vessels at E16, E18, and P4 [35]. On the other hand, progenitor
migration in the RMS does not seem to rely on the vasculature, as the vast majority of neuroblast
neurites in P4 RMS have little or no association with blood vessels [35]. This is in contrast to radi‐
al migration outside the RMS, where postmitotic doublecortin (DCX) and glial fibrillary acidic
protein (GFAP)-positive cells associate with blood vessels during migration into superficial
cortical layers [40]. Interestingly, IPC have been suggested to maintain a stronger interaction
with blood vessels, as T-brain gene-2 (Tbr2)-eGFP progenitors in M-phase reside closer to blood
vessels when compared to total phosphohistone H3-positive progenitors [40]. Furthermore,
these dividing IPC are often found at vessel branch points, which have previously been ob‐
served to be sites of glial tumor mitosis and subsequent migration [70].
Mounting evidence suggests that Tbr2 progenitors are temporally and spatially correlated
with the appearance of cortical vasculature, and even follow and mimic the pattern of nascent
blood vessels. Similarly, the positions of IPC during mitosis, migration and differentiation are
all correlated with EC development in the SVZ. Even detection of Tbr2-positive cells correlates
with the appearance of vascularization, as Tbr2 cell density is highest in the vascularized lateral
regions as compared to the nearly avascular medial regions in the dorsal cortex of E12 embryos
[39]. Moreover, ectopic overexpression of vascular endothelial growth factor (VEGF)-A causes
IPC to follow a pattern of aberrant vascular growth. Interestingly, leading EC tip cells have
been observed to associate with some Tbr2-positive IPC in M-phase, suggesting a functional
interaction during division. These data collectively suggest the SVZ vasculature serves as a
niche for mitotic IPC [39], and provides instructive and permissive cues for stem and progen‐
itor cell expansion and tissue invasion [71].
3.5. Parallels between embryonic neurogenesis and adult neurogenesis
Similarities between embryonic and adult NSC at the cellular level and across their extracel‐
lular microenvironments have been reported, and selective labeling of radial glia has demon‐
strated a direct link between these cells, indicating that NSC are most likely contained within
the neuroepithelial-radial glia-astrocyte lineage [72, 73]. Furthermore, reports indicate adult
SVZ NSC retain specialized characteristics of radial glia. However, the molecular characteris‐
tics that confer progenitor potential onto astroglial cells and distinguish them from those with
normal support function remain largely unknown [53].
From adult NSC, also referred to as Type B cells in the SVZ, an apical process at times
intercalates between ependymal cells lining the lateral ventricular surface, potentially serving
to both anchor and present NSC to circulating factors in the cerebrospinal fluid (CSF).
Embryonic radial glia also share this apical process, and most likely contain a similar profile
of specialized apical junctions at the site of this primary cilium [53]. Similarly, the longer basal
process that radial glia extend towards the surface of the brain during embryonic development
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apical or basal processes and a basal location relative to the apical surface [52]. While their
contact with neighboring blood vessels has not been confirmed, their appearance in the cortex
seems to follow that of blood vessel invasion in the cortical wall [19]. Furthermore, behavioral
differences between radial glia and IPC have been noted. IP cells progress through the cell
cycle away from the ventricle, and do not undergo interkinetic nuclear migration, thus,
allowing differentiation from radial glia based on spatial location during mitosis [19, 63].
At later stages of cortical development, the SVZ progenitor pool continues to expand via IPC
symmetric divisions. Further aiding in expansion, progenitors from the ventral telencephalon
may even migrate dorsally to contribute to the SVZ progenitor pool [19]. Upon completion of
cortical neurogenesis, radial glia transition into astrocytes and exit the VZ, leaving a single
layer of ependymal cells lining the ventricle [57]. Consequently, proliferative IPC become the
predominant component of the cortical progenitor pool, and eventually comprise the majority
of mitotic progenitors as embryonic neurogenesis nears completion. Interestingly, while only
a single layer of VZ-derived ependymal cells remains postnatally, IPC are present in large
numbers in the postnatal SVZ, and persist into adulthood [19]. Aside from generating cortical
neurons, postnatal and adult progenitors have been demonstrated to generate neurons
destined for the olfactory bulb [49, 58, 64], and possibly all excitatory neurons of the upper
cortical layers [58]. Thus, IPC in the SVZ play a vital role in cortical neurogenesis during
embryonic development as well as in the adult.
Interestingly, a novel progenitor type termed the outer SVZ (OSVZ) progenitor has recently
been identified and appears to exist in all mammals, albeit to varying extents [52]. These
progenitors have a modified radial morphology, but are exclusively localized to the SVZ.
OSVZ cells are enriched in mammals with larger cerebral cortices, and their appearance during
mid-gestation seems to coincide with the onset of neurogenesis [52, 65-69]. OSVZ progenitors
are peculiar in that they possess characteristics reminiscent of both radial glia and IPC. They
display radial morphology and express radial glial markers paired box protein-6 (Pax6),
phospho-vimentin, glial fibrillary acidic protein (GFAP), and brain lipid-binding protein
(BLBP), and also display random cleavage planes, where both proliferative self-renewing
symmetrical divisions and asymmetric divisions producing OSVZ daughter and progenitor
have been reported. However, an apical process is absent in these cells while their basal process
is retained throughout mitosis [65-67].
3.4. Vascular cues during embryonic neurogenesis
It has been suggested that the developing cortical vasculature within the SVZ promotes IPC
expansion during neurogenesis by providing a suitable microenvironment for IPC accumu‐
lation and division [39]. It is noteworthy that brain EC share similar molecular profiles with
their neighboring NSC. For example, ventral and dorsal EC, as well as NSC, express Dlx1/5
and Nkx2.1, and Pax6, respectively, while pial EC are negative for all three [41]. This strongly
suggests that mechanisms of patterning during early angiogenesis and neurogenesis in the
brain are shared.
A strong association between NSC and blood vessels exists during embryonic and adult neuro‐
genesis, especially in regard to cell cycle regulation [33-35]. The filopodia of endothelial tip cells
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extend towards the ventricular surface where radial glia divide, and even interact with pial fi‐
bers of radial glia in the hindbrain [39]. Additionally, dividing cells in the embryonic SVZ reside
statistically closer to blood vessels than predicted by chance, and recent studies report a syn‐
chronization of SVZ cell division with the formation of ventricular vascular plexuses [40]. This
vascular relationship is apparent in the emerging RMS as well, where dividing cells have been
reported to associate with blood vessels at E16, E18, and P4 [35]. On the other hand, progenitor
migration in the RMS does not seem to rely on the vasculature, as the vast majority of neuroblast
neurites in P4 RMS have little or no association with blood vessels [35]. This is in contrast to radi‐
al migration outside the RMS, where postmitotic doublecortin (DCX) and glial fibrillary acidic
protein (GFAP)-positive cells associate with blood vessels during migration into superficial
cortical layers [40]. Interestingly, IPC have been suggested to maintain a stronger interaction
with blood vessels, as T-brain gene-2 (Tbr2)-eGFP progenitors in M-phase reside closer to blood
vessels when compared to total phosphohistone H3-positive progenitors [40]. Furthermore,
these dividing IPC are often found at vessel branch points, which have previously been ob‐
served to be sites of glial tumor mitosis and subsequent migration [70].
Mounting evidence suggests that Tbr2 progenitors are temporally and spatially correlated
with the appearance of cortical vasculature, and even follow and mimic the pattern of nascent
blood vessels. Similarly, the positions of IPC during mitosis, migration and differentiation are
all correlated with EC development in the SVZ. Even detection of Tbr2-positive cells correlates
with the appearance of vascularization, as Tbr2 cell density is highest in the vascularized lateral
regions as compared to the nearly avascular medial regions in the dorsal cortex of E12 embryos
[39]. Moreover, ectopic overexpression of vascular endothelial growth factor (VEGF)-A causes
IPC to follow a pattern of aberrant vascular growth. Interestingly, leading EC tip cells have
been observed to associate with some Tbr2-positive IPC in M-phase, suggesting a functional
interaction during division. These data collectively suggest the SVZ vasculature serves as a
niche for mitotic IPC [39], and provides instructive and permissive cues for stem and progen‐
itor cell expansion and tissue invasion [71].
3.5. Parallels between embryonic neurogenesis and adult neurogenesis
Similarities between embryonic and adult NSC at the cellular level and across their extracel‐
lular microenvironments have been reported, and selective labeling of radial glia has demon‐
strated a direct link between these cells, indicating that NSC are most likely contained within
the neuroepithelial-radial glia-astrocyte lineage [72, 73]. Furthermore, reports indicate adult
SVZ NSC retain specialized characteristics of radial glia. However, the molecular characteris‐
tics that confer progenitor potential onto astroglial cells and distinguish them from those with
normal support function remain largely unknown [53].
From adult NSC, also referred to as Type B cells in the SVZ, an apical process at times
intercalates between ependymal cells lining the lateral ventricular surface, potentially serving
to both anchor and present NSC to circulating factors in the cerebrospinal fluid (CSF).
Embryonic radial glia also share this apical process, and most likely contain a similar profile
of specialized apical junctions at the site of this primary cilium [53]. Similarly, the longer basal
process that radial glia extend towards the surface of the brain during embryonic development
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is also shared by adult NSC of the SVZ. In the adult SVZ, this basal process projects radially
or tangentially, depending on location, eventually terminating in specialized endfeet on the
surface of blood vessels [33, 74, 75]. These vascular contacts may be analogous to those of radial
glia during development, as branch contacts with the overlying vasculature also occur [53].
This suggests that adult SVZ NSC share core properties with the embryonic radial glia from
which they are derived from, allowing them to retain progenitor function throughout life.
These similarities are also observed in adult NSC of the SGZ in the hippocampal dentate gyrus.
Early anatomical studies suggest that radial glia in the dentate neurepithelium transition to
the different astrocyte populations of the dentate gyrus, including radial astrocytes [76, 77].
While experimental evidence linking radial glia to adult SGZ radial astrocytes is lacking [53],
it is possible that this derivation occurs, and further studies will be needed to clarify this lineage
relationship. However, the primary cilium of radial glia is present on SGZ progenitors and
adult radial astrocytes, and is essential for progenitor proliferation and generation of postnatal
radial astrocytes, thus establishing its requirement for neurogenesis. From a signaling
standpoint, the primary cilium serves as an integration site for signaling via pathways such as
Shh. Interestingly, this cilium seems to be specific to the radial astrocytic NSC pool in the
hippocampus. Non-stem cell astrocytes are not affected by lack of primary cilium or Shh
signaling, suggesting a unique requirement among these NSC [78, 79].
As in the adult SVZ [80], location seems to dictate specificity, where radial glia in the dorsal tele‐
ncephalon generate only pyramidal excitatory neurons, while those located in the ventral tele‐
ncephalon give rise to nonpyramidal inhibitory interneurons [81]. Studies from several mouse
models demonstrate that neurons can migrate into the cortical plate (CP) radially or tangential‐
ly [82-84]. This type of migration is mirrored in the adult SVZ, where neuroblast progenitors mi‐
grate tangentially through the rostral migratory stream towards the olfactory bulb, destined to
become inhibitory interneurons. Features of interkinetic nuclear migration are also shared by
radial glia and adult NSC. While mitotic cells are found only adjacent to the lumen of the neural
tube, nuclei of cells in S-phase are found in the outer half of neural epithelium [19, 54]. This cor‐
relation of cell cycle with spatial location occurs in the adult SVZ as well, where basally located
blood vessels are proposed to exert growth control over proximal NSC by providing a prolifera‐
tion-inducing microenvironment. This is in contrast to NSC located apically, either adjacent to
or within the ependymal layer, which are immunoreactive for mitotic markers [33, 34, 75, 85].
These findings highlight basic properties that are common to embryonic radial glia and adult
SVZ and SGZ NSC. Given the evidence, it is highly likely that a microenvironment similar to
the one which supports embryonic neurogenesis persists throughout development and is
maintained in the adult neural stem cell niche.
4. The adult NSC niche
4.1. Cellular architecture of the adult SGZ and SVZ
As previously mentioned, two prominent germinal regions of the adult brain have been
identified to function as stem cell or neurogenic niches, allowing for continuous generation of
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new neurons. The SVZ represents the largest neurogenic stem cell region within the adult
brain. It resides within a narrow region of the lateral ventricular wall, roughly four to five cells
in diameter [86]. Progenitors generated from this region migrate through the RMS towards the
olfactory bulb, where differentiation into at least five interneuron subtypes has been reported.
In fact, it is estimated that 30,000–60,000 new neurons are generated in the rodent olfactory
bulb per day [87, 88]. Differentiation into oligodendrocytes of the corpus callosal white matter
also occurs, albeit to a lesser extent [89, 90]. A second neurogenic region, the SGZ, is located
between the hilus and the granule cell layer of the dentate gyrus within the hippocampal
formation. In contrast to SVZ progenitors, granule neurons born from this region migrate short
distances to the granule cell layer, where differentiation commences [91]. Whether bona fide
NSC exist in the adult mammalian hippocampus is currently under investigation, as in vivo
lineage tracing assays suggest that separate progenitors responsible for neurogenesis and
gliogenesis exist in the SGZ [92-94].
A group of distinct cell  types in the adult SVZ help maintain this specialized niche mi‐
croenvironment:  putative NSC (type B cells),  transit-amplifying cells  (type C cells),  neu‐
roblasts  (type  A  cells),  ependymal  cells,  and  specialized  vascular  endothelium  [34,  95].
There is  no definitive marker of  NSC, and researchers rely on combinations of  overlap‐
ping markers,  as well  as spatial  location within the niche to identify NSC. Accordingly,
NSC are  usually  identified  by  their  apical  location,  superficial  to  the  ependymal  layer,
and  slow  cell  cycle  time  of  ~  28  days  [96];  however,  their  expression  of  Sox  2  and  9,
GFAP,  and  CD133/prominin-1  are  not  exclusive  [33,  34,  74].  The  presumptive  lineage
progression from stem cell to more differentiated progenitor is as follows: NSC generate
transit amplifying cells that differentiate into migrating neuroblast progenitors.
Non-dividing ependymal cells are multiciliated, and form a single layer lining the ventricle
surface, acting as a physical barrier separating the brain parenchyma from the cerebrospinal
fluid (CSF) [97]. While ependymal cell cilia contribute to CSF flow, they have also been reported
to affect the migration of young neurons by creating gradients of Slit chemorepellents that
guide anterior neuroblast migration [98]. An en face view of the lateral ventricle wall reveals a
planar organization, commonly referred to as “pinwheel organization”, where the apical
process of NSC is surrounded by a mosaic of ependymal cells [33, 74, 99]. Through studies
mapping numbers of ventricle-contacting NSC along the ventricular surface, “hot spots,” or
areas of stem cell activation, have been revealed [100-102]. Currently a topic of debate is
whether ependymal cells can function as multipotent NSC. Previous studies have demon‐
strated that CD133/prominin-1 positive ependymal cells are in fact multipotent, and during
ischemia become active to generate neuroblasts and astrocytes [103, 104]. However, a more
recent study using split-Cre technology demonstrated a subset of CD133/prominin-1 positive
cells within the ependymal layer are immunoreactive for GFAP, suggesting that these double
positive radial-like cells are NSC, not ependymal cells [98, 105].
Two astrocytic populations have been proposed to reside in the SVZ [100]. Type B NSC
astrocytes reside underneath the ependymal layer, while non-stem cell astrocytes are more
superficial and differ in morphology [33, 34, 74, 99]. NSC are closely associated with ependy‐
mal cells, and at times extend a short, apical, non-motile primary cilium that innervates
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is also shared by adult NSC of the SVZ. In the adult SVZ, this basal process projects radially
or tangentially, depending on location, eventually terminating in specialized endfeet on the
surface of blood vessels [33, 74, 75]. These vascular contacts may be analogous to those of radial
glia during development, as branch contacts with the overlying vasculature also occur [53].
This suggests that adult SVZ NSC share core properties with the embryonic radial glia from
which they are derived from, allowing them to retain progenitor function throughout life.
These similarities are also observed in adult NSC of the SGZ in the hippocampal dentate gyrus.
Early anatomical studies suggest that radial glia in the dentate neurepithelium transition to
the different astrocyte populations of the dentate gyrus, including radial astrocytes [76, 77].
While experimental evidence linking radial glia to adult SGZ radial astrocytes is lacking [53],
it is possible that this derivation occurs, and further studies will be needed to clarify this lineage
relationship. However, the primary cilium of radial glia is present on SGZ progenitors and
adult radial astrocytes, and is essential for progenitor proliferation and generation of postnatal
radial astrocytes, thus establishing its requirement for neurogenesis. From a signaling
standpoint, the primary cilium serves as an integration site for signaling via pathways such as
Shh. Interestingly, this cilium seems to be specific to the radial astrocytic NSC pool in the
hippocampus. Non-stem cell astrocytes are not affected by lack of primary cilium or Shh
signaling, suggesting a unique requirement among these NSC [78, 79].
As in the adult SVZ [80], location seems to dictate specificity, where radial glia in the dorsal tele‐
ncephalon generate only pyramidal excitatory neurons, while those located in the ventral tele‐
ncephalon give rise to nonpyramidal inhibitory interneurons [81]. Studies from several mouse
models demonstrate that neurons can migrate into the cortical plate (CP) radially or tangential‐
ly [82-84]. This type of migration is mirrored in the adult SVZ, where neuroblast progenitors mi‐
grate tangentially through the rostral migratory stream towards the olfactory bulb, destined to
become inhibitory interneurons. Features of interkinetic nuclear migration are also shared by
radial glia and adult NSC. While mitotic cells are found only adjacent to the lumen of the neural
tube, nuclei of cells in S-phase are found in the outer half of neural epithelium [19, 54]. This cor‐
relation of cell cycle with spatial location occurs in the adult SVZ as well, where basally located
blood vessels are proposed to exert growth control over proximal NSC by providing a prolifera‐
tion-inducing microenvironment. This is in contrast to NSC located apically, either adjacent to
or within the ependymal layer, which are immunoreactive for mitotic markers [33, 34, 75, 85].
These findings highlight basic properties that are common to embryonic radial glia and adult
SVZ and SGZ NSC. Given the evidence, it is highly likely that a microenvironment similar to
the one which supports embryonic neurogenesis persists throughout development and is
maintained in the adult neural stem cell niche.
4. The adult NSC niche
4.1. Cellular architecture of the adult SGZ and SVZ
As previously mentioned, two prominent germinal regions of the adult brain have been
identified to function as stem cell or neurogenic niches, allowing for continuous generation of
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new neurons. The SVZ represents the largest neurogenic stem cell region within the adult
brain. It resides within a narrow region of the lateral ventricular wall, roughly four to five cells
in diameter [86]. Progenitors generated from this region migrate through the RMS towards the
olfactory bulb, where differentiation into at least five interneuron subtypes has been reported.
In fact, it is estimated that 30,000–60,000 new neurons are generated in the rodent olfactory
bulb per day [87, 88]. Differentiation into oligodendrocytes of the corpus callosal white matter
also occurs, albeit to a lesser extent [89, 90]. A second neurogenic region, the SGZ, is located
between the hilus and the granule cell layer of the dentate gyrus within the hippocampal
formation. In contrast to SVZ progenitors, granule neurons born from this region migrate short
distances to the granule cell layer, where differentiation commences [91]. Whether bona fide
NSC exist in the adult mammalian hippocampus is currently under investigation, as in vivo
lineage tracing assays suggest that separate progenitors responsible for neurogenesis and
gliogenesis exist in the SGZ [92-94].
A group of distinct cell  types in the adult  SVZ help maintain this specialized niche mi‐
croenvironment:  putative NSC (type B cells),  transit-amplifying cells  (type C cells),  neu‐
roblasts  (type  A  cells),  ependymal  cells,  and  specialized  vascular  endothelium  [34,  95].
There is  no definitive marker of  NSC, and researchers rely on combinations of  overlap‐
ping markers,  as well  as spatial  location within the niche to identify NSC. Accordingly,
NSC are  usually  identified  by  their  apical  location,  superficial  to  the  ependymal  layer,
and  slow  cell  cycle  time  of  ~  28  days  [96];  however,  their  expression  of  Sox  2  and  9,
GFAP,  and  CD133/prominin-1  are  not  exclusive  [33,  34,  74].  The  presumptive  lineage
progression from stem cell to more differentiated progenitor is as follows: NSC generate
transit amplifying cells that differentiate into migrating neuroblast progenitors.
Non-dividing ependymal cells are multiciliated, and form a single layer lining the ventricle
surface, acting as a physical barrier separating the brain parenchyma from the cerebrospinal
fluid (CSF) [97]. While ependymal cell cilia contribute to CSF flow, they have also been reported
to affect the migration of young neurons by creating gradients of Slit chemorepellents that
guide anterior neuroblast migration [98]. An en face view of the lateral ventricle wall reveals a
planar organization, commonly referred to as “pinwheel organization”, where the apical
process of NSC is surrounded by a mosaic of ependymal cells [33, 74, 99]. Through studies
mapping numbers of ventricle-contacting NSC along the ventricular surface, “hot spots,” or
areas of stem cell activation, have been revealed [100-102]. Currently a topic of debate is
whether ependymal cells can function as multipotent NSC. Previous studies have demon‐
strated that CD133/prominin-1 positive ependymal cells are in fact multipotent, and during
ischemia become active to generate neuroblasts and astrocytes [103, 104]. However, a more
recent study using split-Cre technology demonstrated a subset of CD133/prominin-1 positive
cells within the ependymal layer are immunoreactive for GFAP, suggesting that these double
positive radial-like cells are NSC, not ependymal cells [98, 105].
Two astrocytic populations have been proposed to reside in the SVZ [100]. Type B NSC
astrocytes reside underneath the ependymal layer, while non-stem cell astrocytes are more
superficial and differ in morphology [33, 34, 74, 99]. NSC are closely associated with ependy‐
mal cells, and at times extend a short, apical, non-motile primary cilium that innervates
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between the ependyma to directly contact the CSF within the ventricle [33, 74, 99]. While NSC
are relatively quiescent, transit-amplifying cells are highly proliferative, and remain localized
to the SVZ [95, 100]. Neuroblasts, on the other hand, migrate through astrocytic tubes in the
RMS to the olfactory bulb, where interneuron differentiation occurs [106, 107]. Interestingly,
experiments using viral targeting and genetic lineage tracing in neonatal and adult mice have
revealed that specific subtypes of interneurons in the olfactory bulb are derived from specific
locations within dorsal, medial, and ventral portions of the adult SVZ [108-112]. Interestingly,
while the vascular beds of the SVZ and SGZ both support adult neurogenesis, the SVZ
vasculature is somewhat unique. Differences in permeability, stability, and perivascular cell
coverage are thought to account for these differences. NSC and transit-amplifying cells both
display an intimate relationship with SVZ blood vessels, as 3-dimensional niche modeling
indicates closer proximity and increased vascular contact relative to other SVZ cells. Interest‐
ingly, these vascular associations are further exaggerated in niche regeneration models [33,
34]. Additionally, NSC extend a long basal process that terminates on blood vessels in the form
of specialized endfeet, potentially serving to integrate vascular cues [33, 74, 99].
4.2. NSC-Vascular EC associations within the SVZ and SGZ
NSC are not randomly distributed throughout the brain; rather, they are concentrated around
blood vessels, allowing constant access to circulating signaling molecules and nutrient
metabolites [113, 114]. The SVZ and SGZ both present functional neurogenic environments,
maintaining neural stem and progenitor cells (NSPC) in poised and undifferentiated states.
Regulatory processes within the SVZ niche can be controlled via secreted neurotrophic and
angiogenic factors, such as Wnt, Shh, and TGF-β [115]. For example, circulating complement
factors have been shown to promote basal and ischemia-induced neurogenesis, and compo‐
nents of complement signaling are present on transit-amplifying cells and neural progenitors
in vivo [116]. The vascular-derived factors, stromal cell derived factor (SDF)-1 and angiopoietin
(Ang)-1, promote neuroblast proliferation and survival [117], and when expressed on EC, serve
as “molecular migratory scaffolds” [118, 119] to damaged areas post stroke [120]. EC them‐
selves have even been shown to regulate NSC self-renewal [37, 86, 101, 121]. Interaction with
the vascular endothelium may in fact be a vital component of the niche, as radiation-induced
disruption of endothelial cell–SGZ precursor cell interaction results in a loss of neurogenic
potential, as is the case after NSC transplantation into an irradiated host. [122].
Within the SGZ, nestin-expressing radial astrocytes are localized to areas near blood vessels
[91], and there exists an anatomical relationship between proliferating neural progenitors and
EC in the hippocampus [101, 123, 124]. In contrast to the SVZ, where angiogenic sprouting and
division of EC are absent [34], surges of EC division are said to be spatially and temporally
related to clusters of neurogenesis in the SGZ [101]. In the hippocampus, angiogenesis and
neurogenesis are coupled, as suggested by high levels of VEGF and VEGFR2 [101], and the
shared responsiveness to similar growth factors, e.g., neurotrophins, neuropilins, semaphorins
and ephrins [125-127]. In fact, similar bidirectional communication occurs within the higher
vocal center (HVC) of the songbird brain, where increases in angiogenesis are said to be
coupled to testosterone-induced upregulation of VEGF and VEGFR2 in neurons and astro‐
Neural Stem Cells - New Perspectives208
cytes, respectively. The newly generated capillaries produce BDNF (brain-derived neurotro‐
phic factor) that subsequently promotes the recruitment and migration of newly born neurons
[121]. Similarly, exercise-induced angiogenesis in the hippocampus is met with increased
expression of NGF (nerve growth factor) and BDNF [126], leading to robust increases in
neurogenesis [128-130].
In contrast to other areas of the brain, where the BBB is strictly maintained by EC tight junctions,
pericyte coverage, and astrocyte endfeet, a modified BBB has been proposed to exist in the
SVZ. The lack of astrocyte endfeet and endothelial cell tight junctions, as revealed by aqua‐
porin-4 and zonula occludens-1 immunostaining, respectively, demonstrate major structural
differences in the SVZ vascular endothelium. Under homeostatic conditions, the majority of
BrdU+ label-retaining NSC and transit amplifying cells reside significantly closer, and fre‐
quently make direct contact, to the vasculature; furthermore, after antimitotic cytosine-β-D-
arabinofuranoside (Ara-C) treatment to ablate rapidly proliferating cells and induce NSC-
mediated repopulation, these vascular associations are increased [33, 34]. At times, transit-
amplifying cells can be seen contacting the vasculature at sites lacking astrocyte endfeet and
pericyte coverage, suggesting that sites along the vessel are primed for intercellular commu‐
nication. In fact, fluorescent tracer experiments have proposed that differences in the ultra‐
structural composition of SVZ blood vessels may be responsible for the detection of sodium
fluorescein in the SVZ after perfusion into the blood; however, access to the SVZ from the
cerebral spinal fluid cannot be dismissed as an entry point. Integrin-α6β1 partially mediates
the adhesion between NSPC and blood vessels through the binding of laminins that are highly
concentrated around SVZ blood vessels. In vitro and in vivo blocking experiments using an
integrin-blocking antibody (GoH3) have demonstrated a crucial role for this interaction in the
attachment, spreading, and proliferation of NSPC [33].
The vascular environment in the RMS has also been suggested to be somewhat specialized,
where migrating neuroblasts en route to the olfactory bulb are found closely apposed to blood
vessels. Interestingly, blood vessels in this region are parallel and aligned with the direction
of the RMS, and the density of vessels is significantly higher when compared to equally cell-
dense areas of the brain [131]. It has been reported that over 80% of RMS vessels are lined with
migrating neuroblasts [132], and degradation of ECM through vascular EC secretion of matrix
metalloproteinases (MMPs) opens a path for their migration [133]. This observation has
prompted some to suggest that increased vessel density is a consequence of greater metabolic
demand by migrating progenitors.
5. Vascular regulation of adult neurogenesis
5.1. EC regulation of NSPC
Through cytokines and secreted factors, direct contact in vivo, or within the confines of the
coculture system, EC exert their influence over NSC to regulate fate specification, differentia‐
tion, quiescence and proliferation (Figure 1). Early experiments established a crude role for EC
regulation of NSC, where increases in neurite outgrowth and maturation, and enhanced
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between the ependyma to directly contact the CSF within the ventricle [33, 74, 99]. While NSC
are relatively quiescent, transit-amplifying cells are highly proliferative, and remain localized
to the SVZ [95, 100]. Neuroblasts, on the other hand, migrate through astrocytic tubes in the
RMS to the olfactory bulb, where interneuron differentiation occurs [106, 107]. Interestingly,
experiments using viral targeting and genetic lineage tracing in neonatal and adult mice have
revealed that specific subtypes of interneurons in the olfactory bulb are derived from specific
locations within dorsal, medial, and ventral portions of the adult SVZ [108-112]. Interestingly,
while the vascular beds of the SVZ and SGZ both support adult neurogenesis, the SVZ
vasculature is somewhat unique. Differences in permeability, stability, and perivascular cell
coverage are thought to account for these differences. NSC and transit-amplifying cells both
display an intimate relationship with SVZ blood vessels, as 3-dimensional niche modeling
indicates closer proximity and increased vascular contact relative to other SVZ cells. Interest‐
ingly, these vascular associations are further exaggerated in niche regeneration models [33,
34]. Additionally, NSC extend a long basal process that terminates on blood vessels in the form
of specialized endfeet, potentially serving to integrate vascular cues [33, 74, 99].
4.2. NSC-Vascular EC associations within the SVZ and SGZ
NSC are not randomly distributed throughout the brain; rather, they are concentrated around
blood vessels, allowing constant access to circulating signaling molecules and nutrient
metabolites [113, 114]. The SVZ and SGZ both present functional neurogenic environments,
maintaining neural stem and progenitor cells (NSPC) in poised and undifferentiated states.
Regulatory processes within the SVZ niche can be controlled via secreted neurotrophic and
angiogenic factors, such as Wnt, Shh, and TGF-β [115]. For example, circulating complement
factors have been shown to promote basal and ischemia-induced neurogenesis, and compo‐
nents of complement signaling are present on transit-amplifying cells and neural progenitors
in vivo [116]. The vascular-derived factors, stromal cell derived factor (SDF)-1 and angiopoietin
(Ang)-1, promote neuroblast proliferation and survival [117], and when expressed on EC, serve
as “molecular migratory scaffolds” [118, 119] to damaged areas post stroke [120]. EC them‐
selves have even been shown to regulate NSC self-renewal [37, 86, 101, 121]. Interaction with
the vascular endothelium may in fact be a vital component of the niche, as radiation-induced
disruption of endothelial cell–SGZ precursor cell interaction results in a loss of neurogenic
potential, as is the case after NSC transplantation into an irradiated host. [122].
Within the SGZ, nestin-expressing radial astrocytes are localized to areas near blood vessels
[91], and there exists an anatomical relationship between proliferating neural progenitors and
EC in the hippocampus [101, 123, 124]. In contrast to the SVZ, where angiogenic sprouting and
division of EC are absent [34], surges of EC division are said to be spatially and temporally
related to clusters of neurogenesis in the SGZ [101]. In the hippocampus, angiogenesis and
neurogenesis are coupled, as suggested by high levels of VEGF and VEGFR2 [101], and the
shared responsiveness to similar growth factors, e.g., neurotrophins, neuropilins, semaphorins
and ephrins [125-127]. In fact, similar bidirectional communication occurs within the higher
vocal center (HVC) of the songbird brain, where increases in angiogenesis are said to be
coupled to testosterone-induced upregulation of VEGF and VEGFR2 in neurons and astro‐
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cytes, respectively. The newly generated capillaries produce BDNF (brain-derived neurotro‐
phic factor) that subsequently promotes the recruitment and migration of newly born neurons
[121]. Similarly, exercise-induced angiogenesis in the hippocampus is met with increased
expression of NGF (nerve growth factor) and BDNF [126], leading to robust increases in
neurogenesis [128-130].
In contrast to other areas of the brain, where the BBB is strictly maintained by EC tight junctions,
pericyte coverage, and astrocyte endfeet, a modified BBB has been proposed to exist in the
SVZ. The lack of astrocyte endfeet and endothelial cell tight junctions, as revealed by aqua‐
porin-4 and zonula occludens-1 immunostaining, respectively, demonstrate major structural
differences in the SVZ vascular endothelium. Under homeostatic conditions, the majority of
BrdU+ label-retaining NSC and transit amplifying cells reside significantly closer, and fre‐
quently make direct contact, to the vasculature; furthermore, after antimitotic cytosine-β-D-
arabinofuranoside (Ara-C) treatment to ablate rapidly proliferating cells and induce NSC-
mediated repopulation, these vascular associations are increased [33, 34]. At times, transit-
amplifying cells can be seen contacting the vasculature at sites lacking astrocyte endfeet and
pericyte coverage, suggesting that sites along the vessel are primed for intercellular commu‐
nication. In fact, fluorescent tracer experiments have proposed that differences in the ultra‐
structural composition of SVZ blood vessels may be responsible for the detection of sodium
fluorescein in the SVZ after perfusion into the blood; however, access to the SVZ from the
cerebral spinal fluid cannot be dismissed as an entry point. Integrin-α6β1 partially mediates
the adhesion between NSPC and blood vessels through the binding of laminins that are highly
concentrated around SVZ blood vessels. In vitro and in vivo blocking experiments using an
integrin-blocking antibody (GoH3) have demonstrated a crucial role for this interaction in the
attachment, spreading, and proliferation of NSPC [33].
The vascular environment in the RMS has also been suggested to be somewhat specialized,
where migrating neuroblasts en route to the olfactory bulb are found closely apposed to blood
vessels. Interestingly, blood vessels in this region are parallel and aligned with the direction
of the RMS, and the density of vessels is significantly higher when compared to equally cell-
dense areas of the brain [131]. It has been reported that over 80% of RMS vessels are lined with
migrating neuroblasts [132], and degradation of ECM through vascular EC secretion of matrix
metalloproteinases (MMPs) opens a path for their migration [133]. This observation has
prompted some to suggest that increased vessel density is a consequence of greater metabolic
demand by migrating progenitors.
5. Vascular regulation of adult neurogenesis
5.1. EC regulation of NSPC
Through cytokines and secreted factors, direct contact in vivo, or within the confines of the
coculture system, EC exert their influence over NSC to regulate fate specification, differentia‐
tion, quiescence and proliferation (Figure 1). Early experiments established a crude role for EC
regulation of NSC, where increases in neurite outgrowth and maturation, and enhanced
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migration were observed in cocultures of SVZ explants with EC [134]. NSC are reported to
respond to pro-angiogenic factors [135-137] that promote NSPC proliferation, neurogenesis,
synaptogenesis, axonal growth, and neuroprotection [138]. Studies in tumor and stroke models
have also uncovered neural regulatory roles of EC. EC can protect stem cells and tumor cells
from radiation damage [139, 140], and in preclinical models where NSPC isolated from stroke
boundary are cocultured with cerebral EC, significant increases in neural progenitor cell
proliferation, neuronal differentiation, and capillary tube formation are observed [141]. Even
cotransplantation of EC with NSPC increases survival and proliferation as compared to
transplantation of neural precursors alone [142]. Similarly, coculture of adult NSC with EC
results in self-renewal and symmetric neural cell division, leading to enhanced neurogenesis
through an increase in nestin+ precursor number [37]. Interestingly, when stroke-activated rat
brain EC are cocultured with SVZ cells, progenitor proliferation and neuron number are
increased by 28% and 46%, respectively, when compared to coculture with normal EC. This
suggests that activated EC are more potent in promoting neurogenesis, potentially through
modulation of Sox2 and Hes6 levels in SVZ cells [143], although further investigation is
required to identify the mechanisms involved.
VEGF, EGF, LIF
IL-6, SCF, PEDF
FGF-2, EGF, BMP, BDNF
IFG-1, PDGF, TGF-β, Collagen IV
Laminin, Erythropoietin, Prolactin
Eph & ephrin, NO, Betacellulin
PROLIFERATION




BDNF, IGF-1, SCF, SDF-1
GRO-α, Angiopoietin, Laminin
Erythropoietin, Eph & ephrin
MIGRATION
*Referring to adult suvbentricular and subrangular zones
BDNF:  Brain-derived neurotrophic factor; GRO-α:  Growth-related oncogene alpha; LIF:  Leukemia inhibitory factor; VEGF:  Vascular endothelial
growth factor; FGF-2:  Fibroblast growth factor-2; EGF:  Epidermal growth factor; BMP:  Bone morphogenetic protein; PDGF:  Platelet-derived growth
factor; SCF: Stem cell factor; PEDF:  Pigment epithelial-derived factor ; SDF-1:  Stromal cell-derived factor-1; TGFβ:  Transforming growth factor beta;
NO: Nitric oxide; CXCR4:  Chemokine receptor type 4; EGFR:  Epidermal growth factor receptor; CSPG:  Chondroitin sulfate proteoglycan
Influence of niche effectors on adult eural st m cell behavior.*Referring to adult suvbentricular and subrangular‐
zones. BDNF: Brain-derived neurotrophicfactor;GRO-oz Growth-related oncogene alpha; LIF: Leukemiainhibitoryfac‐
tor;VEGF: Vascularendothelial growth factor; FGF-2: Fibroblastgrowthfactor-2; EGF: Epidermal growth factor; BMP:
Bone morphogenetic protein; PDGF: Platelet-derived growth factor; SCF: Stem cell factor; PEDF: Pigmentepithelial-de‐
rived factor; SDF-l: Stromal cell-derived factor-l;TGF[3: Transforming growth factor beta; NO: Nitric oxide; CXCR4: Che‐
mokine receptor type 4; EGFR: Epidermalgrowthfactorreceptor;CSPG: Chondroitin sulfate proteoglycan
Figure 1. Regulatory effects on adult neural stem and progenitors
Neural Stem Cells - New Perspectives210
Mock treatment with serum-rich endothelial growth media induces NSC differentiation into
neurons and astrocytes [31], indicating that EC-mediated regulation of NSPC self-renewal and
differentiation may be mediated through the release of certain growth factors, including PEDF
or VEGF [144, 145]. Cytokine expression profiles of human umbilical vein and cerebral
microvascular EC reveal that a large number of chemokines, growth factors, adhesion
molecules and ECM proteins are expressed by these cells [146]. Levels of these signaling
molecules varied under stimulating and nonstimulating conditions as well as by EC type,
highlighting the diverse signaling potential that exists even among endothelial subtypes.
Studies of adult neurogenic niche regulation have identified a number of growth factors and
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migration were observed in cocultures of SVZ explants with EC [134]. NSC are reported to
respond to pro-angiogenic factors [135-137] that promote NSPC proliferation, neurogenesis,
synaptogenesis, axonal growth, and neuroprotection [138]. Studies in tumor and stroke models
have also uncovered neural regulatory roles of EC. EC can protect stem cells and tumor cells
from radiation damage [139, 140], and in preclinical models where NSPC isolated from stroke
boundary are cocultured with cerebral EC, significant increases in neural progenitor cell
proliferation, neuronal differentiation, and capillary tube formation are observed [141]. Even
cotransplantation of EC with NSPC increases survival and proliferation as compared to
transplantation of neural precursors alone [142]. Similarly, coculture of adult NSC with EC
results in self-renewal and symmetric neural cell division, leading to enhanced neurogenesis
through an increase in nestin+ precursor number [37]. Interestingly, when stroke-activated rat
brain EC are cocultured with SVZ cells, progenitor proliferation and neuron number are
increased by 28% and 46%, respectively, when compared to coculture with normal EC. This
suggests that activated EC are more potent in promoting neurogenesis, potentially through
modulation of Sox2 and Hes6 levels in SVZ cells [143], although further investigation is
required to identify the mechanisms involved.
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Mock treatment with serum-rich endothelial growth media induces NSC differentiation into
neurons and astrocytes [31], indicating that EC-mediated regulation of NSPC self-renewal and
differentiation may be mediated through the release of certain growth factors, including PEDF
or VEGF [144, 145]. Cytokine expression profiles of human umbilical vein and cerebral
microvascular EC reveal that a large number of chemokines, growth factors, adhesion
molecules and ECM proteins are expressed by these cells [146]. Levels of these signaling
molecules varied under stimulating and nonstimulating conditions as well as by EC type,
highlighting the diverse signaling potential that exists even among endothelial subtypes.
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The vascular-derived molecules shown to locally regulate the adult NSC niche include
leukemia inhibitory factor (LIF), brain-derived neurotrophic factor (BDNF), VEGF, platelet-
derived growth factor (PDGF), pigment epithelial-derived factor (PEDF), betacellulin (BTC),
and laminins and integrins [33, 121, 147]. However, there are additional factors reported to
influence NSPC behavior which may be derived from the NSC niche vasculature, although
this has not yet been demonstrated, including fibroblast growth factor 2 (FGF-2), epidermal
growth factor (EGF), interleukin-6 (IL-6), stem cell factor (SCF), insulin growth factor-1 (IGF-1),
transforming growth factor-β (TGF-β), bone morphogenic proteins (BMP), SDF-1/CXCR4,
collagen IV, Eph/ephrins, angiopoietin, nitric oxide (NO), erythropoietin and prolactins. We
review advances made toward understanding the cellular and molecular role of these factors
since last reviewed [148].
5.2. Endothelium-derived niche effectors
5.2.1. VEGFs
VEGF signaling is a complex signaling hierarchy involving several isoforms (e.g., VEF-A, -B,
-C, -D) that result from alternative splicing of the VEGF gene. VEGFs are highly implicated in
NSPC survival, proliferation, and neuroblast migration and maturation [149-154]. Along with
the recent identification of VEGFR3/Flt4 expression in the adult SVZ, all corresponding
receptors, including VEGFR1/Flt1 and VEGFR2/Flk1, are expressed within the NSPC pool
[149, 154, 155]. While VEGFR1 negatively regulates adult olfactory neurogenesis and RMS
migration by altering VEGF-A bioavailability, VEGFR2 and VEGFR3 both appear to positively
regulate neurogenesis [133, 155]; in addition, VEGFR2 has also been reported to affect vascular
proliferation [154]. This ability of VEGF family members to regulate both neurogenesis and
angiogenesis may be important in clinical settings of intracerebral hemorrhage, where
transplantation of human NSPC overexpressing VEGF have been shown to increase micro‐
vessel density and promote NSPC engraftment in sites of tissue damage [156, 157].
In VEGFR1 signaling-deficient (Flt-1 TK-/-) mice, the increased levels of VEGF-A and subse‐
quent phospohorylation of VEGFR2 in NPSC are thought to account for the altered RMS
migration, demonstrating a critical role for VEGF-A in this process [154]. Reported to be
required for hippocampal neurogenesis in the adult rat [145], EC, ependymal cells and the
choroid plexus secrete VEGF at neurogenic sites, which serves as a survival factor to stimulate
NSPC self-renewal. Neurospheres, as well as reactive astrocytes, have been shown to express
VEGF-A [158, 159], and infusion into the lateral ventricle after cerebral ischemia acts as a
trophic survival factor for NSPC and increases neurogenesis, most likely through the VEGFR2/
Flk-1 receptor [37, 150, 152]. Similarly, other studies suggest that in vitro VEGF stimulation
increases the number of BrdU-labeled precursors, which is attenuated in the presence of
SU1598, a Flk-1 receptor tyrosine kinase inhibitor, further supporting mediation through
VEGFR2/Flk-1 [123]. Although VEGF-A is reported to have a direct role in signaling during
development [101, 123, 150], evidence also supports an indirect role when it is secreted by
ependymal cells, through the stimulated release of BDNF from EC [121, 152].
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However, in experiments comparing the numbers of primary Ki67+ adult neural precursors in
NestincreFlk1+/− and NestincreFlk−/− short-term cultures, it was found that VEGF-A signaling does
not appear to affect the proliferation of these cells, and individual neurospheres that proliferate
clonally from Flk1+/+ and Flk1−/− mice are of comparable size and cell number [160]. Similar
studies demonstrate VEGF-A secreted from cerebral endothelial cells promotes migration of
oligodendrocyte precursor cells (OPCs), but not proliferation, as treatment with a Flk-1
neutralizing antibody only affected OPC propagation [161]. Therefore, VEGF-A signaling may
exert control over NSCs via the regulation of survival; this potential mechanism should be
further explored, especially given that an internal autocrine role for VEGF-A in HSC survival
has been demonstrated[162].
More recently, a direct requirement for VEGFR3 in neurogenesis has been established, and
Vegfr3::YFP reporter mice demonstrate expression in NSC [155]. Interestingly, coexpression
with VEGF-C along the walls of the lateral ventricle is also observed. Accordingly, an increase
in neurogenesis is said to occur from VEGFR3+ NSC after VEGF-C stimulation, deletion of
VEGFR3 in neural cells and SVZ astrocytes, as well as VEGFR3 inhibition via blocking
antibodies, all lead to a reduction in neurogenesis. In vitro, VEGF-C treatment also increases
BrdU incorporation in YFP+EGFR+ NSC [155].
5.2.2. BDNF & IGF
BDNF is secreted by EC and induces the differentiation of astrocyte precursors [147, 163], and
in vivo has been shown to influence proliferation and differentiation of NSPC in adult neuro‐
genic regions [121, 134]. As mentioned previously, in vivo experiments suggest that VEGF-
induced secretion of BDNF from higher vocal center (HVC) capillary vasculature in the
songbird brain results in newly born neuron recruitment. Interestingly, BDNF secretion in this
region is quite high, as canary brain EC secrete an average of 1 ng BDNF/106 cells/24 h [121,
164]; a study of adult-derived human brain EC revealed a comparable amount of BDNF
secretion [147]. In vitro, BDNF release from EC supports SVZ-derived neuron outgrowth,
survival, and migration [147]. Although subependymal astrocytes also secrete BDNF, it may
be sequestered at the cell surface; this is partly mediated by the truncated gp95 extracellular
domain of TrkB, a high affinity receptor for BDNF, which prevents its release into the sur‐
rounding space [147]. This has been proposed to be a mechanism whereby regions of NSC
expansion exclude BDNF, limiting its availability only to those areas supporting differentiation
and maturation. Interestingly, while NSC and transit-amplifying cells express the low-affinity
neurotrophin receptor p75, expression of TrkB is only found on lineage-restricted neuroblasts.
Additionally, it has been suggested that BDNF acts in a positive feedback loop to reduce
proliferation and increase neuroblast differentiation through the release of NO by NSPC [165,
166]. Thus, endothelial-derived BDNF appears to serve chemoattraction and survival roles for
neuronal progenitors [167].
Studies of exercise-induced neurogenic cognitive enhancement in the dentate gyrus have
linked BDNF with IGF-1 [168]. Exercise stimulates uptake of IGF-1 from the bloodstream in
the hippocampus, leading to an increase in the number of BrdU+ hippocampal neurons as well
as upregulation of BDNF mRNA and protein levels [169, 170]. The neurogenic effect of IGF-1
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The vascular-derived molecules shown to locally regulate the adult NSC niche include
leukemia inhibitory factor (LIF), brain-derived neurotrophic factor (BDNF), VEGF, platelet-
derived growth factor (PDGF), pigment epithelial-derived factor (PEDF), betacellulin (BTC),
and laminins and integrins [33, 121, 147]. However, there are additional factors reported to
influence NSPC behavior which may be derived from the NSC niche vasculature, although
this has not yet been demonstrated, including fibroblast growth factor 2 (FGF-2), epidermal
growth factor (EGF), interleukin-6 (IL-6), stem cell factor (SCF), insulin growth factor-1 (IGF-1),
transforming growth factor-β (TGF-β), bone morphogenic proteins (BMP), SDF-1/CXCR4,
collagen IV, Eph/ephrins, angiopoietin, nitric oxide (NO), erythropoietin and prolactins. We
review advances made toward understanding the cellular and molecular role of these factors
since last reviewed [148].
5.2. Endothelium-derived niche effectors
5.2.1. VEGFs
VEGF signaling is a complex signaling hierarchy involving several isoforms (e.g., VEF-A, -B,
-C, -D) that result from alternative splicing of the VEGF gene. VEGFs are highly implicated in
NSPC survival, proliferation, and neuroblast migration and maturation [149-154]. Along with
the recent identification of VEGFR3/Flt4 expression in the adult SVZ, all corresponding
receptors, including VEGFR1/Flt1 and VEGFR2/Flk1, are expressed within the NSPC pool
[149, 154, 155]. While VEGFR1 negatively regulates adult olfactory neurogenesis and RMS
migration by altering VEGF-A bioavailability, VEGFR2 and VEGFR3 both appear to positively
regulate neurogenesis [133, 155]; in addition, VEGFR2 has also been reported to affect vascular
proliferation [154]. This ability of VEGF family members to regulate both neurogenesis and
angiogenesis may be important in clinical settings of intracerebral hemorrhage, where
transplantation of human NSPC overexpressing VEGF have been shown to increase micro‐
vessel density and promote NSPC engraftment in sites of tissue damage [156, 157].
In VEGFR1 signaling-deficient (Flt-1 TK-/-) mice, the increased levels of VEGF-A and subse‐
quent phospohorylation of VEGFR2 in NPSC are thought to account for the altered RMS
migration, demonstrating a critical role for VEGF-A in this process [154]. Reported to be
required for hippocampal neurogenesis in the adult rat [145], EC, ependymal cells and the
choroid plexus secrete VEGF at neurogenic sites, which serves as a survival factor to stimulate
NSPC self-renewal. Neurospheres, as well as reactive astrocytes, have been shown to express
VEGF-A [158, 159], and infusion into the lateral ventricle after cerebral ischemia acts as a
trophic survival factor for NSPC and increases neurogenesis, most likely through the VEGFR2/
Flk-1 receptor [37, 150, 152]. Similarly, other studies suggest that in vitro VEGF stimulation
increases the number of BrdU-labeled precursors, which is attenuated in the presence of
SU1598, a Flk-1 receptor tyrosine kinase inhibitor, further supporting mediation through
VEGFR2/Flk-1 [123]. Although VEGF-A is reported to have a direct role in signaling during
development [101, 123, 150], evidence also supports an indirect role when it is secreted by
ependymal cells, through the stimulated release of BDNF from EC [121, 152].
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However, in experiments comparing the numbers of primary Ki67+ adult neural precursors in
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clonally from Flk1+/+ and Flk1−/− mice are of comparable size and cell number [160]. Similar
studies demonstrate VEGF-A secreted from cerebral endothelial cells promotes migration of
oligodendrocyte precursor cells (OPCs), but not proliferation, as treatment with a Flk-1
neutralizing antibody only affected OPC propagation [161]. Therefore, VEGF-A signaling may
exert control over NSCs via the regulation of survival; this potential mechanism should be
further explored, especially given that an internal autocrine role for VEGF-A in HSC survival
has been demonstrated[162].
More recently, a direct requirement for VEGFR3 in neurogenesis has been established, and
Vegfr3::YFP reporter mice demonstrate expression in NSC [155]. Interestingly, coexpression
with VEGF-C along the walls of the lateral ventricle is also observed. Accordingly, an increase
in neurogenesis is said to occur from VEGFR3+ NSC after VEGF-C stimulation, deletion of
VEGFR3 in neural cells and SVZ astrocytes, as well as VEGFR3 inhibition via blocking
antibodies, all lead to a reduction in neurogenesis. In vitro, VEGF-C treatment also increases
BrdU incorporation in YFP+EGFR+ NSC [155].
5.2.2. BDNF & IGF
BDNF is secreted by EC and induces the differentiation of astrocyte precursors [147, 163], and
in vivo has been shown to influence proliferation and differentiation of NSPC in adult neuro‐
genic regions [121, 134]. As mentioned previously, in vivo experiments suggest that VEGF-
induced secretion of BDNF from higher vocal center (HVC) capillary vasculature in the
songbird brain results in newly born neuron recruitment. Interestingly, BDNF secretion in this
region is quite high, as canary brain EC secrete an average of 1 ng BDNF/106 cells/24 h [121,
164]; a study of adult-derived human brain EC revealed a comparable amount of BDNF
secretion [147]. In vitro, BDNF release from EC supports SVZ-derived neuron outgrowth,
survival, and migration [147]. Although subependymal astrocytes also secrete BDNF, it may
be sequestered at the cell surface; this is partly mediated by the truncated gp95 extracellular
domain of TrkB, a high affinity receptor for BDNF, which prevents its release into the sur‐
rounding space [147]. This has been proposed to be a mechanism whereby regions of NSC
expansion exclude BDNF, limiting its availability only to those areas supporting differentiation
and maturation. Interestingly, while NSC and transit-amplifying cells express the low-affinity
neurotrophin receptor p75, expression of TrkB is only found on lineage-restricted neuroblasts.
Additionally, it has been suggested that BDNF acts in a positive feedback loop to reduce
proliferation and increase neuroblast differentiation through the release of NO by NSPC [165,
166]. Thus, endothelial-derived BDNF appears to serve chemoattraction and survival roles for
neuronal progenitors [167].
Studies of exercise-induced neurogenic cognitive enhancement in the dentate gyrus have
linked BDNF with IGF-1 [168]. Exercise stimulates uptake of IGF-1 from the bloodstream in
the hippocampus, leading to an increase in the number of BrdU+ hippocampal neurons as well
as upregulation of BDNF mRNA and protein levels [169, 170]. The neurogenic effect of IGF-1
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may be mediated in part through estrogen signaling, as estrogen antagonists reduce neuro‐
genesis within the dentate gyrus [171]. From a clinical standpoint, IGF-1 may be involved in
neurodegenerative disease progression, such as Alzheimer’s and stroke, where levels of
circulating IGF-1 are altered [170].
5.2.3. PDGF
PDGF signaling has been shown to affect stem cell properties and lineage bias [98, 172].
Vascular EC secrete PDGF-B as a disulfide-linked homodimer (PDGF-BB), and via a specific
positively charged C-terminal retention motif, it interacts with heparin sulfate proteoglycans
within the ECM to aid in localized retention [173-176]. Specifically within the CNS, it regulates
oligodendrocyte precursor cell number. Interestingly, PDGF-B is implicated in brain tumor
formation, where activation of its signaling pathway is present in more than 80% oligoden‐
drogliomas and 50–100% of astrocytomas[177]. Thus, identifying which cells respond to PDGF
is crucial to elucidate mechanisms involved in these brain cancers.
In the SVZ, putative NSC and most GFAP+ cells have been shown to express PDGFRα, and
become activated in the presence of PDGF-AA [178]. Accordingly, PDGF is reported to have
mitogenic and differentiation actions on neural progenitor cells [179-181], and synergy with
bFGF has been reported to enhance neurosphere generation [178]. After intracerebroventric‐
ular infusion of PDGF-AA, astrocyte-derived periventricular hyperplasias are formed, and
increases in oligodendrogenesis are observed at the expense of olfactory bulb neurogenesis.
While EGF infusion elicits a similar proliferative response in the SVZ, staining for PDGFRα
and EGFR reveals expression in distinct populations, suggesting that they label stem cells and
transit-amplifying progenitors, respectively. Conversely, conditional ablation of PDGRα in the
SVZ decreases oligodendrogenesis while having little effect on neurogenesis [178]. Thus,
PDGF signaling may play a role in maintaining the balance between neurogenesis and
oligodendrogenesis.
5.2.4. SCF
SCF, also known as Kit ligand, has been reported to be expressed by a variety of cell types
including vascular EC [182, 183]. Previous reports indicate that within the CNS, SCF/Kit-ligand
signaling influences oligodendrocyte precursors prior to differentiation towards a myelinated
phenotype. Although Kit belongs to the same class of tyrosine kinase receptors as PDGF
receptors, their effects on NSPC are different. In nestin+ NSCs isolated from embryonic rat
cortex, more than 93% express SCF. More recent studies demonstrate that SCF acts as a
chemoattractant and survival factor for NSPCs during early stages of differentiation while
having no effect on proliferation or differentiation [184-186].
5.2.5. PEDF
PEDF is secreted by a variety of cell types, and can interact with the ECM, most notably
collagen-I [187-189]. Being the first soluble factor shown to selectively activate type B NSC,
PEDF seems to contribute to stem cell maintenance within the neurogenic niche. In the adult
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mouse brain, expression is restricted to endothelial and ependymal cells, suggesting that PEDF
is in fact a niche-derived signal. Accordingly, Western blot analysis on conditioned media from
cultures indicate that PEDF is specifically secreted by endothelial and ependymal cells [144,
190, 191]. Aside from acting as a brake on cell cycle progression by promoting NSC self-renewal
without affecting proliferation [192], recent evidence suggests an additional role in renewing
symmetric divisions. Interestingly, PEDF has been implicated in regulating certain aspects of
Notch signaling by modulating the NFκB pathway. The role of Notch signaling in NSC
maintenance is well characterized [193], and NSC treated with PEDF upregulate Notch
effectors Hes1 and Hes5, as well as the Sry-related HMG box-transcription factor Sox2 [194].
In cells with low levels of Notch signaling, PEDF enhances Notch-dependent transcription by
relieving repression of Notch-responsive promoters by the transcriptional co-repressor N-
CoR, thereby potentiating symmetric cell division [195]. Additionally, BrdU-labeled mice
treated with PEDF display an increase in the number of BrdU+GFAP+ cells, and injection with
a C-terminal blocking peptide to PEDF reveals no significant change in the number of BrdU
+GFAP+ cells compared with vehicle-injected controls. Taken together, these data suggest that
PEDF may not be a survival factor for NSC, and may instead serve to activate NSC by
stimulating self-renewal [194].
5.2.6. Nitric Oxide (NO)
A variety of mechanisms have been proposed for NO regulation of NSPC, perhaps accounting
for conflicting studies suggesting opposing roles on NSPC proliferation. Early reports
demonstrated a role for NO in the repression of adult neurogenesis, as exposure to NOS
inhibitors L-NAME and 7-NI increased neurogenesis in the dentate gyrus and SVZ [165, 166,
196, 197]. However, its effects seem to depend on the signaling pathway involved. Potentially
through NO-induced S-nitrosylation of the EGFR [198], NO inhibits PI3K/Akt signaling to
suppress NSPC proliferation, both in culture and in vivo [199]. However, bypassing the EGFR
induces proliferation through activation of p21Ras, leading to an increase in activation levels
of c-Myc, p90RSK and Elk-1, and subsequent reduction in p27Kip1 [200]. BDNF may be involved
in this process as well, as its stimulatory effect on neuronal differentiation is blocked by L-
NAME. Interestingly, NSC express and release NO, suggesting a feedback mechanism
whereby NSC-produced NO induces production of BDNF from the vascular bed [201]. EC also
produce NO via eNOS, and a decrease in SVZ cell proliferation and migration post-stroke is
observed in eNOS-deficient mice. Interestingly, BDNF levels are also reduced in eNOS-/-
ischemic mice, and BDNF treatment rescues the decrease in neurosphere formation, prolifer‐
ation, and neurite outgrowth in cultured eNOS-/- neurospheres [202].
5.2.7. Vascular ECM: Laminins, collagens, fractones
The ECM is an integral component of the NSC niche, regulating signaling by providing,
storing, and compartmentalizing growth factors and cytokines indispensable for proliferation,
differentiation and adhesion. Within the SVZ, a unique basal lamina, rich in laminins,
collagen-1 and collagen IV, extends from perivascular cells as ‘fractones’ [203]. Each fractone
consists of a base, attached to the perivascular cell, a stem that crosses the SVZ, and bulbs that
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may be mediated in part through estrogen signaling, as estrogen antagonists reduce neuro‐
genesis within the dentate gyrus [171]. From a clinical standpoint, IGF-1 may be involved in
neurodegenerative disease progression, such as Alzheimer’s and stroke, where levels of
circulating IGF-1 are altered [170].
5.2.3. PDGF
PDGF signaling has been shown to affect stem cell properties and lineage bias [98, 172].
Vascular EC secrete PDGF-B as a disulfide-linked homodimer (PDGF-BB), and via a specific
positively charged C-terminal retention motif, it interacts with heparin sulfate proteoglycans
within the ECM to aid in localized retention [173-176]. Specifically within the CNS, it regulates
oligodendrocyte precursor cell number. Interestingly, PDGF-B is implicated in brain tumor
formation, where activation of its signaling pathway is present in more than 80% oligoden‐
drogliomas and 50–100% of astrocytomas[177]. Thus, identifying which cells respond to PDGF
is crucial to elucidate mechanisms involved in these brain cancers.
In the SVZ, putative NSC and most GFAP+ cells have been shown to express PDGFRα, and
become activated in the presence of PDGF-AA [178]. Accordingly, PDGF is reported to have
mitogenic and differentiation actions on neural progenitor cells [179-181], and synergy with
bFGF has been reported to enhance neurosphere generation [178]. After intracerebroventric‐
ular infusion of PDGF-AA, astrocyte-derived periventricular hyperplasias are formed, and
increases in oligodendrogenesis are observed at the expense of olfactory bulb neurogenesis.
While EGF infusion elicits a similar proliferative response in the SVZ, staining for PDGFRα
and EGFR reveals expression in distinct populations, suggesting that they label stem cells and
transit-amplifying progenitors, respectively. Conversely, conditional ablation of PDGRα in the
SVZ decreases oligodendrogenesis while having little effect on neurogenesis [178]. Thus,
PDGF signaling may play a role in maintaining the balance between neurogenesis and
oligodendrogenesis.
5.2.4. SCF
SCF, also known as Kit ligand, has been reported to be expressed by a variety of cell types
including vascular EC [182, 183]. Previous reports indicate that within the CNS, SCF/Kit-ligand
signaling influences oligodendrocyte precursors prior to differentiation towards a myelinated
phenotype. Although Kit belongs to the same class of tyrosine kinase receptors as PDGF
receptors, their effects on NSPC are different. In nestin+ NSCs isolated from embryonic rat
cortex, more than 93% express SCF. More recent studies demonstrate that SCF acts as a
chemoattractant and survival factor for NSPCs during early stages of differentiation while
having no effect on proliferation or differentiation [184-186].
5.2.5. PEDF
PEDF is secreted by a variety of cell types, and can interact with the ECM, most notably
collagen-I [187-189]. Being the first soluble factor shown to selectively activate type B NSC,
PEDF seems to contribute to stem cell maintenance within the neurogenic niche. In the adult
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mouse brain, expression is restricted to endothelial and ependymal cells, suggesting that PEDF
is in fact a niche-derived signal. Accordingly, Western blot analysis on conditioned media from
cultures indicate that PEDF is specifically secreted by endothelial and ependymal cells [144,
190, 191]. Aside from acting as a brake on cell cycle progression by promoting NSC self-renewal
without affecting proliferation [192], recent evidence suggests an additional role in renewing
symmetric divisions. Interestingly, PEDF has been implicated in regulating certain aspects of
Notch signaling by modulating the NFκB pathway. The role of Notch signaling in NSC
maintenance is well characterized [193], and NSC treated with PEDF upregulate Notch
effectors Hes1 and Hes5, as well as the Sry-related HMG box-transcription factor Sox2 [194].
In cells with low levels of Notch signaling, PEDF enhances Notch-dependent transcription by
relieving repression of Notch-responsive promoters by the transcriptional co-repressor N-
CoR, thereby potentiating symmetric cell division [195]. Additionally, BrdU-labeled mice
treated with PEDF display an increase in the number of BrdU+GFAP+ cells, and injection with
a C-terminal blocking peptide to PEDF reveals no significant change in the number of BrdU
+GFAP+ cells compared with vehicle-injected controls. Taken together, these data suggest that
PEDF may not be a survival factor for NSC, and may instead serve to activate NSC by
stimulating self-renewal [194].
5.2.6. Nitric Oxide (NO)
A variety of mechanisms have been proposed for NO regulation of NSPC, perhaps accounting
for conflicting studies suggesting opposing roles on NSPC proliferation. Early reports
demonstrated a role for NO in the repression of adult neurogenesis, as exposure to NOS
inhibitors L-NAME and 7-NI increased neurogenesis in the dentate gyrus and SVZ [165, 166,
196, 197]. However, its effects seem to depend on the signaling pathway involved. Potentially
through NO-induced S-nitrosylation of the EGFR [198], NO inhibits PI3K/Akt signaling to
suppress NSPC proliferation, both in culture and in vivo [199]. However, bypassing the EGFR
induces proliferation through activation of p21Ras, leading to an increase in activation levels
of c-Myc, p90RSK and Elk-1, and subsequent reduction in p27Kip1 [200]. BDNF may be involved
in this process as well, as its stimulatory effect on neuronal differentiation is blocked by L-
NAME. Interestingly, NSC express and release NO, suggesting a feedback mechanism
whereby NSC-produced NO induces production of BDNF from the vascular bed [201]. EC also
produce NO via eNOS, and a decrease in SVZ cell proliferation and migration post-stroke is
observed in eNOS-deficient mice. Interestingly, BDNF levels are also reduced in eNOS-/-
ischemic mice, and BDNF treatment rescues the decrease in neurosphere formation, prolifer‐
ation, and neurite outgrowth in cultured eNOS-/- neurospheres [202].
5.2.7. Vascular ECM: Laminins, collagens, fractones
The ECM is an integral component of the NSC niche, regulating signaling by providing,
storing, and compartmentalizing growth factors and cytokines indispensable for proliferation,
differentiation and adhesion. Within the SVZ, a unique basal lamina, rich in laminins,
collagen-1 and collagen IV, extends from perivascular cells as ‘fractones’ [203]. Each fractone
consists of a base, attached to the perivascular cell, a stem that crosses the SVZ, and bulbs that
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terminate just underneath the ependymal layer [204]. The branched configuration of fractones
has been suggested to enable sequestration and subsequent presentation of growth factors and
other signaling molecules to stem cells and progenitors to regulate their proliferation, activa‐
tion, and differentiation within the niche [205].
Other important ECM molecules secreted by niche cells are laminin and fibronectin, both of
which have been implicated in neural stem cell growth, differentiation, and migration. In
addition to promoting neuroepithelial proliferation and differentiation during development,
they also function as permissive substrates, supporting the migration of cerebellar neural
precursors in vitro and neural progenitors through the RMS in vivo [206]. Most recently, the
importance of laminin–integrin interactions within the SVZ support a role in migration,
spreading and proliferation of NSPC [37]. Several in vitro studies have highlighted a critical
role for β1-integrin in mediating multiple effects of ECM on NSC in a temporally and spatially
controlled manner. For example, genetic ablation of β1-integrin results in reduced neural
progenitor proliferation, increased cell death, and impairment of cell migration on different
ECM substrates [207]. In β1-integrin-deficient neurospheres, β1-integrin signaling is not
required for NSC maintenance, and instead seems to cooperate with growth factor signaling
to regulate progenitor number [208]. In vivo, the role of laminins in migration and recruitment
are critical, as injection of intact laminin and peptide infusion mimicking the E8 domain of the
laminin α chain dramatically redirect neuroblast migration towards the site of administration.
Interestingly, inhibiting the α6 or β1 subunits with antibodies also recapitulates the migratory
defect without causing neuroblast death [209].
Collagen IV and chondroitin sulfate proteoglycans (CSPG) are also present in the microenvir‐
onment, and have been demonstrated to exert control over proliferation, leading to differen‐
tiation. While collagen IV inhibits proliferation of rat NSPCs and promotes differentiation into
neurons [210], treatment of neurospheres or telencephalic ventricles with enzymes degrading
CSPG glycosminoglycans leads to a reduction in cell proliferation and self-renewal of radial
glia; interestingly, the increase in astrocyte formation is at the expense of neuronal differen‐
tiation [211]. Additionally, sulfation of chondroitin sulfate polymers in vitro modulates the
activities and effects of various growth and morphogenetic factors that control NSC prolifer‐
ation, maintenance, and differentiation [212].
5.3. Other putative endothelial-derived niche effectors
5.3.1. FGF-2
FGF-2 (aka (b)FGF) is detected in the endothelium of tumor capillaries in vivo, as well as at
sites of vessel branching within the basal lamina of capillaries. In vitro studies suggest
significant amounts of FGF-2 can also localize to the ECM in cell culture. Normally found to
be extracellular, FGF-2 is reported to modulate cell function in an autocrine manner, and
depending on the molecular weight isoform, may or may not be secreted; secreted FGF acts
through intracellular signaling mechanisms [213]. While EC can secrete this potent angiogenic
factor [214] to regulate proliferation, migration and differentiation, type B NSC respond to
[113, 215-218] and express the corresponding receptor [178, 219, 220]. Within the CNS, FGF-2
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has been shown to affect neurogenesis and proliferation of cortical progenitors [220-222].
Interestingly, FGF-2 infusion increases adult SVZ proliferation while decreasing the number
of newly born neurons, suggesting that FGF-2 serves to maintain SVZ self-renewal [223]. In
fact, Fgf-2 knockout mice display a decrease in olfactory bulb size, presumably owing to
attentuated output from neurogenic regions. Although FGF-2 can promote NSC proliferation,
it does not act alone to maintain self-renewal, and must work with other factors to accomplish
this [37]. In addition to inducing VEGF expression in EC, FGF-2 can prime neural precursor
responsiveness towards EGF [218].
5.3.2. EGF & Betacellulin
While the specific cell type(s) expressing and secreting EGF remains unidentified within the
adult NSC niche, several reports suggest an EC orgin. Affymetrix microarray analysis has
revealed that human dermal microvascular EC express EGF, and that this expression is further
upregulated in coculture with head and neck squamous cell carcinoma cells [224]. Similarly,
an antibody-based human cytokine array has demonstrated that EGF is expressed and secreted
by dermal microvascular endothelial cells with or without VEGF stimulation, suggesting basal
expression of EGF within some EC [146]. Within the SVZ, receptors for EGF are predominantly
expressed by the type C transit-amplifying cells apposed to capillaries. Furthermore, EGFR
expression can be further induced by SDF-1 and PEDF [34, 85, 225, 226]. Intraventricular
infusion of EGF increases the number of type B NSC contacting the ventricle [219], and leads
to transit-amplifying cell proliferation while arresting neuroblast production. In vitro, EGF
stimulates neurosphere generation from transit-amplifying cells, and is said to cause reversion
to a more ‘stem-like’ phenotype [219]. Curiously, transit-amplifying cells with elevated EGFR
signaling also show non-cell autonomous defects in Notch signaling, leading to elevated Numb
levels in the stem compartment [227].
Recently, another member of the EGF family, BTC, has been shown to play a critical role in
SVZ regulation. mRNA transcripts for BTC are detectable in EC, and immunofluorescent
analysis reveals protein expression in EC of microcapillaries and in the choroid plexus, with
the latter demonstrating greater expression. After intraventricular infusion, NSC and neuro‐
blast compartments are expanded, promoting neurogenesis both in the olfactory bulb and the
dentate gyrus. Defects in neuroblast regeneration are observed post cytosine-β-arabinofura‐
noside (Ara-C) infusion in Btc-null mice in comparison to wild-type littermates. Although
related to EGF, its effects in the SVZ are slightly different, and it has been suggested that its
ability to act on distinct receptors expressed on NSC and neuroblasts, EGFR and Erb4 respec‐
tively, may account for these differential effects.
5.3.3. BMPs & LIF & IL-6
In addition to high levels of BMP2 and BMP4 production in astroglia within the SVZ, it has
been demonstrated that brain EC can act as potential sources of BMP. mRNA transcripts for
BMP2 and BMP4 were found in the bEnd.3 endothelial cell line, as well as in primary brain
EC. Furthermore, BMP4 protein was also detected in these brain EC [228]. Shown to counteract
neurogenesis in vitro and in vivo [229-231], BMP signaling increases astrocyte formation,
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terminate just underneath the ependymal layer [204]. The branched configuration of fractones
has been suggested to enable sequestration and subsequent presentation of growth factors and
other signaling molecules to stem cells and progenitors to regulate their proliferation, activa‐
tion, and differentiation within the niche [205].
Other important ECM molecules secreted by niche cells are laminin and fibronectin, both of
which have been implicated in neural stem cell growth, differentiation, and migration. In
addition to promoting neuroepithelial proliferation and differentiation during development,
they also function as permissive substrates, supporting the migration of cerebellar neural
precursors in vitro and neural progenitors through the RMS in vivo [206]. Most recently, the
importance of laminin–integrin interactions within the SVZ support a role in migration,
spreading and proliferation of NSPC [37]. Several in vitro studies have highlighted a critical
role for β1-integrin in mediating multiple effects of ECM on NSC in a temporally and spatially
controlled manner. For example, genetic ablation of β1-integrin results in reduced neural
progenitor proliferation, increased cell death, and impairment of cell migration on different
ECM substrates [207]. In β1-integrin-deficient neurospheres, β1-integrin signaling is not
required for NSC maintenance, and instead seems to cooperate with growth factor signaling
to regulate progenitor number [208]. In vivo, the role of laminins in migration and recruitment
are critical, as injection of intact laminin and peptide infusion mimicking the E8 domain of the
laminin α chain dramatically redirect neuroblast migration towards the site of administration.
Interestingly, inhibiting the α6 or β1 subunits with antibodies also recapitulates the migratory
defect without causing neuroblast death [209].
Collagen IV and chondroitin sulfate proteoglycans (CSPG) are also present in the microenvir‐
onment, and have been demonstrated to exert control over proliferation, leading to differen‐
tiation. While collagen IV inhibits proliferation of rat NSPCs and promotes differentiation into
neurons [210], treatment of neurospheres or telencephalic ventricles with enzymes degrading
CSPG glycosminoglycans leads to a reduction in cell proliferation and self-renewal of radial
glia; interestingly, the increase in astrocyte formation is at the expense of neuronal differen‐
tiation [211]. Additionally, sulfation of chondroitin sulfate polymers in vitro modulates the
activities and effects of various growth and morphogenetic factors that control NSC prolifer‐
ation, maintenance, and differentiation [212].
5.3. Other putative endothelial-derived niche effectors
5.3.1. FGF-2
FGF-2 (aka (b)FGF) is detected in the endothelium of tumor capillaries in vivo, as well as at
sites of vessel branching within the basal lamina of capillaries. In vitro studies suggest
significant amounts of FGF-2 can also localize to the ECM in cell culture. Normally found to
be extracellular, FGF-2 is reported to modulate cell function in an autocrine manner, and
depending on the molecular weight isoform, may or may not be secreted; secreted FGF acts
through intracellular signaling mechanisms [213]. While EC can secrete this potent angiogenic
factor [214] to regulate proliferation, migration and differentiation, type B NSC respond to
[113, 215-218] and express the corresponding receptor [178, 219, 220]. Within the CNS, FGF-2
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has been shown to affect neurogenesis and proliferation of cortical progenitors [220-222].
Interestingly, FGF-2 infusion increases adult SVZ proliferation while decreasing the number
of newly born neurons, suggesting that FGF-2 serves to maintain SVZ self-renewal [223]. In
fact, Fgf-2 knockout mice display a decrease in olfactory bulb size, presumably owing to
attentuated output from neurogenic regions. Although FGF-2 can promote NSC proliferation,
it does not act alone to maintain self-renewal, and must work with other factors to accomplish
this [37]. In addition to inducing VEGF expression in EC, FGF-2 can prime neural precursor
responsiveness towards EGF [218].
5.3.2. EGF & Betacellulin
While the specific cell type(s) expressing and secreting EGF remains unidentified within the
adult NSC niche, several reports suggest an EC orgin. Affymetrix microarray analysis has
revealed that human dermal microvascular EC express EGF, and that this expression is further
upregulated in coculture with head and neck squamous cell carcinoma cells [224]. Similarly,
an antibody-based human cytokine array has demonstrated that EGF is expressed and secreted
by dermal microvascular endothelial cells with or without VEGF stimulation, suggesting basal
expression of EGF within some EC [146]. Within the SVZ, receptors for EGF are predominantly
expressed by the type C transit-amplifying cells apposed to capillaries. Furthermore, EGFR
expression can be further induced by SDF-1 and PEDF [34, 85, 225, 226]. Intraventricular
infusion of EGF increases the number of type B NSC contacting the ventricle [219], and leads
to transit-amplifying cell proliferation while arresting neuroblast production. In vitro, EGF
stimulates neurosphere generation from transit-amplifying cells, and is said to cause reversion
to a more ‘stem-like’ phenotype [219]. Curiously, transit-amplifying cells with elevated EGFR
signaling also show non-cell autonomous defects in Notch signaling, leading to elevated Numb
levels in the stem compartment [227].
Recently, another member of the EGF family, BTC, has been shown to play a critical role in
SVZ regulation. mRNA transcripts for BTC are detectable in EC, and immunofluorescent
analysis reveals protein expression in EC of microcapillaries and in the choroid plexus, with
the latter demonstrating greater expression. After intraventricular infusion, NSC and neuro‐
blast compartments are expanded, promoting neurogenesis both in the olfactory bulb and the
dentate gyrus. Defects in neuroblast regeneration are observed post cytosine-β-arabinofura‐
noside (Ara-C) infusion in Btc-null mice in comparison to wild-type littermates. Although
related to EGF, its effects in the SVZ are slightly different, and it has been suggested that its
ability to act on distinct receptors expressed on NSC and neuroblasts, EGFR and Erb4 respec‐
tively, may account for these differential effects.
5.3.3. BMPs & LIF & IL-6
In addition to high levels of BMP2 and BMP4 production in astroglia within the SVZ, it has
been demonstrated that brain EC can act as potential sources of BMP. mRNA transcripts for
BMP2 and BMP4 were found in the bEnd.3 endothelial cell line, as well as in primary brain
EC. Furthermore, BMP4 protein was also detected in these brain EC [228]. Shown to counteract
neurogenesis in vitro and in vivo [229-231], BMP signaling increases astrocyte formation,
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possibly through activation of transcriptional regulators of Smads to control cell-cycle exit.
Indeed, when embryonic and adult NSPC are cocultured with brain EC, the canonical BMP/
Smad pathway becomes activated to reduce proliferation and induce NSPC cell-cycle exit in
the presence of EGF and FGF-2 [228]. LIF and IL-6 belong to the cohort of endothelial-secreted
factors that promote self-renewal of adult NSC [232], and when synergize with BMP factors
to promote self-renewal of embryonic stem cells through activation of gp130-mediated STAT
signaling, which induces astrogenesis [232, 233].
5.3.4. SDF-1 & growth-related oncogene-α & angiopoietin
A chemokine previously shown to direct migration of leukocytes during inflammation, SDF-1/
CXCL12 signaling via its CXCR4 receptor also provides migratory cues for NSPC recruitment
from the lateral ventricle to the nascent dentate gyrus during CNS development; interestingly,
SDF-1/CXCR4 expression by EC and neurons persists in the adult dentate gyrus. In the SVZ,
neural cells express CXCR4 while ependymal cells and vascular EC express SDF-1 [226].
Neuroblasts expressing CXCR4 migrate towards and are attracted to activated EC of cerebral
vessels that secrete SDF-1α [234-238]. While neurospheres express CXCR4, human cerebral EC
have been shown to secrete growth-related oncogene-α, also a ligand for CXCR4 [239]. More
recently, evidence of progenitor homing to SVZ EC in a SDF1/CXCR4-dependent manner has
been demonstrated, where SDF1 upregulates EGFR and α6-integrin in activated NSC and
transit amplifying cells, thereby enhancing activation state and the binding to laminin on
resident vessels. SDF1 was also shown to increase the motility of migrating neuroblasts
towards the olfactory bulb [34, 226].
Recent reports also suggest shared receptor/cytokine signaling between NSC and the vascu‐
lature concerning growth related CXCR4/oncogene-α and Ang-1/Tie2 [240, 241]. Ang-1 can be
expressed by EC, as well as mural cells, and seems to be upregulated poststroke. While also
having a general neuroprotective effect on the nervous system, it has been shown to directly
regulate stem cell differentiation and migration through the Tie2 and CXCR4 receptors [235,
237, 242-244].
5.3.5. TGF-β1
Latent TGF-β1 is secreted by EC, pericytes, glia and neurons. Reported to induce VEGF
expression by vascular EC and gliomas [245, 246], TGF-β1 serves as an important neurogenic
growth factor. Produced in a latent form in mesenchymal and epithelial cell types, EC and
mural cells have also been shown to produce a latent form of TGF-β1 which can be activated
in endothelial cell-mural cell cocultures [247, 248]. Because Tgf-β1 knockout mouse models
demonstrate a reduced potential for neuron survival [249], and transgenic mouse models
overexpressing Tgf-β1 under control of the GFAP promoter show a reduction in NSCP
proliferation [250], it is believed that TGF-β1 has no impact on NSP identity or on differentia‐
tion. Rather, it is believed to affect proliferative potential, as demonstrated by an arrest in the
G0/G1 phase of the cell cycle [251]. In cell culture, NSC and progenitors express TGFβRI, II
and III, and TGF-β1 decreases the expansion of these cells in a dose-dependent manner [252].
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5.3.6. Ephs and ephrins
Belonging to a family of receptor tyrosine kinases and associated transmembrane ligands,
Ephrins and Eph receptors have established roles in vascular development. However, more
recent data suggest both a role for Eph receptor and ephrin ligand interaction within the CNS,
and this interaction can occur between endothelial and nonvascular tissues. For example,
during development, the close proximity of EphB3/4 on intersomitic vessels with ephrin-
B1/B2 of somites seems to imply bidirectional communication [253]. Within the SVZ, EphA7
seems to localize to ependymal cells and astrocytes. Interestingly, the cells immunoreactive
for EphA7 also express nestin, a marker associated with NSC. Additionally, ephrin-B2/3 is
localized to SVZ astrocytes. By contrast, ephrin-A2 is predominantly expressed on transit-
amplifying cells and neuroblasts [254, 255]. Although ephrin-B2 is not cell type exclusive
within the SVZ, it has been shown to selectively mark arterial endothelium in the adult, as well
as surrounding smooth muscle cells and pericytes [256]. While EphA7 and ephrin-A2 nega‐
tively regulate NSPC proliferation, EphB1–2/EphA4 and ephrin-B2/3 direct neuroblast
migration and directly or indirectly regulate NSPC proliferation. Interestingly, infusion of
antibody-clustered ephrin-B2-Fc or EphB2-Fc into the lateral ventricle increases SVZ prolifer‐
ation, suggesting that B-class ephrins and Ephs may promote proliferation [254, 255, 257]. A
correlation between EphB2 and Notch signaling has also been proposed, wherein EphB2 acts
downstream of Notch to maintain ependymal identity under homeostatic conditions, while
regulating conversion to astrocytes after injury [258].
5.4. Circulating effectors:
5.4.1. Erythropoietin & prolactin
Systemic transport of erythropoietins and prolactins via blood circulation has been dem‐
onstrated to have effects within the CNS. Prolactin, in cooperation with TGF-α, promotes
SVZ proliferation and neuronal differentiation. It has been proposed that prolactin serves
as an important contributor to the increase in neurogenesis during pregnancy [259]; how‐
ever, the responsiveness to prolactin within the dentate gyrus is negligible [259, 260]. Al‐
though erythropoietin synthesis can be activated in astrocytes and neurons [261-263], it is
also possible that circulating erythropoietin, from the kidneys, can cross the BBB to exert
neuroprotective  effects.  Significant  amounts  of  the  erythropoietin  receptor  are  localized
to the surface of EC and within caveoli [264, 265], and systemic administration of eryth‐
ropoietin has been shown to penetrate the BBB as an intact molecule [266]. These obser‐
vations  certainly  suggest  that  erythropoietin  can  reach  the  brain;  however,  the  precise
mechanism mediating this transport is unknown. Erythropoietin has been shown to stim‐
ulate NSPC production and prevent apoptosis during embryonic development. Addition‐
ally, it serves as a paracrine neuroprotective mediator of ischemia in the brain [267], and
erythropoietin-activated  EC promote  the  migration  of  neuroblasts  through the  secretion
of MMP-2 and 9. [268]. Thus, further investigation of the penetrance and potential func‐
tion of erythropoietin in the adult NSC niche is warranted.
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Its remarkable ability to penetrate throughout the entire body to regulate and respond to
distinct microenvironments simultaneously has truly earned the vasculature the term of
‘master regulator’. It plays a crucial role in embryonic and adult neurogenesis, where its
secretion and/or systemic circulation of growth factors, serves to regulate the growth and
behavior of stem and progenitor cells. Although a handful of signaling molecules have been
identified thus far, it is likely that there are many more unidentified effectors that influence
NSC behavior. From a neuro-regenerative perspective, identifying factors responsible for
modulating specific stem cell behaviors is crucial, whether the goal is preventing further tissue
loss or potentiating endogenous repair mechanisms. Towards this goal, stem cell-based
therapies offer the intriguing possibility of accomplishing both. Therefore, understanding the
intrinsic and extrinsic mechanisms responsible for modulating NSPC behavior will be critical
for the development of more targeted therapies. As mounting evidence points to a strong
interdependent relationship between neurogenesis and the vasculature, therapies aimed at
targeting both compartments hold great promise.
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1. Introduction
The discovery of neural stem cells (NSCs) at the beginning of the nineties led many people to
consider definitively broken the dogma of a static central nervous system (CNS) made up of
non-renewable elements [1-3]. In parallel, the occurrence and characterization of adult
neurogenesis in the olfactory bulb and hippocampus [3-5] triggered new hopes for brain repair.
Twenty years after, the dream of regenerative medicine applied to brain/spinal cord injuries
and neurodegenerative diseases is still very far [6,7]. As a matter of fact, adult neurogenesis
in mammals occurs mainly within two restricted areas known as ‘neurogenic sites’ [3,8]: the
forebrain subventricular zone (SVZ); reviewed in [9] and the hippocampal dentate gyrus
(subgranular zone, SGZ); reviewed in [10]. As a direct consequence of such topographical
localization, most of the CNS parenchyma out of the two ‘classic’ neurogenic sites remains
substantially a non-renewable tissue. Actually, most of the traumatic/vascular injuries and
neurodegenerative diseases do occur in ‘non-neurogenic’ regions and no efficacious therapies
capable of restoring CNS structure and functions through cell replacement are at present
available. Thus, two decades after the discovery of NSCs and the reaching of a satisfactory
characterization of adult neurogenic sites, a gap remains between the occurrence of stem/
progenitor cells in the CNS of adult mammals and their effective capability to serve in brain
repair. Several aspects do converge in explaining this gap [11], partially accounting for the
heterogeneity of CNS structural plasticity in mammals (summarized in Table 1)
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In this chapter the neurogenic/gliogenic potential of the mammalian brain parenchyma in
vivo will be analyzed with particular reference to variables involved in its heterogeneity (e.g.,
animal species, age, CNS regions; see Figure 1 and Table 1). In particular, these variables do
determine the tissue environment in which stem/progenitor cells are immersed, what seems
to be extremely important for their activity and outcome. In addition, the origin and nature of
stem/progenitor cells would also contribute to their neurogenic/gliogenic potential. It is now
well known that cells may have a broader potential than they normally exhibit in vivo when
Figure 1. Heterogeneity of postnatal ⁄ adult neurogenic processes in different mammals by considering different as‐
pects and mammalian species. B, Schematic summary of the main sources (progenitor cells) of adult mammalian neu‐
rogenesis, its outcome in vivo ⁄ in culture system, and its possible activation after lesion. In the case of many
parenchymal regions, some of these steps are still obscure. BLBP, brain lipid-binding protein; EGL, external germinal
layer; GABA, c-aminobutyric acid; Ng2, nerve ⁄ glial antigen 2 proteoglycan; NPY, Neuropeptide Y; SGZ, subgranular
zone; SPL, subpial layer; SVZ, subventricular zone; VMM, ventral migratory mass; VMS, ventrocaudal migratory stream;
MMS, medial migratory stream; DMS, dorsal migratory stream. Adapted from Ref [30].
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Figure 2. Schematic summary of the features and location of different neurogenic/gliogenic processes occurring
spontaneously in the CNS of postnatal and adult mammals. Red dots indicate newlyborn cells. SVZ, subventricular
zone; SGZ, subgranular zone; EGL, external germinal layer; SPL, subpial layer (rabbit); PSA, PSA-NCAM; Map5, microtu‐
bule-associated protein 1B; P23, postnatal day 23. Question marks indicate lack of knowledge about the origin, late
differentiative steps, and final integration of newly generated parenchymal neurons. Adapted from Ref [32].
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exposed to a different environment, either in vitro or in vivo [29]. Hence, in order to avoid one
of the most common misunderstandings, namely the confusion between occurrence of de
novo cell proliferation in the CNS tissue and existence of true gliogenic/neurogenic processes,
here the attention will be focused on the outcome(s) of the newly generated progeny [30].
A. Variables affecting the nature and features of adult neurogenesis
Animal species (animal world) General plasticity and persistent neurogenesis are usually reduced across phylogeny; in
parallel, the reparative/regenerative potential is also reduced
Animal species (mammals) Unlike previous belief and current bias, remarkable differences in the location and
extension of adult neurogenesis do exist among mammals
Age Some neurogenic processes are extensions of delayed developmental programs
(postnatal/protracted neurogenesis) whereas others persist throughout life (persistent
neurogenesis). All neurogenic processes are progressively reduced with age
Microenvironment (niche) A well defined neural stem cell niche sustains neurogenesis in neurogenic sites (SVZ,
SGZ), whereas a niche has not been characterized in parenchymal neurogenesis
Origin of stem/progenitor
cells
Neurogenic sites (SVZ, SGZ) directly derive from persistence and modification of pre-
existing, embryonic germinal layers, whereas for parenchymal cell genesis such direct
link is not clear
Location in the CNS Location either within a germinal layer-derived niche or in the parenchyma redirects to
the two previous points; in parenchymal neurogenesis many variations are linked to
local cues of the different CNS regions involved
Function In physiology: linked to the different ecological niches of the animals (present in all
animals)
In repair: linked to the species; in invertebrates and non-mammalian vertebrates the
physiological function is associated with function in repair, whereas in birds and
mammals it is only linked to physiology/homeostasis of specific systems
B. Main differences between cell genesis in adult neurogenic sites and in the parenchyma
Neurogenic sites Parenchyma
Location Restricted Widespread
Primary progenitor cells Stem cells Progenitors
Microenvironment Stem cell niche Mature neuropil
Origin Germinal layer-derived No direct link with germinal layers
Fate (progeny) Mainly neurons
(some astrocytes and oligodendrocytes)
Mainly glial cells
(some neurons)
Fate (process) Complete Incomplete
Table 1. Heterogeneity of adult neuro-glio-genesis
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Since developmental changes also account for loss of CNS reparative/regenerative capacities
and neuro-glio-genic potential, a paragraph will be devoted to the progenitor cell develop‐
mental origin. Then, a brief summary of comparative adult neurogenesis will be given.
Evolutionary explanations can provide an understanding of the logic followed (or not) by
neurogenic processes through phylogeny, also accounting for the failure in mammalian CNS
repair/regeneration and scarce usefulness of adult neurogenesis as a possible solution for brain
repair [31,32].
2. Developmental origin of adult neurogenic/gliogenic processes
What makes it possible the remarkable neurogenesis occurring in neurogenic sites is their
direct origin from embryonic germinal layers which retain stem/progenitor cells along with
the ‘niche’ environment allowing their activity [10,33]. The SVZ and SGZ actually are remnants
of their embryonic counterpart, from which they maintain several cellular and molecular
aspects [9] in parallel with an adaptation to the changing anatomy of the postnatal and adult
brain [34,35].
During development, the CNS originates from the neuroepithelium, pseudostratified epithe‐
lial cells that maintain contact with both the ventricular and pial surfaces. As brain thickness
increases, neuroepitheial cells transform into radial glia [33,36]. Beside their classic role as
scaffolding for migrating neurons during embryogenesis and their subsequent transformation
into parenchymal astrocytes of the mature CNS [37,38], radial glia cells behave as stem cells,
leading to the genesis of astrocytes, neurons [39,40], and, to a lesser extent, oligodendrocytes
[41]. Thus radial glial cells not only serve as progenitors for many neurons and glial cells soon
after birth, but also give rise to adult SVZ stem cells that continue to produce neurons
throughout adult life [41]. The origin of astrocytes that function as neural progenitors in the
adult hippocampus has not been determined experimentally. A connection to radial glial cells,
has been suggested even in the hippocampal SGZ [42,43]. The relationship of adult NSCs to
their developmental precursors offers clues to the unique characteristics that distinguish these
germinal astrocytes from other astroglial cells in the brain parenchyma [33]. Indeed, paren‐
chymal astrocytes lose very early their stem cell potential (around postnatal day 10 in mice
[44]), although they can still proliferate in the severe gliosis induced after lesion [45], and
resume multipotentiality in vitro [46].
On the other hand, gliogenesis persists throughout the CNS in the form of parenchymal cell
genesis capable of creating new oligodendrocytes and, to a lesser extent, astrocytes, throughout
life [12,15]. Most of this gliogenic activity is attributed to synantocytes/polydendrocytes (Ng2+
cells; see below) which are widespread in the CNS tissue and whose origin is still partially
obscure. Oligodendrocytes originate from migratory and mitotic embryonic precursors which
progressively mature into postmitotic myelin-producing cells. The sequential expression of
developmental markers defines distinct phenotypic stages in the oligodendrocyte lineage,
characterized by proliferative capacities, migratory abilities and changes in morphology. Most
knowledge on this issue comes from studies on the rodent embryonic spinal cord. The first
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exposed to a different environment, either in vitro or in vivo [29]. Hence, in order to avoid one
of the most common misunderstandings, namely the confusion between occurrence of de
novo cell proliferation in the CNS tissue and existence of true gliogenic/neurogenic processes,
here the attention will be focused on the outcome(s) of the newly generated progeny [30].
A. Variables affecting the nature and features of adult neurogenesis
Animal species (animal world) General plasticity and persistent neurogenesis are usually reduced across phylogeny; in
parallel, the reparative/regenerative potential is also reduced
Animal species (mammals) Unlike previous belief and current bias, remarkable differences in the location and
extension of adult neurogenesis do exist among mammals
Age Some neurogenic processes are extensions of delayed developmental programs
(postnatal/protracted neurogenesis) whereas others persist throughout life (persistent
neurogenesis). All neurogenic processes are progressively reduced with age
Microenvironment (niche) A well defined neural stem cell niche sustains neurogenesis in neurogenic sites (SVZ,
SGZ), whereas a niche has not been characterized in parenchymal neurogenesis
Origin of stem/progenitor
cells
Neurogenic sites (SVZ, SGZ) directly derive from persistence and modification of pre-
existing, embryonic germinal layers, whereas for parenchymal cell genesis such direct
link is not clear
Location in the CNS Location either within a germinal layer-derived niche or in the parenchyma redirects to
the two previous points; in parenchymal neurogenesis many variations are linked to
local cues of the different CNS regions involved
Function In physiology: linked to the different ecological niches of the animals (present in all
animals)
In repair: linked to the species; in invertebrates and non-mammalian vertebrates the
physiological function is associated with function in repair, whereas in birds and
mammals it is only linked to physiology/homeostasis of specific systems
B. Main differences between cell genesis in adult neurogenic sites and in the parenchyma
Neurogenic sites Parenchyma
Location Restricted Widespread
Primary progenitor cells Stem cells Progenitors
Microenvironment Stem cell niche Mature neuropil
Origin Germinal layer-derived No direct link with germinal layers
Fate (progeny) Mainly neurons
(some astrocytes and oligodendrocytes)
Mainly glial cells
(some neurons)
Fate (process) Complete Incomplete
Table 1. Heterogeneity of adult neuro-glio-genesis
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Since developmental changes also account for loss of CNS reparative/regenerative capacities
and neuro-glio-genic potential, a paragraph will be devoted to the progenitor cell develop‐
mental origin. Then, a brief summary of comparative adult neurogenesis will be given.
Evolutionary explanations can provide an understanding of the logic followed (or not) by
neurogenic processes through phylogeny, also accounting for the failure in mammalian CNS
repair/regeneration and scarce usefulness of adult neurogenesis as a possible solution for brain
repair [31,32].
2. Developmental origin of adult neurogenic/gliogenic processes
What makes it possible the remarkable neurogenesis occurring in neurogenic sites is their
direct origin from embryonic germinal layers which retain stem/progenitor cells along with
the ‘niche’ environment allowing their activity [10,33]. The SVZ and SGZ actually are remnants
of their embryonic counterpart, from which they maintain several cellular and molecular
aspects [9] in parallel with an adaptation to the changing anatomy of the postnatal and adult
brain [34,35].
During development, the CNS originates from the neuroepithelium, pseudostratified epithe‐
lial cells that maintain contact with both the ventricular and pial surfaces. As brain thickness
increases, neuroepitheial cells transform into radial glia [33,36]. Beside their classic role as
scaffolding for migrating neurons during embryogenesis and their subsequent transformation
into parenchymal astrocytes of the mature CNS [37,38], radial glia cells behave as stem cells,
leading to the genesis of astrocytes, neurons [39,40], and, to a lesser extent, oligodendrocytes
[41]. Thus radial glial cells not only serve as progenitors for many neurons and glial cells soon
after birth, but also give rise to adult SVZ stem cells that continue to produce neurons
throughout adult life [41]. The origin of astrocytes that function as neural progenitors in the
adult hippocampus has not been determined experimentally. A connection to radial glial cells,
has been suggested even in the hippocampal SGZ [42,43]. The relationship of adult NSCs to
their developmental precursors offers clues to the unique characteristics that distinguish these
germinal astrocytes from other astroglial cells in the brain parenchyma [33]. Indeed, paren‐
chymal astrocytes lose very early their stem cell potential (around postnatal day 10 in mice
[44]), although they can still proliferate in the severe gliosis induced after lesion [45], and
resume multipotentiality in vitro [46].
On the other hand, gliogenesis persists throughout the CNS in the form of parenchymal cell
genesis capable of creating new oligodendrocytes and, to a lesser extent, astrocytes, throughout
life [12,15]. Most of this gliogenic activity is attributed to synantocytes/polydendrocytes (Ng2+
cells; see below) which are widespread in the CNS tissue and whose origin is still partially
obscure. Oligodendrocytes originate from migratory and mitotic embryonic precursors which
progressively mature into postmitotic myelin-producing cells. The sequential expression of
developmental markers defines distinct phenotypic stages in the oligodendrocyte lineage,
characterized by proliferative capacities, migratory abilities and changes in morphology. Most
knowledge on this issue comes from studies on the rodent embryonic spinal cord. The first
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oligodendrocyte-committed cell appears at embryonic day 12 (E12) in two columns in the
ventral ventricular zone of the motor neuron progenitor domain [47], which is defined by the
expression of Olig2 [48]. The embryonic oligodendrocyte precursors are identified by their
expression of platelet-derived growth factor alpha receptor (PDGFRα) [49]. The appearence
of the oligodendrocyte lineage-associated markers Olig2 (essential for oligodendrocyte
specification and differentiation) and PDGFRα (which permits the expansion of the original
precursor population) is dependent on the concentrations of Sonic hedgehog (Shh) [50,51]. One
or two days after their appearance, PDGFRα+ cells exit the ventricular zone and expand by
local proliferation and migration first in the ventral spinal cord region and then dorsally [52].
Finally, they occupy the entire parenchyma by the time of birth [49]. A dorsal source of
oligodendrocyte precursors was also shown to contribute to oligodendrogenesis in the spinal
cord and hindbrain [53,54]. Fate mapping experiments revealed a double source of oligoden‐
drocyte precursors in the forebrain: cells expressing oligodendrocyte lineage markers, such as
Olig1, Olig2, Sox10 and PDGFRα, first appear ventrally, in the neuroepithelium of the medial
ganglionic eminence, and then migrate laterally and dorsally into all parts of the developing
forebrain by E16 to birth [55]. However, several studies have provided evidence for a dorsal
and later source of oligodendrocyte precursors in the lateral and/or caudal ganglionic emi‐
nence(s), which constitute a second wave of cells invading the cortex only by E18 [54,56].
Nevertheless, adult oligodendrocyte derive only by dorsal precursors, since medial ganglionic
eminence-derived precursors were demonstrated to completely disappear after birth [56]. On
the whole, it is thought that a unique oligodendrocyte population can derive from progenitor
domains defined by different signaling molecules, in contrast to what has been established for
neuronal specification during embryonic development, where different parts of the ventricular
zone generate distinct types of neurons. In the rodent CNS, once PDGFRα+ cells have left the
ventricular zone, they start to be termed ‘oligodendrocyte progenitor cells’ and acquire their
most typical marker: an integral membrane chondroitin sulphate proteoglycan named Ng2
(nerve/glial antigen 2). Ng2 expression becomes detectable only at E14 [57], thus, from E17 to
adulthood all PDGFRα+ cells are Ng2+, and, conversely, all the parenchymal (non-vascular)
Ng2+ cells are PDGFRα+ [57,58]. Early embryonic Ng2+/PDGFαR+ OPCs are small, undiffer‐
entiated, proliferative and motile cells [59]. During embryogenesis, their morphology changes
rapidly from a simple oval or polygonal cell body with few unbranched processes to a more
differentiated and branched shape with a smaller cell soma [57,60].
Coming back to adult neurogenesis, non mammalian vertebrates including fish, amphibians,
and reptiles harbor a more widespread genesis of neurons in the parenchyma. Such processes,
due to their location, are apparently independent from the primitive germinal layers. Never‐
theless, recent studies which analysed in more detail the origin of adult neurogenesis in fish
show that all neurogenic processes likely originate from remnants of the germinal layers;
reviewed in [61]. Teleost proliferation zones reflect a general proliferation pattern along the
ventricular walls of the brain, distinctly localized in all its subdivisions along the rostrocaudal
axis. Between 12 and 16 distinct proliferation zones have been recognized in different teleost
species [61]. Hence, across different animal classes, most stem cell populations retain contact
to the ventricular system, and they appear as neuroepithelial cells, radial glial or astroglial cell
types. The different shapes of these progenitors have been suggested to be a secondary
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consequence of the architecture of the developing parenchyma overlying the ventricular stem
cell zone of the embryo [9]. This common pattern across animal species, along with data
reported above on the origin of cycling glial progenitors in mammals, indirectly suggests that
adult parenchymal neuro-glio-genesis ultimately derives from embryonic germinal layers, yet
being able to persist independently in some cases.
3. Comparative adult neurogenesis and brain repair
Unlike  mammals,  other  classes  of  vertebrates  including  fish,  amphibians,  and  reptiles,
harbor a more widespread adult neurogenesis in the parenchyma. In these animals, stem
and progenitor cells, in addition to their role in physiological plasticity, also participate in
brain repair and regeneration. Failure in mammalian brain repair after traumatic,  vascu‐
lar,  and  neurodegenerative  injuries  is  due  to:  i)  a  strong  reduction  in  the  extension  of
neurogenic regions within the whole CNS; ii) a substantial lack of CNS reparative/regener‐
ative  capacity;  iii)  the  fact  that  adult  neurogenic  sites  subserve  specific  physiological
functions rather than brain repair;  for review, see [11,62,63].  It  is  important to note that
although the occurrence of good neurogenic potentials would generally favor brain repair
(at  least  by making available stem/progenitor  cells)  there is  not  a  direct,  linear relation‐
ship  between  occurrence  of  stem/progenitor  cells  and  repair/regeneration,  the  latter
processes strongly depending on the tissue environment and/or tissue reactions; for selected
examples of neurogenesis and regeneration see [64].
Neurogenic processes are detectable in wide regions of the CNS in invertebrates and non-
mammalian vertebrates [61,65,66], whereas in mammals they are restricted to two privileged
areas (neurogenic sites) and the remaining CNS is largely made up of non-renewable tissue
[30,67,68]. The state of substantial ‘general plasticity’ and cell renewal existing in the oldest
living metazoans, so that all cell types, including neurons, are balanced in their production
and loss [69,70], is progressively reduced in vertebrates, although fish and amphibians still
maintain remarkable regenerative capacities [71,72]. Then, in birds and mammals a transition
between regeneration permissive and non-permissive stages occurs soon after birth, and
highly-restricted spots of adult neurogenesis subserve homeostatic functions in specific neural
circuits [73,74]. The decrease in neurogenic abilities occurs in parallel with topographical/
numerical restriction of germinal layer-derived stem cell niches, whereas the decrease in
regenerative abilities occurs in parallel with other aspects: the impossibility to re-access to
embryonic developmental programs during adulthood [75], the lack of differentiated cells
capable of dedifferentiation [76], the development of a strong immune surveillance [77] and
the consequent tissue reactions, most of which detrimental (reviewed in [11,64]). In some cases,
the stem cells found in the CNS of non-mammalian vertebrates are deployed for postnatal
development of parts of the brain until the final structure is reached. In other cases, postnatal
neurogenesis continues into adulthood leading to a net increase of the number of neurons with
age. Finally, in other cases, stem cells fuel neuronal turnover. An example is the protracted
development of the cerebellar granular layer in mammals, which in adult teleosts actually
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oligodendrocyte-committed cell appears at embryonic day 12 (E12) in two columns in the
ventral ventricular zone of the motor neuron progenitor domain [47], which is defined by the
expression of Olig2 [48]. The embryonic oligodendrocyte precursors are identified by their
expression of platelet-derived growth factor alpha receptor (PDGFRα) [49]. The appearence
of the oligodendrocyte lineage-associated markers Olig2 (essential for oligodendrocyte
specification and differentiation) and PDGFRα (which permits the expansion of the original
precursor population) is dependent on the concentrations of Sonic hedgehog (Shh) [50,51]. One
or two days after their appearance, PDGFRα+ cells exit the ventricular zone and expand by
local proliferation and migration first in the ventral spinal cord region and then dorsally [52].
Finally, they occupy the entire parenchyma by the time of birth [49]. A dorsal source of
oligodendrocyte precursors was also shown to contribute to oligodendrogenesis in the spinal
cord and hindbrain [53,54]. Fate mapping experiments revealed a double source of oligoden‐
drocyte precursors in the forebrain: cells expressing oligodendrocyte lineage markers, such as
Olig1, Olig2, Sox10 and PDGFRα, first appear ventrally, in the neuroepithelium of the medial
ganglionic eminence, and then migrate laterally and dorsally into all parts of the developing
forebrain by E16 to birth [55]. However, several studies have provided evidence for a dorsal
and later source of oligodendrocyte precursors in the lateral and/or caudal ganglionic emi‐
nence(s), which constitute a second wave of cells invading the cortex only by E18 [54,56].
Nevertheless, adult oligodendrocyte derive only by dorsal precursors, since medial ganglionic
eminence-derived precursors were demonstrated to completely disappear after birth [56]. On
the whole, it is thought that a unique oligodendrocyte population can derive from progenitor
domains defined by different signaling molecules, in contrast to what has been established for
neuronal specification during embryonic development, where different parts of the ventricular
zone generate distinct types of neurons. In the rodent CNS, once PDGFRα+ cells have left the
ventricular zone, they start to be termed ‘oligodendrocyte progenitor cells’ and acquire their
most typical marker: an integral membrane chondroitin sulphate proteoglycan named Ng2
(nerve/glial antigen 2). Ng2 expression becomes detectable only at E14 [57], thus, from E17 to
adulthood all PDGFRα+ cells are Ng2+, and, conversely, all the parenchymal (non-vascular)
Ng2+ cells are PDGFRα+ [57,58]. Early embryonic Ng2+/PDGFαR+ OPCs are small, undiffer‐
entiated, proliferative and motile cells [59]. During embryogenesis, their morphology changes
rapidly from a simple oval or polygonal cell body with few unbranched processes to a more
differentiated and branched shape with a smaller cell soma [57,60].
Coming back to adult neurogenesis, non mammalian vertebrates including fish, amphibians,
and reptiles harbor a more widespread genesis of neurons in the parenchyma. Such processes,
due to their location, are apparently independent from the primitive germinal layers. Never‐
theless, recent studies which analysed in more detail the origin of adult neurogenesis in fish
show that all neurogenic processes likely originate from remnants of the germinal layers;
reviewed in [61]. Teleost proliferation zones reflect a general proliferation pattern along the
ventricular walls of the brain, distinctly localized in all its subdivisions along the rostrocaudal
axis. Between 12 and 16 distinct proliferation zones have been recognized in different teleost
species [61]. Hence, across different animal classes, most stem cell populations retain contact
to the ventricular system, and they appear as neuroepithelial cells, radial glial or astroglial cell
types. The different shapes of these progenitors have been suggested to be a secondary
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consequence of the architecture of the developing parenchyma overlying the ventricular stem
cell zone of the embryo [9]. This common pattern across animal species, along with data
reported above on the origin of cycling glial progenitors in mammals, indirectly suggests that
adult parenchymal neuro-glio-genesis ultimately derives from embryonic germinal layers, yet
being able to persist independently in some cases.
3. Comparative adult neurogenesis and brain repair
Unlike  mammals,  other  classes  of  vertebrates  including  fish,  amphibians,  and  reptiles,
harbor a more widespread adult neurogenesis in the parenchyma. In these animals, stem
and progenitor cells, in addition to their role in physiological plasticity, also participate in
brain repair and regeneration. Failure in mammalian brain repair after traumatic,  vascu‐
lar,  and  neurodegenerative  injuries  is  due  to:  i)  a  strong  reduction  in  the  extension  of
neurogenic regions within the whole CNS; ii) a substantial lack of CNS reparative/regener‐
ative  capacity;  iii)  the  fact  that  adult  neurogenic  sites  subserve  specific  physiological
functions rather than brain repair;  for review, see [11,62,63].  It  is  important to note that
although the occurrence of good neurogenic potentials would generally favor brain repair
(at  least  by making available stem/progenitor  cells)  there is  not  a  direct,  linear relation‐
ship  between  occurrence  of  stem/progenitor  cells  and  repair/regeneration,  the  latter
processes strongly depending on the tissue environment and/or tissue reactions; for selected
examples of neurogenesis and regeneration see [64].
Neurogenic processes are detectable in wide regions of the CNS in invertebrates and non-
mammalian vertebrates [61,65,66], whereas in mammals they are restricted to two privileged
areas (neurogenic sites) and the remaining CNS is largely made up of non-renewable tissue
[30,67,68]. The state of substantial ‘general plasticity’ and cell renewal existing in the oldest
living metazoans, so that all cell types, including neurons, are balanced in their production
and loss [69,70], is progressively reduced in vertebrates, although fish and amphibians still
maintain remarkable regenerative capacities [71,72]. Then, in birds and mammals a transition
between regeneration permissive and non-permissive stages occurs soon after birth, and
highly-restricted spots of adult neurogenesis subserve homeostatic functions in specific neural
circuits [73,74]. The decrease in neurogenic abilities occurs in parallel with topographical/
numerical restriction of germinal layer-derived stem cell niches, whereas the decrease in
regenerative abilities occurs in parallel with other aspects: the impossibility to re-access to
embryonic developmental programs during adulthood [75], the lack of differentiated cells
capable of dedifferentiation [76], the development of a strong immune surveillance [77] and
the consequent tissue reactions, most of which detrimental (reviewed in [11,64]). In some cases,
the stem cells found in the CNS of non-mammalian vertebrates are deployed for postnatal
development of parts of the brain until the final structure is reached. In other cases, postnatal
neurogenesis continues into adulthood leading to a net increase of the number of neurons with
age. Finally, in other cases, stem cells fuel neuronal turnover. An example is the protracted
development of the cerebellar granular layer in mammals, which in adult teleosts actually
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becomes a persistent neurogenesis, where the granular layer continuously grows and no
definite adult cerebellar size is reached [61].
In addition, when considering mammals, the failure in CNS repair is a result of evolutionary
constraints in which the injured tissue would not favor a strategy of regeneration but rather
one of minimizing further damage (e.g., gliotic reaction [78]). Hence, as a consequence of
multiple, converging aspects, CNS regenerative capacity in mammals could have reached a
point of non-return, in parallel with the persistence of some neurogenic processes which
remain mainly focused on physiological functions (e.g., cell renewal/addition in selective
neural circuits linked to learning/memory tasks [73,74]).
An increased consciousness that the scarce reparative capacity of the mammalian CNS
depends on multiple aspects should indicate that it is very unlike the finding of a single
molecular factor or pharmacological treatment capable of eliciting repair/regeneration.
Comparative results from vertebrate species of different classes have demonstrated that adult
neurogenesis is widespread among vertebrates but is employed by different species in
different functional contexts [74,79,80], and a growing number of reports show a remarkable
heterogeneity even among mammals [17-19]. This variability concerns both the organization/
extension/function of the two neurogenic sites and many examples of parenchymal neuro‐
genesis; reviewed in [30] (see below). This fact, along with our still incomplete knowledge of
adult neurogenesis in humans (especially within the parenchyma), partially hampers the
reaching of well established ‘common rules’ which might be used in the translation of
experimental preclinical data to human medicine. Thus, dealing with mammalian CNS
structural plasticity, high levels of heterogeneity involving different ‘types’ of neurogenic
processes should be taken into account.
4. Heterogeneity of cell genesis in the mammalian CNS
We now know that ‘classic’ neurogenic sites are consistently present in all mammals studied,
although with some differences, particularly when the outcome(s) of the neurogenic process
are involved [30]. The occurrence of a rostral migratory stream which is active throughout life
in rodents but temporally restricted to the postnatal period in humans [81] is a prototypical
example of variability among mammals. Indeed, in humans this neurogenic process seems to
fall in a delayed developmental process rather than adult neurogenesis (see below).
In addition to neurogenic sites, studies carried out during the last two decades revealed the
presence of local, parenchymal progenitors which retain some proliferative capacity in most
of the mature mammalian CNS [12,14,15,17-19,82] (Figure 1). This fact suggests that structural
plasticity involving de novo cell genesis in the CNS could be more widespread than previously
thought. As a consequence of the increasing number of reports investigating adult neurogen‐
esis in mammals, our perception of this biological process has gained new perspectives and
nuances; for deeper analysis see [30,66,83,84]. What was previously thought as “the genesis of
new neurons in restricted brain areas endowed with NSCs”, can now be intended as a highly
heterogeneous phenomenon (summarized in Figures 1 and 2), whose heterogeneity depends
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on several variables (see Table 1). The main elements of heterogeneity can be summarized as
follows: i) the location of progenitors (gathered within restricted neurogenic sites or widely
spread out in the parenchyma); ii) the nature of the progenitors (bona fide NSCs versus different
types of progenitors); iii) the genetic and molecular features of the progenitors (cell lineage:
neuronal-like versus glial-like; identification of differentiative stages dependent on the
available markers); iv) the existence or not of well characterized neurogenic niches (absence
of niches or occurrence of atypical/non-identified niches in the parenchyma?); v) the extension
in time after birth (protracted, transient persistent neurogenesis); vi) the ultimate fate of the
progeny in terms of cell lineage (neuronal versus glial; astrocytic versus oligodendrocytic); vii)
the ultimate fate of the progeny in terms of cell integration into circuits (complete versus
incomplete neurogenesis); viii) the spontaneous occurrence of the process versus its injury-
induced appearance. This latter point could be considered a further step beyond the so-called
‘constitutive’ neurogenesis, namely the spontaneous, continuous genesis of new neurons as
part of a physiologic, homeostatic process [85].
Due to the multifaceted aspects of the above mentioned processes, some problems of termi‐
nology can also be raised (see Refs. [30,32]). A common misunderstanding consists of a
different use of the word ‘neurogenesis’, which can be intended either as ‘genesis of neurons’
or as ‘genesis of neural cells’, i.e. neurons and glia. Embryonic neurogenesis, namely the
process of building up the whole CNS, involves both neuro- and glio-genesis, occurring in
largely overlapping and strictly intermingled phases, whereas neurogenesis and gliogenesis
can occur separately in the adult. The landscape is even more complex, since research on adult
neurogenesis brought developmental neuroscience within the mature brain, and the intermix
of structurally plastic changes involving cell genesis/differentiation with the fully assembled
adult tissue is accompanied by a previously unexpected intermix of cell lineages (e.g., newly
formed neuroblasts arising from astrocytic-like stem cells in vivo). For this reason, in this review
article, when not speaking of well characterized cell lineages, the notion of ‘cell genesis’ instead
of ‘neurogenesis’ will be used, since in most ‘neurogenic’ processes different cell types can be
considered among the progenitors, and different progenies can be generated. Hence, apart
from detailed knowledge gathered around the activity of SVZ and SGZ neurogenic sites, many
aspects of parenchymal cell genesis remain obscure and/or unesplored, as a consequence of
the heterogeneity depicted above. In the last few years, parenchymal neuro-glio-genesis was
among the most studied, yet less known, issues, due to the widespread location of the
progenitor cells and to the substantial lack of markers which specifically identify their real
origin as well as the stage-specific steps of their differentiation. As a consequence, the presence/
absence of neurogenic processes within different CNS parenchymal regions in different
mammalian species is still quite controversial and debatable. In most cases, parenchymal cell
genesis occurs at low levels, at the limit of technical detection. Furthermore, in some cases it
is very difficult to show its final outcome(s), most of the parenchymal neurogenesis appearing
‘incomplete’ as to the final differentiation/integration of the progeny [30] (Figure 2). Finally,
to correctly classify both germinal layer-derived and parenchymal neurogenesis some other
aspects should be taken into account, such as the temporal extension of ‘protracted’/’transi‐
ent’developmental neurogenic processes with respect to a ‘constitutive’/’persistent’ neuro‐
genesis [30]. A further aspect is that of lesion-induced neuro-glio-genesis, namely the genesis
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becomes a persistent neurogenesis, where the granular layer continuously grows and no
definite adult cerebellar size is reached [61].
In addition, when considering mammals, the failure in CNS repair is a result of evolutionary
constraints in which the injured tissue would not favor a strategy of regeneration but rather
one of minimizing further damage (e.g., gliotic reaction [78]). Hence, as a consequence of
multiple, converging aspects, CNS regenerative capacity in mammals could have reached a
point of non-return, in parallel with the persistence of some neurogenic processes which
remain mainly focused on physiological functions (e.g., cell renewal/addition in selective
neural circuits linked to learning/memory tasks [73,74]).
An increased consciousness that the scarce reparative capacity of the mammalian CNS
depends on multiple aspects should indicate that it is very unlike the finding of a single
molecular factor or pharmacological treatment capable of eliciting repair/regeneration.
Comparative results from vertebrate species of different classes have demonstrated that adult
neurogenesis is widespread among vertebrates but is employed by different species in
different functional contexts [74,79,80], and a growing number of reports show a remarkable
heterogeneity even among mammals [17-19]. This variability concerns both the organization/
extension/function of the two neurogenic sites and many examples of parenchymal neuro‐
genesis; reviewed in [30] (see below). This fact, along with our still incomplete knowledge of
adult neurogenesis in humans (especially within the parenchyma), partially hampers the
reaching of well established ‘common rules’ which might be used in the translation of
experimental preclinical data to human medicine. Thus, dealing with mammalian CNS
structural plasticity, high levels of heterogeneity involving different ‘types’ of neurogenic
processes should be taken into account.
4. Heterogeneity of cell genesis in the mammalian CNS
We now know that ‘classic’ neurogenic sites are consistently present in all mammals studied,
although with some differences, particularly when the outcome(s) of the neurogenic process
are involved [30]. The occurrence of a rostral migratory stream which is active throughout life
in rodents but temporally restricted to the postnatal period in humans [81] is a prototypical
example of variability among mammals. Indeed, in humans this neurogenic process seems to
fall in a delayed developmental process rather than adult neurogenesis (see below).
In addition to neurogenic sites, studies carried out during the last two decades revealed the
presence of local, parenchymal progenitors which retain some proliferative capacity in most
of the mature mammalian CNS [12,14,15,17-19,82] (Figure 1). This fact suggests that structural
plasticity involving de novo cell genesis in the CNS could be more widespread than previously
thought. As a consequence of the increasing number of reports investigating adult neurogen‐
esis in mammals, our perception of this biological process has gained new perspectives and
nuances; for deeper analysis see [30,66,83,84]. What was previously thought as “the genesis of
new neurons in restricted brain areas endowed with NSCs”, can now be intended as a highly
heterogeneous phenomenon (summarized in Figures 1 and 2), whose heterogeneity depends
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on several variables (see Table 1). The main elements of heterogeneity can be summarized as
follows: i) the location of progenitors (gathered within restricted neurogenic sites or widely
spread out in the parenchyma); ii) the nature of the progenitors (bona fide NSCs versus different
types of progenitors); iii) the genetic and molecular features of the progenitors (cell lineage:
neuronal-like versus glial-like; identification of differentiative stages dependent on the
available markers); iv) the existence or not of well characterized neurogenic niches (absence
of niches or occurrence of atypical/non-identified niches in the parenchyma?); v) the extension
in time after birth (protracted, transient persistent neurogenesis); vi) the ultimate fate of the
progeny in terms of cell lineage (neuronal versus glial; astrocytic versus oligodendrocytic); vii)
the ultimate fate of the progeny in terms of cell integration into circuits (complete versus
incomplete neurogenesis); viii) the spontaneous occurrence of the process versus its injury-
induced appearance. This latter point could be considered a further step beyond the so-called
‘constitutive’ neurogenesis, namely the spontaneous, continuous genesis of new neurons as
part of a physiologic, homeostatic process [85].
Due to the multifaceted aspects of the above mentioned processes, some problems of termi‐
nology can also be raised (see Refs. [30,32]). A common misunderstanding consists of a
different use of the word ‘neurogenesis’, which can be intended either as ‘genesis of neurons’
or as ‘genesis of neural cells’, i.e. neurons and glia. Embryonic neurogenesis, namely the
process of building up the whole CNS, involves both neuro- and glio-genesis, occurring in
largely overlapping and strictly intermingled phases, whereas neurogenesis and gliogenesis
can occur separately in the adult. The landscape is even more complex, since research on adult
neurogenesis brought developmental neuroscience within the mature brain, and the intermix
of structurally plastic changes involving cell genesis/differentiation with the fully assembled
adult tissue is accompanied by a previously unexpected intermix of cell lineages (e.g., newly
formed neuroblasts arising from astrocytic-like stem cells in vivo). For this reason, in this review
article, when not speaking of well characterized cell lineages, the notion of ‘cell genesis’ instead
of ‘neurogenesis’ will be used, since in most ‘neurogenic’ processes different cell types can be
considered among the progenitors, and different progenies can be generated. Hence, apart
from detailed knowledge gathered around the activity of SVZ and SGZ neurogenic sites, many
aspects of parenchymal cell genesis remain obscure and/or unesplored, as a consequence of
the heterogeneity depicted above. In the last few years, parenchymal neuro-glio-genesis was
among the most studied, yet less known, issues, due to the widespread location of the
progenitor cells and to the substantial lack of markers which specifically identify their real
origin as well as the stage-specific steps of their differentiation. As a consequence, the presence/
absence of neurogenic processes within different CNS parenchymal regions in different
mammalian species is still quite controversial and debatable. In most cases, parenchymal cell
genesis occurs at low levels, at the limit of technical detection. Furthermore, in some cases it
is very difficult to show its final outcome(s), most of the parenchymal neurogenesis appearing
‘incomplete’ as to the final differentiation/integration of the progeny [30] (Figure 2). Finally,
to correctly classify both germinal layer-derived and parenchymal neurogenesis some other
aspects should be taken into account, such as the temporal extension of ‘protracted’/’transi‐
ent’developmental neurogenic processes with respect to a ‘constitutive’/’persistent’ neuro‐
genesis [30]. A further aspect is that of lesion-induced neuro-glio-genesis, namely the genesis
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of new cells as a consequence of different types of CNS injury [18,25,26,86] or altered homeo‐
stasis [87]. This is an important point since many lines of research in the field of neural repair
directed to manipulate stem cells in the perspective of intracerebral transplantation did not
produced substantial therapeutic innovations. As an alternative, another approach might be
that of stimulating/modulating the endogenous sources of cell progenitors present both in
germinal layer-derived stem cell niches (SVZ and hippocampus) and in the parenchyma.
5. Parenchymal neurogenesis
Spontaneous (constitutive) parenchymal neurogenesis can be considered as a very rare
phenomenon in mammals, and its regional location has been shown to be dependent on the
animal species, age, and physiological⁄pathological states [30]. Different examples of neuro‐
genesis occurring outside the two neurogenic sites have been described in rodents [17,82],
rabbits [18,19] and monkeys [22,88]. Remarkable differences can be observed between closely
related orders (e.g., rodents and lagomorphs [18,19]), between species (e.g., rat and mouse
[17,23,89,90]), and even different strains [91,92].
Most parenchymal neurogenesis described in adult rodents seems to occur spontaneously at
very low levels, rather being elicited/enhanced after specific physiological or pathological
conditions [17,82,86,87] (see below). Dayer and colleagues [17] showed the occurrence of new
neurons in the deep layers of the rat cerebral cortex. By labelling newlyborn cells with multiple
intra-peritoneal injections of BrdU and using markers of both immature and mature neurons
to characterize the new cells through a detailed confocal analysis at different survival times,
they demonstrated genesis of new GABAergic interneurons in both neocortex and striatum.
At 4-5 weeks survival time, the 0.4 +/- 0.13% of the BrdU+ cells were mature NeuN+ neurons
in the neocortex. Morphologic and phenotypic analyses assert these cells belong to different
categories of cortical interneurons. Interestingly, although several BrdU+/DCX+/Tuc4+
neuroblasts were identified close to the SVZ periventricular region, the great majority of
cortical BrdU+ cells were positive for Ng2. From these data the Authors suggested that adult
cortical newborn interneurons might originate from in situ progenitors. Other examples of
spontaneous parenchymal neurogenesis have been described in lagomorphs. In rabbits, newly
generated neurons are spontaneously produced in other regions of the adult brain starting
from local, parenchymal progenitors. In the caudate nucleus, newly formed neuroblasts form
longitudinally-arranged, doublecortin (DCX) and PSA-NCAM immunoreactive striatal chains
similar to the SVZ chains [18]. These neuroblasts are generated from clusters of proliferating
cells which express the astroglial marker brain lipid binding protein (BLBP), and about 1/6 of
surviving cells differentiate into calretinin striatal interneurons. Always in rabbits, in sharp
contrast with our common knowledge concerning the CNS of other mammals studied so far,
a remarkable genesis of cells is detectable in the peripuberal, and to a lesser extent, adult
cerebellar cortex [19]. Systemically-administered BrdU detected at different post-injection
survival times (up to two months) reveals newly generated PSA-NCAM+/DCX+/Pax2+
interneurons of neuroepithelial origin homogeneously distributed in the cerebellar cortex.
Thus, in the striatal and cerebellar parenchyma of lagomorphs new neurons are generated
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independently from the remnants of germinal layers, yet their final outcome and their role in
the adult neural circuits remains obscure; reviewed in [30].
The heterogeneity in parenchymal neurogenesis adds to that described for neurogenic
processes occurring in adult neurogenic sites, which have been related to adaptation to
ecological pressures [80]. At present, this is one of the most satisfactory functional explanations
for adult neurogenesis in the entire phylogenetic tree, along with multiple, genetically-
determined variables spanning from the brain anatomy/developmental history to the animal
lifespan [93]. This range of possibilities can also be increased by non-genetic variables, such as
experience-dependent cues [79,80].
Among the unsolved issues of parenchymal neurogenesis are the numerous reports which
have not been confirmed by further studies or by other laboratories [22,23,26,94-96], along with
a series of data which have been denied in studies trying to reproduce the same results
[24,97-99]. Without entering in the scientific and technical discussion about these controversies,
it is evident that we still not grasp the real limits of parenchymal neurogenesis and that further
studies are required before finally accept or deny the existence of some neurogenic processes.
A case placed in between the spontaneous and experimentally-induced neurogenesis, is that
of the hypothalamus. Several publications based on experiments carried out on rodents have
been reporting data on this brain region as a new site for adult constitutive neurogenesis in
mammals (for review see [100]). Under physiological conditions, both in rats [101] and mice
[102,103], proliferative activity does occur in the ependymal layer of the third ventricle and
within the surrounding parenchyma. In rats, Xu and collaborators using electron microscopy
and immunohistochemistry showed that tanycytes lining the 3rd ventricle proliferate and
express molecules usually found in glial, stem-like progenitor cells, such as BLBP and nestin.
The presence of putative neural progenitors was further supported by the isolation of cells
able to give rise to neurospheres from the hypothalamus. One month after BrdU injection,
proliferating cells, some of which expressing Hu protein, were detected in the surrounding
parenchyma. Similar results were obtained in mice [102], yet in both rodent species no clear
evidence has supported constitutive and complete hypothalamic adult neurogenesis under
physiological conditions. A significant increase in hypothalamic proliferating cells can be
obtained by performing i.v. delivery of BrdU (350% more positive nuclei, in comparison to i.p.
treated animals), nevertheless, in spite of such cell proliferation the level of neurogenesis in
the intact hypothalamus seems to be arrested at a very premature stage. On the other hand,
growth factor infusion [82,101,104] or certain experimental conditions/models, such as
prolonged heat exposure [105] and the mutant mice investigated by Pierce and Xu (2010), seem
to increase neurogenesis in the hypothalamus. Intracerebroventricular infusion of insulin
growth factor I in rats [104] triggered an intense proliferation along the 3rd periventricular area
and in the parenchyma of the caudal hypothalamus. As concerns the genesis of new neurons,
after i.v. treatment with bFGF in rats [101], and CNTF in mice [82], it was shown that prolif‐
eration induced by growth factors can be followed by genesis of newborn neurons. Detailed
morphological and molecular analyses of the 3rd periventricular region of these animals
showed interesting architectural similarities with the SVZ neurogenic niche (e.g., proliferating
astroglial cells contacting the ventricle by an apical process bearing a single cilium), with
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of new cells as a consequence of different types of CNS injury [18,25,26,86] or altered homeo‐
stasis [87]. This is an important point since many lines of research in the field of neural repair
directed to manipulate stem cells in the perspective of intracerebral transplantation did not
produced substantial therapeutic innovations. As an alternative, another approach might be
that of stimulating/modulating the endogenous sources of cell progenitors present both in
germinal layer-derived stem cell niches (SVZ and hippocampus) and in the parenchyma.
5. Parenchymal neurogenesis
Spontaneous (constitutive) parenchymal neurogenesis can be considered as a very rare
phenomenon in mammals, and its regional location has been shown to be dependent on the
animal species, age, and physiological⁄pathological states [30]. Different examples of neuro‐
genesis occurring outside the two neurogenic sites have been described in rodents [17,82],
rabbits [18,19] and monkeys [22,88]. Remarkable differences can be observed between closely
related orders (e.g., rodents and lagomorphs [18,19]), between species (e.g., rat and mouse
[17,23,89,90]), and even different strains [91,92].
Most parenchymal neurogenesis described in adult rodents seems to occur spontaneously at
very low levels, rather being elicited/enhanced after specific physiological or pathological
conditions [17,82,86,87] (see below). Dayer and colleagues [17] showed the occurrence of new
neurons in the deep layers of the rat cerebral cortex. By labelling newlyborn cells with multiple
intra-peritoneal injections of BrdU and using markers of both immature and mature neurons
to characterize the new cells through a detailed confocal analysis at different survival times,
they demonstrated genesis of new GABAergic interneurons in both neocortex and striatum.
At 4-5 weeks survival time, the 0.4 +/- 0.13% of the BrdU+ cells were mature NeuN+ neurons
in the neocortex. Morphologic and phenotypic analyses assert these cells belong to different
categories of cortical interneurons. Interestingly, although several BrdU+/DCX+/Tuc4+
neuroblasts were identified close to the SVZ periventricular region, the great majority of
cortical BrdU+ cells were positive for Ng2. From these data the Authors suggested that adult
cortical newborn interneurons might originate from in situ progenitors. Other examples of
spontaneous parenchymal neurogenesis have been described in lagomorphs. In rabbits, newly
generated neurons are spontaneously produced in other regions of the adult brain starting
from local, parenchymal progenitors. In the caudate nucleus, newly formed neuroblasts form
longitudinally-arranged, doublecortin (DCX) and PSA-NCAM immunoreactive striatal chains
similar to the SVZ chains [18]. These neuroblasts are generated from clusters of proliferating
cells which express the astroglial marker brain lipid binding protein (BLBP), and about 1/6 of
surviving cells differentiate into calretinin striatal interneurons. Always in rabbits, in sharp
contrast with our common knowledge concerning the CNS of other mammals studied so far,
a remarkable genesis of cells is detectable in the peripuberal, and to a lesser extent, adult
cerebellar cortex [19]. Systemically-administered BrdU detected at different post-injection
survival times (up to two months) reveals newly generated PSA-NCAM+/DCX+/Pax2+
interneurons of neuroepithelial origin homogeneously distributed in the cerebellar cortex.
Thus, in the striatal and cerebellar parenchyma of lagomorphs new neurons are generated
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independently from the remnants of germinal layers, yet their final outcome and their role in
the adult neural circuits remains obscure; reviewed in [30].
The heterogeneity in parenchymal neurogenesis adds to that described for neurogenic
processes occurring in adult neurogenic sites, which have been related to adaptation to
ecological pressures [80]. At present, this is one of the most satisfactory functional explanations
for adult neurogenesis in the entire phylogenetic tree, along with multiple, genetically-
determined variables spanning from the brain anatomy/developmental history to the animal
lifespan [93]. This range of possibilities can also be increased by non-genetic variables, such as
experience-dependent cues [79,80].
Among the unsolved issues of parenchymal neurogenesis are the numerous reports which
have not been confirmed by further studies or by other laboratories [22,23,26,94-96], along with
a series of data which have been denied in studies trying to reproduce the same results
[24,97-99]. Without entering in the scientific and technical discussion about these controversies,
it is evident that we still not grasp the real limits of parenchymal neurogenesis and that further
studies are required before finally accept or deny the existence of some neurogenic processes.
A case placed in between the spontaneous and experimentally-induced neurogenesis, is that
of the hypothalamus. Several publications based on experiments carried out on rodents have
been reporting data on this brain region as a new site for adult constitutive neurogenesis in
mammals (for review see [100]). Under physiological conditions, both in rats [101] and mice
[102,103], proliferative activity does occur in the ependymal layer of the third ventricle and
within the surrounding parenchyma. In rats, Xu and collaborators using electron microscopy
and immunohistochemistry showed that tanycytes lining the 3rd ventricle proliferate and
express molecules usually found in glial, stem-like progenitor cells, such as BLBP and nestin.
The presence of putative neural progenitors was further supported by the isolation of cells
able to give rise to neurospheres from the hypothalamus. One month after BrdU injection,
proliferating cells, some of which expressing Hu protein, were detected in the surrounding
parenchyma. Similar results were obtained in mice [102], yet in both rodent species no clear
evidence has supported constitutive and complete hypothalamic adult neurogenesis under
physiological conditions. A significant increase in hypothalamic proliferating cells can be
obtained by performing i.v. delivery of BrdU (350% more positive nuclei, in comparison to i.p.
treated animals), nevertheless, in spite of such cell proliferation the level of neurogenesis in
the intact hypothalamus seems to be arrested at a very premature stage. On the other hand,
growth factor infusion [82,101,104] or certain experimental conditions/models, such as
prolonged heat exposure [105] and the mutant mice investigated by Pierce and Xu (2010), seem
to increase neurogenesis in the hypothalamus. Intracerebroventricular infusion of insulin
growth factor I in rats [104] triggered an intense proliferation along the 3rd periventricular area
and in the parenchyma of the caudal hypothalamus. As concerns the genesis of new neurons,
after i.v. treatment with bFGF in rats [101], and CNTF in mice [82], it was shown that prolif‐
eration induced by growth factors can be followed by genesis of newborn neurons. Detailed
morphological and molecular analyses of the 3rd periventricular region of these animals
showed interesting architectural similarities with the SVZ neurogenic niche (e.g., proliferating
astroglial cells contacting the ventricle by an apical process bearing a single cilium), with
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tanycytes as primary proliferating elements lining the 3rd ventricle [104]. Yet, additional studies
are necessary to clearly demonstrate/confirm whether hypothalamic newborn neurons
generated after physiological/pathological stimulation actually become part of the pre-existing
circuits playing a role in energy-balance mechanisms.
Taking into account the multifaceted aspects dealing with parenchymal neurogenesis,
difficulties encountered in such type of research are not only technical. They are also linked to
the occurrence of processes placed in the middle between two well characterized extremes of
structural plasticity, such as synaptic plasticity, and ‘complete’ adult neurogenesis. In a recent
review article [30] five levels have been dissected in the neurogenic processes in order to
critically evaluate/compare different parenchymal neurogenic events (see also Figure 2). The
subsequent steps span from cell division to possible integration of specified/differentiated
elements into the CNS tissue, and according to this view, only when any of the five steps are
filled the neurogenic process should be classified as ‘complete’. As a result, all the parenchymal
neurogenic processes described until now can actually be considered as incomplete. This could
explain why many claims of neurogenic processes were subsequently refuted because not
sustained by experimental evidence. The piriform cortex is one of those regions in which results
reported by different researchers are quite controversial; see for example [88,106-108]. Since
long time, this cortical region is known to harbor a population of neurons immunoreactive for
PSA-NCAM and DCX [108-110], which are two markers highly expressed in newly generated
neurons but also present in non newly generated cells [110]. Indeed, deeper investigations
have shown that the piriform cortex contains a population of immature, non-newly generated
neurons which display very few (or no) synapses and are frequently ensheathed by glial
lamellae [108]. These cells, by remaining in an immature state for indeterminate time, can
represent a ‘reservoir’ of neurons that could possibly be recruited into the preexisting neural
circuits although not generated ex novo [111].
In conclusion, alternative and multiple forms of plasticity involving neurons can overlap
within the so-called non-neurogenic tissue, affecting preexisting cells/circuits and increasing
the complexity of the whole picture of brain structural remodeling.
6. Lesion-induced (reactive) neurogenesis
Brain lesions have been shown to stimulate neurogenesis in normally non-neurogenic regions
such as the neocortex and the striatum. In the neocortex these responses are limited to specific
conditions such as targeted apoptosis or mild ischemia [23,86,112,113]. By contrast, several
lesion paradigms, associated to both strong or mild degeneration and inflammation, have been
shown to induce neurogenesis in the striatum [25,28,114]. It is unknown if lesioned neocortex
and striatum have distinct needs for immature neurons or if the neocortical tissue response is
more detrimental for neurogenesis. This fundamental point reveals our very poor knowledge
of lesion-induced neurogenesis. Indeed, despite an intense research, we have only little
information regarding the nature, fate and potential of the progenitors stimulated by brain
lesions, the mechanisms that trigger their activation and eventually their functional role.
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Initial studies in both cortex and striatum reported that a tiny fraction of lesion-induced
neurons may differentiate into projection neurons, suggesting that endogenous neuronal
progenitors may have the potential to replace degenerated neurons [23,25,115]. However, these
results have not been confirmed by others [28,116]. Moreover, it is now clear that most of the
lesion-induced neurons have a transient existence and, at least in the striatum, they do not
express markers of projection neurons nor transcription factors involved in their specification
[28,116]. Several attempts have been made to increase the survival of these cells, with little
success [117]. An intriguing possibility to be explored is that lesion-induced neuroblasts
occurring in multiple forms of brain injury are committed to transient neuronal types, which
contribute to restorative rather than replacement mechanisms [28,63]. This idea is further
supported by data showing that a transient existence often characterizes also cortical and
striatal neurons generated in normal conditions [18,89].
Neuronal progenitors in the SVZ and SGZ have been shown to respond to injuries by strongly
increasing their proliferation, in the SVZ, also migrating towards damaged regions [25,115].
In parallel, recent reports have showed that in the degenerated neocortex and striatum, new
neurons can also be produced locally from parenchymal neuronal progenitors [28,83,113]. In
the neocortex, Ohira et al. [86] showed that mild ischemia might stimulate the generation of
newborn GABAergic interneurons from progenitors residing in cortical layer I. These cells
were not quiescent in normal conditions as they expressed the endogeneous marker of cell
proliferation Ki67 and they could be labeled with retroviral vectors. Ohira and coworkers could
not define the exact nature of the parenchymal progenitors, which, intriguingly, are very close
to the leptomeninges, from which neuronal progenitors have been recently isolated [118,119].
More specific lineage tracing study will be necessary to confirm the real origin of neural
progenitors activated after lesion. Lineage tracing has shown that reactive astrocytes isolated
from the adult neocortex can give rise to neurospheres in vitro [46,120]. To date, the only in
vivo evidence that neocortical astrocytes can be neurogenic has been obtained in early post-
natal mice after hypoxia/Ischemia [113]. A recent study showed that even if the neural stem
cells derived from adult neocortical astrocytes maintain the capacity for self-renew when
transplanted in the SVZ, they were still unable to produce neurons [121]. This observation
casted some doubts over the actual role of these cells as neuronal progenitors in vivo. None‐
theless, this result may only indicate that the neurogenic potential of cortical and SVZ
progenitors rely on distinct factors.
Another example of the in vivo genesis of new neurons within the lesioned brain parenchyma
has been obtained in the striatum in a mice model of progressive striatal degeneration, the
Creb1CamkcreCrem-/- mutant mice (CBCM) [28,122]. In this model the SVZ acts as a source of
postmitotic neuroblasts that enter the striatum from a specific subcallosal migratory stream,
as individual elements. Luzzati and coworkers [28] showed that the striatum of CBCM mice
contains also tightly clustered neuroblasts which originate locally from parenchymal prolif‐
erating progenitors. These cells showed features of intermediate neuronal progenitors of the
SVZ and SGZ such as clustering and co-expression of glial (Sox2, Sox9, BLBP) and neuronal
markers (Dlx, Sp8, DCX), and the expression of the EGFr [123-126]. This study clearly shows
that the mature parenchyma can be permissive to neuronal genesis, although Luzzati and
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tanycytes as primary proliferating elements lining the 3rd ventricle [104]. Yet, additional studies
are necessary to clearly demonstrate/confirm whether hypothalamic newborn neurons
generated after physiological/pathological stimulation actually become part of the pre-existing
circuits playing a role in energy-balance mechanisms.
Taking into account the multifaceted aspects dealing with parenchymal neurogenesis,
difficulties encountered in such type of research are not only technical. They are also linked to
the occurrence of processes placed in the middle between two well characterized extremes of
structural plasticity, such as synaptic plasticity, and ‘complete’ adult neurogenesis. In a recent
review article [30] five levels have been dissected in the neurogenic processes in order to
critically evaluate/compare different parenchymal neurogenic events (see also Figure 2). The
subsequent steps span from cell division to possible integration of specified/differentiated
elements into the CNS tissue, and according to this view, only when any of the five steps are
filled the neurogenic process should be classified as ‘complete’. As a result, all the parenchymal
neurogenic processes described until now can actually be considered as incomplete. This could
explain why many claims of neurogenic processes were subsequently refuted because not
sustained by experimental evidence. The piriform cortex is one of those regions in which results
reported by different researchers are quite controversial; see for example [88,106-108]. Since
long time, this cortical region is known to harbor a population of neurons immunoreactive for
PSA-NCAM and DCX [108-110], which are two markers highly expressed in newly generated
neurons but also present in non newly generated cells [110]. Indeed, deeper investigations
have shown that the piriform cortex contains a population of immature, non-newly generated
neurons which display very few (or no) synapses and are frequently ensheathed by glial
lamellae [108]. These cells, by remaining in an immature state for indeterminate time, can
represent a ‘reservoir’ of neurons that could possibly be recruited into the preexisting neural
circuits although not generated ex novo [111].
In conclusion, alternative and multiple forms of plasticity involving neurons can overlap
within the so-called non-neurogenic tissue, affecting preexisting cells/circuits and increasing
the complexity of the whole picture of brain structural remodeling.
6. Lesion-induced (reactive) neurogenesis
Brain lesions have been shown to stimulate neurogenesis in normally non-neurogenic regions
such as the neocortex and the striatum. In the neocortex these responses are limited to specific
conditions such as targeted apoptosis or mild ischemia [23,86,112,113]. By contrast, several
lesion paradigms, associated to both strong or mild degeneration and inflammation, have been
shown to induce neurogenesis in the striatum [25,28,114]. It is unknown if lesioned neocortex
and striatum have distinct needs for immature neurons or if the neocortical tissue response is
more detrimental for neurogenesis. This fundamental point reveals our very poor knowledge
of lesion-induced neurogenesis. Indeed, despite an intense research, we have only little
information regarding the nature, fate and potential of the progenitors stimulated by brain
lesions, the mechanisms that trigger their activation and eventually their functional role.
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Initial studies in both cortex and striatum reported that a tiny fraction of lesion-induced
neurons may differentiate into projection neurons, suggesting that endogenous neuronal
progenitors may have the potential to replace degenerated neurons [23,25,115]. However, these
results have not been confirmed by others [28,116]. Moreover, it is now clear that most of the
lesion-induced neurons have a transient existence and, at least in the striatum, they do not
express markers of projection neurons nor transcription factors involved in their specification
[28,116]. Several attempts have been made to increase the survival of these cells, with little
success [117]. An intriguing possibility to be explored is that lesion-induced neuroblasts
occurring in multiple forms of brain injury are committed to transient neuronal types, which
contribute to restorative rather than replacement mechanisms [28,63]. This idea is further
supported by data showing that a transient existence often characterizes also cortical and
striatal neurons generated in normal conditions [18,89].
Neuronal progenitors in the SVZ and SGZ have been shown to respond to injuries by strongly
increasing their proliferation, in the SVZ, also migrating towards damaged regions [25,115].
In parallel, recent reports have showed that in the degenerated neocortex and striatum, new
neurons can also be produced locally from parenchymal neuronal progenitors [28,83,113]. In
the neocortex, Ohira et al. [86] showed that mild ischemia might stimulate the generation of
newborn GABAergic interneurons from progenitors residing in cortical layer I. These cells
were not quiescent in normal conditions as they expressed the endogeneous marker of cell
proliferation Ki67 and they could be labeled with retroviral vectors. Ohira and coworkers could
not define the exact nature of the parenchymal progenitors, which, intriguingly, are very close
to the leptomeninges, from which neuronal progenitors have been recently isolated [118,119].
More specific lineage tracing study will be necessary to confirm the real origin of neural
progenitors activated after lesion. Lineage tracing has shown that reactive astrocytes isolated
from the adult neocortex can give rise to neurospheres in vitro [46,120]. To date, the only in
vivo evidence that neocortical astrocytes can be neurogenic has been obtained in early post-
natal mice after hypoxia/Ischemia [113]. A recent study showed that even if the neural stem
cells derived from adult neocortical astrocytes maintain the capacity for self-renew when
transplanted in the SVZ, they were still unable to produce neurons [121]. This observation
casted some doubts over the actual role of these cells as neuronal progenitors in vivo. None‐
theless, this result may only indicate that the neurogenic potential of cortical and SVZ
progenitors rely on distinct factors.
Another example of the in vivo genesis of new neurons within the lesioned brain parenchyma
has been obtained in the striatum in a mice model of progressive striatal degeneration, the
Creb1CamkcreCrem-/- mutant mice (CBCM) [28,122]. In this model the SVZ acts as a source of
postmitotic neuroblasts that enter the striatum from a specific subcallosal migratory stream,
as individual elements. Luzzati and coworkers [28] showed that the striatum of CBCM mice
contains also tightly clustered neuroblasts which originate locally from parenchymal prolif‐
erating progenitors. These cells showed features of intermediate neuronal progenitors of the
SVZ and SGZ such as clustering and co-expression of glial (Sox2, Sox9, BLBP) and neuronal
markers (Dlx, Sp8, DCX), and the expression of the EGFr [123-126]. This study clearly shows
that the mature parenchyma can be permissive to neuronal genesis, although Luzzati and
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coworkers could not trace the origin of the observed striatal parenchymal neuronal progeni‐
tors. Nonetheless, two possibilities can be considered: i) striatal neuronal progenitors could
derive from the displacement of primary/intermediate progenitors from the SVZ; ii) they could
represent local cells becoming neurogenic in response to neurodegeneration.
Together, these data suggests that specific degenerative conditions can stimulate the produc‐
tion of new neurons not only in the neurogenic niches but also in the mature brain parenchyma.
This tissue has been classically considered non-permissive for neuronal progenitors, an idea
mainly derived from the observation that SVZ and SGZ neural stem cells differentiate only
into glial cells when transplanted into the brain parenchyma (for review, see [127]). In light on
the accumulating evidence for parenchymal neurogenesis, the classical concept that the mature
brain parenchyma is not permissive for the genesis of new neurons should be restricted to SVZ
and SGZ progenitors. Yet, future studies should better analyze whether factors modulating
the lesion-induced parenchymal neurogenic potential may differ from those acting on 'classic'
neurogenic site progenitors.
7. Parenchymal gliogenesis
In the past, neurogenesis and gliogenesis had always been kept separate, the latter being
considered less important than the former. In recent years, adult gliogenesis has been re-
evaluated as many populations of progenitor cells with glial-like features and proliferative
capacity have been shown to exist in the mature mammalian CNS [13,15]. Actually, paren‐
chymal cell genesis in the so-called non-neurogenic regions is mainly gliogenic. In most regions
of the CNS, parenchymal progenitors assure a slow process of ‘constitutive’ gliogenesis leading
to renewal of oligodendrocytes and, to a lesser extent, astrocytes [12,15,128]. In rodents, the
major population of cycling progenitors located outside the germinal niches are Ng2+ cells
morphologically, antigenically, functionally distinct from mature astrocytes, oligodendrocytes
and microglia [12-15]. These cells are also called ‘polydendrocytes’ to highlight their stellate
morphology and lineal relationship to oligodendrocytes [15], ‘synantocytes’ [14] for their
contiguity to neurons, or ‘oligodendrocyte progenitor cells’ (OPCs) because found able of
generating myelinating oligodendrocytes [12,129,130]. Nevertheless, many polydendrocytes
remain as a resident cell population of Ng2-expressing cells in the mature white and grey
matter after oligodendrocytes are generated. Thus it is widely accepted they represent the
fourth CNS major glial population [15], representing 2-9% of total cells [13]. In the last decade,
Ng2+ cells have generated a lot of interest among neuroscientists, because they show a series
of features quite unusual in OPCs. These include: i) an almost uniform distribution in both
grey and white matter areas; ii) a stellate morphology; iii) an intimate association with neurons
from which they receive synapses [13,14]; iv) proliferative capacity in the adult brain [13,131,
132], and v) a potential for giving rise to astrocytes and neurons that may be recruited to areas
of lesion in the context of brain injury or pathology [128]. At present, it is generally accepted
that polydendrocytes are OPCs, even if the demonstration that polydendrocytes differentiate
into mature myelinating oligodendrocytes in vivo is challenging, because Ng2 expression is
lost before the terminal differentiation of these cells and the appearance of mature oligoden‐
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drocyte antigens. Some observations provide circumstantial evidences for the oligodendro‐
glial fate of polydendrocytes in vivo. For instance, they co-express the PDGFRα, and during
the first postnatal week, in the corpus callosum and cortex, they start expressing the immature
oligodendrocyte antigen O4 [133]. Polydendrocytes also express the basic helix-loop-helix
(bHLH) transcription factors Olig1 and Olig2, which are required for oligodendrocyte
specification and differentiation [132,134] as well as Sox9 and Sox10 transcription factors.
Moreover, pulse-chase labelling of proliferating cells using 5-bromo-2′-deoxyuridine (BrdU)
revealed that the number of BrdU+Ng2+ cells decreases while that of BrdU+ oligodendrocytes
increases over time [12,135]. Cell grafting experiments have shown that polydendrocytes give
rise to myelinating cells when they are transplanted into an environment free of endogenous
myelinating cells [136]. Recently, more direct evidence for the oligodendroglial fate of
polydendrocytes was obtained from cell fate-mapping experiments using transgenic mice that
express Cre recombinase (Cre) in Ng2-expressing cells or that express inducible Cre (CreeR),
under the regulation of the Cspg4, PDGFRα or Olig2 genes, which enable determination of the
fate of polydendrocytes at a given time during development [95,137,138]. These studies
showed that oligodendrocytes continue to be generated in the mature brain.
Early cell-culture studies showed that OPCs purified from rat optic nerves differentiate not
only into oligodendrocytes but also into process-bearing ‘type-2 astrocytes’ in the presence of
serum factors, which led to the concept of bipotential oligodendrocyte type-2-astrocyte (O-2A)
progenitor cells [139]. There are now controversial observations suggesting that bipotentiality
of polydendrocytes might be real or an in vitro artifact [136,140,141], and most likely these cells
are inherently capable of differentiating into astrocytes but are prevented from fulfilling their
astroglial fate in the normal in vivo environment [128].
On the whole, while all of these studies consistently support the oligodendrocyte lineage of
the Ng2+ cells, the genesis of astrocytes from Ng2+ cells is confirmed only during postnatal
ages. All these different and sometimes controversial results may be explained by some
methodological/technical differences, but may also reflect heterogeneity in progenitor cell
populations⁄subpopulations (mostly not yet identified), which is far to be elucidated [98]. In
this context, we have recently identified a population of multipolar glial cells immunoreactive
for the microtubule associated protein 5 (Map5) [142], which share features but also differences
with Ng2+ progenitor cells [19]. These multipolar, Map5+ cells are newly generated, paren‐
chymal elements of the oligodendroglial lineage, which represent a stage-specific population
of polydendrocytes (Crociara et al., in preparation; Figure 2).
8. Conclusion and future perspectives
The CNS of mammals, in spite of having lost most of its regenerative/repair capacity with
respect to other phyla, is endowed with remarkable plasticity. This property is heterogene‐
ously distributed in different regions and can manifest in different ways. A better knowledge
of the various forms of spontaneous and lesion-induced structural plasticity, of their mutual
relationships and of the relative underlying mechanisms is fundamental in order to figure out
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are inherently capable of differentiating into astrocytes but are prevented from fulfilling their
astroglial fate in the normal in vivo environment [128].
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the Ng2+ cells, the genesis of astrocytes from Ng2+ cells is confirmed only during postnatal
ages. All these different and sometimes controversial results may be explained by some
methodological/technical differences, but may also reflect heterogeneity in progenitor cell
populations⁄subpopulations (mostly not yet identified), which is far to be elucidated [98]. In
this context, we have recently identified a population of multipolar glial cells immunoreactive
for the microtubule associated protein 5 (Map5) [142], which share features but also differences
with Ng2+ progenitor cells [19]. These multipolar, Map5+ cells are newly generated, paren‐
chymal elements of the oligodendroglial lineage, which represent a stage-specific population
of polydendrocytes (Crociara et al., in preparation; Figure 2).
8. Conclusion and future perspectives
The CNS of mammals, in spite of having lost most of its regenerative/repair capacity with
respect to other phyla, is endowed with remarkable plasticity. This property is heterogene‐
ously distributed in different regions and can manifest in different ways. A better knowledge
of the various forms of spontaneous and lesion-induced structural plasticity, of their mutual
relationships and of the relative underlying mechanisms is fundamental in order to figure out
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new efficacious therapeutic perspectives for brain repair. During the last two decades, the
discovery of neural stem cells and the studies on adult neurogenesis have opened the intri‐
guing possibility of cell replacement-aimed therapeutic strategies. Under pressure of this
perspective, studies on CNS stem cells and progenitors have increased exponentially, some‐
times leading to excessive emphasis about theoretical correlations between neuro-glio-genic
processes and brain repair. In this context, focusing on the ‘real’ neurogenic/gliogenic potential
of the mammalian CNS should avoid to turn an exciting biological discovery into a therapeutic
illusion. Indeed, the approach of regenerative medicine applied to the CNS is still hampered
by overwhelming problems concerning the final integration of both transplanted and endo‐
genously-induced cells [6]. The reason of this failure might be mostly due to evolutionary
constraints [78], and to the fact that cell renewal typical of adult constitutive neurogenesis is
primarily involved in tissue homeostasis of highly restricted regions, being hardly useful in
response to external injury and neurodegenerative brain damage affecting the parenchyma
[11,62]. On the other hand, the parenchymal cell genesis might represent a new plastic potential
to be explored within wide regions of the CNS, including those areas affected by different
neurodegenerative diseases and traumatic injuries. With respect to classic SVZ and SGZ
neurogenesis, parenchymal neuro-glio-genesis does constitute an alternative source of
progenitors, although with different outcomes [30]. Indeed, a vast number of reports currently
published in this domain, although accurate and carried out with multiple technical ap‐
proaches, do suggest that in most cases newly formed elements barely survive and do not fully
integrate. In addition, the extreme heterogeneity of parenchymal neuro-glio-genesis makes the
brain parenchyma a harsh territory, in which many questions remain unanswered and new
ones are opened (see Box 1). For instance, beside a deep knowledge on the cell cycle and early
cell lineage in neurogenic sites (see for example [143,144]), such information is starting to be
gathered only in specific perenchymal regions and or situations [145,146]. Hence, further
studies of parenchymal stem/progenitor cells, on their origin and their different fates and
outcomes, should grant new challenges in the multifaceted field of CNS structural plasticity
and repair.
• Which is the real extension of parenchymal cell genesis in the CNS of different mammals and in humans?
• Do parenchymal progenitors divide asymmetrically?
• Which are the real stemness properties of different parenchymal progenitors?
• Which stem/progenitor cells do contribute to postnatal neurogenesis but become depleted as their progeny
differentiates, and which continue to replenish the stem/progenitor cell reservoir?
• Which is the origin of the different types of parenchymal progenitors?
• What is(are) the ultimate fate(s) of parenchymal neuro-glio-genesis?
• Which are the specific stimuli that can trigger quiescent parenchymal progenitor cell division and differentiation?
• Can the fate of parenchymal progenitors be altered by microenvironmental cues or it is predetermined? To which
extent these changes do depend on regional localization?
• Can distinct parenchymal stem/progenitor cells be forced to produce unusual progeny if needed?
• Which are the factors leading to the progressive decrease of neurogenic and gliogenic activity with increasing age,
both in neurogenic sites and parenchyma?
Box 1. Some open questions
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1. Introduction
Animals that possess regenerative abilities are widespread in the animal kingdom [1]. Hydra,
planarian, zebrafish, newt and axolotl are known prominent species, and the cellular aspects
of the stem cell system for regeneration are well elucidated [2]. However, few animals can be
used to investigate the molecular basis of neuronal regeneration, in spite of the presence of
prominent regenerative animals, as mentioned above. Planarians, for instance, can regenerate
a functional brain after amputation in a few days, even from non-brain tissue [3,4]. Newts can
regenerate several tissues and organs (i.e., lens, limbs, jaws, hearts and tails) with recovery of
function and physiology after injury or tissue removal [5-8]. These animals achieve regenera‐
tion of missing nervous system utilizing stem cells. However, it is difficult to regenerate
nervous system in mammalians, including human beings, although these animals possess
neural stem cells. Therefore, regenerative animals provide unique opportunities to investigate
the generation and utilization of stem cells to repair lost or injured tissue in non-regenerative
animals. On the other hand, the successful derivation of neural cells from human embryonic
stem cells (ESCs) [9] and induced pluripotent stem cells (iPSCs) [10,11] under in vitro conditions
provides a new experimental strategy for clinical translation. In other words, although human
beings lack regenerative abilities, the new clinical strategy of “regenerative medicine,”
including cell-transplantation therapy, has been developed to recover lost neural functions by
using stem cells. This research field has become a greatly advancing scientific field worldwide.
© 2013 Nishimura et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
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In this chapter, we focus on the molecular systems of generation of functional dopaminergic
(DA) neurons in vivo and/or in vitro in regenerative and non-regenerative animals. The first
topic investigates how regenerative animals recruit new DA neurons from stem cells after
injury. The second topic explores how to generate DA neurons from mammalian ESCs and
iPSCs under in vitro conditions. The third topic evaluates clinical applications for human neural
disease, especially Parkinson’s disease.
2. DA neuronal regeneration in regenerative animals
Freshwater planarians, Plathelminthes, have a primitive central nervous system (CNS) that is
composed of a well-organized brain and a pair of ventral nerve cords [12]. Large-scale
expression analyses have revealed that many neural genes involved in vertebrate brain
development and function are also expressed in distinct domains of the planarian CNS [13,14].
These results indicate that the planarian CNS is functionally regionalized according to a
discrete expression of neural-specific genes.
We recently discovered that the planarian CNS contains dopamine, serotonin, γ-aminobutyric
acid (GABA) and acetylcholine, which are known to be present in mammalians, and that the
planarian nervous system constitutes particular neural networks and functions [15-19]. Since
planarians possess pluripotent stem cells throughout their entire bodies, their CNS can be
completely regenerated along with recovery of morphology and function after amputation [20].
Recently, two different processes of DA neuroregeneration in the planarian Dugesia japonica
have been described. One involves DA neuroregeneration accompanied by brain regeneration
after artificial amputation [15,21]. The other involves DA neuronal regeneration after selective
degeneration of DA neurons by the DA neurotoxin 6-hydroxydopamine (6-OHDA) [22].
Although both of these processes are achieved by manipulating pluripotent stem cells, the
systems of the processes are different between these regenerative processes [23]. In this section,
we focus on these two processes of DA neuroregeneration in planarians, one of prominent
regenerative animals.
2.1. Brain regeneration and DA neuroregeneration in planarians
Planarians can regenerate a functional brain within 7-10 days after amputation. This regener‐
ative process can be divided into at least five steps: (1) anterior blastema formation, (2) brain
rudiment formation, (3) pattern formation, (4) neural network formation and (5) functional
recovery. Each step is defined by sequential gene expression alterations that are similar to those
observed in mammalian brain development [20].
2.1.1. The early stage of brain regeneration after amputation
The first step of head regeneration after amputation is wound closure, which involves adhesion
of the dorsal and ventral tissues, thereby inducing activation of noggin-like gene A (DjnlgA) at
the edge of the amputated site [24]. Subsequently, a blastema (a mass of cells derived from
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pluripotent stem cells) is formed by mitogen-activated protein (MAP) kinase activation 24
hours after amputation [25,26]. It has been revealed that blastema cells are supplied from the
post-blastema region via mitosis from G2-phase pluripotent stem cells. Activation of c-Jun-N-
terminal kinase (JNK) after amputation induces G2/M transition and supplies blastema cells.
Subsequently, activation of extracellular signal-related kinase (ERK) signalling is required for
blastema cells to exit the undifferentiated state and enter the differentiation state in order to
form the brain rudiment [27]. Similarly, activation of ERK signalling facilitates exit from self-
renewal and regulates differentiation signals, as in mouse ESCs [28]. These findings indicate
that planarian stem cells and mouse ESCs may possess a similar molecular basis for cell fate
determination.
After the formation of the brain rudiment, the wnt and bone morphogenic protein (BMP)
signaling pathways regulate brain polarity along the anterior-posterior axis [29,30] and the
dorso-ventral axis [31,32], respectively. Therefore, pluripotent stem cells are regulated by
various signals in spacio and temporal manners to form the brain. Similarly, wnt and BMP
signaling pathways also regulate polarity of neural tube formation in mammalian early
development [33,34].
2.1.2. The stem cell system of DA neuroregeneration in the head regeneration process
During head regeneration, DA neurons begin to appear in future brain regions starting three
days after amputation. On day 5, the number of new DA neurons increases and axons start to
extend. On day 7, brain regeneration is complete along with complete reconstruction of DA
neurons (Figure 1A) [15]. Other neurotransmitter-synthesizing neurons, such as GABAergic,
octopaminergic (OA) and cholinergic neurons are also regenerated in a similar manner from
pluripotent stem cells during brain regeneration [17-19]. Recently, we revealed that the
numbers of each type of different brain neurons are maintained in a constant ratio that is
dependent on body size in intact planarians [21]. For instance, the ratio of DA neurons to OA
neurons is 2:1 in intact planarian brains. Interestingly, in the early stage of brain regeneration,
the ratio is larger than 2:1; however, it is gradually restored to 2:1 during brain regeneration.
The ratio among different neuronal cell types fluctuates in the early stages of regeneration and
is gradually restored to the original ratio. These data suggested that non-cell-autonomous
mechanisms utilized to adjust the ratio among different types of brain neurons [21].
2.2. DA neuronal regeneration after selective DA lesions
We recently established an experimental model to investigate cell-type specific regeneration
following selective degeneration by 6-hydroxydopamine (6-OHDA), a DA neurotoxin [22].
According to our observations, DA neurons are completely degenerated within 24 hours after 6-
OHDA-administration. Newly generated DA neurons begin to appear in the brain four days
after 6-OHDA-induced lesions. Thereafter, the number and the axons of DA neurons gradual‐
ly recover over a period of several days. Finally, DA neurons are completely recovered within
14 days after 6-OHDA-induced lesions (Figure 1B). Bromodeoxyuridine (BrdU)-pulse and chase
experiments indicate that newly generated DA neurons are derived from proliferative stem cells
that enter the S-phase in the trunk region and migrate to the head region from the trunk region
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without entering the M-phase (i.e., they remain in the G2-phase) and then give rise to DA neurons
in the head region (Figure 1C). In addition, histological analyses support the hypothesis that
pluripotent stem cells may directly give rise to differentiated DA neurons in planarians (Figure
1D, E). This observation suggests that G2-phase proliferating stem cells can respond to degener‐
ation of DA neurons and are committed to DA neurons in planarians [22].
Although most vertebrates show low regenerative capabilities, newts have powerful regen‐
erative abilities among adult vertebrates. Surprisingly, adult newts regenerate brain tissue
after partial brainectomy in spite of having a complex brain structure [35,36]. Recent reports
indicate that newts maintain the neurogenic potential to repair lost midbrain DA neurons,
even in the adult state [37]. Although proliferative abilities are essentially quiescent in the
midbrain of adult newts, quiescent ependymoglia cells are activated by the degeneration of
midbrain DA neurons. Additionally, activated ependymoglia cells start to proliferate and
differentiate to DA neurons to repair lost DA neurons. This neurogenic potential is activated
under conditions of injury-responsive cell-replacement and not under homeostatic conditions
[38,39]. These reports indicated that these regenerative animals possess unique stem cells
system to regenerative missing DA neurons.
3. Strategies for generation of DA neurons in non-regenerative animals
Regenerative animals easily regenerate lost brain and neural tissues by maturating stem cells.
Regenerative animals provide us unique ideas to generate neural tissue from mammalian
pluripotent stem cells such as ESCs and iPSCs.
Although the capacity for brain formation is present during the developmental stage among
animals, including human beings, it is difficult to regenerate missing neurons and brain tissue
in the adult state. It has been reported that neurogenesis homeostatically occurs in the restricted
regions of the adult mammalian brain such as hippocampus and subventricular zone [40,41].
However, it remains controversial whether dopaminergic neurogenesis/neuroregeneration
occurs in the adult mammalian midbrain [42,43] and whether neurogenic potential is “lost”
or “quiescent” in the adult mammalian brain. Regardless, this potential is not adequate to
recover missing neurons and brain tissue in the adult mammalian brain. If human beings had
an adequate regenerative potential, some types of neural disorders and brain injuries might
be self-curable. However, it is difficult to self-repair neurodegenerative disorders. Therefore,
it is strongly expected that neuronal differentiation techniques will contribute for therapeutic
applications, such as cell-transplantation therapy using ESCs/iPSCs.
Parkinson’s disease (PD) is a candidate disease for the expected application of cell-transplan‐
tation therapy. PD is an intractable neurodegenerative disorder that arises from the progres‐
sive death of DA neurons in the substantia nigra pars compacta. Although human beings lack
adequate abilities to regenerate DA neurons, techniques to generate midbrain DA neurons
from ESCs/iPSCs in vitro have been developed and are being improved for use in cell-
transplantation therapy (Figure 2).
Neural Stem Cells - New Perspectives274
3.1. Induction of midbrain DA neurons in vitro from ESCs/iPSCs
In 2000, it was reported that stromal cell-derived inducing activity (SDIA) strongly promotes
neural induction in mouse ESCs co-cultured with mouse PA6 stromal cells under serum-free
conditions without growth factors [44]. SDIA-induced neurons contain high amounts of DA
neurons and are integrated into the 6-OHDA-lesioned mouse striatum after transplantation.
Additionally, it has been proven that functional DA neurons can be differentiated from primate
and human ESCs using SDIA [45,46]. Therefore, the establishment of the SDIA method opened
new fields for both basic neuroscience research and therapeutic applications.
Figure 1. A) The regeneration process of DA neurons after decapitation. Immunofluorescence of brain DA neurons
one day, three days, five days and seven days after decapitation. (B) The process of DA neuronal regeneration in the
brain after 6-OHDA-induced-lesions. Immunofluorescence of brain DA neurons in an intact brain three days, seven
days and 14 days after 6-OHDA-administration. (C) BrdU-incorporation is detected in newly generated DA neurons
five days after 6-OHDA-administration. Double-immunofluorescence of tyrosine hydroxylase (TH; green) and BrdU
(magenta). The arrowheads indicate BrdU/TH-double positive neurons. (D, E) Double-fluorescence of TH mRNA
(green) and PiwiA proteins (a marker for pluripotent stem cells; magenta) seven days after 6-OHDA-administration.
Scale bars: 200 µm (A-D), 50 µm (high magnification image in C) and 50 µm (E). (F) A schematic drawing of the pla‐
narian brain nervous system and an image of the distribution of DA neurons. The blue color represents the brain. The
orange color represents ventral nerve cords (VNCs). The green cells are DA neurons.
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five days after 6-OHDA-administration. Double-immunofluorescence of tyrosine hydroxylase (TH; green) and BrdU
(magenta). The arrowheads indicate BrdU/TH-double positive neurons. (D, E) Double-fluorescence of TH mRNA
(green) and PiwiA proteins (a marker for pluripotent stem cells; magenta) seven days after 6-OHDA-administration.
Scale bars: 200 µm (A-D), 50 µm (high magnification image in C) and 50 µm (E). (F) A schematic drawing of the pla‐
narian brain nervous system and an image of the distribution of DA neurons. The blue color represents the brain. The
orange color represents ventral nerve cords (VNCs). The green cells are DA neurons.
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Recently, the molecular mechanisms of mammalian brain development have become better
understood. The expression and secretion of patterning factors facilitate neural induction and
define anterior-posterior and dorso-ventral patterning of the mammalian brain. For instance,
mammalian midbrain development is governed by fibroblast growth factor 8 (FGF8) and Sonic
hedgehog (Shh), which are locally expressed at the midbrain-hindbrain boundary and the
ventral neural tube, respectively [47]. The floor plate is located along the ventral midline of
the neural tube and is known to function as a signaling center during brain development and
a source of midbrain DA neurons [48,49]. Midbrain DA neuronal specification is regulated by
several transcription factors, including Lmx1a, FoxA2, Nurr1 and Pitx3 [50-53]. Therefore,
cellular aspects of brain development provide ideas for improving the differentiation methods
of authentic neural identity and subtype specification, such as differentiating DA neurons from
ESCs/iPSCs in vitro.
Recently, neural lineage commitment has been improved with dual inhibition of SMAD
signaling by bone morphogenic protein (BMP) inhibitor (noggin and dorsomorphine) and
transforming growth factor-ß (TGF-ß)/activin/nodal inhibitor (SB431542). These combinations
promote efficient neural induction of both human ESCs and iPSCs in serum-free, floating
cultures of embryoid body-like aggregates (SFEB) and stromal (PA6) feeder co-cultures [54,55].
In addition, GSK3ß inhibitor (CHIR99021) strongly activates wnt signaling and induces the
Lmx1a expression in FoxA2-positive floor plate precursors and the neurogenic conversion of
human ESC-derived midbrain floor plates towards DA neurons [56]. This differentiation
method mimics mammalian brain development.
Recently, human ESCs/iPSCs maintenance and differentiation have been advanced in order to
achieve clinical translation, which results in chemically defined conditions and the elimination
of animal-derived components and the need for feeder cells [57,58].
Figure 2. A) A phase contrast image of colonies of undifferentiated human iPSCs on SNL feeder cells. (B) DA neurons
derived from human iPSCs differentiated using the SFEB method in vitro. Double-immunofluorescence of ßIII-tubulin
(TubßIII), a neuronal marker (green), and TH, a marker of DA neurons (magenta). Scale bars: 500 µm (A) and 50 µm
(B).
Neural Stem Cells - New Perspectives276
4. Towards the clinical application of ESCs/iPSC-derived DA neurons in
Parkinson’s disease
Clinically, PD is estimated to affect approximately 1% of the population over 65 years of age,
and PD patients often exhibit muscle rigidity, tremors, bradykinesia and akinesia. Currently,
the primary clinical treatment for PD is dopamine replacement therapy using L-dihydroxy‐
phenylalanine (L-DOPA) and/or dopamine receptor agonists. Although pharmacotherapy
temporarily improves parkinsonian symptoms, the efficacy of pharmacotherapy is gradually
lost over long-term treatment, and the wearing-off phenomenon, the on-off phenomenon and
drug-induced dyskinesia develop. In addition, the progression of the degeneration of midbrain
DA neurons cannot be delayed. Therefore, new strategies such as cell transplantation therapy
are expected to recover lost DA neurons.
The first clinical trial of cell transplantation using human fetal ventral midbrain in PD patients
was performed in the latter half of the 1980’s [59]. Currently, over 400 PD patients have been
evaluated in this clinical trial. Some PD patients who underwent grafting have exhibited
drastic improvements in movement symptoms. However, strict ethical problems remain
regarding the use of human fetal cells for the treatment of human disease. Therefore, efficient
methods need to be developed for differentiating DA neurons from ESCs/iPSCs, instead of
using human fetal cells, as described above. In addition, the efficiency and safety of ESCs/
iPSCs-derived DA neurons should be evaluated in vivo experiments using animal models
before conducting human trials. In general, DA neurotoxins such as rotenone, 6-OHDA and
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) are used to create parkinsonian animal
models with rodents and non-human primates. In particular, since the pathological symptoms
and brain anatomy of monkeys are similar to those of humans, the outcomes of monkey trials
strongly contribute to realizing human trials.
4.1. Preclinical trials of human ESCs/iPSC-derived DA neurons for PD
In 2005, it was reported that intra-striatal primate ESC-derived DA neurons survive and
function in the putamen in MPTP-lesioned primate parkinsonian models [60]. In that study,
positron emission tomography imaging revealed that [18F]-F-DOPA uptake increased in
grafted monkeys 14 weeks after transplantation. In addition, the neurological scores of the
grafted monkeys improved in comparison with that observed in sham-operated monkeys
starting from 10 weeks after transplantation. This study is the first report to indicate the
functional efficiency of grafted DA neurons derived from primate ESCs and has opened up
the possibility for transplantation therapy using ESC-derived DA neurons.
Meanwhile, human ESC/iPSC-derive DA neurons have the potential to improve motor
function in PD model rats after intra-striatal grafting [56,61,62]. However, some problems, such
as tumorigenicity, remain in clinical trials. We recently reported that long-term neural
maturation (> 28 days) of human ESCs reduces tumorigenicity after grafting in primate
parkinsonian models. In addition, motor symptoms are also improved by grafting human ESC-
derived DA neurons that have maturated over a long term (42 days). These results suggest
that human ESC-derived DA neurons that are differentiated for appropriate terms strongly
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and brain anatomy of monkeys are similar to those of humans, the outcomes of monkey trials
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positron emission tomography imaging revealed that [18F]-F-DOPA uptake increased in
grafted monkeys 14 weeks after transplantation. In addition, the neurological scores of the
grafted monkeys improved in comparison with that observed in sham-operated monkeys
starting from 10 weeks after transplantation. This study is the first report to indicate the
functional efficiency of grafted DA neurons derived from primate ESCs and has opened up
the possibility for transplantation therapy using ESC-derived DA neurons.
Meanwhile, human ESC/iPSC-derive DA neurons have the potential to improve motor
function in PD model rats after intra-striatal grafting [56,61,62]. However, some problems, such
as tumorigenicity, remain in clinical trials. We recently reported that long-term neural
maturation (> 28 days) of human ESCs reduces tumorigenicity after grafting in primate
parkinsonian models. In addition, motor symptoms are also improved by grafting human ESC-
derived DA neurons that have maturated over a long term (42 days). These results suggest
that human ESC-derived DA neurons that are differentiated for appropriate terms strongly
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contribute to both reducing the risk of tumor genesis and improving parkinsonian motor
dysfunction [46]. Recently, we first reported that human iPSC-derived DA neurons that are
differentiated under feeder-free and serum-free conditions survived in an MPTP-lesioned
primate parkinsonian model for six months [63]. This report may support the therapeutic
potential of human iPSCs for future clinical trials.
5. Stem cell utilization in vivo and in vitro for non-regenerative animals:
Lessons from regenerative animals
Although the number of regenerative animals used to investigate DA neuronal regenera‐
tion is  limited,  the  cellular  mechanisms of  DA neuronal  regeneration are  starting  to  be
understood [22,39]. The cellular and molecular mechanisms for DA neuronal regeneration
in regenerative animals provide new ideas for generation of DA neurons in non-regenera‐
tive animals. Our histological analysis of regeneration indicates that pluripotent stem cells
may directly give rise to differentiated DA neurons in the planarian head region (Figure
1D, E) [22]. In addition, we have not yet obtained direct evidence for the presence of neural
stem cells in planarians. First, we have not observed proliferating cells in the brain, either
during regeneration or  in  intact  brains.  Second,  the  expression of  the  planarian musashi
family  of  genes  supports  the  above  hypothesis.  Musashi,  an  RNA  binding  protein,  is
expressed in neural  stem cells  in various animals[64].  Although three musashi-like genes
(DjmlgA-C) have been isolated from planarians, the expressions of these genes are detect‐
ed in the planarian CNS and are not  eliminated by X-ray irradiation [65].  These results
indicate  that  planarian  musashi-like  genes  are  expressed  in  differentiated  cells,  not  in
proliferative stem cells. Based on these observations, we speculate that the neural stem cell
system most likely evolved at a later stage of evolution [66].
In the case of brain regeneration, the brain rudiment is formed inside of the blastema. The
cells that participate in blastema formation already exist from the proliferative state, and a
portion of these cells start to form the brain rudiment [25,26]. Therefore, the commitment
of DA neurons may immediately occur after brain rudiment and brain pattern formation.
In the case of DA neuronal regeneration after 6-OHDA-induced lesions, G2-phase stem cells
are recruited into DA neurons in the brain. Since the presence of neural stem cells were not
clarified in planarians, the key roles for differentiation into DA neurons from pluripotent stem
cells would function in G2-phase in the cell cycle. The neurons remaining in the brain after 6-
OHDA-induced lesions may play an important role in sensing the loss of DA neurons and
recruiting G2-phase stem cells into DA neurons [22]. Recent findings using eukaryote cells
indicate that cell fate determination of either self-renewal or differentiation occurs during the
G2/M phase in the cell cycle [67]. Therefore, the results of our study concerning the cellular
system of DA neuronal regeneration are supported by these observations. Therefore, G2-phase
stem cell strongly contributed to DA neuronal regeneration by response to extrinsic environ‐
ment in planarians. However, we have not yet understand a clear answer regarding which
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signal molecules contribute to the recruitment of G2-phase stem cells to DA neurons in
planarians.
In the case of newts, another regenerative animals, quiescent ependymoglia cells can sense
degeneration of DA neurons, and re-enter into the cell cycle to restore lost DA neurons [39].
In this case, DA receptor-expressing surrounding cells (i.e., ependymoglia cells) respond to the
degeneration of DA neurons via DA receptor signaling, and contribute to regenerate DA
neurons. Therefore, the responsibility of stem cells to extrinsic environment is important for
DA neuronal regeneration in both planarians and newts.
The findings from regenerative animals may provide any idea to generate DA neurons from
ESCs/iPSCs of non-regenerative animals. Recent strategies for DA neuronal induction from
ESCs/iPSCs have based on mimicking midbrain development, that is, the activation of
morphogenic factors and transcriptional regulation. In addition, the establishment of 3-
dimensional (3D) culture systems strongly contributes to mimicking the complicated organo‐
genesis and lead to the acquisition of sub-regional identities because the cells respond to
extrinsic signals [57, 69].
Recently, Kirkeby et al. developed an induction method for human ESC-derived DA neurons
using dual-SMAD inhibition with embryoid body formation. The gene expression profile and
transplantation aspects of human ESC-derived DA neurons can be recaptured in the human
fetal midbrain [70], suggesting that 3D cultures are suitable for mimicking brain organogenetic
processes in authentic midbrain DA neurons.
In  addition,  our  findings  in  planarians  may  contribute  to  improving  strategies  of  cell-
transplantation therapy. That is, how to integrate ESCs/iPSC-derived grafting neurons into
the host brain. We found that commitment to DA neurons in stem cells occurs during the
G2-phase of the cell cycle. Which state of committed cells can be easily incorporated into
lesioned regions and whether the location of commitment activates important factor(s) in
the  incorporation  of  committed  cells  into  appropriate  positions  should  be  considered.
Additionally, both planarians and newts showed drastic behavioral recovery according to
DA neuronal regeneration [22,37]. This suggested that regenerated DA neurons contribut‐
ed to functional recover by integrating to the existing neural circuit. We speculate that this
phenomenon may provide to the any ideas how to integrate ESCs/iPSC-derived neurons
into existing neural circuit after grafting and contribute to recover the motor function. We
will attempt to answer several important questions in our future works. A deeper under‐
standing of the answers to the above questions may provide unique clues regarding not
only how to commit DA neurons in vitro,  but also how to optimize cell-transplantation
therapy in the future.
6. Conclusion
Stem cell research is an interesting field in basic science due to its potential therapeutic
applications. It is now extensively studied to investigate that the cellular and molecular
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indicate  that  planarian  musashi-like  genes  are  expressed  in  differentiated  cells,  not  in
proliferative stem cells. Based on these observations, we speculate that the neural stem cell
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morphogenic factors and transcriptional regulation. In addition, the establishment of 3-
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extrinsic signals [57, 69].
Recently, Kirkeby et al. developed an induction method for human ESC-derived DA neurons
using dual-SMAD inhibition with embryoid body formation. The gene expression profile and
transplantation aspects of human ESC-derived DA neurons can be recaptured in the human
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mechanisms of DA neuronal regeneration in many regenerative animals in vivo have been
described over the last several years, although numerous unclear issues remain. Important
aspects learned from regenerative animals suggest that the cell sources and stem cell systems
of DA neuronal regeneration may reflect several concepts in the achievement of regeneration,
even among regenerative animals. Therefore, it is difficult to find a common rule for DA
neuronal regeneration among animals. However, this trend in regenerative biology will be
more emphasized by discoveries made in future studies of regenerative animals, and will
provide hints about more efficient utilization of stem cells towards clinical application.
Importantly, studying the diversity of regenerative contexts in different animals may contrib‐
ute to highlighting diverse concepts and attractive clues for investigating the generation of DA
neurons in vivo and in vitro in regenerative medicine.
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1. Introduction
Regenerative processes occurring under physiological (maintenance) [1-3] and pathological
(reparative) [4-6] conditions are a fundamental part of life, and vary greatly among different
species, individuals, and tissues. Despite the central nervous system (CNS) has been consid‐
ered for years as a perennial tissue, it has recently become clear that both physiological and
reparative regeneration occur also within the CNS to sustain tissue homeostasis and repair.
Importantly, the proliferation and differentiation of endogenous neural stem cells (NSCs)
residing within the healthy CNS, or surviving injury, are considered crucial in sustaining these
events. However, these processes are not robust enough to promote a functional and stable
recovery of the nervous system architecture. Thus, the development of cell-based therapies
designed to promote functional (direct vs. indirect) neural cell replacement was anticipated [7].
Nevertheless, most of the experimental cell therapies with neural lineage-committed progen‐
itors have failed to foster substantial repair in disease models where the anatomical and
functional damage is widespread and an inflamed and/or degenerative microenvironment co-
exists. Conversely, the systemic injection of in vitro expanded neural stem/precursor cells
(NPCs) – both as neurospheres as well as plastic-adherent monolayers - has provided a
remarkable amelioration of the clinico-pathological features of rodents affected by experi‐
mental inflammatory CNS disorders that include experimental autoimmune encephalomye‐
litis (EAE), cerebral ischemic/haemorrhagic stroke, spinal cord injury (SCI) and traumatic brain
injury (TBI). This has been shown to be dependent on the capacity of transplanted NPCs to
engage multiple mechanisms of action within specific microenvironments in vivo [8]. Among
a wide range of potential therapeutic actions – and in addition to the expected cell replacement
– this phenomenon may also occur via several bystander effects. These effects are heterogeneous
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and likely exerted by undifferentiated NPCs releasing immune regulatory and neuroprotec‐
tive molecules within specific microenvironments in response to local stimuli elicited by
inflammatory cells (therapeutic plasticity). The molecular and cellular mechanism(s) that sustain
the multifaceted therapeutic plasticity of NPCs remain far from being fully characterized [9].
The transplantation of undifferentiated exogenous NPCs very efficiently protects the CNS
from experimental chronic degeneration induced by inflammation both in small rodents (mice
and rats) [10-14] as well as in non-human primates [15]. Specific homing of systemically
injected NPCs is shown, so far, in experimental models of multiple sclerosis (MS), ischemic/
haemorrhagic stroke, SCI and TBI, and epilepsy. In vitro and in vivo data provide extensive
evidence of the molecular mechanisms behind the ability of NPCs to cross the blood-brain
barrier (BBB) and specifically accumulate at the sites of inflammation/tissue damage [16-18].
After entering the CNS using constitutively functional cell adhesion molecules and inflam‐
matory chemokine receptors, systemically injected NPCs accumulate at the level of perivas‐
cular CNS areas, where they establish atypical ectopic perivascular niches [16, 19]. In these areas,
a much likely active cell-to-cell communication takes place between transplanted NPCs and
the different cells of the atypical niche. As consequence of this, transplanted NPCs survive while
displaying undifferentiated features, and promote neuroprotection by releasing immune
modulatory molecules and neurotrophic factors in situ. Further evidence exists about an
additional peripheral immune-modulatory effect exerted by NPCs [20, 21]. Systemically
injected NPCs, in fact, enter also peripheral organs (e.g. draining lymph nodes and spleen)
were they accumulate at the boundaries of blood vessels and interact closely with lymphocytes
and professional antigen presenting cells (APCs), impairing their maturation and functional
activation [15, 22, 23].
NPC-based therapies have been therefore considered a plausible alternative strategy for the
treatment of neurological inflammatory disorders. However, some urgent and still unclear
questions have to be solved prior to straightforwardly translate most of these exciting
experimental observations into clinical medicines, such as: (i) the ideal stem cell source,
whether it has to be derived from pluripotent or multipotent sources; (ii) the ideal route of cell
administration, whether it has to be focal or systemic; (iii) the optimal time point for cell
administration, depending on the disease characteristics; (iv) the ideal balance between
differentiation and persistence of stem cells into the targeted tissue and (v) the ideal mechanism
of tissue repair to foster, whether it has to be cell replacement or tissue protection/healing.
Further, while some encouraging efforts are being devoted towards the development of
guidelines and establishment of explorative phase I clinical trials, still one of the major
constraints to the easy translation into human medicines is represented by the immunogenicity
of allogeneic stem cells, and the modest expandability of somatic human NPCs in vitro. Within
this scenario, the emerging figure of induced pluripotent stem (iPS) cells [24], induced neuronal
(iN) cells [25] and/or induced neural stem cells (iNSCs) [26] holds a new exciting promise.
In this chapter we will describe the most recent evidence of the remarkable therapeutic
plasticity of transplanted NPCs, when injected systemically in inflammation-driven CNS
degeneration experimental models. We will first focus on the evidence that inspired the
modern stem cell experimental therapies and then elaborate on the mechanisms regulating the
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cross talk between somatic NPCs and the dysfunctional microenvironment, both at the outer
and inner endothelial sides, and their clinico-pathological impact. Finally, we will discuss the
rationale of the most recent explorative trials that are bringing neural stem cell therapies into
the clinic.
2. Adult neural stem cells
2.1. A change in the dogma
Stem cells (SCs) possess the unique ability to self-renew and differentiate into different cell
types in the body. Their contribution is essential during embryonic and early post-natal life,
where they regulate morphogenesis and development by properly balancing proliferation and
differentiation. Though their number is destined to decrease with time, their presence in adult
organisms is still required to ensure homeostasis and repair. While the regenerating properties
of some tissues (e.g., the skin) and organs (e.g., the liver) are undisputed, the brain with its
unique organization and complexity was considered for long time an exception. In fact, the
dogmatic concept ‘no new neurons after birth’ (1913) expressed by Santiago Ramon y Cajal,
sustaining the limitation of neurogenesis to prenatal life, has been resonating for decades
within the scientific community, finally becoming an established belief. NSCs were thought
to be present within the brain only during the developmental stage. It was only in the late 60’s,
thanks to the availability of new techniques and advanced tools of investigation, that the
picture of the brain as an immutable organ started to be reviewed. Altman and colleagues,
using (3H)-thymidine pulses and autoradiographs, first demonstrated the presence of prolif‐
erating neurons in different regions of the post-natal brain in rats [1, 2, 27]. However, the
turning point was marked later in 1983 when Goldman and Nottebohm at Rockfeller Univer‐
sity (USA) described newly generated neurons at the level of the hyperstriatum ventrale, pars
caudalis (HVc), of the ventricular zone in intact adult female canaries [3] Subsequently,
numerous pioneering experiments contributed in demonstrating that specific regions of the
mammalian CNS undergo a continuous, though moderate, level of neurogenesis throughout
adult life [28].
2.2. Adult neurogenesis in physiological conditions
Today it is widely accepted that in the adult mammalian brain, newly generated cells derive
from NSCs residing in two regions [29], the ventricular-subventricular zone (V-SVZ) of the
forebrain lateral ventricles [2, 27, 30] and the subgranular zone (SGZ) of the dentate gyrus (DG)
of the hippocampus [1, 31, 32] (Figure 1). Because of the peculiar cellular organization and
exclusive microenvironment, these neurogenic regions are commonly referred to as germinal-
like niches [33, 34]. Although different, these two areas share an extremely organized and
specialized microenvironment where NSCs can strategically interact with a rich vascular
plexus [35, 36], while communicating with their progeny and neighbouring NSCs as well as
with differentiated neural cells trough specialized structures (e.g. primary cilium, basal and
apical processes). Altogether, these cellular components provide a unique milieu of extracel‐
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lular matrix proteins and growth factors other than electrical stimuli, which define the dynamic
characteristic of the adult brain stem cell niches. In here, a strictly regulated balance between
proliferation and differentiation of NSCs ensure the maintenance of a constant, though
quantitatively modest, pool of progenitor cells throughout lifetime [37].
Figure 1. Schematic representations of the adult V-SVZ and SGZ neurogenic compartments.A and C, coronal sec‐
tions of the adult mouse brain showing the localization of the V-SVZ and SGZ of the hippocampus. B and D, cytoarchi‐
tecture of the V-SVZ (B), and of the SGZ of the DG of the hippocampus (D) in the adult mammalian brain. B,
Composition of the B1 cell domain into the V-SVZ. NSCs or type B1 cells (blue) extend from the proximal domain (do‐
main I, dark grey) to the distal domain (domain III, light grey). At the level of the ventricles, B1 cells contact the CSF
with their primary cilium extruding in the centre of a rosette of multi-ciliated ependymal cells (yellow), forming the
typical pinwheel-like structures on the ventricular surface. Here, NSCs can sense different signals circulating into the
CSF. In the distal domain, type B1 cells contact the blood vessels (red) with their specialized end-foot terminations. In
the intermediate domain (or domain II) type B1 cells give rise to IPCs (or type C cells, green), which are transit-amplify‐
ing cells generating neuroblasts (or type A cells, red). In this domain they are also in contact with their progeny, neigh‐
bouring cells and neuronal terminations. D, Composition of the RA domain at the level of the DG of the SGZ. RAs (or
type 1 cells, blue) extend from the hilus of the hippocampus (domain I, dark gray) to the IML (distal domain or domain
III, light gray). At the level of domain I, RAs sense the hilus microenvironment with their primary cilium and contact
other RAs, IPCs and blood vessels (red). RAs extend, trough their main shaft, into the distal domain where their arbori‐
sations receive signals from glial cells and neuronal terminations. RAs give rise to IPCs that mature (trough blue IPC1 or
type 2a cells, and light green IPC2 or type 2b cells) and differentiate into immature granule cells (IGC, red). During
their maturation, IPCs move from the proximal domain to the intermediate domain (or domain II, composed by SGZ
and GCL), where RAs receive signals from the progeny, neighbouring NSCs, interneurons (purple) and microglia (grey).
Finally IGC differentiate into mature GC (green), which extend their axons into the hilus and arbores dendrites into the
distal domain. Only few new-born neurons survive and become a long-lasting GC (pink).
2.2.1. Defining the cellular composition of the V-SVZ
The V-SVZ is situated in proximity of the lateral ventricles and contains slow-cycling SCs
with astroglial properties that express glial-fibrillary acidic protein (GFAP), called type B1
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cells. These cells give rise to intermediate progenitor cells (IPCs) or type C cells, which lose
GFAP immunoreactivity and acquire the expression of  the distal-less  homeobox (Dlx)-2.
These cells finally give origin to a pool of neuroblasts (type A cells) expressing the polysia‐
lylated form of neural cell adhesion molecule (PSA-NCAM) and the early neuronal marker
doublecourtin (DCX) [38].  Within rodent’s brain these neuroblasts form chains of migra‐
tion along the rostral migratory stream (RMS) to reach the olfactory bulb (OB), where they
terminally differentiate into at least six different subtypes of OB interneurons, depending on
their origin along the axes of the V-SVZ [39-41]. The V-SVZ niche (Figure 1 A-B) can be
divided in three differently organized domains where self-renewing B1 cells receive different
signals: proximal (or apical, I), intermediate (II) and distal (or basal, III) [37]. Type B1 cells retain
the typical apical-basal bi-polarity of their embryonic predecessors (radial glia) [42] extend‐
ing their processes along the three different domains and spanning the cerebrospinal fluid
(CSF) and the blood stream. In the proximal domain (composed by VZ and part of the SVZ)
Type B1 cells are enclosed within a cluster of ependymal (type E) cells, which sense the CSF
by means of motile cilia and create an appropriate gradient of molecules within the VZ [43].
Type B1  cells  are  therefore  physically  separated from the  ventricles.  Nevertheless,  their
contact with the CSF is still made possible by a single apical primary cilium extruding in the
centre of a rosette of type E cells. Typically, these apical end-foot terminations cluster together
to finally arise in the middle of a layer of E cells forming a characteristic pinwheel structure
resembling the embryonic forebrain germinal zone [36, 42]. Recently, it has been shown that
the  expression of  the  adhesion and signalling molecule  vascular  cell  adhesion molecule
(VCAM)-1 is critical for the correct positioning of these protrusions and the preservation of
this complex structure [44]. The small apical surface of B1 cells gives them the chance to
sense the CSF which contains soluble factors, such as insulin-like growth factor (IGF)-2, bone
morphogenetic proteins (BMPs) and Noggin, Wnts, Sonic hedgehog (Shh) and retinoic acid,
able to modulate NSCs behaviour [45]. At the same time a long basal process from the opposite
pole (distal domain), bridges B1 cells to the surrounding vascular plexus that runs in the
parenchymal side of the V-SVZ. Here, with a specialized end-foot termination, type B1 cells
contact endothelial cells (ECs) of the blood vessels, thus being influenced from soluble factors
released from ECs and/or possibly by molecules produced far away from the niche and
released in the blood stream. The intermediate domain (composed by the SVZ) contains B1
cell progeny, such as IPCs and neuroblasts, which participate in the maintenance of the niche
equilibrium perhaps trough mechanisms of direct feedback on NSCs providing informa‐
tion about the number of new neurons already generated. This balance, seems to be regulated
on one side by canonical Notch signalling trough ligands released or expressed by both IPCs
and neighbouring B1 cells [46, 47] and on the other side by neurotransmitters [e.g. gamma-
aminobutyric acid (GABA)] secreted by neuroblasts [48]. Importantly, while many studies
have focussed on the role of the microenvironment on the functionality of NSCs [49], much
less is known about the role that NSCs themselves exert on the definition of the niche. Recently
it has been shown that NSCs in the germinal niches do secrete a multitude of factors, among
which some with immune modulatory potentials that may influence the behaviour of the
surrounding cells, including microglia [50]. In parallel to the rodent CNS, the lateral wall of
the lateral ventricles (and the hippocampus) of the human brain contains NSCs that generate
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cells. These cells give rise to intermediate progenitor cells (IPCs) or type C cells, which lose
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parenchymal side of the V-SVZ. Here, with a specialized end-foot termination, type B1 cells
contact endothelial cells (ECs) of the blood vessels, thus being influenced from soluble factors
released from ECs and/or possibly by molecules produced far away from the niche and
released in the blood stream. The intermediate domain (composed by the SVZ) contains B1
cell progeny, such as IPCs and neuroblasts, which participate in the maintenance of the niche
equilibrium perhaps trough mechanisms of direct feedback on NSCs providing informa‐
tion about the number of new neurons already generated. This balance, seems to be regulated
on one side by canonical Notch signalling trough ligands released or expressed by both IPCs
and neighbouring B1 cells [46, 47] and on the other side by neurotransmitters [e.g. gamma-
aminobutyric acid (GABA)] secreted by neuroblasts [48]. Importantly, while many studies
have focussed on the role of the microenvironment on the functionality of NSCs [49], much
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it has been shown that NSCs in the germinal niches do secrete a multitude of factors, among
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surrounding cells, including microglia [50]. In parallel to the rodent CNS, the lateral wall of
the lateral ventricles (and the hippocampus) of the human brain contains NSCs that generate
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new neurons throughout adult life [51-53]. A total of four layers have been observed forming
the  human lateral  ventricular  wall,  which  comprise  a  monolayer  of  ependymal  cells,  a
hypocellular gap, a ribbon of astrocytes, and a transitional zone into the brain parenchyma
[52, 54]. Unlike the rodent and non-human primate brain [55], SVZ astrocytes of the human
brain are separated from the ependyma by a hypocellular gap [52]. The presence of promi‐
nent neurogenesis in the V-SVZ as well as of a RMS of migrating neuroblasts in the human
brain has been, however, intensively debated (for a preview, see [56]). Initially it was reported
the existence of a ribbon of astrocytes in the adult human V-SVZ that function as multipo‐
tent NSCs in culture although, only few proliferating cells and no evidence of chains of
migratory (β-III tubulin positive) immature neurons were observed [52]. In contrast, a later
report evidenced a robust cell proliferation in adult human V-SVZ and the presence of a
RMS of neuroblasts along a lateral ventricular extension that connects the lateral ventricle to
the OB [51]. Finally, two recent studies have provided evidence of a small ventricular lumen
connecting the lateral ventricles to the OB that is observed only in the foetal [57], but not
adult, human brain [55, 58]. Interestingly, the absence of this ventricular extension has been
confirmed even in the postnatal infant human brain [58], whereas a new medial migratory
stream (MMS) targeting the prefrontal cortex has been observed. Altogether these findings
suggest a dynamic evolution in human SVZ neurogenesis throughout life; with the infant
human SVZ, RMS and MMS activity, undergoing a progressive extinction at ages older than
18 months post-natal [58].
2.2.2. Defining the cellular composition of the SGZ
The second putative progenitor cell compartment is located in the SGZ of the DG of the
hippocampus (Figure 1C-D), namely the region of the brain involved in learning and memory
[1, 31, 32]. In this area, NSCs residing at the interface of the hilus and dentate gyrus are called
type-1 progenitors or radial astrocytes (RAs) [59] and they mainly correspond to astroglial cells
[60]. They mature in dentate granule cells and migrate towards the granule cell layer (GCL) to
finally integrate into hippocampal circuitry [59]. RAs, unlike B1 cells of the V-SVZ, are found
deeper into the brain parenchyma, surrounded by neurons, neighbouring RAs and other glial
cells but without any chance to contact the CSF [37]. However, B1 cells and RAs share some
key features: they both express astroglial markers, have ultrastructural characteristics of
astrocytes [41] and possess long processes reaching different compartments of the niche far
away from where the cell bodies reside [37]. RAs function as the primary precursors for the
generation of new dentate granule neurons, either directly or via the generation of IPC1 (type
2a cells) and IPC2 (type 2b cells) [61]. Similarly to the V-SVZ, also the SGZ can be subdivided
in a proximal, intermediate and distal domain along which RAs, with their polarized structure
(apical-basal), span from the hilus interface (proximal domain) to the inner molecular layer
(IML, distal domain) [37]. The proximal domain contains the primary cilium (important for
Sonic hedgehog (Shh) signalling), which sense the hilus microenvironment, and lateral
processes contacting other RAs and IPCs and, importantly, blood vessels. Here ECs release
vascular endothelial growth factor (VEGF), IGF and brain-derived neurotrophic factor (BDNF)
responsible for the regulation of the balance between proliferation and differentiation. RAs
have their cell bodies in the SGZ and extend their main shaft along the GCL, which compose
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the intermediate domain. In this area astrocytes receive inputs from their progeny, including
immature and mature granule neurons, IPCs and different neuronal and glial (e.g. microglia)
cell types. Type 2a cells expressing Achaete-scute homolog (Ascl)-1 (also known as Mash-1) -
a transcription factor important for neuronal commitment - are likely to originate in the
proximal domain and then rapidly migrate into the intermediate one, where they divide once
before differentiating into type 2b cells that will express DCX [62]. Similarly to V-SVZ, feedback
mechanisms from the progeny, such as canonical and non-canonical Notch signalling are
responsible for the quiescence of RAs or their transition to IPCs [63, 64]. In the IML, RAs
terminate with an elaborate and branched structure contacting glial cells, neuronal processes
and synapses. Although the contacts taking place in this area are still not completely under‐
stood, it seems probable that the GABAergic and glutamatergic inputs coming from inter‐
neurons and mossy cells, are important for the regulation of NSCs [65]. These astrocyte-like
cells of CNS germinal areas work as real pacemakers of adult neurogenesis, as they receive
internal and external inputs from their main shaft as well as from the end-foot of their radial
processes that contact ECs in the V-SVZ [42], or embedded into the molecular layer in the SGZ
[41]. However, despite the relatively high rate of neurogenesis, only a minority of new born
cells eventually survive, mature and integrate within the existing circuitries at the level of the
GCL of the hippocampus [66]. In parallel, postnatal SGZ neurogenesis in the human brain has
been demonstrated to occur across the lifespan [55]. Although the role of new born neurons
generating in the SGZ is not yet fully understood, increasing evidence suggest a possible role
in learning and memory function [55].
3. CNS inflammation effects on endogenous adult NSC niches
3.1. Switching from an immune-privileged to an immune-specialized state
Protection and homeostasis are fundamental keystones for the proper maintenance of the CNS.
Hence, brain and spinal cord must be kept under an extreme security state to ensure their fully
functionality and, ultimately, the survival of an organism. However, in the past the CNS has
been often regarded as an immune privileged site, where immune cells were not supposed to
enter and interact with cells of the nervous system. This common belief was strongly supported
by observations showing lack of lymphatic vessels, absence of parenchymal APCs, low
expression of constitutive major histocompatibility complex (MHC) class I and II molecules
within the brain parenchyma, as well as poor rejection of transplanted allo- or xeno-graft. In
the last decades this historical concept has been extensively revised, and there is now con‐
vincing evidence that the CNS is instead an immune specialized site, where a complex regimen
of immune surveillance does occur under physiological as well as pathological conditions and
is essential to guarantee its optimal functionality [67]. It is now clear that cells of both the innate
(microglia and monocyte-derived macrophages) and the adaptive (mainly CD4+ cells) immune
system are present within the brain parenchyma and exert beneficial effects on adult brain
plasticity and neurogenesis, as well as on the spontaneous attempt of the CNS to self-repair
following an injury [68].
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stood, it seems probable that the GABAergic and glutamatergic inputs coming from inter‐
neurons and mossy cells, are important for the regulation of NSCs [65]. These astrocyte-like
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[41]. However, despite the relatively high rate of neurogenesis, only a minority of new born
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GCL of the hippocampus [66]. In parallel, postnatal SGZ neurogenesis in the human brain has
been demonstrated to occur across the lifespan [55]. Although the role of new born neurons
generating in the SGZ is not yet fully understood, increasing evidence suggest a possible role
in learning and memory function [55].
3. CNS inflammation effects on endogenous adult NSC niches
3.1. Switching from an immune-privileged to an immune-specialized state
Protection and homeostasis are fundamental keystones for the proper maintenance of the CNS.
Hence, brain and spinal cord must be kept under an extreme security state to ensure their fully
functionality and, ultimately, the survival of an organism. However, in the past the CNS has
been often regarded as an immune privileged site, where immune cells were not supposed to
enter and interact with cells of the nervous system. This common belief was strongly supported
by observations showing lack of lymphatic vessels, absence of parenchymal APCs, low
expression of constitutive major histocompatibility complex (MHC) class I and II molecules
within the brain parenchyma, as well as poor rejection of transplanted allo- or xeno-graft. In
the last decades this historical concept has been extensively revised, and there is now con‐
vincing evidence that the CNS is instead an immune specialized site, where a complex regimen
of immune surveillance does occur under physiological as well as pathological conditions and
is essential to guarantee its optimal functionality [67]. It is now clear that cells of both the innate
(microglia and monocyte-derived macrophages) and the adaptive (mainly CD4+ cells) immune
system are present within the brain parenchyma and exert beneficial effects on adult brain
plasticity and neurogenesis, as well as on the spontaneous attempt of the CNS to self-repair
following an injury [68].
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3.2. Effects of inflammation on neurogenesis
Studies conducted over the last decade have extensively proved that the immune and nervous
systems interact by engaging an active bidirectional crosstalk. Indeed, the expression of
receptors able to recognize inflammatory mediators released by activated immune cells allows
endogenous progenitor cells to increase their proliferation rate and specifically home to the
site of inflammation after a trauma. As a consequence, both acute [69, 70] and chronic CNS
inflammation [6, 71] has been shown to perturb the anatomical architecture and functional
activity of adult germinal niches.
Work on EAE mice, the most widely accepted model of MS, has shown that chronic CNS
inflammation in myelin oligodendrocyte glycoprotein (MOG)35-55-immunized mice causes a
transient decrease in the proliferation rate of both C and B1 type cells and a contemporary
increased accumulation of neuroblasts within the V-SVZ [6]. This effect, observed during the
peak of the disease, was attributed to cell non-autonomous factors, such as pro-inflammato‐
ry (Th1) cytokines [e.g. interferon (IFN)- and its intracellular effector Stat-1]. However, these
data contrast with other studies showing how inflammatory demyelination in MOG+/- mice
immunized with purified mouse myelin increased proliferation and mobilization of neural
progenitor cells from the V-SVZ of adult mice. Surprisingly, while new born cells generat‐
ed at the level of V-SVZ commonly intended to differentiate into neurons, in response to
EAE,  these  cells  were  able  to  generate  astrocytes  and  oligodendrocytes  as  well,  thus
suggesting  that  inflammation  can  diverge  (at  least  partially)  their  intrinsic  nature  [4].
Increased proliferation, measured in terms of BrdU-positive cells, has been found also at the
level  of  the  hippocampus  both  during  the  acute  and  chronic  phases  of  the  disease  in
MOG35-55 immunized mice. Similarly to the observed accumulation of neuroblasts in the
V-SVZ, autoimmune inflammation leads to increased numbers of immature DCX-positive
cells in the DG of the hippocampus [72]. Even though some alterations in the Notch, Wnt/β-
catenin, Shh, and BDNF signalling pathways have been observed, their real contribution to
the  deregulation  of  hippocampal  neurogenesis  in  the  course  of  chronic  autoimmune
neuroinflammation  needs  to  be  further  confirmed [72].  In  addition,  magnetic  resonance
imaging (MRI) techniques revealed structural alterations in the hippocampus, evidencing
marked hippocampal atrophy [73], which may correlate with deficits in attention, informa‐
tion processing capacity and long-term memory observed in the majority of MS patients.
Enhanced proliferation during the acute phase of the disease has been observed in proteoli‐
pid  protein  (PLP)139-151-induced  relapsing  EAE  in  SJL  mice.  However,  during  both  the
relapsing and chronic phase of the disease, the number of SVZ progenitors cells decreased,
without changes in the ultrastructural features of the type B, C or A cells, but accompa‐
nied by an impaired maturation of oligodendrocyte progenitor cells (OPCs). This suggests
that the chronic activation of glial cells (namely microglia and astrocytes) might be deleteri‐
ous for the repair potential of endogenous brain stem/progenitor cells. Indeed, minocycline-
induced inactivation of microglia during the chronic phase in relapsing-remitting EAE mice
was associated with an improvement in the number of proliferating Sox2/Bromodeoxyuri‐
dine  (BrdU)+  neural  stem cells  [74].  Finally,  models  of  targeted  focal  EAE,  obtained  by
stereotactic injection of cytokines [e.g. tumor necrosis factor (TNF)-α and INF-γ] in rodents
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pre-immunized with a sub-clinical amount of myelin peptides, allowed to better analyse the
time course effect of auto-immune inflammation in the neurogenic areas. In this experimen‐
tal model a decreased proliferation in the proximity of the V-SVZ was observed at 3 days,
followed by an increase at 7 days after the injection of the cytokines, suggesting a regenera‐
tive attempt at the level of the V-SVZ area. Interestingly, the concomitant death of neuro‐
blasts, the decreased type C cell proliferation, and the reduction of type A migrating cells,
during the initial phase, might explain the impaired long-term olfactory memory observed
by means of behavioural analysis [75]. Altogether, these findings suggest the existence of a
compensatory mechanism of the injured brain in its attempt to counteract neuronal injury
and disturbed conductivity resulting from T cell attack to the myelin sheaths wrapping the
axons, which is among the most accepted causes of EAE and MS [76].
In agreement with what described in animal models, SVZ activation and expansion have been
found at the level of periventricular active and chronic active lesions in MS patients, thus
suggesting that the repetitive exposure to inflammatory insults does not completely exhaust
the proliferative potential of the SVZ [77]. V-SVZ from post-mortem brains shows an altered
balance between neurogenesis and gliogenesis, likely related to these inflammation effects
within the neurogenic niche of MS patients [78]. Interestingly, the majority of MS patients show
deficits in attention, information processing capacity and long-term memory, thus suggesting
that neuronal damage in MS can result not only in motor and sensory deficits but also cognitive
impairment. In support of these MRI techniques revealed structural alterations in the hippo‐
campus, evidencing marked hippocampal atrophy [73].
Acute events, occurring in non-autoimmune diseases such as stroke, have been similarly
proved of giving rise to increased proliferation of endogenous NSCs in the V-SVZ. These cells
migrate from the neurogenic niche towards the ischemic boundary regions of the striatum and
cerebral cortex, where they differentiate into mature striatal neurons [79-81]. During this
(injury-reactive) site-specific homing, newly generated neuroblasts form chain-like structures
in association with reactive astrocytes and blood vessels in the striatum, a reminiscence of the
embryonic migration of type A cells along the RMS [82, 83]. Initially, this potential self-repair
mechanism was supposed to happen only during the acute post-stroke phase. However,
subsequent studies showed that stroke-induced neurogenesis is an extensive and long-lasting
(up to 2 weeks) event, with continuous production of mature striatal neurons for several
months after the insult [84]. Unfortunately, the vast majority of migrating new born neurons
die within few weeks after the ischemia, and only few damaged cells (about 0.1%) are replaced
by newly generated neurons [85]. Similar evidence of stroke-induced neurogenesis has been
reported in post-mortem brains, where new born neurons are present in the ischemic penum‐
bra surrounding cerebral cortical infarcts, preferentially localized in the vicinity of blood
vessels [80]. The identification of those factors able to influence NSCs proliferation, homing
and survival after stroke may have a great therapeutic impact. Several cytokines and growth
factors that may be released by injured cells are thought to play a substantial role in promoting
the observed neurogenic response after stroke. Among these, ciliary neurotrophic factor
(CNTF) [86], transforming growth factor (TGF)-α [87], VEGF [88], fibroblast growth factor
(FGF)-2 [89] and erythropoietin (Epo) [90] have been proposed.
Systemic stem cell therapies and brain diseases
http://dx.doi.org/10.5772/55426
295
3.2. Effects of inflammation on neurogenesis
Studies conducted over the last decade have extensively proved that the immune and nervous
systems interact by engaging an active bidirectional crosstalk. Indeed, the expression of
receptors able to recognize inflammatory mediators released by activated immune cells allows
endogenous progenitor cells to increase their proliferation rate and specifically home to the
site of inflammation after a trauma. As a consequence, both acute [69, 70] and chronic CNS
inflammation [6, 71] has been shown to perturb the anatomical architecture and functional
activity of adult germinal niches.
Work on EAE mice, the most widely accepted model of MS, has shown that chronic CNS
inflammation in myelin oligodendrocyte glycoprotein (MOG)35-55-immunized mice causes a
transient decrease in the proliferation rate of both C and B1 type cells and a contemporary
increased accumulation of neuroblasts within the V-SVZ [6]. This effect, observed during the
peak of the disease, was attributed to cell non-autonomous factors, such as pro-inflammato‐
ry (Th1) cytokines [e.g. interferon (IFN)- and its intracellular effector Stat-1]. However, these
data contrast with other studies showing how inflammatory demyelination in MOG+/- mice
immunized with purified mouse myelin increased proliferation and mobilization of neural
progenitor cells from the V-SVZ of adult mice. Surprisingly, while new born cells generat‐
ed at the level of V-SVZ commonly intended to differentiate into neurons, in response to
EAE,  these  cells  were  able  to  generate  astrocytes  and  oligodendrocytes  as  well,  thus
suggesting  that  inflammation  can  diverge  (at  least  partially)  their  intrinsic  nature  [4].
Increased proliferation, measured in terms of BrdU-positive cells, has been found also at the
level  of  the  hippocampus  both  during  the  acute  and  chronic  phases  of  the  disease  in
MOG35-55 immunized mice. Similarly to the observed accumulation of neuroblasts in the
V-SVZ, autoimmune inflammation leads to increased numbers of immature DCX-positive
cells in the DG of the hippocampus [72]. Even though some alterations in the Notch, Wnt/β-
catenin, Shh, and BDNF signalling pathways have been observed, their real contribution to
the  deregulation  of  hippocampal  neurogenesis  in  the  course  of  chronic  autoimmune
neuroinflammation  needs  to  be  further  confirmed [72].  In  addition,  magnetic  resonance
imaging (MRI) techniques revealed structural alterations in the hippocampus, evidencing
marked hippocampal atrophy [73], which may correlate with deficits in attention, informa‐
tion processing capacity and long-term memory observed in the majority of MS patients.
Enhanced proliferation during the acute phase of the disease has been observed in proteoli‐
pid  protein  (PLP)139-151-induced  relapsing  EAE  in  SJL  mice.  However,  during  both  the
relapsing and chronic phase of the disease, the number of SVZ progenitors cells decreased,
without changes in the ultrastructural features of the type B, C or A cells, but accompa‐
nied by an impaired maturation of oligodendrocyte progenitor cells (OPCs). This suggests
that the chronic activation of glial cells (namely microglia and astrocytes) might be deleteri‐
ous for the repair potential of endogenous brain stem/progenitor cells. Indeed, minocycline-
induced inactivation of microglia during the chronic phase in relapsing-remitting EAE mice
was associated with an improvement in the number of proliferating Sox2/Bromodeoxyuri‐
dine  (BrdU)+  neural  stem cells  [74].  Finally,  models  of  targeted  focal  EAE,  obtained  by
stereotactic injection of cytokines [e.g. tumor necrosis factor (TNF)-α and INF-γ] in rodents
Neural Stem Cells - New Perspectives294
pre-immunized with a sub-clinical amount of myelin peptides, allowed to better analyse the
time course effect of auto-immune inflammation in the neurogenic areas. In this experimen‐
tal model a decreased proliferation in the proximity of the V-SVZ was observed at 3 days,
followed by an increase at 7 days after the injection of the cytokines, suggesting a regenera‐
tive attempt at the level of the V-SVZ area. Interestingly, the concomitant death of neuro‐
blasts, the decreased type C cell proliferation, and the reduction of type A migrating cells,
during the initial phase, might explain the impaired long-term olfactory memory observed
by means of behavioural analysis [75]. Altogether, these findings suggest the existence of a
compensatory mechanism of the injured brain in its attempt to counteract neuronal injury
and disturbed conductivity resulting from T cell attack to the myelin sheaths wrapping the
axons, which is among the most accepted causes of EAE and MS [76].
In agreement with what described in animal models, SVZ activation and expansion have been
found at the level of periventricular active and chronic active lesions in MS patients, thus
suggesting that the repetitive exposure to inflammatory insults does not completely exhaust
the proliferative potential of the SVZ [77]. V-SVZ from post-mortem brains shows an altered
balance between neurogenesis and gliogenesis, likely related to these inflammation effects
within the neurogenic niche of MS patients [78]. Interestingly, the majority of MS patients show
deficits in attention, information processing capacity and long-term memory, thus suggesting
that neuronal damage in MS can result not only in motor and sensory deficits but also cognitive
impairment. In support of these MRI techniques revealed structural alterations in the hippo‐
campus, evidencing marked hippocampal atrophy [73].
Acute events, occurring in non-autoimmune diseases such as stroke, have been similarly
proved of giving rise to increased proliferation of endogenous NSCs in the V-SVZ. These cells
migrate from the neurogenic niche towards the ischemic boundary regions of the striatum and
cerebral cortex, where they differentiate into mature striatal neurons [79-81]. During this
(injury-reactive) site-specific homing, newly generated neuroblasts form chain-like structures
in association with reactive astrocytes and blood vessels in the striatum, a reminiscence of the
embryonic migration of type A cells along the RMS [82, 83]. Initially, this potential self-repair
mechanism was supposed to happen only during the acute post-stroke phase. However,
subsequent studies showed that stroke-induced neurogenesis is an extensive and long-lasting
(up to 2 weeks) event, with continuous production of mature striatal neurons for several
months after the insult [84]. Unfortunately, the vast majority of migrating new born neurons
die within few weeks after the ischemia, and only few damaged cells (about 0.1%) are replaced
by newly generated neurons [85]. Similar evidence of stroke-induced neurogenesis has been
reported in post-mortem brains, where new born neurons are present in the ischemic penum‐
bra surrounding cerebral cortical infarcts, preferentially localized in the vicinity of blood
vessels [80]. The identification of those factors able to influence NSCs proliferation, homing
and survival after stroke may have a great therapeutic impact. Several cytokines and growth
factors that may be released by injured cells are thought to play a substantial role in promoting
the observed neurogenic response after stroke. Among these, ciliary neurotrophic factor
(CNTF) [86], transforming growth factor (TGF)-α [87], VEGF [88], fibroblast growth factor
(FGF)-2 [89] and erythropoietin (Epo) [90] have been proposed.
Systemic stem cell therapies and brain diseases
http://dx.doi.org/10.5772/55426
295
Much less is known about the presence of adult neurogenesis after SCI. Most likely, this can
be ascribed to a more diffuse scepticism concerning the existence of stem cells within the spinal
cord. Indeed, even if the spinal cord is generally considered a non-neurogenic tissue, multi‐
potent precursors can be isolated and propagated in vitro [91, 92]. In addition, spinal neuro‐
genesis has been shown to occur to a limited extent in response to several types of trauma
[93-95]. In a very recent study, the modulation of neurogenesis in the more canonical niches
of the adult brain has been investigated following SCI in rats. Interestingly, BrdU+ positive
cells were found to be significantly decreased both at the level of the V-SVZ and the SGZ in
subacute [15 days post injury (dpi)] condition. However, while V-SVZ proliferation returns to
normal levels at 90 dpi, this does not happen at the hippocampal level. This could be equally
explained by either a higher plasticity in the V-SVZ or a higher sensibility of the SGZ [96].
Alterations in adult neurogenesis have been extensively observed in a multitude of models of
other neurodegenerative diseases. Rats suffering by pilocarpine-induced temporal lobe
epilepsy (TLE), exhibit increased neurogenesis in the V-SVZ [97] as well as in the SGZ [98]
after a period of latency and then it lasts for several weeks following prolonged seizures
activity. Further, status epilepticus (SE) seems to accelerate the maturation and integration of
adult new born DG cells [99]. However, chronic TLE induces a decrease of neurogenesis, as
children affected by frequent seizures show decreased numbers of newly generated neurons
and proliferating cells [100]. Impaired (cell type specific) proliferation of V-SVZ as well as SGZ
progenitors has been observed also in experimental models of Alzheimer’s disease (AD) [101].
While it is not clear whether this is reflected in an increased [102] or decreased neurogenesis
[103], mainly because of the high number of different models used [104, 105], a recent study
suggested that abnormalities at the level of both the neurogenic niches might precede the onset
of amyloid deposition and memory impairments [106]. Interestingly, in post-mortem brains
of patients with AD, it has been observed an increase of neurogenesis into the SGZ accompa‐
nied by depletion in the V-SVZ [107].
3.3. The double face of inflammation
According to what described, it is suggestive that the CNS is able to start a beneficial, though
limited, process of self-repair. However, most of the new born cells generated following injury
are destined to die within few weeks, maybe due to a failure in their integration or due to the
inflammatory milieu. Even if these cells have been shown to fully differentiate into mature
neurons [82], the very low rate of occurrence imposes logical concerns regarding the thera‐
peutic value of this regenerative response to brain injury [81, 108]. Because of the rearrange‐
ments occurring in the neurogenic niches after an inflammatory event, the immune system has
been accredited as one of the major responsible of this failure. This assumption is further
corroborated by the observation that the increasing complexity of the immune system over the
evolutionary process has been accompanied by a concomitant loss of regenerative capacity
[109]. Also, several findings link inflammation to the pathogenesis of neurodegenerative
disorders and anti-inflammatory drugs seem to be promising candidates for their treatment.
Recent studies suggest that inflammation may indeed have a neuroprotective effect [110].
Nevertheless, the real effect of inflammation in several of these pathologies still needs to be
completely clarified.
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The early (acute) post-traumatic phase of a neuroinflammatory process involves the action of
resident microglial cells. These cells of myeloid origin are usually present in a resting but
dynamic state, ready to shift their activity and undergo morphological and functional trans‐
formations in response to any kind of brain damage or injury [111, 112]. While on one side the
selective ablation of microglia has been shown to exacerbate the ischemic injury in a mouse
model of focal cerebral ischemia [113], on the other side mounting evidence indicates that
chronic microglial activation may also contribute to the development and progression of
neurodegenerative disorders, mainly through the release of pro-inflammatory cytokines such
as interleukin (IL)-1, IL-6, and TNF-α [114]. As an example, infiltrating blood-derived macro‐
phages have been shown to exert a beneficial role in an experimental model of SCI, where they
contribute to limit the action of activated resident microglia, whose prolonged presence would
finally lead to detrimental consequences [115]. Indeed, when the activity of microglia is not
properly contained, their action may lead to a prolonged (chronic) inflammation eventually
culminating in the formation of fibrotic tissue.
Endogenous T cells are key components of the protective immunity process. As such, phys‐
iological trafficking of lymphocytes through the CNS is required to support the essential
function of immune surveillance [116]. Cellular composition analysis of the CSF of healthy
patients has revealed that up to 80% of the total number of cells is represented by central
memory and effector memory T-cells. This atypical composition, which is very different from
the one of the blood, also suggests a major role for the CSF in the defence of the CNS [117].
Indeed, the CSF drains the interstitial fluid of the CNS and brings CNS antigens to the cervical
lymph nodes, thus supplying for the absence of a proper lymphatic drainage [118, 119].
Following the seminal observation that self-specific T-cells recognizing myelin basic protein
were able to protect injured CNS neurons from secondary degeneration in a rat model of optic
nerve crash injury [120], several studies further supported the idea that T cell-dependent
autoimmunity might promote recovery from CNS injuries [121, 122]. These studies finally
culminated with the idea that boosting T-cell response to CNS antigens by means of immuni‐
zation with CNS myelin-associated self-antigens could have enhanced this therapeutic
potential [123-125]. Also, myelin-reactive T-cells possess neuroprotective effects, which may
be essentially attributed to their ability to release neurotrophic factors such as BDNF, nerve
growth factor (NGF) and CNTF [126]. Importantly though, auto-reactive T-cells showing this
protective effect may turn out to be harmful if escaping the control exerted by the immune
system, finally resulting into the development of autoimmune diseases such as MS. Therefore,
a strict control is required to finely tune the balance between the good and the bad [76].
To further complicate the scene, several inflammatory mediators, such as TNF-α, TGF-β, IL-1,
IL-6, IL-10 and IL-12 may have contrasting effects (e.g neuroprotective vs. neurotoxic) de‐
pending on the overall context. As an example, the role of IL-6 is crucial for the induction of
EAE [127], and its overexpression exacerbates tissue injury in experimental models of SCI [128,
129]. Also, high levels of this inflammatory marker in the blood of patients undergoing
inflammatory response after stroke correlates with the disease severity and poor clinical
outcome [130]. Accordingly, the use of monoclonal antibody directed towards IL-6 proved to
be beneficial in the treatment of acute SCI and MOG35-55-induced EAE [131, 132]. However,
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of the adult brain has been investigated following SCI in rats. Interestingly, BrdU+ positive
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normal levels at 90 dpi, this does not happen at the hippocampal level. This could be equally
explained by either a higher plasticity in the V-SVZ or a higher sensibility of the SGZ [96].
Alterations in adult neurogenesis have been extensively observed in a multitude of models of
other neurodegenerative diseases. Rats suffering by pilocarpine-induced temporal lobe
epilepsy (TLE), exhibit increased neurogenesis in the V-SVZ [97] as well as in the SGZ [98]
after a period of latency and then it lasts for several weeks following prolonged seizures
activity. Further, status epilepticus (SE) seems to accelerate the maturation and integration of
adult new born DG cells [99]. However, chronic TLE induces a decrease of neurogenesis, as
children affected by frequent seizures show decreased numbers of newly generated neurons
and proliferating cells [100]. Impaired (cell type specific) proliferation of V-SVZ as well as SGZ
progenitors has been observed also in experimental models of Alzheimer’s disease (AD) [101].
While it is not clear whether this is reflected in an increased [102] or decreased neurogenesis
[103], mainly because of the high number of different models used [104, 105], a recent study
suggested that abnormalities at the level of both the neurogenic niches might precede the onset
of amyloid deposition and memory impairments [106]. Interestingly, in post-mortem brains
of patients with AD, it has been observed an increase of neurogenesis into the SGZ accompa‐
nied by depletion in the V-SVZ [107].
3.3. The double face of inflammation
According to what described, it is suggestive that the CNS is able to start a beneficial, though
limited, process of self-repair. However, most of the new born cells generated following injury
are destined to die within few weeks, maybe due to a failure in their integration or due to the
inflammatory milieu. Even if these cells have been shown to fully differentiate into mature
neurons [82], the very low rate of occurrence imposes logical concerns regarding the thera‐
peutic value of this regenerative response to brain injury [81, 108]. Because of the rearrange‐
ments occurring in the neurogenic niches after an inflammatory event, the immune system has
been accredited as one of the major responsible of this failure. This assumption is further
corroborated by the observation that the increasing complexity of the immune system over the
evolutionary process has been accompanied by a concomitant loss of regenerative capacity
[109]. Also, several findings link inflammation to the pathogenesis of neurodegenerative
disorders and anti-inflammatory drugs seem to be promising candidates for their treatment.
Recent studies suggest that inflammation may indeed have a neuroprotective effect [110].
Nevertheless, the real effect of inflammation in several of these pathologies still needs to be
completely clarified.
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resident microglial cells. These cells of myeloid origin are usually present in a resting but
dynamic state, ready to shift their activity and undergo morphological and functional trans‐
formations in response to any kind of brain damage or injury [111, 112]. While on one side the
selective ablation of microglia has been shown to exacerbate the ischemic injury in a mouse
model of focal cerebral ischemia [113], on the other side mounting evidence indicates that
chronic microglial activation may also contribute to the development and progression of
neurodegenerative disorders, mainly through the release of pro-inflammatory cytokines such
as interleukin (IL)-1, IL-6, and TNF-α [114]. As an example, infiltrating blood-derived macro‐
phages have been shown to exert a beneficial role in an experimental model of SCI, where they
contribute to limit the action of activated resident microglia, whose prolonged presence would
finally lead to detrimental consequences [115]. Indeed, when the activity of microglia is not
properly contained, their action may lead to a prolonged (chronic) inflammation eventually
culminating in the formation of fibrotic tissue.
Endogenous T cells are key components of the protective immunity process. As such, phys‐
iological trafficking of lymphocytes through the CNS is required to support the essential
function of immune surveillance [116]. Cellular composition analysis of the CSF of healthy
patients has revealed that up to 80% of the total number of cells is represented by central
memory and effector memory T-cells. This atypical composition, which is very different from
the one of the blood, also suggests a major role for the CSF in the defence of the CNS [117].
Indeed, the CSF drains the interstitial fluid of the CNS and brings CNS antigens to the cervical
lymph nodes, thus supplying for the absence of a proper lymphatic drainage [118, 119].
Following the seminal observation that self-specific T-cells recognizing myelin basic protein
were able to protect injured CNS neurons from secondary degeneration in a rat model of optic
nerve crash injury [120], several studies further supported the idea that T cell-dependent
autoimmunity might promote recovery from CNS injuries [121, 122]. These studies finally
culminated with the idea that boosting T-cell response to CNS antigens by means of immuni‐
zation with CNS myelin-associated self-antigens could have enhanced this therapeutic
potential [123-125]. Also, myelin-reactive T-cells possess neuroprotective effects, which may
be essentially attributed to their ability to release neurotrophic factors such as BDNF, nerve
growth factor (NGF) and CNTF [126]. Importantly though, auto-reactive T-cells showing this
protective effect may turn out to be harmful if escaping the control exerted by the immune
system, finally resulting into the development of autoimmune diseases such as MS. Therefore,
a strict control is required to finely tune the balance between the good and the bad [76].
To further complicate the scene, several inflammatory mediators, such as TNF-α, TGF-β, IL-1,
IL-6, IL-10 and IL-12 may have contrasting effects (e.g neuroprotective vs. neurotoxic) de‐
pending on the overall context. As an example, the role of IL-6 is crucial for the induction of
EAE [127], and its overexpression exacerbates tissue injury in experimental models of SCI [128,
129]. Also, high levels of this inflammatory marker in the blood of patients undergoing
inflammatory response after stroke correlates with the disease severity and poor clinical
outcome [130]. Accordingly, the use of monoclonal antibody directed towards IL-6 proved to
be beneficial in the treatment of acute SCI and MOG35-55-induced EAE [131, 132]. However,
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IL-6 knockout mice showed significantly increased of chronic (but not acute) lesion volumes
and worse long-term functional outcome after stroke [133]. This may imply the need of a finely
tuned regulation, most likely depending on their precise timing and location other than on the
specific nature of the disease. Indeed, while some pathologies such as MS, SCI, stroke, TBI and
are characterized by an acute inflammatory event followed by secondary neurodegeneration,
others, such as epilepsy, Alzheimer’s disease (AD), Parkinson’s disease (PD), and Hunting‐
ton’s disease (HD) are instead caused by primary neurodegeneration subsequently leading to
secondary reactive inflammation [19].
As described in this paragraph, the CNS is able to regulate the proliferation rate within the
adult neurogenic niches as an extreme attempt to respond to damages in both primary and
secondary inflammatory neurodegenerative diseases. Nevertheless, this process is not robust
enough to effectively re-establish the complex functionality of the CNS. Therefore, protocols
aiming at pharmacological manipulation of endogenous precursors from germinal niche(s),
in vivo, might be therapeutically inefficacious in inflammatory CNS disorders. Thank to the
development of protocols allowing in vitro growth and large scale-up of brain-derived NPCs
[134], innovative therapies, for both acute and chronic CNS inflammatory disorders, based on
stem cell transplants have been proposed [7]. Transplantation of adult exogenous NPCs
represents, in fact, an alternative, and possibly more efficacious, therapeutic approach that
might overcome the limited endogenous repair. Motivated by the ambitious expectation to
achieve CNS repair (and/or regeneration) via functional neural cell replacement, many
different preclinical studies have evidenced a potential benefit of NPC-based treatments in
experimental animal models of several neurological diseases [8].
4. Exogenous NPC-based therapies: The systemic administration
4.1. Systemic injection and functional recovery
Following the seminal observation that systemically delivered NPCs were able to target an
intracranial tumour in rodent (both mice and rats) model of experimental brain tumours [135],
numerous studies started to investigate the validity of this administration route in a variety of
CNS disorders. Over the last decade, data have been provided on the feasibility of systemic
NPC transplants via either intravenous (i.v.) cell injection into the blood stream, or interacer‐
ebroventricular (i.c.v.)/intrathecal (i.t.) into the CSF, in experimental CNS disease models
[10-13, 16, 136-138]. Adult somatic mouse NPCs, administered 22 days post immunization
(dpi) greatly reduced the functional impairment observed in chronic MOG35-55-immunized
EAE mice [11]. Also, rat NPC neurospheres, administered i.c.v. or i.t. in rats affected by acute
EAE, attenuate the clinical symptoms when administered at the same day of disease induction
(0 dpi) [136]. Intravenous injected mouse NPCs were proved to be efficacious in PLP139-151
immunized relapsing EAE mice [16]. Indeed, mice, treated with NPCs at the disease onset or
at the time of the first relapse, recovered faster and showed a decrease in the relapse rate
compared to controls. At the end of the follow-up (90 dpi) both treatments resulted in a lower
relapsing remitting EAE cumulative score [16]. Finally, MOG35-55-immunized chronic EAE
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mice receiving either mouse neurospheres (i.c.v) or single cell NPCs (i.v.), at 6 and 8 dpi
respectively also showed significant clinical amelioration [20, 139].
The therapeutic efficacy of systemically administered NPCs has been later observed in a
different pathological context, such as stroke. Mouse somatic NPCs, systemically transplanted
3 days after middle cerebral artery occlusion (MCAo), resulted in a better recovery, signifi‐
cantly improving the neurological severity score starting from 18 days post transplantation
(dpt) until the end of the follow-up (30 dpt) [140]. Similar neurological improvements were
observed in rats subjected to MCAo and common carotid artery occlusion (CCAo) after i.t.
transplantation (7 days after stroke) of rat NPCs [141]. Significant locomotor recovery was also
observed after acute systemic NPC transplant in mice suffering from contusion SCI [13].
Similarly to rodent cells, human NPCs have been proved to be therapeutically efficacious.
Foetal NPCs administered either i.v. or i.t. at the disease onset, reduced the severity of
MOG1-125-induced chronic EAE in common marmosets [15]. Further, human embryonic stem
cell (ESC)-derived NPCs have been shown to reduce disease severity of chronic EAE mice
[142]. Human immortalized NPCs have been widely enrolled in stroke models. The systemic
injection of the HB1.F3 NPC line resulted in neurological improvements of rats treated 1 day
after MCAo or intracerebral hemorrhage (ICH) stroke models [12, 137, 138]. The same line
resulted therapeutically effective also in quinolinic acid-induced experimental HD in rats,
where NPCs administered intravenously at 7 days after disease induction, significantly
ameliorated the behavioural outcome [14].
All these evidences showing behavioural recovery upon systemic injection of NPCs in different
CNS inflammatory models, led to the investigation of the molecular mechanisms standing
behind, since this capacity bears the hope of developing less invasive surgical techniques to
implant therapeutic adult human stem cells into patients affected by highly debilitating CNS
disorders, such as MS, stroke, SCI, epilepsy, PD, AD and HD.
4.2. Homing capacity: NPCs breach the CNS barriers
Brain and spinal cord are protected by a complex control system, composed by tight barriers
shielding the action of a unique troop of immune cells. Indeed, to access the brain and spinal
cord parenchyma, circulating cells have to breach through all the barriers that closely seal the
CNS from the surrounding environment. Namely, these are the blood-brain barrier (BBB) at
the level of parenchymal capillaries and post-capillary venules, the blood-cerebrospinal fluid
barrier (BCSFB) at the level of the choroid plexus in the brain ventricles, and the blood-
leptomeningeal barrier (BLMB) at the level of the leptomeningeal/subarachnoid space. The
main role of these barriers is to maintain the chemical composition of the CNS microenviron‐
ment, thus ensuring the proper functionality of neuronal circuits, synaptic transmission and
remodelling, angiogenesis, and neurogenesis in the adult brain, while their rupture is involved
in many neuroinflammatory disorders [143]. Because of the existence of such barriers, the
access of systemically injected NPCs to the CNS parenchyma seems quite unlikely.
Structurally, the main component of the BBB is represented by specialized ECs characterized
by the absence of fenestrae, low pinocytotic activity and by the presence of intercellular tight
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represents, in fact, an alternative, and possibly more efficacious, therapeutic approach that
might overcome the limited endogenous repair. Motivated by the ambitious expectation to
achieve CNS repair (and/or regeneration) via functional neural cell replacement, many
different preclinical studies have evidenced a potential benefit of NPC-based treatments in
experimental animal models of several neurological diseases [8].
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Following the seminal observation that systemically delivered NPCs were able to target an
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numerous studies started to investigate the validity of this administration route in a variety of
CNS disorders. Over the last decade, data have been provided on the feasibility of systemic
NPC transplants via either intravenous (i.v.) cell injection into the blood stream, or interacer‐
ebroventricular (i.c.v.)/intrathecal (i.t.) into the CSF, in experimental CNS disease models
[10-13, 16, 136-138]. Adult somatic mouse NPCs, administered 22 days post immunization
(dpi) greatly reduced the functional impairment observed in chronic MOG35-55-immunized
EAE mice [11]. Also, rat NPC neurospheres, administered i.c.v. or i.t. in rats affected by acute
EAE, attenuate the clinical symptoms when administered at the same day of disease induction
(0 dpi) [136]. Intravenous injected mouse NPCs were proved to be efficacious in PLP139-151
immunized relapsing EAE mice [16]. Indeed, mice, treated with NPCs at the disease onset or
at the time of the first relapse, recovered faster and showed a decrease in the relapse rate
compared to controls. At the end of the follow-up (90 dpi) both treatments resulted in a lower
relapsing remitting EAE cumulative score [16]. Finally, MOG35-55-immunized chronic EAE
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mice receiving either mouse neurospheres (i.c.v) or single cell NPCs (i.v.), at 6 and 8 dpi
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3 days after middle cerebral artery occlusion (MCAo), resulted in a better recovery, signifi‐
cantly improving the neurological severity score starting from 18 days post transplantation
(dpt) until the end of the follow-up (30 dpt) [140]. Similar neurological improvements were
observed in rats subjected to MCAo and common carotid artery occlusion (CCAo) after i.t.
transplantation (7 days after stroke) of rat NPCs [141]. Significant locomotor recovery was also
observed after acute systemic NPC transplant in mice suffering from contusion SCI [13].
Similarly to rodent cells, human NPCs have been proved to be therapeutically efficacious.
Foetal NPCs administered either i.v. or i.t. at the disease onset, reduced the severity of
MOG1-125-induced chronic EAE in common marmosets [15]. Further, human embryonic stem
cell (ESC)-derived NPCs have been shown to reduce disease severity of chronic EAE mice
[142]. Human immortalized NPCs have been widely enrolled in stroke models. The systemic
injection of the HB1.F3 NPC line resulted in neurological improvements of rats treated 1 day
after MCAo or intracerebral hemorrhage (ICH) stroke models [12, 137, 138]. The same line
resulted therapeutically effective also in quinolinic acid-induced experimental HD in rats,
where NPCs administered intravenously at 7 days after disease induction, significantly
ameliorated the behavioural outcome [14].
All these evidences showing behavioural recovery upon systemic injection of NPCs in different
CNS inflammatory models, led to the investigation of the molecular mechanisms standing
behind, since this capacity bears the hope of developing less invasive surgical techniques to
implant therapeutic adult human stem cells into patients affected by highly debilitating CNS
disorders, such as MS, stroke, SCI, epilepsy, PD, AD and HD.
4.2. Homing capacity: NPCs breach the CNS barriers
Brain and spinal cord are protected by a complex control system, composed by tight barriers
shielding the action of a unique troop of immune cells. Indeed, to access the brain and spinal
cord parenchyma, circulating cells have to breach through all the barriers that closely seal the
CNS from the surrounding environment. Namely, these are the blood-brain barrier (BBB) at
the level of parenchymal capillaries and post-capillary venules, the blood-cerebrospinal fluid
barrier (BCSFB) at the level of the choroid plexus in the brain ventricles, and the blood-
leptomeningeal barrier (BLMB) at the level of the leptomeningeal/subarachnoid space. The
main role of these barriers is to maintain the chemical composition of the CNS microenviron‐
ment, thus ensuring the proper functionality of neuronal circuits, synaptic transmission and
remodelling, angiogenesis, and neurogenesis in the adult brain, while their rupture is involved
in many neuroinflammatory disorders [143]. Because of the existence of such barriers, the
access of systemically injected NPCs to the CNS parenchyma seems quite unlikely.
Structurally, the main component of the BBB is represented by specialized ECs characterized
by the absence of fenestrae, low pinocytotic activity and by the presence of intercellular tight
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junctions (TJs) [144]. This clutched arrangement prevents the free passage of molecules, while
the transport of nutrients into the CNS and the discard of toxic molecules into the circulation
is ensured by active mechanisms, thus guarantying a proper neuronal activity [145]. Moreover,
the BBB is an essential constituent of the so-called neurovascular unit, a boundary zone defined
on one side by the endothelium basement membrane (located in the abluminal side of the
vasculature) and on the other by the parenchymal basement membrane, which establishes the
ultimate border between the perivascular space and the CNS parenchyma. In post-capillary
venules these two membranes lay in close proximity, leaving just a narrow perivascular space
in between, which becomes more significant at the level of arteries and veins. In this area,
occasional APCs (leptomeningeal mesothelial cells) reside and play a major role in the
immunosurveilance program of the CNS. Finally, the inner and outer sides of the parenchymal
basement membrane are juxtaposed to the glia limitans, whose crossing seems to be crucial for
the effective triggering of a neuroinflammation process [146, 147]. The functionality of the BBB
in clinical situations, such as those occurring in some neurodegenerative disorders like MS,
ischemic stroke, sub-arachnoid haemorrhage, TBI and AD is markedly reduced, leading to an
increased permeability and trafficking of immune cells into the CNS parenchyma [148-152].
Most of the knowledge about the mechanisms that allow circulating cells to breach the
barrier(s) [117, 153, 154] and move into the CNS parenchyma comes from observations
conducted with models of CNS inflammation. Initial studies showed how intravenously
injected radioactively labelled encephalitogenic T cells were able to cross the BBB of healthy
recipients [153]. It was also shown that, while activation is mandatory for T-cells to cross the
endothelial barrier and reach perivascular spaces, antigen specificity is dispensable to further
cross the glia limitans and invade the CNS parenchyma after having encountered the appro‐
priate APCs [155].
The extravasation of specific T cells requires a multistep process [156]. The first step, known
as capture  (in non-inflamed endothelia) or tethering  (in inflamed endothelia) and rolling  is
represented by an initial,  transient contact  promoted by the specific  interaction between
members of the selectin and integrin families expressed by the activated endothelium with
their respective ligands on circulating immune cells.  It  has been shown how the recruit‐
ment  of  inflammatory  cells  across  the  BBB  involves  α4-integrin  and  its  ligands  of  the
immunoglobulin (Ig) superfamily, namely vascular cell adhesion molecule (VCAM)-1 and
mucosal  addressin cell  adhesion molecule  (MAdCAM)-1 [147].  Upon this  initial  contact,
circulating cells decrease their initial speed and resist the shear stress created by the blood
flow, mainly through endothelial intercellular adhesion molecule (ICAM)-1 and VCAM-1,
but not ICAM-2 [157]. Elegant studies have consistently shown that the inhibition of the
dimeric  α4β1-integrin  and  its  cognate  receptor  VCAM-1  on  the  activated  endothelium
prevented the accumulation of leukocytes in the CNS and the development of EAE [158].
Interestingly, when the inflammatory process is started, α4β1-integrin is no more dispensa‐
ble for T-cell capture or rolling [159].
The following step requires the firm adhesion and crawling of T-cells along the vascular wall.
This is orchestrated by some chemokines and chemoattractants, such as stromal cell-derived
factor (SDF)-1α/CXCL12 [160], monocyte chemoattractant protein (MCP)-1/CCL2 [161],
Neural Stem Cells - New Perspectives300
regulated and normal T cell expressed and secreted (RANTES)/CCL5 [162], EBI1 ligand
chemokine (ELC)/CCL19, secondary lymphoid-tissue chemokine (SLC)/CCL21 released by the
inflamed endothelia and CCR7 [163]. By binding to their G-coupled receptor (e.g.: C-X-C
chemokine receptor -CXCR- type 4 for SDF-1 and CCR2 for MCP-1), these chemokines transmit
an inside out signalling to T-cell surface integrins, which undergo dramatic conformational
modifications thus increasing their avidity (specificity for the ligand). Once engaged in such a
firm adhesion, T-cells need to make their way through the endothelium. To this purpose they
start probing the vasculature to find the optimal site to breach the wall. Following adhesion
to blood vessel walls, leukocytes undergo a series of actin rearrangements that eventually mark
their transition to a more flatten and polarized shape [164]. Finally, T-cells cross the border
either by paracellular or transcellular diapedesis or by creating pores through the cells -
transcellular diapedesis -. While the former require the disassembly of the intercellular junction
structure, the latter involves the formation of “cell-in-cell” interactions through the arrange‐
ment of docking structures or transmigratory cups enriched in ICAM-1 and VCAM-1, which
partially embrace migrating leukocytes [165].
A very similar sequential process has been shown being recapitulated when systemically
injected NPCs specifically home to the site of damage. In fact, NPCs posses the ability to reach
the cerebral parenchyma where they eventually induce recovery in animal models of neuro‐
degenerative diseases such as EAE [10, 11] stroke [12, 166], SCI [167, 168], epilepsy [138, 169],
HD [14], other than glioblastoma [135, 170]. The first studies showing the extravasation
capacity of NPCs [10-12] clearly demonstrated that this capacity was strictly related to the
activation of the ECs by an inflammation process occurring within the brain. NPCs adminis‐
tered either i.c.v. or i.v. to healthy animals were, in fact, never observed inside the CNS, while
mainly accumulating in peripheral organs, or remaining confined in the ventricles or subar‐
achnoid space. Only after activation of endothelial cells, exogenous NPCs were observed to
accumulate into the CNS. Systemically injected NPCs are, in fact, able to follow a gradient of
chemoattractants (e.g. pro-inflammatory cytokines and chemokines) released by the inflam‐
matory lesions into the blood stream and CSF. Following these signals, NPCs rapidly reach
the source of pro-inflammatory molecules within and interact with the activated endothelial/
ependymal cells around inflamed CNS tissues. At this level, NPCs and endothelial cells start
an organized sequence of events resembling those described for T cell extravasation that allow
the selective entrance and specific homing of transplanted cells in multifocal inflammatory CNS
areas [16]. Interestingly enough, only small percentages (between 1-5%) of the systemically
administered NPCs actually infiltrate and integrate within the CNS [11, 13, 140]. Mouse SVZ-
derived adult NPCs transplanted in a subacute model of brain inflammation were shown to
adhere to the CD49d counterligand VCAM-1 [16]. Further in vivo experiments showed that
migration of mouse NPCs towards the site of damage is dependent on the CXCR4-SDF-1α
signalling in mouse models of MS and brain tumour [17, 171]. In stroke models, the up-
regulation of VCAM-1 on the surface of endothelial cells facilitates the targeting and the
subsequent extravasation of VLA-4 expressing NPCs to the site of injury [18]. In line with this,
mouse NPCs sorted via FACS for the presence of VLA-4 revealed a more efficient transendo‐
thelial migration in a mouse model of stroke after intracarotid injection [18]. More recently it
Systemic stem cell therapies and brain diseases
http://dx.doi.org/10.5772/55426
301
junctions (TJs) [144]. This clutched arrangement prevents the free passage of molecules, while
the transport of nutrients into the CNS and the discard of toxic molecules into the circulation
is ensured by active mechanisms, thus guarantying a proper neuronal activity [145]. Moreover,
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vasculature) and on the other by the parenchymal basement membrane, which establishes the
ultimate border between the perivascular space and the CNS parenchyma. In post-capillary
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in between, which becomes more significant at the level of arteries and veins. In this area,
occasional APCs (leptomeningeal mesothelial cells) reside and play a major role in the
immunosurveilance program of the CNS. Finally, the inner and outer sides of the parenchymal
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increased permeability and trafficking of immune cells into the CNS parenchyma [148-152].
Most of the knowledge about the mechanisms that allow circulating cells to breach the
barrier(s) [117, 153, 154] and move into the CNS parenchyma comes from observations
conducted with models of CNS inflammation. Initial studies showed how intravenously
injected radioactively labelled encephalitogenic T cells were able to cross the BBB of healthy
recipients [153]. It was also shown that, while activation is mandatory for T-cells to cross the
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represented by an initial,  transient contact  promoted by the specific  interaction between
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their respective ligands on circulating immune cells.  It  has been shown how the recruit‐
ment  of  inflammatory  cells  across  the  BBB  involves  α4-integrin  and  its  ligands  of  the
immunoglobulin (Ig) superfamily, namely vascular cell adhesion molecule (VCAM)-1 and
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circulating cells decrease their initial speed and resist the shear stress created by the blood
flow, mainly through endothelial intercellular adhesion molecule (ICAM)-1 and VCAM-1,
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dimeric  α4β1-integrin  and  its  cognate  receptor  VCAM-1  on  the  activated  endothelium
prevented the accumulation of leukocytes in the CNS and the development of EAE [158].
Interestingly, when the inflammatory process is started, α4β1-integrin is no more dispensa‐
ble for T-cell capture or rolling [159].
The following step requires the firm adhesion and crawling of T-cells along the vascular wall.
This is orchestrated by some chemokines and chemoattractants, such as stromal cell-derived
factor (SDF)-1α/CXCL12 [160], monocyte chemoattractant protein (MCP)-1/CCL2 [161],
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regulated and normal T cell expressed and secreted (RANTES)/CCL5 [162], EBI1 ligand
chemokine (ELC)/CCL19, secondary lymphoid-tissue chemokine (SLC)/CCL21 released by the
inflamed endothelia and CCR7 [163]. By binding to their G-coupled receptor (e.g.: C-X-C
chemokine receptor -CXCR- type 4 for SDF-1 and CCR2 for MCP-1), these chemokines transmit
an inside out signalling to T-cell surface integrins, which undergo dramatic conformational
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structure, the latter involves the formation of “cell-in-cell” interactions through the arrange‐
ment of docking structures or transmigratory cups enriched in ICAM-1 and VCAM-1, which
partially embrace migrating leukocytes [165].
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injected NPCs specifically home to the site of damage. In fact, NPCs posses the ability to reach
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achnoid space. Only after activation of endothelial cells, exogenous NPCs were observed to
accumulate into the CNS. Systemically injected NPCs are, in fact, able to follow a gradient of
chemoattractants (e.g. pro-inflammatory cytokines and chemokines) released by the inflam‐
matory lesions into the blood stream and CSF. Following these signals, NPCs rapidly reach
the source of pro-inflammatory molecules within and interact with the activated endothelial/
ependymal cells around inflamed CNS tissues. At this level, NPCs and endothelial cells start
an organized sequence of events resembling those described for T cell extravasation that allow
the selective entrance and specific homing of transplanted cells in multifocal inflammatory CNS
areas [16]. Interestingly enough, only small percentages (between 1-5%) of the systemically
administered NPCs actually infiltrate and integrate within the CNS [11, 13, 140]. Mouse SVZ-
derived adult NPCs transplanted in a subacute model of brain inflammation were shown to
adhere to the CD49d counterligand VCAM-1 [16]. Further in vivo experiments showed that
migration of mouse NPCs towards the site of damage is dependent on the CXCR4-SDF-1α
signalling in mouse models of MS and brain tumour [17, 171]. In stroke models, the up-
regulation of VCAM-1 on the surface of endothelial cells facilitates the targeting and the
subsequent extravasation of VLA-4 expressing NPCs to the site of injury [18]. In line with this,
mouse NPCs sorted via FACS for the presence of VLA-4 revealed a more efficient transendo‐
thelial migration in a mouse model of stroke after intracarotid injection [18]. More recently it
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was shown that also the CCR2/CCL2 interaction is substantially involved in the recruitment
of systemically delivered NPCs in a mouse model of stroke [172].
In vitro experiments confirmed that mouse NPCs express many functional receptors on theirs
surfaces, among which the α4 subunit of the integrin VLA-4 [16], the SDF-1α receptor CXCR4
[173] and CD44, a cell-surface glycoprotein that binds to hyaluronic acid (HA) and is expressed
also in activated T cells [174, 175]. Interestingly, NPCs led to the formation of transmigratory
cups, enriched in multiple adhesion molecules such as ICAM-1 and VCAM-1, on the surface
of endothelial cells [175] as previously shown for T lymphocytes diapedesis [176].
Similarly, also immortalized human NPC lines express CD44 [175] and CXCR4 [173]. However,
in a recent study, human NPCs were shown to interact with activated ECs through integrins
α2, α6 and β1 rather than CXCR4 [177]. Further, human NPCs express the receptors CXCR1
and CXCR5, which mediate their in vitro migration across a monolayer of human brain ECs in
response to IL-8/CXCL8 and B lymphocyte chemoattractant (BLC)/CXCL13, chemokines
previously known to favour the trans-endothelial migration of immune cells [178].
All these evidences suggest that systemically injected mouse and human NPCs share the
expression of a variety of functional immune-like receptors, such as functional cell adhesion
molecules (e.g. CD44 and VLA-4) and inflammatory chemokine receptors (e.g. CCR2, CCR5
and CXCR4), giving them a unique leukocyte-like molecular signature. This characteristic,
allowing NPC interaction with activated endothelial and ependymal cells, represents an
essential requirement in the therapeutic paradigm of systemic delivery. Therefore, the
discovery of the specific homing ability of NPCs across the BBB opened new frontiers for the
treatment of CNS diseases, in particular for those diseases characterized by disseminated
damage.
4.3. NPC interaction with the dysfunctional CNS microenvironment: The establishment of
ectopic niches
Consistent data exists reporting the ability of i.v. injected NPCs to cross the BBB and accumu‐
late into the CNS. Here, exogenous NPCs co-exist with different host components, such as ECs,
infiltrating inflammatory cells, activated macrophages/microglia and reactive astrocytes [19].
In this context, the intimate association with ECs, the physical proximity to the vasculature
and the enhanced expression of stem cell regulators and growth factors involved both in
angiogenesis and neurogenesis has been described to play a major role in defining a molecular
architecture reminiscent of prototypical germinal stem cell niches [16]. Within these atypical
ectopic perivascular niches, in addition to hierarchical (mother-to-daughter) communication, a
sophisticated level of cell-to-cell horizontal communication takes place between transplanted
NPCs and resident cells. Recent evidences confirm that NPCs are able to communicate with
host cells via cellular contacts. For instance, functional gap junction formation has been shown
to allow exogenous NPCs to rescue host neurons and their projections in animal models of
Purkinje neurodegeneration. Gap junctions permitted the trans-cellular delivery of homeo‐
stasis-modulating molecules, as well as directly influenced the coordinated activity of the host
network via Ca++ waves. Moreover, hypoxic preconditioning of NPCs before their in vitro
engraftment increased Connexin 43 expression and improved subsequent communication
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with host cells [179]. Possible mechanisms of communication include also secretion of growth
factors, hormones, cytokines, chemokines and small molecular mediators [180], cell-to-cell
interactions via tunnelling nanotubes [181] and secretion of circular membrane vesicles [182],
other than cell-to-cell contacts [183].
Correlative evidence suggest that, depending on local inflammatory milieu, transplanted
NPCs may either remain in the niche while maintaining an undifferentiated state, or move out
from the niche, finally acquiring a terminally differentiated phenotype [16]. When systemically
injected in chronic EAE mice, syngenic NPCs were found almost exclusively in areas of CNS
damage, mainly within the submeningeal space in close proximity to subpial inflammatory
foci (after i.t. stem cell injection), or around post-capillary venules (after i.v. stem cell injection)
[11]. Ten days after transplantation, relatively few cells were found in the CNS parenchyma
and at 30 dpi many of the surviving donor cells were localized deeply within the brain
parenchyma and displayed a marked distribution pattern: most of them were confined within
areas of demyelination and axonal loss, and only very few cells were found within regions
where the myelin architecture was preserved [11]. Similar results were obtained after i.c.v NPC
injection at the peak of EAE in rats: cells entered into the brain or spinal cord parenchyma and
mostly accumulated at sites of inflamed white matter but not into adjacent grey matter regions.
In line with the previous study, after 2 weeks cells had migrated into distant white matter tracts
but, on the contrary, most of them had acquired specific markers of the astroglial and oligo‐
dendroglial lineages [184]. Mouse NPC transplants in rodents affected by EAE are also
associated with significantly reduced glial scar formation [11] and an increased survival and
recruitment of endogenous neural cells participating to the naturally occurring brain repara‐
tive response upon myelin damage [10, 15, 16, 185, 186].
Human NPCs have  shown a  higher  rate  of  cell  integration  after  being  administered  in
different animal models. In particular, the HB1.F3 immortalized cell line, i.v. injected in a
model  of  ischemic  stroke,  were  shown to  enter  the  ischemic  area  and differentiate  into
neurons  and  astrocytes,  similarly  to  what  observed  with  focal  injected  cells  [12,  187].
Transplanted cells  seemed to  adapt  their  fate  accordingly  to  the  region of  engraftment,
showing the appropriate  neuronal  and glial  markers.  NeuN+  and NF+  cells  were identi‐
fied primarily in the CA1 area of the hippocampus and in the dentate gyrus, mixed with
GFAP+ cells. Vimentin, GFAP and NF markers showed a progressive expression during the
first 2-3 weeks after transplantation, suggesting a step-by-step maturation of the cells [187].
The very same line of cells,  injected in a rat  model of ICH [137],  was observed to infil‐
trate the brain, survive and migrate towards the peri-hematomal areas. The cells were found
mainly  differentiating  into  GFAP+  and  NeuN+  cells.  However,  the  rapid  behavioural
recovery observed in ICH rats as soon as 2 weeks after transplantation, suggested that the
NPC therapeutic effect was mainly related to neuroprotection, rather than to integration
into neuronal  circuitry [137,  187],  since the latter  would require longer time to produce
clinical  ameliorations.  A  similar  trend  towards  human  NPC  differentiation  has  been
observed  in  animal  models  of  SCI,  SE  and  HD.  HB1.F3  hNPCs  administered  in  mice
subjected to compression SCI, were observed to differentiate into βIII-tubulin+ neurons at
21  days  after  transplantation  [167].  GABA-immunoreactive  interneurons  were,  instead,
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surfaces, among which the α4 subunit of the integrin VLA-4 [16], the SDF-1α receptor CXCR4
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of endothelial cells [175] as previously shown for T lymphocytes diapedesis [176].
Similarly, also immortalized human NPC lines express CD44 [175] and CXCR4 [173]. However,
in a recent study, human NPCs were shown to interact with activated ECs through integrins
α2, α6 and β1 rather than CXCR4 [177]. Further, human NPCs express the receptors CXCR1
and CXCR5, which mediate their in vitro migration across a monolayer of human brain ECs in
response to IL-8/CXCL8 and B lymphocyte chemoattractant (BLC)/CXCL13, chemokines
previously known to favour the trans-endothelial migration of immune cells [178].
All these evidences suggest that systemically injected mouse and human NPCs share the
expression of a variety of functional immune-like receptors, such as functional cell adhesion
molecules (e.g. CD44 and VLA-4) and inflammatory chemokine receptors (e.g. CCR2, CCR5
and CXCR4), giving them a unique leukocyte-like molecular signature. This characteristic,
allowing NPC interaction with activated endothelial and ependymal cells, represents an
essential requirement in the therapeutic paradigm of systemic delivery. Therefore, the
discovery of the specific homing ability of NPCs across the BBB opened new frontiers for the
treatment of CNS diseases, in particular for those diseases characterized by disseminated
damage.
4.3. NPC interaction with the dysfunctional CNS microenvironment: The establishment of
ectopic niches
Consistent data exists reporting the ability of i.v. injected NPCs to cross the BBB and accumu‐
late into the CNS. Here, exogenous NPCs co-exist with different host components, such as ECs,
infiltrating inflammatory cells, activated macrophages/microglia and reactive astrocytes [19].
In this context, the intimate association with ECs, the physical proximity to the vasculature
and the enhanced expression of stem cell regulators and growth factors involved both in
angiogenesis and neurogenesis has been described to play a major role in defining a molecular
architecture reminiscent of prototypical germinal stem cell niches [16]. Within these atypical
ectopic perivascular niches, in addition to hierarchical (mother-to-daughter) communication, a
sophisticated level of cell-to-cell horizontal communication takes place between transplanted
NPCs and resident cells. Recent evidences confirm that NPCs are able to communicate with
host cells via cellular contacts. For instance, functional gap junction formation has been shown
to allow exogenous NPCs to rescue host neurons and their projections in animal models of
Purkinje neurodegeneration. Gap junctions permitted the trans-cellular delivery of homeo‐
stasis-modulating molecules, as well as directly influenced the coordinated activity of the host
network via Ca++ waves. Moreover, hypoxic preconditioning of NPCs before their in vitro
engraftment increased Connexin 43 expression and improved subsequent communication
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factors, hormones, cytokines, chemokines and small molecular mediators [180], cell-to-cell
interactions via tunnelling nanotubes [181] and secretion of circular membrane vesicles [182],
other than cell-to-cell contacts [183].
Correlative evidence suggest that, depending on local inflammatory milieu, transplanted
NPCs may either remain in the niche while maintaining an undifferentiated state, or move out
from the niche, finally acquiring a terminally differentiated phenotype [16]. When systemically
injected in chronic EAE mice, syngenic NPCs were found almost exclusively in areas of CNS
damage, mainly within the submeningeal space in close proximity to subpial inflammatory
foci (after i.t. stem cell injection), or around post-capillary venules (after i.v. stem cell injection)
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areas of demyelination and axonal loss, and only very few cells were found within regions
where the myelin architecture was preserved [11]. Similar results were obtained after i.c.v NPC
injection at the peak of EAE in rats: cells entered into the brain or spinal cord parenchyma and
mostly accumulated at sites of inflamed white matter but not into adjacent grey matter regions.
In line with the previous study, after 2 weeks cells had migrated into distant white matter tracts
but, on the contrary, most of them had acquired specific markers of the astroglial and oligo‐
dendroglial lineages [184]. Mouse NPC transplants in rodents affected by EAE are also
associated with significantly reduced glial scar formation [11] and an increased survival and
recruitment of endogenous neural cells participating to the naturally occurring brain repara‐
tive response upon myelin damage [10, 15, 16, 185, 186].
Human NPCs have  shown a  higher  rate  of  cell  integration  after  being  administered  in
different animal models. In particular, the HB1.F3 immortalized cell line, i.v. injected in a
model  of  ischemic  stroke,  were  shown to  enter  the  ischemic  area  and differentiate  into
neurons  and  astrocytes,  similarly  to  what  observed  with  focal  injected  cells  [12,  187].
Transplanted cells  seemed to  adapt  their  fate  accordingly  to  the  region of  engraftment,
showing the appropriate  neuronal  and glial  markers.  NeuN+  and NF+  cells  were identi‐
fied primarily in the CA1 area of the hippocampus and in the dentate gyrus, mixed with
GFAP+ cells. Vimentin, GFAP and NF markers showed a progressive expression during the
first 2-3 weeks after transplantation, suggesting a step-by-step maturation of the cells [187].
The very same line of cells,  injected in a rat  model of ICH [137],  was observed to infil‐
trate the brain, survive and migrate towards the peri-hematomal areas. The cells were found
mainly  differentiating  into  GFAP+  and  NeuN+  cells.  However,  the  rapid  behavioural
recovery observed in ICH rats as soon as 2 weeks after transplantation, suggested that the
NPC therapeutic effect was mainly related to neuroprotection, rather than to integration
into neuronal  circuitry [137,  187],  since the latter  would require longer time to produce
clinical  ameliorations.  A  similar  trend  towards  human  NPC  differentiation  has  been
observed  in  animal  models  of  SCI,  SE  and  HD.  HB1.F3  hNPCs  administered  in  mice
subjected to compression SCI, were observed to differentiate into βIII-tubulin+ neurons at
21  days  after  transplantation  [167].  GABA-immunoreactive  interneurons  were,  instead,
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observed originating from HB1.F3 when systemically administered the day after lithium-
pilocarpine induction of experimental SE in rats [138]. Further, HB1.F3 cells injected 7 days
after  unilateral  quinolinic  acid  (QA)-induced  model  of  HD  in  rats  were  found  to  stay
confined  around  blood  vessels,  mostly  in  the  damaged  hemisphere  and  only  partially
differentiating in GFAP+ and NeuN+ cells at 3 weeks post transplantation [14].
Despite these evidences showing the ability of exogenous NPCs to survive and differentiate
into multiple derivatives according to local cues, the majority of the data provided has
substantially failed to show convincing relevant differentiation and integration of transplanted
NPCs in vivo. It is now quite evident that NPCs (and more generally somatic adult SCs) might
protect the CNS trough mechanisms alternative to direct cell replacement, which imply the
interaction of NPCs with both resident neural and immune cells [7, 188]. Cell replacement is
therefore only one of the multiple ways by which transplanted NPCs can promote tissue repair,
and a much more complex therapeutic scenario should be foreseen. The concept of stem cell
therapeutic plasticity (or functional multipotency) has therefore emerged, describing the different
way(s) NPCs use to interact with tissue-resident vs. infiltrating immune cells, at the level of
the inflammatory tissue context in which they are either transplanted or migrate to after
transplantation. These bystander effects, are mainly represented by neuroprotection, which
might occur both through secretion of soluble factors and cell-to-cell contact interactions and
immunomodulation, intended as the capacity of NPCs to influence the activity of the immune
system in the CNS and/or in the periphery, at the level of secondary lymphoid organs [5, 19].
4.3.1. Tissue trophic effects
NPCs may exert their neuroprotective effect by increasing in situ bioavailability of several
molecules, such as neurotrophins, growth factors and developmental stem cell regulators, thus
promoting the survival and function of endogenous glial and neuronal progenitors that
escaped the primary insults [19].
Mouse NPCs systemically injected in mice affected by middle cerebral artery occlusion
(MCAo) were observed to mostly maintain an undifferentiated phenotype, while accumulat‐
ing at the boundaries of the lesioned area [140, 141]. Tissue survival was associated with a
down regulation of inflammation, glial scar formation and neuronal apoptotic cell death at
both mRNA and protein levels [140]. Increased levels of BDNF, NGF and neurotrophin (NT)-3
were found in the CSF of stroke-affected rats after intra-cisterna magna administration of
NPCs. In addition, immunohistochemical analysis of the injured brain revealed an increase of
MHC class I levels in treated rats [141]. Interestingly, this neuroprotective effect in the ischemic
microenvironment seems to start very soon after the systemic administration of cells. In fact,
data have been provided showing an increase in the gene expression levels of IGF-1, VEGF,
TGF-1β, BDNF and CXCL12/SDF1-α in the NPC-transplanted MCAo brain, as soon as 24 hours
after the acute i.c.v. injection [189]. Further, NPCs have been proved to increase in vivo
vascularisation when administered after stroke, most likely due to their ability to increase the
presence of VEGF, FGF, BDNF and chemoattractant factors (such as SDF-1α), which promote
angiogenesis and mobilization of endogenous endothelial progenitors [18, 190]
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More recently, adult mouse NPCs systemically injected in mice (3 injections few hours after
the injury) suffering from acute contusion SCI, showed an undifferentiated morphology
(similarly to what observed in EAE) at the level of the damaged CNS. Ex vivo RT-PCR analysis
showed NPC-driven up regulation of BDNF, NT-3, NGF, leukemia inhibitory factor (LIF) and
TNF- α only at 48h after treatments, while no differences were observed neither at 24h or 7
days after transplantation [13]. Similarly to what observed by indirect evidence in vivo, real-
time PCR gene expression analysis directly revealed high levels of NGF, BDNF and NT-3 and
glial cell line-derived neurotrophic factor (GDNF) in the transcripts of cultured rat NPCs [141,
191]. In addition, in line with the observed pro-angiogeneic effect in vivo after transplantation
of mouse NPCs in stroke models [18, 190], human NPCs were proved to secrete VEGF in
vitro [192].
All these evidences suggested that the underlying molecular mechanisms by which trans‐
planted  NPCs  instruct  tissue  protection  effects  are  partly  related  to  increased  in  vivo
bioavailability of major neurotrophins [11, 138, 139, 193] able to modulate the host environ‐
ment resulting more permissive to regeneration.  Neurotrophins exert  important  roles  as
mediators in cell cycle regulation, cell survival, and differentiation during development and
adulthood.  The  delivery  of  diffusible  proteins  to  the  CNS  has  been  seen  as  a  possible
therapeutic weapon for neurological diseases. However, because the CNS is likely impene‐
trable for many of these diffusible proteins, NPCs might be envisaged as carrier of neurotro‐
phic factors. To this aim, NPCs have been genetically modified to act as Trojan horses  to
deliver the desired diffusible molecules at the site of injury, thus fostering their innate capacity
to secrete neurotrophic and growth factors  [194].  Among all  the candidate neurotrophic
factors to be delivered, GDNF has shown a potent neuroprotective effect on a variety of
neuronal inflammatory models, such as stroke and PD [195-197]. However, its effects are
generally transient and need consecutive administrations to obtain long-standing results.
NPCs over-expressing GDNF can instead provide durable neuroprotective effects, as shown
with mouse NPCs, transplanted i.c.v in rats 3 days after MCAo [198]. The exogenous cells
resulted in an overall increase of cell survival of endogenous cells after the insult, which in
turn  was  associated  to  a  partial  functional  recovery.  Interestingly,  treated  rats  also  dis‐
played a significant increase of the synaptic proteins synaptophysin and post-synaptic density
protein (PSD)-95, suggesting an enhanced neuronal function and a possible reconstruction
of endogenous neural circuitries after the grafting [198]. Finally, a recent study showed that
the intravenous administration HB1.F3 human NPCs transduced with INF-β and cytosine
deaminase (CD), was able to interfere with toll-like-receptor (TLR)-4 (up-regulated into the
site of injury) suppressing the SCI-induced proliferation of reactive astrocytes and promot‐
ing functional recovery [199]. Other neurotrophic factors, such as BDNF and VEGF, have
been over-expressed in NPCs and mainly tested upon intraparenchymal injection in models
of SCI [200] or ICH [201, 202]. Taken together, these data suggest that the clinical ameliora‐
tion observed in CNS disease animal models are, at least in part, mediated by a multilay‐
ered NPC neurotrophic signature.
Systemic stem cell therapies and brain diseases
http://dx.doi.org/10.5772/55426
305
observed originating from HB1.F3 when systemically administered the day after lithium-
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differentiating in GFAP+ and NeuN+ cells at 3 weeks post transplantation [14].
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into multiple derivatives according to local cues, the majority of the data provided has
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NPCs in vivo. It is now quite evident that NPCs (and more generally somatic adult SCs) might
protect the CNS trough mechanisms alternative to direct cell replacement, which imply the
interaction of NPCs with both resident neural and immune cells [7, 188]. Cell replacement is
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therapeutic plasticity (or functional multipotency) has therefore emerged, describing the different
way(s) NPCs use to interact with tissue-resident vs. infiltrating immune cells, at the level of
the inflammatory tissue context in which they are either transplanted or migrate to after
transplantation. These bystander effects, are mainly represented by neuroprotection, which
might occur both through secretion of soluble factors and cell-to-cell contact interactions and
immunomodulation, intended as the capacity of NPCs to influence the activity of the immune
system in the CNS and/or in the periphery, at the level of secondary lymphoid organs [5, 19].
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NPCs may exert their neuroprotective effect by increasing in situ bioavailability of several
molecules, such as neurotrophins, growth factors and developmental stem cell regulators, thus
promoting the survival and function of endogenous glial and neuronal progenitors that
escaped the primary insults [19].
Mouse NPCs systemically injected in mice affected by middle cerebral artery occlusion
(MCAo) were observed to mostly maintain an undifferentiated phenotype, while accumulat‐
ing at the boundaries of the lesioned area [140, 141]. Tissue survival was associated with a
down regulation of inflammation, glial scar formation and neuronal apoptotic cell death at
both mRNA and protein levels [140]. Increased levels of BDNF, NGF and neurotrophin (NT)-3
were found in the CSF of stroke-affected rats after intra-cisterna magna administration of
NPCs. In addition, immunohistochemical analysis of the injured brain revealed an increase of
MHC class I levels in treated rats [141]. Interestingly, this neuroprotective effect in the ischemic
microenvironment seems to start very soon after the systemic administration of cells. In fact,
data have been provided showing an increase in the gene expression levels of IGF-1, VEGF,
TGF-1β, BDNF and CXCL12/SDF1-α in the NPC-transplanted MCAo brain, as soon as 24 hours
after the acute i.c.v. injection [189]. Further, NPCs have been proved to increase in vivo
vascularisation when administered after stroke, most likely due to their ability to increase the
presence of VEGF, FGF, BDNF and chemoattractant factors (such as SDF-1α), which promote
angiogenesis and mobilization of endogenous endothelial progenitors [18, 190]
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More recently, adult mouse NPCs systemically injected in mice (3 injections few hours after
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TNF- α only at 48h after treatments, while no differences were observed neither at 24h or 7
days after transplantation [13]. Similarly to what observed by indirect evidence in vivo, real-
time PCR gene expression analysis directly revealed high levels of NGF, BDNF and NT-3 and
glial cell line-derived neurotrophic factor (GDNF) in the transcripts of cultured rat NPCs [141,
191]. In addition, in line with the observed pro-angiogeneic effect in vivo after transplantation
of mouse NPCs in stroke models [18, 190], human NPCs were proved to secrete VEGF in
vitro [192].
All these evidences suggested that the underlying molecular mechanisms by which trans‐
planted  NPCs  instruct  tissue  protection  effects  are  partly  related  to  increased  in  vivo
bioavailability of major neurotrophins [11, 138, 139, 193] able to modulate the host environ‐
ment resulting more permissive to regeneration.  Neurotrophins exert  important  roles  as
mediators in cell cycle regulation, cell survival, and differentiation during development and
adulthood.  The  delivery  of  diffusible  proteins  to  the  CNS  has  been  seen  as  a  possible
therapeutic weapon for neurological diseases. However, because the CNS is likely impene‐
trable for many of these diffusible proteins, NPCs might be envisaged as carrier of neurotro‐
phic factors. To this aim, NPCs have been genetically modified to act as Trojan horses  to
deliver the desired diffusible molecules at the site of injury, thus fostering their innate capacity
to secrete neurotrophic and growth factors  [194].  Among all  the candidate neurotrophic
factors to be delivered, GDNF has shown a potent neuroprotective effect on a variety of
neuronal inflammatory models, such as stroke and PD [195-197]. However, its effects are
generally transient and need consecutive administrations to obtain long-standing results.
NPCs over-expressing GDNF can instead provide durable neuroprotective effects, as shown
with mouse NPCs, transplanted i.c.v in rats 3 days after MCAo [198]. The exogenous cells
resulted in an overall increase of cell survival of endogenous cells after the insult, which in
turn  was  associated  to  a  partial  functional  recovery.  Interestingly,  treated  rats  also  dis‐
played a significant increase of the synaptic proteins synaptophysin and post-synaptic density
protein (PSD)-95, suggesting an enhanced neuronal function and a possible reconstruction
of endogenous neural circuitries after the grafting [198]. Finally, a recent study showed that
the intravenous administration HB1.F3 human NPCs transduced with INF-β and cytosine
deaminase (CD), was able to interfere with toll-like-receptor (TLR)-4 (up-regulated into the
site of injury) suppressing the SCI-induced proliferation of reactive astrocytes and promot‐
ing functional recovery [199]. Other neurotrophic factors, such as BDNF and VEGF, have
been over-expressed in NPCs and mainly tested upon intraparenchymal injection in models
of SCI [200] or ICH [201, 202]. Taken together, these data suggest that the clinical ameliora‐
tion observed in CNS disease animal models are, at least in part, mediated by a multilay‐
ered NPC neurotrophic signature.
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4.3.2. Regulation of the immune system
Considerable evidence of the immune modulatory capacity of NPCs has derived from transplan‐
tation studies through different routes in the EAE model. As mentioned, transplanted NPCs are
consistently found around inflamed blood vessels, in close contact with both endogenous neural
cells (e.g. astrocytes and neurons) and CNS-infiltrating blood-borne CD45+ immune cells [185].
Also, i.c.v. administered NPCs were found to attenuate brain inflammation primarily through
a reduction of perivascular infiltrates and CD3+ T cells with a concomitant increase of CD25+ and
CD25+/CD62L+ regulatory T cells [136]. Interestingly, i.v. injection of NPCs also protects against
chronic neural tissue loss as well as disease-related disability in EAE, via induction of apopto‐
sis of blood-borne CNS-infiltrating encephalitogenic T cells [185]
NPCs have been shown to possess immune modulatory capacity also in models of stroke,
where T cells do not have a major role in the disease pathology. Irrespectively of the route of
administration (systemically vs. intraparechimally), transplanted NPCs migrate towards the
site of infarct in MCAo and ICH models [12, 137, 138, 203-207] and once reached the ischemic
boundary zone (IBZ), grafted NPCs interact with the inflammatory environment. The sub-
acute (delayed) i.v. injection of mouse NPCs after MCAo in mice, significantly down-regulates
multiple RNA species involved in inflammation, including IFN-γ, TNF-α, IL-1β, IL-6 and
leptin receptor [140]. Therefore, NPCs may exert an immune modulatory action, causing a
profound down regulation of inflammatory lymphoid (T cells) and myeloid (macrophages) cells
within inflamed brain areas.
While the inhibition of the T cell responses by NPCs is a quite established concept [208], the
effect of the interaction between transplanted NPCs and microglia/macrophages is still
controversial, mainly because of the non-univocal data regarding the role sustained by
professional phagocytes under CNS inflammatory conditions. In vivo studies have in fact
produced opposite evidences that might underline once more the bimodal action of some
immune regulators [209]. NPC transplantation promote the infiltration of CD11b+ myeloid
cells into the brain of MCAo mice, thus suggesting that myeloid cell activation might be
required for transplanted NPCs to exert part of their neuroprotective action [189]. Indeed,
MCAo mice in which CD11b+ microglia have been selectively ablated showed exacerbation of
the ischemia-dependent brain injury [113]. However, several studies have showed a significant
reduction of microglia/macrophages in the brain of mice, with either ischemic or haemorrhagic
stroke, together with improved neuronal survival and locomotor functions after NPC trans‐
plantation [22, 140]. Also in this case, NPCs have been engineered in order to increase their
immune modulatory capacity. Recently, mouse NPCs were transduced with IL-10, which has
been proved to efficiently suppress EAE symptoms and promote survival of neurons and
oligodendrocytes [210-212]. Mouse NPCs, transduced with a lentiviral vector encoding IL-10,
showed enhanced ability to induce remyelination, neuronal repair and immune suppression
after systemic injection in EAE mice compared to control NPCs [213].
In vitro, NPCs are shown to increase the apoptosis of PLP139-151-specific Th1 pro-inflammatory
(but not Th2 anti-inflammatory) cells through the engagement of death receptors, including
FasL, TNF-related apoptosis-inducing ligand (TRAIL), and APO3L, on the surface of NPCs [16].
Mouse and rat NPCs also inhibit T cell activation and proliferation in response to T cell recep‐
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tor (TCR)-mediated stimuli (e.g., concanavalin A and anti-CD3/anti-CD28) [136, 214]. NPC/T
lymphocyte co-culture experiments suggest that part of the anti-proliferative effect of NPCs
might depend on the inhibition of IL-2 and IL-6 signalling on T lymphocytes [214]. In addi‐
tion, NPCs have shown a selective pro-apoptotic effect on Th17 cells in vitro via a FasL (CD95L)-
dependent mechanism, identifying the axis Fas-Birc3 as an additional survival pathway for
NPCs [215]. Mouse C17.2 NPCs also suppress T-cell proliferation, at least in part, by reactive
production of the soluble mediators nitric oxide (NO) and prostaglandin E2 (PGE2). High levels
of NO and PGE2 are in fact induced in T cells when co-cultured with NPCs. In addition, inducible
NO synthase (iNOS) and microsomal type 1 PGES (mPGES-1) are detected in NPCs in co-
culture with T-cells, suggesting that NO and PGE2 production in NPCs is induced by expo‐
sure to activated T cells [216].
Human NPCs have been proved to suppress the proliferation and alter the cytokine secretion
profiles of activated T cells on both xenogeneic antigen-specific T cells derived from EAE
induced non-human primates (common marmosets), and allogeneic mitogen-activated T cells.
Co-culture of human NPCs with T cells, revealed their immune modulatory capacity through
both direct cell-to-cell contacts as well as via the release of soluble mediators into the culture
medium [15]. Notably, in contrast to the mouse counterpart, human NPCs have a limited
cytotoxicity against T cells in vitro, given that FasL is only barely detectable on their surface.
However, human NPCs exposed to cytokines express high levels of TNF-α, resulting in a
higher cytotoxic potential against monocytes and macrophages [217]. In line with this,
immortalized human NPCs were also proved, trough direct in vitro experiments, to reduce T
cell activation and proliferation. Conditioned media collected from human NSCs (HB1.F3 line)
in vitro, directly suppress the proliferation of activated human T cells through both induction
of apoptosis and cell cycle arrest. Nonetheless, human NPC-released mediators alter the
cytokine production pattern of T lymphocytes, increasing the expression of IL-4, IL-10, TNF-
α, and IFN-γ and decreasing IL-2, thus affecting the overall activation [200].
4.4. NPC interactions with the dysfunctional non-CNS microenvironment
In parallel to the observed immune modulation and neuroprotection into the CNS, other studies
have shown that systemically injected cells may act also outside the injured CNS. Different
studies, in fact, have reported the capacity of NPCs to target and synergize with immune cells
at the level of secondary lymphoid organs (e.g. draining lymph nodes) and the spleen, result‐
ing in the attenuation of the inflammatory response following EAE, stroke and SCI.
It was initially showed in vitro that NPCs strongly inhibited the ability of EAE-derived lympho‐
cytes to produce pro-inflammatory Th1 cytokines in response to MOG35-55 stimulation. In
addition, specifically activated T cells isolated from EAE mice treated with NPCs, were deficient
in their ability to adoptively transfer EAE (to a naïve host), thus suggesting a long-lasting
inhibition of encephalitogenicity of T cells [20]. Further data have been provided about a specific
and almost exclusive targeting of the peripheral immune system in SJL mice with PLP-in‐
duced EAE, in which NPCs had been injected subcutaneously (s.c.) at 3 and 10 dpi [21]. This
alternative administration protocol showed a significant clinical improvement in EAE mice
despite injected cells were never been consistently found into the inflamed CNS. Sub-cutaneous‐
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ly injected, s.c.-injected cells were mainly found accumulating and persisting (up to 2 months)
at the level of the perivascular areas of the draining lymph nodes, where they interacted with
resident cells. Similarly to what observed in the CNS parenchyma, NPCs accumulated as focal
clusters  around blood vessels  of  the  hilum and medullary/paracortical  areas.  Here  they
established close interactions with endothelial cells and cell-to-cell contacts with CD11c+ DCs,
F4/80+ professional phagocytes and MHC class II+ immune cells [21]. Further, ex vivo analyses of
lymph nodes isolated from NPC-treated EAE mice, showed hampered activation and matura‐
tion of myeloid DCs. This was associated, according to both in vivo and in vitro analyses, to the
release of BMP-4 and TNF-α or TLR agonists. The BMP-dependent effect is highly specific for
immune regulatory NPCs and, in turn, leads to the restraint of encephalitogenic T cell expan‐
sion at sites of antigen presentation. In addition to BMP-4, transplanted NPCs modulated the
local increase of major stem cell fate determinants, including BMP-7, the extracellular matrix
protein tenascin C, Shh and Noggin.  The pattern of NPC accumulation,  the secretion of
extracellular matrix proteins and stem cell regulators, and the lack of expression of neural lineage
antigens (e.g. PSA-NCAM, class III β–tubulin, NeuN, NG-2 and GFAP) once more suggest the
establishment of perivascular atypical ectopic niche-like areas in the peripheral lymph nodes,
similarly to what already seen in the CNS [15]. Supported by these experiments, a successive
step forward was undertaken to test NPCs therapeutic capacity in a non-human primate model
of EAE. Systemically injected foetal human NPCs into MOG74-96-immunized common marmo‐
sets delivered at either the clinical onset of the disease or at subclinical occurrence of MRI
detectable brain lesions, were found not only at the level of perivascular inflammatory CNS areas
but also in secondary lymphoid organs. In parallel to these observations, human NPCs inter‐
fere in vitro with a number of key functions, such as the differentiation of myeloid precursor cells
(MPCs) into immature DC (iDC) and the maturation of iDC to functional mature DCs. A
significant impairment of the differentiation of CD14+ MPCs into CD1a+ iDCs has been report‐
ed when MPCs were cultured with granulocyte macrophage colony-stimulating factor (GM-
CSF) and IL-4 in presence of NPCs [15]. In the same study, NPCs influenced the up regulation
of the co-stimulatory molecules CD80, CD86 and MHC-II on LPS-treated DCs, thus impairing
their capacity to induce a proliferative allogeneic response in mixed leukocyte reaction in vitro.
Clinically wise, the i.v. NPC injection resulted more efficacious than the i.t. NPC treatment. This
might be related to either the higher number of surviving cells or to an additional peripheral
effect. Systemic NPCs were, in fact, subjected to selective capturing into cervical lymph nodes
where they persisted up to 3 months while establishing close contacts with blood-borne
inflammatory cells [15].
Similarly to what observed in EAE models, i.v. administered human NPCs, in a rat model of
ICH, revealed a peripheral therapeutic function in attenuating the inflammatory response to
the insult [22]. In line with previous studies, cells were rarely observed into the injured brain
while the majority of NPCs were found distributed within the systemic organs. In particular,
few NPCs were observed in mesenteric lymph nodes while large numbers were detected in
the spleen, especially in the marginal zone area, which is typically enriched in macrophages.
Once again NPCs were found in close contact with immune cells and some of them were
establishing cell-to-cell contact interactions with CD11b+ spleen macrophages. This result was
probably due to the existence of a link between brain and spleen inflammation, called “brain-
spleen inflammatory coupling”. Remarkably, splenectomy prior to ICH has been shown to
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reduce the initial cerebral oedema and inflammatory cell infiltration caused by stroke [22].
NPC accumulation into the spleen, in this case, modulated brain inflammation by reducing
the level of major inflammatory mediators in stroke, such as TNF-α, IL-6 and nuclear factor-
kappa B (NF-κB), and consequently improved neurologic outcome.
It has been recently shown that mouse NPCs (from fully mismatched C57BL/6 mice) co-
transplanted with pancreatic islet under the kidney capsule of Balb/c diabetic mice prevents
acute islet allograft rejection. This effect was related to a significant reduction of CD4+ T cells
and with a concomitant enrichment of CD4+/CD25+/FoxP3+ regulatory T cells in the spleen,
inducing active tolerance. These data suggest that the peripheral immune-modulation exerted
by NPCs could alleviate the immune reaction leading to organ rejection. Unfortunately this
condition appeared strictly associated with the development of NPC-derived tumours mainly
sustained by insulin secretion from the co-transplanted islets [218].
Whether most of the immune regulatory effects of systemically injected NPCs act mainly into
the CNS or in the periphery is still under debate. Peripheral lymphoid organs have been
demonstrated to play an important role in the regulation of the immune responses to myelin
antigens in EAE and a very sophisticated modulation of T-cell self-reactivity is known to take
place [219-221]. A very recent study proposes a molecular mechanism sustaining NPCs
immune modulation capacity in EAE. The preventive (0 dpi) or therapeutic (10 dpi) i.v.
administration of NPCs resulted in their accumulation in lymph nodes and spleen, with rare
cells observed into the CNS and without any evidence of myelin repair. Nevertheless, treated
mice showed partial clinical recovery. Remarkably, the authors achieved the same results even
transplanting NPC conditioned-medium or minimally irradiated NPCs (unable to differenti‐
ate but capable of secreting cytokines and neurotrophins), evidence sustaining a true periph‐
eral function of NPCs. In particular, the observed clinical amelioration seem to be related to
the selective inhibition of encephalitogenic Th17 cell differentiation through secreted factors.
LIF has been identified as the key factor responsible for the observed inhibition of Th17 cell
differentiation and the authors elucidated the signalling pathway behind this novel mecha‐
nism of action, where LIF antagonizes IL-6-induced Th17 cell differentiation through ERK-
dependent inhibition of STAT3 phosphorylation [23]. Further studies will be needed to
establish the absolute relevance of these pre-clinical data in EAE, where peripheral lymphoid
organs play an important role in the regulation of the immune responses to myelin antigens,
and their potential for future applications in MS. All the preclinical data describing NPC
therapeutic effect upon systemic administration are summarized in Table 1.
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Table 1. Neuro-immune interaction following systemic neural stem cell transplantation in experimental disease
models.
5. Pros and cons of NPC systemic administration
In parallel to the investigation concerning the principal mechanism(s) sustaining NPC
therapeutic efficacy, other questions, such as (i) the ideal administration route, (ii) the amount
of cells to be transplanted and (iii) the optimal time point for cell delivery need to be answered.
Among the different possible routes of cell administration, intravenous cell delivery represents
one of the most attractive because of its technical simplicity and clinical practicability.
However, i.v. and i.t. administrations result in lower numbers of cells infiltrating the CNS,
compared to local stereotaxic-driven intracerebral injections, a reason why local injections of
cells are commonly preferred in clinical trials (see next section) despite the higher invasiveness
of the procedure. Even though initially investigated for multifocal disorders (e.g. MS), in order
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to deliver exogenous cells to all the disseminated inflammatory foci, all the previous experi‐
mental data suggest that intravenous or intrathecal administration routes could be desirable
even for focal damages, such as those occurring in stroke and spinal cord injury [222]. In
experimental animal studies, i.p.c [223-225], i.v. [137, 185] i.a. [222], i.t. [204, 226] and i.c.v. [142,
227] protocols have been tested so far. However, only few comparative studies have been
conducted, testing pros and cons of the different administration routes. These studies (mainly
in animal models of stroke) evidenced the obvious capacity of intraparenchymal injection to
deliver higher numbers of cells in situ, compared to i.c.v. and i.v. [228]. By contrast, systemic
injections are thought to lead to a wider distribution of cells around the focal lesioned area.
This aspect is extremely important if we consider that human stem cells (and in particular
hNPCs) are still a limited resource [229]. Intravenously injected NPCs are firstly delivered to
peripheral organs, such as lungs, liver, spleen and kidney [16, 230]. This whole-body distri‐
bution of exogenous systemic injected NPCs significantly reduces cell homing to the injured
brain [222]. To avoid this problem, at least partially, intra-arterial administration could be a
valid alternative (possibly coupled with pre-interventional imaging-based planning) to
selectively cover an injured volume supplied by several target vessels. Intracarotid injection
has already been proved to be functional for delivering stem cells in models of stroke, TBI and
SCI, resulting in higher numbers of extravasating cells (20%) compared to i.v. injections [18].
Nevertheless, although the number of cells infiltrating the CNS has been sometimes described
as fundamental, or at least proportional to their therapeutic effect [231], others have shown
that very low numbers of cells [140] can result into similar outcomes (in term of functional
recovery) compared to higher numbers of locally injected cells. This effect may be explained
by the fact that cell replacement is unlikely the only mechanism sustaining stem-cell thera‐
peutic potential. Higher starting numbers of cells, in fact, increase the therapeutic potential of
intracerebral administered cells, but did not affected the efficacy of the i.v. injected cells. This
again suggests that the number of cells is much more important for focal than systemic
injections [232].
Importantly, when evaluating the optimal protocol, we should consider the procedure itself,
so that the risk should not outweigh the benefits of the treatment. From this point of view, i.e.
cell injection might be accompanied by increased mortality during cell delivery, probably due
to further ischemia or thrombosis [233, 234]. By contrast, cell transplantation trough the
vertebral artery, into patients affected by SCI, showed no adverse effects [235].
Another important unsolved issue for experimental stem cell therapies is the ideal time point
of transplantation. As described, the inflammatory activation of the CNS, characterizing MS,
stroke, SCI, epilepsy, AD, PD, HD is necessary for the homing of systemically injected cells.
Because of the rapid and dynamic changes occurring into the CNS during these inflammatory
conditions, the time of transplantation should be evaluated carefully. In fact, cell death,
excitotossicity, reactive oxygen species accumulation, inflammatory cell infiltrations and glial
scar formation, cause a rapid evolution in the damaged tissue, while creating an hostile
microenvironment for the engraftment of exogenous cells. This is important irrespectively to
the route of administration. For example, the acute focal transplantation of cells into the
ischemic brain or the injured spinal cord reduces the therapeutic efficacy of the cells, which
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are subjected to highly inflammatory conditions causing cell death [205, 236]. On the contrary,
the sub acute phase (few days after insult, in rodents) of the injury seems to be characterized
by better conditions for stem cell survival and a permissive microenvironment for tissue repair/
healing [237]. Although higher inflammation generally correlates with higher number of cells
infiltrating the CNS, it has been shown that greater numbers of cells accumulated into the
spinal cord after i.v. injection at 7 dpi compared to 3 and 10 dpi [167]. However, the optimal
time window for cell transplantation is still elusive and depends mainly on the type of
pathology and aim of the treatment. While neuroprotection should be addressed in the early
stage of the inflammatory disease, just after the initial insult, cell replacement and neurore‐
generation should be targeted in a later stage, when the lesion has stabilized. Indeed, admin‐
istration route, number of cells and time window and seem intimately related and it is not so
difficult to envisage a future in which a combination of early i.v. and late i.p.c administration
of different stem cell sources will be enrolled for the treatment of so far incurable CNS
disorders.
6. Clinical trials
In the last two decades the clinical potential of stem cells in the field of regenerative/restorative
medicine has been often matter of debate, mainly because of its inconsistent outcome. As an
example, the first attempt to treat a CNS disorder by means of stem cell transplantation took
place in the ‘80s: autologous adrenal medulla cells were intracerebrally transplanted into the
striatum of PD patients to provide a local source of catecholamine. The study was proved safe
although with minimal beneficial effect. Further, the first intrastriatal grafts of human foetal
ventral mesencephalic (neuronal preparations) tissue have provided proof-of-concept that cell
therapy can work in patients affected by PD [238]. However, subsequent randomized, double-
blind, placebo-controlled trials brought to much more sceptical conclusions because of patients
showing functional decline (post transplantation) due to dyskinesias (graft-induced involun‐
tary movements), originated by excessive graft function [239, 240].
Prospectively, many factors can be contended to (partially) justify these patchy results. First,
it is now clear that different cell types are needed for different diseases. If on one side PD and
amyotrophic lateral sclerosis (ALS) patients will require cells with dopaminergic and motor
neuron properties respectively, on the other side, cell replacement in AD patients is much more
complicated by the necessity to replace a large variety of cell populations lost in different brain
areas. Second, even though initially expected and long-term envisaged, neuronal replacement
and circuitry integration of transplanted NPCs have been poorly proved. Third, it as to be
considered that pre-clinical animal studies only represent models of human conditions, and,
as such, they offer an exceptionally homogeneous platform, where the genetic background,
age, and environment are all alike. Clearly, this is not the case with patients. Further, even if
multiple models have been established to investigate different aspects of a given disease, none
of them can faithfully emulate the human pathology in its complexity [241, 242]. This is
particularly challenging considering the rate of progression and lack of validated surrogate
disease markers typical of many neurodegenerative disorders. While these aspects are most
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likely destined to remain unsolved pitfalls, others (including the amount of cells to be
transplanted, the manipulation protocols used, the time of transplantation, the route of cell
delivery and the statistics adopted to analyse the data) need to be ameliorated through the
establishment of common guidelines. In particular, the International Society for Stem Cell
Research (ISSCR) composed with a group of international experts (scientists, surgeons,
ethicists and patient advocates) “The ISSCR Guidelines for the Clinical Translation of Stem
Cells” [243] to trace a roadmap guiding the application of experimental stem cell therapeutics
in patients. Importantly, when translating into clinical trials, the choice of the “ideal patient”
imposes major scientific and ethical constraints. Indeed, if on one side the treatment of the
most chronic/severe patients who were not able to respond to previous treatment lowers the
blame for a possible ineffectiveness of a therapy, on the other side the scenario offered by such
a compromised tissue may hinder the potential effect of the treatment.
The primary importance of patient’s care dramatically impacts also on the choice of the best
route of cell delivery. Indeed, if one side the intravenous injection allows for a less invasive
procedure, on the other, the number of cells delivered to the site of interest is lower compared
to local injections. Further, the intracerebral transplantation has been widely accepted, by both
clinicians and patients, after years of clinical applications and technical improvements. These,
together with the relatively limited availability of human NPCs explains why most of the
clinical trials started so far have nevertheless favoured the adoption of more invasive proce‐
dures, such as intraparenchymal/intracerebroventricular ones (see Table 2). However, as
discussed, the correlation between the number of cells entering the CNS and their efficacy still
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pt: post-transplant; NA: information not available. AR: Active Recruiting; AnR: Active not Recruiting; C: Completed.
Table 2. Active clinical trials with neural stem/precursor cells.
Other challenging problems that need to be faced when approaching the clinic, are related to
safety, product potency, and manufacturing quality of the cell source. Indeed, principles of
good tissue practice (GTP) and good manufacturing practice (GMP) are mandatory require‐
ments, especially when dealing with cells of human origin [244].
Last, but not least, some major issues related to the long-term safety of the cellular product
need to be solved. It is important to stress how, differently from the classical drug-therapy, a
cell-based treatment cannot be discontinued, since once the cells are within the patient they
cannot be removed. Therefore, long-term pre-clinical data need to be collected before trans‐
lating from the bench to the bed-side to avoid the occurrence of dramatic outcomes, such as
the one involving a young patient suffering of Ataxia Telangiectasia who developed a donor-
derived brain tumour following neural stem cell transplantation [245].
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Nevertheless, translational research did not (and should not) stop. As a matter of fact, the huge
amount of data collected so far led to the development of numerous early stage clinical trials.
There are currently 1750 studies employing the use of stem cells in interventional clinical trials,
among which 280 are testing NPCs. Within the total number of clinical studies, 277 worldwide
open trials involve SCs and patients affected by CNS disorders (Figure 2), such as MS, stroke,
SCI, epilepsy, ALS, PD, AD, HD, neuronal ceroid lipofuscinose (NCL), Pelizaeus–Merzbacher
disease (PMD), age-related macular degeneration (AMD) [246]. Several phase I and II clinical
studies with NPCs (9 in highly debilitating CNS disorders, Table 2) have now been started
with the primary aim to verify the safety (mainly in terms of toxicity) and feasibility - rather
than the efficacy - of the treatment. Further, clinical studies are often accompanied by non-
official secondary end-points usually concerning the potential impact in the clinical outcomes.
These explorative trials have certainly a key role in stem cell medicine development, as both
phase II dose-escalation studies and the inclusion of non-fatal diseases with larger population
bases will definitely be facilitated once human safety will be established.
In May 2006 at Oregon Health and Science University (OHSU, Portland, OR, USA) the first
human study involving the transplantation of allogeneic NPCs was started on a fatal rare
neurometabolic syndrome, such as the NCL Batten’s disease. In this open-label dose-escalating
phase I trial, a total of 6 subjects with infantile and late-infantile NCL were transplanted in a
single-stage procedure. StemCell, Inc. proprietary, single donor allogeneic free-floating
Figure 2. Worldwide open experimental clinical trials involving the use of stem cells for CNS disorders. The map
shows the distribution of open stem cell-based clinical trials enrolling patients affected by CNS pathologies and treat‐
ed with different source of SCs. Figure has been generate by clinicaltrials.gov, using the keywords stem cells AND CNS
diseases; the inclusion criteria were only open studies; while the exclusion criteria where studies with unknown status.
Stem cells in the figure include: neural stem/precursor cells, mesenchymal stem cells from the bone marrow and the
adipose tissue, hematopoietic stem cells, embryonic stem cells.
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cultured, foetal-derived brain human NPCs (HuCNS- SC®) were directly administered to the
cerebral hemispheres and lateral ventricles. Immune suppression was administered for 12
months after transplantation. This study has now been completed with one out of 6 patients
died for disease progression, 11 months after treatment. The cell transplantation and combi‐
nation with prolonged immune suppression were both well tolerated [247].
In September of 2009, NeuralStem, Inc. sponsored a phase I trial in ALS at the Emory University
School of Medicine (Atlanta, GA, USA), using proprietary single donor allogeneic, adherent
cultured, foetal-derived spinal NPCs (NSI-566RSC). NSI-566 cells were surgically implanted
on a total of 12 patients via multiple injections directly into the thoracic spinal cord (either
unilateral or bilateral). The clinical assessments demonstrated no evidence of acceleration of
disease progression with the planned 18 months post-transplantation follow up [248, 249].
StemCell, Inc. is also sponsoring other two phase I trials with HuCNS-SC® in X chromosome
linked connatal leukodistrophy PMD (in which oligodendrocytes cannot myelinate axons) and
AMD. With the PMD trial at the University of California, San Francisco (UCSF, San Francisco,
CA, USA), HuCNS-SC® were directly delivered through multiple injections into the brain of
a total of 4 male patients (clinicaltrials.gov identifier no. NCT01005004). Data regarding this
clinical trial has been recently published [250]. The transplantation procedure, the immuno‐
suppression and the cells were well tolerated by all the 4 patients. No adverse effects related
to the implant were detected. MRI investigation before and after the transplantation of cells,
revealed, after 9 months, a consistent donor cell-derived myelination in situ, in three of the
patients. However, these data are just published and under intense scientific discussion. With
the AMD trial at the Retina Foundation of the Southwest (Dallas, TX, USA), HuCNS-SC® are
being delivered directly into the subretinal space of one eye in a single transplant procedure
in a total 16 patients. The estimated completion date of this study is March 2014 (clinicaltri‐
als.gov identifier no. NCT01632527).
In June 2012, the Glasgow Southern General Hospital (Glasgow, Scotland) enrolled the first
patient (of 12 total) of the dose-escalating Pilot Investigation of Stem Cells in Stroke (PISCES)
phase I trial to be transplanted in a single-stage procedure with direct cerebral (intraparen‐
chymal) delivery of Reneuron, Ltd. proprietary single donor allogeneic adherent cultured, c-
myc immortalized foetal-derived brain human NPCs (CTX0E03) (clinicaltrials.gov identifier
no. NCT01151124).
In March 2011, the University Hospital Balgrist (Zurich, Switzerland) enrolled the first patient
(of 12 total) with chronic thoracic (T2–T11) SCI (3 to 12 months after complete and incomplete
cord injuries) to be transplanted with HuCNS-SC® in a further StemCell, Inc. sponsored phase
I/II clinical trial estimated to be concluded in March 2016. A single dose (20x106 cells) of
HuCNS-SC® has been directly implanted through multiple injections into the thoracic spinal
cord, and immune suppression administered for 9 months after transplantation (clinicaltri‐
als.gov identifier no. NCT01321333). In November 2012 started the consequent long-term
follow up of the 12 patients subjected to HuCNS-SC® transplantation that will last until March
2018 (clinicaltrials.gov identifier no. NCT01725880).
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In June 2012, the Azienda Ospedaliera Santa Maria (Terni, Italy) enrolled the very first of total
18 ALS patients to treat with intraspinally implanted allogeneic free-floating cultured, foetal-
derived brain NPCs. (clinicaltrials.gov identifier no. NCT01640067).
Importantly, there are not yet clinical trials with NPCs in MS. However, a consensus paper has
recently been produced by a group of experts to define the uniform guidelines on the devel‐
opment of haematopoietic and non-haematopoietic stem cell therapies for MS [9]. All the
current clinical trials envolving NPCs for CNS disorders are described in Table 2.
While in this paragraph we offer an overview of the current clinical trials involving solely
human NPCs, it has to be said that, in the light of the neuroprotective/immunomodulatory
(rather than cell replacement) properties attributed to stem cells, the therapeutic plasticity of
cells of non-neural origin are being tested as well. Among these, MSCs are emerging as a good
potential candidate, mainly because of their great accessibility and remarkable proliferation.
Also, growing evidence suggests that other than giving origin to multiple derivatives of the
mesodermal lineage (from which they derive), under particular conditions MSCs seem able to
transdifferentiate into neuro-ectodermal cells in vitro [251-254]. However, this ability to convert
from one lineage to another is still highly questionable and opened to different interpretations.
Several studies have also proved the ability of MSCs to survive, migrate and eventually bring
about functional recovery when transplanted into the CNS of different experimental models
of neurological diseases (for a review see [255]). However, the mechanisms yielding to such
rescue are unlikely ascribable merely to cell replacement.
Since 2006, the advent of induced pluripotent stem cells (iPSCs, [24]) technology has brought
new excitement in medical research and clinical therapy, since these cells provide a valuable
alternative without being constrained by ethical issues and immunological incompatibility
[256]. Although still under debate about their long-term safety, the methods for iPSC genera‐
tion, reprogramming and differentiation efficiency, iPSCs represent a break-trough for both
study of disease mechanisms and investigation of potential new treatments (for a perspective
analysis, see [257]).
The potential impact of this technological platform has been further boosted by the scientific
stream emerged from iPSC technology that is the “direct reprogramming” from one somatic
lineage to another. In fact, the direct conversion of fibroblasts to functional neurons (iN cells)
or iNSCs [25, 26], for example, represents one of the most exciting, ultimate technologies for
future application in CNS pathologies. Thanks to these next generation techniques, it will be
possible to derive virtually unlimited numbers of specific neural/neuronal population
bypassing the pluripotent stage, thus likely eliminating the potential presence of unwanted
undifferentiated cells. However, many issues, such as the purity of the cell preparation, the
use of virus-based technologies and the proper in vivo integration and differentiation still need
to be better addressed. Importantly, the availability of such a high number of cells will release
the intravenous protocol from one of its major limit, thus casting new light on its clinical
potentiality.
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AMD. With the PMD trial at the University of California, San Francisco (UCSF, San Francisco,
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a total of 4 male patients (clinicaltrials.gov identifier no. NCT01005004). Data regarding this
clinical trial has been recently published [250]. The transplantation procedure, the immuno‐
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to the implant were detected. MRI investigation before and after the transplantation of cells,
revealed, after 9 months, a consistent donor cell-derived myelination in situ, in three of the
patients. However, these data are just published and under intense scientific discussion. With
the AMD trial at the Retina Foundation of the Southwest (Dallas, TX, USA), HuCNS-SC® are
being delivered directly into the subretinal space of one eye in a single transplant procedure
in a total 16 patients. The estimated completion date of this study is March 2014 (clinicaltri‐
als.gov identifier no. NCT01632527).
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patient (of 12 total) of the dose-escalating Pilot Investigation of Stem Cells in Stroke (PISCES)
phase I trial to be transplanted in a single-stage procedure with direct cerebral (intraparen‐
chymal) delivery of Reneuron, Ltd. proprietary single donor allogeneic adherent cultured, c-
myc immortalized foetal-derived brain human NPCs (CTX0E03) (clinicaltrials.gov identifier
no. NCT01151124).
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cord injuries) to be transplanted with HuCNS-SC® in a further StemCell, Inc. sponsored phase
I/II clinical trial estimated to be concluded in March 2016. A single dose (20x106 cells) of
HuCNS-SC® has been directly implanted through multiple injections into the thoracic spinal
cord, and immune suppression administered for 9 months after transplantation (clinicaltri‐
als.gov identifier no. NCT01321333). In November 2012 started the consequent long-term
follow up of the 12 patients subjected to HuCNS-SC® transplantation that will last until March
2018 (clinicaltrials.gov identifier no. NCT01725880).
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recently been produced by a group of experts to define the uniform guidelines on the devel‐
opment of haematopoietic and non-haematopoietic stem cell therapies for MS [9]. All the
current clinical trials envolving NPCs for CNS disorders are described in Table 2.
While in this paragraph we offer an overview of the current clinical trials involving solely
human NPCs, it has to be said that, in the light of the neuroprotective/immunomodulatory
(rather than cell replacement) properties attributed to stem cells, the therapeutic plasticity of
cells of non-neural origin are being tested as well. Among these, MSCs are emerging as a good
potential candidate, mainly because of their great accessibility and remarkable proliferation.
Also, growing evidence suggests that other than giving origin to multiple derivatives of the
mesodermal lineage (from which they derive), under particular conditions MSCs seem able to
transdifferentiate into neuro-ectodermal cells in vitro [251-254]. However, this ability to convert
from one lineage to another is still highly questionable and opened to different interpretations.
Several studies have also proved the ability of MSCs to survive, migrate and eventually bring
about functional recovery when transplanted into the CNS of different experimental models
of neurological diseases (for a review see [255]). However, the mechanisms yielding to such
rescue are unlikely ascribable merely to cell replacement.
Since 2006, the advent of induced pluripotent stem cells (iPSCs, [24]) technology has brought
new excitement in medical research and clinical therapy, since these cells provide a valuable
alternative without being constrained by ethical issues and immunological incompatibility
[256]. Although still under debate about their long-term safety, the methods for iPSC genera‐
tion, reprogramming and differentiation efficiency, iPSCs represent a break-trough for both
study of disease mechanisms and investigation of potential new treatments (for a perspective
analysis, see [257]).
The potential impact of this technological platform has been further boosted by the scientific
stream emerged from iPSC technology that is the “direct reprogramming” from one somatic
lineage to another. In fact, the direct conversion of fibroblasts to functional neurons (iN cells)
or iNSCs [25, 26], for example, represents one of the most exciting, ultimate technologies for
future application in CNS pathologies. Thanks to these next generation techniques, it will be
possible to derive virtually unlimited numbers of specific neural/neuronal population
bypassing the pluripotent stage, thus likely eliminating the potential presence of unwanted
undifferentiated cells. However, many issues, such as the purity of the cell preparation, the
use of virus-based technologies and the proper in vivo integration and differentiation still need
to be better addressed. Importantly, the availability of such a high number of cells will release
the intravenous protocol from one of its major limit, thus casting new light on its clinical
potentiality.





ALS: Amyotrophic lateral sclerosis
APC: Antigen presenting cell
ASCL1: Achaete-scute homolog 1
BBB: Blood brain barrier
BCSFB: Blood-cerebrospinal fluid barrier
BDNF: Brain-derived neurotrophic factor
BLMB: Blood-leptomeningeal barrier
BMP: Bone morphogenetic protein
BMSC: Bone marrow-derived stem cell
CCAo: Common carotid artery occlusion
CCL: Chemokine (C-C motif) ligand
CCR: C-C chemokine receptor
CNS: Central nervous system
CNTF: Ciliary neurotrophic factor
CSF: Cerebrospinal fluid




DGC: Dentate granule cell
Dlx: Distal-less homeobox
d.p.t.: days post transplantation
EAE: Experimental autoimmune encephalomyelitis
EC: Endothelial cell
ES cells: Embryonic stem cells
FACS: Fluorescence-activated cell sorting
FGF: Fibroblast growth factor
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GABA: Gamma-aminobutyric acid
GCL: Granule cell layer
GDNF: Glial-derived neurotrophic factor
GFAP: Glial-fibrillary acidic protein
GF-CSF: granulocyte macrophage colony stimulating factor
GMP: Good manufacturing practice
GTP: Good tissue practice
HD: Huntington’s disease
hNPC: Human neural stem/precursor cell
Hsp70: Heat shock protein 70
HuCNS-SC: Human CNS stem cell






ICAM: Intercellular adhesion molecule
ICH: Intracerebral hemorrhage
Ig: Immunoglobulin
IGF: Insulin-like growth factor
IL: Interleukin
IML: Inner molecular layer
iN cells: Induced neuronal cells
INF: Interferon
iNOS: inducible nitric oxide synthase
iNSC: Induced neural stem cell
IPC: Intermediate progenitor cell
iPS: Induced pluripotent stem cell
LFA: Leukocyte-function associated antigen
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LIF: Leukemia inhibitory factor
LPS: Lipopolysaccharide
MAdCAM: Mucosal addressin cell adhesion molecule
MCAo: Middle cerebral artery occlusion
MCP: Monocyte chemoattractant protein
MHC: Major histocompatibility complex
MMS: Medial migratory stream
MOG: Myelin oligodendrocyte glycoprotein
MPC: Myeloid precursor cell
MRI: Magnetic resonance imaging
MS: Multiple sclerosis
MSC: Mesenchymal stem cell




NGF: Nerve growth factor
NO: Nitric oxide
NPC: Neural stem/precursor cell
NSC: Neural stem cell
OB: Olfactory bulb




PSA-NCAM: Polysialylated neural cell adhesion molecule
PSGL: P-selectin glycoprotein ligand
pt: Post-transplantation
RA: Radial astrocyte
RMS: Rostral migratory stream
Neural Stem Cells - New Perspectives324
s.c.: Subcutaneous
SCF: Stem cell factor
SCI: Spinal cord injury
SC: Stem cell




SIDS: Stroke-induced immune depression syndrome
TCR: T cell receptor
TGF: Transforming growth factor
TJ: Tight junction
TLE: Temporal lobe epilepsy
TLR: Toll-like receptor
TNF: Tumor necrosis factor
V-SVZ: Ventricular-subventricular zone
VCAM: Vascular cell adhesion molecule
VEGF: Vascular endothelial growth factor
VLA: Very late antigen
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1. Introduction
Neural stem/progenitor cells (NS/PCs), found in both the developing and the adult mamma‐
lian central nervous system (CNS), are a heterogeneous population of multipotent cells with
the potential to self-renew by symmetric cell division or to differentiate into neurons, astrocytes
and oligodendrocytes through asymmetric cell division (Gage, 2000; Alvarez-Buylla et al.,
2001; Temple, 2001; Götz and Huttner, 2005). NS/PCs have been found in almost all regions of
the developing mammalian CNS, including the basal forebrain, cerebral cortex, ganglionic
eminence, hippocampus, cerebellum, neural crest and spinal cord (Temple, 2001). Throughout
development, NS/PCs give rise to neurons and glial cell populations of the CNS. In the adult
CNS, NS/PCs are mainly found in the subventricular zone (SVZ) and subgranular layer (SGL)
of hippocampal dentate gyrus (DG) (Göritz and Frisén, 2012). The ependymal cells lining the
central canal of spinal cord of the adult mouse could be another potential source of adult NS/
PCs (Meletis et al., 2008). Because neurogenesis and gliogenesis occur during different stages
of mammalian brain development, it was long assumed that neurons and glial cells in the CNS
were generated from distinct precursor populations, known as early-embryonic, late-embry‐
onic, and adult NS/PCs. However, abundant evidence has since now demonstrated that
embryonic and adult NS/PCs are likely lineage-related. Neuroepithelial cells behaving as NS/
PCs during very early developmental stages of the mammalian CNS give rise to radial glial
cells around embryonic day 12 (E12). As the progeny of neuroepithelial cells, radial glial cells
act as NS/PCs in the fetal and perinatal brain, and develop into astrocyte-like stem cells in the
adult brains. Astrocyte-like adult stem cells function as stem cells to generate new nerve cells
in the adult mammalian CNS. (Doetsch et al., 1999; Alvarez-Buylla et al., 2001; Merkle et al.,
2004; Merkle and Alvarez-Buylla, 2006).
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Evidence from recent studies indicates that NS/PC self-renewal and the time course of NSC
fate determination are regulated by a combination of nuclear modifications, transcription
factors and extrinsic signals from the stem cell microenvironment, also known as stem cell
niche (Shi et al., 2008). Cell adhesion molecules (CAMs) located on the cell surface bind to the
extracellular matrix (ECM) as well as other cells, thereby connecting cells with their surround‐
ings. As important participants in cell-cell and cell-ECM interactions, CAMs have been shown
to play essential roles in NS/PC development, including proliferation, differentiation, and
migration, through extrinsic signals from the stem cell niche. Furthermore, many CAMs have
been studied for the potential application in repair of CNS and peripheral nervous system
(PNS) damage. Based on the role of CAMs in the NS/PC development and on the repair of
nervous system, many researchers have investigated the possibility of combining CAMs and
stem cell-based transplantation therapy to treat neural disorders and neural injury.
This chapter will discuss the most recent research in CAM functions in NS/PC development,
as well as highlighting the applications and future potential of applying CAMs in stem cell-
based therapy.
2. Cell adhesion molecules
CAMs are transmembrane proteins located on the cell surface through which cells bind or
interact with other cells and the ECM surrounding them. CAMs normally contain three
domains: an intracellular domain by which CAMs bind to cytoskeleton proteins, an extracel‐
lular domain that interacts with the ECM or other CAMs and a transmembrane domain
(Chothia and Jones, 1997). Through these three domains, CAMs can transfer extrinsic signals
from microenvironment or other neighboring cells and trigger diverse signaling pathways.
Although CAMs can be classified by whether they are calcium-dependent or calcium-
independent, most CAMs are categorized into four families: the immunoglobulin superfamily,
the cadherins, the integrins, and the selectins (Brackenbury et al., 1981; Shapiro et al., 2007).
The complexity of structure and functions in the nervous system are achieved by the complex
interconnections among its component cells. Many types of CAM interactions between various
types of neural cells in the nervous system have been reported. Here, the classification and
structure-function relationship of CAMs highly expressed in nervous system or play essential
roles in nervous system will be introduced and briefly discussed.
2.1. Immunoglobulin superfamily cell adhesion molecules
Immunoglobulin superfamily cell adhesion molecules (IgSF CAMs) are a group of calcium-
independent CAMs that share a common structural domain called immunoglobulin (Ig)
domain. Members from IgSF CAMs have diverse binding activities and mechanisms of
function. Certain IgSF CAMs interact through their extracellular domains with the same type
of CAMs, a mechanism referred to as homophilic binding. Conversely, through heterophilic
binding, other IgSF CAMs bind to different CAMs or to other cell surface proteins as well as
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soluble proteins in the ECM, Due to their structural and binding specificity, different IgSF
CAMs have been shown to play distinct roles in the nervous system.
2.1.1. L1CAM subfamily
L1CAM subfamily proteins, which include L1, close homolog of L1 (CHL1), NrCAM, and
Neurofascin, are one of the most well known groups of IgSF CAMs and are widely studied in
the nervous system. L1CAM proteins can homophilically bind to themselves, and based on
their structure, can heterophilically interact with many other IgSF CAMs (e.g. NCAM, TAG-1,
and contractin), ECM molecules (e.g. laminian, tenascins, Src and extracellular signal-
regulated kinases (Erk)), cytoplasmic proteins, including cytosketeton proteins such as
ankyrins, and traffic proteins such as AP-2 (Maness and Schachner, 2007).
The extracellular domain of L1CAM proteins contains six Ig-like domains and four or five
fibronectin type III (FNIII) repeats, followed by a transmembrane domain and cytoplasmic
domain (Fig. 1A). The Ig1 domain of L1/CHL1 can bind neuropilin-1, an important component
of the axonal guidance molecule semaphorin 3A (Sema3A) (Castellani et al., 2002). Similarly,
NrCAM has been shown to bind neuropilin-2 to form a complex that mediates Sema3B and
Sema3F signaling (Falk et al., 2005). Fluorescent bead aggregation and cell binding assays
demonstrate the N-terminal of the L1 Ig1 domain is essential for L1 homophilic binding (Jacob
et al., 2002). Through unique motifs in the Ig6 domains, L1 and CHL1 trigger Erk, mitogen-
activated protein kinase kinase (MAP2K), phosphatidylinositol-3 kinase (PI3 kinase), and Src
signaling pathway by interacting with integrins in some biological processes (Schaefer et al.,
1999; Schmid et al., 2000). The intracellular domains of L1CAMs contain a highly conserved
motif by which L1CAM proteins bind to ankyrins, a group of adaptor proteins linking integral
membrane proteins to the cytoskeleton (Bennett and Baines, 2001). When the cytoplamic
domain of Neurofascin is tyrosine phosphorylated, doublecortin (DCX) is recruited and
mediates the binding of Neurofascin to microtubules (Kizhatil et al., 2002). An alternative
splicing generates a motif YRSL in the cytoplasmic domain of L1 that mediate interactions
between L1 and AP-2, a clathrin adaptor that triggers tyrosine-based signals for endocytosis
(Kamiguchi et al., 1998). L1 was also shown to directly bind to membrane-cytoskeleton linking
ezrin-radixin-moesin (ERM) proteins, through which L1 can bind to the actin cytosketeton and
regulate axonal outgrowth and neuronal differentiation (Dickson et al., 2002). These structure-
dependent interactions between L1CAMs and other ECM molecules, cytoskeleton proteins
and cytoplasmic molecules suggests that are L1CAMs an essential component during the
extrinsic signaling transduction regulating neurite outgrowth, axon growth, cell migration and
differentiation (Maness and Schachner, 2007). Moreover, the intracellular domain of CHL1
directly interacts with synaptic chaperones Hsc70, CSP and alphaSGT, thereby regulating
SNAP25 and VAMP2-induced exocytotic machinery (Andreyeva et al., 2010).
2.1.2. NCAM
Neural cell adhesion molecule (NCAM), also known as CD56, is a glycoprotein expressed on
the cell surface of various cell types, including neurons, glial cells, and natural killer cells.
NCAM is a unique member of IgSF CAMs because of its 27 alternatively spliced mRNAs and
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independent, most CAMs are categorized into four families: the immunoglobulin superfamily,
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independent CAMs that share a common structural domain called immunoglobulin (Ig)
domain. Members from IgSF CAMs have diverse binding activities and mechanisms of
function. Certain IgSF CAMs interact through their extracellular domains with the same type
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soluble proteins in the ECM, Due to their structural and binding specificity, different IgSF
CAMs have been shown to play distinct roles in the nervous system.
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L1CAM subfamily proteins, which include L1, close homolog of L1 (CHL1), NrCAM, and
Neurofascin, are one of the most well known groups of IgSF CAMs and are widely studied in
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ankyrins, and traffic proteins such as AP-2 (Maness and Schachner, 2007).
The extracellular domain of L1CAM proteins contains six Ig-like domains and four or five
fibronectin type III (FNIII) repeats, followed by a transmembrane domain and cytoplasmic
domain (Fig. 1A). The Ig1 domain of L1/CHL1 can bind neuropilin-1, an important component
of the axonal guidance molecule semaphorin 3A (Sema3A) (Castellani et al., 2002). Similarly,
NrCAM has been shown to bind neuropilin-2 to form a complex that mediates Sema3B and
Sema3F signaling (Falk et al., 2005). Fluorescent bead aggregation and cell binding assays
demonstrate the N-terminal of the L1 Ig1 domain is essential for L1 homophilic binding (Jacob
et al., 2002). Through unique motifs in the Ig6 domains, L1 and CHL1 trigger Erk, mitogen-
activated protein kinase kinase (MAP2K), phosphatidylinositol-3 kinase (PI3 kinase), and Src
signaling pathway by interacting with integrins in some biological processes (Schaefer et al.,
1999; Schmid et al., 2000). The intracellular domains of L1CAMs contain a highly conserved
motif by which L1CAM proteins bind to ankyrins, a group of adaptor proteins linking integral
membrane proteins to the cytoskeleton (Bennett and Baines, 2001). When the cytoplamic
domain of Neurofascin is tyrosine phosphorylated, doublecortin (DCX) is recruited and
mediates the binding of Neurofascin to microtubules (Kizhatil et al., 2002). An alternative
splicing generates a motif YRSL in the cytoplasmic domain of L1 that mediate interactions
between L1 and AP-2, a clathrin adaptor that triggers tyrosine-based signals for endocytosis
(Kamiguchi et al., 1998). L1 was also shown to directly bind to membrane-cytoskeleton linking
ezrin-radixin-moesin (ERM) proteins, through which L1 can bind to the actin cytosketeton and
regulate axonal outgrowth and neuronal differentiation (Dickson et al., 2002). These structure-
dependent interactions between L1CAMs and other ECM molecules, cytoskeleton proteins
and cytoplasmic molecules suggests that are L1CAMs an essential component during the
extrinsic signaling transduction regulating neurite outgrowth, axon growth, cell migration and
differentiation (Maness and Schachner, 2007). Moreover, the intracellular domain of CHL1
directly interacts with synaptic chaperones Hsc70, CSP and alphaSGT, thereby regulating
SNAP25 and VAMP2-induced exocytotic machinery (Andreyeva et al., 2010).
2.1.2. NCAM
Neural cell adhesion molecule (NCAM), also known as CD56, is a glycoprotein expressed on
the cell surface of various cell types, including neurons, glial cells, and natural killer cells.
NCAM is a unique member of IgSF CAMs because of its 27 alternatively spliced mRNAs and
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its three major protein isoforms: NCAM-120, NCAM-140, and NCAM-180, so named due to
their molecular weights (Reyes et al., 1991).
These three NCAM isoforms share the same extracellular domain, but vary in their trans‐
membrane domains and cytoplasmic region. The extracellular domain of NCAM contains five
Ig-like domains and two FNIII repeats, followed by a transmembrane domain in NCAM-140
and NCAM-180 isoforms, but a glycophosphatidyl (GPI) anchor linking to the cell membrane
in NCAM-120 (Fig. 1A) (Chothia and Jones, 1997). NCAM-140 has a shorter intracellular
domain compared to NCAM-180. The different domains of NCAMs have been reported to
play distinct roles in binding activities and biological functions. The Ig-like domains have been
shown to be essential for NCAM homophilic binding, and the FNIII repeats are involved in
signaling that regulate neurite outgrowth. Trans-homophilic binding of NCAMs on different
cell surfaces and cis-homophilic binding on the same surface have been observed, and both
binding models play roles in neurite outgrowth (Walmod et al., 2004). Although the mecha‐
nism behind these binding models remains unknown, several studies have suggested that
either Ig1 and Ig2 only or all five Ig-like domains are involved in NCAM trans-homophilic
binding. Both Ig1 and Ig2, and Ig1 and Ig3 have demonstrated important roles in NCAM cis-
homophilic binding (Frei et al., 1992; Ranheimet al., 1996; Atkins et al., 2004). The FNIII repeats
bind fibroblast growth factor receptor (FGFR), which induces NCAM-mediated neurite
outgrowth and plasticity. (Kiselyov et al., 2005). A PDZ-like sequence in the cytoplamic domain
of NCAM-180 is required for NCAM-180-mediated activation of myosin light chain kinase
(MLCK) (Polo-Parada et al., 2005). The intracellular domain of NCAM-180 has also been shown
to be essential for the interaction between NCAM-180 and dopamine D2 receptor, by which
NCAM regulates dopminergic signaling and behavior (Xiao et al., 2009). Non-receptor tyrosine
kinase p59fyn has been found to interact specifically with NCAM-140, which activate p59fyn and
focal adhesion kinase (FAK). The subsequent activation of c-Ras1 triggers the Erk signaling
(Kolkova et al., 2000). Prion protein (PrP) can recruit and stabilize NCAM-140 on lipid rafts
and regulate p59fyn to enhance neurite outgrowth (Santuccione et al., 2005). NCAM-140 also
binds to GFRα, the glial-derived neurotrophic factor (GDNF) receptor, which regulates GDNF-
mediated Schwann cell migration (Paratcha et al., 2003). Additionaly, the unique carbohydrate
motif α-2,8-linked polysialic acid (PSA) on the Ig5 domain, observed only on NCAMs, has
been found to negatively influence the homophilic binding of NCAMs as well as their
interaction with heparin and heparin sulfate, due to the highly negative charge of PSA
(Rutishauser and Landmesser, 1996). Through its inhibition of NCAM homophilic binding and
reduction of cell adhesion during cell migration, PSA exhibits functions during many neural
processes, including those related to learning and memory, and certain neurological disorders
(Becker et al., 1996; Senkov et al., 2006; Stoenica L et al., 2006).
2.1.3. Nectins and Nectin-like molecules
Nectins and Nectin-like molecules (Necls) form another large IgSF CAM family, including four
Nectins (Nectin-1, 2, 3, 4) and five Necls (Necl-1, 2, 3, 4, 5), and exhibit cell-cell adhesive
functions in a wide range of tissues, including epithelia and neuronal tissue (Takai et al.,
2003). All Nectins and Necls share the same structure domains, containing an extracellular
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domain with three Ig-like repeats, through which they play their roles in cell-cell adhesion
activity, a single transmembrane region, and a cytoplasmic domain (Fig. 1A) (Sakisaka and
Takai, 2004). Nectins and Necls can form cis-homo-dimers, and subsequently form trans-homo-
dimers or trans-hetero-dimers through their extracellular Ig-like domains. (Sakisaka and Takai,
2004). Nectins can trans-interact with c-Src, to activate Rac and Cdc42 signaling (Shimizu and
Takai, 2003)., Nectins can bind to F-actin-binding protein afadin through their cytoplasmic
domain. Upon binding afadin, Nectins interact with α-catenin and cadherins, playing a role
in forming cell-cell adhesion junctions and tight junctions in epithelial cells (Takai and
Nakanishi, 2003). Nectins also regulate cell polarization through interacts with Par-3 via their
intracellular domain (Takekuni et al., 2003). In addition, Necls interact with many important
proteins, such as membrane-associated guanylate kinase Dlg3/MPP3, tumor suppressor
DAL-1, CD44, platelet-derived growth factor (PDGF), and Nectins (Yageta et al., 2002;
Fukuhara etal., 2003; Takai et al., 2003; Kakunaga S et al., 2004; ).
2.1.4. TAG-1
TAG-1, also called TAX-1 (human) or axonin-1, a 135 kDa glycoprotein expressed on the
developing axons, belongs to IgSF CAMs superfamily and plays important roles in neurite
outgrowth and cell aggregation. TAG-1 has six Ig-like domains followed by four FNIII repeats
and is anchored to the cell membrane by a GPI tail (Fig. 1A) (Furley et al., 1990). During
development of the central and peripheral nervous system, TAG-1 is transiently expressed
both as a soluble form and a GPI-anchored form (Karagogeos et al., 1991). Binding analysis
revealed that FNIII repeats but not Ig domains are sufficient for homophilic binding, although
both TAG-1 domains types can promote the neurite outgrowth (Tsiotra et al., 1996; Pavlou et
al., 2002). The four amino-terminal Ig-like domains have been shown to be important for TAG-1
and neural glial cell adhesion molecule (NgCAM) cis-position binding, while the Ig5 and Ig6
domains have a strong inhibitory effect on TAG-1 and NgCAM binding (Buchstaller et al.,
1996; Rader et al., 1996). L1 and NrCAM were shown to interact with TAG-1 through its Ig-
like domains in the trans-position (Pavlou et al., 2002).
2.1.5. MAG
Myelin-associated glycoprotein (MAG) is expressed on the surface of oligodendrocytes in the
CNS and Schwann cells in the PNS, and has been implicated in neuron-oligodendrocyte and
oligodendrocyte-oligodendrocyte interactions in the CNS and glia-glia interaction in the PNS
(Sternberger et al., 1979; Quarles, 1984; Martini and Schachner, 1986; Poltorak et al., 1987). Two
MAG isoforms have been identified as small MAG (S-MAG) and large MAG (L-MAG). Similar
to other IgSF CAMs, MAGs contain an identical extracellular domains composed of five Ig-
like domains, a transmembrane segment, and two distinct cytoplasmic domains, which
distinguish the S-MAG and L-MAG (Fig. 1A) (Salzer et al., 1987). MAG binds gangliosides,
the most abundant sialylated glycoconjugates in the nervous system, which are important for
neuron-oligodendrocyte interaction (Schnaar et al., 1998). MAG was shown to interact with
the leucine-rich repeat (LRR)-containing GPI-linked Nogo-66 receptor (NgR), inducing the
inhibition of neurite outgrowth (Fournier et al., 2001; Domeniconi et al., 2002).
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al., 2002). The four amino-terminal Ig-like domains have been shown to be important for TAG-1
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There are many other IgSF CAMs, not to be introduced in this chapter, found in other
mammalian body systems, such as intercellular cell adhesion molecule (ICAM-1, expressed
on endothelial cells and cells of the immune system), vascular cell adhesion molecule
(VCAM-1, expressed on blood vessels), platelet-endothelial cell adhesion molecule (PECAM-1,
expressed on the surface of platelets, monocytes, neutrophils, and some types of T-cells).
2.2. Cadherins
Cadherins, a family of calcium-dependent CAMs, are the major architectural molecules
mediating cell-cell adhesion of extracellular domains at intercellular junctions. The cadherin
superfamily consists of four subgroups, including classic cadherins, protocadherins, desmo‐
somal and unconventional cadherins, which share a similar structure with extracellular Ca2+-
binding domains, known as cadherin repeats (Angst et al., 2001). Although the homophilic
binding of specific cadherin subtypes has been described frequently, several cadherin subtypes
were also found to interact heterophilically (Ahrens et al., 2002).
2.2.1. Classic cadherins
In vertebrates, classic cadherins, including epithelial cadherin, neural cadherin, and placental
cadherin and so on, have five extracellular cadherin repeats, a transmembrane domain, and a
highly conserved intracellular domain (Fig. 1B) (Tepass et al., 2000). By binding to Ca2+ on the
boundary between cadherin repeats, the extracellular domain is stabilized and undergoes
homophilic interactions, which is essential for the adhesion function of cadherins (Nagar et
al., 1996). Both cis- and trans-homophilic interactions were observed in classic cadherin-
mediated cell adhesion (Zhang et al., 2009). Classic cadherins bind to two cytoplasmic proteins,
p120-catenin and β-catenin, through the conserved intracellular motif (Tepass et al., 2000). The
cadherin-β-catenin complex interacts with α-catenin and subsequently associates with actin,
forming an adherin junction and a cell-cell signaling centre together with cytoskeletal and
signaling molecules (Wheelock and Johnson, 2003; Drees et al., 2005). In addition to catenin
proteins, classic cadherins have been observed to interact with many other molecules from
various signaling pathways (Erez et al, 2005). For example, cadherin-mediated cell adhesion
is involved in Wnt, Hedgehog, Ras, and RhoGTPase signaling (Stepniak et al., 2009; Watanabe
et al., 2009; Heuberger and Birchmeier, 2010). Cadherin-catenin complex also interacts with
receptor-type tyrosine kinases, such as FGFRs and epithelial growth factor receptors (EGFRs)
(Mason, 1994; Perrais et al., 2007). Such crosstalk between cadherin system and other signaling
pathways allow cadherins to play critical roles in diverse cell biological behaviors. In humans,
there are 18 cadherins in the classic cadherin superfamily, of which epithelial cadherin (E-
cadherin, or cadherin-1), is the most well studied member. As its name indicates, E-cadherin
is expressed in developmental and adult epithelial tissues. The cytoplasmic tail of E-cadherin,
containing a highly phosphorylated region, is essential for the function of E-cadherin in the
formation cell-cell junction (Tepass et al., 2000). Neural cadherin (N-cadherin or cadherin-2)
is broadly expressed in neuroepithelial cells during early embryonic and neonatal develop‐
ment, particularly in the nuclei and laminae, and neuroanatomical connections during late
embryonic stages and early postnatal development (Redies and Takeichi, 1993). N-cadherin
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has been reported to play critical roles in the establishment of left-right asymmetry and
synaptogenesis as well as catenin-mediated processes related to learning and memory (Benson
and Tanaka, 1998; García-Castro et al., 2000). Placental cadherin (P-cadherin or Cadherin-3) is
highly expressed in undifferentiated cells in epithelial tissues and human embryonic stem cells,
and is a putative stem and precursor cell maker (Raymond et al., 2009).
2.2.2. Protocadherins
With more than 100 having been identified in mammals, protocadherins are the largest
subfamily of cadherins (Hirano and Takeichi, 2012). Protocadherins can be further sorted into
two groups, based on their genomic distribution: clustered protocadherins, whose coding
genes are located on human chromosome 5 in tandem order, and consist of three gene
subclusters Pcdhα, Pcdhβ and Pcdhγ, and non-clustered protocadherins, whose genes are
distributed among different chromosomes and are divided into several subgroups, incuding
δ-protocadherins (Vanhalst et al., 2005). The extracellular domains of protocadherins contain
more than five cadherin motifs, which differ from the characteristic features of classical
cadherins (Fig. 1B) (Sano et al., 1993). Unlike the highly conserved cytoplasmic tails of classic
cadherins, the intracellular domains of protocadherins are variable, suggesting their diverse
functions. Although protocadherins appear to display weaker cell-cell adhesion than classic
cadherins, protocadherins show diverse biological functions in the CNS, including roles in
neuronal differentiation and synaptogenesis (Hirano and Takeichi, 2012).
2.3. Integrins
Integrins are a group of cell surface receptors that form a large CAM subfamily. Integrins are
heterodimeric glycoproteins consisting of two distinct subunits: an α-subunit and β-subunit
that each penetrates the cell membrane once and has a short intracellular tail which is typically
40 to 70 amino acids long. Thus far, 18 α-subunits and 8 β-subunits have been identified and
24 αβ combinations have been observed (Hynes, 2002). The extracellular domain of α-subunits,
which generally are larger than 900 amino acids, is divided into four subdomains containing
a ligand-binding N-terminal region including a sevenfold repeat, among which repeats 5, 6,
and 7 contain a Ca2+- binding structure. Half of the α-subunits contain an extra I-domain, which
contributes a divalent cation-binding site and facilitates an interaction with IgSF CAMs (Fig.
1C) (Landis, et al., 1994). The ectodomains of integrin β-subunits are typically larger than 600
amino acids and contain 8 subdomains, including an N-terminal signal region as well as a
metal-binding site that is directly involved in ligand-integrin interactions (Fig. 1C). The
extracellular N-terminal of α-chain and β-chain form a ligand-binding αβ headpiece (Fig.
1C). Through interactions between their extracellular domain and ECM ligands and other
CAM family members, integrins can perform outside-in signaling to mediate cell response to
its surrounding environment. Moreover, through their intracellular tails, integrins can also
perform inside-out signaling, thereby relaying the intercellular cell state to the extracellular
environment. Using both outside-in and inside-out signal transduction models, integrins not
only aid in facilitating cell-ECM interactions, but also play roles in many other biological
activities, including cell cycling as well as cell growth, survival, and differentiation.
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receptor-type tyrosine kinases, such as FGFRs and epithelial growth factor receptors (EGFRs)
(Mason, 1994; Perrais et al., 2007). Such crosstalk between cadherin system and other signaling
pathways allow cadherins to play critical roles in diverse cell biological behaviors. In humans,
there are 18 cadherins in the classic cadherin superfamily, of which epithelial cadherin (E-
cadherin, or cadherin-1), is the most well studied member. As its name indicates, E-cadherin
is expressed in developmental and adult epithelial tissues. The cytoplasmic tail of E-cadherin,
containing a highly phosphorylated region, is essential for the function of E-cadherin in the
formation cell-cell junction (Tepass et al., 2000). Neural cadherin (N-cadherin or cadherin-2)
is broadly expressed in neuroepithelial cells during early embryonic and neonatal develop‐
ment, particularly in the nuclei and laminae, and neuroanatomical connections during late
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and is a putative stem and precursor cell maker (Raymond et al., 2009).
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With more than 100 having been identified in mammals, protocadherins are the largest
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genes are located on human chromosome 5 in tandem order, and consist of three gene
subclusters Pcdhα, Pcdhβ and Pcdhγ, and non-clustered protocadherins, whose genes are
distributed among different chromosomes and are divided into several subgroups, incuding
δ-protocadherins (Vanhalst et al., 2005). The extracellular domains of protocadherins contain
more than five cadherin motifs, which differ from the characteristic features of classical
cadherins (Fig. 1B) (Sano et al., 1993). Unlike the highly conserved cytoplasmic tails of classic
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functions. Although protocadherins appear to display weaker cell-cell adhesion than classic
cadherins, protocadherins show diverse biological functions in the CNS, including roles in
neuronal differentiation and synaptogenesis (Hirano and Takeichi, 2012).
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Integrins are a group of cell surface receptors that form a large CAM subfamily. Integrins are
heterodimeric glycoproteins consisting of two distinct subunits: an α-subunit and β-subunit
that each penetrates the cell membrane once and has a short intracellular tail which is typically
40 to 70 amino acids long. Thus far, 18 α-subunits and 8 β-subunits have been identified and
24 αβ combinations have been observed (Hynes, 2002). The extracellular domain of α-subunits,
which generally are larger than 900 amino acids, is divided into four subdomains containing
a ligand-binding N-terminal region including a sevenfold repeat, among which repeats 5, 6,
and 7 contain a Ca2+- binding structure. Half of the α-subunits contain an extra I-domain, which
contributes a divalent cation-binding site and facilitates an interaction with IgSF CAMs (Fig.
1C) (Landis, et al., 1994). The ectodomains of integrin β-subunits are typically larger than 600
amino acids and contain 8 subdomains, including an N-terminal signal region as well as a
metal-binding site that is directly involved in ligand-integrin interactions (Fig. 1C). The
extracellular N-terminal of α-chain and β-chain form a ligand-binding αβ headpiece (Fig.
1C). Through interactions between their extracellular domain and ECM ligands and other
CAM family members, integrins can perform outside-in signaling to mediate cell response to
its surrounding environment. Moreover, through their intracellular tails, integrins can also
perform inside-out signaling, thereby relaying the intercellular cell state to the extracellular
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The selectin family of CAMs is a group of calcium-dependent transmembrane glycoproteins.
Three selectins have been identified, including E-selectin (found on endothelial cells), L-
selectin (found on lymphocytes), and P-selectin (found on platelets and endothelial cells). All
identified selectins share a similar extracellular structure, composed of an N-terminal se‐
quence, a calcium-binding lectin domain, an EGF-like domain, in addition to a non-conserved
transmembrane domain, a non-conserved cytoplasmic tail and a differing number of consen‐
sus repeats (Fig. 1D). Selectins have been reported to play important roles in the immune
system associated with inflammation and cancer progression (Barthel et al., 2007).
Figure 1. Schematic diagram of diverse domain structure of different CAM superfamilies. A. IgSF CAM proteins. B.
Cadherins. C. Integrins. D. Selectins
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Figure 2. Roles of cell adhesion molecules in neural stem/precursor cell self-renewal, differentiation, cell survival and
migration.
3. Cell adhesion molecules and neural stem/progenitor cell development
In the mammalian embryonic CNS, NS/PCs are found in almost all regions, and give rise to
every type of neural cells, including various subtypes of neurons, astrocytes, and oligoden
drocytes, forming the most complex and functional organ of the body (Temple, 2001). In the
adult CNS, astrocyte-like type-B stem cells reside only in certain regions, namely as the
subventricular zone (SVZ), from which stem cells migrate into olfactory bulb (OB) and
differentiate into mature neurons, and the SGL of hippocampal DG, from which stem cells
migrate and extend processes into the molecular layer of the hippocampus (Gage, 2000).
Ependymal cells lining the central canal of adult mouse spinal cord can exhibit dramatic
proliferation after spinal cord injury and give rise to newborn glial cells in the injured spinal
cord (Göritz1 and Frisén, 2012). Many CAMs from different subfamilies are expressed in these
neurogenic regions, although their functions have not been fully understood. Increasingly
evidences suggest that CAMs are not only important for maintenance of the architecture and
shape of stem cell niche, but also play essential roles in signaling transduction from the stem
cell niche to regulate cell survival, proliferation, differentiation, and migration. Recent
progress in NS/PC cell fate research indicates that stem cell maintenance and cell fate deter‐
mination are regulated by a combination of epigenetic modulation, intrinsic transcription
factors and extrinsic signals from the NS/PC niche (Shi et al., 2008). Transcriptional factors play
essential roles in NS/PC fate determination by regulating multiple downstream gene expres‐
sion in NS/PCs. However, the functions of these intrinsic factors are regulated by extrinsic cues
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essential roles in NS/PC fate determination by regulating multiple downstream gene expres‐
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through various signaling pathways mediated by cell surface receptors and down-stream
cellular signaling elements. Modulation of cell fate by such extrinsic cues provides an excellent
mechanism for neural progenitor cells to adapt to the environment. As bridging molecules
between extrinsic signals from neighbor cells or the ECM and intracellular transcriptional
regulation, CAMs play critical roles during these processes.
3.1. Cell adhesion molecules regulate neural stem/progenitor cell self-renewal and
proliferation
Self-renewal is essential for NS/PCs to perpetuate and maintain their population in an
undifferentiated state, which is critical for the CNS development, learning and memory-
related plasticity in adult animals as well as replacement for dead cell following injury. Recent
studies showed that the NS/PC niche, comprised of ECM molecules, soluble factors, and cell
surface molecules, is essential for NS/PC identification, maintenance of stem cell population,
and preventing contact with differentiation stimuli and cell apoptotic signals (Doetsch, 2003;
Miller and Gauthier-Fisher, 2009; Moore and Lemischka, 2006). Among the NS/PC niche
molecules, CAMs play a critical role as transducers that mediate signaling between stem cells
and their niche.
IgSF CAMs play diverse roles in the regulation of NS/PC self-renewal and proliferation through
specific signaling pathways. L1 is highly expressed in the developing neurons of the cerebral
cortex, hippocampus, and corpus callosum, with expression declining to low levels with
maturation (Demyanenko et al., 1999). Reduced hippocampal neurons were observed in L1-
deficient mice, suggesting that L1 may have a potential role in neurogenesis (Demyanenko et al.,
1999). Although undifferentiated NS/PCs do not express L1, substrate-coated L1 inhibits the
proliferation of cultured NS/PCs in vitro (Dihné et al., 2003). Further investigation using L1-
deficient precursors suggests the mechanism by which L1 affects NS/PC proliferation is through
heterophilic binding with unknown receptors (Dihné et al., 2003). Ectopic expression of L1 using
human GFAP promoter in NS/PCs, or overexpression of L1 on the ESC-derived neural precur‐
sors resulted in an impaired proliferation in vitro (Bernreuther et al., 2006; Cui et al., 2010; Cui et
al., 2011; Xu et al., 2011). Interestingly, L1 isoform 2 is expressed on the surface of human ESCs, in
which it positively affects proliferation. Deletion of stable L1 decreased hESC proliferation, while
L1 overexpression enhanced proliferation, suggesting the diverse roles of L1 on different cell types
by different mechanisms (Son et al., 2011). In the adult CNS, VCAM-1 is expressed on the apical
processes of type B astrocyte-like adult stem cells in the adult mouse SVZ, and has been report‐
ed to be essential for SVZ cytoarchitecture, maintenance of adult NS/PCs, and neuroblast chain
migration (Kokovay et al., 2012). Blocking VCAM1 expression with VCAM1 antibodies dis‐
rupts position and cytoarchetecture of ependymal cells and type B cells in at ventricular surface.
Further investigation demonstrated that VCAM1 maintains adult NS/PCs through NOX2
production of reactive oxygen species (Kokovay et al., 2012).
Neuroepithelial attachments at adherens junctions are critical for NS/PC maintenance and self-
renewal. As essential molecules during the nervous system development, cadherins have been
reported to play roles in neural tube, neuroepithelial layer and boundary formation, synap‐
togenesis, axon guidance and regulation of NS/PC behaviors. E-cadherin is expressed in the
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embryonic and adult ventricles, where NS/PCs reside, and in clonal stem cell colonies in
vitro. Deletion of E-cadherin results in a reduction of NSC self-renewal, but an increase of
neural precursor proliferation in vivo (Karpowicz et al., 2009). In vitro culture experiments
provide further evidence that loss of E-cadherin reduces NSC self-renewal, while overex‐
pressing E-cadherin results in an increased NSC number, due to the adhesion function of E-
cadherin (Karpowicz et al., 2009). N-cadherin, which is highly expressed in the nervous system,
appears to be important for maintenance of NS/PCs and cell proliferation. During neural tube
development in zebrafish, N-cadherin was shown to restrict proliferation of neural precursors
in the dorsal neural tube by regulating the cell cycle length (Chalasani and Brewster, 2011).
Increased cell division and shortened cell cycle length, mediated by ligand-independent
activation of Hedgehog signaling, were observed in the N-cadherin mutant, (Chalasani and
Brewster, 2011). However, other studies have found opposing effects of N-cadherin. Knock‐
down of N-cadherin expression by in utero electroporation of shRNA targeting N-cadherin
resulted in reduced β-catenin signaling, leading to increased cell cycle exit and enhanced
premature neuronal differentiation. These effects could be rescued by introducing a stabilized
active form of β-catenin (Zhang et al., 2010). Another in vitro study using fusion protein N-
cadhsion-Fc (including extracellular domain of N-cadherin and Fc domain of IgG)-coated
culture conditions demonstrated that N-cadherin-Fc promotes maintenance of the neural
precursor cell lines P19 and MEB5, and promotes proliferation (Yue et al., 2010). In a more
recent study in spinal cord, forkhead transcription factors Foxp2 and Foxp4 suppressed N-
cadherin to promote the detachment of differentiating neurons from the neuroepithelium.
Blocking Foxp2 and Foxp4 function in both mouse and chick enhances progenitor mainte‐
nance, implying that N-cadherin plays diverse in different systems and signaling pathways
(Rousso et al., 2012).
Many integrins are expressed in neurogenic regions of the developing and adult mammalian
CNS. Cultured neurospheres from newborn mouse forebrain express five major integrins,
including α5β1-, α6Aβ1-, αvβ1-, αvβ5-, αvβ8-, and low levels of α6Bβ1-integrin. Antibody
inhibition of α5β1- and αvβ1-integrins reduces NS/PC proliferation (Jacques et al., 1998). With
the use of fluorescence-activated cell sorting, α5β1-integrin was shown to be highly expressed
in multipotent NS/PCs and downregulated during neuronal differentiation, suggesting a role
in maintenance of characteristic NS/PC features (Yoshida et al., 2003). α6β1-integrin, which is
highly expressed in human NS/PCs, is used as a neural precursor cell marker, and was found
to form a functional complex with laminin γ1, and netrin-4 on the NS/PC surface, that promotes
cell proliferation (Hall et al., 2006; Staquicini et al., 2009). Antibody inhibition of β1-integrin
signaling results in an increased population of abventricular dividing precursors, a phenom‐
enon also observed in the neocortex of mice deficient in Laminin α2, a ligand of β1-integrin
(Loulier et al., 2009). Although diminished proliferation was observed in cultured β1-integrin-
deficient neural precursors, a small percentage of β1-integrin-negative cells survived and
formed neurospheres normally, suggesting that β1-integrin is not required for maintenance
of all NS/PCs (Leone et al., 2005). Further investigation has revealed that β1-integrin contrib‐
utes to the maintenance of NS/PCs by activating MAPK signaling (Campos et al., 2004; Wang
et al., 2011). β1-integrin interacts with Notch and EGFR signalling pathways, suggesting that
ECM molecule or growth factor involvement may be important in β1-integrin-mediated
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highly expressed in human NS/PCs, is used as a neural precursor cell marker, and was found
to form a functional complex with laminin γ1, and netrin-4 on the NS/PC surface, that promotes
cell proliferation (Hall et al., 2006; Staquicini et al., 2009). Antibody inhibition of β1-integrin
signaling results in an increased population of abventricular dividing precursors, a phenom‐
enon also observed in the neocortex of mice deficient in Laminin α2, a ligand of β1-integrin
(Loulier et al., 2009). Although diminished proliferation was observed in cultured β1-integrin-
deficient neural precursors, a small percentage of β1-integrin-negative cells survived and
formed neurospheres normally, suggesting that β1-integrin is not required for maintenance
of all NS/PCs (Leone et al., 2005). Further investigation has revealed that β1-integrin contrib‐
utes to the maintenance of NS/PCs by activating MAPK signaling (Campos et al., 2004; Wang
et al., 2011). β1-integrin interacts with Notch and EGFR signalling pathways, suggesting that
ECM molecule or growth factor involvement may be important in β1-integrin-mediated
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regulation of NS/PCs (Campos et al., 2006). β1-integrin is also involved in basic FGF (bFGF)
and EGF-mediated proliferation of neuroepithelial cells (Suzuki et al., 2010). Moreover, the
carbohydrate-binding protein Galectin-1 regulates proliferation of adult NS/PC through
interactions with β1-integrin (Sakaguchi et al., 2010). Additionally, the FNIII domain 6-8 of
ECM molecule tenascin-R inhibits NS/PC proliferation through interactions with β1-integrin,
an effect that is eliminated with antibody inhibition of β1-integrin (Liao et al., 2008). PDGF
stimulates proliferation of oligodendrocyte precursor cells (OPCs) through activation of αvβ3-
integrin, which in turn activates PI3 kinase-dependent signaling pathway (Baron et al., 2002).
Neurovascularization, regulated by αvβ8-integrin, plays essential roles during the CNS
development (Proctor et al., 2005). Analysis of adult β8-integrin-deficient mouse brains shows
abnormalities in the SVZ and RMS, with a smaller OB. Reduced proliferation of cells in the
SVZ and RMS in β8-integrin-deficient brains and smaller neurospheres formed by β8-integrin-
deficient NS/PCs reveal the important role of β8-integrin on NS/PC maintenance, potentially
through transforming growth factor β (TGFβ) signaling (Mobley et al., 2009).
3.2. Cell adhesion molecules regulate neural stem/progenitor cell differentiation
In the mammalian CNS, different neural cell types arise and migrate in a precise tempor‐
ospatial manner. During mouse brain development, neurons first arise around embryonic
day 12 (E12), with neurogenesis peaking at E14 and ceaseing around E18. Astrocytes appear
at approximately E18, with their numbers peaking in the neonatal period, and oligodendro‐
cytes  are  generated  after  birth  when the  neurogenesis  has  largely  subsided  (Bayer  and
Altman, 1991).
In vitro cultured neural precursors showed enhanced neuronal differentiation, associated with
a reduced astrogliogenesis and unchanged oligodendrocyte genesis whether cultured on
substrate-coated L1, or co-cultured with L1-overexpressing fibroblasts (Dihné et al., 2003).
Further analysis of different neuronal subtypes that differentiated from NS/PCs shows that L1
inhibits cholinergic neuron differentiation, but promotes differentiation of GABAergic
neurons (Dihné et al., 2003). Under an in vitro culture system, ectopic expression of L1 in NS/
PCs, or overexpression of L1 on the ESC-derived neural precursors promotes neuronal
differentiation, but inhibits astrocytic differentiation (Bernreuther et al., 2006; Cui et al., 2010;
Cui et al., 2011; Xu et al., 2011). L1 overexpression also resulted in an increased yield of
GABAergic neurons after transplant into lesioned striatum (Bernreuther et al., 2006). Another
important IgSF CAM PSA-NCAM, identified as a neural precursor marker, is expressed by
NS/PCs in neurogenic regions in the developing and certain regions of the adult CNS, such as
SVZ, hippocampus, and rostral migratory stream (RMS) (Seki and Arai, 1993; Bonfanti and
Theodosis, 1994; Doetsch and Alvarez-Buylla, 1996; Alonso, 1999). Polysialic acid (PSA)-
directed migration and differentiation of neural precursors are essential for mouse brain
development. SVZ precursors migrate along the RMS towards the OB, where they differentiate
into interneurons that do not express PSA. Interestingly, specific deletion of PSA from SVZ
precursors using endoneuraminidase-N (Endo N) results in failure of migration and prema‐
ture differentiation. Nestin-positive cells fail to migrate and develop neuronal cell features,
such as long neurites. Furthermore, these cells are positive tyrosine hydroxylase (TH) (Petridis
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et al., 2004). Further investigation revealed that PSA-dependent differentiation requires cell-
cell contact, facilitated by NCAM triggering p59fyn and MAPK p44/42 phosphorylation (Beggs
et al., 1997; Petridis et al., 2004). Through a double-knockout of two PSA synthases ST8SiaII
and ST8SiaIV, PSA was deleted, resulting in an increased number of glial fibrillary acidic
protein (GFAP)-positive astrocytes both in vitro and in vivo (Angata et al., 2007). TAG-1 plays
a role in inhibiting neurogenesis by interacting with amyloid β precursor protein (APP). TAG-1
and APP are co-localized in the neurogenic niche and neural precursors, and can bind to each
other to release APP intracellular domain (AICD), triggering the APP signaling pathway to
negatively regulate neurogenesis (Ma et al., 2008). Fe65 is also expressed in the neurogenic VZ
and has been identified as a downstream element of TAG-1-APP signaling during regulation
of neurogenesis (Ma et al., 2008).
The roles of cadherins on neural differentiation are still not well understood. Although neural
differentiation appears to occur normally in N-cadherin-deficient mice (Kadowaki et al.,
2007), a recent study knocking down N-cadherin expression by in utero eletroporation resulted
in an enhanced neuronal differentiation, likely through β-catenin signaling as it can be rescued
by introducing a stabilized active form of β-catenin (Zhang et al., 2010). Another study showed
that bone morphogenetic protein 4 (BMP4) induces astrocytic differentiation of NS/PCs
through PI3 kinase-mediated upregulation of N-cadherin (Kim et al., 2010).
β4-integrin plays an essential role in NS/PC differentiation. Under in vitro culture system,
knockdown of endogenous β4-integrin inhibits cell differentiation and reduces of FGFR2
expression, while overexpression of β4-integrin in NS/PCs promotes differentiation (Su et al.,
2009). The FNIII domain 6-8 of ECM molecule tenascin-R, through interactions with β1-
integrin, promotes astrocytic differentiation, while preventing differentiation into neurons and
oligodendrocytes; Conversely, epidermal growth factor-like (EGFL) domain of tenascin-R
promotes neuronal differentiation, while reducing differentiation into astrocytes and oligo‐
dendrocytes, through interactions with β1-integrin that can be inhibited with application of
β1-integrin antibody (Liao et al., 2008).
3.3. Cell adhesion molecules regulate neuronal migration
When NS/PCs give birth to neurons or glial cells, the differentiating or differentiated cells will
migrate away from the stem cell niche to their appropriate location. In the developing CNS,
specific neurons migrate in a specific pathway to reach their final destination in the brain. For
example, in the developing cerebral cortex, the newborn neurons generated by radial glial cells
in the embryonic VZ undergo radial migration along the long processes of radial glial cells,
forming the different layers of cortical plate. Newborn interneurons generated from the
ganglionic eminence also migrate in tangential path into the cortex without interacting with
radial glial cells (Ghashghaei et al., 2007). In the adult CNS, NS/PCs from SVZ migrate along
the rostral migratory stream towards the OB and from the SGL of hippocampus migrate a short
distance into molecular layer (Ghashghaei et al., 2007). As cell surface molecules interacting
with the surrounding environment, CAMs play essential roles in cell migration..
Overexpression of L1 using human GFAP promoter in NS/PCs promotes neuronal migration
in in vitro neurosphere migration assays, and also enhances migration of transplanted cells in
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regulation of NS/PCs (Campos et al., 2006). β1-integrin is also involved in basic FGF (bFGF)
and EGF-mediated proliferation of neuroepithelial cells (Suzuki et al., 2010). Moreover, the
carbohydrate-binding protein Galectin-1 regulates proliferation of adult NS/PC through
interactions with β1-integrin (Sakaguchi et al., 2010). Additionally, the FNIII domain 6-8 of
ECM molecule tenascin-R inhibits NS/PC proliferation through interactions with β1-integrin,
an effect that is eliminated with antibody inhibition of β1-integrin (Liao et al., 2008). PDGF
stimulates proliferation of oligodendrocyte precursor cells (OPCs) through activation of αvβ3-
integrin, which in turn activates PI3 kinase-dependent signaling pathway (Baron et al., 2002).
Neurovascularization, regulated by αvβ8-integrin, plays essential roles during the CNS
development (Proctor et al., 2005). Analysis of adult β8-integrin-deficient mouse brains shows
abnormalities in the SVZ and RMS, with a smaller OB. Reduced proliferation of cells in the
SVZ and RMS in β8-integrin-deficient brains and smaller neurospheres formed by β8-integrin-
deficient NS/PCs reveal the important role of β8-integrin on NS/PC maintenance, potentially
through transforming growth factor β (TGFβ) signaling (Mobley et al., 2009).
3.2. Cell adhesion molecules regulate neural stem/progenitor cell differentiation
In the mammalian CNS, different neural cell types arise and migrate in a precise tempor‐
ospatial manner. During mouse brain development, neurons first arise around embryonic
day 12 (E12), with neurogenesis peaking at E14 and ceaseing around E18. Astrocytes appear
at approximately E18, with their numbers peaking in the neonatal period, and oligodendro‐
cytes  are  generated  after  birth  when the  neurogenesis  has  largely  subsided  (Bayer  and
Altman, 1991).
In vitro cultured neural precursors showed enhanced neuronal differentiation, associated with
a reduced astrogliogenesis and unchanged oligodendrocyte genesis whether cultured on
substrate-coated L1, or co-cultured with L1-overexpressing fibroblasts (Dihné et al., 2003).
Further analysis of different neuronal subtypes that differentiated from NS/PCs shows that L1
inhibits cholinergic neuron differentiation, but promotes differentiation of GABAergic
neurons (Dihné et al., 2003). Under an in vitro culture system, ectopic expression of L1 in NS/
PCs, or overexpression of L1 on the ESC-derived neural precursors promotes neuronal
differentiation, but inhibits astrocytic differentiation (Bernreuther et al., 2006; Cui et al., 2010;
Cui et al., 2011; Xu et al., 2011). L1 overexpression also resulted in an increased yield of
GABAergic neurons after transplant into lesioned striatum (Bernreuther et al., 2006). Another
important IgSF CAM PSA-NCAM, identified as a neural precursor marker, is expressed by
NS/PCs in neurogenic regions in the developing and certain regions of the adult CNS, such as
SVZ, hippocampus, and rostral migratory stream (RMS) (Seki and Arai, 1993; Bonfanti and
Theodosis, 1994; Doetsch and Alvarez-Buylla, 1996; Alonso, 1999). Polysialic acid (PSA)-
directed migration and differentiation of neural precursors are essential for mouse brain
development. SVZ precursors migrate along the RMS towards the OB, where they differentiate
into interneurons that do not express PSA. Interestingly, specific deletion of PSA from SVZ
precursors using endoneuraminidase-N (Endo N) results in failure of migration and prema‐
ture differentiation. Nestin-positive cells fail to migrate and develop neuronal cell features,
such as long neurites. Furthermore, these cells are positive tyrosine hydroxylase (TH) (Petridis
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et al., 2004). Further investigation revealed that PSA-dependent differentiation requires cell-
cell contact, facilitated by NCAM triggering p59fyn and MAPK p44/42 phosphorylation (Beggs
et al., 1997; Petridis et al., 2004). Through a double-knockout of two PSA synthases ST8SiaII
and ST8SiaIV, PSA was deleted, resulting in an increased number of glial fibrillary acidic
protein (GFAP)-positive astrocytes both in vitro and in vivo (Angata et al., 2007). TAG-1 plays
a role in inhibiting neurogenesis by interacting with amyloid β precursor protein (APP). TAG-1
and APP are co-localized in the neurogenic niche and neural precursors, and can bind to each
other to release APP intracellular domain (AICD), triggering the APP signaling pathway to
negatively regulate neurogenesis (Ma et al., 2008). Fe65 is also expressed in the neurogenic VZ
and has been identified as a downstream element of TAG-1-APP signaling during regulation
of neurogenesis (Ma et al., 2008).
The roles of cadherins on neural differentiation are still not well understood. Although neural
differentiation appears to occur normally in N-cadherin-deficient mice (Kadowaki et al.,
2007), a recent study knocking down N-cadherin expression by in utero eletroporation resulted
in an enhanced neuronal differentiation, likely through β-catenin signaling as it can be rescued
by introducing a stabilized active form of β-catenin (Zhang et al., 2010). Another study showed
that bone morphogenetic protein 4 (BMP4) induces astrocytic differentiation of NS/PCs
through PI3 kinase-mediated upregulation of N-cadherin (Kim et al., 2010).
β4-integrin plays an essential role in NS/PC differentiation. Under in vitro culture system,
knockdown of endogenous β4-integrin inhibits cell differentiation and reduces of FGFR2
expression, while overexpression of β4-integrin in NS/PCs promotes differentiation (Su et al.,
2009). The FNIII domain 6-8 of ECM molecule tenascin-R, through interactions with β1-
integrin, promotes astrocytic differentiation, while preventing differentiation into neurons and
oligodendrocytes; Conversely, epidermal growth factor-like (EGFL) domain of tenascin-R
promotes neuronal differentiation, while reducing differentiation into astrocytes and oligo‐
dendrocytes, through interactions with β1-integrin that can be inhibited with application of
β1-integrin antibody (Liao et al., 2008).
3.3. Cell adhesion molecules regulate neuronal migration
When NS/PCs give birth to neurons or glial cells, the differentiating or differentiated cells will
migrate away from the stem cell niche to their appropriate location. In the developing CNS,
specific neurons migrate in a specific pathway to reach their final destination in the brain. For
example, in the developing cerebral cortex, the newborn neurons generated by radial glial cells
in the embryonic VZ undergo radial migration along the long processes of radial glial cells,
forming the different layers of cortical plate. Newborn interneurons generated from the
ganglionic eminence also migrate in tangential path into the cortex without interacting with
radial glial cells (Ghashghaei et al., 2007). In the adult CNS, NS/PCs from SVZ migrate along
the rostral migratory stream towards the OB and from the SGL of hippocampus migrate a short
distance into molecular layer (Ghashghaei et al., 2007). As cell surface molecules interacting
with the surrounding environment, CAMs play essential roles in cell migration..
Overexpression of L1 using human GFAP promoter in NS/PCs promotes neuronal migration
in in vitro neurosphere migration assays, and also enhances migration of transplanted cells in
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the injured spinal cord (Xu et al., 2011). L1-overexpression in the neural precursors derived
from ESCs also promotes migration into the lesioned CNS tissues (Bernreuther et al., 2006; Cui
et al., 2011; Xu et al., 2011). The NS/PCs born in the adult SVZ express high levels of PSA-
NCAM, and migrate along the RMS towards the OB and differentiate into interneurons.
Increasingly evidence has demonstrated the importance of PSA in controlling NS/PC migra‐
tion pattern, although PSA is not required for radial migration of interneurons within OB (Hu
et al., 1996). SVZ precursors are unable to migrate when PSA expression is abolished, resulting
in a smaller OB (Cremer et al., 1994; Hu et al., 1996; Angata et al., 2007). Expressed by hippo‐
campal precursors in SGL, PSA is also required for the migration of newborn granule cells
(Burgess et al., 2008). Although the mechanism by which PSA guides the NS/PCs is still not
clear, it has been hypothesized that PSA regulates directed migration towards guidance cues.
A recent study observing the effect of PSA on migration of OPCs showed that PSA-positive
OPCs polarize and directly migrate towards concentration gradients of PDGF, while loss of
the PSA tail of NCAM causes an altered migration pattern in response to PDGF gradients,
indicating the PSA is involved in a regulatory network requiring environmental cues (Zhang
et al., 2004). TAG-1 is expressed by cortical GABAergic interneurons and mediates their
migration from the ganglionic eminence towards the developing cortex. Inhibition of TAG-1
function results in a remarkable reduction of GABAergic interneurons in the cortex (Denaxa
et al., 2001).
Recently it was demonstrated that N-cadherin is involved in radial neuronal migration during
cortical development. In N-cadherin conditional knockout mice, neuroepithelial and radial
glial cells can not expand their cell bodies and processes to span the distance from the
ventricular surface to the pial surface, which is essential for neuronal migration and cortical
lamination, resulting in disorganization of the entire cortex (Kadowaki et al., 2007). Knock‐
down of N-cadherin expression by in utero electroporation reduced β-catenin signaling,
causing enhanced premature neuronal migration, which can be rescued by introducing a
stabilized active form of β-catenin (Zhang et al., 2010). A recent study showed that Rab
GTPases-dependent endocytic pathways are critical for radial migration during the cortical
development, through N-cadherin trafficking (Kawauchi et al., 2010). Deficiency in N-cadherin
also causes mispositioning of neurons in the zebrafish neural tube (Lele et al., 2002). N-cadherin
was also shown to regulate the directional chain migration of cerebellar granule neurons in
zebrafish by continuously coordinating cell-cell contacts and cell polarity through the remod‐
eling of adherens junctions (Rieger et al., 2009). Classic cadherins were also shown to regulate
tangential migration of precerebellar neurons in the caudal hindbrain. N-cadherin, Cadher‐
in-6, Cadherin-8, and Cadherin-11 are expressed in the migratory stream of lateral reticular
nucleus (LRN) and neurons of external cuneate nucleus (ECN). Overexpression of two
dominant negative constructs, a membrane-bound form and a cytoplasmic form, but not full
length N-cadherin and Cadherin-11, inhibits LRN/ECN neuron migration, suggesting classic
cadherins regulate contact-dependent tangential migration probably through their adhesive
functions (Taniguchi et al., 2006). Additionaly, cadherins are also required for neural crest cells
migration (Monier-Gavelle and Duband, 1997; Nakagawa and Takeichi, 1998; Borchers et al.,
2001; Shoval et al., 2007).
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Integrins were also shown to control migration of neural precursors. During migration along
the RMS, antibodies for specific integrins, such as α1-, β1-, and αv-integrins, inhibit neuronal
migration during the stages at which they are expressed (Murase and Horwitz, 2002). β1-
integrins-dificient progenitor cells exhibit impaired migration in different ECM substrates
(Leone et al., 2005). Antibody inhibition of neurosphere-expressed α6β1-integrins results in
inhibition of tangential chain migration of NS/PC in vitro (Jacques et al., 1998). The α6β1-
integrin, laminin γ1, and netrin-4 complex was shown to be a promoter of NS/PC migration
(Staquicini et al., 2009). Another study analyzing adult neural precursors from the striatum
reveals that α6β1- and α5β1-integrins promote cell migration (Tate et al., 2004). β8-integrin
has also been shown to be important for neural precursor migration. Selective deletion of β8-
integrin expression in neuroblasts causes abnormal chain migration and a reduction in OB size
(Mobley et al., 2009; Mobley and McCarty, 2011).
3.4. Cell adhesion molecules regulate cell survival
During embryonic and early postnatal development, approximately 50% of newborn neurons
die due to apoptosis in almost every CNS regions. In adult the CNS, cell death mostly occurs
in the regions of neurogenesis. For example, in the adult hippocampus, about 70% of newborn
neurons die within three weeks after failing to form the functional connections with the
existing neural circuits. CAMs have been shown to play essential roles during apoptosis
signaling.
In the in vitro culture system, mouse or human L1Fc fusion proteins can protect cerebellar
granule neurons from cell death induced by growth factor deprivation, staurosporine treat‐
ment, and oxidative stress (Loers et al., 2005). With the use of specific inhibitors of signal
transduction molecules, PI3-kinase activity was shown to be important for the neuroprotective
effect of L1. Moreover, protein kinase PDK1 and Akt were found to be potential downstream
targets (Loers et al., 2005). In other in vitro assays, coated L1 had no effect on the extent of
precursor cell death, measured by TUNEL staining (Dihné et al., 2003). Ectopic expression of
L1 also showed no effect on cell death of ESC-derived neural precursors, suggesting diverse
roles of L1 on different cell types (Bernreuther et al., 2006). PSA-NCAM is also involved in
neuronal survival. After removal or inactivation of PSA using Endo N, impaired survival was
observed in cultured cortical neurons. This effect of PSA has been shown to be involved the
BDNF signaling pathway (Vutskits et al., 2001). In NCAM-deficient mice, increased cell
apoptosis was observed in the SVZ and the RMS. Interestingly, increased cell death occurred
in the PSA+NCAM+ neuroblasts, but not in PSA-NCAM+ astrocyte, suggesting that PSA-NCAM
but not NCAM is important for cell survival (Gascon et al., 2007).
Cadherins, such N-cadherin and Pcdhγs, have also been found to be involved in neural cell
survival. N-cadherin can enhance cell survival of both mouse spinal cord neurons and rat
hippocampal neurons in vitro through pro-apoptotic protein Bim-related signaling pathway
(Lelièvre et al., 2012). A cyclic peptide including a functional binding motif HAVDI in the
extracellular domain 1 of N-cadherin promote in vitro survival of different population of CNS
neurons, by binding to and clustering N-cadherin in neurons and thereby activating N-
cadherin/FGFR signaling cascade (Skaper et al., 2004). Pcdhγs is proven to be involved in
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the injured spinal cord (Xu et al., 2011). L1-overexpression in the neural precursors derived
from ESCs also promotes migration into the lesioned CNS tissues (Bernreuther et al., 2006; Cui
et al., 2011; Xu et al., 2011). The NS/PCs born in the adult SVZ express high levels of PSA-
NCAM, and migrate along the RMS towards the OB and differentiate into interneurons.
Increasingly evidence has demonstrated the importance of PSA in controlling NS/PC migra‐
tion pattern, although PSA is not required for radial migration of interneurons within OB (Hu
et al., 1996). SVZ precursors are unable to migrate when PSA expression is abolished, resulting
in a smaller OB (Cremer et al., 1994; Hu et al., 1996; Angata et al., 2007). Expressed by hippo‐
campal precursors in SGL, PSA is also required for the migration of newborn granule cells
(Burgess et al., 2008). Although the mechanism by which PSA guides the NS/PCs is still not
clear, it has been hypothesized that PSA regulates directed migration towards guidance cues.
A recent study observing the effect of PSA on migration of OPCs showed that PSA-positive
OPCs polarize and directly migrate towards concentration gradients of PDGF, while loss of
the PSA tail of NCAM causes an altered migration pattern in response to PDGF gradients,
indicating the PSA is involved in a regulatory network requiring environmental cues (Zhang
et al., 2004). TAG-1 is expressed by cortical GABAergic interneurons and mediates their
migration from the ganglionic eminence towards the developing cortex. Inhibition of TAG-1
function results in a remarkable reduction of GABAergic interneurons in the cortex (Denaxa
et al., 2001).
Recently it was demonstrated that N-cadherin is involved in radial neuronal migration during
cortical development. In N-cadherin conditional knockout mice, neuroepithelial and radial
glial cells can not expand their cell bodies and processes to span the distance from the
ventricular surface to the pial surface, which is essential for neuronal migration and cortical
lamination, resulting in disorganization of the entire cortex (Kadowaki et al., 2007). Knock‐
down of N-cadherin expression by in utero electroporation reduced β-catenin signaling,
causing enhanced premature neuronal migration, which can be rescued by introducing a
stabilized active form of β-catenin (Zhang et al., 2010). A recent study showed that Rab
GTPases-dependent endocytic pathways are critical for radial migration during the cortical
development, through N-cadherin trafficking (Kawauchi et al., 2010). Deficiency in N-cadherin
also causes mispositioning of neurons in the zebrafish neural tube (Lele et al., 2002). N-cadherin
was also shown to regulate the directional chain migration of cerebellar granule neurons in
zebrafish by continuously coordinating cell-cell contacts and cell polarity through the remod‐
eling of adherens junctions (Rieger et al., 2009). Classic cadherins were also shown to regulate
tangential migration of precerebellar neurons in the caudal hindbrain. N-cadherin, Cadher‐
in-6, Cadherin-8, and Cadherin-11 are expressed in the migratory stream of lateral reticular
nucleus (LRN) and neurons of external cuneate nucleus (ECN). Overexpression of two
dominant negative constructs, a membrane-bound form and a cytoplasmic form, but not full
length N-cadherin and Cadherin-11, inhibits LRN/ECN neuron migration, suggesting classic
cadherins regulate contact-dependent tangential migration probably through their adhesive
functions (Taniguchi et al., 2006). Additionaly, cadherins are also required for neural crest cells
migration (Monier-Gavelle and Duband, 1997; Nakagawa and Takeichi, 1998; Borchers et al.,
2001; Shoval et al., 2007).
Neural Stem Cells - New Perspectives362
Integrins were also shown to control migration of neural precursors. During migration along
the RMS, antibodies for specific integrins, such as α1-, β1-, and αv-integrins, inhibit neuronal
migration during the stages at which they are expressed (Murase and Horwitz, 2002). β1-
integrins-dificient progenitor cells exhibit impaired migration in different ECM substrates
(Leone et al., 2005). Antibody inhibition of neurosphere-expressed α6β1-integrins results in
inhibition of tangential chain migration of NS/PC in vitro (Jacques et al., 1998). The α6β1-
integrin, laminin γ1, and netrin-4 complex was shown to be a promoter of NS/PC migration
(Staquicini et al., 2009). Another study analyzing adult neural precursors from the striatum
reveals that α6β1- and α5β1-integrins promote cell migration (Tate et al., 2004). β8-integrin
has also been shown to be important for neural precursor migration. Selective deletion of β8-
integrin expression in neuroblasts causes abnormal chain migration and a reduction in OB size
(Mobley et al., 2009; Mobley and McCarty, 2011).
3.4. Cell adhesion molecules regulate cell survival
During embryonic and early postnatal development, approximately 50% of newborn neurons
die due to apoptosis in almost every CNS regions. In adult the CNS, cell death mostly occurs
in the regions of neurogenesis. For example, in the adult hippocampus, about 70% of newborn
neurons die within three weeks after failing to form the functional connections with the
existing neural circuits. CAMs have been shown to play essential roles during apoptosis
signaling.
In the in vitro culture system, mouse or human L1Fc fusion proteins can protect cerebellar
granule neurons from cell death induced by growth factor deprivation, staurosporine treat‐
ment, and oxidative stress (Loers et al., 2005). With the use of specific inhibitors of signal
transduction molecules, PI3-kinase activity was shown to be important for the neuroprotective
effect of L1. Moreover, protein kinase PDK1 and Akt were found to be potential downstream
targets (Loers et al., 2005). In other in vitro assays, coated L1 had no effect on the extent of
precursor cell death, measured by TUNEL staining (Dihné et al., 2003). Ectopic expression of
L1 also showed no effect on cell death of ESC-derived neural precursors, suggesting diverse
roles of L1 on different cell types (Bernreuther et al., 2006). PSA-NCAM is also involved in
neuronal survival. After removal or inactivation of PSA using Endo N, impaired survival was
observed in cultured cortical neurons. This effect of PSA has been shown to be involved the
BDNF signaling pathway (Vutskits et al., 2001). In NCAM-deficient mice, increased cell
apoptosis was observed in the SVZ and the RMS. Interestingly, increased cell death occurred
in the PSA+NCAM+ neuroblasts, but not in PSA-NCAM+ astrocyte, suggesting that PSA-NCAM
but not NCAM is important for cell survival (Gascon et al., 2007).
Cadherins, such N-cadherin and Pcdhγs, have also been found to be involved in neural cell
survival. N-cadherin can enhance cell survival of both mouse spinal cord neurons and rat
hippocampal neurons in vitro through pro-apoptotic protein Bim-related signaling pathway
(Lelièvre et al., 2012). A cyclic peptide including a functional binding motif HAVDI in the
extracellular domain 1 of N-cadherin promote in vitro survival of different population of CNS
neurons, by binding to and clustering N-cadherin in neurons and thereby activating N-
cadherin/FGFR signaling cascade (Skaper et al., 2004). Pcdhγs is proven to be involved in
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neural cell survival. Abolishing Pcdhγs gene cluster results in the apoptosis of spinal inter‐
neurons, and retinal interneurons and ganglion cells, but the mechanism of Pcdhγs in cell
survival is still unclear (Wang et al., 2002; Lefebvre et al., 2008).
Integrins also play a role regulation of cell survival. Cultured β1-integrin-deficient neural
progenitors display high levels of cell death (Leone et al., 2005). Inhibition of phosphatidu‐
choline-specific phospholipase C in cultured neural cells results in a reduction of cell survival,
associated with upregulation of β4-integrin and Rb protein (Lv et al., 2006).
4. Applications of cell adhesion molecules in stem cell-based regenerative
therapy
Many CAMs have been investigated for pre-clinical studies in the treatment of neural injury
and neurodegenerative disorders as their roles in CNS development and regeneration after
CNS injury have been revealed. L1 has been reported to play important roles in neuronal
survival and migration as well as neurite outgrowth and extension, axonal guidance and
synaptic plasticity in vitro and in vivo (Hortsch, 1996). Thus, it has been studied as a target for
the treatment of neurodegeneration and neural injuries. Application of soluble L1Fc to injured
rat spinal cords significantly improved locomotor recovery compared to both the PBS-
treatment group and the IgM antibody control group (Roonprapunt et al., 2003). Further
analysis using biotinylated dextran amine for corticospinal axon labeling revealed that L1Fc
promoted axonal growth (Roonprapunt et al., 2003). Another study using adeno-associated
virus (AAV)-mediated L1 expression also promoted functional recovery including stepping
ability and muscle coordination after mouse spinal cord injury (Chen et al., 2007). Increased
regeneration of corticospinal tract axons and levels of 5-hydroxytryptamine (5-HT), an
important neurotransmitter, were observed in the AAV-L1-treated spinal cord, along with a
reduction of astrocytes and reduced expression of the neurite outgrowth-inhibitor and
chondroitin sulfate proteoglycan NG2. Increased expression level of cyclic AMP, phosphory‐
lated CREB, Rac1 and MAPK and a reduction of GTP-RhoA expression were observed in AAV-
L1-treated spinal cord, revealing that exogenous L1 promotes functional recovery by
triggering multiple signaling pathways (Chen et al., 2007). The reparative effects of L1 on spinal
cord injury were achieved after acute application of L1. A separate study applying AAV-L1
alone, Chondroitinase ABC (ChaseABC) alone, which degrades chondroitin sulfates that
inhibit neurite outgrowth, or a combination of AAV-L1 and ChaseABC to treat the sub-chronic
spinal cord injury (Lee et al., 2012). Results revealed that when compared to the AAV-green
fluorescent protein (GFP) injection control group, AAV-L1 treatment improves voluntary
movements, while ChaseABC application enhances body weight support. Injection of the
combination of AAV-L1 and ChaseABC results in improvement in both parameters, with
increased densities of cholinergic and GABAergic terminals in motor neuron and enhanced
synaptic rearrangements (Lee et al., 2012).
Polysialic acid (PSA) is a long linear homopolymer glycan carried by NCAMs that plays
essential roles in PSA-NCAM-mediated activities, including cell-cell interaction and cell
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migration (Hu et al., 1996; Johnson et al., 2005). Numerous studies have used PSA to promote
adult CNS or PNS repair. Expression of PSA at the lesion site can loosen scar tissue and reduce
inhibitory interactions with growth cones. Thus, engineered overexpression of PSA on the
astrocyte scar enhanced Purkinje cell axonal regeneration in the lesioned cerebellum of growth
related genes L1/GAP-43 double transgenic mice (Zhang et al., 2007). Similarly, induced
expression of PSA in the glial scar of injured spinal cords promoted regeneration of sensory
axons (Zhang et al., 2007). PSA glycomimetics has also been reported to promote plasticity and
functional recovery after spinal cord injury in mice (Mehanna, 2010). PSA was also applied in
the study of regeneration following peripheral nerve injury. PSA glycomimetic promotes
myelination and functional recovery after peripheral nerve injury (Mehanna et al., 2009). PSA-
mimetic enhances Schwann cell proliferation and process elongation in vitro, which may be
mediated by interaction with Schwann cell-expressed NCAM and FGFR (Mehanna et al., 2009).
Human natural killer cell glycan (HNK-1) is found on glycolipids and glycoproteins, including
many CAMs, such as L1, NCAM, MAG, TAG-1 in the nervous system, and has been shown
to play roles in cell recognition and adhesion (Morita et al., 2008). Application of HNK-1 mimic
peptide in injured peripheral nerves resulted in larger motor neuron somata and enhanced
axonal remyelination resulting in better functional recovery compared to the mice treated with
a scrambled peptide (Simova et al., 2006). In vitro assays demonstrated that HNK-1 mimic
peptide enhances neurite outgrowth and survival of motor neurons (Simova et al., 2006).
Due to the role of CAMs in the NS/PC development and repair of nervous system injury,
many  researchers  have  investigated  the  possibility  of  combining  CAMs  and  stem  cell-
based transplantation therapy to treat  neural  disorder and neural  injury models.  As the
most widely studied CAM associated with neural regeneration, L1 has been investigated
as a potential candidate for stem cell-based therapeutic strategy for treatment of neurode‐
generative  diseases  or  regeneration  after  neural  injury.  Overexpresion  of  L1  in  NS/PCs
results in a reduced proliferation, enhanced neuronal migration and differentiation, as well
as  decreased astrogenesis  using an in  vitro  culture  system and enhanced migration and
survival of grafted cell after transplantation into the injured spinal cord (Xu et al., 2011).
Transplanted L1-overexpressing NS/PCs increased soma size and enhanced synaptic input
to host motor neuron in the lesion site. Moreover, an increase in axons expressing tyrosine
hydroxylase—a enzyme vital  for  the  synthesis  of  catecholaminergic  neurotransmitters—
distal to the lesion site was observed in mice recipients of L1-expressing NS/PCs transplan‐
tation (Xu et al., 2011). Overall a significantly improved locomotor functional recovery was
observed  in  mice  transplanted  with  L1-expressing  precursors  when  compared  to  mice
transplanted  with  wild-type  NS/PCs  after  spinal  cord  injury  (Xu  et  al.,  2011).  The  L1-
overexpressing neural precursor derived from ESCs exhibits decreased cell proliferation in
vitro,  enhanced neuronal differentiation both in vitro  and in vivo  resulting in a diminish‐
ed astrocytic differentiation in vivo without affecting cell death compared to wild-type cells
(Bernreuther et al.,  2006; Cui et al.,  2010; Cui et al.,  2011).  Transplantation of L1-overex‐
pressing ESC-derived neural precursors at the lesion site after spinal cord injury reduces
glial  scar  volume,  enhances  graft  size,  promotes  neuronal  migration,  and  decreases  the
microglial/macrophage  reaction  in  the  lesion  site,  and  thereby  improves  locomotor
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neural cell survival. Abolishing Pcdhγs gene cluster results in the apoptosis of spinal inter‐
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virus (AAV)-mediated L1 expression also promoted functional recovery including stepping
ability and muscle coordination after mouse spinal cord injury (Chen et al., 2007). Increased
regeneration of corticospinal tract axons and levels of 5-hydroxytryptamine (5-HT), an
important neurotransmitter, were observed in the AAV-L1-treated spinal cord, along with a
reduction of astrocytes and reduced expression of the neurite outgrowth-inhibitor and
chondroitin sulfate proteoglycan NG2. Increased expression level of cyclic AMP, phosphory‐
lated CREB, Rac1 and MAPK and a reduction of GTP-RhoA expression were observed in AAV-
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triggering multiple signaling pathways (Chen et al., 2007). The reparative effects of L1 on spinal
cord injury were achieved after acute application of L1. A separate study applying AAV-L1
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inhibit neurite outgrowth, or a combination of AAV-L1 and ChaseABC to treat the sub-chronic
spinal cord injury (Lee et al., 2012). Results revealed that when compared to the AAV-green
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distal to the lesion site was observed in mice recipients of L1-expressing NS/PCs transplan‐
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overexpressing neural precursor derived from ESCs exhibits decreased cell proliferation in
vitro,  enhanced neuronal differentiation both in vitro  and in vivo  resulting in a diminish‐
ed astrocytic differentiation in vivo without affecting cell death compared to wild-type cells
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functional recovery (Cui et al., 2011). In addition to application in treatment for spinal cord
injury, L1-expressing NS/PCs have also been studied as potential candidates in neurodege‐
nerative disease models, such as Huntington’s and Parkinson’s disease. In a quinolinic acid-
induced Huntington’s disease mouse model, L1-overexpressing neural precursors derived
from ESCs generated more graft-derived GABAergic neurons in the lesioned striatum and
improved locomotor functional recovery in rotation behavior test compared to the control
mice transplanted wild-type cells (Bernreuther et al.,  2006).  In the MPTP-induced mouse
model  of  Parkinson’s  disease,  transplantation  of  L1-overexpressing  ESC-derived  neural
precursors led to a better functional recovery in apomorphine-induced rotation test when
compared to  the mice treated with wild-type cells  and vehicle-injected mice (Cui  et  al.,
2010).  Further  morphological  analysis  revealed  an  increased  number  of  dopaminergic
neurons, leading to increased dopamine level in the striatum ipsilateral to the transplanta‐
tion region of L1-expressing neural precursors (Cui et al.,  2010). Due to the L1-mediated
promotion  of  neurite  outgrowth  and neuronal  survival  by  homophilic  binding,  NS/PCs
overexpressing trimerized L1 extracellular domain and full length L1 were transplanted in
to  the  injured  spinal  cord.  The  injured  mice  transplanted  with  NS/PCs  overexpressing
trimerized L1 extracellular domain and full length L1 exhibit improved functional recovery
in locomotor behavior after spinal cord injury when compared to the group transplanted
with only L1-overexpressing NS/PCs (He et al., 2012). The trimer-L1-expressing stem cells
displayed  enhanced  reduction  in  glial  scar  volume in  the  lesion  site  and  expression  of
chondroitin sulfates, preventing degeneration of corticospinal axons, promoting remyelina‐
tion and enhancing regrowth of serotonergic axons (He et al., 2012). These results further
demonstrated the potential application of L1-expressing NS/PC transplantation and could
be of great therapeutic value. In cell replacement therapy, the transplanted cells need not
only to be differentiated into proper cell types, but also to migrate into the injured region.
In light of the effects of PSA on cell migration, researchers were motivated to attempt to
overexpress  PSA  in  transplanted  stem  cells.  Ectopic  expression  of  PSA  on  the  ESC-
derived neural precursors results in enhanced migratory ability after transplantation in the
rodent striatum (Glaser et al., 2007).
Stem cell-based therapeutic applications have attracted a great deal of attention as multiple
potential stem cell types were developed, particularly with the establishment of induced
pluripotent stem cells (iPSCs). These stems cells seemed to provide near limitless potential in
treating many human diseases. However, stem cell-based therapeutic applications for
neurological disorders have faced many obstacles and setbacks, such as immunorejection,
tumor formation, and low efficiency resulting from low cell survival, and failure to migrate
and form functional neural connections with existing neural circuitry. Moreover, the molecular
mechanisms that underlie NS/PC proliferation and differentiation into distinct cell types
remain unclear. Nonetheless, advances in stem cell research and advantages of the combina‐
tion of CAMs and stem cells in pre-clinical research, like enhanced cell survival, promoted cell
migration, and increased neuronal differentiation, are encouraging. All these advantages
suggest that CAMs have tremendous potential for application in stem cell-based cell replace‐
ment therapy for neurodegenerative diseases and spinal injuries.
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1. Introduction
Under physiological conditions, neuronal stem cells (NSCs) can undergo both self-renewal
and differentiation stages. The formation of new neurons, neurogenesis, is a vital process by
which the brain maintains its lifelong plasticity in response to extrinsic and intrinsic changes.
However, the exact mechanisms that regulate NSC self-renewal and differentiation are largely
unknown. NSCs become stimulated after neuronal injury and can migrate at pathological sites
(Nakatomi et al., 2002; Russo et al., 2011) that dictate the potential of NSCs therapeutic use in
pathological conditions of the central nervous system. In this chapter, we describe the effect
of neuroinflammation in NSCs and discuss whether the inflammatory mediators can epige‐
netically affect the capacity of NSCs and alter their proliferation and differentiation ability.
The mechanism by which the inflammatory environment influences the NSC niche and thus,
alters the self-renewal, survival, migration, and differentiation of the NSCs is currently
unknown (Martino and Pluchino, 2006). Several studies have focused the effects of inflamma‐
tion on the regenerative capacity of NSCs subjected to microglial activation after an acute injury
or after LPS treatment. Overall, the connection between brain inflammation and NSC neuro‐
genesis and the role of the niche in the modulation of neuronal differentiation under alternative
conditions are under intense investigation.
To gain further insight into these phenomena, we describe epigenetic mechanisms, including
DNA methylation and histone modification in NSCs inflammation. DNA methylation and
histone modification are known to play significant roles in the modulation of stem cell
proliferation and differentiation (Li and Zhao, 2008). Regarding DNA methylation, methylated
CpG-binding protein (MBD) deficiency results the suppression of NSCs differentiation.
Therefore, to identify the downstream target genes of MBDs has potential in NSCs differen‐
tiation study. Histone modifications are another important epigenetic mark. There are many
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types of post-translational modifications of the residues at histone tails, including methylation
of lysines and arginines, acetylation, phosphorylation, ubiquitination, SUMOylation, and
ADP-ribosylation. Among the histone modifications, histone H3 lysine (K) methylation is a
central epigenetic modification with both activating and repressive roles in eukaryotic
chromatin (Reinberg et al., 2004).
Next, we will focus on epigenetic involvement in neurodegenerative diseases and NSCs.
Actually, inflammatory stimuli induce beneficial effects (e.g., phagocytosis of debris and
apoptotic cells), and inflammation is linked to tissue repair processes, uncontrolled inflam‐
mation may result in production of neurotoxic factors that amplify underlying disease states
and pathogenesis of Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral
sclerosis (ALS), multiple sclerosis (MS), and a growing number of other nervous system
pathologies (Glass et al., 2010). Here, endogenous NSCs cannot fully compensate the neuronal
loss in such neurodegenerative diseases. The possible reasons include the lack of trophic
support and inhibitory signals within the brain microenvironment (Croft and Przyborski,
2009), indicative of oxidative stress (Kelly et al., 2011) and age-related neuroinflammation. In
summary, the recent development of stem cells technology open new areas of research aimed
at stimulating neuronal regeneration in the brain during aging, neuroinflammation and
neurodegenerative diseases (Russo et al., 2011). Here, we overview the therapeutic approach
of NSC and how these stem cells are responsible for brain homeostasis, induction of neuro‐
genesis in several diseased states. Finally, this chapter indicates the possibility of combination
therapy of epigenetic drug with NSC transplantation in these neurodegenerative diseases.
2. Epigenetics and neuroinflammation
Alterations in cell signaling by environmental changes can remodel epigenetic marks (Borrelli
et al., 2008; Weaver et al., 2007). Epigenetics thus presents potential explanations for sustained
changes in transcriptional activity associated with cell differentiation, learning and memory,
age-related neurodegeneration and effects of early experience, repeated drug exposure,
chronic stress, and environmental toxins. The implicit hypothesis is that environmental signals
alter chromatin modifications, which then serve as the mechanism for the transcriptional
‘plasticity’ that mediates sustained variation in neural function (Meaney and Ferguson-Smith,
2010). Although most extensively studied in embryonic stem cells, such ‘bivalent’ domains,
which are also found in the adult brain (Sanz et al., 2008), suggest a developmentally ‘poised’
state awaiting environmental direction. Indeed, such states may mark the potential for
plasticity. The same epigenetic mark can recruit effectors that activate as well as others that
repress transcription. We describe the detail epigenetic changes in NSC later in this chapter.
We summarize the recent evidence that physiological and environmental signals influence
adaptive transcriptional responses in neurons through the epigenetic modification of chro‐
matin. We highlight to the regulation of histone modifications and DNA methylation in
response to neuroinflammation and related signaling. In addition, mechanisms that induce
chromatin modifications in association with multiprotein complexes on neuronal gene
promoters are mentioned.
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3. NSC and inflammation
To maintain brain homeostasis, NSCs are highly controlled under physiological conditions in
which the stem cell niche is vital for the NSC self-renewal, proliferation, differentiation, and
migration. NSCs become activated after neuronal injury and migrate to the site of injury,
indicating that some regulators at the injury site can guide the migration of precursor cells.
Damaged neurons can be repaired by the activation of endogenous neuronal stem cells, which
migrate to regions of the brain injury, differentiate into neuronal cells, and integrate into
neuronal circuits (Belmadani et al., 2006; Russo et al., 2011) The mechanism by which the
inflammatory environment influences the NSC niche and thus, alters the self-renewal,
survival, migration, and differentiation of the NSCs is currently unknown (Martino and
Pluchino, 2006). Alterations of NSC functions either pro-neurogenic or anti-neurogenic in
inflammation may depend on the NSC niche and activation of brain microglial cells. It is
reported that activated microglia in inflammatory conditions can inhibit neurogenesis
(Butovsky et al., 2006). On the contrary, activated microglia also showed helpful for neuro‐
genesis (Hanisch and Kettenmann, 2007). Inflammatory cytokines and nitric oxide (NO)
released by microglial cells can inhibit the adult neurogenesis. Activation of microglia with
LPS results the production of inflammatory mediators in vitro, including TNF-α and IL-6, that
inhibit the generation of neurons from NSCs (Monje et al., 2003). However, modification of
microglial status by other cytokines, such as IL-4 or low dose interferon-γ (IFN-γ) changes
their phenotype to strongly promote neurogenesis (Butovsky et al., 2006). However, the
positive effects are at least partly dependent on microglia production of insulin-like growth
factor-1 (IGF-1), a potent proneurogenic growth factor. Though controversial, this raises the
possibility that some types of controlled inflammation may be exploited in CNS regeneration
or in combating neurological diseases that have pronounced chronic proinflammatory
components (Rolls et al., 2009)
Several studies have focused the effects of inflammation on the regenerative capacity of NSCs
subjected to microglial activation after an acute injury or after LPS treatment. It is reported
that TLR4 is expressed by NSCs, and LPS suppresses the proliferation of NSCs under culture
conditions via an NF-κB-dependent mechanism (Monje et al., 2003; Rolls et al., 2007). In
addition, TLR4 can directly modulate the self-renewal and cell-fate decision of neuronal
progenitor cells (Rolls et al., 2007). Overall, the effects of proinflammatory signaling on NSCs
go beyond simple changes in the abundance of new neurons (Carpentier and Palmer, 2009). It
is shown that the neurons generated during the period of inflammation are morphologically
normal, with normal cell body location, polarity, and branching, yet they display an accentu‐
ated inhibitory or excitatory responses in immature versus mature neurons, respectively
(Jakubs et al., 2008). So, the functions of new neurons are severely affected by immune
signaling. Moreover, the connection between brain inflammation and NSC neurogenesis and
the role of the niche in the modulation of neuronal differentiation under alternative conditions
are under intense investigation.
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3. NSC and inflammation
To maintain brain homeostasis, NSCs are highly controlled under physiological conditions in
which the stem cell niche is vital for the NSC self-renewal, proliferation, differentiation, and
migration. NSCs become activated after neuronal injury and migrate to the site of injury,
indicating that some regulators at the injury site can guide the migration of precursor cells.
Damaged neurons can be repaired by the activation of endogenous neuronal stem cells, which
migrate to regions of the brain injury, differentiate into neuronal cells, and integrate into
neuronal circuits (Belmadani et al., 2006; Russo et al., 2011) The mechanism by which the
inflammatory environment influences the NSC niche and thus, alters the self-renewal,
survival, migration, and differentiation of the NSCs is currently unknown (Martino and
Pluchino, 2006). Alterations of NSC functions either pro-neurogenic or anti-neurogenic in
inflammation may depend on the NSC niche and activation of brain microglial cells. It is
reported that activated microglia in inflammatory conditions can inhibit neurogenesis
(Butovsky et al., 2006). On the contrary, activated microglia also showed helpful for neuro‐
genesis (Hanisch and Kettenmann, 2007). Inflammatory cytokines and nitric oxide (NO)
released by microglial cells can inhibit the adult neurogenesis. Activation of microglia with
LPS results the production of inflammatory mediators in vitro, including TNF-α and IL-6, that
inhibit the generation of neurons from NSCs (Monje et al., 2003). However, modification of
microglial status by other cytokines, such as IL-4 or low dose interferon-γ (IFN-γ) changes
their phenotype to strongly promote neurogenesis (Butovsky et al., 2006). However, the
positive effects are at least partly dependent on microglia production of insulin-like growth
factor-1 (IGF-1), a potent proneurogenic growth factor. Though controversial, this raises the
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4. Epigenetic significance in NSC-inflammation
Epigenetic refers to any heritable influence (in the progeny of cells or individuals) on chro‐
mosome or gene function that is not accompanied by a change in DNA sequence (Yoder et al.,
1997). It includes processes such as DNA methylation, histone modification and noncoding
RNA expression. Appropriate gene function either activation or repression at inflammatory
stages of NSC progression could be achieved by such epigenetic regulation. Here, we cover
recent reports involving the role of epigenetic mechanisms in NSC-inflammation and its fate
on NSC mechanisms. One of the important epigenetic mechanisms, DNA methylation in the
genome is established by a family of DNA methyltransferases (DNMTs). Maintenance of
methylation patterns is achieved by a function of DNMT1 during DNA replication, while de
novo methylation is primarily catalyzed by DNMT3a and DNMT3b. DNA methylation is
responsible for the regulation of gene expression, where two mechanisms are involved. First,
methylation of CpG dinucleotides affects DNA structure and can directly interfere with the
binding of TFs to their target sequences(Takizawa et al., 2001); second, a more pervasive effect,
methyl-CpG-binding domain (MBD)-containing protein family members can bind to genes
with methylated CpG dinucleotides, thereby suppressing the genes’ expression (Nan et al.,
1997) Though, DNA methylation is actively involved in the acquisition of multipotentiality in
NSC from early-, mid- to late-gestation. Here, we mainly focus on two well-studied pathways
that act synergistically to promote astrocytic differentiation of NSC are those activated by the
interleukin-6 (IL-6) family of cytokines such as leukemia inhibitory factor (LIF), ciliary
neurotrophic factor (CNTF) and cardiotrophin-1 (CT-1) and bone morphogenetic protein
(BMP) signaling (Juliandi et al., 2010). In early- and mid-gestational NSCs, astrocytic gene
promoters such as glial fibrillary acidic protein (GFAP) are hypermethylated, a status that
impedes binding of the STAT3-p300 ⁄CBP-SMADs complex to its target sequence and thus
prevents these NSCs from differentiating into astrocytes even when the cells are stimulated
by astrocyte-inducing cytokines (Takizawa et al., 2001). These IL-6 family cytokines have been
shown to be expressed in NSCs and neurons in the fetal mouse brain (Barnabe-Heider et al.,
2005); but how DNA methylation of IL-6 does affect of NSC differentiation in inflammation is
not disclosed. On the contrary, the STAT3 binding site-containing GFAP promoter in NSCs at
late gestation is barely methylated, so that upon LIF stimulation these NSCs can differentiate
into astrocytes (Takizawa et al., 2001). Overall, the genome-wide DNA methylation status of
NSCs in well-defined inflammatory conditions may give us possible clue of gene specific
methylation status of NSC whether DNA methylation can play an important role in defining
the NSC fate from neurogenesis to astrocytogenesis in inflammatory conditions. Notch
signaling is a conserved pathway from insects to mammals, which contributes to cell-to-cell
communication (Louvi and Artavanis-Tsakonas, 2006) and controls cell fate determination in
the CNS (Lundkvist and Lendahl, 2001). Upon Notch activation by its ligand, the Notch
intracellular domain (NICD) is released from the plasma membrane and is translocated into
the nucleus, where it converts a particular repressor complex into an activator complex
(Nakayama et al., 2008). It is confirmed that Notch ligands are indeed expressed in neuronally
committed NPCs and young neurons, and that these ligands activate Notch signaling in the
residual NSCs. Further, forced expression of NICD in midgestational NSCs induced the
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upregulation of nuclear factor 1A (NF1A), which in turn accelerated demethylation of
astrocytic gene promoters by preventing DNMT1 from binding to them and thus allowed
precocious astrocytic differentiation in response to LIF stimulation (Namihira et al., 2009).
It has shown that methyl binding domain (MBD) proteins expressed predominantly in
neurons, and not in astrocytes or oligodendrocytes, in the CNS (Kishi and Macklis, 2004); may
regulate in NSC differentiation. It was found that exon1 of GFAP are hypermethylated in all
neural cell types and that only in neurons, methyl-CpG-binding protein 2 (MeCP2), a member
of the MBD family, is highly expressed and binds to this methylated exon1 region (Setoguchi
et al., 2006) that is linked to block the astrocyte differentiation. Indeed, ectopic expression of
MeCP2 directs NSCs to become neurons and inhibits astrocytic differentiation, even in the
presence of astrocyte-inducing cytokines such as LIF and BMP2 (Tsujimura et al., 2009). MBD1-
deficient NSCs generate fewer neurons than do wild type NSCs, suggesting an important role
for MBD1 in neuronal fate specification (Zhao et al., 2003).
Histone proteins within the chromosome play a significant role in chromatin structure, gene
transcription and epigenetic information. Multiple modifications decorate each histone tail
within the nucleosome, and some amino acids on the histone tail can be modified in several
different ways. Covalent modifications of histone taile include methylation, acetylation,
phosphorylation, ubiquitylation, sumoylation, glycosylation, biotinylation, carbonylation and
adenosine diphosphate (ADP)-ribosylation (Strahl and Allis, 2000). Among these, modifica‐
tions by histone acetylation and methylation are the most common. Acetylation and deacety‐
lation of lysine residue in histone tails is mediated by histone acetyl transferases (HATs) and
histone deacetylases (HDACs), respectively (Hsieh and Gage, 2005). Histone acetylation by
HATs is responsible for open chromatin (euchromatin) formation that leads to transcriptional
activation. Conversely, HDACs result decrease of histone acetylation and formation of
condensed chromatin (heterochromatin) that causes transcriptional silencing. Adult hippo‐
campal-derived NSCs differentiate predominantly into neurons, at the expense of astrocytes
and oligodendrocytes, when treated by the antiepileptic and HDAC inhibitor valproic acid
(VPA) in vitro, even in conditions that favor glia-specific differentiation (Hsieh et al., 2004).
VPA-mediated HDAC inhibition upregulates the neuron-specific gene NeuroD, a neurogenic
basic helix-loop-helix transcription factor (TF), is resulting in the induction and suppression,
respectively, of neuronal and glial differentiation. In the developing rat brain and in cultured
E14 NSCs, VPA treatment has also been shown to promote neurogenesis by activating the Ras-
ERK pathway (Jung et al., 2008).
Histone methylation is involved in the regulation of a variety of nuclear processes dedicated
to the maintenance of active and silent states of gene expression, which is essential for cellular
regulation, homeostasis and fate determination (Cloos et al., 2008). There are five lysine
residues in the histone N termini that are prominently methylated. H3K4 and H3K36 meth‐
ylation primarily transduce activating functions, whereas H3K9, H3K27, and H4K20 methyl‐
ation is mainly associated with repressed chromatin. Histone lysine methylationcan result in
mono-, di-, or trimethyl states and each distinct methylation state confers different biological
read-outs. Histone lysine trimethyl states, particularly those with repressive functions, appear
relatively robust because they are stably propagated during several cell divisions (Lachner et
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al., 2004). Among the histone modifications, histone H3 lysine (K) methylation is a central
epigenetic modification with both activating and repressive roles in eukaryotic chromatin
(Reinberg et al., 2004). JmjC domain proteins demethylate histone lysine and arginine residues
in an oxidative reaction that requires Fe (II) and α-ketoglutarate as cofactors. Depending on
their target specificity, JmjC domain proteins promote transcriptional repression or activation,
thereby impacting important processes such as hormone response, stem cell renewal, germ
cell development, and cellular proliferation and differentiation (Beyer et al., 2008). Interest‐
ingly, a range of JmjC proteins is induced in different cancers and has been linked to cell
proliferation (Cloos et al., 2006) and the suppression of senescence (Pfau et al., 2008). Members
of the JMJD2 family that target H3K9me3/me2 and H3K36me3/me2 are highly expressed in
prostate cancer (Wissmann et al., 2007).
Recently, we reported the effect of lipopolysaccharides (LPS) on NSCs epigenetics, where we
used an immortalized neuroectodermal stem cell line, NE-4C. The NE-4C cell line was cloned
from the anterior brain vesicles of E9 mouse embryos lacking functional p53 (Livingstone et
al., 1992). Non-induced NE-4C cells grow as homogeneous, epithelial-like populations, and in
response to all-trans retinoic acid (RA) treatment, they differentiate into neurons on a highly
reproducible schedule (Jelitai et al., 2004). We found that histone demethylase, Jmjd2b is
functional in long-term LPS treatment and regulates the histone demethylation of the pro‐
moters of its target genes that may be crucial in multiple signaling pathways and biological
processes in murine NSCs (NE-4C cells). MetaCore pathway analysis revealed the gene
networks and canonical pathways affected in Jmjd2b-attenuated NE-4C cells that involved
neurophysiological processes (receptor-mediated axon growth repulsion, GABA-A receptor
life cycle), the Notch1-mediated pathway for NF-κB activity modulation, and TGF-β-depend‐
ent induction. Several extrinsic factors affect the histone methylation status of NSCs. In the
postnatal mouse brain, MLL1 is required for neurogenesis and its deficiency in NSCs in the
subventricular zone (SVZ) leads to a glial lineage preference. One of the key downstream
regulators of SVZ neurogenesis, Dlx2, is not expressed in MLL1-deficient NSCs. This is due to
a change in histone methylation of Dlx2, from a single high level of H3K4 trimethylation
(H3K4me3) to a bivalent poised state marked by both activating H3K4me3 and repressive
H3K27me3 (Lim et al., 2009).
We found that Jmjd2b is functional in long-term LPS treatment and regulates the histone
demethylation of the promoters of its target genes that may be crucial in multiple signaling
pathways and biological processes in NE-4C cells. Jmjd2b is a newly identified member of the
histone demethylase Jmjd2 family that is characterized by the catalytic Jumonji C (JmjC)
domain. Jmjd2b specifically targets the trimethylated lysine 9 of histone H3 (H3K9) for
demethylation at pericentric heterochromatin and euchromatin (Fodor et al., 2006). It is
reported that JMJD2B is critical to breast cancer cell survival under conditions of normoxia
and hypoxia, which occurs partially via the regulation of cell cycle progression, is highly
expressed in ERα-positive primary breast cancers, and is an adverse prognostic factor in
hypoxic breast cancers (Yang et al., 2010). In this study, MetaCore pathway analysis was used
to reveal the gene networks and canonical pathways affected in Jmjd2b-kd cells. Among the
network, generation of neurons, neurogenesis, cell differentiation, and cellular developmental
Neural Stem Cells - New Perspectives386
processes were most significantly affected in Jmjd2b-attenuated NE-4C cells. The significantly
downregulated genes were clustered in different networks and canonical pathways. We found
that Jmjd2b-kd NE-4C cells downregulated various key genes involved in neurophysiological
processes (receptor-mediated axon growth repulsion, GABA-A receptor life cycle), the Notch1-
mediated pathway for NF-κB activity modulation, and TGF-β-dependent induction. Jmjd2b
encodes a histone demethylase that has been recently shown to be a HIF-1α target gene (Yang
et al., 2009). Jmjd2b attenuation significantly inhibited p65, iNOS, Bcl2 and TGF-β expression
in JMJD3-kd NE-4C cells. A GeneGo analysis of Jmjd2b-kd NE-4C cells revealed that Jmjd2b
attenuation affected the generation of neurons, neurogenesis, system development, cell
differentiation and cellular development processes. Several genes involved in the receptor-
mediated axon growth repulsion (semaphorin 3a, pleiotrpphin-OSF1, ephrin A receptor 2),
the GABA-A receptor life cycle (GABA-A receptor beta 2), the NOTCH1-mediated pathway
for NF-κB activity modulation (c-Rel, Jagged 1, p65/p52) and the TGF-β-dependent induction
(TGF-β2, Jagged1, N-cadherin, Lef1) were directly or indirectly affected by Jmjd2b attenuation.
We predict that Jmjd2b recruitment may be necessary for the expression of regulated genes
from several pathways that are crucial for various neurological functions. These results suggest
that LPS has an inflammatory effect on NE-4C cells via epigenetic modulation.
It has also been reported that the mRNA expression of NeuroD, a neural progenitor cell marker,
was significantly decreased in the hippocampus of aged mice compared with that in young
mice. In light of previous results, we examined the presence of H3K9me3 at the NeuroD
promoter but did not observe a reduction of the H3K9me3 level in Jmjd2b-kd NE-4C cells. We
predicted that other histone modifications might be involved at the promoter site of NeuroD
for its expression. However, the functions of most histone demethylases, including Jmjd2b,
are not clear under inflammatory conditions, and the mechanism by which Jmjd2b epigenet‐
ically regulates gene expression in NSC inflammation has not been well shown. Therefore, the
clarification of the function of Jmjd2b may help to identify novel therapeutic targets for brain
inflammation.
5. Epigenetic regulations of proinflammatory cytokines in NSC
Cytokines are the secreted molecules that mediate communication between immune cells and
between immune system and host. Cytokines encompass a broad class of signaling molecules
that have the potential to influence an immense variety of signals that regulate NSC function,
including growth factor production, electrical activity, synaptic function, and axonal path
finding (Carpentier and Palmer, 2009). We will focus our discussion on the epigenetic regula‐
tions of inflammatory cytokines in NSC. Though, several recent reports shown that important
cytokines include TNF-α, IL-6, and IL-1β have prominent inhibitory effect on adult neurogene‐
sis in vivo. TNF-α can induce apoptosis in NSCs or newborn neurons via TNFR1. TNFR1
signaling, but not that of TNFR2, has been demonstrated to inhibit neurogenesis in the normal
hippocampus (Iosif et al., 2006). In addition, neurogenesis is severely affected by another strong
inflammatory mediator, NO. It has been reported that the SVZ cell proliferation rate is signifi‐
cantly increased after the inhibition of neuronal NOS activity (Sun et al., 2005). Notably, the
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processes were most significantly affected in Jmjd2b-attenuated NE-4C cells. The significantly
downregulated genes were clustered in different networks and canonical pathways. We found
that Jmjd2b-kd NE-4C cells downregulated various key genes involved in neurophysiological
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are not clear under inflammatory conditions, and the mechanism by which Jmjd2b epigenet‐
ically regulates gene expression in NSC inflammation has not been well shown. Therefore, the
clarification of the function of Jmjd2b may help to identify novel therapeutic targets for brain
inflammation.
5. Epigenetic regulations of proinflammatory cytokines in NSC
Cytokines are the secreted molecules that mediate communication between immune cells and
between immune system and host. Cytokines encompass a broad class of signaling molecules
that have the potential to influence an immense variety of signals that regulate NSC function,
including growth factor production, electrical activity, synaptic function, and axonal path
finding (Carpentier and Palmer, 2009). We will focus our discussion on the epigenetic regula‐
tions of inflammatory cytokines in NSC. Though, several recent reports shown that important
cytokines include TNF-α, IL-6, and IL-1β have prominent inhibitory effect on adult neurogene‐
sis in vivo. TNF-α can induce apoptosis in NSCs or newborn neurons via TNFR1. TNFR1
signaling, but not that of TNFR2, has been demonstrated to inhibit neurogenesis in the normal
hippocampus (Iosif et al., 2006). In addition, neurogenesis is severely affected by another strong
inflammatory mediator, NO. It has been reported that the SVZ cell proliferation rate is signifi‐
cantly increased after the inhibition of neuronal NOS activity (Sun et al., 2005). Notably, the
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pathological concentration of NO has a skewing effect on NSC differentiation when the pro-
astroglial fate is very dominant (Covacu et al., 2006). At present, not many studies have been
reported regarding the epigenetic involvement for cytokine regulations in NSC; recently, we
reported LPS could affect NSC in vitro via epigenetic regulation (Das et al., 2012). The in vitro
treatment of NE-4C cells with LPS (1 µg/ml for 96 h) significantly increased Jmjd2b expression
and decreased the levels of H3K9me3. It has been reported that IL-1β suppresses the prolifera‐
tion of hippocampal progenitor cells (Koo and Duman, 2008).The decreased proliferation of
neural stem cells is responsible for decreased neural differentiation, and increased prolifera‐
tion could correspond to the promotion of neurogenesis. We predicted that H3K9me3 is involved
in Jmjd2b-attenuated NE-4C cells. A ChIP analysis showed that Jmjd2b-attenuated samples
experienced an increase in the H3K9me3 on inflammatory signaling-mediated genes. An
induced presence of H3K9me3 has been observed at the promoters of the Notch1, IL-1β, and IL-2
genes in Jmjd2b-kd NE-4C cells, suggesting that Jmjd2b can fine-tune the local chromatin state
to enhance the transcription of these genes (Das et al., 2012).
6. Potential of NSC in neurodegenerative diseases
Neurogenesis by endogenous NSC cannot fully overcome the neuronal loss observed in
neurodegenerative diseases. One reason for this limited response is the lack of trophic support
and inhibitory signals within the brain microenvironment (Croft and Przyborski, 2009),
indicative of oxidative stress and age-related neuroinflammation. These observations stimu‐
lated a search for agents that could increase neurogenesis and enhance neuroprotection (Russo
et al., 2011). Now we will discuss the various neurodegenerative diseases including Alzheim‐
er’sdisease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), multiple
sclerosis (MS), epilepsy, and stroke in inflammatory contexts. Each of the neurodegenerative
diseases considered here is distinguished by a disease-specific mechanism for induction of
inflammatory responses. The distinct pathways for production of inducers of inflammation—
such as Ab, a-synuclein, mutant SOD1, and myelin peptide mimetic—and the specific
anatomical locations at which these processes occur are likely determinants of the specific
pathologicial features of each disease. In particular, TLRs and other pattern recognition
receptors expressed on microglia and astrocytes are likely to play significant roles in initiating
inflammatory responses. Later the downstream signal transduction pathways like NF-ĸB and
AP-1 appear to play general roles in mediating the production of amplifiers and effector
molecules, such as cytokines (e.g., TNF-α, IL-1β, and IL-6), ROS, and NO which involving in
neurotoxicity for all of the neurodegenerative diseases (Glass et al., 2010).
Now we will focus on epigenetic involvement for such neurodegenerative diseases. Genes that
are epigenetically regulated in Alzheimer’s disease are S100A2 (a member of the S100 family
of calcium-binding proteins) and SORBS3 (a sorbin and SH3 domain containing the cell-
adhesionProtein) that display significant different level of DNA methylation (Siegmund et al.,
2007). S100A2 has been previously identified as a metastatic inductor in non-small-cell lung
cancer (Bulk et al., 2009), but its role in Alzheimer’s disease pathogenesis remains unknown.
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Most importantly, S100B, another member of the S100 family, which acts as a neurotrophic
and pro-survival neuronal factor, might have a role in Alzheimer’s disease pathogenesis and
how does the exogenous and endogenous NSC express and epigenetically regulate such
neurotrophic factors is still unknown. Among other epigenetic regulations in the pathogenesis
of PD; DNA hypomethylation of TNF-α can directly lead to specific vulnerability of the
substantianigra could be the direct consequence of PD (Pieper et al., 2008) and that may
potentiate why the cytokine mediate inflammation is one of the major causes for PD. It is also
reported that TNF-α overexpression induces apoptosis in neuronal cells and TNF-α levels are
high in the CSF of patients with Parkinson’s disease (Mogi et al., 1996). Multiple sclerosis is an
inflammatory chronic disease characterized by a demyelinating process, which is followed by
neurodegeneration. Although little is known about the epigenetics of this disease, some
evidence suggests hypomethylation was proven at the promoter region of PADl2 (peptidyl
arginine deiminase, type II), also found to be overexpressed in multiple sclerosis. PADl2
catalyzes the citrullination of myelin basic protein that can change the properties of myelin
(Mastronardi et al., 2007; Urdinguio et al., 2009). Epilepsy is described as a common chronic
neurological disorder characterized by recurrent spontaneous seizures. Sporadic epilepsy can
arise as a result of traumatic brain injury, stroke, abnormalities in brain wiring, toxic-metabolic
etiologies, inflammation, autoimmunity, or an imbalance in the ratio of inhibitory to excitatory
synaptic transmission (Hwang et al, 2012; Berg et al, 2010). Spontaneous seizures activate REST
and promote deacetylation of core histone protein H4 (a mark of gene repression) at the RE1
site of the gria2 promoter (gene encoding the AMPAR subunit GluA2) recruits mSin3A and
CoREST, HDACs-1/2, G9a and MeCP2, while promoting an increase in acetylation of H4 (a
mark of open chromatin) at the promoter of brain-derived neurotrophic factor BDNF
(Tsankova et al, 2004). Although, GluA2 expression was decreased, leading to an increase in
GluA2-lacking, Ca2+-permeable AMPARs at CA3 synapses and neuronal death in CA3.
Alterations of these proteins contribute to the pathophysiology of recurrent seizures. In
epileptic adult rats transplanted fetal NSC (E14 rat) cells differentiated into neurons (13%,
mostly GABAergic) and astrocytes (57%) and showed a reduction of motor seizure by 43% and
severe convulsive seizure by 90% (Waldau et al., 2010). But how does the epigenetic regulators
in exogenous NSC play crucial role in epilepsy yet to disclose. Ischemic insults also trigger
activation of REST in mature hippocampal neurons destined to die and that the increase in
REST correlates with a decrease in histone acetylation and gene silencing of GluA2. This is
significant in that the GluA2 subunit prevents Ca2+ influx via AMPA receptors (AMPARs), is
essential to synapatogenesis, long lasting forms of synaptic plasticity and neuronal death
(Hwang et al., 2012; Liu and Zukin, 2007). Since, REST is a master transcriptional regulator of
neuronal genes in pluripotent stem cells and neural progenitors and that loss of REST during
the late stages of neural differentiation by ubiquitin based proteosomal degradation is required
for acquisition of the neural phenotype (Hwang et al., 2012). The more study needs to answer
how does REST perform at transplanted NSC in stroke model and whether other synaptic
proteins correlate with REST for neuronal death in a clinically relevant ischemic stroke model.
Neuroinflammation on the Epigenetics of Neural Stem Cells
http://dx.doi.org/10.5772/54981
389
pathological concentration of NO has a skewing effect on NSC differentiation when the pro-
astroglial fate is very dominant (Covacu et al., 2006). At present, not many studies have been
reported regarding the epigenetic involvement for cytokine regulations in NSC; recently, we
reported LPS could affect NSC in vitro via epigenetic regulation (Das et al., 2012). The in vitro
treatment of NE-4C cells with LPS (1 µg/ml for 96 h) significantly increased Jmjd2b expression
and decreased the levels of H3K9me3. It has been reported that IL-1β suppresses the prolifera‐
tion of hippocampal progenitor cells (Koo and Duman, 2008).The decreased proliferation of
neural stem cells is responsible for decreased neural differentiation, and increased prolifera‐
tion could correspond to the promotion of neurogenesis. We predicted that H3K9me3 is involved
in Jmjd2b-attenuated NE-4C cells. A ChIP analysis showed that Jmjd2b-attenuated samples
experienced an increase in the H3K9me3 on inflammatory signaling-mediated genes. An
induced presence of H3K9me3 has been observed at the promoters of the Notch1, IL-1β, and IL-2
genes in Jmjd2b-kd NE-4C cells, suggesting that Jmjd2b can fine-tune the local chromatin state
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inflammatory responses. The distinct pathways for production of inducers of inflammation—
such as Ab, a-synuclein, mutant SOD1, and myelin peptide mimetic—and the specific
anatomical locations at which these processes occur are likely determinants of the specific
pathologicial features of each disease. In particular, TLRs and other pattern recognition
receptors expressed on microglia and astrocytes are likely to play significant roles in initiating
inflammatory responses. Later the downstream signal transduction pathways like NF-ĸB and
AP-1 appear to play general roles in mediating the production of amplifiers and effector
molecules, such as cytokines (e.g., TNF-α, IL-1β, and IL-6), ROS, and NO which involving in
neurotoxicity for all of the neurodegenerative diseases (Glass et al., 2010).
Now we will focus on epigenetic involvement for such neurodegenerative diseases. Genes that
are epigenetically regulated in Alzheimer’s disease are S100A2 (a member of the S100 family
of calcium-binding proteins) and SORBS3 (a sorbin and SH3 domain containing the cell-
adhesionProtein) that display significant different level of DNA methylation (Siegmund et al.,
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synaptic transmission (Hwang et al, 2012; Berg et al, 2010). Spontaneous seizures activate REST
and promote deacetylation of core histone protein H4 (a mark of gene repression) at the RE1
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mark of open chromatin) at the promoter of brain-derived neurotrophic factor BDNF
(Tsankova et al, 2004). Although, GluA2 expression was decreased, leading to an increase in
GluA2-lacking, Ca2+-permeable AMPARs at CA3 synapses and neuronal death in CA3.
Alterations of these proteins contribute to the pathophysiology of recurrent seizures. In
epileptic adult rats transplanted fetal NSC (E14 rat) cells differentiated into neurons (13%,
mostly GABAergic) and astrocytes (57%) and showed a reduction of motor seizure by 43% and
severe convulsive seizure by 90% (Waldau et al., 2010). But how does the epigenetic regulators
in exogenous NSC play crucial role in epilepsy yet to disclose. Ischemic insults also trigger
activation of REST in mature hippocampal neurons destined to die and that the increase in
REST correlates with a decrease in histone acetylation and gene silencing of GluA2. This is
significant in that the GluA2 subunit prevents Ca2+ influx via AMPA receptors (AMPARs), is
essential to synapatogenesis, long lasting forms of synaptic plasticity and neuronal death
(Hwang et al., 2012; Liu and Zukin, 2007). Since, REST is a master transcriptional regulator of
neuronal genes in pluripotent stem cells and neural progenitors and that loss of REST during
the late stages of neural differentiation by ubiquitin based proteosomal degradation is required
for acquisition of the neural phenotype (Hwang et al., 2012). The more study needs to answer
how does REST perform at transplanted NSC in stroke model and whether other synaptic
proteins correlate with REST for neuronal death in a clinically relevant ischemic stroke model.
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Finally, more research will be required to understand the epigenetic mechanisms that underlie
the neuroprotective roles of NSC in neurodegenerative diseases.
7. Conclusion
Due to self-renewal ability and differentiation to various neural cell types, NSC has great
potential for clinical treatment of neurological diseases and dysfunctions. This regenerative
capacity of NSC hold a great promise to open new areas of research aimed at stimulating
neuronal regeneration in the brain during aging, neuroinflammation and neurodegenerative
diseases. Epigenetic regulation along with other mechanisms can control these properties of
NSCs. However, our knowledge about the precise mechanisms that control NSC function in
neuroinflammation is still in its infancy and many avenues remain to be explored. The acute
innate proinflammatorysignaling cascade strongly suppresses the production and retentionof
new neurons in the adult brain. Here, the related immune signaling and epigenetic role might
involve that must be addressed. We are just at the beginning of understanding the field. There
are not reproducible comprehensive profiles of the DNA methylomes and histone modifica‐
tions of NSCs in proper inflammatory stages that could generate some biomarkers to test in
disease-associated conditions. Although more neurodevelopmental diseases caused by
mutations in epigenetic genes are being identified, we still do not understand how the
disturbance of DNA methylation and histone modification would directly affect NSC fate
except the regulation of some neurotrophic factors. Moreover, a clear epigenetic interpretation
that control the stimulation of neurogenesis during neuroinflammation, and the integration
of NSC in diseased brain could assist to develop novel therapeutic approaches with a potential
application in neuroinflammatory diseases.
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Properties: Novel Strategies for Cell Therapy
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1. Introduction
Neurons are one among the very few differentiated cell types which are strictly post-mitotic
and therefore non-renewable by sister cell divisions. The production of new neurons, or
neurogenesis, does though occur in limited areas of adult mammalian nervous system, due to
the existence of intrinsic stem cells which has been formally demonstrated by a primary culture
approach on adult brain tissues from mouse [1], man [2,3] and other species [4]. These “neural
stem cells” satisfy the general stemness criteria, i.e.: illimited proliferative activity, self-renewal
capacity, multipotency (i.e. capacity to generate all the differentiated cell types of their host
tissue, which for neural stem cells encompasses neurons, astrocytes, oligodendrocytes),
proliferative reactivity to tissue lesions and physiological signals [5]. This discovery has raised
great promise for clinical repair in neurology and led to coin a novel principle in cell therapy,
which consists in replacing lost neurons by grafting in vitro purified neural stem cells [6,7,8].
This theoretical principle has been challenged by the putative tumour-promoting potential of
grafted proliferative cells. Such risk can reasonably be ruled out by the recent demonstration
that adult brain-derived neural stem cells are highly resilient to tumorigenesis and senescence,
much more than embryonic neuroblasts, embryonic stem cells, induced pluripotent stem cells
or any other stem cell type from adult mammalian tissues [9]. However, the use of homotypic
neural stem cell transplantation in human clinics seems ethically difficult, since it requires
initial sampling of alive brain tissue. In order to overcome this limitation, we have developed
primary neural stem cell culture from adult porcine brain. The pig is indeed the non-primate
species that is immunologically closest to human [10], which already allowed successful
protocols of xenotransplantation in human clinics using in vitro-expanded primary cell
preparations from several adult pig tissues – but not from the nervous system.
© 2013 Liard and Moyse; licensee InTech. This is an open access article distributed under the terms of the
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1. Introduction
Neurons are one among the very few differentiated cell types which are strictly post-mitotic
and therefore non-renewable by sister cell divisions. The production of new neurons, or
neurogenesis, does though occur in limited areas of adult mammalian nervous system, due to
the existence of intrinsic stem cells which has been formally demonstrated by a primary culture
approach on adult brain tissues from mouse [1], man [2,3] and other species [4]. These “neural
stem cells” satisfy the general stemness criteria, i.e.: illimited proliferative activity, self-renewal
capacity, multipotency (i.e. capacity to generate all the differentiated cell types of their host
tissue, which for neural stem cells encompasses neurons, astrocytes, oligodendrocytes),
proliferative reactivity to tissue lesions and physiological signals [5]. This discovery has raised
great promise for clinical repair in neurology and led to coin a novel principle in cell therapy,
which consists in replacing lost neurons by grafting in vitro purified neural stem cells [6,7,8].
This theoretical principle has been challenged by the putative tumour-promoting potential of
grafted proliferative cells. Such risk can reasonably be ruled out by the recent demonstration
that adult brain-derived neural stem cells are highly resilient to tumorigenesis and senescence,
much more than embryonic neuroblasts, embryonic stem cells, induced pluripotent stem cells
or any other stem cell type from adult mammalian tissues [9]. However, the use of homotypic
neural stem cell transplantation in human clinics seems ethically difficult, since it requires
initial sampling of alive brain tissue. In order to overcome this limitation, we have developed
primary neural stem cell culture from adult porcine brain. The pig is indeed the non-primate
species that is immunologically closest to human [10], which already allowed successful
protocols of xenotransplantation in human clinics using in vitro-expanded primary cell
preparations from several adult pig tissues – but not from the nervous system.
© 2013 Liard and Moyse; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 2013 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
2. General properties of neural stem cells in adult mammals
Neural stem cells are identified and isolated in primary cultures of adult nervous tissues in
the presence of epithelial growth factor (EGF) and basic fibroblast growth factor (bFGF), by
the growth of cellular masses called “neurospheres” which include the three neural lineages:
neurons, astrocytes, oligodendrocytes [1]. This primary culture is termed “neurosphere assay”
(NSA) and allows to generate and expand great numbers of proliferative neurogenic cells
through successive passages [11]. Recent methodological refinements allowed to isolate and
distinguish neural stem cells per se from downstream progenitors, i.e. proliferative cells being
committed to a single lineage although yet undifferentiated [12].
Beside  the  two  initially  recognized  and  most  active  neurogenic  structures  of  adult
mammalian brain (the subventricular zone of telencephalon and the subgranular layer of
hippocampal  dentate  gyrus),  several  topographically  restricted  regions  of  the  central
nervous system were shown to yield neurospheres in EGF-bFGF-treated primary culture
and therefore to contain neural stem cells [13,14]. Spatial frequency among tissue and in
vivo  yield of neuronal versus glial progenies are highly variable, ranging among: 95% in
hippocampus and hypothalamus, 60-70% in SVZ-olfactory bulb system, 40% in dorsal vagal
complex, 0% in spinal cord despite as high a proliferation rate as in SVZ [15]. However,
in vitro-expanded neurospheres display strikingly reproducible properties, regarding both
growth dynamics (10-12 days for the primary generation, 6-7 days for the subsequent ones)
and lineage proportions after differentiation commitment by growth factor removal: 25%
neurons, 70% astrocytes, 5% oligodendrocytes [11].
Neural stem cells generate differentiated progenies, like other types of adult stem cells,
through several intermediate stages which can now be distinguished by their respective
marker combinations – or “molecular profiles” or “transcriptomic signatures” (Figure 1). The
biological properties of neural stem cells from adult nervous tissues are reminiscent of those
characterizing neural progenitors from embryos, especially in vitro. However, accumulated
data in the past decade have revealed important differences between these two categories of
neural precursor cells, which led to consider them as distinct cell types. The differences include
indeed intrinsic molecular mechanisms of proliferation and differentiation, as well as recep‐
tivity to extracellular signals [16,17,18]. Most interestingly, neural stem cells from adults are
much less teratogenic than embryonic stem cells and foetal neural progenitors [9,19, 20,21,22].
Primary cultures of neural stem cells from the archetypical subventricular zone of rodent,
which is the most highly proliferative of endogenous neurogenic niches in mammalian brain,
could indeed be maintained over more than 70 successive in vitro generations (or “passages”
in the neurosphere assay) without any alteration of growth kinetics, self-renewal capacity and
lineage potential [9]. In vivo ectopic grafts of in vitro-expanded neurospheres never triggered
tumors in experimental rodents [9], by contrast to primary cultures of other stem cell categories
from adult mammals [19,20,21]. In the recent years, some typical stem cells have been formally
characterized in a variety of mammalian tumors, including neural ones; however, these
“cancer stem cells” are distinct lineages from intrinsic stem cells of healthy tissues and seem
to arise de novo as a consequence of DNA damage independently of tissue stem cells [23]. In
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the case of neural tissues, it must be recalled that beyond early post-natal ages (4-years in man)
brain cancers are exclusively gliomas [24,25]. This fact renders most unlikely that adult neural
cancers might derive from neural stem cells. Indeed, in a recent extensive survey of above 2000
brain metastases from 500 patients, neural stem cells were never found affected [22]. Regarding
neurological repair aims for human clinics, the specially high resilience of adult neural stem












































NeuroG2, Ascl-1, Tbr-2, Olig-2
Transcription factor combinations
as stage markers
EGF        bFGF
Figure 1. The “neuropoietic system” of adult neurogenesis. Modelized from references 15,38.
3. Neurosphere isolation from adult pig brain subventricular zone
Neural progenitors have been isolated from foetal porcine brain by several laboratories in the
last years, by using the neurosphere assay. We decided to develop isolation of adult brain-
derived neural stem cells, because of their higher safety than other available proliferative
neurogenic cell types in terms of oncogenic potential (cf above). Neural stem cells are found
only in rare and discrete structures, the best characterized and most productive of which is the
subventricular zone (SVZ) of the forebrain in rodents. We have isolated and characterized for
the first time the neural stem cells of adult pig SVZ, by transposing the “neurosphere assay”
from routine protocols of rodent studies [26].
3.1. The key to success for the “neurosphere assay”: Adequate tissue sampling
This particular primary culture is known to be hampered by two pitfalls: i) delay between in
vivo blood supply arrest (upon either sacrifice of experimental animals or tissue explantation)
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Neural progenitors have been isolated from foetal porcine brain by several laboratories in the
last years, by using the neurosphere assay. We decided to develop isolation of adult brain-
derived neural stem cells, because of their higher safety than other available proliferative
neurogenic cell types in terms of oncogenic potential (cf above). Neural stem cells are found
only in rare and discrete structures, the best characterized and most productive of which is the
subventricular zone (SVZ) of the forebrain in rodents. We have isolated and characterized for
the first time the neural stem cells of adult pig SVZ, by transposing the “neurosphere assay”
from routine protocols of rodent studies [26].
3.1. The key to success for the “neurosphere assay”: Adequate tissue sampling
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and tissue immersion into appropriate fresh survival medium like the Hank’s one or artificial
cerebrospinal fluid (see below); ii) excess of non-competent tissue around the NSC-containing
area within the microdissected sample.
In order to minimize the duration of brain tissue sampling, which is lengthened in adult pig
by the requirement of dorsal skull sawing, we performed the surgical approach of telencephalic
subventricular region in deeply anesthetized pig instead of immediately after sacrifice. A
rough 10mm-thick, transverse section of midbrain was explanted and immediately transferred
into a large Petri dish filled with fresh Hank’s medium, and the subventricular zone was then
microdissected out of this thick slice on the basis of macroscopical neuroanatomical landmarks
by reference to a detailed pig brain atlas [27]. Despite this precaution, our first neurosphere
assay attempts on adult pig SVZ failed, which was subsequently attributed to improper tissue
sampling. Indeed, the telencephalic subventricular zone is proportionally much larger in adult
pig than in adult rodents, and proliferative activity is already known as highly heterogeneous
among the whole anatomical extent of SVZ in rodent brain [28]. We performed therefore the
subregional mapping of proliferative activity within adult pig SVZ, by Ki-67 immunohisto‐
chemistry using a routine protocol [29,30]. The Ki-67 protein is indeed a phylogenetically
conserved marker which is expressed exclusively during the cell division cycle of eukaryotic
cells, but throughout all its successive phases (G1-S-G2-M); it is therefore widely used in
clinical anatomo-pathology and oncology. Proliferative cells, appearing in situ as Ki-67
immunoreactive nuclei, were almost exclusively grouped in a narrow ventral subfield of the
Nissl-stained subventricular zone, lining the ventral border of lateral ventricle of adult pig
brain (Figure 2). The major lateral territory of adult pig SVZ was almost devoid of Ki-67
labelling (Figure 2). We have confirmed the anatomical restriction of the “niche” to such a small
subfield of neuroanatomically defined SVZ, by specific labelling of the radial glia which has
been extensively characterized in rodent brain SVZ, using double vimentin-glial fibrillary
acidic protein (GFAP) immunohistochemistry [26]. In vitro culture of neural stem cells from
adult pig brain became successful when the SVZ tissue explants were microdissected accord‐
ing to the anatomical lineaments of specific Ki-67 immunoreactive labelling.
3.2. Primary neurospheres from adult pig brain as a vehicle of neural stem cells
For primary cell culture (“neurosphere assay”), a piece of SVZ tissue was microdissected from
the pig forebrain slice in low-calcium artificial cerebrospinal fluid (aCSF: 124 mM NaCl, 5 mM
KCl, 3.2 mM MgCl2, 0.1 mM CaCl2, 26 mM NaHCO3, 100 mM glucose, pH 7.38, according to
Weiss et al., 1996). As previously described [30], the tissue sample was rinsed twice with aCSF,
and digested first in 40 U cystein-EDTA-βmercaptoethanol-preactivated papain (Sigma, L’Isle
D’Abeau, France) for 10 min at 37°C, then in 250 µL undiluted TrypLETM Express solution
(heat-resistant, microbially-produced, purified trypsin-like enzyme, Gibco cat 12604-013,
Invitrogen, Cergy-Pontoise, France) for 10 min at 37°C. After the addition of 750 µL of fresh
aCSF and centrifugation for 8 min at 400g at room temperature, the cell pellet was resuspended
in 1mL culture medium (Dulbecco’s modified Eagle medium [DMEM, Sigma], B27 supplement
[Gibco Invitrogen], 200 U/mL penicillin and 200 µg/mL streptomycin [Gibco Invitrogen])
containing 20ng/mL Epidermal Growth Factor (EGF, Gibco Invitrogen) and 20 ng/mL basic













Figure 2. In situ localization of the proliferative cells of the adult pig SVZ (modified from original data of reference 26).
(A) Macroscopic aspect of Nissl-stained coronal section of adult pig forebrain. (B) Light microscopic aspect of the SVZ
region in a Nissl-stained pig brain section. (C) Ki-67 immunohistochemistry on adjacent section of the previous one,
with high magnification on the boxed area of B. Note the high density of Ki-67-positive nuclei in this area, as
reavealed by brown precipitate, which contrasts with the lateral field of SVZ devoid of Ki-67 immunoreactivity. Leg‐
end: cc: corpus callosum, Cx: cerebral cortex, lv: lateral telencephalic ventricle, S: septum pellucidum, St: striatum, SVZ:
subventricular zone.
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Fibroblast Growth Factor (bFGF, Gibco Invitrogen). The cells were dissociated gently with a
26G steel needle mounted on a disposable 1mL syringe, counted on a Malassez slide, and
seeded at various densities according to purported utilization. Optimal results were obtained
with either Corning 24-well plates or with Falcon 6-well ones. Seedings for basic cell biology
kinetics were performed at 3,000 cells per mL of culture medium (subclonal concentration).
Maximal neurosphere expansion for transplantation or molecular assays was obtained with
seeding at 30,000 cells per mL. Cultures must be monitored daily to follow the morphological
growth of the neurospheres; when their diameter reaches 150µm indeed, growth slows down
while sphere surface apparently thickens and hardens, and culture proves unable to be
expanded any more. Passage (i.e. sphere dissociation, cell resuspension and re-seeding as for
primary culture) was performed therefore when the majority of spheres was 100-120µm in
diameter.
For passage, the primary spheres were collected in sterile tubes, incubated for 45-60 min at
37°C in 250 µL undiluted TrypLETM Express solution (Gibco Invitrogen) per 6 mL culture-
derived pellet, and dissociated gently with a 26G steel syringe; dispersed cells were centri‐
fuged, resuspended in fresh proliferative medium, counted ant their dilution adjusted to be
seeded as above.
Both primary and passaged spheres were prone to two kinds of utilization:
• for neural stem cell expansion, subsequent passages were run in proliferative conditions,
i.e. in the presence of 20ng/mL EGF and 20ng/mL bFGF;
• for cell differentiation, spheres were picked with a Pasteur pipette, seeded in wells contain‐
ing poly-D-lysine (Sigma) precoated sterile coverslips and cultured in the above culture
medium (DMEM, B27, penicillin-streptomycin) in the absence of EGF and bFGF for 7-10
days.
All culture media were renewed by the replacement of 500 µL of medium per well every 2-3
days.
Stemness criteria fulfilment by adult pig SVZ-derived spheres in the presence of EGF and bFGF.
We have observed in our primary neurospheres from adult pig SVZ the properties which have
been established as the seminal criteria of neural stem cells since their pioneering discovery in
adult murine brain [1,11].
The existence of EGF/bFGF-dependent proliferative cells in the ventro-medial SVZ from adult pig
brain was demonstrated by the growth of spherical masses from dissociated pieces of this tissue
[26] which displayed similar morphology and size distribution to neurospheres obtained from
the rat SVZ [30]. Each pair of SVZ samples from 1 pig brain yielded routinely 1 million
dispersed cells for seeding, i.e. the total number of cells collected per pig SVZ was about 10
times that of mouse SVZ [11,31]. The pig SVZ spheres appeared though after a longer delay in
culture (9-12 days in vitro [DIV]) than primary neurospheres from adult rat SVZ (3-4 DIV: 30).
Each pair of SVZ from one pig generated 3000 primary spheres after 2 weeks in the present
culture conditions and at initial seeding densities of 30,000 cells per mL. These primary cells
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could be expanded linearly on this base through several passages (up to 6 with no change of
growth slope) [26].
The self-renewal capacity of primary sphere-generating cells from adult pig SVZ was established by
the obtention of novel spheres from dissociation of mature primary Spheres. Re-seeding of
dispersed neurosphere cells in the same proliferative medium after 12-14 DIV led to novel
“secondary” spheres that were morphologically similar to the primary spheres and grew
slightly faster than primary spheres. A second passage at 8-10 DIV led to tertiary spheres that
displayed similar morphology and growth rate to secondary spheres. In two independent
cultures from 2 pigs each, 5-6 subsequent passages could be performed with similar aspects
and cell number amplifications of respective generations. The second passage regularly
triggered a 3-time-magnification of total cell number, while other passage increments (I, III
and next ones) averaged 20-30% [26].
The multipotentiality and neural character of EGF/bFGF-dependent proliferative cells of adult pig
SVZ were demonstrated on mature spheres which were deprived of the 2 mitogens after having
reached proliferative maturity, by immunocytochemical detection of neuronal and neuroglial
markers in three distinct subpopulations of each sphere – according to the classical lineage test
of neurosphere assay [1,11,30]. Quantitative analysis with confocal microscopy indicated that
all neurospheres from adult pig SVZ yielded similar proportions of the three neural lineages:
25% neurons, 70% astrocytes, 5% oligodendrocytes. A discrete distribution of the three cell
lineages was also reproducibly observed inside the neurospheres, with oligodendrocytes being
buried in the core of the spheres while both astrocytes and neurons were concentrated at the
periphery [26].
3.3. Transcriptomic signature of neural stem cells in adult pig SVZ neurospheres
We have assayed the expression of phenotypic markers by RT-PCR on total RNA from
proliferative, undifferentiated SVZ neurospheres of adult pig SVZ, which were collected at the
second or third generation as described above. Pig SVZ neurospheres displayed positive
expression of RNAs encoding for:
• nestin, an intermediate filament which is systematically expressed by neural stem cells and
embryonic neural progenitors;
• the proliferation marker cyclin D1;
• the neural stem cell proteins Sox-2, Hes-1, p75NTR (the low-affinity receptor of neurotro‐
phins), Lhx2;
• the neuronal proteins βIII-tubulin, doublecortin (DCX), neuron-specific enolase (NSE),
Internexin α, Pbx1, Mash1, NeuroD1;
• the oligodendrocyte markers CNPase, Olig-2, PDGF-Rα (Figure 3).
The astrocyte marker glial fibrillary acidic protein (GFAP) has been detected on differentiated
neurospheres from adult pig SVZ by immunocytochemistry using the antibody against cow
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lineages was also reproducibly observed inside the neurospheres, with oligodendrocytes being
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3.3. Transcriptomic signature of neural stem cells in adult pig SVZ neurospheres
We have assayed the expression of phenotypic markers by RT-PCR on total RNA from
proliferative, undifferentiated SVZ neurospheres of adult pig SVZ, which were collected at the
second or third generation as described above. Pig SVZ neurospheres displayed positive
expression of RNAs encoding for:
• nestin, an intermediate filament which is systematically expressed by neural stem cells and
embryonic neural progenitors;
• the proliferation marker cyclin D1;
• the neural stem cell proteins Sox-2, Hes-1, p75NTR (the low-affinity receptor of neurotro‐
phins), Lhx2;
• the neuronal proteins βIII-tubulin, doublecortin (DCX), neuron-specific enolase (NSE),
Internexin α, Pbx1, Mash1, NeuroD1;
• the oligodendrocyte markers CNPase, Olig-2, PDGF-Rα (Figure 3).
The astrocyte marker glial fibrillary acidic protein (GFAP) has been detected on differentiated
neurospheres from adult pig SVZ by immunocytochemistry using the antibody against cow
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GFAP (cf above) but its transcript could not be detected in the proliferative neurosphere RNAs
(probably due to unknown specificity of porcine gene sequence and primers therefore).
The lack of Olig-1 transcripts is expected at this pro-differentiating stage since this gene is
expressed in the late phase of oligodendroglial lineage maturation [32,33]; it is also in keeping
with Hes-1 detection in the present proliferative spheres, since Hes-1 overexpression was
shown to correlate with Olig-1 down-regulation during differentiation [34,35].
In the persistent absence of any specific marker of either neural stem cell or neural committed
progenitors, this series of transcripts fits best with the molecular profile of neural stem/
precursor cells which has been characterized in rodents and human [36,37,38]. On these bases,
we may assume that the major cell type in our adult pig SVZ-derived neurospheres correspond
to neural multipotent progenitors, i.e. a stage of the neural lineage that is slightly more mature
than the primitive neural stem cells but equally multipotent [26]. This interpretation is
supported by additional RT-PCR data in our neurospheres: the absence of the stemness gene
transcripts CD133 and SDF-1 [39], the weakness of nucleostemin expression [40], and the lack
of detectable cyclin D2, which was demonstrated to specifically drive neural stem cells into
































































































Figure 3. Transcriptomic profile of proliferative neurospheres from adult pig SVZ (modified from original data of refer‐
ence 26). Agarose gel electrophoretic analysis of amplicons from RT-PCR on proliferative neurosphere RNA with pri‐
mers designed on the basis of human and/or pig genomic sequences. Stem cell markers: Nestin, Hes-1, Lhx-2, p75NTR,
Sox-2, Cyclin D1, Cyclin D2. Committed progenitor markers: Pbx1, βIII-tubulin, internexin-α, NeuroD, NSE, DCX,
Mash-1, CNPase, PDGFR-α. PCR products are shown beside co-electrophoresed commercial DNA ladders.
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cyclins D [41]. Cyclin D1, which was readily expressed in the present material, conversely
operates in actively dividing neural progenitors like in most of proliferating cell types in adult
organisms.
The present data can be compared with published molecular profiling of neural progenitor
cultures from the pig foetal brain [42,43] or adult retina [44,45]. Among the 13 markers that
have been addressed by RT-PCR on mRNA extracts of proliferating neurospheres, nine yielded
similar results between foetal and adult SVZ, i.e. either negativity (CD133, SDF-1) or positivity
(nestin, Sox-2, Hes-1, Pbx-1, β-III-tubulin, doublecortin, Nogo-A). Two differences were
encountered between expanded neural cells from adult and foetal brains. The first of these was
the detectable expression of cyclin D2 in foetal, but not adult, pig neurospheres. This indicates
that neural stem cell expansion is higher in foetal than in adult neurosphere cultures [42].
Furthermore, the lack of Ki-67 detection in pre-differentiation neurospheres from foetal [42],
but not adult (present data) supports the same interpretation, since primitive neural stem cells
are much less actively dividing than neural precursors at the immediately subsequent
maturation stage [46]. Interestingly, the published molecular profile of in vitro expanded
human embryonic neural stem cells (hNSC) is very close, but not identical, to those of pig
neural precursor cells. The major difference was the expression of the stemness gene CD133
in hNSCs that otherwise expressed both Ki-67 and GFAP like adult and foetal pig cells,
respectively [42].
In the future, production of neural stem/progenitor cells from the adult pig by the present
procedure can promote cell therapy improvements, first in animal models, but also in clinical
attempts to repair neural lesions in the use of adult human. By analogy with other tissues [47,
48], adult pig neural precursor cells should be feasible for transplantation into diseased
humans without immune rejection [49,50]. The present study thus provides the substratum
for an alternative source to human allografts for transplantation in neurodegenerative
disorders or injuries, which is now open to experimentation.
3.4. In vitro lineage labelling
In order to track in vivo the fate of transplanted neural stem cells and their progenies, in vitro-
expanded neurospheres must be labeled prior to transplantation with a tag which will be
retained permanently and transmitted through division without affecting survival and
differentiation of labeled cells.
The easiest and long-established tagging method for living cell tracking after transplantation,
is incubation of dividing cells with a labeled analog of DNA biosynthesis precursors: nucleo‐
tides. Two tools are available: tritiated thymidine (3H-Thy) and bromo-deoxy-uridine (BrdU),
and can be detected in situ by autoradiography and immunohistochemistry respectively. These
tags are easy to apply and detect, but they have the major inconvenient to fade across subse‐
quent rows of cell division because of the semi-replicative mechanism of DNA replication.
Practically, this nuclear labeling becomes undetectable after 2 successive divisions of initially
labeled cells.
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respectively [42].
In the future, production of neural stem/progenitor cells from the adult pig by the present
procedure can promote cell therapy improvements, first in animal models, but also in clinical
attempts to repair neural lesions in the use of adult human. By analogy with other tissues [47,
48], adult pig neural precursor cells should be feasible for transplantation into diseased
humans without immune rejection [49,50]. The present study thus provides the substratum
for an alternative source to human allografts for transplantation in neurodegenerative
disorders or injuries, which is now open to experimentation.
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In order to track in vivo the fate of transplanted neural stem cells and their progenies, in vitro-
expanded neurospheres must be labeled prior to transplantation with a tag which will be
retained permanently and transmitted through division without affecting survival and
differentiation of labeled cells.
The easiest and long-established tagging method for living cell tracking after transplantation,
is incubation of dividing cells with a labeled analog of DNA biosynthesis precursors: nucleo‐
tides. Two tools are available: tritiated thymidine (3H-Thy) and bromo-deoxy-uridine (BrdU),
and can be detected in situ by autoradiography and immunohistochemistry respectively. These
tags are easy to apply and detect, but they have the major inconvenient to fade across subse‐
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Another, more recent procedure allows true lineage-labeling without fading across successive
rows of division: it consists in applying a viral vector of the green fluorescent protein (GFP)
gene, either by in vivo stereotaxic surgery into the stem cell-containing niche [51] or in vitro on
expanded primary neurospheres [52]. In collaboration with a retrovirology laboratory (U421
INSERM, Ecole Normale Supérieure, Lyon, France), we have chosen the latter approach [53]
and used a lentiviral vector of green fluorescent protein gene (LV-GFP) which had already
been validated for human dendritic cells [54]. LV-GFP was freshly synthetized, titrated and
tested as previously described [55] stored at -80°C and unfrozen just before use. Adult pig
SVZ-derived neurospheres were initially expanded through at least 2 passages. Then, 4-5 days
after the last passage, the growing neurospheres were preincubated 30 minutes in the presence
of 1mM polybrene (Sigma) and void lentiviral particles (VLP for optimal integration yield; 55)
at 0.1 x MOI (multiplicity of infection), and further incubated 2h with fresh culture medium
containing 1mM polybrene and LV-GFP at 0.3x MOI; incubation medium was then replaced
by fresh standard culture medium. LV-GFP-infected neurospheres were allowed 3 days
culture in standard conditions for optimal lineage labeling (Figure 4).
4. Improvement of post-lesional neural outcome with primary pig
neurosphere transplantation inside a venous autograft
Cell therapy for the nervous system has encountered a major empirical obstacle: in adult
mammalian brain,  the neurogenic  potential  of  neural  stem cells  is  inhibited by intrinsic
tissue microenvironment  except  for  the  very few naturally  neurogenic  areas,  which has
been formally demonstrated by heterotopic transplantation studies [56]. To overcome this
problem, we developed a novel paradigm in order to improve post-lesion regeneration in
peripheral  nerves:  transplantation  of  in  vitro-expanded,  proliferating  neurospheres  from
adult pig subventricular zone inside a homotypic venous graft which is sutured at both
ends onto the lesioned nerve ends.
Bridging a long nerve gap with a homotypic venous graft is already used in human neurology
in order to ameliorate post-lesional recovery of peripheral nerves [57,58,59,60], but it was
barely explored for neuronal cell therapy applications. The disabilities resulting from periph‐
eral nerve lesions in adults typically display no neuron loss but pathway disruption, upon
disappearance of distal axonal segments, which was extensively documented to lead to
restricted or aberrant synaptic reconnexion of surviving neurons [61]. We postulated that
neural stem cell grafting on the lesion site might overcome this limitation, by generating chains
of interconnected neurons that would functionally replace the lost nerve substance more
efficiently than existing severed neuronal axons.
To  test  this  hypothesis,  we  attempted  transplantation  of  the  proliferating  neurospheres
from adult  pig subventricular  zone (SVZ) which we had characterized above,  inside an
autologous  venous  graft,  following  surgical  transsection  of  nervis  cruralis  with  30mm-
long gap in adult pig [53]. The following section summarizes the hallmarks of this study,
methods and results [53].
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4.1. The experimental cell therapy paradigm and its functional outcome
Our lesion model was unilateral transsection of nervis cruralis with 30 mm-long gap in adult
pig, under anesthesia. This lesion induces a major motor defect, consisting in the loss of the
right leg extension over the thigh, which can be quantified by electromyography of the crural-
innervated muscle quadriceps. Our experimental cell therapy paradigm consisted in bridging
the nerve gap immediately after damage with an autologous venous segment (sampled from
vena mammalian externalis) which was sutured at the proximal end over the perinevre of the
severed nerve, filled through the opposite end of the venous graft with freshly prepared
suspension of in vitro-expanded neurospheres from adult pig SVZ (300 µL, 1000 neurospheres)




Figure 4. Lineage labelling of neurospheres from adult pig SVZ by in vitro viral transfer of GFP gene (modelized from refer‐
ences 54, 55]. The functional structure of the lentiviral GFP vector is schematized in (A) (see 54 for more details). (B,C) Label‐
led neurospheres 3 days after in vitro infection with the lentiviral vector of GFP, as observed under a photonic microscope
with natural light (B) or green fluorescence (C). (D) In situ detection of neurosphere-derived GFP in a transplanted venous
bridge at 8 months after lesion, by fluorescent light microscopy. Legend: CMV: cytomegalovirus; gag: infection competen‐
cy coding sequence; GFP: green fluorescent protein; PPT: purine-rich element (to increase exon recognition); RRE: RNA ex‐
port responsive element; SIV: Simian immunodeficiency virus. Scale bars: 50 μm (B,C), 0.5mm (D).
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over the distal end of the severed nerve (Figure 5). Control animals did not receive neuro‐
spheres in the venous shaft before saturation. The transplanted neurospheres had been
expanded in vitro from adult pig SVZ through 2-3 passages and have been labeled in vitro with
either BrdU (for short-term post-lesional survival times) or lentivirally-transferred fluorescent
protein gene (see above, section II.4) prior to transplantation (Liard et al 2012).
B
A
Figure 5. Surgical paradigm for adult pig neural stem cell (ANSCs) transplantation inside a venous graft (modelized
from reference 53]. (A) Surgical bridging of lesioned nerve by a venous graft (below the forceps tips; the arrow points
to the distal, unsutured end of the graft). (B) Procedure schematization.
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Lesion-induced loss of leg extension on the thigh became definitive in controls (up to 8 months
after lesion) but was reversed by 90-180 days after neurosphere-filled vein grafting. Prior to
surgery, electromyograms of muscle quadriceps vast internal displayed amplitudes of 4.9 to
6.1 mV and post-stimulus latencies of 0.89 to 3.7 ms. Immediately after surgical realization of
nervis cruralis substance loss, electromyograms of muscle quadriceps were negative for all
experimental animals. Electromyography showed stimulo-detection recovery in neurosphere-
transplanted pigs which was partial at 180 days after lesion and almost complete by 240 days,
while electromyograms of controls were still negative (Liard et al 2012). Interestingly, in
neurosphere-transplanted pigs, post-stimulus latencies returned earlier to normal (i.e., at 180
days post-lesion) than electromyogram amplitude (which was fairly detectable although much
lower than on intact leg).
Therefore, transplanting in vitro purified-expanded adult neural stem cells inside a venous
neuroguide on the site of a peripheral nerve lesion promoted efficient functional recovery in
adult pig [26]. We further addressed the underlying mechanisms by post-mortem immuno‐
histochemical analysis of the bridged nerve (see below).
4.2. Exclusively neuronal fate of grafted neurosphere cells
In order to assess the fate of transplanted neurosphere cells [53], we euthanized the experimen‐
tal animals at various post-lesion intervals, sampled the experimental vein-bridged nerve
segment and processed it for immunohistochemistry (fixation by 24-hour-immersion at 4°C into
a buffered 4% paraformaldehyde solution, cryoprotection in 30% sucrose-containing phos‐
phate buffer). After snap-freezing in isopentane at -45°C, serial sagittal sections were collected
from each frozen vein-bridged nerve segment in a cryostat and processed for phenotypic marker
immunohistofluorescence. Fluorescent dyes were chosen so as to be compared with either
intrinsic green fluorescent protein (GFP) or with BrdU immunohistofluorescence, depending
on the method for neurosphere cell labeling prior to transplantation [53].
At 8 days after lesion-transplantation, BrdU-positive cells were localized inside the venous tube
as flattened spherical groups and were all immunoreactive for the specific marker of imma‐
ture migration-prone neurons: doublecortin (DCX) [53]. At longer survival delays assessed (45
to 240 days) all neurosphere-derived cells, whether labeled with BrdU or virally-transferred
GFP, expressed the specific marker of mature neurons: neuronal nuclear antigen (NeuN) or
neurofilament protein NF-68 (Figure 4; modified from ref 53). By contrast, none of labeled
neurosphere-derived cells coexpressed any of glial markers assessed: CNPase (for myelinat‐
ing glia, i.e. oligodendrocytes or Schwann cells), S-100β and GFAP (for astrocytes), at either of
post-lesional delays. Therefore adult neural stem cell-derived progenies of grafted neurospheres inside
the  venous  bridge  survived  and differentiated  into  neurons  exclusively  [53].  Moreover,  newly-
formed neurons distributed inside the venous graft along the longitudinal axis of the severed
nerve, which suggests that new neurons would have created gap-filling interconnected chains
in-between the proximal and distal ends of the severed nerve. However, such issue remains to
be investigated by using a more resolutive approach (electron microscopy).
Our finding contrasts with numerous previous attempts to improve post-lesional repair of
peripheral with putatively regenerating cell transplantation. The latter strategy, or cell therapy,
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has been attempted with primary cultures of Schwann cells [62,63], olfactory bulb enshealting
cells [64], or various types of stem cells [65]. In all these studies, progenies of grafted stem cells
mostly proved to be glial cells, which indirectly enhance axonal regeneration [65,66,67]. Since
none of these paradigms used vascular bridge for stem cell transplantation, our results suggest
that the venous wall per se stimulates neuronal differentiation of stem cell progenies. It is in
keeping with the recent demonstrations that vascular walls favor neurogenesis from adult
neural stem cells [68,69,70], which is mediated in rodent models by the vascular endothelium-
derived growth factor (VEGF) [71,72,73,74]. Our results suggest that choosing a venous trunk
versus an artificial neuroguide to bridge a nerve gap is an interesting solution because of
intrinsic property. Furthermore, all surgeons are able to take a vein trunk on superficial vein
network and this is much less expensive than neurotubes in emergency conditions.
4.3. Graft-induced activation of intrinsic Schwann cells in the lesioned nerve
At 180 and 240 days after nerve lesion and GFP-expressing neurosphere transplantation, CNPase
immunohistofluorescent labeling was much higher than in vein-bridged lesioned controls which
had not received neurosphere transplantation [53]. Both the number of CNPase-immunoreac‐
tive Schwann cell processes and their labeling intensities, as quantified by computerized image
analysis, were significantly higher in neurosphere-grafted nerves than in controls [26]. Our result
is in keeping with a previous report showing that a venous graft favored Schwann cell prolifer‐
ation after nerve lesion [75]. In our paradigm though, since controls have received a neurosphere-
devoid venous graft, our results indicated that neurosphere cells emit diffusible signals that
stimulate Schwann cells. Therefore, adult neural stem cell-derived progenies of grafted neurospheres
inside the venous bridge promoted activation of intrinsic myelinating Schwann cells. This result is in
keeping with accumulating reports demonstrating that primary neurospheres from adult brain
tissues do secrete in vitro some neurotrophic factors [76,77].
Altogether, our novel cell therapy paradigm in adult pig promotes efficient functional recovery
of a peripheral nerve after lesion with long substance loss, correlatively with genesis of new
neurons in-between the lesional gap and activation of intrinsic myelinating cells.
Similar results have been obtained in adult rat by using a similar strategy (Xu et al 2012) or
mesenchymal stem cells combined with acellular conduits (Zhao et al 2012, Jia et al 2012). From
both our and others’ studies though (as reviewed in ref 66), a pending issue remains unad‐
dressed: which is the long-term fate of ectopic graft-derived new neurons? The putative
formation of ectopic multisynaptic neuronal nets bridging the gap between the two sides of
the lesional gap, as suggested by the topographical distribution of new neurons (see above),
is made plausible by previous experimental demonstrations of synaptic connectivity between
ectopic stem cell-derived new neurons and host neural net, both in neurogenic [56] and non-
neurogenic (Lu et al 2012) adult structures of mammalian central nervous system. However,
this issue requires to be directly addressed by means of electron microscopy.
Another question arising from our results, concerns the potential long term negative effects of
grafted stem cell-derived ectopic neurons. Such transplantation might indeed result into
neuromas: either neoplastic neuromas deriving from the grafted proliferative stem cells
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(Johnson et al 2012), or non-neoplastic neuromas consisting in aberrant axonal swellings
(Rajput et al 2012).
5. Future applications of these new paradigms
The results above (sections II & III) bring about a proof-of-concept for future improvements
of neurological clinics. However, before it can be tested in human patients, our paradigm
deserves some improvements.
5.1. Alternative source of adult neural stem cells
The direct transposition of the present cell therapy strategy to human patients would raise
ethical problems, regarding either autologous sampling of patient’s subventricular zone as a
source of neurogenic neurospheres, or xenotransplantation of neurospheres from adult pig
SVZ due to currently discussed virological risks of porcine tissues [10]. A convenient alterna‐
tive can be provided by the recently discovered neurogenic stem cells of biopsied human
olfactory mucosa [84]. This tissue has been demonstrated indeed to harbor a population of
mesenchymal stem cells which displays the same neurogenic properties as original neural stem
cells after isolation and expansion in primary culture. To this aim, olfactory mucosa biopsies
are enzymatically and mechanically separated from the olfactory neuroepithelium, and the
cell suspension from the resulting tissue (olfactory chorion) is seeded in a Dulbecco’s medium
(DMEM) supplemented with F12 supplement and 10% fetal bovine serum. This primary
culture yields adherent proliferating cells that are self-renewable under passage into the same
medium. Upon seeding into serum-free DMEM supplemented with insulin, transferrin,
selenium, EGF and bFGF, olfactory chorion-derived cells grow into typical neurospheres that
exhibit the same morphology, growth kinetics and multipotentiality as neurospheres from
SVZ [3,85,86,87]. These in vitro-expanded neurogenic neurospheres were then demonstrated
to restore function and plasticity after brain lesions in adult rodents [88]. This cell preparation
would therefore represent a convenient alternative for clinical application of our cell therapy
strategy for post-lesional repair of peripheral nerves. The long-term safety of this novel cell
type should however be checked precisely in future assays, since cell therapies with mesen‐
chymal stem cells were recently documented to elicit neuromas in human patients [89].
5.2. Alternative neuroguide
Another issue in our cell therapy strategy concerns the use of autologous venous shaft as a
neuroguide. Although largely used in human clinics [57, 58], such procedure has indeed been
reported to generate inflammatory or necrotic outcomes. This risk could be avoided by using
a synthetic neuroguide which has already been shown to favor neurogenesis from transplanted
neural stem cells [59,60,90,91]. The basic neuroguide structure can be manufactured by diverse
methods: spinning mandrel technology, sheet rolling, injection-molding, freeze-drying, and
electro-spinning.
It will be interesting to study this cell enhancement with FDA- and CE-approved neuroguides
[60, 90]:
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• Nerve tubes from biodegradable and biological materials:
• type 1 collagen =Integra NeuraGen ® ; Neuro-matrix and Neurolac [91,92,93] with retro‐
spective studies [94];
• Nerve tubes from biodegradable and synthetic materials :
• polyglycolic acid PGA = NEUROTUBE® [95,96] ;
• poly-lactic-glycolic acid (PLGA) ;
• poly-L-lactide-caprolactone (PLCL) Neurolac® [97];
• polyvinyl alcohol hydrogel SaluBridge.
• Nerve guide with internal multitubular architecture, which is required for bridging long
nerve gaps. If we take this point of view, acellular nerve graft Axogen’Avance ® is prom‐
issing and obtained by cryocongelation and chimical treatment from human nerves [93,98].
The graft can be handled like an autograft, held by epineurium and bridge gaps up to 50
mm.
With synthetic neurotube, three-dimensional scaffold can be obtained by electrospinning and
progress with nanotechnologies. This approach could be optimized with extracellular matrix
(ECM) proteins or peptides (laminin-1) and neurotrophic growth factors like basic fibroblast
growth factor (bFGF), brain derived neurotrophic factor (BDNF) or nerve growth factor (NGF)
[99].
Above all maybe, the use of acellular or totally synthetic conduits for nerve gap bridging is a
priori likely to reduce the risk of post-operative neuromas. More systematic and extensive
studies are required to evaluate properly the risk over benefit probability ratios of all available
combinations. For instance, a novel cell therapy strategy which differs from ours merely by
using an acellular vein graft, was recently reported to produce only 35-75% of neural cells,
including glial and proliferative cells along with neurons [100]. The highly positive pro-repair
impact of autologous vein wall, which we have empirically demonstrated, may prove difficult
to mimic with man-controlled substitutes.
6. Conclusion
Thus, transplantation of neural stem cells from adult mammalian brain inside an autologous
venous graft provides an efficient repair strategy, in the pig model. Our study provides the
proof-of-concept for further study in human clinics. It also provides progress in basic cell
biology, since the grafted exogenous neurospheres were shown to promote nerve regeneration
through 2 distinct original mechanisms: i) indirect activation of intrinsic myelinating glial cells
(as recently reviewed in 66), and ii) genesis of new neurons aligned in-between the two ends
of the severed nerve. The latter one is totally novel in the field of post-lesional plasticity and
repair of peripheral nerves. It deserves though further analysis, by deciphering the neuro‐
transmitter phenotype of neurosphere-derived new neurons and their ultrastructural pattern
of connectivity.
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